data_1bnr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bnr _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.425 HD11 ' HB2' ' A' ' 13' ' ' TYR . 11.1 mt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -144.48 62.41 1.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.952 . . . . 0.0 109.705 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -140.0 -174.56 3.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.923 . . . . 0.0 109.323 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 98' ' ' LYS . 21.3 m-85 -77.31 -60.84 2.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.256 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -33.46 70.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.371 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.28 -48.99 60.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 6' ' ' THR . 41.6 t -68.31 -36.37 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -1.144 . . . . 0.0 109.207 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.1 -38.86 87.78 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.78 -54.79 19.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.546 -0.721 . . . . 0.0 109.118 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE1' ' CD2' ' A' ' 17' ' ' TYR . 47.9 t80 -55.39 -26.67 42.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.844 . . . . 0.0 109.218 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 1.2 mt -72.84 -60.5 2.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.428 -0.795 . . . . 0.0 109.376 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.426 ' NE2' ' OXT' ' A' ' 110' ' ' ARG . 2.9 mt-30 -70.49 -5.21 27.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.025 -1.047 . . . . 0.0 109.565 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 m -93.15 -68.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.17 -0.956 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD2' ' CE1' ' A' ' 13' ' ' TYR . 58.8 m-85 -89.63 3.96 50.95 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.644 -0.66 . . . . 0.0 109.553 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.7 m170 43.89 51.46 6.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER 177.39 130.38 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.536 -0.728 . . . . 0.0 109.117 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 17.6 mt -47.61 159.37 0.44 Allowed Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.093 -1.004 . . . . 0.0 109.131 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.58 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 4.1 Cg_exo -54.7 158.43 10.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.17 1.913 . . . . 0.0 110.454 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.21 -6.3 33.55 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.373 -0.829 . . . . 0.0 109.03 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.3 28.61 8.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.89 . . . . 0.0 109.463 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.596 ' CE1' ' CB ' ' A' ' 50' ' ' SER . 1.6 m-30 -113.59 79.03 1.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.505 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -94.26 127.96 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.906 . . . . 0.0 108.983 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 25' ' ' ILE . 44.0 p -46.66 176.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 109.992 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.24 -48.64 56.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.102 -0.999 . . . . 0.0 109.161 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -51.57 -36.42 45.3 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' HD13 ' A' ' 33' ' ' LEU . 10.1 mm-40 -60.62 -43.27 97.66 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.592 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . . . -65.21 -33.52 76.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.197 -0.94 . . . . 0.0 108.529 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' CG ' ' CE3' ' A' ' 35' ' ' TRP . 1.0 OUTLIER -66.17 -31.68 72.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.31 87.42 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.448 -0.782 . . . . 0.0 109.519 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -80.82 -7.12 59.34 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.672 -0.642 . . . . 0.0 109.878 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 45' ' ' VAL . . . 104.18 68.49 0.76 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.595 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 2.6 t90 -126.52 133.4 51.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -1.172 . . . . 0.0 109.664 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.507 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 39.3 t -89.6 132.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.595 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.448 0 O-C-N 120.876 -1.14 . . . . 0.0 110.23 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.083 0.468 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 35' ' ' TRP . 6.6 tp -57.96 -65.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.121 -0.987 . . . . 0.0 109.049 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.66 -11.13 2.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.836 -0.54 . . . . 0.0 110.228 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -78.98 -39.06 35.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.97 -1.081 . . . . 0.0 109.723 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 35' ' ' TRP . 33.3 m -96.64 -15.26 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.466 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.65 63.92 6.18 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 4.0 Cg_exo -59.59 164.87 10.55 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.191 1.927 . . . . 0.0 110.39 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.11 54.75 24.72 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.455 ' HG2' HG12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -152.26 162.98 40.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.589 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.596 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -139.04 159.75 41.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.462 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.54 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 3.7 mm -105.01 111.89 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.512 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.58 165.0 33.33 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.64 22.56 28.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.414 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 39.8 m-20 -97.28 145.44 26.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -1.141 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.3 mm -65.54 143.74 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.587 ' CE2' HD13 ' A' ' 63' ' ' LEU . 86.0 t80 . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.302 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.58 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 13.1 mttt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.243 0.544 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.587 HD13 ' CE2' ' A' ' 56' ' ' PHE . 48.5 mt -114.36 147.22 37.49 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.918 . . . . 0.0 109.161 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.608 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 2.4 Cg_endo -62.38 87.99 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.166 1.911 . . . . 0.0 110.182 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.262 0.553 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.584 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 6.7 m95 -107.64 175.4 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.434 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.652 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 1.4 mmt180 -128.47 137.84 52.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.349 -0.844 . . . . 0.0 108.785 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HA ' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -116.96 157.89 24.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.022 -1.049 . . . . 0.0 110.102 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.5 ' HB2' ' CG2' ' A' ' 88' ' ' ILE . . . -148.64 151.03 34.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -0.813 . . . . 0.0 109.129 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -73.03 131.15 41.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.697 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.495 HG22 ' CD1' ' A' ' 7' ' ' PHE . 20.5 mm -115.74 126.15 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.3 -0.875 . . . . 0.0 108.885 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER 68.6 117.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.033 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.413 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 2.5 t80 -170.44 125.21 0.73 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.136 -0.977 . . . . 0.0 109.586 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.01 -80.25 0.46 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.0 p -143.93 156.22 44.35 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.759 -0.588 . . . . 0.0 109.458 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.39 -167.9 17.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 83' ' ' ARG . 1.5 m-85 -65.34 149.67 49.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -1.187 . . . . 0.0 109.264 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.603 ' CB ' ' CZ ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -46.99 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.076 -1.015 . . . . 0.0 109.133 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.77 179.89 3.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.606 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -108.21 11.59 27.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.451 ' OD1' HG21 ' A' ' 100' ' ' THR . 63.4 m-20 -96.22 129.37 43.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.537 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.3 OUTLIER -155.68 156.09 34.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.213 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.586 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 18.9 tt -112.26 160.49 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.997 -1.064 . . . . 0.0 109.287 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 73' ' ' GLU . 3.4 mm? -130.48 103.52 6.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.652 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 34.0 p90 -99.62 140.42 33.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.813 -1.18 . . . . 0.0 108.93 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.47 176.03 5.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.164 -0.96 . . . . 0.0 110.377 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 p -65.47 -25.17 67.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.447 -0.783 . . . . 0.0 109.576 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 26.7 p-10 -89.65 17.57 6.34 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.571 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.79 26.04 7.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.659 -0.65 . . . . 0.0 110.291 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.503 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 7.0 mt -80.34 113.42 18.51 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.586 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 2.8 mt -106.82 119.88 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -1.0 . . . . 0.0 110.617 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.608 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 16.3 m-85 -122.89 117.45 25.62 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.44 147.06 24.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.981 -1.075 . . . . 0.0 110.21 -178.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -132.8 125.71 30.7 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.451 HG21 ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -108.65 29.11 7.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.728 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -150.0 20.16 0.88 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.643 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER 79.06 68.83 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.389 -0.819 . . . . 0.0 110.073 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.568 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 8.1 m-85 54.44 17.5 1.61 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 110.153 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.475 ' CB ' ' OD2' ' A' ' 101' ' ' ASP . 3.9 mm-40 -92.54 -15.85 26.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 109.093 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.501 ' N ' ' OD2' ' A' ' 101' ' ' ASP . 40.8 m -144.54 147.13 32.83 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 62' ' ' LYS . 75.5 m-85 -140.49 130.0 24.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.839 -1.163 . . . . 0.0 110.58 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 89.9 m -120.05 133.67 55.47 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.23 115.41 18.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.47 HD13 HD13 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -109.84 -83.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 109.536 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.464 ' HB2' HD11 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -140.65 53.87 1.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.469 ' O ' HD11 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -137.19 -170.58 2.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 98' ' ' LYS . 46.2 m-85 -75.18 -58.66 3.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.269 -0.895 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.442 ' OD1' ' NH2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -71.09 -31.5 67.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.808 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.75 -52.27 30.38 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 6' ' ' THR . 99.9 t -66.74 -42.79 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -1.131 . . . . 0.0 109.386 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' HB3' HD11 ' A' ' 96' ' ' ILE . . . -57.32 -38.18 73.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.454 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.9 m-20 -65.46 -55.67 16.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.563 -0.711 . . . . 0.0 109.224 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.688 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 53.7 t80 -58.55 -21.32 52.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 109.195 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -74.99 -64.28 1.08 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.394 -0.816 . . . . 0.0 109.212 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -70.43 -5.62 29.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.021 . . . . 0.0 109.45 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.458 HG23 ' CD1' ' A' ' 17' ' ' TYR . 67.9 m -93.85 -67.08 0.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 109.662 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.688 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 78.2 m-85 -89.95 3.66 52.44 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.567 -0.708 . . . . 0.0 109.533 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.47 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 25.8 m170 43.75 51.75 6.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.721 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 7.8 ptmt 175.89 129.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.461 -0.774 . . . . 0.0 109.168 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 14.7 mt -44.04 161.06 0.22 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.139 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.5 Cg_exo -53.51 159.91 5.81 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.124 1.883 . . . . 0.0 110.403 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.75 -3.31 24.48 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.348 -0.845 . . . . 0.0 109.147 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -117.47 34.67 5.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.95 . . . . 0.0 109.61 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.615 ' CE1' ' CB ' ' A' ' 50' ' ' SER . 1.5 m-30 -115.34 90.83 3.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.544 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.2 pt -97.27 124.09 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.925 . . . . 0.0 109.14 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 25' ' ' ILE . 12.2 p -45.44 172.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 109.637 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.575 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.86 -42.36 73.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 109.087 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 t -53.98 -37.24 63.76 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.509 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -59.78 -44.28 93.99 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 42' ' ' LEU . . . -61.49 -39.79 92.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.251 -0.906 . . . . 0.0 108.59 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.557 ' CG ' ' CE3' ' A' ' 35' ' ' TRP . 34.0 mt-30 -61.36 -34.86 76.0 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.27 -33.77 74.08 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.442 -0.786 . . . . 0.0 109.38 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.12 -13.74 58.39 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.653 -0.654 . . . . 0.0 109.997 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.462 ' O ' HG12 ' A' ' 45' ' ' VAL . . . 111.74 46.06 0.8 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.606 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 2.9 t90 -106.8 133.13 51.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -1.191 . . . . 0.0 109.725 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.523 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 9.1 p -89.57 134.55 28.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.473 0 O-C-N 120.898 -1.126 . . . . 0.0 110.618 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.505 ' OD1' ' CG1' ' A' ' 36' ' ' VAL . 3.2 p-10 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.136 0.493 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.579 HD11 ' CD1' ' A' ' 35' ' ' TRP . 8.1 tp -60.34 -64.65 0.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.962 -1.087 . . . . 0.0 109.191 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.12 -10.05 5.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.735 -0.603 . . . . 0.0 110.158 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 41' ' ' ASN . 27.6 t70 -79.1 -28.66 43.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.018 -1.051 . . . . 0.0 109.6 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 34' ' ' GLY . 4.4 m -110.04 -13.87 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.67 68.11 12.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.65 155.74 51.87 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.206 1.938 . . . . 0.0 110.251 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.03 54.67 24.86 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.41 ' HG2' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -153.88 120.1 5.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -1.131 . . . . 0.0 109.469 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.615 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -91.53 166.11 13.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.593 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.544 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 2.3 mm -112.13 107.78 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 0.0 109.667 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.94 156.35 27.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.425 ' CA ' HD13 ' A' ' 20' ' ' LEU . . . 104.92 32.74 3.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.469 ' OD2' ' CD ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -109.65 155.05 21.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -1.202 . . . . 0.0 109.403 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.0 mm -70.65 151.06 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.565 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.597 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 70.7 t80 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 3.4 mptm? . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.355 0.598 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.597 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 11.2 mt -99.0 146.22 31.31 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.338 -0.851 . . . . 0.0 109.215 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.473 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 4.0 Cg_exo -60.93 104.19 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.156 1.904 . . . . 0.0 110.323 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 71' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.291 0.567 . . . . 0.0 109.563 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.591 ' CZ2' ' HB3' ' A' ' 63' ' ' LEU . 18.9 m95 -149.22 171.03 17.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.61 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 93.4 mtt180 -131.99 151.92 51.45 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -126.72 152.47 46.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.992 -1.067 . . . . 0.0 110.469 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.06 151.5 35.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.754 . . . . 0.0 108.992 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -73.43 137.93 44.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.993 -1.067 . . . . 0.0 109.789 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.493 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 21.8 mm -116.99 112.15 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 108.89 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.2 t-20 74.02 123.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.15 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 6.7 t80 -170.41 119.19 0.56 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.262 -0.899 . . . . 0.0 109.439 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.3 -43.9 2.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.124 -0.985 . . . . 0.0 109.561 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 173.63 169.1 0.18 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.613 -0.679 . . . . 0.0 109.444 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.96 -161.7 21.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -70.43 143.76 51.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -1.108 . . . . 0.0 109.685 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.515 ' NH2' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -40.73 142.13 0.49 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER -87.79 -176.45 5.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.181 -0.949 . . . . 0.0 109.752 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.92 3.89 19.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.801 . . . . 0.0 109.558 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.509 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 8.1 m-20 -89.68 128.93 36.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.107 -0.995 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.532 ' O ' ' CG2' ' A' ' 99' ' ' THR . 83.7 mtt180 -159.05 161.77 36.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.521 ' CD1' HG23 ' A' ' 96' ' ' ILE . 1.3 tt -122.93 153.06 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.13 -0.981 . . . . 0.0 109.672 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.466 HD11 ' O ' ' A' ' 72' ' ' ARG . 3.8 mm? -118.88 120.65 37.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.565 -0.709 . . . . 0.0 109.217 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.603 ' CD2' ' HB2' ' A' ' 72' ' ' ARG . 1.7 p90 -113.91 138.36 50.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.851 -1.156 . . . . 0.0 109.011 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.455 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -107.67 172.87 6.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 110.295 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.5 p -66.41 -22.57 66.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.319 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 30.8 p-10 -89.59 16.4 7.84 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.561 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.65 30.39 6.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.755 -0.59 . . . . 0.0 110.316 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.552 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 7.4 mt -83.59 117.72 23.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 88' ' ' ILE . 2.5 mt -114.84 109.43 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.096 -1.003 . . . . 0.0 110.615 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.525 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 21.5 m-85 -112.93 120.75 42.49 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -88.81 152.19 21.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.903 -1.123 . . . . 0.0 110.359 -178.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -136.38 123.83 22.1 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.69 29.22 7.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.82 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -150.11 20.71 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.042 -1.036 . . . . 0.0 109.889 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 48.7 t-80 79.52 70.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.46 -0.775 . . . . 0.0 109.877 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.411 ' OH ' ' OE1' ' A' ' 73' ' ' GLU . 40.6 m-85 49.43 20.91 0.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 110.155 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.451 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . 2.7 mt-30 -91.88 -14.47 29.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 0.0 109.022 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.522 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 97.6 m -144.55 157.14 44.36 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 92.3 m-85 -146.84 121.64 9.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.894 -1.129 . . . . 0.0 110.242 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -115.13 130.4 56.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 109.018 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.67 113.67 16.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.049 -1.032 . . . . 0.0 109.411 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.427 ' O ' ' CG ' ' A' ' 110' ' ' ARG . 2.4 pt -111.28 -25.65 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.642 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.52 ' HB2' ' CD1' ' A' ' 96' ' ' ILE . 1.3 mtt-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.56 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.414 HG23 ' HG3' ' A' ' 21' ' ' PRO . 3.6 mt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -128.09 40.93 3.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -133.39 -175.17 3.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.627 ' CD1' ' CB ' ' A' ' 98' ' ' LYS . 31.6 m-85 -78.94 -47.91 15.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.34 -40.38 70.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.904 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.33 -51.79 35.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' A' ' 6' ' ' THR . 41.2 t -63.29 -43.99 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.16 -1.2 . . . . 0.0 109.15 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HB2' ' NH2' ' A' ' 110' ' ' ARG . . . -56.61 -39.35 73.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.442 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.1 OUTLIER -61.9 -55.64 27.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.594 -0.692 . . . . 0.0 109.154 179.322 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.679 ' CE1' ' CD2' ' A' ' 17' ' ' TYR . 12.6 t80 -57.6 -23.74 52.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.296 -0.877 . . . . 0.0 109.242 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 2.2 mt -71.45 -63.51 1.1 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.391 -0.818 . . . . 0.0 109.11 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -71.05 -4.99 27.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 109.414 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.551 HG23 ' CD2' ' A' ' 17' ' ' TYR . 48.4 m -91.2 -70.13 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.829 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.679 ' CD2' ' CE1' ' A' ' 13' ' ' TYR . 96.8 m-85 -89.91 -4.2 57.65 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.652 -0.655 . . . . 0.0 109.583 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.3 m170 57.04 51.74 10.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.671 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 172.34 129.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.565 -0.709 . . . . 0.0 109.101 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 74' ' ' ALA . 21.1 mt -45.47 148.52 1.19 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.207 -0.933 . . . . 0.0 108.995 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.578 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.1 Cg_exo -53.12 160.36 4.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.112 1.875 . . . . 0.0 110.474 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.61 -8.27 33.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.353 -0.842 . . . . 0.0 109.14 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 39.5 p30 -95.2 21.97 7.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.509 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.578 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.2 m-85 -114.77 84.14 2.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.761 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.8 pp -96.62 126.18 49.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 25' ' ' ILE . 16.9 p -46.9 174.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.51 -43.75 69.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.076 -1.015 . . . . 0.0 109.042 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.17 -38.99 69.03 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.524 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 10.5 mm-40 -58.51 -39.25 79.57 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.55 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . . . -68.21 -36.61 79.81 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.522 ' HG3' ' CE3' ' A' ' 35' ' ' TRP . 25.5 mt-30 -60.74 -34.73 74.87 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.96 -34.86 70.39 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.28 -18.69 45.0 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.52 0.676 . . . . 0.0 110.002 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.04 38.56 0.95 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.6 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 10.9 t90 -100.85 121.86 42.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -1.156 . . . . 0.0 109.133 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.515 ' CG1' ' OD1' ' A' ' 41' ' ' ASN . 10.6 p -89.94 113.11 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.285 -0.884 . . . . 0.0 108.962 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.575 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.724 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.515 ' OD1' ' CG1' ' A' ' 36' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' ASP . 12.2 tp -54.35 -63.37 1.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.318 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -42.0 -25.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.436 -0.79 . . . . 0.0 110.147 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -79.89 -44.42 20.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.013 -1.054 . . . . 0.0 110.639 -179.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 35' ' ' TRP . 33.6 m -94.72 -52.15 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.879 -1.138 . . . . 0.0 110.556 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -119.92 74.59 19.88 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.886 -1.134 . . . . 0.0 109.918 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.9 Cg_endo -63.06 166.09 15.23 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.165 1.91 . . . . 0.0 110.263 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.455 ' O ' ' HD2' ' A' ' 49' ' ' LYS . . . 43.38 59.24 3.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -139.03 162.56 34.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 0.0 109.438 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 4.3 m -129.33 133.66 47.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.865 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.548 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 6.5 mm -96.41 107.56 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.058 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.6 171.2 33.61 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.46 71.25 1.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 10.2 m-20 -159.66 165.42 32.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -1.105 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.446 ' CD1' HG22 ' A' ' 70' ' ' THR . 23.7 mm -69.27 149.73 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.312 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 45.9 t80 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 2.0 mmmt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.389 0.614 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.626 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 61.0 mt -122.25 148.66 52.76 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.416 -0.803 . . . . 0.0 108.933 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.554 ' HD2' ' CZ2' ' A' ' 71' ' ' TRP . 2.7 Cg_endo -60.61 96.45 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.111 1.874 . . . . 0.0 110.037 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.84 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.446 HG22 ' CD1' ' A' ' 55' ' ' ILE . 19.9 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.581 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 32.9 m95 -89.05 146.57 24.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.975 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.59 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 4.1 mtm180 -120.58 140.08 52.03 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -107.62 161.78 14.56 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.004 -1.06 . . . . 0.0 110.551 -178.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.49 ' HB1' ' CG2' ' A' ' 88' ' ' ILE . . . -145.93 148.16 32.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.515 -0.74 . . . . 0.0 109.183 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.462 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 1.3 m-20 -72.55 141.39 48.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.42 -0.8 . . . . 0.0 109.543 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.582 HG13 ' CE1' ' A' ' 7' ' ' PHE . 20.3 mm -135.78 137.46 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 71.62 38.72 0.95 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.479 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -69.62 136.93 51.81 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.327 -0.858 . . . . 0.0 109.576 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -129.64 -80.26 0.56 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.0 109.384 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.3 m -168.15 -178.06 3.53 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.697 -0.627 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 62.9 -155.56 41.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 81' ' ' GLY . 3.3 m-85 -49.45 175.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -1.171 . . . . 0.0 109.57 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -60.62 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.392 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.86 -172.78 2.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.21 1.83 13.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.501 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 5.2 m-20 -109.06 131.37 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.981 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.1 OUTLIER -148.88 139.71 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.234 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.576 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 12.5 tt -99.57 142.82 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.047 -1.033 . . . . 0.0 109.587 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.578 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.5 mm? -115.2 114.48 25.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.368 -0.833 . . . . 0.0 109.469 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.59 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 5.0 p90 -108.72 138.5 44.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.823 -1.173 . . . . 0.0 108.739 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.565 ' HB3' ' CD2' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -111.49 177.27 4.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.904 -1.122 . . . . 0.0 110.761 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 p -65.84 -21.18 66.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.564 -0.71 . . . . 0.0 110.387 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.486 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 10.3 p-10 -89.01 13.43 12.92 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.181 -0.949 . . . . 0.0 108.95 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.562 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.6 OUTLIER 68.17 26.59 7.04 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.665 -0.647 . . . . 0.0 111.003 178.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.518 ' CD1' ' HG2' ' A' ' 64' ' ' PRO . 8.4 mt -87.67 130.37 34.82 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.576 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 9.5 mt -120.72 108.88 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 110.391 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 108' ' ' LYS . 15.1 m-85 -107.43 112.34 25.09 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.627 ' CB ' ' CD1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -88.96 133.5 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.033 -1.042 . . . . 0.0 109.772 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -116.07 122.68 45.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 108.971 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.5 p -104.96 26.83 8.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.357 -0.84 . . . . 0.0 109.822 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 22.2 p30 -149.72 25.98 0.84 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.088 -1.007 . . . . 0.0 109.624 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 12.2 t-80 76.14 74.16 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.462 ' OH ' ' NE ' ' A' ' 87' ' ' ARG . 3.7 m-85 42.15 29.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.743 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER -99.64 -19.32 16.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 105' ' ' THR . 13.1 t -147.73 106.88 3.86 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 71.8 m-85 -93.04 125.39 37.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.127 -0.983 . . . . 0.0 110.387 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 2.6 m -112.93 125.93 54.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.401 -0.812 . . . . 0.0 108.949 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.499 ' HB2' ' CE1' ' A' ' 97' ' ' TYR . 8.9 ttmt -78.96 113.53 17.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.015 -1.053 . . . . 0.0 109.649 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.464 HD12 ' HG2' ' A' ' 98' ' ' LYS . 3.5 pt -116.05 -4.36 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.584 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.522 ' HB2' ' CG1' ' A' ' 96' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.441 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -139.59 57.82 1.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 10' ' ' VAL . 79.2 p -142.58 -177.56 5.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.34 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 100' ' ' THR . 34.2 m-85 -75.64 -57.22 4.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.93 -37.35 72.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.924 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.0 -50.76 56.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 6' ' ' THR . 84.9 t -64.21 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.445 ' HB2' HD11 ' A' ' 96' ' ' ILE . . . -59.05 -36.51 75.15 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -55.54 15.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.513 -0.742 . . . . 0.0 109.039 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.677 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 42.7 t80 -60.2 -19.59 54.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 109.226 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.524 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 0.9 OUTLIER -76.62 -63.26 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.379 -0.826 . . . . 0.0 109.492 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 24.8 pt20 -70.53 -8.63 52.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.049 -1.032 . . . . 0.0 109.515 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.9 m -93.43 -62.43 1.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 109.782 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.677 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 30.3 m-85 -89.47 2.03 55.09 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.671 -0.643 . . . . 0.0 109.57 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.446 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 16.7 m170 42.99 46.97 4.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.297 -0.877 . . . . 0.0 109.669 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 5.1 pttt 177.73 129.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.485 -0.76 . . . . 0.0 109.147 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 18.4 mt -44.6 160.66 0.23 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.165 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.7 Cg_exo -53.52 158.86 7.15 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.038 1.825 . . . . 0.0 110.374 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -72.37 -3.86 26.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.165 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.66 7.84 28.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.614 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.598 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 1.6 m-30 -92.05 77.18 5.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.8 pt -89.58 129.17 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.031 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 25' ' ' ILE . 28.6 p -44.29 169.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.0 109.447 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -67.62 -47.09 70.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.093 -1.005 . . . . 0.0 109.109 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -53.81 -37.13 63.22 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.475 ' O ' HD13 ' A' ' 33' ' ' LEU . 1.2 mt-10 -59.03 -40.9 86.42 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.583 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . . . -66.99 -35.34 79.73 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.589 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 2.7 mm-40 -62.42 -34.07 76.03 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.37 -36.92 83.76 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.7 mp -81.01 -5.57 57.75 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.73 -0.606 . . . . 0.0 110.255 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . 105.94 62.39 0.62 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.589 ' CE3' ' HG2' ' A' ' 31' ' ' GLN . 10.7 t90 -131.54 118.92 20.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -1.156 . . . . 0.0 109.046 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.2 t -90.86 110.16 21.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.184 -0.948 . . . . 0.0 108.872 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.55 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.273 -0.892 . . . . 0.0 109.63 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.466 ' C ' ' ND2' ' A' ' 41' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.166 0.508 . . . . 0.0 109.844 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 35' ' ' TRP . 11.0 tp -52.53 -66.86 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.118 -0.989 . . . . 0.0 109.214 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.37 -14.87 3.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.482 -0.761 . . . . 0.0 109.932 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -79.46 -33.98 41.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.989 . . . . 0.0 110.017 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -100.12 -53.7 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.158 -0.964 . . . . 0.0 109.648 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -113.81 80.13 4.96 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.485 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 1.8 Cg_endo -62.88 164.79 17.97 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.227 1.951 . . . . 0.0 110.466 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 42.41 50.65 5.57 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 5.0 mmtp -145.78 103.71 3.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -1.15 . . . . 0.0 109.509 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.538 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 2.0 m -89.89 159.22 17.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.545 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 2.3 mm -99.63 134.7 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.51 149.39 11.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.11 27.69 4.98 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -96.33 145.33 25.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -1.185 . . . . 0.0 109.471 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.8 mm -65.68 145.03 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.567 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.618 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 71.6 t80 . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 0.0 109.186 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 106' ' ' PHE . 6.1 mmtt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.618 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 57.5 mt -91.1 146.8 34.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.514 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 2.1 Cg_endo -62.17 155.67 54.97 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.096 1.864 . . . . 0.0 110.22 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.585 ' CE3' HD12 ' A' ' 63' ' ' LEU . 5.4 m95 -129.2 173.31 10.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.595 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -122.24 143.37 49.64 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.539 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -126.56 151.04 48.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.86 -1.15 . . . . 0.0 110.408 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.471 ' HB3' ' OH ' ' A' ' 90' ' ' TYR . . . -143.16 148.84 37.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.801 . . . . 0.0 109.196 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.464 ' OD2' ' HB ' ' A' ' 51' ' ' ILE . 0.9 OUTLIER -76.2 132.59 40.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 76' ' ' ILE . 19.4 mm -110.83 134.54 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 7.2 m-20 64.13 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.912 . . . . 0.0 109.457 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 46.2 t80 -170.59 129.82 0.84 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.275 -0.891 . . . . 0.0 109.493 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.0 -80.04 0.62 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.349 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.88 165.53 35.92 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.715 -0.616 . . . . 0.0 109.421 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.38 -151.56 19.94 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.76 -172.29 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -1.098 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.461 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -72.56 -152.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.06 -177.68 5.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.376 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -116.48 15.86 15.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.584 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 14.6 m-20 -111.59 130.63 55.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.532 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -154.18 152.31 30.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 109.424 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.58 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 4.0 tt -113.31 138.32 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.272 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.3 mm? -109.8 116.14 31.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.35 -0.843 . . . . 0.0 109.869 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.595 ' CD2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -104.78 143.1 33.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.829 -1.169 . . . . 0.0 108.922 178.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.448 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -106.58 172.58 6.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.177 -0.952 . . . . 0.0 110.316 -179.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 94.7 p -64.67 -24.92 67.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.844 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 36.8 p-10 -89.73 18.93 5.05 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.423 -0.798 . . . . 0.0 108.926 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.575 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.62 28.12 7.51 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.689 -0.632 . . . . 0.0 110.286 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.47 ' HG ' ' OD2' ' A' ' 93' ' ' ASP . 9.0 mt -79.87 106.71 12.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.58 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 1.6 mt -104.41 111.66 34.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.101 -1.0 . . . . 0.0 110.823 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.514 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 20.4 m-85 -111.61 154.9 24.18 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.463 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -122.69 141.54 51.66 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.771 -1.205 . . . . 0.0 109.489 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -129.68 120.1 24.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.207 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.539 HG21 ' CE2' ' A' ' 7' ' ' PHE . 44.2 p -104.72 28.54 6.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.44 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -148.12 22.71 1.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 109.481 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 30.1 t-80 77.15 79.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.357 -0.839 . . . . 0.0 109.631 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 11.6 m-85 44.53 53.51 7.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.627 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.449 ' HB2' ' HB2' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -120.43 -80.81 0.63 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.0 109.215 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.0 p -89.93 105.36 17.76 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 103' ' ' TYR . 79.6 m-85 -96.28 125.63 40.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.882 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.463 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 56.3 m -111.83 136.4 51.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.432 -0.792 . . . . 0.0 108.956 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -80.06 125.77 30.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.529 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.5 pt -129.96 12.19 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.495 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -138.19 41.71 2.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.247 -0.908 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.524 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 11.7 p -128.46 -168.09 1.86 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 98' ' ' LYS . 58.2 m-85 -77.44 -51.99 9.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.53 -40.71 69.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.838 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.34 -51.27 38.75 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 6' ' ' THR . 58.8 t -64.13 -43.23 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -1.151 . . . . 0.0 109.32 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -56.98 -40.18 76.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.461 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -62.07 -55.32 30.2 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.532 -0.73 . . . . 0.0 109.3 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.49 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 26.2 t80 -57.69 -24.62 57.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.401 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.5 mt -71.55 -62.55 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.038 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -70.93 -5.5 31.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.119 -0.988 . . . . 0.0 109.428 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.505 HG23 ' CD2' ' A' ' 17' ' ' TYR . 54.1 m -91.49 -69.9 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.943 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CD2' HG23 ' A' ' 16' ' ' THR . 96.6 m-85 -89.7 -5.98 56.53 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.631 -0.668 . . . . 0.0 109.63 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 23.3 m170 58.15 58.06 3.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -0.85 . . . . 0.0 109.769 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER 163.99 129.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 53' ' ' GLY . 19.9 mt -45.69 147.14 1.63 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.123 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.576 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.3 Cg_exo -53.06 163.24 2.26 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.2 1.934 . . . . 0.0 110.733 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.07 -7.34 34.92 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 109.144 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -92.29 7.2 43.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.473 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.576 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 3.5 m-85 -103.34 83.56 2.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.199 -0.938 . . . . 0.0 109.75 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.1 pt -95.62 126.73 48.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 25' ' ' ILE . 28.0 p -47.95 176.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.087 -1.008 . . . . 0.0 109.607 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.585 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.43 -46.36 64.05 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.381 -0.927 . . . . 0.0 109.162 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.17 -36.63 61.11 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.518 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 1.3 mm-40 -60.42 -41.13 93.33 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -67.75 -33.14 74.27 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -62.12 -37.59 85.7 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.66 -35.75 68.75 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.461 -0.774 . . . . 0.0 109.586 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.518 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -81.16 -19.37 43.57 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.652 -0.655 . . . . 0.0 110.357 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.2 45.42 0.49 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.592 ' CD1' HD11 ' A' ' 42' ' ' LEU . 15.6 t90 -110.55 120.74 43.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -1.131 . . . . 0.0 109.272 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.41 110.73 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.347 -0.846 . . . . 0.0 109.098 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.57 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.609 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 41' ' ' ASN . 1.2 p-10 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.592 HD11 ' CD1' ' A' ' 35' ' ' TRP . 9.1 tp -60.54 -50.86 71.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 0.0 109.258 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -62.8 -10.75 14.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 0.0 109.674 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 41' ' ' ASN . 9.8 t0 -92.95 -33.99 13.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 110.161 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 35' ' ' TRP . 34.0 m -110.72 -50.44 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.998 -1.064 . . . . 0.0 110.125 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' N ' HG22 ' A' ' 45' ' ' VAL . . . -124.42 70.74 55.35 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.969 -1.082 . . . . 0.0 109.829 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.7 Cg_endo -63.29 -179.76 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.168 1.912 . . . . 0.0 110.242 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 40.75 55.99 3.17 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 17.3 mmtt -141.17 160.09 40.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -1.112 . . . . 0.0 109.637 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.569 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 67.0 m -127.64 138.55 52.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.468 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.532 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 10.4 mm -102.17 105.3 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 108.967 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -160.3 179.47 35.8 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.47 ' N ' HD13 ' A' ' 20' ' ' LEU . . . 91.81 -4.55 78.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.53 ' OD1' ' CG ' ' A' ' 73' ' ' GLU . 7.5 p30 -93.57 163.17 13.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -1.123 . . . . 0.0 109.348 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.48 ' CG2' HG23 ' A' ' 70' ' ' THR . 22.4 mt -59.58 159.42 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.516 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.625 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 6.4 t80 . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.859 . . . . 0.0 109.332 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 5.8 mmtm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.321 0.582 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.625 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 42.8 mt -94.68 143.88 26.96 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.0 109.04 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.505 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 1.8 Cg_endo -62.89 84.09 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.001 1.8 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.48 HG23 ' CG2' ' A' ' 55' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.588 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 5.7 m95 -131.82 169.3 16.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.646 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 21.2 mmt180 -120.74 136.64 54.82 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.354 -0.841 . . . . 0.0 108.78 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.585 ' CB ' ' CD1' ' A' ' 89' ' ' LEU . 17.1 pt-20 -118.94 162.13 19.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.985 . . . . 0.0 110.386 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.46 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -152.85 147.84 26.48 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -71.51 140.8 50.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.618 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.488 HG22 ' CD1' ' A' ' 7' ' ' PHE . 25.4 mm -134.16 130.82 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.1 m-20 73.27 37.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.464 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.451 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 23.3 t80 -69.47 136.82 52.01 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.282 -0.886 . . . . 0.0 109.609 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.34 -79.66 0.38 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.246 -0.909 . . . . 0.0 109.377 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.76 175.71 4.45 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.67 -0.643 . . . . 0.0 109.405 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 72.64 73.74 0.83 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 81' ' ' GLY . 3.6 m-85 56.35 164.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -1.134 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -49.11 171.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.43 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -108.08 -173.83 2.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 109.246 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.32 -8.54 20.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 109.744 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.5 m-20 -91.33 128.66 37.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.599 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.528 ' CZ ' ' OH ' ' A' ' 103' ' ' TYR . 5.4 mtt180 -158.15 150.66 22.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 109.242 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.467 ' HB ' HG13 ' A' ' 76' ' ' ILE . 4.6 tt -108.68 149.81 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.949 -1.094 . . . . 0.0 109.937 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.585 ' CD1' ' CB ' ' A' ' 73' ' ' GLU . 3.5 mm? -122.33 106.99 11.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.437 -0.789 . . . . 0.0 109.462 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.646 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 22.3 p90 -101.91 140.79 35.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.89 -1.131 . . . . 0.0 109.082 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.506 ' HB2' ' CH2' ' A' ' 71' ' ' TRP . 5.3 t -105.98 174.19 5.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.267 -0.896 . . . . 0.0 110.292 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 p -66.07 -21.79 66.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.579 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.481 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 25.0 p-10 -89.56 16.02 8.45 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.441 -0.787 . . . . 0.0 108.898 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.577 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.1 m95 67.26 29.76 7.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.689 -0.632 . . . . 0.0 110.774 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.481 ' HG ' ' OD2' ' A' ' 93' ' ' ASP . 10.0 mt -87.3 118.01 26.45 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 110' ' ' ARG . 3.3 mt -109.33 113.52 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.505 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 16.7 m-85 -113.01 113.12 25.02 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.27 131.64 35.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.045 -1.034 . . . . 0.0 109.977 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 1.1 t -115.56 123.81 49.43 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.501 -0.749 . . . . 0.0 108.995 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.481 HG21 ' CE2' ' A' ' 7' ' ' PHE . 4.4 p -108.95 30.48 6.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.793 . . . . 0.0 109.395 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 17.6 p-10 -150.0 19.16 0.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.389 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 2.2 t-80 79.46 68.51 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.43 -0.794 . . . . 0.0 109.509 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.528 ' OH ' ' CZ ' ' A' ' 87' ' ' ARG . 10.0 m-85 49.41 22.62 0.73 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.652 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.67 -18.14 21.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 99' ' ' THR . 23.1 m -150.18 108.51 3.78 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 86.2 m-85 -95.25 128.73 42.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.165 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 8.2 m -114.17 128.16 56.24 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.385 -0.822 . . . . 0.0 108.836 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -79.11 121.05 24.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 110' ' ' ARG . 2.1 pt -117.45 -39.06 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.5 ' HB2' ' CD1' ' A' ' 96' ' ' ILE . 3.8 mtt-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.503 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.507 HG21 HD11 ' A' ' 4' ' ' ILE . 15.0 mm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -129.9 52.87 1.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.465 ' O ' HD11 ' A' ' 76' ' ' ILE . 8.8 p -145.6 178.07 8.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.553 ' CG ' HG22 ' A' ' 76' ' ' ILE . 24.3 m-85 -74.56 -53.0 10.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.04 -35.39 71.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 0.0 109.966 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.25 -51.58 31.99 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' A' ' 6' ' ' THR . 21.7 t -67.46 -38.29 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -1.168 . . . . 0.0 109.414 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -61.04 -39.1 88.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.3 OUTLIER -64.42 -55.15 22.89 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.578 -0.701 . . . . 0.0 109.134 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 27.3 t80 -60.48 -21.36 62.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.173 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.1 mt -73.02 -63.46 1.17 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.776 . . . . 0.0 109.242 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -70.94 -8.69 54.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.039 . . . . 0.0 109.403 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.536 HG23 ' CD2' ' A' ' 17' ' ' TYR . 52.9 m -88.98 -67.71 0.82 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 110.032 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 89.5 m-85 -89.44 -2.74 58.49 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.569 -0.707 . . . . 0.0 109.538 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.49 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 17.2 m170 53.47 53.72 11.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.375 -0.828 . . . . 0.0 109.762 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER 166.72 129.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 19' ' ' LYS . 65.1 mt -44.05 147.48 0.92 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.219 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.578 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 7.8 Cg_exo -53.02 162.89 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.247 1.965 . . . . 0.0 110.516 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -69.33 -6.68 31.2 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.326 -0.859 . . . . 0.0 109.01 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -93.73 7.22 45.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 109.483 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.578 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 2.0 m-85 -97.18 99.79 11.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.104 -0.997 . . . . 0.0 109.555 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 25' ' ' ILE . 1.1 pt -107.82 118.61 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 108.986 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 25' ' ' ILE . 21.5 p -45.52 170.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 109.37 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.584 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -65.56 -45.29 83.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.095 -1.003 . . . . 0.0 109.088 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -54.36 -39.5 67.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.081 -1.012 . . . . 0.0 108.299 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 33' ' ' LEU . 21.1 mt-10 -59.38 -39.97 85.03 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.573 ' HB1' ' CE3' ' A' ' 35' ' ' TRP . . . -67.18 -34.52 77.71 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.206 -0.934 . . . . 0.0 108.643 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -63.98 -35.29 80.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.38 -34.77 72.83 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.37 -0.831 . . . . 0.0 109.265 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.3 -15.83 54.29 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.424 0.631 . . . . 0.0 110.276 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.463 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 110.8 36.6 1.84 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.59 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 4.9 t90 -101.69 123.31 45.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.181 -1.188 . . . . 0.0 109.135 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.41 119.18 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 108.776 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.59 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.426 0 O-C-N 121.194 -0.941 . . . . 0.0 109.795 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.433 ' OD1' ' HA ' ' A' ' 35' ' ' TRP . 47.3 p-10 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.16 0.505 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.575 HD11 ' CD1' ' A' ' 35' ' ' TRP . 8.5 tp -66.32 -52.02 51.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.307 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -55.21 -16.62 3.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.751 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -87.21 -52.96 5.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 110.289 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 34' ' ' GLY . 21.7 m -94.68 -47.7 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.044 -1.035 . . . . 0.0 110.316 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB2' ' HG3' ' A' ' 49' ' ' LYS . . . -115.78 78.6 7.18 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 109.776 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -63.19 154.32 68.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.188 1.925 . . . . 0.0 110.191 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 43.1 63.68 1.96 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 46' ' ' ALA . 6.8 mmtm -134.63 117.19 15.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -1.166 . . . . 0.0 109.405 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.1 m -90.01 128.05 36.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.869 . . . . 0.0 109.622 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.536 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 6.5 mm -91.21 105.9 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.144 -0.973 . . . . 0.0 108.999 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.27 169.46 32.11 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.32 36.53 4.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -128.02 170.71 12.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.178 . . . . 0.0 109.31 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.4 mm -70.23 150.34 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.641 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 13.5 t80 . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.141 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.581 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.266 0.555 . . . . 0.0 109.523 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.641 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 64.3 mt -115.02 153.67 47.12 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.102 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.536 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 2.7 Cg_endo -61.57 86.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.2 1.933 . . . . 0.0 110.155 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.584 ' CE3' HD12 ' A' ' 63' ' ' LEU . 10.3 m95 -112.23 157.62 20.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.689 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.647 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 12.0 mmt180 -115.38 140.85 48.76 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 108.667 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.522 ' CB ' ' CD1' ' A' ' 89' ' ' LEU . 2.3 pp20? -115.67 156.16 26.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 110.167 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -142.81 150.37 39.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 0.0 109.421 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.517 ' OD1' ' NE ' ' A' ' 87' ' ' ARG . 3.6 m-20 -71.97 142.34 49.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.5 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.553 HG22 ' CG ' ' A' ' 7' ' ' PHE . 21.6 mm -136.74 145.23 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 110.004 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.01 15.4 8.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.822 . . . . 0.0 109.823 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.566 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 14.6 t80 -69.61 114.71 8.07 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.095 -1.003 . . . . 0.0 109.628 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.3 m -119.67 -79.65 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.271 -0.893 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 p -148.62 166.49 28.14 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.72 -0.612 . . . . 0.0 109.392 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.12 -179.34 52.86 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -46.48 165.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -1.146 . . . . 0.0 109.489 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -54.09 176.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -0.981 . . . . 0.0 109.405 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 5.1 p30 -115.53 -168.58 1.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.3 p -116.0 13.64 15.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.319 -0.863 . . . . 0.0 109.424 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.445 ' C ' ' HG2' ' A' ' 87' ' ' ARG . 1.1 m-20 -102.59 126.87 49.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.627 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.547 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -145.6 143.33 29.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.47 -0.769 . . . . 0.0 109.168 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.576 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 3.9 tt -109.51 134.85 50.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.862 -1.149 . . . . 0.0 109.089 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.4 mm? -106.75 111.34 23.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 109.992 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.647 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 2.8 p90 -101.69 141.91 33.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.053 -1.029 . . . . 0.0 108.402 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.525 ' OG ' ' CE2' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -106.43 172.43 6.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.049 -1.032 . . . . 0.0 110.633 -178.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.4 p -66.57 -21.95 66.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.472 -0.768 . . . . 0.0 109.522 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.481 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 36.6 p-10 -89.48 16.3 7.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.561 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 68.12 28.57 6.55 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.658 -0.651 . . . . 0.0 110.471 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.481 ' HG ' ' OD2' ' A' ' 93' ' ' ASP . 9.9 mt -85.65 112.32 20.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.576 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 2.0 mt -100.79 125.41 54.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.031 -1.043 . . . . 0.0 110.469 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.536 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 8.1 m-85 -122.89 159.18 28.75 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -131.29 142.18 50.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.757 -1.214 . . . . 0.0 110.024 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -130.13 127.59 40.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.103 -0.998 . . . . 0.0 108.948 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.18 12.34 30.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -132.16 24.6 4.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.166 -0.959 . . . . 0.0 109.494 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.7 t-80 76.43 75.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 109.824 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.564 ' HA ' ' CE1' ' A' ' 106' ' ' PHE . 14.5 m-85 52.21 60.96 3.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 109.624 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -135.08 -71.33 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.29 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.403 ' OG1' ' OD2' ' A' ' 101' ' ' ASP . 1.2 p -89.45 92.59 9.18 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.581 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 83.8 m-85 -89.45 110.08 20.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.238 -0.914 . . . . 0.0 110.03 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 57.3 m -102.82 139.84 37.87 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 2.3 tttt -85.05 125.12 32.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.569 -0.707 . . . . 0.0 109.491 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.64 -10.07 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.418 179.84 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.406 ' O ' ' ND2' ' A' ' 5' ' ' ASN . 5.1 p-10 -136.89 59.28 1.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.123 -0.986 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -148.05 -167.44 2.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 109.472 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 98' ' ' LYS . 38.2 m-85 -77.41 -59.95 2.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.356 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.78 -31.68 68.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.813 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.92 -54.4 18.21 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 6' ' ' THR . 59.0 t -63.11 -41.72 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.361 -1.082 . . . . 0.0 109.002 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -58.96 -35.67 73.54 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.465 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.3 OUTLIER -64.91 -56.36 13.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.501 -0.749 . . . . 0.0 109.204 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.634 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 30.7 t80 -60.82 -20.14 61.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.186 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.4 mt -73.6 -62.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.833 . . . . 0.0 109.299 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -71.5 -8.95 57.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.928 -1.107 . . . . 0.0 109.405 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 87.7 m -89.49 -66.07 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.153 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 82.4 m-85 -88.99 -6.53 57.16 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.512 -0.743 . . . . 0.0 109.417 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.51 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 15.5 m170 57.28 55.56 5.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.764 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 2.5 pttt 160.93 129.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 74' ' ' ALA . 36.0 mt -44.53 147.45 1.04 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.023 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.5 Cg_exo -54.11 162.91 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.021 1.814 . . . . 0.0 110.586 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.91 -7.16 32.29 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.396 -0.815 . . . . 0.0 109.04 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -92.61 6.55 46.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.648 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CE1' ' HB3' ' A' ' 50' ' ' SER . 1.7 m-85 -100.61 81.93 2.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.758 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.4 pt -92.7 127.36 44.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 25' ' ' ILE . 43.4 p -48.1 176.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 109.351 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.81 -46.84 62.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 0.0 109.238 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -53.3 -35.8 60.53 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.095 -1.003 . . . . 0.0 108.46 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.47 ' O ' HD11 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -59.39 -41.22 88.88 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.536 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -68.17 -36.26 79.34 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.576 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 6.5 mt-30 -61.14 -32.64 72.35 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.62 -34.16 72.41 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.344 -0.848 . . . . 0.0 109.587 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.471 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 2.6 mp -81.29 -16.27 52.99 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.426 0.631 . . . . 0.0 110.051 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.28 40.38 0.88 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.586 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 11.1 t90 -105.06 117.26 33.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -1.137 . . . . 0.0 109.329 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -89.94 110.8 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.852 . . . . 0.0 108.705 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.57 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.792 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.571 ' HA ' ' CD1' ' A' ' 35' ' ' TRP . 12.1 tp -58.94 -63.68 1.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 109.647 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.72 -14.45 0.92 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.717 -0.614 . . . . 0.0 110.566 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.1 -36.2 41.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.846 -1.159 . . . . 0.0 110.114 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 35' ' ' TRP . 19.8 m -110.4 -0.33 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.929 -1.107 . . . . 0.0 110.008 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.491 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.99 61.08 4.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 4.8 Cg_exo -59.63 152.28 63.67 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.065 1.843 . . . . 0.0 110.213 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.18 55.4 21.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -135.56 176.36 8.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -1.184 . . . . 0.0 109.72 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.567 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 70.3 m -146.07 136.44 23.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.33 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.537 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 11.5 mm -99.37 106.97 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 109.037 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.71 168.18 35.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.33 -7.5 51.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.47 160.57 26.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.117 -1.225 . . . . 0.0 109.37 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.496 HG21 ' N ' ' A' ' 56' ' ' PHE . 12.7 mm -70.07 144.81 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 109.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.6 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 13.5 t80 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.569 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 3.8 mptp? . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.36 0.6 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.6 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 58.7 mt -100.56 149.97 36.57 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 108.931 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.636 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 5.1 Cg_exo -59.04 85.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.052 1.835 . . . . 0.0 110.359 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' A' ' 71' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.586 ' CE3' HD12 ' A' ' 63' ' ' LEU . 9.5 m95 -147.71 169.47 19.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -125.03 136.67 53.91 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.536 ' CB ' ' CD1' ' A' ' 89' ' ' LEU . 20.1 pt-20 -114.67 152.28 32.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.033 . . . . 0.0 110.296 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -141.11 152.45 44.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 109.298 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.461 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 1.1 m-20 -73.44 139.08 45.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 109.324 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 22.2 mm -132.26 137.73 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.944 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 1.4 m-20 72.53 9.71 5.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 0.0 110.186 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -69.83 143.45 52.88 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.083 -1.01 . . . . 0.0 109.606 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.8 p -139.58 -58.85 0.57 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.58 163.29 12.29 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.76 -0.588 . . . . 0.0 109.518 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 82' ' ' PHE . . . 82.97 -178.9 53.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 81' ' ' GLY . 3.1 m-85 -45.59 159.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -1.19 . . . . 0.0 109.391 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -70.33 160.74 31.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.928 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.79 -167.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.332 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.65 28.11 8.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 109.714 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 2.2 m-20 -109.68 127.5 54.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.118 -0.989 . . . . 0.0 109.659 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.533 ' O ' ' CG2' ' A' ' 99' ' ' THR . 5.9 mtt180 -157.38 145.14 18.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 109.592 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.582 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 4.4 tt -102.69 132.39 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 109.084 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.5 mm? -103.61 103.16 13.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 109.577 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.65 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 7.2 p90 -98.22 141.31 31.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 108.86 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.477 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -105.15 168.93 8.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.151 -0.968 . . . . 0.0 110.392 -178.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.6 p -65.13 -20.41 66.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 24.8 p-10 -89.69 17.6 6.36 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.459 -0.776 . . . . 0.0 108.911 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.558 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.04 27.71 6.93 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.762 -0.586 . . . . 0.0 110.438 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.487 ' CD1' ' HB2' ' A' ' 64' ' ' PRO . 8.8 mt -86.52 102.58 14.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.582 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 3.0 mt -94.25 121.81 45.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.18 -0.95 . . . . 0.0 110.71 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.636 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 7.8 m-85 -121.09 164.02 17.47 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -135.8 144.65 45.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.83 -1.169 . . . . 0.0 109.81 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -132.01 129.66 40.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -0.891 . . . . 0.0 109.126 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 p -119.66 27.51 8.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.615 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 10.5 p30 -146.25 22.59 1.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.935 . . . . 0.0 109.466 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.554 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.9 t-80 80.22 70.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.519 -0.738 . . . . 0.0 109.315 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' ' 102' ' ' HIS . 18.8 m-85 42.85 26.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.666 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 102' ' ' HIS . 3.7 mm-40 -93.62 -17.5 23.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 108.958 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 101' ' ' ASP . 82.0 m -149.61 138.24 20.88 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.569 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 96.5 m-85 -124.01 136.02 54.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.979 . . . . 0.0 110.035 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.432 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.4 m -126.01 137.07 53.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.801 . . . . 0.0 109.024 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -79.72 134.79 36.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.107 -0.995 . . . . 0.0 109.688 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 2.0 pt -142.4 57.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 0.0 109.403 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 1.6 mtm-85 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.468 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -140.59 58.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 0.0 109.362 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.466 ' O ' HD11 ' A' ' 76' ' ' ILE . 4.5 p -142.33 -167.27 2.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.524 ' CE1' ' HB2' ' A' ' 98' ' ' LYS . 31.4 m-85 -76.99 -61.44 1.98 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.146 -0.971 . . . . 0.0 109.186 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.43 -33.47 69.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 109.83 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.7 -55.02 15.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 6' ' ' THR . 95.7 t -63.04 -40.11 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -1.119 . . . . 0.0 108.926 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.451 ' HB2' ' HG3' ' A' ' 110' ' ' ARG . . . -59.48 -35.85 74.9 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.08 -56.74 10.0 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 35.0 t80 -54.58 -25.96 29.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.222 -0.924 . . . . 0.0 108.73 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 3.3 mt -69.52 -60.31 2.41 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -70.81 -5.33 29.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.025 . . . . 0.0 109.492 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.45 HG23 ' CD1' ' A' ' 17' ' ' TYR . 28.0 m -90.73 -70.91 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.859 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 68.7 m-85 -89.79 -4.78 57.47 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.67 -0.644 . . . . 0.0 109.642 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.492 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 17.8 m170 57.6 57.19 4.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.9 . . . . 0.0 109.356 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 7.2 ptmt 166.24 130.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 74' ' ' ALA . 20.0 mt -43.16 147.26 0.72 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.266 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.575 ' HA ' ' CE1' ' A' ' 13' ' ' TYR . 8.2 Cg_exo -53.27 164.13 2.05 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.199 1.933 . . . . 0.0 110.463 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.48 -4.94 29.37 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.362 -0.836 . . . . 0.0 108.975 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -95.05 11.09 33.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.64 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.575 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 5.7 m-85 -105.48 92.94 4.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 109.845 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.3 pp -104.01 127.78 57.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 25' ' ' ILE . 68.7 p -48.94 178.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.51 -48.4 55.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.026 -1.046 . . . . 0.0 109.566 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -53.46 -37.03 62.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.125 -0.984 . . . . 0.0 108.512 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.524 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 18.7 mt-10 -59.88 -39.97 87.09 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.569 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . . . -69.69 -32.56 71.24 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.453 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 2.6 mt-30 -65.86 -30.69 71.34 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.44 76.44 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.457 -0.777 . . . . 0.0 109.362 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -80.96 -11.27 59.6 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.479 0.657 . . . . 0.0 109.978 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.02 53.75 0.74 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.624 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 1.6 t90 -108.97 135.96 49.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -1.131 . . . . 0.0 109.555 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.475 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 6.1 t -89.75 128.26 41.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.624 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.455 0 O-C-N 120.988 -1.07 . . . . 0.0 110.275 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.082 0.468 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.591 HD11 ' CD1' ' A' ' 35' ' ' TRP . 6.0 tp -66.96 -63.53 1.04 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 108.935 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.94 -10.45 2.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.823 -0.548 . . . . 0.0 110.143 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -35.19 44.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 109.741 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 46' ' ' ALA . 33.3 m -98.49 -48.12 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.158 -0.964 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.501 ' N ' HG22 ' A' ' 45' ' ' VAL . . . -117.45 77.03 10.07 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.295 -0.878 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.448 ' O ' ' HD2' ' A' ' 49' ' ' LYS . 3.0 Cg_endo -60.41 155.25 47.93 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.235 1.956 . . . . 0.0 110.326 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.53 63.83 4.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 46' ' ' ALA . 3.2 mptt -140.44 155.01 46.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -1.111 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.539 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 48.9 m -133.91 123.51 24.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.401 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.534 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 6.6 mm -81.15 105.46 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.019 -1.051 . . . . 0.0 109.017 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -150.65 172.8 30.34 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.522 -1.323 . . . . 0.0 109.851 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.95 10.72 62.44 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 4.4 m-20 -83.34 143.46 30.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -1.121 . . . . 0.0 109.403 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.439 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 13.6 mm -69.57 136.22 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 109.457 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.667 ' CE1' ' CD1' ' A' ' 103' ' ' TYR . 73.9 t80 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.393 -0.817 . . . . 0.0 109.29 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.561 HD21 ' CH2' ' A' ' 71' ' ' TRP . 4.2 mt -95.13 146.64 31.68 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.205 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.467 ' HG2' HD12 ' A' ' 95' ' ' LEU . 2.4 Cg_endo -62.26 84.55 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.026 1.818 . . . . 0.0 109.837 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.605 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.258 0.551 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.566 ' CH2' ' HB3' ' A' ' 95' ' ' LEU . 11.9 m95 -102.65 172.85 6.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.634 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 3.6 mtt180 -127.79 132.92 49.44 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HA ' HD12 ' A' ' 89' ' ' LEU . 2.1 pt-20 -116.59 146.82 42.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.906 -1.121 . . . . 0.0 110.627 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -137.04 148.04 46.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.473 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 2.0 m-20 -72.49 122.63 21.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.484 HG13 ' HB ' ' A' ' 88' ' ' ILE . 30.5 mm -110.69 137.73 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 70.74 122.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 109.25 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.425 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 2.2 t80 -170.13 110.24 0.4 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.02 -78.73 0.58 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.88 155.29 32.65 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.701 -0.624 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.05 -160.09 14.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -66.63 155.77 36.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -1.154 . . . . 0.0 109.507 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 82' ' ' PHE . 12.1 mtm180 -51.75 -178.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.35 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.514 ' O ' ' NH2' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -120.53 -167.98 1.56 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.46 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.5 p -127.55 18.67 6.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 109.565 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.469 ' OD2' ' HA ' ' A' ' 100' ' ' THR . 4.3 m-20 -105.12 129.72 53.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 109.387 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 5.5 mmt180 -146.99 140.81 25.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.56 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.586 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 3.3 tt -93.34 129.18 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 108.82 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.578 HD13 ' CG ' ' A' ' 56' ' ' PHE . 4.6 mm? -101.11 93.69 5.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 110.194 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 38.2 p90 -91.5 139.85 30.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.889 -1.132 . . . . 0.0 108.652 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.477 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -105.47 170.36 7.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.097 -1.002 . . . . 0.0 110.722 -178.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.9 -22.38 66.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 109.6 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 14.5 p-10 -89.79 18.8 5.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.589 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 69.22 26.54 5.4 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.817 -0.552 . . . . 0.0 110.244 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.566 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.7 mt -82.32 92.6 6.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.586 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 12.8 mt -90.64 112.41 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 110.372 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.495 ' CG ' HD22 ' A' ' 63' ' ' LEU . 20.1 m-85 -114.03 167.14 10.92 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.524 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -137.28 130.14 30.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.951 -1.093 . . . . 0.0 109.655 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -119.76 119.07 32.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 109.26 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.469 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 21.1 p -104.16 22.17 15.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.523 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.6 OUTLIER -138.46 22.64 2.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.494 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.534 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 7.1 t-80 77.8 73.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 109.455 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.667 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 34.5 m-85 43.02 43.96 3.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.802 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.413 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 2.2 mm-40 -117.14 -17.01 10.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.249 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' THR . 51.9 m -150.38 94.97 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.332 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.545 ' CE1' ' HA ' ' A' ' 103' ' ' TYR . 14.1 m-85 -90.63 116.76 28.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.747 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 90.4 m -107.86 139.49 42.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.276 -0.89 . . . . 0.0 108.8 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -79.3 127.99 32.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 109.605 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.408 ' CG2' ' HE2' ' A' ' 98' ' ' LYS . 1.5 pt -112.75 -42.04 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.572 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.451 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.491 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -141.99 61.77 1.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.463 ' O ' HD11 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -147.75 -175.19 4.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.538 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 98' ' ' LYS . 25.2 m-85 -73.79 -56.73 4.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.509 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -31.4 67.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.972 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.18 -55.39 9.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 6' ' ' THR . 38.8 t -65.83 -40.64 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -1.133 . . . . 0.0 109.296 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -58.35 -42.0 85.94 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.34 -55.01 36.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.544 -0.723 . . . . 0.0 109.101 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.681 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 35.5 t80 -59.09 -21.96 60.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.267 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.553 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.7 mt -73.1 -61.16 1.91 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 0.0 109.337 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.57 -9.18 57.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.005 -1.06 . . . . 0.0 109.591 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.2 m -89.62 -65.28 1.03 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.681 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 71.9 m-85 -89.18 -11.36 44.0 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.582 -0.698 . . . . 0.0 109.24 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 19.1 m170 61.01 53.72 3.6 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.369 -0.832 . . . . 0.0 109.491 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 7.1 pttm 166.97 129.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 19' ' ' LYS . 37.7 mt -44.94 151.74 0.61 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.155 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.584 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.2 Cg_exo -54.6 163.42 3.83 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.147 1.898 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -7.24 33.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.332 -0.855 . . . . 0.0 109.001 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.27 31.82 2.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.526 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.584 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.3 m-85 -121.9 82.45 1.95 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 0.0 109.776 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.5 pt -92.26 128.71 43.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.301 -0.875 . . . . 0.0 108.684 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 25' ' ' ILE . 18.5 p -47.23 174.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.139 -0.975 . . . . 0.0 109.26 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.73 -43.68 68.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.193 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -55.34 -38.81 69.23 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.153 -0.967 . . . . 0.0 108.464 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 5.5 mm-40 -57.84 -40.61 80.46 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.494 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -67.02 -37.34 83.96 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.493 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 4.6 mt-30 -60.98 -32.66 72.21 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.19 -36.88 81.08 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.359 -0.838 . . . . 0.0 109.717 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -81.03 -8.73 59.84 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.65 -0.656 . . . . 0.0 110.318 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' HG23 ' A' ' 45' ' ' VAL . . . 106.54 51.55 0.8 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.59 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 9.3 t90 -118.37 124.46 47.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -1.115 . . . . 0.0 109.052 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 t -90.64 113.02 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.153 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.45 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.436 ' O ' HG21 ' A' ' 45' ' ' VAL . 6.9 p-10 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.58 HD11 ' CD1' ' A' ' 35' ' ' TRP . 10.5 tp -63.1 -57.56 10.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.397 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -49.48 -20.61 0.75 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -37.44 23.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 0.0 110.355 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -106.98 -54.34 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.005 -1.059 . . . . 0.0 110.101 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.53 ' CB ' ' HG3' ' A' ' 49' ' ' LYS . . . -113.38 80.06 4.33 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.114 -0.991 . . . . 0.0 109.699 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 2.1 Cg_endo -62.16 156.57 49.48 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.238 1.959 . . . . 0.0 110.333 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.53 56.39 4.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.53 ' HG3' ' CB ' ' A' ' 46' ' ' ALA . 5.3 mmtp -127.79 119.86 26.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -1.13 . . . . 0.0 109.446 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -89.74 137.55 32.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.327 -0.858 . . . . 0.0 109.48 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.535 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 5.3 mm -104.27 113.9 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 108.922 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.55 173.03 40.45 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.92 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.11 6.26 55.85 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.419 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 1.7 m-20 -87.09 148.33 25.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -1.204 . . . . 0.0 109.39 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 55' ' ' ILE . 15.5 mm -67.77 139.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.61 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.596 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 62.8 t80 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.333 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.575 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 35.6 mttm . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.243 0.544 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.596 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 63.6 mt -93.64 148.36 35.28 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.209 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.569 ' HD2' ' CZ2' ' A' ' 71' ' ' TRP . 3.5 Cg_exo -60.1 84.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.109 1.873 . . . . 0.0 110.186 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.876 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 64' ' ' PRO . 19.9 m95 -132.41 172.17 12.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.73 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.634 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 65.1 mtt180 -136.94 148.65 47.09 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.513 ' CB ' ' CD1' ' A' ' 89' ' ' LEU . 9.1 pt-20 -124.1 158.67 31.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.048 -1.032 . . . . 0.0 110.467 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -148.76 152.3 36.33 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.459 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 1.4 m-20 -78.67 131.83 36.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.107 -0.996 . . . . 0.0 109.516 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 6' ' ' THR . 30.3 mm -116.7 124.42 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.545 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.453 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 20.7 m-20 69.5 118.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.483 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -170.57 138.94 1.53 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.291 -0.88 . . . . 0.0 109.549 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.67 -79.74 0.49 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.084 -1.01 . . . . 0.0 109.478 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.6 p -140.98 171.1 14.53 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.79 -176.34 54.59 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -48.98 167.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -1.169 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -68.55 -179.87 1.49 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.932 . . . . 0.0 109.609 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -110.0 -172.77 2.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.91 . . . . 0.0 109.405 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -108.17 10.94 27.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 109.581 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 82.0 m-20 -100.37 128.03 46.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.661 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.525 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.1 OUTLIER -152.39 158.24 42.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.787 . . . . 0.0 109.164 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.519 ' CD1' HG21 ' A' ' 96' ' ' ILE . 1.6 tt -118.42 146.33 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.014 -1.054 . . . . 0.0 109.345 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.513 ' CD1' ' CB ' ' A' ' 73' ' ' GLU . 3.2 mm? -117.93 113.14 21.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.463 -0.773 . . . . 0.0 109.68 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 2.5 p90 -105.99 140.39 39.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.842 -1.161 . . . . 0.0 108.934 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.462 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -107.49 174.93 5.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.915 . . . . 0.0 110.444 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -23.34 66.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 109.815 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 42.6 p30 -89.62 16.58 7.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.424 -0.797 . . . . 0.0 108.969 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.564 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.94 27.66 7.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.769 -0.582 . . . . 0.0 110.522 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 14.5 mt -83.66 114.96 21.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.519 HG21 ' CD1' ' A' ' 88' ' ' ILE . 4.8 mt -111.2 107.65 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 110.574 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.532 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 26.5 m-85 -106.97 117.84 35.12 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -89.19 145.27 25.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 109.924 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -130.49 122.63 28.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 0.0 109.09 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.405 HG21 ' CG ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -110.95 30.66 6.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.633 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.5 OUTLIER -150.21 21.88 0.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER 78.73 73.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.405 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 26.8 m-85 43.78 26.22 0.12 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.392 -0.818 . . . . 0.0 109.682 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -97.05 -18.17 19.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.001 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.465 ' HB ' ' OD2' ' A' ' 101' ' ' ASP . 24.1 m -143.27 142.89 31.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.575 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 86.7 m-85 -133.65 123.77 25.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.086 -1.009 . . . . 0.0 110.267 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -114.18 132.44 56.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.497 -0.752 . . . . 0.0 109.0 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -79.5 109.36 13.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 109.54 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 1.1 pt -125.38 65.78 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.483 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 72.6 mtm180 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -143.0 53.87 1.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.467 ' O ' HD11 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -144.63 -176.23 4.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.547 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 98' ' ' LYS . 31.4 m-85 -75.86 -57.9 3.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 0.0 109.556 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -71.17 -31.65 67.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.937 . . . . 0.0 109.901 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.95 -52.87 21.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.479 HG23 ' OH ' ' A' ' 24' ' ' TYR . 46.6 t -67.1 -46.95 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -1.117 . . . . 0.0 109.332 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.453 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -55.61 -38.06 68.95 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -62.98 -55.1 28.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.482 -0.761 . . . . 0.0 109.093 179.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 18.0 t80 -62.53 -17.67 60.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.318 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.549 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.4 mt -75.75 -63.37 1.32 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.444 -0.785 . . . . 0.0 109.252 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -11.56 61.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.98 -1.075 . . . . 0.0 109.412 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.3 m -89.74 -64.45 1.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.962 . . . . 0.0 110.069 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.689 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 67.7 m-85 -89.48 -0.16 57.3 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.458 -0.776 . . . . 0.0 109.568 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.481 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 19.2 m170 47.91 47.16 18.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.295 -0.878 . . . . 0.0 109.685 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 14.4 ptmt 173.85 128.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.458 HD13 ' OH ' ' A' ' 90' ' ' TYR . 23.0 mt -45.94 147.89 1.58 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.154 -0.966 . . . . 0.0 109.022 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.5 Cg_exo -53.56 160.42 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.016 1.811 . . . . 0.0 110.469 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.07 -10.32 29.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.258 -0.901 . . . . 0.0 108.981 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 50.9 p30 -92.18 20.68 5.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.588 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.9 m-85 -115.96 87.79 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 109.725 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.2 pt -99.23 123.15 51.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.299 -0.876 . . . . 0.0 108.735 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 25' ' ' ILE . 19.8 p -45.99 172.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 109.501 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -67.26 -45.5 76.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.0 -1.062 . . . . 0.0 109.029 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -39.5 67.31 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 18.8 mt-10 -59.37 -38.54 80.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.573 ' HB1' ' CE3' ' A' ' 35' ' ' TRP . . . -67.37 -38.68 85.15 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.097 -1.002 . . . . 0.0 108.544 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 27.4 mt-30 -60.37 -35.39 75.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.1 -34.83 70.6 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.305 -0.872 . . . . 0.0 109.335 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.43 -18.09 46.56 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.694 -0.629 . . . . 0.0 110.271 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.49 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . 115.64 36.36 1.18 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.601 ' CD1' HD11 ' A' ' 42' ' ' LEU . 9.5 t90 -100.3 122.35 42.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -1.174 . . . . 0.0 109.122 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.77 110.46 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.161 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.569 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 35' ' ' TRP . 56.8 p30 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.601 HD11 ' CD1' ' A' ' 35' ' ' TRP . 6.2 tp -62.45 -46.26 89.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.469 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -61.96 -11.32 12.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.867 . . . . 0.0 109.877 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.45 -51.37 4.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.13 -0.981 . . . . 0.0 109.983 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.514 HG23 ' CA ' ' A' ' 35' ' ' TRP . 28.9 m -91.7 -47.3 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.851 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.507 ' N ' HG22 ' A' ' 45' ' ' VAL . . . -118.96 76.59 14.74 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 109.433 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.7 Cg_endo -63.46 155.15 64.17 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.234 1.956 . . . . 0.0 110.562 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 42.74 70.24 0.53 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 3.7 mmpt? -142.01 160.36 40.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.258 -1.142 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 3.0 m -124.16 130.37 52.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.889 . . . . 0.0 109.398 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.544 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 17.5 mm -93.12 104.61 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.158 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -158.38 168.2 34.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.82 -15.85 51.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.469 ' OD2' ' HB ' ' A' ' 26' ' ' THR . 3.4 m-20 -79.95 148.41 31.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -1.199 . . . . 0.0 109.331 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 56' ' ' PHE . 14.0 mt -51.54 166.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.366 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 9.0 t80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.456 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.566 ' CB ' ' CE2' ' A' ' 106' ' ' PHE . 12.8 mmtt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.389 0.614 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 44.2 mt -105.38 157.23 34.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.968 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.472 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 2.8 Cg_endo -61.84 84.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.005 1.803 . . . . 0.0 109.63 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.632 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.583 ' CE3' HD12 ' A' ' 63' ' ' LEU . 15.0 m95 -141.13 157.56 45.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.638 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 28.8 mtp180 -119.07 129.29 55.01 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.575 ' CB ' ' CD1' ' A' ' 89' ' ' LEU . 12.4 pt-20 -106.3 151.08 25.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.053 -1.029 . . . . 0.0 110.22 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' CA ' ' A' ' 52' ' ' GLY . . . -138.66 150.97 46.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.46 -0.775 . . . . 0.0 109.111 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.467 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -74.41 136.92 42.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.052 -1.03 . . . . 0.0 109.573 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.469 HG13 ' HB ' ' A' ' 88' ' ' ILE . 22.1 mm -120.31 123.32 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.231 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER 72.04 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.269 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 8.6 t80 -170.39 141.5 1.99 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.144 -0.973 . . . . 0.0 109.537 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.01 -78.81 0.19 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -144.58 161.2 39.71 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.642 -0.661 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.38 -175.32 34.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -55.02 179.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -1.177 . . . . 0.0 109.405 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -175.8 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.44 179.88 3.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.4 m -110.96 8.47 22.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' ' 87' ' ' ARG . 25.5 m-20 -108.94 128.53 55.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.106 -0.996 . . . . 0.0 109.384 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 3.6 mmt180 -143.03 169.94 16.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 109.289 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.563 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 3.9 tt -134.15 129.64 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.026 -1.046 . . . . 0.0 108.598 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.575 ' CD1' ' CB ' ' A' ' 73' ' ' GLU . 3.1 mm? -104.87 104.23 13.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.638 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 10.2 p90 -96.31 139.07 32.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.939 -1.101 . . . . 0.0 108.459 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.468 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -100.72 170.88 8.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 -178.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 p -65.22 -21.85 66.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.41 -0.806 . . . . 0.0 109.311 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 27.4 p-10 -89.87 18.08 6.05 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.567 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.1 m95 68.21 29.89 5.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.281 0.562 . . . . 0.0 110.165 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.459 ' HG ' ' OD2' ' A' ' 93' ' ' ASP . 6.9 mt -85.17 97.53 9.95 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.563 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 3.5 mt -90.24 118.66 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.118 -0.989 . . . . 0.0 110.468 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 108' ' ' LYS . 9.0 m-85 -117.32 158.4 24.44 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 7.3 ptpt -126.29 153.38 44.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.943 -1.098 . . . . 0.0 109.428 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -140.66 118.28 11.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.445 -0.785 . . . . 0.0 109.115 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.402 HG21 ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -101.81 25.56 8.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.594 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -142.66 18.74 2.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 109.417 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 4.3 t-80 78.2 85.82 0.07 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.379 -0.826 . . . . 0.0 109.981 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.441 ' OH ' ' OE2' ' A' ' 73' ' ' GLU . 33.9 m-85 41.61 27.13 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.385 -0.822 . . . . 0.0 110.067 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.527 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 7.1 tp60 -89.13 -71.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.927 . . . . 0.0 108.982 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.439 HG21 ' OD1' ' A' ' 101' ' ' ASP . 14.2 t -97.61 164.1 12.56 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CE2' ' CB ' ' A' ' 62' ' ' LYS . 92.3 m-85 -145.45 121.15 10.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.914 -1.116 . . . . 0.0 109.947 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 2.0 m -118.28 133.47 55.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 0.0 109.322 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 3.6 ttpm? -79.63 131.92 36.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.435 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 110' ' ' ARG . 1.3 pt -119.8 -45.59 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.501 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.277 0.56 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -146.1 62.63 1.24 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.404 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 p -145.08 -175.55 4.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.502 ' CD1' ' HB2' ' A' ' 98' ' ' LYS . 41.7 m-85 -79.57 -54.4 5.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.718 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -33.6 69.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 0.0 110.01 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.27 -53.03 23.78 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 76' ' ' ILE . 41.5 t -66.76 -38.85 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.336 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.82 85.17 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.461 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.6 OUTLIER -64.55 -55.45 20.42 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.471 -0.768 . . . . 0.0 109.163 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.556 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 19.6 t80 -59.53 -20.36 54.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.275 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -75.58 -64.38 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.199 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -70.75 -5.55 30.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.976 -1.077 . . . . 0.0 109.34 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.571 HG23 ' CD1' ' A' ' 17' ' ' TYR . 56.2 m -94.29 -66.45 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 109.562 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.571 ' CD1' HG23 ' A' ' 16' ' ' THR . 83.3 m-85 -89.86 3.46 52.9 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.705 -0.622 . . . . 0.0 109.439 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.477 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 19.7 m170 44.76 48.76 8.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 17.5 pttt 175.17 129.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.479 -0.763 . . . . 0.0 109.159 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 74' ' ' ALA . 30.1 mt -47.14 149.01 1.82 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.207 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.9 Cg_exo -53.54 161.82 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.045 1.83 . . . . 0.0 110.422 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -68.73 -7.43 33.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.084 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -92.43 11.15 27.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 109.529 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 3.2 m-85 -105.11 90.26 3.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.753 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.1 pp -99.29 123.6 52.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 25' ' ' ILE . 44.5 p -47.9 176.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.579 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.21 -47.98 59.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.107 -0.996 . . . . 0.0 109.104 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 m -53.51 -38.85 64.11 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.492 ' O ' HD13 ' A' ' 33' ' ' LEU . 26.8 mm-40 -57.85 -41.07 81.62 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.582 ' HB1' ' CE3' ' A' ' 35' ' ' TRP . . . -66.69 -33.91 76.69 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 1.7 mt-30 -62.53 -34.65 77.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.01 72.75 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.466 -0.771 . . . . 0.0 109.592 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.5 mp -80.78 -15.89 55.23 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.451 0.643 . . . . 0.0 110.134 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 113.89 40.31 1.0 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.582 ' CE3' ' HB1' ' A' ' 30' ' ' ALA . 11.1 t90 -106.88 118.92 37.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -1.176 . . . . 0.0 109.244 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 t -89.87 111.92 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.844 . . . . 0.0 108.966 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.573 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.955 . . . . 0.0 109.729 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.451 ' C ' ' ND2' ' A' ' 41' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.149 0.5 . . . . 0.0 109.774 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.571 HD11 ' CD1' ' A' ' 35' ' ' TRP . 10.2 tp -59.09 -55.25 37.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.33 -19.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.108 -0.995 . . . . 0.0 110.091 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -96.56 -29.48 13.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.094 . . . . 0.0 110.762 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 34' ' ' GLY . 32.3 m -103.44 -52.57 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.819 -1.175 . . . . 0.0 110.3 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.428 ' N ' ' CG2' ' A' ' 45' ' ' VAL . . . -127.05 66.19 66.64 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.945 -1.097 . . . . 0.0 109.46 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 2.1 Cg_endo -62.02 168.27 9.29 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.218 1.946 . . . . 0.0 110.353 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 50.67 45.82 47.67 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.52 163.14 27.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -1.198 . . . . 0.0 109.507 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.525 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 42.8 m -129.41 126.1 38.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.421 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.533 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 7.2 mm -90.18 106.56 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.142 -0.974 . . . . 0.0 108.907 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.81 169.73 34.64 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.06 -9.31 50.55 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.507 ' OD1' ' CG ' ' A' ' 73' ' ' GLU . 2.6 p30 -86.25 145.23 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -1.139 . . . . 0.0 109.507 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.4 mm -49.78 161.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.146 -0.971 . . . . 0.0 109.419 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 14.5 t80 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.388 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.52 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 2.7 mttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.29 0.567 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.635 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 31.7 mt -101.01 142.75 25.24 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.21 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.503 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 1.9 Cg_endo -62.92 107.77 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.045 1.83 . . . . 0.0 110.096 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.609 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 6.5 m95 -108.89 173.31 6.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.59 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 53.3 mtt180 -130.88 150.57 51.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.507 ' CG ' ' OD1' ' A' ' 54' ' ' ASP . 20.8 pt-20 -128.55 155.48 44.84 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.008 -1.058 . . . . 0.0 110.418 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 20' ' ' LEU . . . -146.98 148.1 31.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.735 . . . . 0.0 109.102 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.467 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -68.81 149.26 49.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 109.595 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.527 ' CD1' HG22 ' A' ' 10' ' ' VAL . 29.1 mm -141.25 145.02 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.274 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.491 ' N ' HG21 ' A' ' 76' ' ' ILE . 73.7 m-20 61.19 39.83 15.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 109.476 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.476 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 60.5 t80 -69.68 128.42 36.37 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.336 -0.853 . . . . 0.0 109.597 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.24 -79.92 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.204 -0.935 . . . . 0.0 109.422 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -172.53 -177.75 1.81 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.642 -0.661 . . . . 0.0 109.486 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.515 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . 67.44 78.21 0.28 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER 56.46 164.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -1.169 . . . . 0.0 109.313 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 171.97 0.05 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.21 -0.931 . . . . 0.0 109.334 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -103.74 -171.75 1.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.601 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.34 -4.92 13.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.902 . . . . 0.0 109.415 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 65.0 m-20 -93.87 129.42 40.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.459 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.525 ' O ' ' CG2' ' A' ' 99' ' ' THR . 11.4 mtt180 -152.79 150.88 29.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.206 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.513 HD12 ' CG2' ' A' ' 96' ' ' ILE . 4.3 tt -106.98 149.36 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.185 -0.947 . . . . 0.0 109.441 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.581 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.5 mm? -117.95 124.69 48.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.374 -0.829 . . . . 0.0 109.515 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -113.26 140.96 47.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.841 -1.162 . . . . 0.0 108.839 179.063 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.579 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 11.4 t -108.27 173.78 6.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.3 p -66.36 -22.77 66.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.474 ' OD2' HD13 ' A' ' 95' ' ' LEU . 28.4 p-10 -89.67 15.65 9.21 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.575 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.36 31.59 6.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.708 -0.62 . . . . 0.0 110.461 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.474 HD13 ' OD2' ' A' ' 93' ' ' ASP . 9.8 mt -87.34 125.05 34.0 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.513 ' CG2' HD12 ' A' ' 88' ' ' ILE . 1.8 mt -117.62 113.75 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.098 -1.001 . . . . 0.0 110.677 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.503 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 21.6 m-85 -113.52 117.45 31.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.502 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.21 136.15 33.18 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.961 -1.087 . . . . 0.0 109.8 -179.119 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -122.89 128.66 50.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 108.996 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.416 HG23 ' OD1' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.3 31.2 6.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.606 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -149.88 20.67 0.89 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -0.937 . . . . 0.0 109.36 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 19.6 t-80 76.6 68.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.804 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 5.7 m-85 56.28 55.1 6.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.954 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.43 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER -120.87 -81.56 0.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 108.641 179.396 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.441 HG22 ' OD2' ' A' ' 101' ' ' ASP . 17.2 p -90.56 105.25 17.69 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.52 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 83.2 m-85 -90.0 126.52 35.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 110.142 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -111.33 126.98 55.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 108.949 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 24.3 tttt -79.34 117.49 20.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.019 -1.051 . . . . 0.0 109.441 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.442 ' O ' ' HG2' ' A' ' 110' ' ' ARG . 1.4 pt -110.21 -24.76 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.876 . . . . 0.0 109.627 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 109' ' ' ILE . 2.8 mtt-85 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -138.94 58.46 1.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.468 ' O ' HD11 ' A' ' 76' ' ' ILE . 1.2 p -146.42 -178.26 6.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.606 ' CD1' ' CB ' ' A' ' 98' ' ' LYS . 11.3 m-85 -73.68 -57.15 4.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.404 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.35 -36.42 71.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 109.824 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.52 -49.98 57.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 6' ' ' THR . 90.0 t -66.03 -44.83 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -1.161 . . . . 0.0 109.278 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.78 67.25 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.83 -56.03 14.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.501 -0.75 . . . . 0.0 109.045 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.641 ' CE1' ' CG ' ' A' ' 17' ' ' TYR . 67.4 t80 -58.97 -17.7 27.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.145 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.482 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.6 mt -78.59 -59.84 2.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.241 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.8 -9.67 57.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 109.489 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.478 HG21 ' CD1' ' A' ' 17' ' ' TYR . 99.6 m -95.49 -61.57 1.44 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 109.947 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CG ' ' CE1' ' A' ' 13' ' ' TYR . 6.2 m-85 -89.31 0.67 56.62 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.697 -0.627 . . . . 0.0 109.581 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 18.1 m170 42.76 48.59 4.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 2.9 pttm 176.84 130.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.508 -0.745 . . . . 0.0 109.128 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 14.2 mt -43.76 160.96 0.21 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 109.182 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.564 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 3.1 Cg_exo -55.41 159.31 10.85 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.105 1.87 . . . . 0.0 110.456 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.7 p30 -72.1 -4.71 30.54 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 108.988 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -111.73 31.87 5.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.484 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.609 ' CE1' ' CB ' ' A' ' 50' ' ' SER . 1.6 m-30 -114.09 78.78 1.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.932 . . . . 0.0 109.449 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 2.2 pt -90.94 128.02 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.357 -0.839 . . . . 0.0 108.977 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 25' ' ' ILE . 46.2 p -46.49 174.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.857 . . . . 0.0 109.516 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.82 -46.46 65.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.046 -1.034 . . . . 0.0 109.307 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -51.75 -36.07 45.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 108.388 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 33' ' ' LEU . 16.0 mm-40 -60.43 -43.63 96.58 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . . . -64.12 -34.6 78.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 16.5 mt-30 -62.46 -37.57 86.44 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.44 79.59 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.461 -0.775 . . . . 0.0 109.658 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.01 -12.62 59.33 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.626 -0.672 . . . . 0.0 110.002 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.525 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . 109.98 68.92 0.6 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.598 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 13.0 t90 -137.01 120.81 17.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -1.136 . . . . 0.0 109.191 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 9.8 p -89.85 116.56 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.261 -0.899 . . . . 0.0 108.702 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.526 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.278 0.561 . . . . 0.0 109.634 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD11 ' CD1' ' A' ' 35' ' ' TRP . 13.0 tp -53.05 -65.94 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -46.3 -23.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.433 -0.792 . . . . 0.0 110.056 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -80.19 -40.34 27.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.088 -1.007 . . . . 0.0 110.447 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -93.17 -55.18 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.035 -1.041 . . . . 0.0 110.227 -179.409 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HB2' ' HD2' ' A' ' 49' ' ' LYS . . . -120.76 72.73 22.47 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.959 -1.088 . . . . 0.0 110.01 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.5 Cg_endo -63.67 -178.66 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.239 1.959 . . . . 0.0 110.343 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 43.29 46.25 6.65 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.463 ' HD2' ' HB2' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -149.48 167.13 27.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -1.158 . . . . 0.0 109.43 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.609 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -141.89 162.8 34.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.356 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.531 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 4.8 mm -110.57 117.93 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -0.876 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.33 158.17 29.86 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.463 ' HA2' ' OH ' ' A' ' 90' ' ' TYR . . . 95.08 9.5 58.18 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.496 ' OD2' ' CG ' ' A' ' 27' ' ' LYS . 2.4 m-20 -85.92 142.46 28.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -1.152 . . . . 0.0 109.376 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.8 mm -52.63 149.59 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.581 ' CD1' HD13 ' A' ' 89' ' ' LEU . 49.0 t80 . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.952 . . . . 0.0 109.594 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 32.6 mttm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.283 0.563 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.58 HD13 ' CE2' ' A' ' 56' ' ' PHE . 22.8 mt -124.47 151.0 66.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.404 -0.81 . . . . 0.0 108.866 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 5.3 Cg_exo -59.51 85.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.143 1.895 . . . . 0.0 110.281 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.565 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 36.9 m95 -127.49 140.13 52.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.631 ' CB ' ' CE1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -111.0 125.31 53.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.295 -0.878 . . . . 0.0 109.134 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CB ' HD12 ' A' ' 89' ' ' LEU . 2.4 pt-20 -96.88 146.26 25.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.175 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -133.2 147.99 52.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.4 m-20 -70.29 142.93 52.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.59 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.487 HG22 HD11 ' A' ' 76' ' ' ILE . 19.5 mm -135.47 141.95 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.861 . . . . 0.0 109.558 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 9.6 m120 61.6 34.58 17.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.7 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.442 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 56.5 t80 -69.47 143.82 53.41 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.151 -0.968 . . . . 0.0 109.512 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.69 -80.15 0.49 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -170.41 179.67 3.31 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.629 -0.67 . . . . 0.0 109.448 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.446 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . 67.05 -149.12 51.0 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 83' ' ' ARG . 2.4 m-85 -53.5 164.42 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -1.104 . . . . 0.0 109.552 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 82' ' ' PHE . 1.4 mmm-85 -55.98 -164.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.474 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.12 -172.81 2.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.579 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.82 -1.23 11.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 109.589 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 71.0 m-20 -104.96 129.04 53.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 109.519 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.2 OUTLIER -147.23 141.54 26.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.342 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.546 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 6.8 tt -102.27 125.27 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 109.313 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.581 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.9 mm? -94.53 99.97 12.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.951 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.631 ' CE1' ' CB ' ' A' ' 72' ' ' ARG . 22.5 p90 -99.36 140.09 34.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.923 -1.111 . . . . 0.0 108.687 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 8.0 t -108.01 169.53 8.56 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.146 -0.971 . . . . 0.0 110.607 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -65.28 -19.37 65.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.421 -0.8 . . . . 0.0 109.638 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 29.8 p-10 -89.62 16.87 7.1 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.582 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 68.27 30.03 5.75 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.684 -0.635 . . . . 0.0 110.341 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 7.8 mt -87.16 101.0 13.07 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.546 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 4.1 mt -97.27 115.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.344 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.475 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 10.2 m-85 -118.93 161.81 19.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.606 ' CB ' ' CD1' ' A' ' 7' ' ' PHE . 3.7 ptmt -132.06 143.76 50.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.868 -1.145 . . . . 0.0 110.032 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -130.53 120.55 24.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 108.935 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.59 26.69 8.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 0.0 109.857 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -147.78 21.86 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.08 -1.012 . . . . 0.0 109.84 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 10.6 t-80 77.17 71.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.412 ' OH ' ' OE1' ' A' ' 73' ' ' GLU . 15.0 m-85 50.43 20.35 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 110.035 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.52 ' CB ' ' OD1' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -86.96 -20.59 27.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 108.862 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 35.3 p -144.7 157.35 44.23 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.572 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 73.4 m-85 -141.29 119.53 12.15 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.001 -1.062 . . . . 0.0 110.034 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 3.1 m -112.88 136.5 52.45 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.426 -0.796 . . . . 0.0 108.939 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -83.58 129.1 34.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 0.5 OUTLIER -130.24 19.84 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.428 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.371 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.427 ' O ' HG21 ' A' ' 4' ' ' ILE . 5.5 mt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.276 0.56 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -141.9 57.71 1.49 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.357 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.448 ' O ' HG22 ' A' ' 10' ' ' VAL . 3.9 p -144.8 -168.93 3.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.221 -0.925 . . . . 0.0 109.67 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 86' ' ' ASP . 46.6 m-85 -76.79 -57.61 3.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.872 . . . . 0.0 109.582 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -34.82 71.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.137 -0.977 . . . . 0.0 109.99 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.88 -52.79 26.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 6' ' ' THR . 67.4 t -64.14 -45.6 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -1.149 . . . . 0.0 109.114 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -56.73 -36.55 69.86 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.0 OUTLIER -63.5 -56.22 17.83 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.492 -0.755 . . . . 0.0 109.023 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.675 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 32.3 t80 -59.19 -21.13 58.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 108.848 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 3.6 mt -71.01 -61.32 1.8 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -70.98 -8.93 56.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 109.348 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 86.5 m -85.02 -67.84 0.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.865 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.675 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 98.6 m-85 -95.68 4.17 53.26 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.676 -0.64 . . . . 0.0 109.743 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 16.6 m170 50.92 50.62 18.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.498 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER 171.53 130.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 19' ' ' LYS . 21.4 mt -44.14 150.39 0.62 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 108.96 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.576 ' HA ' ' CE1' ' A' ' 13' ' ' TYR . 8.8 Cg_exo -53.51 162.93 2.94 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.055 1.837 . . . . 0.0 110.535 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.17 -6.87 37.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.355 -0.84 . . . . 0.0 109.016 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 27.7 p30 -90.92 -1.07 57.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.506 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.571 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.7 m-85 -92.14 91.58 7.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 109.891 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.6 pp -96.77 118.61 43.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.31 -0.869 . . . . 0.0 108.771 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 25' ' ' ILE . 13.2 p -43.07 166.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.579 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.591 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -64.15 -43.61 94.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.148 -0.97 . . . . 0.0 108.903 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.52 -38.89 64.19 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.478 ' O ' HD13 ' A' ' 33' ' ' LEU . 1.6 mt-10 -58.21 -40.84 82.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.522 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -64.34 -38.81 92.36 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.416 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 3.5 mm100 -60.05 -36.35 77.12 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.69 -39.16 87.47 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.354 -0.841 . . . . 0.0 109.602 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.8 mp -81.12 -8.03 59.68 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.704 -0.623 . . . . 0.0 110.205 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.06 67.39 0.76 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.633 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 9.4 t90 -136.82 118.94 15.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.157 . . . . 0.0 109.031 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.81 113.55 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.804 . . . . 0.0 109.072 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.58 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.213 -0.929 . . . . 0.0 109.65 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.458 ' O ' HG21 ' A' ' 45' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.201 0.524 . . . . 0.0 109.82 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.633 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 4.5 tp -61.95 -45.21 94.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.07 -1.019 . . . . 0.0 109.48 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.49 -10.38 11.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.911 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -105.3 -24.99 12.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 110.27 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 41' ' ' ASN . 34.8 m -115.03 -49.57 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.963 -1.086 . . . . 0.0 110.051 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -129.74 62.22 62.32 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 2.2 Cg_endo -61.71 177.9 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.133 1.889 . . . . 0.0 110.176 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 49' ' ' LYS . . . 43.96 60.93 3.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 4.6 mttt -159.52 123.63 3.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -1.151 . . . . 0.0 109.577 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 1.8 m -90.03 134.81 34.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.616 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.539 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 8.4 mm -96.08 108.76 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.181 -0.95 . . . . 0.0 108.775 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.09 167.15 32.75 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.45 -6.96 50.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.33 154.35 29.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -1.165 . . . . 0.0 109.245 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.439 HG21 ' N ' ' A' ' 56' ' ' PHE . 19.5 mm -68.46 142.37 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.641 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 10.6 t80 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.263 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.444 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.229 0.537 . . . . 0.0 109.715 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.641 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 58.8 mt -89.5 148.43 40.3 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 108.987 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.563 ' HD2' ' CH2' ' A' ' 71' ' ' TRP . 5.3 Cg_exo -59.69 94.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.08 1.854 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.577 ' CZ2' ' HB3' ' A' ' 63' ' ' LEU . 10.5 m95 -112.76 166.59 11.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 0.0 109.562 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.629 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -120.49 132.23 55.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 108.745 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -111.95 153.65 26.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.07 -1.019 . . . . 0.0 110.405 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.445 ' HB2' HG21 ' A' ' 88' ' ' ILE . . . -141.18 152.56 44.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.502 -0.749 . . . . 0.0 109.19 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.473 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 5.7 m-20 -74.54 141.51 44.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 109.245 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 22.2 mm -135.41 145.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.145 -0.972 . . . . 0.0 109.771 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 65.32 33.84 8.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.472 -0.768 . . . . 0.0 109.81 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.48 ' HA ' ' OD1' ' A' ' 84' ' ' ASN . 17.1 t80 -69.49 137.84 52.9 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.68 -79.88 0.45 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.288 -0.882 . . . . 0.0 109.392 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.83 179.25 6.03 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.739 -0.6 . . . . 0.0 109.475 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.19 -162.95 42.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.53 150.68 6.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.204 -1.174 . . . . 0.0 109.394 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.92 173.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.686 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.48 ' OD1' ' HA ' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -107.36 -167.97 1.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.401 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -114.62 11.27 16.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.453 ' C ' ' HG2' ' A' ' 87' ' ' ARG . 42.8 m-20 -96.75 125.67 41.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.056 -1.028 . . . . 0.0 109.52 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -144.65 158.71 43.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 0.0 109.594 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 97' ' ' TYR . 7.2 tt -122.9 131.58 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.569 HD13 ' CG ' ' A' ' 56' ' ' PHE . 3.5 mm? -105.63 96.95 6.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.626 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 36.3 p90 -92.84 139.74 30.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.898 -1.126 . . . . 0.0 108.559 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.455 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -105.64 170.53 7.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.138 -0.976 . . . . 0.0 110.565 -178.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -21.37 66.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -0.794 . . . . 0.0 109.388 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 54.8 p30 -89.57 17.53 6.3 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.587 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.8 29.5 5.12 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.723 -0.611 . . . . 0.0 110.375 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.538 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 7.5 mt -86.4 96.54 10.05 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 110' ' ' ARG . 8.7 mt -94.64 111.21 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 110.342 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.49 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 9.7 m-85 -110.52 162.48 14.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -129.8 152.37 49.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.98 -1.075 . . . . 0.0 109.329 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.2 118.18 11.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.892 . . . . 0.0 109.031 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 27.01 8.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 109.767 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -145.57 20.21 1.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.478 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 5.8 t-80 78.8 74.3 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -0.815 . . . . 0.0 109.786 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.492 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 29.3 m-85 44.64 24.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 102' ' ' HIS . 5.0 mm-40 -94.67 -16.41 23.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.998 . . . . 0.0 108.887 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.5 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 1.4 m -150.28 136.7 18.89 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 98' ' ' LYS . 71.2 m-85 -124.25 131.37 53.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.01 -1.056 . . . . 0.0 110.33 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -126.11 131.87 52.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 4.5 tttt -79.34 128.25 33.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.037 -1.039 . . . . 0.0 109.549 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pt -112.12 -45.14 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.529 ' HB2' ' CD1' ' A' ' 96' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.462 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -146.63 60.6 1.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 10' ' ' VAL . 14.0 p -144.6 -167.58 2.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.932 . . . . 0.0 109.523 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.56 ' CD1' HG22 ' A' ' 76' ' ' ILE . 37.3 m-85 -79.17 -59.99 2.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.444 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.56 -31.0 67.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.58 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.89 -52.33 29.4 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 76' ' ' ILE . 58.0 t -64.6 -44.66 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -1.152 . . . . 0.0 109.138 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.453 ' HA ' HD13 ' A' ' 14' ' ' LEU . . . -56.06 -38.87 71.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -56.51 16.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.499 -0.751 . . . . 0.0 109.138 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.64 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 22.5 t80 -58.66 -20.21 46.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.045 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.5 mt -73.33 -63.17 1.24 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.458 -0.776 . . . . 0.0 109.001 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.417 ' HG3' HD13 ' A' ' 96' ' ' ILE . 7.2 mt-30 -71.93 -5.96 38.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.091 . . . . 0.0 109.391 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.58 HG23 ' CD1' ' A' ' 17' ' ' TYR . 51.0 m -91.15 -66.8 0.9 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.166 -0.959 . . . . 0.0 110.044 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 85.0 m-85 -89.22 -10.93 45.15 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.62 -0.675 . . . . 0.0 109.362 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 22.5 m170 62.57 54.61 2.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.392 -0.817 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER 162.56 130.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 19' ' ' LYS . 31.5 mt -43.67 148.51 0.71 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.91 . . . . 0.0 109.116 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 12.0 Cg_exo -51.49 163.49 1.11 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.072 1.848 . . . . 0.0 110.552 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.7 -7.03 35.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.357 -0.84 . . . . 0.0 109.057 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.444 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 5.6 p30 -92.15 2.54 56.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.85 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 6.8 m-85 -99.24 93.21 5.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.095 -1.003 . . . . 0.0 109.818 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.1 pp -98.77 118.98 46.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.27 -0.894 . . . . 0.0 108.925 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 25' ' ' ILE . 30.0 p -44.58 169.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -65.53 -44.56 86.51 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.136 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -54.58 -39.61 67.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 1.3 mt-10 -58.63 -39.92 81.87 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 42' ' ' LEU . . . -65.44 -39.43 92.05 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.144 -0.972 . . . . 0.0 108.443 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 9.2 mt-30 -59.77 -35.22 74.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.18 73.39 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 109.367 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.489 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.37 -15.77 54.27 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.703 -0.623 . . . . 0.0 110.205 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . 112.49 44.59 0.83 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.583 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 8.6 t90 -109.37 124.48 51.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -1.177 . . . . 0.0 109.239 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 t -91.08 113.32 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.835 . . . . 0.0 109.083 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.491 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.561 HD11 ' CD1' ' A' ' 35' ' ' TRP . 10.9 tp -56.77 -60.94 2.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 109.581 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -43.56 -24.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.926 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -82.13 -49.44 10.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 110.64 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 31.8 m -95.14 -50.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.906 -1.121 . . . . 0.0 110.488 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.479 ' N ' HG22 ' A' ' 45' ' ' VAL . . . -117.13 76.8 8.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.003 -1.061 . . . . 0.0 109.805 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 Cg_endo -62.85 154.23 67.66 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.235 1.956 . . . . 0.0 110.364 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 45.32 73.9 0.25 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -154.42 123.07 6.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.556 ' HB2' ' CD1' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -89.77 131.97 35.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.878 . . . . 0.0 109.472 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.537 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 11.5 mm -91.16 109.85 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.186 -0.946 . . . . 0.0 109.2 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -161.92 175.63 38.42 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.459 ' HA2' ' OH ' ' A' ' 90' ' ' TYR . . . 88.32 33.73 10.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' OD1' ' OE2' ' A' ' 73' ' ' GLU . 2.2 p30 -131.05 143.37 50.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -1.225 . . . . 0.0 109.497 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 54' ' ' ASP . 1.1 mp -44.08 147.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.832 . . . . 0.0 109.003 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.644 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 8.1 t80 . . . . . 0 C--N 1.302 -1.469 0 O-C-N 121.311 -0.868 . . . . 0.0 109.211 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.5 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 7.5 mtpp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.644 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 28.5 mt -115.07 152.2 46.4 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.175 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.602 ' CG ' ' CZ ' ' A' ' 97' ' ' TYR . 2.9 Cg_endo -61.44 156.65 45.33 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.131 1.887 . . . . 0.0 110.233 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.549 ' CE3' HD12 ' A' ' 63' ' ' LEU . 16.4 m95 -137.13 171.51 14.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.509 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 90' ' ' TYR . 8.7 mmt180 -133.06 143.2 49.2 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.391 -0.818 . . . . 0.0 108.819 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.529 ' CB ' HD12 ' A' ' 89' ' ' LEU . 17.3 pt-20 -121.0 149.4 42.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.14 -0.975 . . . . 0.0 110.123 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 87' ' ' ARG . . . -139.53 146.28 39.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.363 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.501 ' HA ' ' HG3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -65.24 141.17 58.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.519 -0.738 . . . . 0.0 109.629 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.56 HG22 ' CD1' ' A' ' 7' ' ' PHE . 23.1 mm -129.47 122.71 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.948 . . . . 0.0 109.833 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 5.2 m120 77.48 43.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 109.868 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.495 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 36.6 t80 -70.08 149.25 47.83 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.191 -0.943 . . . . 0.0 109.317 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.79 -78.19 0.16 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.171 -0.956 . . . . 0.0 109.488 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.8 m -165.96 168.66 15.51 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.729 -0.607 . . . . 0.0 109.615 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 78.21 -179.25 51.94 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.6 OUTLIER -43.61 165.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -1.087 . . . . 0.0 109.431 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -50.66 175.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.562 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 1.3 p30 -109.37 -169.17 1.43 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.892 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.46 9.18 18.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.91 . . . . 0.0 109.508 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 61.6 m-20 -107.21 129.24 54.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.501 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -150.02 174.6 12.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.894 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.53 ' CD1' HG23 ' A' ' 96' ' ' ILE . 5.6 tt -137.64 128.68 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 109.119 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.3 mm? -103.29 102.99 12.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.398 -0.814 . . . . 0.0 110.32 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 72' ' ' ARG . 32.1 p90 -99.38 139.94 34.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.999 -1.063 . . . . 0.0 108.559 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -103.62 173.2 6.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.059 -1.026 . . . . 0.0 110.826 -178.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 p -66.01 -19.9 66.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.509 -0.745 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 47.5 p-10 -89.58 17.05 6.79 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.582 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 66.89 29.22 8.39 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.726 -0.609 . . . . 0.0 109.989 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 6.9 mt -85.33 99.14 10.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.53 HG23 ' CD1' ' A' ' 88' ' ' ILE . 2.6 mt -93.83 116.92 36.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 110.408 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.602 ' CZ ' ' CG ' ' A' ' 64' ' ' PRO . 7.2 m-85 -116.8 155.58 28.71 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -121.49 154.12 37.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.754 -1.217 . . . . 0.0 109.713 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -140.69 125.01 17.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.496 -0.752 . . . . 0.0 108.993 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.441 HG21 ' OD1' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.65 29.38 7.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.784 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.524 ' OD2' ' CG2' ' A' ' 105' ' ' THR . 0.9 OUTLIER -150.24 21.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.114 -0.991 . . . . 0.0 109.687 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 2.2 t-80 76.61 72.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 109.261 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.46 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 9.2 m-85 50.33 20.8 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.739 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.472 ' HB2' ' CB ' ' A' ' 101' ' ' ASP . 1.2 mt-30 -86.87 -19.98 28.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.913 . . . . 0.0 109.143 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.524 ' CG2' ' OD2' ' A' ' 101' ' ' ASP . 34.3 p -146.51 157.5 43.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.5 ' CE2' ' HB3' ' A' ' 62' ' ' LYS . 82.6 m-85 -141.98 125.11 16.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 110.042 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -117.0 133.96 55.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.359 -0.838 . . . . 0.0 109.018 179.416 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -79.73 128.3 33.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.596 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 6.8 pt -127.85 17.04 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.524 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -141.25 53.35 1.55 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.463 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.74 -172.76 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.417 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.564 ' CZ ' HG23 ' A' ' 76' ' ' ILE . 47.2 m-85 -80.24 -61.96 1.82 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.482 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -30.99 67.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.35 -50.27 45.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 6' ' ' THR . 96.7 t -65.89 -45.8 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -1.115 . . . . 0.0 109.294 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.93 -35.93 69.62 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.432 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.1 OUTLIER -64.51 -55.68 19.07 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 22.6 t80 -58.61 -23.13 58.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 0.0 109.183 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 5.4 mt -71.9 -63.83 1.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.353 -0.842 . . . . 0.0 108.949 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.402 ' HG3' ' HD2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -71.01 -5.04 28.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.102 -0.999 . . . . 0.0 109.364 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.564 HG23 ' CD2' ' A' ' 17' ' ' TYR . 31.2 m -91.93 -69.96 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -0.952 . . . . 0.0 109.844 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 81.9 m-85 -89.76 -4.82 57.48 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.684 -0.635 . . . . 0.0 109.596 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 21.4 m170 57.51 57.81 4.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 162.51 129.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 74' ' ' ALA . 19.0 mt -44.05 148.24 0.82 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.287 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.5 Cg_exo -55.35 164.49 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.172 1.915 . . . . 0.0 110.444 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.81 -5.81 33.05 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.306 -0.871 . . . . 0.0 108.868 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.499 ' ND2' ' HB2' ' A' ' 21' ' ' PRO . 23.2 p30 -92.14 9.79 32.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.525 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.561 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 4.6 m-85 -108.14 99.79 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.006 . . . . 0.0 109.753 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 26' ' ' THR . 2.1 pt -106.46 124.45 61.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 108.725 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 25' ' ' ILE . 20.5 p -47.0 176.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.817 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.588 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.19 -44.76 68.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.1 -1.0 . . . . 0.0 109.092 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 m -54.49 -39.9 68.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.525 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 1.7 mm-40 -58.67 -39.73 81.52 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HB1' ' CE3' ' A' ' 35' ' ' TRP . . . -67.2 -34.56 77.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 108.663 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.501 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 18.6 mt-30 -65.95 -30.75 71.37 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.29 -37.87 84.73 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.692 0.758 . . . . 0.0 109.579 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -80.93 -8.25 59.7 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.649 -0.657 . . . . 0.0 110.124 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.01 61.77 0.71 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.619 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 1.7 t90 -118.55 135.45 54.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.195 -1.179 . . . . 0.0 109.599 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.51 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 3.5 t -89.73 131.66 36.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.619 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.494 0 O-C-N 120.965 -1.085 . . . . 0.0 110.311 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.464 ' C ' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.141 0.496 . . . . 0.0 109.995 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' A' ' 35' ' ' TRP . 11.7 tp -52.94 -66.58 0.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 109.111 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.79 -14.64 1.48 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.787 -0.571 . . . . 0.0 110.359 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.8 -36.56 42.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.89 -1.131 . . . . 0.0 109.516 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -105.49 -1.6 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 109.503 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.4 62.69 5.58 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 109.31 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 5.6 Cg_exo -58.42 152.92 50.95 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.203 1.935 . . . . 0.0 110.286 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 49.8 66.55 2.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.459 ' HD2' HG12 ' A' ' 25' ' ' ILE . 30.7 mmtp -151.88 154.64 36.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.671 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.504 ' HB2' ' CD1' ' A' ' 24' ' ' TYR . 1.8 m -135.34 124.91 25.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.537 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 11.9 mm -74.64 104.97 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -151.35 173.21 30.8 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.403 ' N ' HD13 ' A' ' 20' ' ' LEU . . . 84.17 15.27 69.83 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.48 154.31 17.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -1.151 . . . . 0.0 109.409 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.4 mm -70.08 149.67 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.632 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 60.6 t80 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.043 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.227 0.537 . . . . 0.0 109.756 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.632 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 41.1 mt -89.85 145.11 32.65 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.151 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.613 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 2.8 Cg_endo -60.31 156.23 41.84 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.025 1.816 . . . . 0.0 110.359 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.261 0.553 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.587 ' CE3' HD12 ' A' ' 63' ' ' LEU . 3.9 m95 -122.93 173.57 7.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.554 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.591 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 1.1 mmt180 -121.58 148.83 44.0 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HA ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -128.8 153.8 47.06 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.877 -1.139 . . . . 0.0 110.249 -179.304 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 20' ' ' LEU . . . -143.05 148.77 37.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.423 -0.798 . . . . 0.0 109.241 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.6 OUTLIER -77.45 124.07 27.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.727 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.564 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 22.3 mm -110.85 138.86 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.113 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.452 ' OD1' HG23 ' A' ' 76' ' ' ILE . 14.9 m120 61.58 112.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.069 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 6.8 t80 -170.45 133.95 1.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.062 -1.024 . . . . 0.0 109.674 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -140.9 -79.43 0.27 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.226 -0.921 . . . . 0.0 109.364 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 m -146.14 160.03 42.49 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.716 -0.615 . . . . 0.0 109.436 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.9 -169.15 18.79 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -64.07 144.45 57.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -1.177 . . . . 0.0 109.485 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 82' ' ' PHE . 5.2 mtm180 -43.97 163.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 109.219 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -106.84 -171.11 1.82 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.944 . . . . 0.0 109.651 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.43 23.28 9.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.475 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.5 m-20 -109.24 132.03 54.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.373 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 36.8 mtt180 -157.81 157.73 33.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.55 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.483 ' CG1' HG23 ' A' ' 96' ' ' ILE . 1.5 tt -112.93 139.64 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.245 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.4 mm? -108.45 126.59 53.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.795 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.595 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -116.69 140.05 49.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.857 -1.152 . . . . 0.0 108.666 178.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.44 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -108.12 176.01 5.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.193 -0.942 . . . . 0.0 110.379 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 p -64.23 -25.2 67.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.408 -0.808 . . . . 0.0 110.441 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.476 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -89.3 16.84 6.76 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.108 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.561 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.4 m95 67.5 29.31 7.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.713 -0.617 . . . . 0.0 110.737 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.518 ' CD1' ' HG2' ' A' ' 64' ' ' PRO . 8.8 mt -83.79 121.87 27.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.522 ' CG1' ' HB2' ' A' ' 110' ' ' ARG . 1.8 mt -115.42 112.82 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 110.75 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.613 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 26.1 m-85 -112.07 118.66 36.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -88.88 136.13 33.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.818 -1.176 . . . . 0.0 109.866 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 105' ' ' THR . 0.1 OUTLIER -125.54 131.46 52.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.392 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.2 p -114.75 31.75 6.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.159 -0.963 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -150.26 20.4 0.85 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 109.565 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.537 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.5 t-80 79.08 73.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.496 -0.753 . . . . 0.0 109.971 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.474 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 5.0 m-85 51.57 37.73 20.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.04 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.435 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 19.7 tp60 -104.29 -72.29 0.71 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.135 -0.978 . . . . 0.0 109.052 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 99' ' ' THR . 0.8 OUTLIER -93.16 124.41 37.12 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.533 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 96.7 m-85 -112.17 121.66 45.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.067 -1.021 . . . . 0.0 110.065 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 3.8 m -108.64 130.81 55.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.386 -0.821 . . . . 0.0 109.087 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -79.41 113.8 17.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.047 -1.033 . . . . 0.0 109.668 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.452 HD12 ' CD1' ' A' ' 88' ' ' ILE . 29.5 pt -113.21 -14.98 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 109.328 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.522 ' HB2' ' CG1' ' A' ' 96' ' ' ILE . 1.1 mtt-85 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.237 0.541 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -134.57 49.44 2.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -135.31 -169.93 2.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 0.0 109.443 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 76' ' ' ILE . 42.6 m-85 -80.14 -59.64 2.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.213 -0.929 . . . . 0.0 109.463 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -28.72 65.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.969 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.37 -51.27 33.03 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 76' ' ' ILE . 38.7 t -67.04 -49.36 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -1.153 . . . . 0.0 109.167 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 109' ' ' ILE . . . -53.88 -37.04 63.3 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.27 -55.63 23.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 23.2 t80 -59.94 -18.3 44.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.429 -0.794 . . . . 0.0 109.03 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.493 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.7 OUTLIER -76.1 -63.82 1.23 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.328 -0.857 . . . . 0.0 109.296 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.439 ' NE2' ' HD3' ' A' ' 110' ' ' ARG . 3.1 pt20 -70.51 -8.49 51.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.906 -1.121 . . . . 0.0 109.353 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.498 HG23 ' CD1' ' A' ' 17' ' ' TYR . 27.7 m -91.9 -65.7 0.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.782 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 96.3 m-85 -89.51 3.3 52.88 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.713 -0.617 . . . . 0.0 109.5 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.534 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 16.6 m170 45.01 45.48 8.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.6 OUTLIER 174.43 129.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 74' ' ' ALA . 18.4 mt -45.46 150.73 0.84 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 108.754 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 10.9 Cg_exo -52.98 160.06 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.084 1.856 . . . . 0.0 110.453 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -69.59 -5.89 27.52 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.309 -0.87 . . . . 0.0 109.202 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -93.44 2.87 56.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.336 -0.853 . . . . 0.0 109.628 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.2 m-85 -93.76 92.72 7.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.002 . . . . 0.0 109.943 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.8 pt -100.99 125.3 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.264 -0.897 . . . . 0.0 108.937 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 25' ' ' ILE . 12.1 p -45.96 172.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.544 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.16 -43.09 71.57 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.964 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -39.1 64.14 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' O ' HD13 ' A' ' 33' ' ' LEU . 5.5 mt-10 -59.67 -41.31 90.32 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.557 ' HB1' ' CE3' ' A' ' 35' ' ' TRP . . . -65.08 -35.98 82.88 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 0.0 108.63 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -63.03 -36.25 82.95 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.22 79.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.447 -0.783 . . . . 0.0 109.533 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.8 mp -81.17 -11.25 59.48 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.365 0.602 . . . . 0.0 110.261 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 45' ' ' VAL . . . 107.68 56.77 0.59 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.582 ' CD1' HD11 ' A' ' 42' ' ' LEU . 9.8 t90 -127.89 115.48 18.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -1.141 . . . . 0.0 109.025 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 t -90.14 112.04 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 108.994 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.581 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.195 -0.94 . . . . 0.0 109.422 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.416 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.582 HD11 ' CD1' ' A' ' 35' ' ' TRP . 9.8 tp -59.54 -52.98 63.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.449 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -56.67 -14.96 3.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 109.871 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.83 -53.83 4.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.024 . . . . 0.0 110.331 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 46' ' ' ALA . 20.4 m -89.88 -48.1 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 110.16 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.507 ' N ' HG22 ' A' ' 45' ' ' VAL . . . -116.85 77.35 8.5 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.993 . . . . 0.0 109.542 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 2.7 Cg_endo -60.92 159.47 29.25 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.21 1.94 . . . . 0.0 110.4 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.85 57.28 4.09 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.459 ' HD3' HG12 ' A' ' 25' ' ' ILE . 2.9 mmtt -137.65 110.16 7.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -1.141 . . . . 0.0 109.588 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 9.2 m -89.7 133.93 34.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.4 -0.813 . . . . 0.0 109.229 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.542 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 10.2 mm -91.06 111.48 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.102 -0.999 . . . . 0.0 109.176 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.91 169.21 33.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.77 12.71 55.25 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 5.6 m-20 -104.95 143.86 32.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -1.21 . . . . 0.0 109.38 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 54' ' ' ASP . 7.3 mt -44.44 152.22 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 109.571 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.62 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 9.9 t80 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.139 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.578 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 8.0 mptt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.335 0.588 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.62 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 56.2 mt -91.59 140.71 25.32 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.24 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' A' ' 95' ' ' LEU . 3.2 Cg_exo -61.53 84.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.078 1.852 . . . . 0.0 110.067 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.784 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.3 0.571 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.592 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 8.2 m95 -139.79 151.26 45.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 109.299 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.636 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 10.0 mpt_? -110.75 139.16 46.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.202 -0.936 . . . . 0.0 108.671 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HA ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -117.77 158.22 25.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.008 . . . . 0.0 110.269 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB3' HD12 ' A' ' 20' ' ' LEU . . . -147.91 152.95 38.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.464 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -75.39 142.6 43.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 109.323 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.573 HG23 ' CE1' ' A' ' 7' ' ' PHE . 16.8 mm -131.14 121.73 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.09 -1.006 . . . . 0.0 109.732 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.509 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER 71.63 116.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 109.698 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -170.64 127.77 0.78 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.351 -0.843 . . . . 0.0 109.493 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -121.47 -27.91 4.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.745 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 79' ' ' THR . 0.6 OUTLIER 168.91 -174.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.391 -0.818 . . . . 0.0 109.703 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 82' ' ' PHE . . . 67.07 174.7 6.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.456 ' O ' ' O ' ' A' ' 83' ' ' ARG . 7.5 m-85 -43.81 152.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -1.15 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -46.65 171.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.9 OUTLIER -106.38 -174.74 2.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 m -106.37 3.99 28.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 0.0 109.48 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.2 m-20 -95.9 129.5 43.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 109.53 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 27.2 mtt180 -154.64 178.53 10.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.181 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.481 ' CD1' HG23 ' A' ' 96' ' ' ILE . 3.7 tt -135.23 150.95 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.562 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.1 mm? -121.69 109.45 14.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.376 -0.827 . . . . 0.0 109.707 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.636 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 7.9 p90 -104.55 138.89 40.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 109.302 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.583 ' OG ' ' CH2' ' A' ' 71' ' ' TRP . 1.4 m -107.23 174.3 5.95 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.288 -0.882 . . . . 0.0 110.396 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -65.3 -23.9 67.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 109.593 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.467 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 17.8 p-10 -89.7 18.15 5.82 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 108.858 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.56 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.4 m95 66.39 29.49 9.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.677 -0.639 . . . . 0.0 110.173 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.538 ' CD1' ' HG2' ' A' ' 64' ' ' PRO . 5.7 mt -81.03 112.5 18.48 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.481 HG23 ' CD1' ' A' ' 88' ' ' ILE . 2.0 mt -109.52 110.83 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.782 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.466 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 31.5 m-85 -113.91 113.49 24.92 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.518 ' CG ' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -89.36 133.76 34.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 110.215 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -117.13 128.96 55.65 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.553 HG21 ' CZ ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -112.33 28.23 8.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.18 -0.95 . . . . 0.0 109.645 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.7 OUTLIER -150.18 22.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.463 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 8.7 t-80 77.54 71.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.381 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.426 ' OH ' ' HD2' ' A' ' 87' ' ' ARG . 5.1 m-85 50.76 20.91 0.82 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.826 . . . . 0.0 109.752 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 101' ' ' ASP . 1.2 mm-40 -90.33 -17.4 27.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -0.96 . . . . 0.0 108.87 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.473 ' O ' ' HB ' ' A' ' 99' ' ' THR . 14.9 t -143.81 161.5 38.46 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.578 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 99.4 m-85 -148.76 119.72 7.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.817 -1.177 . . . . 0.0 110.223 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.518 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 3.8 m -108.96 124.82 51.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.515 -0.741 . . . . 0.0 109.1 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -79.42 101.13 7.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.447 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.527 HD13 ' CB ' ' A' ' 11' ' ' ALA . 38.1 pt -104.63 18.18 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.478 ' CD ' HD13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.454 ' O ' HG21 ' A' ' 6' ' ' THR . 29.9 p-10 -143.76 69.74 1.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.516 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.464 ' O ' HD11 ' A' ' 76' ' ' ILE . 1.5 p -149.03 -173.15 4.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.436 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.532 ' CD1' ' HB2' ' A' ' 98' ' ' LYS . 24.1 m-85 -77.65 -60.29 2.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.893 . . . . 0.0 109.429 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -33.97 70.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.69 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.24 -50.3 46.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 6' ' ' THR . 76.0 t -66.78 -46.98 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -1.147 . . . . 0.0 109.337 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -54.69 -38.4 66.97 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.457 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.4 OUTLIER -63.85 -55.77 20.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.518 -0.739 . . . . 0.0 109.246 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.664 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 42.0 t80 -58.18 -21.08 45.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.374 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.51 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.7 OUTLIER -75.38 -63.87 1.19 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.401 -0.812 . . . . 0.0 109.317 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' OE1' ' CG ' ' A' ' 110' ' ' ARG . 46.8 mt-30 -70.58 -5.72 31.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.034 -1.041 . . . . 0.0 109.389 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 82.6 m -94.5 -67.37 0.86 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.678 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.664 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 66.6 m-85 -89.78 3.2 53.59 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 109.567 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.9 m170 44.14 51.09 7.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER 175.35 129.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 15.7 mt -43.84 160.02 0.23 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.99 . . . . 0.0 109.417 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.575 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 3.3 Cg_exo -55.22 159.23 10.46 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.236 1.957 . . . . 0.0 110.553 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.56 -5.05 30.44 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.374 -0.829 . . . . 0.0 108.947 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 21' ' ' PRO . 6.1 p30 -111.42 32.74 5.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.498 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 50' ' ' SER . 1.2 m-30 -115.18 81.06 1.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.062 -1.024 . . . . 0.0 109.363 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.1 pt -88.14 123.35 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.253 -0.905 . . . . 0.0 108.978 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 25' ' ' ILE . 82.8 p -46.92 175.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.335 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.593 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.24 -45.32 66.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.997 -1.064 . . . . 0.0 109.052 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -52.08 -33.42 39.24 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 108.361 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' O ' HD13 ' A' ' 33' ' ' LEU . 1.5 mm-40 -61.3 -46.53 89.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.92 80.33 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.498 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 33.3 mt-30 -64.45 -33.73 76.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.62 -37.89 85.6 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.19 -8.96 59.85 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.741 -0.599 . . . . 0.0 109.972 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 101.67 71.23 0.91 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.623 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -128.2 137.69 52.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -1.188 . . . . 0.0 109.441 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' ' OD1' ' A' ' 41' ' ' ASN . 9.8 p -89.58 128.77 41.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.623 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.009 -1.057 . . . . 0.0 110.384 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.529 ' OD1' ' CG1' ' A' ' 36' ' ' VAL . 2.6 p-10 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.111 0.481 . . . . 0.0 110.058 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.578 HD12 ' CD1' ' A' ' 35' ' ' TRP . 6.9 tp -56.85 -65.66 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 109.198 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.29 -9.87 3.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.798 -0.564 . . . . 0.0 110.252 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 3.7 m-20 -78.93 -30.29 44.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.973 -1.079 . . . . 0.0 109.41 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 34' ' ' GLY . 30.8 m -107.61 -14.18 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.341 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -149.3 65.24 7.83 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 109.376 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 3.1 Cg_exo -60.97 161.94 20.65 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.2 1.933 . . . . 0.0 110.317 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.52 38.34 42.82 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 15.8 mmtt -135.58 113.29 10.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -1.161 . . . . 0.0 109.55 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.579 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -89.68 155.43 19.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.531 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 5.4 mm -103.11 111.66 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.839 . . . . 0.0 109.405 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -154.1 160.09 29.21 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.08 19.91 27.25 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.528 ' HB2' ' CG ' ' A' ' 73' ' ' GLU . 4.5 m-20 -88.13 148.11 24.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -1.199 . . . . 0.0 109.467 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.0 mm -68.68 137.49 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.835 . . . . 0.0 109.758 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.641 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 78.2 t80 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 108.957 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 6.4 mtpt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.306 0.574 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.641 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 12.7 mt -94.18 147.29 33.13 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 0.0 109.279 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.567 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 2.4 Cg_endo -62.03 119.14 6.12 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.139 1.893 . . . . 0.0 110.174 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.365 0.603 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.574 ' CZ3' HD23 ' A' ' 63' ' ' LEU . 11.5 m95 -128.74 154.11 46.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.583 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 7.3 mmt180 -117.72 148.65 41.81 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 54' ' ' ASP . 5.9 pt-20 -125.49 155.02 41.19 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.789 -1.194 . . . . 0.0 110.11 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -144.16 155.59 43.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 109.416 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 3.4 m-20 -80.24 143.44 33.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.601 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.48 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 37.3 mm -127.85 119.0 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 73.83 108.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.674 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.513 ' CE1' ' HA ' ' A' ' 83' ' ' ARG . 23.3 t80 -170.71 118.81 0.52 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.336 -0.852 . . . . 0.0 109.46 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.42 -80.1 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.393 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.8 m -137.19 145.1 43.29 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.726 -0.609 . . . . 0.0 109.385 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.2 -174.25 15.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -61.71 140.69 58.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.158 -1.201 . . . . 0.0 109.426 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.513 ' HA ' ' CE1' ' A' ' 78' ' ' TYR . 45.5 mtp180 -44.04 167.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 109.346 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.42 -176.98 3.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.961 . . . . 0.0 109.684 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -113.5 15.67 18.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 109.311 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.432 ' OD2' HG21 ' A' ' 100' ' ' THR . 0.7 OUTLIER -97.96 130.45 44.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.225 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.525 ' CZ ' ' OH ' ' A' ' 103' ' ' TYR . 2.3 mtt180 -152.54 179.57 8.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.967 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.461 ' O ' HG21 ' A' ' 88' ' ' ILE . 1.8 tt -138.77 141.39 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -0.835 . . . . 0.0 108.884 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.3 mm? -111.61 125.09 53.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.365 -0.834 . . . . 0.0 109.667 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -111.3 142.61 43.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.921 -1.112 . . . . 0.0 108.839 179.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -110.88 171.77 7.27 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.186 -0.946 . . . . 0.0 110.184 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.0 p -64.59 -25.76 68.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.435 -0.791 . . . . 0.0 109.518 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.476 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 14.1 p-10 -90.01 19.8 4.68 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.573 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.0 27.77 8.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.68 -0.638 . . . . 0.0 110.133 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.532 ' CD1' ' HG2' ' A' ' 64' ' ' PRO . 7.2 mt -79.62 116.78 20.01 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.402 HG13 ' OXT' ' A' ' 110' ' ' ARG . 2.5 mt -114.6 108.05 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.088 -1.007 . . . . 0.0 110.56 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.567 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 24.9 m-85 -108.25 116.83 32.69 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -88.6 137.97 31.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.867 -1.146 . . . . 0.0 109.997 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -122.0 127.3 50.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.432 HG21 ' OD2' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -111.89 29.37 7.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.11 -0.994 . . . . 0.0 109.59 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -150.06 22.44 0.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.726 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.523 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.5 OUTLIER 77.42 69.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.525 ' OH ' ' CZ ' ' A' ' 87' ' ' ARG . 14.8 m-85 49.45 21.81 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.798 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.453 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . 4.8 mt-30 -88.0 -17.29 31.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 108.97 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.476 ' O ' ' HB ' ' A' ' 99' ' ' THR . 23.0 m -147.27 155.79 42.36 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . 90.2 m-85 -139.76 116.44 10.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.973 -1.08 . . . . 0.0 110.11 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 1.7 m -107.65 127.27 53.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 113.95 17.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 109.646 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.519 HG22 ' CD ' ' A' ' 98' ' ' LYS . 3.5 pt -109.3 -24.25 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.646 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.425 ' OXT' ' O ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.429 HG23 ' HA ' ' A' ' 10' ' ' VAL . 2.7 mp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -142.67 47.33 1.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.456 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -136.75 -170.19 2.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.348 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.524 ' CZ ' HG23 ' A' ' 76' ' ' ILE . 52.3 m-85 -77.38 -59.57 2.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.402 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -31.19 67.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.894 . . . . 0.0 109.783 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 4' ' ' ILE . . . -68.56 -51.96 28.31 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.457 HG23 ' OH ' ' A' ' 24' ' ' TYR . 73.7 t -66.09 -45.91 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -1.118 . . . . 0.0 109.313 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -55.95 -38.86 70.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.49 -55.6 26.0 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.679 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 35.1 t80 -58.06 -22.35 49.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.327 -0.858 . . . . 0.0 109.046 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER -71.61 -62.87 1.25 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.43 -0.794 . . . . 0.0 108.989 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -71.28 -5.6 33.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.042 -1.036 . . . . 0.0 109.317 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 25.2 m -89.82 -69.48 0.72 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.952 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.679 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 77.5 m-85 -89.47 -7.79 54.3 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.626 -0.671 . . . . 0.0 109.463 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 23.1 m170 61.01 57.89 2.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.707 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 10.1 ptpt 160.64 129.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.466 HD12 ' HB3' ' A' ' 74' ' ' ALA . 30.4 mt -44.46 147.33 1.04 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 108.997 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.582 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.3 Cg_exo -52.41 160.1 3.86 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.043 1.829 . . . . 0.0 110.336 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -7.74 32.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.139 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -91.75 7.33 42.25 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.582 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.3 m-85 -98.43 98.44 9.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -0.93 . . . . 0.0 109.677 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.473 ' O ' HD11 ' A' ' 51' ' ' ILE . 1.9 pp -106.07 121.34 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 108.953 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 25' ' ' ILE . 16.8 p -46.35 173.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.667 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.87 -44.41 69.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.131 -0.98 . . . . 0.0 108.996 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 m -53.5 -38.7 63.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 2.3 mm-40 -59.51 -39.35 83.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.525 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -67.55 -37.54 82.85 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.139 -0.976 . . . . 0.0 108.624 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -61.98 -33.02 73.54 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.31 74.74 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.437 -0.789 . . . . 0.0 109.358 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.537 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.0 mp -81.17 -15.52 55.51 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.4 0.619 . . . . 0.0 110.181 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.422 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 110.44 44.53 0.98 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.641 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 5.6 t90 -109.19 121.29 44.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -1.104 . . . . 0.0 109.184 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 t -89.62 116.31 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.312 -0.867 . . . . 0.0 108.86 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 0.0 109.75 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.468 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.216 0.531 . . . . 0.0 109.724 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.641 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 5.9 tp -58.56 -53.39 58.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.542 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.22 -19.17 1.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.937 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.11 -32.87 15.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.0 110.292 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -103.17 -57.65 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.929 -1.107 . . . . 0.0 109.683 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.514 ' CB ' ' HE2' ' A' ' 49' ' ' LYS . . . -114.12 79.69 5.11 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.423 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -62.18 156.92 47.49 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.252 1.968 . . . . 0.0 110.197 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.7 69.33 0.63 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HE2' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -150.62 116.0 5.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.48 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 5.7 m -89.54 132.22 35.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.532 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 15.8 mm -87.17 104.83 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.364 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.56 168.42 34.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.16 -16.27 38.86 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.73 164.2 23.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -1.159 . . . . 0.0 109.3 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 56' ' ' PHE . 29.9 mm -67.81 166.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.922 . . . . 0.0 109.515 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.633 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 23.0 t80 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.31 -0.869 . . . . 0.0 109.457 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.581 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.331 0.586 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.633 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 20.9 mt -101.05 152.13 37.8 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.386 -0.821 . . . . 0.0 108.945 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.58 ' HD2' ' CZ2' ' A' ' 71' ' ' TRP . 5.7 Cg_exo -56.52 86.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.058 1.839 . . . . 0.0 110.072 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.889 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.583 ' CZ3' HD23 ' A' ' 63' ' ' LEU . 44.2 m95 -83.56 149.95 26.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.157 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -125.17 144.81 50.26 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 17.2 pt-20 -115.36 159.54 20.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.854 -1.154 . . . . 0.0 110.479 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 20' ' ' LEU . . . -146.3 149.58 34.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.468 -0.77 . . . . 0.0 109.297 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.401 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -71.97 138.68 48.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.524 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 19.8 mm -129.93 138.13 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.686 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 73.21 38.0 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.787 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -69.74 139.81 53.38 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.137 -0.977 . . . . 0.0 109.468 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.32 -79.84 0.38 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.504 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.5 163.18 12.48 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.788 -0.57 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.0 -159.26 52.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 83' ' ' ARG . 10.4 m-85 -51.11 147.64 5.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -1.124 . . . . 0.0 109.529 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 82' ' ' PHE . 5.5 mtp180 -53.04 -173.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.308 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -118.33 179.77 4.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.57 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -100.67 12.81 36.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.327 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.461 ' OD1' ' HA ' ' A' ' 100' ' ' THR . 50.3 m-20 -104.9 128.86 53.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.354 -0.841 . . . . 0.0 109.55 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.525 ' O ' ' CG2' ' A' ' 99' ' ' THR . 68.5 mtt180 -153.91 163.69 39.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.139 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.524 ' CD1' HG23 ' A' ' 96' ' ' ILE . 4.3 tt -121.89 155.39 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.154 -0.966 . . . . 0.0 109.518 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.578 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.4 mm? -122.36 114.81 21.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.656 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.65 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 3.1 p90 -106.86 139.6 41.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.858 -1.151 . . . . 0.0 109.172 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.563 ' OG ' ' CZ3' ' A' ' 71' ' ' TRP . 1.3 m -110.06 173.7 6.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 p -64.77 -25.25 67.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.617 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.487 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 9.8 p-10 -89.73 18.44 5.55 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.415 -0.803 . . . . 0.0 108.971 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.585 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.45 27.41 8.02 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.743 -0.598 . . . . 0.0 110.233 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.538 ' CD1' ' HG2' ' A' ' 64' ' ' PRO . 6.2 mt -79.57 116.44 19.78 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.524 HG23 ' CD1' ' A' ' 88' ' ' ILE . 5.9 mt -114.9 105.86 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.43 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.518 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 23.0 m-85 -106.05 120.61 42.23 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.449 ' HB3' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -89.4 150.58 22.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 110.191 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -136.42 131.79 34.6 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.461 ' HA ' ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -114.32 6.25 16.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 109.874 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.516 ' HB2' ' CB ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -125.43 24.68 7.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.143 -0.973 . . . . 0.0 109.397 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.6 t-80 76.53 76.01 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.92 . . . . 0.0 109.493 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.488 ' O ' ' CZ ' ' A' ' 106' ' ' PHE . 14.7 m-85 48.93 21.6 0.48 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.516 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -94.02 -34.87 12.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.011 -1.056 . . . . 0.0 109.118 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.475 ' O ' ' HB ' ' A' ' 99' ' ' THR . 95.2 m -121.14 140.81 51.49 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.581 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 94.9 m-85 -134.36 115.55 14.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.043 -1.036 . . . . 0.0 110.131 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 11.2 m -110.15 137.09 48.38 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.358 -0.839 . . . . 0.0 108.947 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -79.68 114.42 18.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 10.5 pt -132.05 68.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.878 . . . . 0.0 109.281 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 3.5 mtp180 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.263 0.554 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -149.95 54.76 0.93 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.507 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 2.2 p -139.16 -168.82 2.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 98' ' ' LYS . 32.9 m-85 -79.82 -57.7 3.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.619 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.53 -32.46 69.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 0.0 109.792 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.9 -50.04 50.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 6' ' ' THR . 35.1 t -66.98 -43.58 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -1.124 . . . . 0.0 109.385 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.453 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -57.51 -37.2 72.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.12 -56.32 13.61 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.538 -0.726 . . . . 0.0 109.242 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.638 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 15.8 t80 -60.76 -18.45 54.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 109.064 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.2 mt -74.5 -65.61 0.84 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.499 -0.751 . . . . 0.0 108.975 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -70.26 -6.7 36.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.988 -1.07 . . . . 0.0 109.254 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 19.8 m -89.42 -68.48 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 96.5 m-85 -92.0 6.42 46.44 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.627 -0.671 . . . . 0.0 109.642 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 19.0 m170 44.97 47.65 9.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.407 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 175.83 129.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 74' ' ' ALA . 27.0 mt -46.03 149.53 1.21 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.196 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.576 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 6.8 Cg_exo -53.93 162.56 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.114 1.876 . . . . 0.0 110.639 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -70.79 -5.71 32.26 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.38 -0.825 . . . . 0.0 109.034 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 53.6 p30 -91.75 0.24 57.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.869 . . . . 0.0 109.596 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.576 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 3.2 m-85 -89.87 107.92 19.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.056 -1.027 . . . . 0.0 109.579 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.532 ' O ' ' CG1' ' A' ' 25' ' ' ILE . 1.7 pp -111.95 115.34 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 109.08 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 25' ' ' ILE . 81.7 p -44.59 168.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.307 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HG2' ' CG2' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.68 -41.18 88.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.929 -1.107 . . . . 0.0 109.175 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.05 -47.54 82.82 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.467 ' HB2' HD11 ' A' ' 25' ' ' ILE . 47.2 mm-40 -50.63 -35.19 29.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.639 ' CB ' ' CE3' ' A' ' 35' ' ' TRP . . . -70.03 -40.91 74.91 Favored 'General case' 0 C--O 1.202 -1.438 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -60.03 -18.88 49.52 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.345 -1.472 . . . . 0.0 108.01 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 -48.0 64.08 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.541 -0.724 . . . . 0.0 111.675 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.592 HD21 ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -81.81 -0.07 41.64 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.928 -1.107 . . . . 0.0 111.713 -178.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.561 ' N ' HD21 ' A' ' 33' ' ' LEU . . . 108.94 25.93 5.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.893 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.639 ' CE3' ' CB ' ' A' ' 30' ' ' ALA . 10.5 t90 -89.12 123.46 33.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.895 -1.356 . . . . 0.0 109.191 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 t -91.93 114.51 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 108.917 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.585 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.232 -0.917 . . . . 0.0 109.789 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.325 0.584 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 3.7 tp -64.42 -41.01 96.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.344 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -63.26 -9.22 10.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.921 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -102.67 -36.72 8.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.039 -1.038 . . . . 0.0 110.211 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.536 HG23 ' CA ' ' A' ' 35' ' ' TRP . 28.7 m -108.13 -44.93 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.101 -1.0 . . . . 0.0 110.056 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.492 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -128.7 59.95 46.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.835 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 1.7 Cg_endo -62.58 171.08 6.04 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.175 1.917 . . . . 0.0 110.253 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.17 52.21 5.07 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -139.33 135.98 34.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -1.169 . . . . 0.0 109.557 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.495 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 13.3 m -101.64 121.79 42.68 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.235 -0.916 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.539 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 11.3 mm -79.58 105.07 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.161 -0.962 . . . . 0.0 108.902 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -140.9 172.03 23.85 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.456 -1.354 . . . . 0.0 109.932 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.78 11.65 61.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -84.49 146.97 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -1.195 . . . . 0.0 109.392 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.422 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 19.5 mm -70.2 141.4 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.58 ' CE2' HD13 ' A' ' 63' ' ' LEU . 70.6 t80 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.447 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.56 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.245 0.545 . . . . 0.0 109.591 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.58 HD13 ' CE2' ' A' ' 56' ' ' PHE . 23.4 mt -93.32 147.95 34.69 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 109.257 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.494 ' HG2' ' CD1' ' A' ' 95' ' ' LEU . 3.1 Cg_exo -60.89 162.76 17.91 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.108 1.872 . . . . 0.0 110.223 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.93 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.552 ' CZ3' HD23 ' A' ' 63' ' ' LEU . 8.8 m95 -107.52 161.49 14.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 109.471 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.647 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -117.73 131.25 56.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 0.0 108.819 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.535 ' CB ' HD12 ' A' ' 89' ' ' LEU . 3.6 pt-20 -107.44 147.49 30.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.316 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.474 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -135.17 147.27 49.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.468 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -70.78 137.01 49.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.354 -0.841 . . . . 0.0 109.818 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.505 ' CD1' HG22 ' A' ' 10' ' ' VAL . 21.5 mm -132.47 134.58 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.847 . . . . 0.0 109.428 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.1 m-20 69.9 125.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.259 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 6.4 t80 -170.4 136.47 1.33 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.201 -0.937 . . . . 0.0 109.615 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.26 -79.56 0.35 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.382 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -153.79 154.89 34.83 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.717 -0.614 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.9 -171.63 20.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.57 169.07 0.72 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -1.159 . . . . 0.0 109.388 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -56.73 177.14 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.158 -0.964 . . . . 0.0 109.315 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 0.2 OUTLIER -118.99 -174.05 2.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.875 . . . . 0.0 109.535 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 p -115.22 29.63 7.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 52.9 m-20 -114.14 128.84 56.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.573 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.539 ' O ' ' CG2' ' A' ' 99' ' ' THR . 2.2 mtt180 -156.73 137.27 13.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.388 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.596 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 5.1 tt -93.12 126.11 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.117 -0.989 . . . . 0.0 109.258 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.535 HD12 ' CB ' ' A' ' 73' ' ' GLU . 4.0 mm? -95.67 100.36 12.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.472 -0.767 . . . . 0.0 109.994 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.647 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 28.8 p90 -97.54 140.35 32.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.983 -1.073 . . . . 0.0 108.525 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.472 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.3 OUTLIER -107.84 172.37 6.87 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.985 -1.072 . . . . 0.0 110.761 -178.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -22.19 66.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.5 -0.75 . . . . 0.0 109.826 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 41.8 p-10 -89.58 17.88 5.97 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.382 -0.824 . . . . 0.0 108.829 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.567 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.84 23.96 8.29 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.634 -0.666 . . . . 0.0 110.104 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.494 ' CD1' ' HG2' ' A' ' 64' ' ' PRO . 7.2 mt -79.64 101.18 8.2 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.596 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 5.5 mt -96.5 118.26 42.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.22 -0.925 . . . . 0.0 110.631 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.47 ' O ' HG13 ' A' ' 88' ' ' ILE . 11.9 m-85 -120.11 160.97 21.79 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.57 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -131.79 122.02 25.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.756 -1.215 . . . . 0.0 110.056 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -108.69 131.14 55.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 109.01 179.349 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 p -115.12 18.15 16.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.7 OUTLIER -139.18 23.55 2.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER 78.33 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 50.35 20.89 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.808 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.77 -15.23 26.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.114 -0.992 . . . . 0.0 109.076 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.52 ' CG2' ' OD2' ' A' ' 101' ' ' ASP . 12.5 t -148.78 145.35 27.54 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 62' ' ' LYS . 53.7 m-85 -135.99 111.45 9.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.919 -1.113 . . . . 0.0 110.153 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.522 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.8 m -98.34 131.31 44.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.426 -0.796 . . . . 0.0 108.906 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 76.5 tttt -80.03 122.35 26.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.548 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 pt -119.68 15.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.484 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.489 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.426 ' CG2' ' C ' ' A' ' 9' ' ' GLY . 13.3 mt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -144.22 49.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.489 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 1.2 p -138.68 -173.82 3.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.368 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.607 ' CE2' ' CG2' ' A' ' 100' ' ' THR . 38.2 m-85 -76.57 -57.08 4.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.576 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -32.09 69.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 109.875 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.426 ' C ' ' CG2' ' A' ' 4' ' ' ILE . . . -67.59 -52.76 28.15 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.524 HG22 ' CD1' ' A' ' 76' ' ' ILE . 21.8 t -65.27 -40.71 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -1.14 . . . . 0.0 109.192 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.587 ' HB3' HD13 ' A' ' 109' ' ' ILE . . . -59.23 -37.11 76.71 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 1.242 ' OD1' ' NH2' ' A' ' 110' ' ' ARG . 0.7 OUTLIER -65.52 -55.81 15.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.523 -0.736 . . . . 0.0 109.161 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.641 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 38.0 t80 -60.77 -19.24 58.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.185 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 0.6 OUTLIER -74.94 -60.53 2.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.405 -0.81 . . . . 0.0 109.311 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -71.03 -10.9 60.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.905 -1.122 . . . . 0.0 109.254 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.529 HG23 ' CD1' ' A' ' 17' ' ' TYR . 38.7 m -89.42 -66.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.876 . . . . 0.0 110.411 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 71.0 m-85 -89.38 -6.74 56.35 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.61 -0.681 . . . . 0.0 109.742 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.496 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 18.5 m170 55.94 58.6 4.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.414 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 161.65 131.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 74' ' ' ALA . 33.3 mt -44.47 150.17 0.69 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 109.252 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.584 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 7.4 Cg_exo -53.62 163.27 2.87 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.151 1.901 . . . . 0.0 110.428 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -71.22 -4.88 28.03 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.345 -0.847 . . . . 0.0 109.028 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -95.76 11.76 32.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.606 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.584 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 3.1 m-85 -101.77 109.75 21.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.152 -0.967 . . . . 0.0 109.484 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.4 pp -115.73 118.08 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.327 -0.858 . . . . 0.0 108.989 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.485 ' O ' ' O ' ' A' ' 25' ' ' ILE . 14.2 p -45.82 171.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.301 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.58 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -67.9 -42.94 80.39 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.942 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.6 m -55.43 -41.36 72.68 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.482 ' O ' HD13 ' A' ' 33' ' ' LEU . 11.8 mm-40 -57.11 -40.88 77.93 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.577 ' HB1' ' CE3' ' A' ' 35' ' ' TRP . . . -64.18 -36.84 85.36 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' OE1' ' CE3' ' A' ' 35' ' ' TRP . 6.7 mm100 -60.38 -39.21 86.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.31 -35.52 73.94 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.455 -0.778 . . . . 0.0 109.832 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.7 mp -81.23 -14.02 57.93 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.628 -0.67 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 110.77 40.39 1.32 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.582 ' CD1' HD11 ' A' ' 42' ' ' LEU . 10.9 t90 -109.92 118.9 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -1.19 . . . . 0.0 108.993 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -91.35 111.33 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.334 -0.854 . . . . 0.0 109.106 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.578 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.215 -0.928 . . . . 0.0 109.598 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 44' ' ' ASP . 1.8 p-10 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.228 0.537 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.582 HD11 ' CD1' ' A' ' 35' ' ' TRP . 5.8 tp -62.81 -44.95 94.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.185 -0.947 . . . . 0.0 109.666 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.29 -8.1 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 110.128 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 32.7 m-20 -101.6 -22.72 14.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.019 -1.051 . . . . 0.0 110.258 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 35' ' ' TRP . 17.9 m -121.18 -48.54 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.909 -1.12 . . . . 0.0 110.124 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -127.55 60.57 44.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.119 -0.988 . . . . 0.0 110.115 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 1.7 Cg_endo -62.66 -179.55 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.172 1.914 . . . . 0.0 110.177 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.44 59.66 3.03 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HG2' HG12 ' A' ' 25' ' ' ILE . 3.8 mttp -151.51 171.48 17.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -1.157 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.528 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 19.4 m -137.34 118.9 14.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.564 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.549 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 8.7 mm -76.99 103.64 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.048 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -147.38 171.2 28.06 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.86 7.87 54.87 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.434 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 9.7 m-20 -79.99 145.12 32.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -1.209 . . . . 0.0 109.313 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mm -69.97 138.05 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.537 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.58 ' CE2' HD13 ' A' ' 63' ' ' LEU . 60.0 t80 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.827 . . . . 0.0 109.359 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 1.9 mttt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.282 0.563 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.58 HD13 ' CE2' ' A' ' 56' ' ' PHE . 16.9 mt -94.88 146.39 31.29 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 0.0 109.122 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.459 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 3.8 Cg_exo -60.35 86.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.059 1.839 . . . . 0.0 110.209 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.966 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.272 0.558 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.576 ' CZ3' HD23 ' A' ' 63' ' ' LEU . 23.1 m95 -136.98 165.89 24.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.583 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 35.0 mtt180 -132.87 143.78 49.75 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.671 ' OE2' ' OH ' ' A' ' 103' ' ' TYR . 10.4 pt-20 -121.48 155.39 35.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.972 -1.08 . . . . 0.0 110.459 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HB3' HD12 ' A' ' 20' ' ' LEU . . . -146.77 148.96 32.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 109.144 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -68.72 133.04 47.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.565 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 26.3 mm -119.46 116.09 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.965 . . . . 0.0 109.644 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 72.49 124.29 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.868 . . . . 0.0 109.631 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -170.59 148.06 2.99 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.286 -0.884 . . . . 0.0 109.468 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.98 -79.84 0.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.453 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -145.3 171.86 13.97 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.754 -0.591 . . . . 0.0 109.452 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.61 -166.55 43.55 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -62.89 179.36 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -1.125 . . . . 0.0 109.428 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -78.56 164.55 24.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -104.72 -168.32 1.46 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.299 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.523 ' HB3' ' N ' ' A' ' 102' ' ' HIS . 13.3 m -105.1 16.44 25.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.0 109.649 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.661 ' OD2' HG23 ' A' ' 100' ' ' THR . 0.9 OUTLIER -96.66 126.78 42.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.638 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.618 ' O ' ' CG2' ' A' ' 99' ' ' THR . 1.9 mtt180 -160.09 150.69 18.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 109.499 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.609 HD13 HD12 ' A' ' 109' ' ' ILE . 3.3 tt -108.29 156.64 8.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 109.23 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.453 HD12 ' CB ' ' A' ' 73' ' ' GLU . 3.4 mm? -125.95 107.17 10.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.428 -0.795 . . . . 0.0 109.376 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.583 ' CE2' ' HB3' ' A' ' 72' ' ' ARG . 1.6 p90 -102.44 139.02 38.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.795 -1.191 . . . . 0.0 109.025 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.442 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -108.12 174.64 5.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.262 -0.899 . . . . 0.0 110.396 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.4 p -65.29 -24.68 67.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 45.5 p30 -89.76 18.06 5.96 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.581 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.02 29.66 7.9 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.725 -0.609 . . . . 0.0 110.048 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.491 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 9.0 mt -82.21 113.06 19.78 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.523 HG23 ' CD1' ' A' ' 88' ' ' ILE . 2.0 mt -109.24 114.89 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 110.366 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.858 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 26.8 m-85 -121.27 118.63 30.03 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.579 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -88.51 117.3 27.35 Favored 'General case' 0 N--CA 1.492 1.632 1 N-CA-C 125.7 5.444 . . . . 0.0 125.7 -179.282 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.618 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -108.69 131.14 55.21 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 124.652 3.387 . . . . 0.0 109.01 -170.31 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.661 HG23 ' OD2' ' A' ' 86' ' ' ASP . 1.9 p -115.12 18.15 16.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.7 OUTLIER -139.18 23.55 2.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER 78.33 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.671 ' OH ' ' OE2' ' A' ' 73' ' ' GLU . 15.5 m-85 50.35 20.89 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.808 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.77 -15.23 26.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.114 -0.992 . . . . 0.0 109.076 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.52 ' CG2' ' OD2' ' A' ' 101' ' ' ASP . 12.5 t -148.78 145.35 27.54 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.858 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . 53.7 m-85 -135.99 111.45 9.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.919 -1.113 . . . . 0.0 110.153 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.522 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.8 m -98.34 131.31 44.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.426 -0.796 . . . . 0.0 108.906 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -80.03 122.35 26.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.548 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.609 HD12 HD13 ' A' ' 88' ' ' ILE . 11.3 pt -119.68 15.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.484 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 1.242 ' NH2' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.489 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.88 103.6 3.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.402 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.76 -173.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 0.0 109.649 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.425 HD11 ' HB2' ' A' ' 13' ' ' TYR . 11.1 mt -112.0 117.51 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.873 . . . . 0.0 109.369 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -144.48 62.41 1.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.952 . . . . 0.0 109.705 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.445 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -140.0 -174.56 3.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.923 . . . . 0.0 109.323 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 98' ' ' LYS . 21.3 m-85 -77.31 -60.84 2.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.256 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -33.46 70.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.371 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.28 -48.99 60.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 6' ' ' THR . 41.6 t -68.31 -36.37 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -1.144 . . . . 0.0 109.207 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.1 -38.86 87.78 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.78 -54.79 19.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.546 -0.721 . . . . 0.0 109.118 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE1' ' CD2' ' A' ' 17' ' ' TYR . 47.9 t80 -55.39 -26.67 42.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.844 . . . . 0.0 109.218 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.486 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 1.2 mt -72.84 -60.5 2.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.428 -0.795 . . . . 0.0 109.376 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.426 ' NE2' ' OXT' ' A' ' 110' ' ' ARG . 2.9 mt-30 -70.49 -5.21 27.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.025 -1.047 . . . . 0.0 109.565 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 m -93.15 -68.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.17 -0.956 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD2' ' CE1' ' A' ' 13' ' ' TYR . 58.8 m-85 -89.63 3.96 50.95 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.644 -0.66 . . . . 0.0 109.553 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.7 m170 43.89 51.46 6.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER 177.39 130.38 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.536 -0.728 . . . . 0.0 109.117 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 17.6 mt -47.61 159.37 0.44 Allowed Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.093 -1.004 . . . . 0.0 109.131 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.58 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 4.1 Cg_exo -54.7 158.43 10.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.17 1.913 . . . . 0.0 110.454 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.21 -6.3 33.55 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.373 -0.829 . . . . 0.0 109.03 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.3 28.61 8.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.89 . . . . 0.0 109.463 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.596 ' CE1' ' CB ' ' A' ' 50' ' ' SER . 1.6 m-30 -113.59 79.03 1.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.505 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -94.26 127.96 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.906 . . . . 0.0 108.983 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 25' ' ' ILE . 44.0 p -46.66 176.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 109.992 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.581 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.24 -48.64 56.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.102 -0.999 . . . . 0.0 109.161 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -51.57 -36.42 45.3 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.486 ' O ' HD13 ' A' ' 33' ' ' LEU . 10.1 mm-40 -60.62 -43.27 97.66 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.592 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . . . -65.21 -33.52 76.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.197 -0.94 . . . . 0.0 108.529 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' CG ' ' CE3' ' A' ' 35' ' ' TRP . 1.0 OUTLIER -66.17 -31.68 72.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.31 87.42 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.448 -0.782 . . . . 0.0 109.519 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -80.82 -7.12 59.34 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.672 -0.642 . . . . 0.0 109.878 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 45' ' ' VAL . . . 104.18 68.49 0.76 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.595 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 2.6 t90 -126.52 133.4 51.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -1.172 . . . . 0.0 109.664 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.507 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 39.3 t -89.6 132.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.595 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -63.88 -6.86 6.62 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.876 -1.14 . . . . 0.0 110.23 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -44.55 -24.06 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 109.102 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.591 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER 68.96 28.27 5.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.563 -0.711 . . . . 0.0 109.8 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.633 ' CA ' ' CE1' ' A' ' 82' ' ' PHE . . . -127.06 10.51 6.98 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -159.26 27.1 0.2 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.11 -1.229 . . . . 0.0 109.861 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 35' ' ' TRP . 6.6 tp -57.96 -65.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.121 -0.987 . . . . 0.0 109.049 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.66 -11.13 2.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.836 -0.54 . . . . 0.0 110.228 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -78.98 -39.06 35.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.97 -1.081 . . . . 0.0 109.723 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 35' ' ' TRP . 33.3 m -96.64 -15.26 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.466 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.65 63.92 6.18 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 4.0 Cg_exo -59.59 164.87 10.55 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.191 1.927 . . . . 0.0 110.39 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.11 54.75 24.72 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.455 ' HG2' HG12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -152.26 162.98 40.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.589 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.596 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -139.04 159.75 41.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.462 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.54 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 3.7 mm -105.01 111.89 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.512 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.58 165.0 33.33 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.64 22.56 28.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.414 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 39.8 m-20 -97.28 145.44 26.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -1.141 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.3 mm -65.54 143.74 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.587 ' CE2' HD13 ' A' ' 63' ' ' LEU . 86.0 t80 -117.89 86.35 2.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.302 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.2 p -70.39 -4.07 20.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 109.861 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.573 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 1.0 OUTLIER 76.89 62.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -48.09 -25.94 1.64 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.39 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.18 -58.6 2.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.409 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.416 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . 113.68 85.77 1.42 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.58 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 13.1 mttt -149.95 15.8 0.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -1.133 . . . . 0.0 109.588 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.587 HD13 ' CE2' ' A' ' 56' ' ' PHE . 48.5 mt -114.36 147.22 37.49 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.918 . . . . 0.0 109.161 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.608 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 2.4 Cg_endo -62.38 87.99 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.166 1.911 . . . . 0.0 110.182 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.32 -176.91 32.92 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -147.23 179.07 7.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -1.188 . . . . 0.0 109.51 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.7 t -60.51 142.21 55.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.424 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.47 -30.83 7.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.505 ' HG2' ' N ' ' A' ' 70' ' ' THR . 5.9 ttt180 -86.7 155.47 20.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 109.321 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.505 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 7.6 m -129.34 145.9 51.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 0.0 109.557 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.584 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 6.7 m95 -107.64 175.4 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.434 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.652 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 1.4 mmt180 -128.47 137.84 52.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.349 -0.844 . . . . 0.0 108.785 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' HA ' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -116.96 157.89 24.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.022 -1.049 . . . . 0.0 110.102 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.5 ' HB2' ' CG2' ' A' ' 88' ' ' ILE . . . -148.64 151.03 34.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -0.813 . . . . 0.0 109.129 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -73.03 131.15 41.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.697 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.495 HG22 ' CD1' ' A' ' 7' ' ' PHE . 20.5 mm -115.74 126.15 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.3 -0.875 . . . . 0.0 108.885 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER 68.6 117.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.033 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.413 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 2.5 t80 -170.44 125.21 0.73 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.136 -0.977 . . . . 0.0 109.586 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.01 -80.25 0.46 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.0 p -143.93 156.22 44.35 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.759 -0.588 . . . . 0.0 109.458 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.39 -167.9 17.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.633 ' CE1' ' CA ' ' A' ' 40' ' ' GLY . 1.5 m-85 -65.34 149.67 49.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -1.187 . . . . 0.0 109.264 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.603 ' CB ' ' CZ ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -46.99 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.076 -1.015 . . . . 0.0 109.133 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.77 179.89 3.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.606 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -108.21 11.59 27.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.451 ' OD1' HG21 ' A' ' 100' ' ' THR . 63.4 m-20 -96.22 129.37 43.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.537 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.3 OUTLIER -155.68 156.09 34.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.213 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.586 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 18.9 tt -112.26 160.49 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.997 -1.064 . . . . 0.0 109.287 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 73' ' ' GLU . 3.4 mm? -130.48 103.52 6.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.652 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 34.0 p90 -99.62 140.42 33.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.813 -1.18 . . . . 0.0 108.93 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.47 176.03 5.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.164 -0.96 . . . . 0.0 110.377 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 p -65.47 -25.17 67.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.447 -0.783 . . . . 0.0 109.576 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 26.7 p-10 -89.65 17.57 6.34 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.571 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.79 26.04 7.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.659 -0.65 . . . . 0.0 110.291 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.503 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 7.0 mt -80.34 113.42 18.51 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.586 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 2.8 mt -106.82 119.88 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -1.0 . . . . 0.0 110.617 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.608 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 16.3 m-85 -122.89 117.45 25.62 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.44 147.06 24.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.981 -1.075 . . . . 0.0 110.21 -178.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -132.8 125.71 30.7 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.451 HG21 ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -108.65 29.11 7.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.728 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -150.0 20.16 0.88 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.643 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER 79.06 68.83 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.389 -0.819 . . . . 0.0 110.073 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.568 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 8.1 m-85 54.44 17.5 1.61 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 110.153 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.475 ' CB ' ' OD2' ' A' ' 101' ' ' ASP . 3.9 mm-40 -92.54 -15.85 26.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 109.093 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.501 ' N ' ' OD2' ' A' ' 101' ' ' ASP . 40.8 m -144.54 147.13 32.83 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 62' ' ' LYS . 75.5 m-85 -140.49 130.0 24.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.839 -1.163 . . . . 0.0 110.58 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 89.9 m -120.05 133.67 55.47 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.23 115.41 18.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.47 HD13 HD13 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -109.84 -83.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 109.536 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.464 ' HB2' HD11 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.283 0.563 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.94 99.76 9.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.423 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.8 m -71.6 -173.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -122.45 96.02 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 109.472 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -140.65 53.87 1.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.469 ' O ' HD11 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -137.19 -170.58 2.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 98' ' ' LYS . 46.2 m-85 -75.18 -58.66 3.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.269 -0.895 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.442 ' OD1' ' NH2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -71.09 -31.5 67.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.808 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.75 -52.27 30.38 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 6' ' ' THR . 99.9 t -66.74 -42.79 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -1.131 . . . . 0.0 109.386 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' HB3' HD11 ' A' ' 96' ' ' ILE . . . -57.32 -38.18 73.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.454 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.9 m-20 -65.46 -55.67 16.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.563 -0.711 . . . . 0.0 109.224 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.688 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 53.7 t80 -58.55 -21.32 52.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 109.195 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 0.4 OUTLIER -74.99 -64.28 1.08 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.394 -0.816 . . . . 0.0 109.212 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -70.43 -5.62 29.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.021 . . . . 0.0 109.45 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.458 HG23 ' CD1' ' A' ' 17' ' ' TYR . 67.9 m -93.85 -67.08 0.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 109.662 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.688 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 78.2 m-85 -89.95 3.66 52.44 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.567 -0.708 . . . . 0.0 109.533 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.47 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 25.8 m170 43.75 51.75 6.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.721 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 7.8 ptmt 175.89 129.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.461 -0.774 . . . . 0.0 109.168 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 14.7 mt -44.04 161.06 0.22 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.139 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.5 Cg_exo -53.51 159.91 5.81 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.124 1.883 . . . . 0.0 110.403 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.75 -3.31 24.48 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.348 -0.845 . . . . 0.0 109.147 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -117.47 34.67 5.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.95 . . . . 0.0 109.61 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.615 ' CE1' ' CB ' ' A' ' 50' ' ' SER . 1.5 m-30 -115.34 90.83 3.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.544 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.2 pt -97.27 124.09 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.925 . . . . 0.0 109.14 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 25' ' ' ILE . 12.2 p -45.44 172.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 109.637 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.575 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.86 -42.36 73.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 109.087 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 t -53.98 -37.24 63.76 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.509 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -59.78 -44.28 93.99 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 42' ' ' LEU . . . -61.49 -39.79 92.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.251 -0.906 . . . . 0.0 108.59 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.557 ' CG ' ' CE3' ' A' ' 35' ' ' TRP . 34.0 mt-30 -61.36 -34.86 76.0 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.27 -33.77 74.08 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.442 -0.786 . . . . 0.0 109.38 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.12 -13.74 58.39 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.653 -0.654 . . . . 0.0 109.997 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.462 ' O ' HG12 ' A' ' 45' ' ' VAL . . . 111.74 46.06 0.8 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.606 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 2.9 t90 -106.8 133.13 51.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -1.191 . . . . 0.0 109.725 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.523 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 9.1 p -89.57 134.55 28.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -63.42 -5.26 3.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.898 -1.126 . . . . 0.0 110.618 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 17.7 p -45.97 -25.21 0.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.858 -1.152 . . . . 0.0 108.411 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.598 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 3.4 mttt 72.55 39.06 0.74 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.726 -0.609 . . . . 0.0 109.751 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.558 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -131.44 -28.61 0.63 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.373 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.505 ' OD1' ' CG1' ' A' ' 36' ' ' VAL . 3.2 p-10 -121.4 33.73 5.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.876 -1.367 . . . . 0.0 110.248 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.579 HD11 ' CD1' ' A' ' 35' ' ' TRP . 8.1 tp -60.34 -64.65 0.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.962 -1.087 . . . . 0.0 109.191 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.12 -10.05 5.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.735 -0.603 . . . . 0.0 110.158 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 41' ' ' ASN . 27.6 t70 -79.1 -28.66 43.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.018 -1.051 . . . . 0.0 109.6 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 34' ' ' GLY . 4.4 m -110.04 -13.87 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.67 68.11 12.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.65 155.74 51.87 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.206 1.938 . . . . 0.0 110.251 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.03 54.67 24.86 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.41 ' HG2' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -153.88 120.1 5.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -1.131 . . . . 0.0 109.469 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.615 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -91.53 166.11 13.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.593 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.544 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 2.3 mm -112.13 107.78 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 0.0 109.667 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.94 156.35 27.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.425 ' CA ' HD13 ' A' ' 20' ' ' LEU . . . 104.92 32.74 3.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' OD2' ' CD ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -109.65 155.05 21.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -1.202 . . . . 0.0 109.403 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.0 mm -70.65 151.06 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.565 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.597 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 70.7 t80 -129.41 88.82 2.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 4.3 t -64.37 -10.17 22.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.091 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.584 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 49.4 t-20 65.04 52.24 1.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.537 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -54.55 -53.71 50.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.506 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -54.06 -41.95 68.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.99 58.07 2.41 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 3.4 mptm? -121.27 -7.95 9.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.342 -1.093 . . . . 0.0 109.565 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.597 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 11.2 mt -99.0 146.22 31.31 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.338 -0.851 . . . . 0.0 109.215 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.473 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 4.0 Cg_exo -60.93 104.19 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.156 1.904 . . . . 0.0 110.323 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.432 ' HA2' ' HD3' ' A' ' 69' ' ' ARG . . . -149.8 126.85 2.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 68' ' ' GLY . 6.8 mttt -90.44 170.35 10.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -1.176 . . . . 0.0 109.532 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.6 p -50.56 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 109.691 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 116.32 22.73 4.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.432 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -112.84 121.46 44.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -1.114 . . . . 0.0 109.404 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -96.81 -178.65 4.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.88 . . . . 0.0 109.563 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.591 ' CZ2' ' HB3' ' A' ' 63' ' ' LEU . 18.9 m95 -149.22 171.03 17.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.61 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 93.4 mtt180 -131.99 151.92 51.45 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -126.72 152.47 46.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.992 -1.067 . . . . 0.0 110.469 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -148.06 151.5 35.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.754 . . . . 0.0 108.992 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -73.43 137.93 44.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.993 -1.067 . . . . 0.0 109.789 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.493 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 21.8 mm -116.99 112.15 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 108.89 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.2 t-20 74.02 123.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.15 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 6.7 t80 -170.41 119.19 0.56 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.262 -0.899 . . . . 0.0 109.439 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.3 -43.9 2.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.124 -0.985 . . . . 0.0 109.561 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 173.63 169.1 0.18 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.613 -0.679 . . . . 0.0 109.444 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.96 -161.7 21.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -70.43 143.76 51.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -1.108 . . . . 0.0 109.685 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.519 ' HB2' ' HB3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -40.73 142.13 0.49 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER -87.79 -176.45 5.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.181 -0.949 . . . . 0.0 109.752 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.92 3.89 19.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.801 . . . . 0.0 109.558 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.509 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 8.1 m-20 -89.68 128.93 36.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.107 -0.995 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.532 ' O ' ' CG2' ' A' ' 99' ' ' THR . 83.7 mtt180 -159.05 161.77 36.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.521 ' CD1' HG23 ' A' ' 96' ' ' ILE . 1.3 tt -122.93 153.06 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.13 -0.981 . . . . 0.0 109.672 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.466 HD11 ' O ' ' A' ' 72' ' ' ARG . 3.8 mm? -118.88 120.65 37.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.565 -0.709 . . . . 0.0 109.217 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.603 ' CD2' ' HB2' ' A' ' 72' ' ' ARG . 1.7 p90 -113.91 138.36 50.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.851 -1.156 . . . . 0.0 109.011 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.455 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -107.67 172.87 6.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 110.295 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.5 p -66.41 -22.57 66.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.319 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 30.8 p-10 -89.59 16.4 7.84 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.561 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.65 30.39 6.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.755 -0.59 . . . . 0.0 110.316 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.552 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 7.4 mt -83.59 117.72 23.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 88' ' ' ILE . 2.5 mt -114.84 109.43 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.096 -1.003 . . . . 0.0 110.615 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.525 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 21.5 m-85 -112.93 120.75 42.49 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -88.81 152.19 21.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.903 -1.123 . . . . 0.0 110.359 -178.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -136.38 123.83 22.1 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.69 29.22 7.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.82 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -150.11 20.71 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.042 -1.036 . . . . 0.0 109.889 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 48.7 t-80 79.52 70.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.46 -0.775 . . . . 0.0 109.877 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.411 ' OH ' ' OE1' ' A' ' 73' ' ' GLU . 40.6 m-85 49.43 20.91 0.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 110.155 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.451 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . 2.7 mt-30 -91.88 -14.47 29.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 0.0 109.022 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.522 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 97.6 m -144.55 157.14 44.36 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 92.3 m-85 -146.84 121.64 9.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.894 -1.129 . . . . 0.0 110.242 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -115.13 130.4 56.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 109.018 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.67 113.67 16.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.049 -1.032 . . . . 0.0 109.411 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.427 ' O ' ' CG ' ' A' ' 110' ' ' ARG . 2.4 pt -111.28 -25.65 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.642 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.52 ' HB2' ' CD1' ' A' ' 96' ' ' ILE . 1.3 mtt-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.56 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -113.26 143.14 44.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -76.56 168.52 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.477 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.414 HG23 ' HG3' ' A' ' 21' ' ' PRO . 3.6 mt -138.5 67.84 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.464 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -128.09 40.93 3.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 0.6 OUTLIER -133.39 -175.17 3.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.627 ' CD1' ' CB ' ' A' ' 98' ' ' LYS . 31.6 m-85 -78.94 -47.91 15.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.34 -40.38 70.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.904 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.33 -51.79 35.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' A' ' 6' ' ' THR . 41.2 t -63.29 -43.99 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.16 -1.2 . . . . 0.0 109.15 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.514 ' HB2' ' NH2' ' A' ' 110' ' ' ARG . . . -56.61 -39.35 73.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.442 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.1 OUTLIER -61.9 -55.64 27.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.594 -0.692 . . . . 0.0 109.154 179.322 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.679 ' CE1' ' CD2' ' A' ' 17' ' ' TYR . 12.6 t80 -57.6 -23.74 52.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.296 -0.877 . . . . 0.0 109.242 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 2.2 mt -71.45 -63.51 1.1 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.391 -0.818 . . . . 0.0 109.11 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -71.05 -4.99 27.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 109.414 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.551 HG23 ' CD2' ' A' ' 17' ' ' TYR . 48.4 m -91.2 -70.13 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.829 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.679 ' CD2' ' CE1' ' A' ' 13' ' ' TYR . 96.8 m-85 -89.91 -4.2 57.65 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.652 -0.655 . . . . 0.0 109.583 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.3 m170 57.04 51.74 10.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.671 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 172.34 129.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.565 -0.709 . . . . 0.0 109.101 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.461 HD12 ' HB3' ' A' ' 74' ' ' ALA . 21.1 mt -45.47 148.52 1.19 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.207 -0.933 . . . . 0.0 108.995 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.578 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.1 Cg_exo -53.12 160.36 4.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.112 1.875 . . . . 0.0 110.474 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.61 -8.27 33.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.353 -0.842 . . . . 0.0 109.14 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.449 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 39.5 p30 -95.2 21.97 7.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.509 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.578 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.2 m-85 -114.77 84.14 2.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.761 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.8 pp -96.62 126.18 49.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 25' ' ' ILE . 16.9 p -46.9 174.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.51 -43.75 69.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.076 -1.015 . . . . 0.0 109.042 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.17 -38.99 69.03 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.524 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 10.5 mm-40 -58.51 -39.25 79.57 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.55 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . . . -68.21 -36.61 79.81 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.522 ' HG3' ' CE3' ' A' ' 35' ' ' TRP . 25.5 mt-30 -60.74 -34.73 74.87 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.96 -34.86 70.39 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.28 -18.69 45.0 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.52 0.676 . . . . 0.0 110.002 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.04 38.56 0.95 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.6 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 10.9 t90 -100.85 121.86 42.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -1.156 . . . . 0.0 109.133 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.515 ' CG1' ' OD1' ' A' ' 41' ' ' ASN . 10.6 p -89.94 113.11 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.285 -0.884 . . . . 0.0 108.962 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.575 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -63.99 -10.77 23.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.724 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.551 ' O ' ' CE2' ' A' ' 82' ' ' PHE . 15.7 m -76.28 -74.2 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.158 -0.964 . . . . 0.0 109.535 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.4 mttp -62.42 -29.55 70.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.451 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.12 64.94 2.61 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.515 ' OD1' ' CG1' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -111.77 43.47 1.54 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -1.151 . . . . 0.0 109.51 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' ASP . 12.2 tp -54.35 -63.37 1.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.318 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -42.0 -25.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.436 -0.79 . . . . 0.0 110.147 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -79.89 -44.42 20.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.013 -1.054 . . . . 0.0 110.639 -179.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 35' ' ' TRP . 33.6 m -94.72 -52.15 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.879 -1.138 . . . . 0.0 110.556 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -119.92 74.59 19.88 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.886 -1.134 . . . . 0.0 109.918 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.9 Cg_endo -63.06 166.09 15.23 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.165 1.91 . . . . 0.0 110.263 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.455 ' O ' ' HD2' ' A' ' 49' ' ' LYS . . . 43.38 59.24 3.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -139.03 162.56 34.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 0.0 109.438 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 4.3 m -129.33 133.66 47.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.865 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.548 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 6.5 mm -96.41 107.56 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.058 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.6 171.2 33.61 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.46 71.25 1.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 10.2 m-20 -159.66 165.42 32.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -1.105 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.446 ' CD1' HG22 ' A' ' 70' ' ' THR . 23.7 mm -69.27 149.73 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.312 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.626 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 45.9 t80 -112.79 144.48 42.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.496 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 15.7 m -44.67 -86.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.43 -0.794 . . . . 0.0 109.939 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 57' ' ' SER . 7.6 t-20 68.26 5.78 4.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.912 -0.493 . . . . 0.0 109.687 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -55.03 9.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.333 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -52.01 -43.48 63.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.404 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.07 66.04 0.39 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 2.0 mmmt -118.45 -11.56 9.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -1.163 . . . . 0.0 109.485 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.626 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 61.0 mt -122.25 148.66 52.76 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.416 -0.803 . . . . 0.0 108.933 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.554 ' HD2' ' CZ2' ' A' ' 71' ' ' TRP . 2.7 Cg_endo -60.61 96.45 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.111 1.874 . . . . 0.0 110.037 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.96 162.28 38.82 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.489 ' HB2' ' NE ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -139.68 178.65 7.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -1.139 . . . . 0.0 109.494 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.2 m -70.26 94.27 0.91 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.72 59.61 2.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' CZ ' ' O ' ' A' ' 64' ' ' PRO . 21.0 ttp180 -131.84 143.36 50.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -1.157 . . . . 0.0 109.525 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.446 HG22 ' CD1' ' A' ' 55' ' ' ILE . 19.9 m -120.91 128.3 52.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.224 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.581 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 32.9 m95 -89.05 146.57 24.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.975 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.59 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 4.1 mtm180 -120.58 140.08 52.03 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -107.62 161.78 14.56 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.004 -1.06 . . . . 0.0 110.551 -178.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.49 ' HB1' ' CG2' ' A' ' 88' ' ' ILE . . . -145.93 148.16 32.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.515 -0.74 . . . . 0.0 109.183 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.462 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 1.3 m-20 -72.55 141.39 48.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.42 -0.8 . . . . 0.0 109.543 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.582 HG13 ' CE1' ' A' ' 7' ' ' PHE . 20.3 mm -135.78 137.46 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 71.62 38.72 0.95 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.479 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -69.62 136.93 51.81 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.327 -0.858 . . . . 0.0 109.576 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -129.64 -80.26 0.56 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.0 109.384 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.3 m -168.15 -178.06 3.53 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.697 -0.627 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 62.9 -155.56 41.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' CE2' ' O ' ' A' ' 38' ' ' SER . 3.3 m-85 -49.45 175.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -1.171 . . . . 0.0 109.57 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -60.62 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.392 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.86 -172.78 2.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.21 1.83 13.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.501 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 5.2 m-20 -109.06 131.37 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.981 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.1 OUTLIER -148.88 139.71 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.234 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.576 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 12.5 tt -99.57 142.82 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.047 -1.033 . . . . 0.0 109.587 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.5 mm? -115.2 114.48 25.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.368 -0.833 . . . . 0.0 109.469 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.59 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 5.0 p90 -108.72 138.5 44.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.823 -1.173 . . . . 0.0 108.739 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.565 ' HB3' ' CD2' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -111.49 177.27 4.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.904 -1.122 . . . . 0.0 110.761 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 p -65.84 -21.18 66.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.564 -0.71 . . . . 0.0 110.387 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.486 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 10.3 p-10 -89.01 13.43 12.92 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.181 -0.949 . . . . 0.0 108.95 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.562 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.6 OUTLIER 68.17 26.59 7.04 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.665 -0.647 . . . . 0.0 111.003 178.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.518 ' CD1' ' HG2' ' A' ' 64' ' ' PRO . 8.4 mt -87.67 130.37 34.82 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.576 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 9.5 mt -120.72 108.88 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 110.391 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.499 ' CE1' ' HB2' ' A' ' 108' ' ' LYS . 15.1 m-85 -107.43 112.34 25.09 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.627 ' CB ' ' CD1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -88.96 133.5 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.033 -1.042 . . . . 0.0 109.772 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -116.07 122.68 45.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 108.971 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.5 p -104.96 26.83 8.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.357 -0.84 . . . . 0.0 109.822 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 22.2 p30 -149.72 25.98 0.84 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.088 -1.007 . . . . 0.0 109.624 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 12.2 t-80 76.14 74.16 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.462 ' OH ' ' NE ' ' A' ' 87' ' ' ARG . 3.7 m-85 42.15 29.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.743 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER -99.64 -19.32 16.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 105' ' ' THR . 13.1 t -147.73 106.88 3.86 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 71.8 m-85 -93.04 125.39 37.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.127 -0.983 . . . . 0.0 110.387 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 2.6 m -112.93 125.93 54.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.401 -0.812 . . . . 0.0 108.949 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.499 ' HB2' ' CE1' ' A' ' 97' ' ' TYR . 8.9 ttmt -78.96 113.53 17.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.015 -1.053 . . . . 0.0 109.649 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.464 HD12 ' HG2' ' A' ' 98' ' ' LYS . 3.5 pt -116.05 -4.36 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.584 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.522 ' HB2' ' CG1' ' A' ' 96' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.441 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.287 0.565 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 66.95 97.15 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 m -151.76 171.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.502 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.88 100.32 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -139.59 57.82 1.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 10' ' ' VAL . 79.2 p -142.58 -177.56 5.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.34 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.539 ' CE2' HG21 ' A' ' 100' ' ' THR . 34.2 m-85 -75.64 -57.22 4.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.93 -37.35 72.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.924 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.0 -50.76 56.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 6' ' ' THR . 84.9 t -64.21 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' HB2' HD11 ' A' ' 96' ' ' ILE . . . -59.05 -36.51 75.15 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -55.54 15.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.513 -0.742 . . . . 0.0 109.039 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.677 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 42.7 t80 -60.2 -19.59 54.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 109.226 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.524 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 0.9 OUTLIER -76.62 -63.26 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.379 -0.826 . . . . 0.0 109.492 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 24.8 pt20 -70.53 -8.63 52.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.049 -1.032 . . . . 0.0 109.515 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.9 m -93.43 -62.43 1.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 109.782 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.677 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 30.3 m-85 -89.47 2.03 55.09 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.671 -0.643 . . . . 0.0 109.57 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.446 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 16.7 m170 42.99 46.97 4.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.297 -0.877 . . . . 0.0 109.669 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 17' ' ' TYR . 5.1 pttt 177.73 129.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.485 -0.76 . . . . 0.0 109.147 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 18.4 mt -44.6 160.66 0.23 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.165 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.7 Cg_exo -53.52 158.86 7.15 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.038 1.825 . . . . 0.0 110.374 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -72.37 -3.86 26.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.165 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.66 7.84 28.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.614 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.598 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 1.6 m-30 -92.05 77.18 5.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.8 pt -89.58 129.17 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.031 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 25' ' ' ILE . 28.6 p -44.29 169.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.0 109.447 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -67.62 -47.09 70.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.093 -1.005 . . . . 0.0 109.109 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -53.81 -37.13 63.22 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' O ' HD13 ' A' ' 33' ' ' LEU . 1.2 mt-10 -59.03 -40.9 86.42 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.583 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . . . -66.99 -35.34 79.73 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.589 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 2.7 mm-40 -62.42 -34.07 76.03 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.37 -36.92 83.76 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.7 mp -81.01 -5.57 57.75 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.73 -0.606 . . . . 0.0 110.255 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . 105.94 62.39 0.62 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.589 ' CE3' ' HG2' ' A' ' 31' ' ' GLN . 10.7 t90 -131.54 118.92 20.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -1.156 . . . . 0.0 109.046 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 39' ' ' LYS . 39.2 t -90.86 110.16 21.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.184 -0.948 . . . . 0.0 108.872 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.55 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -48.56 -22.97 0.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.273 -0.892 . . . . 0.0 109.63 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 m -105.73 55.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.919 . . . . 0.0 109.626 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -149.44 -50.94 0.15 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.489 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.71 10.26 56.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.466 ' C ' ' ND2' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -95.26 31.11 2.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -1.147 . . . . 0.0 109.844 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 35' ' ' TRP . 11.0 tp -52.53 -66.86 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.118 -0.989 . . . . 0.0 109.214 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.37 -14.87 3.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.482 -0.761 . . . . 0.0 109.932 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -79.46 -33.98 41.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.989 . . . . 0.0 110.017 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -100.12 -53.7 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.158 -0.964 . . . . 0.0 109.648 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -113.81 80.13 4.96 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.485 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 1.8 Cg_endo -62.88 164.79 17.97 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.227 1.951 . . . . 0.0 110.466 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 42.41 50.65 5.57 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 5.0 mmtp -145.78 103.71 3.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -1.15 . . . . 0.0 109.509 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.538 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 2.0 m -89.89 159.22 17.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.545 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 2.3 mm -99.63 134.7 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.51 149.39 11.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.11 27.69 4.98 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -96.33 145.33 25.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -1.185 . . . . 0.0 109.471 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.8 mm -65.68 145.03 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.567 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.618 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 71.6 t80 -121.4 90.02 3.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 0.0 109.186 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 11.7 p -70.15 -4.98 23.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.859 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.577 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 3.9 t-20 73.97 57.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.631 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -49.5 -40.46 37.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -84.65 -67.89 0.76 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.291 -0.881 . . . . 0.0 109.413 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.32 63.54 0.35 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 106' ' ' PHE . 6.1 mmtt -127.57 -3.17 6.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.137 -1.213 . . . . 0.0 109.598 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.618 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 57.5 mt -91.1 146.8 34.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.514 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 2.1 Cg_endo -62.17 155.67 54.97 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.096 1.864 . . . . 0.0 110.22 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.4 -174.03 21.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.63 166.31 11.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -1.11 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.9 m -64.87 107.07 1.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.452 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.52 0.94 9.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' CZ ' ' OG ' ' A' ' 91' ' ' SER . 62.3 ttt180 -86.68 155.38 20.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -1.194 . . . . 0.0 109.494 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.52 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -109.62 153.49 24.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.91 . . . . 0.0 109.451 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.585 ' CE3' HD12 ' A' ' 63' ' ' LEU . 5.4 m95 -129.2 173.31 10.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.595 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -122.24 143.37 49.64 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.539 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -126.56 151.04 48.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.86 -1.15 . . . . 0.0 110.408 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.471 ' HB3' ' OH ' ' A' ' 90' ' ' TYR . . . -143.16 148.84 37.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.801 . . . . 0.0 109.196 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.464 ' OD2' ' HB ' ' A' ' 51' ' ' ILE . 0.9 OUTLIER -76.2 132.59 40.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 76' ' ' ILE . 19.4 mm -110.83 134.54 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 7.2 m-20 64.13 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.912 . . . . 0.0 109.457 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 46.2 t80 -170.59 129.82 0.84 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.275 -0.891 . . . . 0.0 109.493 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.0 -80.04 0.62 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.349 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.88 165.53 35.92 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.715 -0.616 . . . . 0.0 109.421 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.38 -151.56 19.94 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.76 -172.29 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -1.098 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.461 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -72.56 -152.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.06 -177.68 5.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.376 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -116.48 15.86 15.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.584 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 14.6 m-20 -111.59 130.63 55.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.532 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -154.18 152.31 30.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 109.424 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.58 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 4.0 tt -113.31 138.32 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.272 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.3 mm? -109.8 116.14 31.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.35 -0.843 . . . . 0.0 109.869 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.595 ' CD2' ' HB2' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -104.78 143.1 33.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.829 -1.169 . . . . 0.0 108.922 178.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.523 ' OG ' ' CZ ' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -106.58 172.58 6.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.177 -0.952 . . . . 0.0 110.316 -179.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 94.7 p -64.67 -24.92 67.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.844 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 36.8 p-10 -89.73 18.93 5.05 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.423 -0.798 . . . . 0.0 108.926 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.575 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.62 28.12 7.51 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.689 -0.632 . . . . 0.0 110.286 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.47 ' HG ' ' OD2' ' A' ' 93' ' ' ASP . 9.0 mt -79.87 106.71 12.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.58 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 1.6 mt -104.41 111.66 34.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.101 -1.0 . . . . 0.0 110.823 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.514 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 20.4 m-85 -111.61 154.9 24.18 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.463 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -122.69 141.54 51.66 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.771 -1.205 . . . . 0.0 109.489 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -129.68 120.1 24.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.207 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.539 HG21 ' CE2' ' A' ' 7' ' ' PHE . 44.2 p -104.72 28.54 6.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.44 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -148.12 22.71 1.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 109.481 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 30.1 t-80 77.15 79.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.357 -0.839 . . . . 0.0 109.631 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 11.6 m-85 44.53 53.51 7.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.627 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.449 ' HB2' ' HB2' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -120.43 -80.81 0.63 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.0 109.215 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.0 p -89.93 105.36 17.76 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 103' ' ' TYR . 79.6 m-85 -96.28 125.63 40.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.882 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.463 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 56.3 m -111.83 136.4 51.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.432 -0.792 . . . . 0.0 108.956 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -80.06 125.77 30.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.529 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.5 pt -129.96 12.19 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.495 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 56.78 -174.29 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.456 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.74 139.94 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 109.478 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.4 82.45 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -138.19 41.71 2.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.247 -0.908 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.524 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 11.7 p -128.46 -168.09 1.86 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.547 ' CD1' ' HB2' ' A' ' 98' ' ' LYS . 58.2 m-85 -77.44 -51.99 9.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.53 -40.71 69.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.838 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.34 -51.27 38.75 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 6' ' ' THR . 58.8 t -64.13 -43.23 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -1.151 . . . . 0.0 109.32 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -56.98 -40.18 76.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.461 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -62.07 -55.32 30.2 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.532 -0.73 . . . . 0.0 109.3 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.49 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 26.2 t80 -57.69 -24.62 57.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.401 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.5 mt -71.55 -62.55 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.038 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -70.93 -5.5 31.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.119 -0.988 . . . . 0.0 109.428 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.505 HG23 ' CD2' ' A' ' 17' ' ' TYR . 54.1 m -91.49 -69.9 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.943 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CD2' HG23 ' A' ' 16' ' ' THR . 96.6 m-85 -89.7 -5.98 56.53 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.631 -0.668 . . . . 0.0 109.63 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 23.3 m170 58.15 58.06 3.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -0.85 . . . . 0.0 109.769 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER 163.99 129.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 53' ' ' GLY . 19.9 mt -45.69 147.14 1.63 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.123 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.576 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.3 Cg_exo -53.06 163.24 2.26 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.2 1.934 . . . . 0.0 110.733 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.07 -7.34 34.92 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 109.144 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -92.29 7.2 43.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.473 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.576 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 3.5 m-85 -103.34 83.56 2.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.199 -0.938 . . . . 0.0 109.75 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.1 pt -95.62 126.73 48.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 25' ' ' ILE . 28.0 p -47.95 176.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.087 -1.008 . . . . 0.0 109.607 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.585 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.43 -46.36 64.05 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.381 -0.927 . . . . 0.0 109.162 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.17 -36.63 61.11 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.518 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 1.3 mm-40 -60.42 -41.13 93.33 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -67.75 -33.14 74.27 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -62.12 -37.59 85.7 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.66 -35.75 68.75 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.461 -0.774 . . . . 0.0 109.586 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.518 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -81.16 -19.37 43.57 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.652 -0.655 . . . . 0.0 110.357 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.2 45.42 0.49 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.592 ' CD1' HD11 ' A' ' 42' ' ' LEU . 15.6 t90 -110.55 120.74 43.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -1.131 . . . . 0.0 109.272 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.41 110.73 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.347 -0.846 . . . . 0.0 109.098 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.57 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -64.15 -17.51 63.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.609 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.9 -48.78 15.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.463 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.541 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.6 mmmt -84.03 -8.09 59.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.418 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 47.93 83.6 0.02 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 41' ' ' ASN . 1.2 p-10 -136.34 45.84 2.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -1.118 . . . . 0.0 109.507 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.592 HD11 ' CD1' ' A' ' 35' ' ' TRP . 9.1 tp -60.54 -50.86 71.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 0.0 109.258 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -62.8 -10.75 14.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 0.0 109.674 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 41' ' ' ASN . 9.8 t0 -92.95 -33.99 13.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 110.161 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 35' ' ' TRP . 34.0 m -110.72 -50.44 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.998 -1.064 . . . . 0.0 110.125 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' N ' HG22 ' A' ' 45' ' ' VAL . . . -124.42 70.74 55.35 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.969 -1.082 . . . . 0.0 109.829 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.7 Cg_endo -63.29 -179.76 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.168 1.912 . . . . 0.0 110.242 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 40.75 55.99 3.17 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 17.3 mmtt -141.17 160.09 40.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -1.112 . . . . 0.0 109.637 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.569 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 67.0 m -127.64 138.55 52.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.468 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.532 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 10.4 mm -102.17 105.3 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 108.967 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -160.3 179.47 35.8 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.47 ' N ' HD13 ' A' ' 20' ' ' LEU . . . 91.81 -4.55 78.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.53 ' OD1' ' CG ' ' A' ' 73' ' ' GLU . 7.5 p30 -93.57 163.17 13.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -1.123 . . . . 0.0 109.348 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.48 ' CG2' HG23 ' A' ' 70' ' ' THR . 22.4 mt -59.58 159.42 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.516 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.625 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 6.4 t80 -101.54 145.85 28.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.859 . . . . 0.0 109.332 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 49.1 m -42.54 -87.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.406 -0.809 . . . . 0.0 109.807 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 57' ' ' SER . 2.2 t-20 79.89 13.95 0.96 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.59 -52.38 47.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.36 -0.837 . . . . 0.0 109.423 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.02 -49.9 11.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.67 61.37 0.56 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 5.8 mmtm -94.93 -12.38 26.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -1.196 . . . . 0.0 109.45 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.625 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 42.8 mt -94.68 143.88 26.96 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.0 109.04 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.505 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 1.8 Cg_endo -62.89 84.09 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.001 1.8 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.84 154.44 22.19 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -98.2 168.0 10.51 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.139 -1.212 . . . . 0.0 109.486 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 m -60.23 130.96 49.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.519 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.26 -30.29 9.36 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.72 131.6 35.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -1.178 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.48 HG23 ' CG2' ' A' ' 55' ' ' ILE . 0.8 OUTLIER -98.64 179.95 4.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.516 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.588 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 5.7 m95 -131.82 169.3 16.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.646 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 21.2 mmt180 -120.74 136.64 54.82 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.354 -0.841 . . . . 0.0 108.78 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.585 ' CB ' ' CD1' ' A' ' 89' ' ' LEU . 17.1 pt-20 -118.94 162.13 19.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.985 . . . . 0.0 110.386 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.46 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -152.85 147.84 26.48 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -71.51 140.8 50.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.618 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.488 HG22 ' CD1' ' A' ' 7' ' ' PHE . 25.4 mm -134.16 130.82 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.1 m-20 73.27 37.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.464 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.451 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 23.3 t80 -69.47 136.82 52.01 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.282 -0.886 . . . . 0.0 109.609 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.34 -79.66 0.38 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.246 -0.909 . . . . 0.0 109.377 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.76 175.71 4.45 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.67 -0.643 . . . . 0.0 109.405 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 72.64 73.74 0.83 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 39' ' ' LYS . 3.6 m-85 56.35 164.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -1.134 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -49.11 171.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.43 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -108.08 -173.83 2.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 109.246 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.32 -8.54 20.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 109.744 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.5 m-20 -91.33 128.66 37.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.599 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.528 ' CZ ' ' OH ' ' A' ' 103' ' ' TYR . 5.4 mtt180 -158.15 150.66 22.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 109.242 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.467 ' HB ' HG13 ' A' ' 76' ' ' ILE . 4.6 tt -108.68 149.81 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.949 -1.094 . . . . 0.0 109.937 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.585 ' CD1' ' CB ' ' A' ' 73' ' ' GLU . 3.5 mm? -122.33 106.99 11.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.437 -0.789 . . . . 0.0 109.462 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.646 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 22.3 p90 -101.91 140.79 35.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.89 -1.131 . . . . 0.0 109.082 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.506 ' HB2' ' CH2' ' A' ' 71' ' ' TRP . 5.3 t -105.98 174.19 5.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.267 -0.896 . . . . 0.0 110.292 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 p -66.07 -21.79 66.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.579 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.481 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 25.0 p-10 -89.56 16.02 8.45 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.441 -0.787 . . . . 0.0 108.898 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.577 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.1 m95 67.26 29.76 7.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.689 -0.632 . . . . 0.0 110.774 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.481 ' HG ' ' OD2' ' A' ' 93' ' ' ASP . 10.0 mt -87.3 118.01 26.45 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.5 ' CD1' ' HB2' ' A' ' 110' ' ' ARG . 3.3 mt -109.33 113.52 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.505 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 16.7 m-85 -113.01 113.12 25.02 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.27 131.64 35.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.045 -1.034 . . . . 0.0 109.977 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 1.1 t -115.56 123.81 49.43 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.501 -0.749 . . . . 0.0 108.995 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.481 HG21 ' CE2' ' A' ' 7' ' ' PHE . 4.4 p -108.95 30.48 6.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.793 . . . . 0.0 109.395 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 17.6 p-10 -150.0 19.16 0.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.389 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 2.2 t-80 79.46 68.51 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.43 -0.794 . . . . 0.0 109.509 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.528 ' OH ' ' CZ ' ' A' ' 87' ' ' ARG . 10.0 m-85 49.41 22.62 0.73 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.652 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.67 -18.14 21.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 99' ' ' THR . 23.1 m -150.18 108.51 3.78 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 86.2 m-85 -95.25 128.73 42.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.165 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 8.2 m -114.17 128.16 56.24 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.385 -0.822 . . . . 0.0 108.836 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -79.11 121.05 24.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 110' ' ' ARG . 2.1 pt -117.45 -39.06 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.5 ' HB2' ' CD1' ' A' ' 96' ' ' ILE . 3.8 mtt-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.503 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.67 101.95 9.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.0 m -112.39 -174.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.849 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.507 HG21 HD11 ' A' ' 4' ' ' ILE . 15.0 mm -90.36 82.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.388 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -129.9 52.87 1.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.465 ' O ' HD11 ' A' ' 76' ' ' ILE . 8.8 p -145.6 178.07 8.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.553 ' CG ' HG22 ' A' ' 76' ' ' ILE . 24.3 m-85 -74.56 -53.0 10.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.04 -35.39 71.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 0.0 109.966 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.25 -51.58 31.99 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' A' ' 6' ' ' THR . 21.7 t -67.46 -38.29 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -1.168 . . . . 0.0 109.414 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -61.04 -39.1 88.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.3 OUTLIER -64.42 -55.15 22.89 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.578 -0.701 . . . . 0.0 109.134 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 27.3 t80 -60.48 -21.36 62.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.173 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.1 mt -73.02 -63.46 1.17 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.776 . . . . 0.0 109.242 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -70.94 -8.69 54.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.039 . . . . 0.0 109.403 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.536 HG23 ' CD2' ' A' ' 17' ' ' TYR . 52.9 m -88.98 -67.71 0.82 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 110.032 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 89.5 m-85 -89.44 -2.74 58.49 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.569 -0.707 . . . . 0.0 109.538 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.49 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 17.2 m170 53.47 53.72 11.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.375 -0.828 . . . . 0.0 109.762 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER 166.72 129.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' A' ' 19' ' ' LYS . 65.1 mt -44.05 147.48 0.92 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.219 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.578 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 7.8 Cg_exo -53.02 162.89 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.247 1.965 . . . . 0.0 110.516 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -69.33 -6.68 31.2 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.326 -0.859 . . . . 0.0 109.01 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -93.73 7.22 45.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 109.483 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.578 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 2.0 m-85 -97.18 99.79 11.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.104 -0.997 . . . . 0.0 109.555 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 25' ' ' ILE . 1.1 pt -107.82 118.61 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 108.986 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 25' ' ' ILE . 21.5 p -45.52 170.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 109.37 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.584 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -65.56 -45.29 83.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.095 -1.003 . . . . 0.0 109.088 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -54.36 -39.5 67.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.081 -1.012 . . . . 0.0 108.299 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' HD13 ' A' ' 33' ' ' LEU . 21.1 mt-10 -59.38 -39.97 85.03 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.573 ' HB1' ' CE3' ' A' ' 35' ' ' TRP . . . -67.18 -34.52 77.71 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.206 -0.934 . . . . 0.0 108.643 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -63.98 -35.29 80.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.38 -34.77 72.83 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.37 -0.831 . . . . 0.0 109.265 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.3 -15.83 54.29 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.424 0.631 . . . . 0.0 110.276 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.463 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 110.8 36.6 1.84 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.59 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 4.9 t90 -101.69 123.31 45.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.181 -1.188 . . . . 0.0 109.135 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 39' ' ' LYS . 21.2 t -89.41 119.18 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 108.776 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.59 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -66.85 -35.23 79.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.194 -0.941 . . . . 0.0 109.795 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -43.17 63.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 0.0 109.564 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 6.5 mttt -83.18 -8.23 59.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 109.61 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 39' ' ' LYS . . . 46.14 96.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.433 ' OD1' ' HA ' ' A' ' 35' ' ' TRP . 47.3 p-10 -146.14 43.22 1.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -1.182 . . . . 0.0 109.686 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.575 HD11 ' CD1' ' A' ' 35' ' ' TRP . 8.5 tp -66.32 -52.02 51.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.307 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -55.21 -16.62 3.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.751 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -87.21 -52.96 5.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 110.289 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 34' ' ' GLY . 21.7 m -94.68 -47.7 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.044 -1.035 . . . . 0.0 110.316 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.473 ' HB2' ' HG3' ' A' ' 49' ' ' LYS . . . -115.78 78.6 7.18 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 109.776 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -63.19 154.32 68.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.188 1.925 . . . . 0.0 110.191 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 43.1 63.68 1.96 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 46' ' ' ALA . 6.8 mmtm -134.63 117.19 15.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -1.166 . . . . 0.0 109.405 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.1 m -90.01 128.05 36.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.869 . . . . 0.0 109.622 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.536 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 6.5 mm -91.21 105.9 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.144 -0.973 . . . . 0.0 108.999 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.27 169.46 32.11 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.32 36.53 4.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -128.02 170.71 12.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.178 . . . . 0.0 109.31 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.4 mm -70.23 150.34 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.641 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 13.5 t80 -102.84 149.48 24.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.141 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 8.8 m -50.17 -90.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.519 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.549 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 23.4 t-20 67.6 20.3 9.68 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.602 -0.686 . . . . 0.0 109.465 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -57.46 -47.93 80.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 109.362 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.84 -34.54 30.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.826 . . . . 0.0 109.395 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.16 66.23 0.6 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.581 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -97.09 -4.93 38.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -1.195 . . . . 0.0 109.523 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.641 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 64.3 mt -115.02 153.67 47.12 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.102 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.536 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 2.7 Cg_endo -61.57 86.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.2 1.933 . . . . 0.0 110.155 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.64 173.16 31.71 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -128.73 -172.9 2.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -1.113 . . . . 0.0 109.401 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.04 128.21 35.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.528 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.51 -6.86 57.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.506 ' HG2' ' N ' ' A' ' 70' ' ' THR . 7.6 ttt180 -98.68 151.36 20.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -1.18 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.506 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 39.0 m -125.71 146.88 49.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.584 ' CE3' HD12 ' A' ' 63' ' ' LEU . 10.3 m95 -112.23 157.62 20.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.689 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.647 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 12.0 mmt180 -115.38 140.85 48.76 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 108.667 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.522 ' CB ' ' CD1' ' A' ' 89' ' ' LEU . 2.3 pp20? -115.67 156.16 26.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 110.167 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -142.81 150.37 39.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 0.0 109.421 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.517 ' OD1' ' NE ' ' A' ' 87' ' ' ARG . 3.6 m-20 -71.97 142.34 49.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.5 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.553 HG22 ' CG ' ' A' ' 7' ' ' PHE . 21.6 mm -136.74 145.23 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 110.004 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.01 15.4 8.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.822 . . . . 0.0 109.823 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.566 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 14.6 t80 -69.61 114.71 8.07 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.095 -1.003 . . . . 0.0 109.628 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.3 m -119.67 -79.65 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.271 -0.893 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 p -148.62 166.49 28.14 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.72 -0.612 . . . . 0.0 109.392 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.12 -179.34 52.86 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' CZ ' ' C ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -46.48 165.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -1.146 . . . . 0.0 109.489 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -54.09 176.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -0.981 . . . . 0.0 109.405 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 5.1 p30 -115.53 -168.58 1.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.3 p -116.0 13.64 15.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.319 -0.863 . . . . 0.0 109.424 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.445 ' C ' ' HG2' ' A' ' 87' ' ' ARG . 1.1 m-20 -102.59 126.87 49.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.627 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.547 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -145.6 143.33 29.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.47 -0.769 . . . . 0.0 109.168 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.576 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 3.9 tt -109.51 134.85 50.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.862 -1.149 . . . . 0.0 109.089 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.4 mm? -106.75 111.34 23.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 109.992 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.647 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 2.8 p90 -101.69 141.91 33.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.053 -1.029 . . . . 0.0 108.402 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.525 ' OG ' ' CE2' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -106.43 172.43 6.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.049 -1.032 . . . . 0.0 110.633 -178.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.4 p -66.57 -21.95 66.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.472 -0.768 . . . . 0.0 109.522 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.481 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 36.6 p-10 -89.48 16.3 7.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.561 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 68.12 28.57 6.55 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.658 -0.651 . . . . 0.0 110.471 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.481 ' HG ' ' OD2' ' A' ' 93' ' ' ASP . 9.9 mt -85.65 112.32 20.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.576 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 2.0 mt -100.79 125.41 54.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.031 -1.043 . . . . 0.0 110.469 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.536 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 8.1 m-85 -122.89 159.18 28.75 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.546 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -131.29 142.18 50.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.757 -1.214 . . . . 0.0 110.024 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -130.13 127.59 40.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.103 -0.998 . . . . 0.0 108.948 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.18 12.34 30.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -132.16 24.6 4.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.166 -0.959 . . . . 0.0 109.494 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.7 t-80 76.43 75.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 109.824 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.564 ' HA ' ' CE1' ' A' ' 106' ' ' PHE . 14.5 m-85 52.21 60.96 3.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 109.624 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -135.08 -71.33 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.29 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.403 ' OG1' ' OD2' ' A' ' 101' ' ' ASP . 1.2 p -89.45 92.59 9.18 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.581 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 83.8 m-85 -89.45 110.08 20.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.238 -0.914 . . . . 0.0 110.03 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 57.3 m -102.82 139.84 37.87 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 2.3 tttt -85.05 125.12 32.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.569 -0.707 . . . . 0.0 109.491 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.64 -10.07 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.418 179.84 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -90.67 119.94 31.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.415 ' CG2' ' OD1' ' A' ' 5' ' ' ASN . 4.2 m -92.67 164.81 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.474 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.3 mt -91.17 85.9 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.938 . . . . 0.0 109.421 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.415 ' OD1' ' CG2' ' A' ' 3' ' ' VAL . 5.1 p-10 -136.89 59.28 1.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.123 -0.986 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.426 ' O ' HG22 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -148.05 -167.44 2.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 109.472 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 98' ' ' LYS . 38.2 m-85 -77.41 -59.95 2.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.356 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.78 -31.68 68.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.813 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.92 -54.4 18.21 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 6' ' ' THR . 59.0 t -63.11 -41.72 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.361 -1.082 . . . . 0.0 109.002 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -58.96 -35.67 73.54 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.465 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.3 OUTLIER -64.91 -56.36 13.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.501 -0.749 . . . . 0.0 109.204 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.634 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 30.7 t80 -60.82 -20.14 61.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.186 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.4 mt -73.6 -62.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.833 . . . . 0.0 109.299 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -71.5 -8.95 57.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.928 -1.107 . . . . 0.0 109.405 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 87.7 m -89.49 -66.07 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.153 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 82.4 m-85 -88.99 -6.53 57.16 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.512 -0.743 . . . . 0.0 109.417 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.51 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 15.5 m170 57.28 55.56 5.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.764 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 2.5 pttt 160.93 129.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.451 HD12 ' HB3' ' A' ' 74' ' ' ALA . 36.0 mt -44.53 147.45 1.04 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.023 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.5 Cg_exo -54.11 162.91 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.021 1.814 . . . . 0.0 110.586 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.91 -7.16 32.29 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.396 -0.815 . . . . 0.0 109.04 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -92.61 6.55 46.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.648 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CE1' ' HB3' ' A' ' 50' ' ' SER . 1.7 m-85 -100.61 81.93 2.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.758 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.4 pt -92.7 127.36 44.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 25' ' ' ILE . 43.4 p -48.1 176.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 109.351 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.81 -46.84 62.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 0.0 109.238 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -53.3 -35.8 60.53 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.095 -1.003 . . . . 0.0 108.46 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.47 ' O ' HD11 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -59.39 -41.22 88.88 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.536 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -68.17 -36.26 79.34 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.576 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 6.5 mt-30 -61.14 -32.64 72.35 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.62 -34.16 72.41 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.344 -0.848 . . . . 0.0 109.587 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.471 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 2.6 mp -81.29 -16.27 52.99 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.426 0.631 . . . . 0.0 110.051 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.28 40.38 0.88 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.586 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 11.1 t90 -105.06 117.26 33.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -1.137 . . . . 0.0 109.329 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.445 ' HB ' ' HG3' ' A' ' 39' ' ' LYS . 43.5 t -89.94 110.8 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.852 . . . . 0.0 108.705 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.57 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -48.87 -50.38 35.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.792 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -54.92 -61.31 2.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.926 . . . . 0.0 109.923 -179.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' CB ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 mtpp -42.8 -43.58 4.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 109.79 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.426 ' HA3' ' CZ ' ' A' ' 82' ' ' PHE . . . 80.04 38.24 19.64 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.5 ' OD1' ' CB ' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -113.11 44.35 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -1.116 . . . . 0.0 109.325 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.571 ' HA ' ' CD1' ' A' ' 35' ' ' TRP . 12.1 tp -58.94 -63.68 1.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 109.647 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.72 -14.45 0.92 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.717 -0.614 . . . . 0.0 110.566 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.1 -36.2 41.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.846 -1.159 . . . . 0.0 110.114 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 35' ' ' TRP . 19.8 m -110.4 -0.33 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.929 -1.107 . . . . 0.0 110.008 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.99 61.08 4.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 4.8 Cg_exo -59.63 152.28 63.67 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.065 1.843 . . . . 0.0 110.213 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.18 55.4 21.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -135.56 176.36 8.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -1.184 . . . . 0.0 109.72 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.567 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 70.3 m -146.07 136.44 23.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.33 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.537 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 11.5 mm -99.37 106.97 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 109.037 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.71 168.18 35.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.33 -7.5 51.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.47 160.57 26.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.117 -1.225 . . . . 0.0 109.37 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.496 HG21 ' N ' ' A' ' 56' ' ' PHE . 12.7 mm -70.07 144.81 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 109.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.6 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 13.5 t80 -89.21 144.13 26.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 17.5 t -43.54 -89.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.878 . . . . 0.0 109.609 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 57' ' ' SER . 2.4 t-20 78.61 16.33 1.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.621 -0.675 . . . . 0.0 109.436 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 -45.08 80.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.349 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -81.51 -67.99 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.422 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.46 54.35 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.569 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 3.8 mptp? -90.28 -10.75 43.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -1.124 . . . . 0.0 109.484 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.6 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 58.7 mt -100.56 149.97 36.57 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 108.931 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.636 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 5.1 Cg_exo -59.04 85.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.052 1.835 . . . . 0.0 110.359 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.92 142.4 7.86 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.99 -171.6 3.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -1.143 . . . . 0.0 109.5 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -69.42 142.33 53.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.477 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.55 -15.29 60.59 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -84.91 156.38 21.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -1.131 . . . . 0.0 109.609 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' A' ' 71' ' ' TRP . 0.0 OUTLIER -125.7 178.95 5.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.475 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.586 ' CE3' HD12 ' A' ' 63' ' ' LEU . 9.5 m95 -147.71 169.47 19.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -125.03 136.67 53.91 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.536 ' CB ' ' CD1' ' A' ' 89' ' ' LEU . 20.1 pt-20 -114.67 152.28 32.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.033 . . . . 0.0 110.296 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.466 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -141.11 152.45 44.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 109.298 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 1.1 m-20 -73.44 139.08 45.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 109.324 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.476 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 22.2 mm -132.26 137.73 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.944 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 1.4 m-20 72.53 9.71 5.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 0.0 110.186 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -69.83 143.45 52.88 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.083 -1.01 . . . . 0.0 109.606 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.8 p -139.58 -58.85 0.57 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.58 163.29 12.29 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.76 -0.588 . . . . 0.0 109.518 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 82' ' ' PHE . . . 82.97 -178.9 53.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.439 ' CZ ' ' O ' ' A' ' 39' ' ' LYS . 3.1 m-85 -45.59 159.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -1.19 . . . . 0.0 109.391 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -70.33 160.74 31.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.928 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.79 -167.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.332 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.65 28.11 8.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 109.714 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 2.2 m-20 -109.68 127.5 54.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.118 -0.989 . . . . 0.0 109.659 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.533 ' O ' ' CG2' ' A' ' 99' ' ' THR . 5.9 mtt180 -157.38 145.14 18.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 109.592 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.582 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 4.4 tt -102.69 132.39 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 109.084 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.5 mm? -103.61 103.16 13.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 109.577 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.65 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 7.2 p90 -98.22 141.31 31.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 108.86 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.477 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -105.15 168.93 8.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.151 -0.968 . . . . 0.0 110.392 -178.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.6 p -65.13 -20.41 66.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 24.8 p-10 -89.69 17.6 6.36 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.459 -0.776 . . . . 0.0 108.911 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.558 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.04 27.71 6.93 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.762 -0.586 . . . . 0.0 110.438 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.487 ' CD1' ' HB2' ' A' ' 64' ' ' PRO . 8.8 mt -86.52 102.58 14.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.582 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 3.0 mt -94.25 121.81 45.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.18 -0.95 . . . . 0.0 110.71 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.636 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 7.8 m-85 -121.09 164.02 17.47 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -135.8 144.65 45.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.83 -1.169 . . . . 0.0 109.81 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -132.01 129.66 40.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -0.891 . . . . 0.0 109.126 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 p -119.66 27.51 8.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.615 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 10.5 p30 -146.25 22.59 1.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.935 . . . . 0.0 109.466 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.554 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.9 t-80 80.22 70.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.519 -0.738 . . . . 0.0 109.315 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' ' 102' ' ' HIS . 18.8 m-85 42.85 26.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.666 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 102' ' ' HIS . 3.7 mm-40 -93.62 -17.5 23.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 108.958 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.454 ' OG1' ' OD2' ' A' ' 101' ' ' ASP . 82.0 m -149.61 138.24 20.88 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.569 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 96.5 m-85 -124.01 136.02 54.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.979 . . . . 0.0 110.035 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.432 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.4 m -126.01 137.07 53.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.801 . . . . 0.0 109.024 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -79.72 134.79 36.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.107 -0.995 . . . . 0.0 109.688 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 2.0 pt -142.4 57.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 0.0 109.403 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 1.6 mtm-85 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.468 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.14 115.25 27.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.374 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.7 t -137.85 172.23 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.74 86.99 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.454 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -140.59 58.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 0.0 109.362 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.466 ' O ' HD11 ' A' ' 76' ' ' ILE . 4.5 p -142.33 -167.27 2.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.524 ' CE1' ' HB2' ' A' ' 98' ' ' LYS . 31.4 m-85 -76.99 -61.44 1.98 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.146 -0.971 . . . . 0.0 109.186 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.43 -33.47 69.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 109.83 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.7 -55.02 15.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 6' ' ' THR . 95.7 t -63.04 -40.11 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -1.119 . . . . 0.0 108.926 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.451 ' HB2' ' HG3' ' A' ' 110' ' ' ARG . . . -59.48 -35.85 74.9 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.08 -56.74 10.0 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 35.0 t80 -54.58 -25.96 29.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.222 -0.924 . . . . 0.0 108.73 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 3.3 mt -69.52 -60.31 2.41 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -70.81 -5.33 29.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.025 . . . . 0.0 109.492 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.45 HG23 ' CD1' ' A' ' 17' ' ' TYR . 28.0 m -90.73 -70.91 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.859 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 68.7 m-85 -89.79 -4.78 57.47 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.67 -0.644 . . . . 0.0 109.642 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.492 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 17.8 m170 57.6 57.19 4.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.9 . . . . 0.0 109.356 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 7.2 ptmt 166.24 130.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD13 ' HB3' ' A' ' 74' ' ' ALA . 20.0 mt -43.16 147.26 0.72 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.266 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.575 ' HA ' ' CE1' ' A' ' 13' ' ' TYR . 8.2 Cg_exo -53.27 164.13 2.05 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.199 1.933 . . . . 0.0 110.463 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.48 -4.94 29.37 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.362 -0.836 . . . . 0.0 108.975 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -95.05 11.09 33.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.64 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.575 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 5.7 m-85 -105.48 92.94 4.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 109.845 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.3 pp -104.01 127.78 57.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 25' ' ' ILE . 68.7 p -48.94 178.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.51 -48.4 55.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.026 -1.046 . . . . 0.0 109.566 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -53.46 -37.03 62.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.125 -0.984 . . . . 0.0 108.512 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.524 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 18.7 mt-10 -59.88 -39.97 87.09 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.569 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . . . -69.69 -32.56 71.24 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.453 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 2.6 mt-30 -65.86 -30.69 71.34 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.44 76.44 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.457 -0.777 . . . . 0.0 109.362 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -80.96 -11.27 59.6 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.479 0.657 . . . . 0.0 109.978 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.02 53.75 0.74 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.624 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 1.6 t90 -108.97 135.96 49.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -1.131 . . . . 0.0 109.555 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.475 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 6.1 t -89.75 128.26 41.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.624 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -60.82 -11.1 6.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.988 -1.07 . . . . 0.0 110.275 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -45.75 -25.28 0.47 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.921 -1.112 . . . . 0.0 109.146 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.581 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 8.2 mttt 72.83 29.96 1.81 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.374 -0.829 . . . . 0.0 109.591 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.584 ' CA ' ' CE1' ' A' ' 82' ' ' PHE . . . -127.89 9.31 6.76 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.031 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -158.62 35.11 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.973 -1.31 . . . . 0.0 109.988 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.591 HD11 ' CD1' ' A' ' 35' ' ' TRP . 6.0 tp -66.96 -63.53 1.04 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 108.935 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.94 -10.45 2.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.823 -0.548 . . . . 0.0 110.143 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -35.19 44.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 109.741 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 46' ' ' ALA . 33.3 m -98.49 -48.12 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.158 -0.964 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.501 ' N ' HG22 ' A' ' 45' ' ' VAL . . . -117.45 77.03 10.07 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.295 -0.878 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.448 ' O ' ' HD2' ' A' ' 49' ' ' LYS . 3.0 Cg_endo -60.41 155.25 47.93 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.235 1.956 . . . . 0.0 110.326 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.53 63.83 4.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 46' ' ' ALA . 3.2 mptt -140.44 155.01 46.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -1.111 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.539 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 48.9 m -133.91 123.51 24.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.401 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.534 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 6.6 mm -81.15 105.46 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.019 -1.051 . . . . 0.0 109.017 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -150.65 172.8 30.34 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.522 -1.323 . . . . 0.0 109.851 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.95 10.72 62.44 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 4.4 m-20 -83.34 143.46 30.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -1.121 . . . . 0.0 109.403 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.439 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 13.6 mm -69.57 136.22 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 109.457 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.667 ' CE1' ' CD1' ' A' ' 103' ' ' TYR . 73.9 t80 -111.39 91.16 3.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.393 -0.817 . . . . 0.0 109.29 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 0.2 OUTLIER -70.09 -4.84 23.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.826 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.584 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 5.6 t-20 77.06 70.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 109.626 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -41.5 65.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -0.916 . . . . 0.0 109.331 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -89.54 -65.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.38 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . 114.2 49.93 0.52 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.7 -2.07 16.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -1.131 . . . . 0.0 109.545 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.561 HD21 ' CH2' ' A' ' 71' ' ' TRP . 4.2 mt -95.13 146.64 31.68 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.205 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.467 ' HG2' HD12 ' A' ' 95' ' ' LEU . 2.4 Cg_endo -62.26 84.55 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.026 1.818 . . . . 0.0 109.837 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.3 -164.98 32.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.35 -165.84 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -1.124 . . . . 0.0 109.352 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.9 m -70.18 101.89 1.97 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 0.0 109.468 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.03 55.95 8.66 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.419 ' NH2' ' CG ' ' A' ' 93' ' ' ASP . 13.0 ttt180 -108.13 152.5 24.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -1.185 . . . . 0.0 109.349 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.8 m -122.0 133.52 54.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 109.516 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.566 ' CH2' ' HB3' ' A' ' 95' ' ' LEU . 11.9 m95 -102.65 172.85 6.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.634 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 3.6 mtt180 -127.79 132.92 49.44 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.472 ' HA ' HD12 ' A' ' 89' ' ' LEU . 2.1 pt-20 -116.59 146.82 42.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.906 -1.121 . . . . 0.0 110.627 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -137.04 148.04 46.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.473 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 2.0 m-20 -72.49 122.63 21.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.484 HG13 ' HB ' ' A' ' 88' ' ' ILE . 30.5 mm -110.69 137.73 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 70.74 122.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 109.25 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.425 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 2.2 t80 -170.13 110.24 0.4 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.02 -78.73 0.58 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.88 155.29 32.65 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.701 -0.624 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.05 -160.09 14.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.584 ' CE1' ' CA ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -66.63 155.77 36.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -1.154 . . . . 0.0 109.507 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.474 ' HG3' ' HB3' ' A' ' 39' ' ' LYS . 12.1 mtm180 -51.75 -178.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.35 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.514 ' O ' ' NH2' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -120.53 -167.98 1.56 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.46 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.5 p -127.55 18.67 6.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 109.565 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.469 ' OD2' ' HA ' ' A' ' 100' ' ' THR . 4.3 m-20 -105.12 129.72 53.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 109.387 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 5.5 mmt180 -146.99 140.81 25.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.56 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.586 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 3.3 tt -93.34 129.18 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 108.82 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD13 ' CG ' ' A' ' 56' ' ' PHE . 4.6 mm? -101.11 93.69 5.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 110.194 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 38.2 p90 -91.5 139.85 30.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.889 -1.132 . . . . 0.0 108.652 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.477 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -105.47 170.36 7.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.097 -1.002 . . . . 0.0 110.722 -178.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.9 -22.38 66.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 109.6 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 14.5 p-10 -89.79 18.8 5.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.589 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 69.22 26.54 5.4 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.817 -0.552 . . . . 0.0 110.244 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.566 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.7 mt -82.32 92.6 6.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.586 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 12.8 mt -90.64 112.41 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 110.372 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.495 ' CG ' HD22 ' A' ' 63' ' ' LEU . 20.1 m-85 -114.03 167.14 10.92 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.524 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -137.28 130.14 30.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.951 -1.093 . . . . 0.0 109.655 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -119.76 119.07 32.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 109.26 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.469 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 21.1 p -104.16 22.17 15.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.523 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.6 OUTLIER -138.46 22.64 2.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.494 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.534 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 7.1 t-80 77.8 73.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 109.455 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.667 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 34.5 m-85 43.02 43.96 3.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.802 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.413 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 2.2 mm-40 -117.14 -17.01 10.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.249 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' THR . 51.9 m -150.38 94.97 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.332 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.545 ' CE1' ' HA ' ' A' ' 103' ' ' TYR . 14.1 m-85 -90.63 116.76 28.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.747 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 90.4 m -107.86 139.49 42.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.276 -0.89 . . . . 0.0 108.8 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -79.3 127.99 32.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 109.605 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.408 ' CG2' ' HE2' ' A' ' 98' ' ' LYS . 1.5 pt -112.75 -42.04 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.572 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.451 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.491 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.24 0.543 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.97 142.19 31.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.543 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 m -146.9 -173.66 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.455 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mt -113.18 93.75 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.501 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -141.99 61.77 1.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.463 ' O ' HD11 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -147.75 -175.19 4.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.538 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 98' ' ' LYS . 25.2 m-85 -73.79 -56.73 4.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.509 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -31.4 67.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.972 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.18 -55.39 9.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 6' ' ' THR . 38.8 t -65.83 -40.64 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -1.133 . . . . 0.0 109.296 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -58.35 -42.0 85.94 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.34 -55.01 36.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.544 -0.723 . . . . 0.0 109.101 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.681 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 35.5 t80 -59.09 -21.96 60.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.267 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.553 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.7 mt -73.1 -61.16 1.91 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 0.0 109.337 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.57 -9.18 57.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.005 -1.06 . . . . 0.0 109.591 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.2 m -89.62 -65.28 1.03 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.681 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 71.9 m-85 -89.18 -11.36 44.0 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.582 -0.698 . . . . 0.0 109.24 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 19.1 m170 61.01 53.72 3.6 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.369 -0.832 . . . . 0.0 109.491 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 7.1 pttm 166.97 129.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 19' ' ' LYS . 37.7 mt -44.94 151.74 0.61 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.155 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.584 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.2 Cg_exo -54.6 163.42 3.83 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.147 1.898 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -7.24 33.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.332 -0.855 . . . . 0.0 109.001 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.27 31.82 2.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.526 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.584 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.3 m-85 -121.9 82.45 1.95 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 0.0 109.776 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.5 pt -92.26 128.71 43.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.301 -0.875 . . . . 0.0 108.684 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 25' ' ' ILE . 18.5 p -47.23 174.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.139 -0.975 . . . . 0.0 109.26 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.73 -43.68 68.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.193 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -55.34 -38.81 69.23 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.153 -0.967 . . . . 0.0 108.464 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 5.5 mm-40 -57.84 -40.61 80.46 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.494 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -67.02 -37.34 83.96 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.493 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 4.6 mt-30 -60.98 -32.66 72.21 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.19 -36.88 81.08 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.359 -0.838 . . . . 0.0 109.717 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -81.03 -8.73 59.84 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.65 -0.656 . . . . 0.0 110.318 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' HG23 ' A' ' 45' ' ' VAL . . . 106.54 51.55 0.8 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.59 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 9.3 t90 -118.37 124.46 47.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -1.115 . . . . 0.0 109.052 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 39' ' ' LYS . 4.8 t -90.64 113.02 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.153 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -67.27 -16.43 64.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.45 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -89.47 -13.38 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.437 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -113.7 -9.84 13.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 109.492 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.57 65.54 3.1 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.436 ' O ' HG21 ' A' ' 45' ' ' VAL . 6.9 p-10 -120.82 43.11 2.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -1.187 . . . . 0.0 109.496 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.58 HD11 ' CD1' ' A' ' 35' ' ' TRP . 10.5 tp -63.1 -57.56 10.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.397 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -49.48 -20.61 0.75 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -37.44 23.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 0.0 110.355 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -106.98 -54.34 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.005 -1.059 . . . . 0.0 110.101 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.53 ' CB ' ' HG3' ' A' ' 49' ' ' LYS . . . -113.38 80.06 4.33 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.114 -0.991 . . . . 0.0 109.699 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 2.1 Cg_endo -62.16 156.57 49.48 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.238 1.959 . . . . 0.0 110.333 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.53 56.39 4.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.53 ' HG3' ' CB ' ' A' ' 46' ' ' ALA . 5.3 mmtp -127.79 119.86 26.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -1.13 . . . . 0.0 109.446 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -89.74 137.55 32.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.327 -0.858 . . . . 0.0 109.48 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.535 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 5.3 mm -104.27 113.9 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 108.922 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.55 173.03 40.45 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.92 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.11 6.26 55.85 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.419 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 1.7 m-20 -87.09 148.33 25.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -1.204 . . . . 0.0 109.39 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 55' ' ' ILE . 15.5 mm -67.77 139.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.61 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.596 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 62.8 t80 -101.7 92.32 4.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.333 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 6.0 p -70.24 -4.67 22.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 109.748 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.581 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 1.2 t-20 71.48 89.41 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 109.527 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -49.57 -36.63 24.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 109.413 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -124.65 -70.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.344 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.43 72.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.575 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 35.6 mttm -116.08 -7.7 11.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -1.152 . . . . 0.0 109.591 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.596 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 63.6 mt -93.64 148.36 35.28 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.209 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.569 ' HD2' ' CZ2' ' A' ' 71' ' ' TRP . 3.5 Cg_exo -60.1 84.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.109 1.873 . . . . 0.0 110.186 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -96.22 167.5 25.07 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -148.28 -170.8 3.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -1.131 . . . . 0.0 109.364 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 t -67.29 96.01 0.46 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.453 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.79 57.84 2.0 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.517 ' NH1' ' OD2' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -125.94 136.92 53.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -1.138 . . . . 0.0 109.582 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.16 160.32 19.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 64' ' ' PRO . 19.9 m95 -132.41 172.17 12.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.73 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.634 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 65.1 mtt180 -136.94 148.65 47.09 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.513 ' CB ' ' CD1' ' A' ' 89' ' ' LEU . 9.1 pt-20 -124.1 158.67 31.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.048 -1.032 . . . . 0.0 110.467 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -148.76 152.3 36.33 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.459 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 1.4 m-20 -78.67 131.83 36.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.107 -0.996 . . . . 0.0 109.516 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.463 HD11 ' O ' ' A' ' 6' ' ' THR . 30.3 mm -116.7 124.42 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.545 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.453 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 20.7 m-20 69.5 118.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.483 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -170.57 138.94 1.53 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.291 -0.88 . . . . 0.0 109.549 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.67 -79.74 0.49 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.084 -1.01 . . . . 0.0 109.478 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.6 p -140.98 171.1 14.53 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.79 -176.34 54.59 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -48.98 167.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -1.169 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -68.55 -179.87 1.49 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.932 . . . . 0.0 109.609 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -110.0 -172.77 2.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.91 . . . . 0.0 109.405 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -108.17 10.94 27.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 109.581 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 82.0 m-20 -100.37 128.03 46.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.661 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.525 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.1 OUTLIER -152.39 158.24 42.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.787 . . . . 0.0 109.164 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.519 ' CD1' HG21 ' A' ' 96' ' ' ILE . 1.6 tt -118.42 146.33 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.014 -1.054 . . . . 0.0 109.345 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.513 ' CD1' ' CB ' ' A' ' 73' ' ' GLU . 3.2 mm? -117.93 113.14 21.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.463 -0.773 . . . . 0.0 109.68 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 2.5 p90 -105.99 140.39 39.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.842 -1.161 . . . . 0.0 108.934 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.462 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -107.49 174.93 5.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.915 . . . . 0.0 110.444 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -23.34 66.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 109.815 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.517 ' OD2' ' NH1' ' A' ' 69' ' ' ARG . 42.6 p30 -89.62 16.58 7.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.424 -0.797 . . . . 0.0 108.969 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.564 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.94 27.66 7.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.769 -0.582 . . . . 0.0 110.522 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 14.5 mt -83.66 114.96 21.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.519 HG21 ' CD1' ' A' ' 88' ' ' ILE . 4.8 mt -111.2 107.65 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 110.574 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.532 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 26.5 m-85 -106.97 117.84 35.12 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -89.19 145.27 25.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 109.924 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -130.49 122.63 28.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 0.0 109.09 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.405 HG21 ' CG ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -110.95 30.66 6.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.633 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.5 OUTLIER -150.21 21.88 0.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER 78.73 73.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.405 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 26.8 m-85 43.78 26.22 0.12 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.392 -0.818 . . . . 0.0 109.682 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -97.05 -18.17 19.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.001 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.465 ' HB ' ' OD2' ' A' ' 101' ' ' ASP . 24.1 m -143.27 142.89 31.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.575 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 86.7 m-85 -133.65 123.77 25.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.086 -1.009 . . . . 0.0 110.267 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -114.18 132.44 56.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.497 -0.752 . . . . 0.0 109.0 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -79.5 109.36 13.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 109.54 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 1.1 pt -125.38 65.78 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.483 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 72.6 mtm180 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.414 ' O ' ' HB3' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.314 0.578 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.454 ' O ' HG12 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -179.25 140.26 0.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.53 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 2' ' ' GLN . 2.5 m -156.1 153.99 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.473 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.48 87.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.524 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -143.0 53.87 1.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.467 ' O ' HD11 ' A' ' 76' ' ' ILE . 0.8 OUTLIER -144.63 -176.23 4.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.547 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 98' ' ' LYS . 31.4 m-85 -75.86 -57.9 3.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 0.0 109.556 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -71.17 -31.65 67.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.937 . . . . 0.0 109.901 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.95 -52.87 21.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.479 HG23 ' OH ' ' A' ' 24' ' ' TYR . 46.6 t -67.1 -46.95 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -1.117 . . . . 0.0 109.332 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.453 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -55.61 -38.06 68.95 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 8' ' ' ASP . 0.4 OUTLIER -62.98 -55.1 28.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.482 -0.761 . . . . 0.0 109.093 179.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 18.0 t80 -62.53 -17.67 60.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.318 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.549 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.4 mt -75.75 -63.37 1.32 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.444 -0.785 . . . . 0.0 109.252 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -11.56 61.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.98 -1.075 . . . . 0.0 109.412 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.3 m -89.74 -64.45 1.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.962 . . . . 0.0 110.069 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.689 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 67.7 m-85 -89.48 -0.16 57.3 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.458 -0.776 . . . . 0.0 109.568 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.481 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 19.2 m170 47.91 47.16 18.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.295 -0.878 . . . . 0.0 109.685 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 14.4 ptmt 173.85 128.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.458 HD13 ' OH ' ' A' ' 90' ' ' TYR . 23.0 mt -45.94 147.89 1.58 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.154 -0.966 . . . . 0.0 109.022 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.5 Cg_exo -53.56 160.42 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.016 1.811 . . . . 0.0 110.469 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.07 -10.32 29.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.258 -0.901 . . . . 0.0 108.981 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 50.9 p30 -92.18 20.68 5.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.588 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.9 m-85 -115.96 87.79 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 109.725 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.2 pt -99.23 123.15 51.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.299 -0.876 . . . . 0.0 108.735 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.473 ' O ' ' O ' ' A' ' 25' ' ' ILE . 19.8 p -45.99 172.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 109.501 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -67.26 -45.5 76.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.0 -1.062 . . . . 0.0 109.029 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -39.5 67.31 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.5 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 18.8 mt-10 -59.37 -38.54 80.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.573 ' HB1' ' CE3' ' A' ' 35' ' ' TRP . . . -67.37 -38.68 85.15 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.097 -1.002 . . . . 0.0 108.544 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 27.4 mt-30 -60.37 -35.39 75.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.1 -34.83 70.6 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.305 -0.872 . . . . 0.0 109.335 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.43 -18.09 46.56 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.694 -0.629 . . . . 0.0 110.271 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.49 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . 115.64 36.36 1.18 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.601 ' CD1' HD11 ' A' ' 42' ' ' LEU . 9.5 t90 -100.3 122.35 42.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -1.174 . . . . 0.0 109.122 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.77 110.46 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.161 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.569 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -60.33 -14.24 17.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.32 -63.19 1.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.55 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 29.9 mttp -80.36 0.61 32.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.664 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 44.42 84.08 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 35' ' ' TRP . 56.8 p30 -122.44 44.46 2.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.208 -1.172 . . . . 0.0 109.503 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.601 HD11 ' CD1' ' A' ' 35' ' ' TRP . 6.2 tp -62.45 -46.26 89.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.469 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -61.96 -11.32 12.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.867 . . . . 0.0 109.877 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.45 -51.37 4.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.13 -0.981 . . . . 0.0 109.983 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.514 HG23 ' CA ' ' A' ' 35' ' ' TRP . 28.9 m -91.7 -47.3 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.851 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.507 ' N ' HG22 ' A' ' 45' ' ' VAL . . . -118.96 76.59 14.74 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 109.433 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.7 Cg_endo -63.46 155.15 64.17 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.234 1.956 . . . . 0.0 110.562 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 42.74 70.24 0.53 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 3.7 mmpt? -142.01 160.36 40.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.258 -1.142 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 3.0 m -124.16 130.37 52.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.889 . . . . 0.0 109.398 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.544 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 17.5 mm -93.12 104.61 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.158 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -158.38 168.2 34.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.82 -15.85 51.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' OD2' ' HB ' ' A' ' 26' ' ' THR . 3.4 m-20 -79.95 148.41 31.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -1.199 . . . . 0.0 109.331 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 56' ' ' PHE . 14.0 mt -51.54 166.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.366 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 9.0 t80 -106.88 145.83 31.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.54 ' OG ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -45.52 -88.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.671 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 57' ' ' SER . 9.9 t-20 78.36 20.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.622 -0.673 . . . . 0.0 109.374 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -74.25 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.397 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -62.78 -35.92 81.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.384 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.45 77.07 1.23 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.566 ' CB ' ' CE2' ' A' ' 106' ' ' PHE . 12.8 mmtt -102.17 -9.01 20.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -1.144 . . . . 0.0 109.51 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 44.2 mt -105.38 157.23 34.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.968 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.484 ' O ' ' NH1' ' A' ' 69' ' ' ARG . 2.8 Cg_endo -61.84 84.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.005 1.803 . . . . 0.0 109.63 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.423 ' C ' ' HG2' ' A' ' 66' ' ' LYS . . . -93.7 164.39 26.52 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HG2' ' C ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -138.44 -148.75 0.27 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -1.151 . . . . 0.0 109.444 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 t -61.02 102.61 0.21 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.452 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.65 72.18 0.43 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.484 ' NH1' ' O ' ' A' ' 64' ' ' PRO . 3.5 ttt180 -114.96 149.48 37.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -1.13 . . . . 0.0 109.568 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.54 171.85 7.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.583 ' CE3' HD12 ' A' ' 63' ' ' LEU . 15.0 m95 -141.13 157.56 45.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.638 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 28.8 mtp180 -119.07 129.29 55.01 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.575 ' CB ' ' CD1' ' A' ' 89' ' ' LEU . 12.4 pt-20 -106.3 151.08 25.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.053 -1.029 . . . . 0.0 110.22 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HA ' ' CA ' ' A' ' 52' ' ' GLY . . . -138.66 150.97 46.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.46 -0.775 . . . . 0.0 109.111 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.467 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -74.41 136.92 42.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.052 -1.03 . . . . 0.0 109.573 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.469 HG13 ' HB ' ' A' ' 88' ' ' ILE . 22.1 mm -120.31 123.32 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.231 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER 72.04 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.269 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 8.6 t80 -170.39 141.5 1.99 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.144 -0.973 . . . . 0.0 109.537 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.01 -78.81 0.19 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -144.58 161.2 39.71 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.642 -0.661 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.38 -175.32 34.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CE1' ' O ' ' A' ' 39' ' ' LYS . 1.1 m-85 -55.02 179.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -1.177 . . . . 0.0 109.405 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -175.8 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.44 179.88 3.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.4 m -110.96 8.47 22.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.464 ' O ' ' HD3' ' A' ' 87' ' ' ARG . 25.5 m-20 -108.94 128.53 55.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.106 -0.996 . . . . 0.0 109.384 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.464 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 3.6 mmt180 -143.03 169.94 16.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 109.289 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.563 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 3.9 tt -134.15 129.64 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.026 -1.046 . . . . 0.0 108.598 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.575 ' CD1' ' CB ' ' A' ' 73' ' ' GLU . 3.1 mm? -104.87 104.23 13.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.638 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 10.2 p90 -96.31 139.07 32.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.939 -1.101 . . . . 0.0 108.459 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.468 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -100.72 170.88 8.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 -178.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 p -65.22 -21.85 66.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.41 -0.806 . . . . 0.0 109.311 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 27.4 p-10 -89.87 18.08 6.05 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.567 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.1 m95 68.21 29.89 5.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.281 0.562 . . . . 0.0 110.165 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.459 ' HG ' ' OD2' ' A' ' 93' ' ' ASP . 6.9 mt -85.17 97.53 9.95 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.563 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 3.5 mt -90.24 118.66 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.118 -0.989 . . . . 0.0 110.468 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 108' ' ' LYS . 9.0 m-85 -117.32 158.4 24.44 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.496 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 7.3 ptpt -126.29 153.38 44.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.943 -1.098 . . . . 0.0 109.428 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -140.66 118.28 11.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.445 -0.785 . . . . 0.0 109.115 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.402 HG21 ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -101.81 25.56 8.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.594 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -142.66 18.74 2.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 109.417 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 4.3 t-80 78.2 85.82 0.07 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.379 -0.826 . . . . 0.0 109.981 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.441 ' OH ' ' OE2' ' A' ' 73' ' ' GLU . 33.9 m-85 41.61 27.13 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.385 -0.822 . . . . 0.0 110.067 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.527 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 7.1 tp60 -89.13 -71.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.927 . . . . 0.0 108.982 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.439 HG21 ' OD1' ' A' ' 101' ' ' ASP . 14.2 t -97.61 164.1 12.56 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CE2' ' CB ' ' A' ' 62' ' ' LYS . 92.3 m-85 -145.45 121.15 10.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.914 -1.116 . . . . 0.0 109.947 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 2.0 m -118.28 133.47 55.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 0.0 109.322 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 3.6 ttpm? -79.63 131.92 36.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.435 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 110' ' ' ARG . 1.3 pt -119.8 -45.59 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.501 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -111.54 96.78 6.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.401 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -51.66 134.46 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.5 105.53 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -146.1 62.63 1.24 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.404 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.7 p -145.08 -175.55 4.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.502 ' CD1' ' HB2' ' A' ' 98' ' ' LYS . 41.7 m-85 -79.57 -54.4 5.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.718 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -33.6 69.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 0.0 110.01 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.27 -53.03 23.78 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 76' ' ' ILE . 41.5 t -66.76 -38.85 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.336 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.82 85.17 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.461 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.6 OUTLIER -64.55 -55.45 20.42 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.471 -0.768 . . . . 0.0 109.163 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.556 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 19.6 t80 -59.53 -20.36 54.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.275 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -75.58 -64.38 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.199 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -70.75 -5.55 30.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.976 -1.077 . . . . 0.0 109.34 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.571 HG23 ' CD1' ' A' ' 17' ' ' TYR . 56.2 m -94.29 -66.45 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 109.562 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.571 ' CD1' HG23 ' A' ' 16' ' ' THR . 83.3 m-85 -89.86 3.46 52.9 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.705 -0.622 . . . . 0.0 109.439 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.477 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 19.7 m170 44.76 48.76 8.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 17.5 pttt 175.17 129.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.479 -0.763 . . . . 0.0 109.159 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 74' ' ' ALA . 30.1 mt -47.14 149.01 1.82 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.207 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.583 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.9 Cg_exo -53.54 161.82 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.045 1.83 . . . . 0.0 110.422 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -68.73 -7.43 33.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.084 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -92.43 11.15 27.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 109.529 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 3.2 m-85 -105.11 90.26 3.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.753 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.1 pp -99.29 123.6 52.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 25' ' ' ILE . 44.5 p -47.9 176.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.579 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.21 -47.98 59.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.107 -0.996 . . . . 0.0 109.104 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 m -53.51 -38.85 64.11 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.492 ' O ' HD13 ' A' ' 33' ' ' LEU . 26.8 mm-40 -57.85 -41.07 81.62 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.582 ' HB1' ' CE3' ' A' ' 35' ' ' TRP . . . -66.69 -33.91 76.69 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 1.7 mt-30 -62.53 -34.65 77.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.01 72.75 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.466 -0.771 . . . . 0.0 109.592 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.5 mp -80.78 -15.89 55.23 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.451 0.643 . . . . 0.0 110.134 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 113.89 40.31 1.0 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.582 ' CE3' ' HB1' ' A' ' 30' ' ' ALA . 11.1 t90 -106.88 118.92 37.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -1.176 . . . . 0.0 109.244 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 t -89.87 111.92 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.844 . . . . 0.0 108.966 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.573 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -54.64 -18.3 4.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.955 . . . . 0.0 109.729 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -35.57 30.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.765 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.3 mmtp -90.28 -10.7 43.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.805 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 42.96 39.6 3.8 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.451 ' C ' ' ND2' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -94.28 44.06 1.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.149 -1.206 . . . . 0.0 109.774 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.571 HD11 ' CD1' ' A' ' 35' ' ' TRP . 10.2 tp -59.09 -55.25 37.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.33 -19.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.108 -0.995 . . . . 0.0 110.091 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -96.56 -29.48 13.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.094 . . . . 0.0 110.762 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 34' ' ' GLY . 32.3 m -103.44 -52.57 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.819 -1.175 . . . . 0.0 110.3 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.428 ' N ' ' CG2' ' A' ' 45' ' ' VAL . . . -127.05 66.19 66.64 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.945 -1.097 . . . . 0.0 109.46 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.447 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 2.1 Cg_endo -62.02 168.27 9.29 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.218 1.946 . . . . 0.0 110.353 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 50.67 45.82 47.67 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.52 163.14 27.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -1.198 . . . . 0.0 109.507 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.525 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 42.8 m -129.41 126.1 38.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.421 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.533 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 7.2 mm -90.18 106.56 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.142 -0.974 . . . . 0.0 108.907 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.81 169.73 34.64 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.06 -9.31 50.55 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.507 ' OD1' ' CG ' ' A' ' 73' ' ' GLU . 2.6 p30 -86.25 145.23 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -1.139 . . . . 0.0 109.507 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.4 mm -49.78 161.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.146 -0.971 . . . . 0.0 109.419 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 14.5 t80 -101.33 143.11 31.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.388 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.8 t -56.15 -85.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.426 -0.796 . . . . 0.0 109.664 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 57' ' ' SER . 10.2 t-20 80.63 48.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -68.01 -68.54 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -60.75 -42.96 98.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.454 ' HA2' ' OD1' ' A' ' 58' ' ' ASN . . . 102.01 63.61 0.74 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 2.7 mttt -97.73 -6.28 33.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -1.147 . . . . 0.0 109.636 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.635 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 31.7 mt -101.01 142.75 25.24 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.21 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.503 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 1.9 Cg_endo -62.92 107.77 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.045 1.83 . . . . 0.0 110.096 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.41 159.23 28.28 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.14 176.35 5.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.246 -1.149 . . . . 0.0 109.491 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 107.31 3.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.486 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.29 12.6 10.66 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.432 ' HG2' ' N ' ' A' ' 70' ' ' THR . 3.3 ttm180 -114.28 142.51 46.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -1.184 . . . . 0.0 109.608 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.432 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 1.5 m -113.79 151.42 32.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.441 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.609 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 6.5 m95 -108.89 173.31 6.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.59 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 53.3 mtt180 -130.88 150.57 51.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.507 ' CG ' ' OD1' ' A' ' 54' ' ' ASP . 20.8 pt-20 -128.55 155.48 44.84 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.008 -1.058 . . . . 0.0 110.418 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.419 ' HB3' HD12 ' A' ' 20' ' ' LEU . . . -146.98 148.1 31.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.735 . . . . 0.0 109.102 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.467 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -68.81 149.26 49.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 109.595 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.527 ' CD1' HG22 ' A' ' 10' ' ' VAL . 29.1 mm -141.25 145.02 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.274 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.491 ' N ' HG21 ' A' ' 76' ' ' ILE . 73.7 m-20 61.19 39.83 15.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 109.476 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.476 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 60.5 t80 -69.68 128.42 36.37 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.336 -0.853 . . . . 0.0 109.597 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.24 -79.92 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.204 -0.935 . . . . 0.0 109.422 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -172.53 -177.75 1.81 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.642 -0.661 . . . . 0.0 109.486 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.515 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . 67.44 78.21 0.28 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 39' ' ' LYS . 0.7 OUTLIER 56.46 164.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -1.169 . . . . 0.0 109.313 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 171.97 0.05 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.21 -0.931 . . . . 0.0 109.334 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.476 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -103.74 -171.75 1.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.601 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.34 -4.92 13.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.902 . . . . 0.0 109.415 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 65.0 m-20 -93.87 129.42 40.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.459 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.525 ' O ' ' CG2' ' A' ' 99' ' ' THR . 11.4 mtt180 -152.79 150.88 29.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.206 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.513 HD12 ' CG2' ' A' ' 96' ' ' ILE . 4.3 tt -106.98 149.36 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.185 -0.947 . . . . 0.0 109.441 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.581 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.5 mm? -117.95 124.69 48.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.374 -0.829 . . . . 0.0 109.515 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -113.26 140.96 47.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.841 -1.162 . . . . 0.0 108.839 179.063 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.579 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 11.4 t -108.27 173.78 6.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.3 p -66.36 -22.77 66.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.474 ' OD2' HD13 ' A' ' 95' ' ' LEU . 28.4 p-10 -89.67 15.65 9.21 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.575 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.36 31.59 6.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.708 -0.62 . . . . 0.0 110.461 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.474 HD13 ' OD2' ' A' ' 93' ' ' ASP . 9.8 mt -87.34 125.05 34.0 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.513 ' CG2' HD12 ' A' ' 88' ' ' ILE . 1.8 mt -117.62 113.75 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.098 -1.001 . . . . 0.0 110.677 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.503 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 21.6 m-85 -113.52 117.45 31.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.502 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.21 136.15 33.18 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.961 -1.087 . . . . 0.0 109.8 -179.119 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -122.89 128.66 50.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 108.996 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.416 HG23 ' OD1' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.3 31.2 6.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.606 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -149.88 20.67 0.89 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -0.937 . . . . 0.0 109.36 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 19.6 t-80 76.6 68.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.804 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 5.7 m-85 56.28 55.1 6.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.954 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.43 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER -120.87 -81.56 0.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 108.641 179.396 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.441 HG22 ' OD2' ' A' ' 101' ' ' ASP . 17.2 p -90.56 105.25 17.69 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.52 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 83.2 m-85 -90.0 126.52 35.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 110.142 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -111.33 126.98 55.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 108.949 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 24.3 tttt -79.34 117.49 20.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.019 -1.051 . . . . 0.0 109.441 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.442 ' O ' ' HG2' ' A' ' 110' ' ' ARG . 1.4 pt -110.21 -24.76 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.876 . . . . 0.0 109.627 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 109' ' ' ILE . 2.8 mtt-85 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -141.16 102.47 4.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 4' ' ' ILE . 3.5 t 62.95 170.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.506 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 3' ' ' VAL . 3.1 mp -140.87 95.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 109.599 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -138.94 58.46 1.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.468 ' O ' HD11 ' A' ' 76' ' ' ILE . 1.2 p -146.42 -178.26 6.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.606 ' CD1' ' CB ' ' A' ' 98' ' ' LYS . 11.3 m-85 -73.68 -57.15 4.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.404 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.35 -36.42 71.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 109.824 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.52 -49.98 57.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 6' ' ' THR . 90.0 t -66.03 -44.83 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -1.161 . . . . 0.0 109.278 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.78 67.25 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.83 -56.03 14.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.501 -0.75 . . . . 0.0 109.045 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.641 ' CE1' ' CG ' ' A' ' 17' ' ' TYR . 67.4 t80 -58.97 -17.7 27.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.145 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.482 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.6 mt -78.59 -59.84 2.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.241 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.8 -9.67 57.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 109.489 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.478 HG21 ' CD1' ' A' ' 17' ' ' TYR . 99.6 m -95.49 -61.57 1.44 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 109.947 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CG ' ' CE1' ' A' ' 13' ' ' TYR . 6.2 m-85 -89.31 0.67 56.62 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.697 -0.627 . . . . 0.0 109.581 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 18.1 m170 42.76 48.59 4.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 2.9 pttm 176.84 130.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.508 -0.745 . . . . 0.0 109.128 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 14.2 mt -43.76 160.96 0.21 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 109.182 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.564 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 3.1 Cg_exo -55.41 159.31 10.85 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.105 1.87 . . . . 0.0 110.456 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.7 p30 -72.1 -4.71 30.54 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 108.988 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -111.73 31.87 5.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.484 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.609 ' CE1' ' CB ' ' A' ' 50' ' ' SER . 1.6 m-30 -114.09 78.78 1.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.932 . . . . 0.0 109.449 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 2.2 pt -90.94 128.02 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.357 -0.839 . . . . 0.0 108.977 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 25' ' ' ILE . 46.2 p -46.49 174.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.857 . . . . 0.0 109.516 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.82 -46.46 65.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.046 -1.034 . . . . 0.0 109.307 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -51.75 -36.07 45.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 108.388 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.464 ' O ' HD13 ' A' ' 33' ' ' LEU . 16.0 mm-40 -60.43 -43.63 96.58 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HB2' ' CE3' ' A' ' 35' ' ' TRP . . . -64.12 -34.6 78.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 16.5 mt-30 -62.46 -37.57 86.44 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.44 79.59 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.461 -0.775 . . . . 0.0 109.658 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.01 -12.62 59.33 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.626 -0.672 . . . . 0.0 110.002 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.525 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . 109.98 68.92 0.6 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.598 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 13.0 t90 -137.01 120.81 17.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -1.136 . . . . 0.0 109.191 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.528 ' CG1' ' HB2' ' A' ' 39' ' ' LYS . 9.8 p -89.85 116.56 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.261 -0.899 . . . . 0.0 108.702 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -70.22 83.76 0.54 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.526 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.511 ' O ' ' CZ ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER 167.44 -64.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.516 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.528 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -53.11 -23.1 7.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.503 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 82' ' ' PHE . . . 70.66 74.68 0.67 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.435 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -144.3 28.16 1.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -1.173 . . . . 0.0 109.634 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD11 ' CD1' ' A' ' 35' ' ' TRP . 13.0 tp -53.05 -65.94 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -46.3 -23.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.433 -0.792 . . . . 0.0 110.056 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -80.19 -40.34 27.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.088 -1.007 . . . . 0.0 110.447 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -93.17 -55.18 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.035 -1.041 . . . . 0.0 110.227 -179.409 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HB2' ' HD2' ' A' ' 49' ' ' LYS . . . -120.76 72.73 22.47 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.959 -1.088 . . . . 0.0 110.01 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.5 Cg_endo -63.67 -178.66 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.239 1.959 . . . . 0.0 110.343 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 43.29 46.25 6.65 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.463 ' HD2' ' HB2' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -149.48 167.13 27.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -1.158 . . . . 0.0 109.43 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.609 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -141.89 162.8 34.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.356 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.531 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 4.8 mm -110.57 117.93 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -0.876 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -161.33 158.17 29.86 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.463 ' HA2' ' OH ' ' A' ' 90' ' ' TYR . . . 95.08 9.5 58.18 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.496 ' OD2' ' CG ' ' A' ' 27' ' ' LYS . 2.4 m-20 -85.92 142.46 28.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -1.152 . . . . 0.0 109.376 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.8 mm -52.63 149.59 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.581 ' CD1' HD13 ' A' ' 89' ' ' LEU . 49.0 t80 -110.96 144.59 39.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.952 . . . . 0.0 109.594 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 3.7 m -43.99 -92.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.578 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 57' ' ' SER . 8.5 t-20 74.63 5.27 4.47 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.4 -0.813 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -69.98 -26.06 63.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 109.294 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -80.92 0.2 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.39 40.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 32.6 mttm -88.07 -8.68 55.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -1.191 . . . . 0.0 109.526 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.58 HD13 ' CE2' ' A' ' 56' ' ' PHE . 22.8 mt -124.47 151.0 66.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.404 -0.81 . . . . 0.0 108.866 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 5.3 Cg_exo -59.51 85.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.143 1.895 . . . . 0.0 110.281 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.453 ' HA2' ' HD3' ' A' ' 69' ' ' ARG . . . -160.02 139.0 5.86 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -104.2 -166.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.517 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.7 m -68.48 95.0 0.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.594 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.91 -6.65 4.1 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.46 ' NH1' ' CG ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -93.82 136.95 33.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -1.165 . . . . 0.0 109.446 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.12 150.25 26.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.425 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.565 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 36.9 m95 -127.49 140.13 52.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.631 ' CB ' ' CE1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -111.0 125.31 53.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.295 -0.878 . . . . 0.0 109.134 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' CB ' HD12 ' A' ' 89' ' ' LEU . 2.4 pt-20 -96.88 146.26 25.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.175 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -133.2 147.99 52.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.4 m-20 -70.29 142.93 52.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.59 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.487 HG22 HD11 ' A' ' 76' ' ' ILE . 19.5 mm -135.47 141.95 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.861 . . . . 0.0 109.558 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 9.6 m120 61.6 34.58 17.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.7 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.442 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 56.5 t80 -69.47 143.82 53.41 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.151 -0.968 . . . . 0.0 109.512 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.69 -80.15 0.49 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -170.41 179.67 3.31 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.629 -0.67 . . . . 0.0 109.448 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.446 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . 67.05 -149.12 51.0 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.511 ' CZ ' ' O ' ' A' ' 38' ' ' SER . 2.4 m-85 -53.5 164.42 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -1.104 . . . . 0.0 109.552 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 82' ' ' PHE . 1.4 mmm-85 -55.98 -164.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.474 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.12 -172.81 2.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.579 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.82 -1.23 11.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 109.589 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 71.0 m-20 -104.96 129.04 53.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 109.519 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.2 OUTLIER -147.23 141.54 26.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.342 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.546 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 6.8 tt -102.27 125.27 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 109.313 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.581 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.9 mm? -94.53 99.97 12.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.951 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.631 ' CE1' ' CB ' ' A' ' 72' ' ' ARG . 22.5 p90 -99.36 140.09 34.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.923 -1.111 . . . . 0.0 108.687 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 8.0 t -108.01 169.53 8.56 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.146 -0.971 . . . . 0.0 110.607 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -65.28 -19.37 65.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.421 -0.8 . . . . 0.0 109.638 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 29.8 p-10 -89.62 16.87 7.1 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.582 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 68.27 30.03 5.75 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.684 -0.635 . . . . 0.0 110.341 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 7.8 mt -87.16 101.0 13.07 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.546 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 4.1 mt -97.27 115.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.344 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.475 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 10.2 m-85 -118.93 161.81 19.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.606 ' CB ' ' CD1' ' A' ' 7' ' ' PHE . 3.7 ptmt -132.06 143.76 50.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.868 -1.145 . . . . 0.0 110.032 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -130.53 120.55 24.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 108.935 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.59 26.69 8.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 0.0 109.857 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -147.78 21.86 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.08 -1.012 . . . . 0.0 109.84 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 10.6 t-80 77.17 71.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.412 ' OH ' ' OE1' ' A' ' 73' ' ' GLU . 15.0 m-85 50.43 20.35 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 110.035 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.52 ' CB ' ' OD1' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -86.96 -20.59 27.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 108.862 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 35.3 p -144.7 157.35 44.23 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.572 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 73.4 m-85 -141.29 119.53 12.15 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.001 -1.062 . . . . 0.0 110.034 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 3.1 m -112.88 136.5 52.45 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.426 -0.796 . . . . 0.0 108.939 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -83.58 129.1 34.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 0.5 OUTLIER -130.24 19.84 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.428 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.371 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.251 0.548 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.416 ' O ' ' O ' ' A' ' 3' ' ' VAL . 3.9 mm-40 -125.79 95.79 4.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.555 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.416 ' O ' ' O ' ' A' ' 2' ' ' GLN . 1.9 t 51.85 178.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.427 ' O ' HG21 ' A' ' 4' ' ' ILE . 5.5 mt -124.46 78.76 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.226 -0.921 . . . . 0.0 109.613 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -141.9 57.71 1.49 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.357 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.448 ' O ' HG22 ' A' ' 10' ' ' VAL . 3.9 p -144.8 -168.93 3.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.221 -0.925 . . . . 0.0 109.67 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 86' ' ' ASP . 46.6 m-85 -76.79 -57.61 3.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.872 . . . . 0.0 109.582 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -34.82 71.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.137 -0.977 . . . . 0.0 109.99 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.88 -52.79 26.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 6' ' ' THR . 67.4 t -64.14 -45.6 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -1.149 . . . . 0.0 109.114 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -56.73 -36.55 69.86 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.0 OUTLIER -63.5 -56.22 17.83 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.492 -0.755 . . . . 0.0 109.023 179.36 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.675 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 32.3 t80 -59.19 -21.13 58.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 108.848 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 3.6 mt -71.01 -61.32 1.8 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -70.98 -8.93 56.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 109.348 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 86.5 m -85.02 -67.84 0.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.865 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.675 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 98.6 m-85 -95.68 4.17 53.26 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.676 -0.64 . . . . 0.0 109.743 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 16.6 m170 50.92 50.62 18.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.498 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER 171.53 130.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 19' ' ' LYS . 21.4 mt -44.14 150.39 0.62 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 108.96 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.576 ' HA ' ' CE1' ' A' ' 13' ' ' TYR . 8.8 Cg_exo -53.51 162.93 2.94 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.055 1.837 . . . . 0.0 110.535 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.17 -6.87 37.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.355 -0.84 . . . . 0.0 109.016 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.443 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 27.7 p30 -90.92 -1.07 57.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.506 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.571 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.7 m-85 -92.14 91.58 7.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 109.891 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.6 pp -96.77 118.61 43.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.31 -0.869 . . . . 0.0 108.771 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.475 ' O ' ' O ' ' A' ' 25' ' ' ILE . 13.2 p -43.07 166.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.579 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.591 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -64.15 -43.61 94.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.148 -0.97 . . . . 0.0 108.903 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.52 -38.89 64.19 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.478 ' O ' HD13 ' A' ' 33' ' ' LEU . 1.6 mt-10 -58.21 -40.84 82.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.522 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -64.34 -38.81 92.36 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.416 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 3.5 mm100 -60.05 -36.35 77.12 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.69 -39.16 87.47 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.354 -0.841 . . . . 0.0 109.602 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.8 mp -81.12 -8.03 59.68 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.704 -0.623 . . . . 0.0 110.205 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.06 67.39 0.76 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.633 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 9.4 t90 -136.82 118.94 15.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.157 . . . . 0.0 109.031 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.81 113.55 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.804 . . . . 0.0 109.072 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.58 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -59.17 -16.25 19.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.213 -0.929 . . . . 0.0 109.65 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 t -80.1 -31.82 39.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.965 . . . . 0.0 109.444 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.1 OUTLIER -97.01 -9.7 27.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 43.71 45.3 7.15 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.458 ' O ' HG21 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -97.78 45.29 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.102 -1.234 . . . . 0.0 109.82 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.633 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 4.5 tp -61.95 -45.21 94.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.07 -1.019 . . . . 0.0 109.48 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.49 -10.38 11.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.911 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -105.3 -24.99 12.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 110.27 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 41' ' ' ASN . 34.8 m -115.03 -49.57 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.963 -1.086 . . . . 0.0 110.051 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -129.74 62.22 62.32 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.464 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 2.2 Cg_endo -61.71 177.9 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.133 1.889 . . . . 0.0 110.176 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 49' ' ' LYS . . . 43.96 60.93 3.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 4.6 mttt -159.52 123.63 3.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -1.151 . . . . 0.0 109.577 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 1.8 m -90.03 134.81 34.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.616 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.539 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 8.4 mm -96.08 108.76 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.181 -0.95 . . . . 0.0 108.775 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.09 167.15 32.75 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.45 -6.96 50.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.33 154.35 29.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -1.165 . . . . 0.0 109.245 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.439 HG21 ' N ' ' A' ' 56' ' ' PHE . 19.5 mm -68.46 142.37 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.641 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 10.6 t80 -84.06 108.13 16.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.263 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' PHE . 3.1 t -42.43 -39.61 2.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.0 110.121 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.582 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 11.9 t-20 51.36 29.67 5.35 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.507 -0.746 . . . . 0.0 109.515 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -45.14 -52.45 9.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.518 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -63.02 -58.24 7.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' HA2' ' OD1' ' A' ' 58' ' ' ASN . . . 98.88 47.46 1.91 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.444 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -96.74 -2.43 44.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.173 -1.192 . . . . 0.0 109.715 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.641 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 58.8 mt -89.5 148.43 40.3 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 108.987 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.563 ' HD2' ' CH2' ' A' ' 71' ' ' TRP . 5.3 Cg_exo -59.69 94.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.08 1.854 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' CA ' ' HD3' ' A' ' 69' ' ' ARG . . . -164.83 170.25 39.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -72.34 -172.56 0.94 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -1.167 . . . . 0.0 109.52 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.0 m -61.25 88.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 0.0 109.385 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.82 60.81 1.56 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.478 ' CZ ' ' OG ' ' A' ' 91' ' ' SER . 4.7 ttp180 -80.42 163.64 23.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -1.162 . . . . 0.0 109.594 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.68 108.46 19.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.326 -0.859 . . . . 0.0 109.31 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.577 ' CZ2' ' HB3' ' A' ' 63' ' ' LEU . 10.5 m95 -112.76 166.59 11.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 0.0 109.562 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.629 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -120.49 132.23 55.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 108.745 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.523 ' CB ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -111.95 153.65 26.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.07 -1.019 . . . . 0.0 110.405 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.445 ' HB2' HG21 ' A' ' 88' ' ' ILE . . . -141.18 152.56 44.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.502 -0.749 . . . . 0.0 109.19 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.473 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 5.7 m-20 -74.54 141.51 44.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 109.245 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 77' ' ' ASN . 22.2 mm -135.41 145.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.145 -0.972 . . . . 0.0 109.771 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 65.32 33.84 8.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.472 -0.768 . . . . 0.0 109.81 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.48 ' HA ' ' OD1' ' A' ' 84' ' ' ASN . 17.1 t80 -69.49 137.84 52.9 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.68 -79.88 0.45 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.288 -0.882 . . . . 0.0 109.392 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.83 179.25 6.03 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.739 -0.6 . . . . 0.0 109.475 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.19 -162.95 42.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.53 150.68 6.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.204 -1.174 . . . . 0.0 109.394 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.92 173.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.686 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.48 ' OD1' ' HA ' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -107.36 -167.97 1.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.401 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -114.62 11.27 16.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.453 ' C ' ' HG2' ' A' ' 87' ' ' ARG . 42.8 m-20 -96.75 125.67 41.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.056 -1.028 . . . . 0.0 109.52 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -144.65 158.71 43.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 0.0 109.594 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.469 ' CG1' ' O ' ' A' ' 97' ' ' TYR . 7.2 tt -122.9 131.58 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.569 HD13 ' CG ' ' A' ' 56' ' ' PHE . 3.5 mm? -105.63 96.95 6.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.626 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 36.3 p90 -92.84 139.74 30.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.898 -1.126 . . . . 0.0 108.559 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.478 ' OG ' ' CZ ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -105.64 170.53 7.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.138 -0.976 . . . . 0.0 110.565 -178.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -21.37 66.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -0.794 . . . . 0.0 109.388 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 54.8 p30 -89.57 17.53 6.3 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.587 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.8 29.5 5.12 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.723 -0.611 . . . . 0.0 110.375 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.538 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 7.5 mt -86.4 96.54 10.05 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.529 ' CD1' ' HB2' ' A' ' 110' ' ' ARG . 8.7 mt -94.64 111.21 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 110.342 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.49 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 9.7 m-85 -110.52 162.48 14.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -129.8 152.37 49.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.98 -1.075 . . . . 0.0 109.329 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.2 118.18 11.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.892 . . . . 0.0 109.031 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 27.01 8.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 109.767 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -145.57 20.21 1.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.478 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 5.8 t-80 78.8 74.3 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -0.815 . . . . 0.0 109.786 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.492 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 29.3 m-85 44.64 24.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 102' ' ' HIS . 5.0 mm-40 -94.67 -16.41 23.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.998 . . . . 0.0 108.887 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.5 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 1.4 m -150.28 136.7 18.89 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 98' ' ' LYS . 71.2 m-85 -124.25 131.37 53.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.01 -1.056 . . . . 0.0 110.33 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -126.11 131.87 52.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 4.5 tttt -79.34 128.25 33.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.037 -1.039 . . . . 0.0 109.549 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pt -112.12 -45.14 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.529 ' HB2' ' CD1' ' A' ' 96' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.462 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.375 0.607 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -160.45 177.52 10.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 109.372 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.2 m -105.73 146.43 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.456 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mp -97.65 92.76 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -146.63 60.6 1.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 10' ' ' VAL . 14.0 p -144.6 -167.58 2.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.932 . . . . 0.0 109.523 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.56 ' CD1' HG22 ' A' ' 76' ' ' ILE . 37.3 m-85 -79.17 -59.99 2.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.444 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.56 -31.0 67.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.58 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.89 -52.33 29.4 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 76' ' ' ILE . 58.0 t -64.6 -44.66 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -1.152 . . . . 0.0 109.138 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.453 ' HA ' HD13 ' A' ' 14' ' ' LEU . . . -56.06 -38.87 71.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -56.51 16.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.499 -0.751 . . . . 0.0 109.138 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.64 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 22.5 t80 -58.66 -20.21 46.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.045 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.5 mt -73.33 -63.17 1.24 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.458 -0.776 . . . . 0.0 109.001 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.417 ' HG3' HD13 ' A' ' 96' ' ' ILE . 7.2 mt-30 -71.93 -5.96 38.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.091 . . . . 0.0 109.391 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.58 HG23 ' CD1' ' A' ' 17' ' ' TYR . 51.0 m -91.15 -66.8 0.9 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.166 -0.959 . . . . 0.0 110.044 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 85.0 m-85 -89.22 -10.93 45.15 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.62 -0.675 . . . . 0.0 109.362 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 22.5 m170 62.57 54.61 2.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.392 -0.817 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER 162.56 130.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.436 ' C ' ' O ' ' A' ' 19' ' ' LYS . 31.5 mt -43.67 148.51 0.71 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.91 . . . . 0.0 109.116 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 12.0 Cg_exo -51.49 163.49 1.11 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.072 1.848 . . . . 0.0 110.552 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.7 -7.03 35.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.357 -0.84 . . . . 0.0 109.057 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.444 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 5.6 p30 -92.15 2.54 56.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.85 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 6.8 m-85 -99.24 93.21 5.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.095 -1.003 . . . . 0.0 109.818 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.1 pp -98.77 118.98 46.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.27 -0.894 . . . . 0.0 108.925 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 25' ' ' ILE . 30.0 p -44.58 169.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -65.53 -44.56 86.51 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.136 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -54.58 -39.61 67.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.489 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 1.3 mt-10 -58.63 -39.92 81.87 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 42' ' ' LEU . . . -65.44 -39.43 92.05 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.144 -0.972 . . . . 0.0 108.443 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 9.2 mt-30 -59.77 -35.22 74.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.18 73.39 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 109.367 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.489 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.37 -15.77 54.27 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.703 -0.623 . . . . 0.0 110.205 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 45' ' ' VAL . . . 112.49 44.59 0.83 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.583 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 8.6 t90 -109.37 124.48 51.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -1.177 . . . . 0.0 109.239 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 t -91.08 113.32 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.835 . . . . 0.0 109.083 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -64.6 -10.74 28.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.491 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 m -90.22 -29.22 18.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.453 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.517 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mttt -103.17 -4.88 23.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.651 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 42.93 62.08 2.42 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -111.75 42.76 1.66 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.143 -1.21 . . . . 0.0 109.415 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.561 HD11 ' CD1' ' A' ' 35' ' ' TRP . 10.9 tp -56.77 -60.94 2.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 109.581 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -43.56 -24.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.926 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -82.13 -49.44 10.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 110.64 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 34' ' ' GLY . 31.8 m -95.14 -50.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.906 -1.121 . . . . 0.0 110.488 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.479 ' N ' HG22 ' A' ' 45' ' ' VAL . . . -117.13 76.8 8.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.003 -1.061 . . . . 0.0 109.805 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.8 Cg_endo -62.85 154.23 67.66 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.235 1.956 . . . . 0.0 110.364 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 45.32 73.9 0.25 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.5 mttp -154.42 123.07 6.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.556 ' HB2' ' CD1' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -89.77 131.97 35.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.878 . . . . 0.0 109.472 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.537 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 11.5 mm -91.16 109.85 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.186 -0.946 . . . . 0.0 109.2 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -161.92 175.63 38.42 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.459 ' HA2' ' OH ' ' A' ' 90' ' ' TYR . . . 88.32 33.73 10.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' OD1' ' OE2' ' A' ' 73' ' ' GLU . 2.2 p30 -131.05 143.37 50.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -1.225 . . . . 0.0 109.497 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 54' ' ' ASP . 1.1 mp -44.08 147.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.832 . . . . 0.0 109.003 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.644 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 8.1 t80 -101.63 146.99 26.96 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.311 -0.868 . . . . 0.0 109.211 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 58.0 m -43.31 -91.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.565 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 57' ' ' SER . 6.8 t-20 77.85 19.26 1.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.53 -0.731 . . . . 0.0 109.448 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -59.96 -72.26 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.915 . . . . 0.0 109.391 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -56.41 -30.48 62.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.943 . . . . 0.0 109.292 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.4 63.55 0.9 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.5 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 7.5 mtpp -91.76 -3.9 55.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -1.142 . . . . 0.0 109.533 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.644 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 28.5 mt -115.07 152.2 46.4 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.175 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.602 ' CG ' ' CZ ' ' A' ' 97' ' ' TYR . 2.9 Cg_endo -61.44 156.65 45.33 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.131 1.887 . . . . 0.0 110.233 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' CA ' ' HD3' ' A' ' 69' ' ' ARG . . . 135.71 -177.12 19.72 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -109.27 175.99 5.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -1.139 . . . . 0.0 109.384 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -65.18 108.18 1.8 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.79 11.61 9.16 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.466 ' HD3' ' CA ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -86.08 133.27 33.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -1.14 . . . . 0.0 109.537 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.35 153.93 18.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.549 ' CE3' HD12 ' A' ' 63' ' ' LEU . 16.4 m95 -137.13 171.51 14.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.509 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 90' ' ' TYR . 8.7 mmt180 -133.06 143.2 49.2 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.391 -0.818 . . . . 0.0 108.819 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' CB ' HD12 ' A' ' 89' ' ' LEU . 17.3 pt-20 -121.0 149.4 42.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.14 -0.975 . . . . 0.0 110.123 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 87' ' ' ARG . . . -139.53 146.28 39.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.363 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.501 ' HA ' ' HG3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -65.24 141.17 58.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.519 -0.738 . . . . 0.0 109.629 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.56 HG22 ' CD1' ' A' ' 7' ' ' PHE . 23.1 mm -129.47 122.71 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.948 . . . . 0.0 109.833 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 5.2 m120 77.48 43.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 109.868 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.495 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 36.6 t80 -70.08 149.25 47.83 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.191 -0.943 . . . . 0.0 109.317 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.79 -78.19 0.16 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.171 -0.956 . . . . 0.0 109.488 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.8 m -165.96 168.66 15.51 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.729 -0.607 . . . . 0.0 109.615 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 78.21 -179.25 51.94 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER -43.61 165.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -1.087 . . . . 0.0 109.431 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -50.66 175.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.562 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 1.3 p30 -109.37 -169.17 1.43 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.892 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.46 9.18 18.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.91 . . . . 0.0 109.508 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 61.6 m-20 -107.21 129.24 54.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.501 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -150.02 174.6 12.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.894 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.53 ' CD1' HG23 ' A' ' 96' ' ' ILE . 5.6 tt -137.64 128.68 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 109.119 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.3 mm? -103.29 102.99 12.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.398 -0.814 . . . . 0.0 110.32 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 72' ' ' ARG . 32.1 p90 -99.38 139.94 34.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.999 -1.063 . . . . 0.0 108.559 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.465 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -103.62 173.2 6.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.059 -1.026 . . . . 0.0 110.826 -178.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 p -66.01 -19.9 66.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.509 -0.745 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.465 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 47.5 p-10 -89.58 17.05 6.79 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.582 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 66.89 29.22 8.39 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.726 -0.609 . . . . 0.0 109.989 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 90' ' ' TYR . 6.9 mt -85.33 99.14 10.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.53 HG23 ' CD1' ' A' ' 88' ' ' ILE . 2.6 mt -93.83 116.92 36.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 110.408 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.602 ' CZ ' ' CG ' ' A' ' 64' ' ' PRO . 7.2 m-85 -116.8 155.58 28.71 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -121.49 154.12 37.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.754 -1.217 . . . . 0.0 109.713 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -140.69 125.01 17.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.496 -0.752 . . . . 0.0 108.993 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.441 HG21 ' OD1' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.65 29.38 7.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.784 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.524 ' OD2' ' CG2' ' A' ' 105' ' ' THR . 0.9 OUTLIER -150.24 21.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.114 -0.991 . . . . 0.0 109.687 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 2.2 t-80 76.61 72.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 109.261 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.46 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 9.2 m-85 50.33 20.8 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.739 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.472 ' HB2' ' CB ' ' A' ' 101' ' ' ASP . 1.2 mt-30 -86.87 -19.98 28.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.913 . . . . 0.0 109.143 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.524 ' CG2' ' OD2' ' A' ' 101' ' ' ASP . 34.3 p -146.51 157.5 43.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.5 ' CE2' ' HB3' ' A' ' 62' ' ' LYS . 82.6 m-85 -141.98 125.11 16.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 110.042 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -117.0 133.96 55.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.359 -0.838 . . . . 0.0 109.018 179.416 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -79.73 128.3 33.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.596 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 6.8 pt -127.85 17.04 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.524 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.252 0.549 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 2' ' ' GLN . 2.8 pt20 -151.92 67.45 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.548 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 m -122.7 160.49 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.505 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mm -91.31 93.66 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -141.25 53.35 1.55 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.463 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.74 -172.76 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.417 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.564 ' CZ ' HG23 ' A' ' 76' ' ' ILE . 47.2 m-85 -80.24 -61.96 1.82 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.482 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -30.99 67.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.35 -50.27 45.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 6' ' ' THR . 96.7 t -65.89 -45.8 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -1.115 . . . . 0.0 109.294 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.93 -35.93 69.62 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.432 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.1 OUTLIER -64.51 -55.68 19.07 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 22.6 t80 -58.61 -23.13 58.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 0.0 109.183 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.511 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 5.4 mt -71.9 -63.83 1.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.353 -0.842 . . . . 0.0 108.949 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.402 ' HG3' ' HD2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -71.01 -5.04 28.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.102 -0.999 . . . . 0.0 109.364 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.564 HG23 ' CD2' ' A' ' 17' ' ' TYR . 31.2 m -91.93 -69.96 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -0.952 . . . . 0.0 109.844 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 81.9 m-85 -89.76 -4.82 57.48 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.684 -0.635 . . . . 0.0 109.596 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 21.4 m170 57.51 57.81 4.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 162.51 129.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 74' ' ' ALA . 19.0 mt -44.05 148.24 0.82 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.287 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.5 Cg_exo -55.35 164.49 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.172 1.915 . . . . 0.0 110.444 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.81 -5.81 33.05 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.306 -0.871 . . . . 0.0 108.868 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.499 ' ND2' ' HB2' ' A' ' 21' ' ' PRO . 23.2 p30 -92.14 9.79 32.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.525 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.561 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 4.6 m-85 -108.14 99.79 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.006 . . . . 0.0 109.753 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.477 ' O ' ' O ' ' A' ' 26' ' ' THR . 2.1 pt -106.46 124.45 61.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 108.725 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 25' ' ' ILE . 20.5 p -47.0 176.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.817 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.588 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.19 -44.76 68.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.1 -1.0 . . . . 0.0 109.092 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 m -54.49 -39.9 68.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.525 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 1.7 mm-40 -58.67 -39.73 81.52 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HB1' ' CE3' ' A' ' 35' ' ' TRP . . . -67.2 -34.56 77.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 108.663 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.501 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 18.6 mt-30 -65.95 -30.75 71.37 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.29 -37.87 84.73 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.692 0.758 . . . . 0.0 109.579 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -80.93 -8.25 59.7 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.649 -0.657 . . . . 0.0 110.124 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.01 61.77 0.71 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.619 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 1.7 t90 -118.55 135.45 54.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.195 -1.179 . . . . 0.0 109.599 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.51 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 3.5 t -89.73 131.66 36.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.619 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -63.09 -8.04 6.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.965 -1.085 . . . . 0.0 110.311 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.481 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 3.0 t -55.26 -17.91 5.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.926 -1.109 . . . . 0.0 109.048 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.577 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 11.3 mtmt 64.59 47.5 2.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -0.809 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.583 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -127.19 -12.8 3.05 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.224 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' C ' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -147.07 27.36 1.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.958 -1.319 . . . . 0.0 109.995 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.586 HD11 ' CD1' ' A' ' 35' ' ' TRP . 11.7 tp -52.94 -66.58 0.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 109.111 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.79 -14.64 1.48 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.787 -0.571 . . . . 0.0 110.359 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.8 -36.56 42.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.89 -1.131 . . . . 0.0 109.516 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -105.49 -1.6 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 109.503 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.4 62.69 5.58 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 109.31 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 5.6 Cg_exo -58.42 152.92 50.95 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.203 1.935 . . . . 0.0 110.286 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 49.8 66.55 2.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.459 ' HD2' HG12 ' A' ' 25' ' ' ILE . 30.7 mmtp -151.88 154.64 36.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.671 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.504 ' HB2' ' CD1' ' A' ' 24' ' ' TYR . 1.8 m -135.34 124.91 25.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.537 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 11.9 mm -74.64 104.97 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -151.35 173.21 30.8 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.403 ' N ' HD13 ' A' ' 20' ' ' LEU . . . 84.17 15.27 69.83 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.48 154.31 17.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -1.151 . . . . 0.0 109.409 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.4 mm -70.08 149.67 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.632 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 60.6 t80 -118.66 91.3 3.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.043 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 26.4 m -69.65 -5.32 23.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 1.1 t-20 70.74 89.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -60.71 -20.85 62.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.404 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -125.4 -51.45 1.63 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.504 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.43 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . 108.82 65.82 0.57 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -120.51 -0.48 10.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -1.149 . . . . 0.0 109.756 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.632 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 41.1 mt -89.85 145.11 32.65 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.151 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.613 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 2.8 Cg_endo -60.31 156.23 41.84 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.025 1.816 . . . . 0.0 110.359 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.17 -173.63 22.35 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -114.21 158.72 20.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.13 126.46 18.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.14 8.67 57.65 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -89.18 132.17 34.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -1.156 . . . . 0.0 109.443 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -90.96 147.6 23.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.587 ' CE3' HD12 ' A' ' 63' ' ' LEU . 3.9 m95 -122.93 173.57 7.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.554 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.591 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 1.1 mmt180 -121.58 148.83 44.0 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' HA ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -128.8 153.8 47.06 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.877 -1.139 . . . . 0.0 110.249 -179.304 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 20' ' ' LEU . . . -143.05 148.77 37.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.423 -0.798 . . . . 0.0 109.241 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.6 OUTLIER -77.45 124.07 27.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.727 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.564 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 22.3 mm -110.85 138.86 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.113 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.452 ' OD1' HG23 ' A' ' 76' ' ' ILE . 14.9 m120 61.58 112.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.069 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 6.8 t80 -170.45 133.95 1.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.062 -1.024 . . . . 0.0 109.674 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -140.9 -79.43 0.27 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.226 -0.921 . . . . 0.0 109.364 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 m -146.14 160.03 42.49 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.716 -0.615 . . . . 0.0 109.436 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.9 -169.15 18.79 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.583 ' CD1' ' HA2' ' A' ' 40' ' ' GLY . 0.3 OUTLIER -64.07 144.45 57.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -1.177 . . . . 0.0 109.485 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.527 ' CD ' ' HG2' ' A' ' 39' ' ' LYS . 5.2 mtm180 -43.97 163.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 109.219 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -106.84 -171.11 1.82 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.944 . . . . 0.0 109.651 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.43 23.28 9.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.475 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.5 m-20 -109.24 132.03 54.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.373 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 36.8 mtt180 -157.81 157.73 33.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.55 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.483 ' CG1' HG23 ' A' ' 96' ' ' ILE . 1.5 tt -112.93 139.64 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.245 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.4 mm? -108.45 126.59 53.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.795 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.595 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -116.69 140.05 49.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.857 -1.152 . . . . 0.0 108.666 178.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.44 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -108.12 176.01 5.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.193 -0.942 . . . . 0.0 110.379 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 p -64.23 -25.2 67.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.408 -0.808 . . . . 0.0 110.441 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.476 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -89.3 16.84 6.76 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.108 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.561 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.4 m95 67.5 29.31 7.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.713 -0.617 . . . . 0.0 110.737 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.518 ' CD1' ' HG2' ' A' ' 64' ' ' PRO . 8.8 mt -83.79 121.87 27.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.522 ' CG1' ' HB2' ' A' ' 110' ' ' ARG . 1.8 mt -115.42 112.82 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 110.75 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.613 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 26.1 m-85 -112.07 118.66 36.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -88.88 136.13 33.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.818 -1.176 . . . . 0.0 109.866 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 105' ' ' THR . 0.1 OUTLIER -125.54 131.46 52.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.392 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.2 p -114.75 31.75 6.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.159 -0.963 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -150.26 20.4 0.85 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 109.565 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.537 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.5 t-80 79.08 73.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.496 -0.753 . . . . 0.0 109.971 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.474 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 5.0 m-85 51.57 37.73 20.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.04 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.435 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 19.7 tp60 -104.29 -72.29 0.71 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.135 -0.978 . . . . 0.0 109.052 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 99' ' ' THR . 0.8 OUTLIER -93.16 124.41 37.12 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.533 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 96.7 m-85 -112.17 121.66 45.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.067 -1.021 . . . . 0.0 110.065 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 3.8 m -108.64 130.81 55.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.386 -0.821 . . . . 0.0 109.087 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -79.41 113.8 17.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.047 -1.033 . . . . 0.0 109.668 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.452 HD12 ' CD1' ' A' ' 88' ' ' ILE . 29.5 pt -113.21 -14.98 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 109.328 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.522 ' HB2' ' CG1' ' A' ' 96' ' ' ILE . 1.1 mtt-85 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -129.69 118.94 22.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.409 ' O ' HG21 ' A' ' 3' ' ' VAL . 15.5 m -70.98 151.3 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 109.438 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mp -114.35 87.55 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.934 . . . . 0.0 109.557 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -134.57 49.44 2.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.484 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -135.31 -169.93 2.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 0.0 109.443 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.573 ' CE1' HG23 ' A' ' 76' ' ' ILE . 42.6 m-85 -80.14 -59.64 2.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.213 -0.929 . . . . 0.0 109.463 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -28.72 65.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.969 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.37 -51.27 33.03 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 76' ' ' ILE . 38.7 t -67.04 -49.36 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -1.153 . . . . 0.0 109.167 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 109' ' ' ILE . . . -53.88 -37.04 63.3 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.27 -55.63 23.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 23.2 t80 -59.94 -18.3 44.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.429 -0.794 . . . . 0.0 109.03 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.493 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.7 OUTLIER -76.1 -63.82 1.23 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.328 -0.857 . . . . 0.0 109.296 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.439 ' NE2' ' HD3' ' A' ' 110' ' ' ARG . 3.1 pt20 -70.51 -8.49 51.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.906 -1.121 . . . . 0.0 109.353 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.498 HG23 ' CD1' ' A' ' 17' ' ' TYR . 27.7 m -91.9 -65.7 0.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.782 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 96.3 m-85 -89.51 3.3 52.88 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.713 -0.617 . . . . 0.0 109.5 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.534 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 16.6 m170 45.01 45.48 8.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.6 OUTLIER 174.43 129.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.437 HD12 ' HB3' ' A' ' 74' ' ' ALA . 18.4 mt -45.46 150.73 0.84 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 108.754 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 10.9 Cg_exo -52.98 160.06 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.084 1.856 . . . . 0.0 110.453 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -69.59 -5.89 27.52 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.309 -0.87 . . . . 0.0 109.202 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.421 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -93.44 2.87 56.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.336 -0.853 . . . . 0.0 109.628 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.2 m-85 -93.76 92.72 7.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.002 . . . . 0.0 109.943 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.8 pt -100.99 125.3 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.264 -0.897 . . . . 0.0 108.937 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 25' ' ' ILE . 12.1 p -45.96 172.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.544 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.16 -43.09 71.57 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.964 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -39.1 64.14 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' O ' HD13 ' A' ' 33' ' ' LEU . 5.5 mt-10 -59.67 -41.31 90.32 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.557 ' HB1' ' CE3' ' A' ' 35' ' ' TRP . . . -65.08 -35.98 82.88 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 0.0 108.63 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -63.03 -36.25 82.95 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.22 79.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.447 -0.783 . . . . 0.0 109.533 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.8 mp -81.17 -11.25 59.48 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.365 0.602 . . . . 0.0 110.261 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.463 ' O ' HG12 ' A' ' 45' ' ' VAL . . . 107.68 56.77 0.59 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.582 ' CD1' HD11 ' A' ' 42' ' ' LEU . 9.8 t90 -127.89 115.48 18.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -1.141 . . . . 0.0 109.025 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.432 ' HB ' ' HB2' ' A' ' 39' ' ' LYS . 14.0 t -90.14 112.04 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 108.994 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.581 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -51.83 -20.89 2.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.195 -0.94 . . . . 0.0 109.422 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.55 ' O ' ' CZ ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -83.94 -49.97 8.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.309 -0.869 . . . . 0.0 109.669 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 40' ' ' GLY . 10.0 mttp -67.3 -13.33 61.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.607 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 39' ' ' LYS . . . 44.26 93.73 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.416 ' O ' ' CG ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -159.86 44.33 0.22 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -1.148 . . . . 0.0 109.444 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.582 HD11 ' CD1' ' A' ' 35' ' ' TRP . 9.8 tp -59.54 -52.98 63.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.449 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -56.67 -14.96 3.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 109.871 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.83 -53.83 4.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.024 . . . . 0.0 110.331 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 46' ' ' ALA . 20.4 m -89.88 -48.1 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 110.16 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.507 ' N ' HG22 ' A' ' 45' ' ' VAL . . . -116.85 77.35 8.5 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.993 . . . . 0.0 109.542 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 2.7 Cg_endo -60.92 159.47 29.25 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.21 1.94 . . . . 0.0 110.4 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.85 57.28 4.09 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.459 ' HD3' HG12 ' A' ' 25' ' ' ILE . 2.9 mmtt -137.65 110.16 7.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -1.141 . . . . 0.0 109.588 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 9.2 m -89.7 133.93 34.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.4 -0.813 . . . . 0.0 109.229 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.542 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 10.2 mm -91.06 111.48 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.102 -0.999 . . . . 0.0 109.176 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.91 169.21 33.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.77 12.71 55.25 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 5.6 m-20 -104.95 143.86 32.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -1.21 . . . . 0.0 109.38 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 54' ' ' ASP . 7.3 mt -44.44 152.22 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 109.571 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.62 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 9.9 t80 -92.42 134.12 35.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.139 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 0.4 OUTLIER -44.28 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.482 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 57' ' ' SER . 10.2 t-20 80.63 39.87 0.07 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -48.21 66.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.315 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.82 -51.03 12.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.898 . . . . 0.0 109.383 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.6 60.56 0.66 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.578 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 8.0 mptt -102.15 -7.5 22.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -1.18 . . . . 0.0 109.64 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.62 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 56.2 mt -91.59 140.71 25.32 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.24 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' A' ' 95' ' ' LEU . 3.2 Cg_exo -61.53 84.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.078 1.852 . . . . 0.0 110.067 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.66 164.29 12.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -118.98 169.8 9.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -1.062 . . . . 0.0 109.334 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.6 m -55.73 103.18 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.878 . . . . 0.0 109.453 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.6 52.55 2.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -126.54 159.21 34.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -1.139 . . . . 0.0 109.483 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.58 170.0 10.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.157 -0.965 . . . . 0.0 109.615 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.592 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 8.2 m95 -139.79 151.26 45.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 109.299 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.636 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 10.0 mpt_? -110.75 139.16 46.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.202 -0.936 . . . . 0.0 108.671 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HA ' HD12 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -117.77 158.22 25.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.008 . . . . 0.0 110.269 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB3' HD12 ' A' ' 20' ' ' LEU . . . -147.91 152.95 38.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.464 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.3 OUTLIER -75.39 142.6 43.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 109.323 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.573 HG23 ' CE1' ' A' ' 7' ' ' PHE . 16.8 mm -131.14 121.73 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.09 -1.006 . . . . 0.0 109.732 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.509 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER 71.63 116.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 109.698 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -170.64 127.77 0.78 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.351 -0.843 . . . . 0.0 109.493 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -121.47 -27.91 4.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.745 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 79' ' ' THR . 0.6 OUTLIER 168.91 -174.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.391 -0.818 . . . . 0.0 109.703 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 82' ' ' PHE . . . 67.07 174.7 6.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CZ ' ' O ' ' A' ' 38' ' ' SER . 7.5 m-85 -43.81 152.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -1.15 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -46.65 171.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.9 OUTLIER -106.38 -174.74 2.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 m -106.37 3.99 28.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 0.0 109.48 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.2 m-20 -95.9 129.5 43.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 109.53 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 27.2 mtt180 -154.64 178.53 10.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.181 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.481 ' CD1' HG23 ' A' ' 96' ' ' ILE . 3.7 tt -135.23 150.95 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.562 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.1 mm? -121.69 109.45 14.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.376 -0.827 . . . . 0.0 109.707 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.636 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 7.9 p90 -104.55 138.89 40.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 109.302 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.583 ' OG ' ' CH2' ' A' ' 71' ' ' TRP . 1.4 m -107.23 174.3 5.95 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.288 -0.882 . . . . 0.0 110.396 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -65.3 -23.9 67.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 109.593 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.467 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 17.8 p-10 -89.7 18.15 5.82 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 108.858 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.56 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.4 m95 66.39 29.49 9.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.677 -0.639 . . . . 0.0 110.173 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.538 ' CD1' ' HG2' ' A' ' 64' ' ' PRO . 5.7 mt -81.03 112.5 18.48 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.481 HG23 ' CD1' ' A' ' 88' ' ' ILE . 2.0 mt -109.52 110.83 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.782 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.466 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 31.5 m-85 -113.91 113.49 24.92 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.518 ' CG ' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -89.36 133.76 34.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 110.215 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -117.13 128.96 55.65 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.553 HG21 ' CZ ' ' A' ' 7' ' ' PHE . 0.7 OUTLIER -112.33 28.23 8.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.18 -0.95 . . . . 0.0 109.645 -179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.7 OUTLIER -150.18 22.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.463 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 8.7 t-80 77.54 71.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.381 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.426 ' OH ' ' HD2' ' A' ' 87' ' ' ARG . 5.1 m-85 50.76 20.91 0.82 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.826 . . . . 0.0 109.752 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.45 ' HB2' ' HB2' ' A' ' 101' ' ' ASP . 1.2 mm-40 -90.33 -17.4 27.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -0.96 . . . . 0.0 108.87 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.473 ' O ' ' HB ' ' A' ' 99' ' ' THR . 14.9 t -143.81 161.5 38.46 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.578 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 99.4 m-85 -148.76 119.72 7.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.817 -1.177 . . . . 0.0 110.223 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.518 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 3.8 m -108.96 124.82 51.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.515 -0.741 . . . . 0.0 109.1 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -79.42 101.13 7.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.447 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.527 HD13 ' CB ' ' A' ' 11' ' ' ALA . 38.1 pt -104.63 18.18 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.478 ' CD ' HD13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -112.8 109.8 19.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.434 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 m -155.22 -174.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mp -106.04 109.49 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -0.885 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.454 ' O ' HG21 ' A' ' 6' ' ' THR . 29.9 p-10 -143.76 69.74 1.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.516 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.464 ' O ' HD11 ' A' ' 76' ' ' ILE . 1.5 p -149.03 -173.15 4.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.436 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.532 ' CD1' ' HB2' ' A' ' 98' ' ' LYS . 24.1 m-85 -77.65 -60.29 2.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.893 . . . . 0.0 109.429 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -33.97 70.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.69 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.24 -50.3 46.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 6' ' ' THR . 76.0 t -66.78 -46.98 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -1.147 . . . . 0.0 109.337 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -54.69 -38.4 66.97 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.457 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.4 OUTLIER -63.85 -55.77 20.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.518 -0.739 . . . . 0.0 109.246 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.664 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 42.0 t80 -58.18 -21.08 45.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.374 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.51 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.7 OUTLIER -75.38 -63.87 1.19 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.401 -0.812 . . . . 0.0 109.317 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' OE1' ' CG ' ' A' ' 110' ' ' ARG . 46.8 mt-30 -70.58 -5.72 31.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.034 -1.041 . . . . 0.0 109.389 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 82.6 m -94.5 -67.37 0.86 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.678 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.664 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 66.6 m-85 -89.78 3.2 53.59 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 109.567 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.9 m170 44.14 51.09 7.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER 175.35 129.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 15.7 mt -43.84 160.02 0.23 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.99 . . . . 0.0 109.417 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.575 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 3.3 Cg_exo -55.22 159.23 10.46 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.236 1.957 . . . . 0.0 110.553 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.56 -5.05 30.44 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.374 -0.829 . . . . 0.0 108.947 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 21' ' ' PRO . 6.1 p30 -111.42 32.74 5.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.498 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 50' ' ' SER . 1.2 m-30 -115.18 81.06 1.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.062 -1.024 . . . . 0.0 109.363 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.1 pt -88.14 123.35 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.253 -0.905 . . . . 0.0 108.978 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 25' ' ' ILE . 82.8 p -46.92 175.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.335 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.593 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.24 -45.32 66.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.997 -1.064 . . . . 0.0 109.052 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -52.08 -33.42 39.24 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 108.361 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' O ' HD13 ' A' ' 33' ' ' LEU . 1.5 mm-40 -61.3 -46.53 89.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.19 -35.92 80.33 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.498 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 33.3 mt-30 -64.45 -33.73 76.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.62 -37.89 85.6 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.19 -8.96 59.85 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.741 -0.599 . . . . 0.0 109.972 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 101.67 71.23 0.91 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.623 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -128.2 137.69 52.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -1.188 . . . . 0.0 109.441 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' CG1' ' OD1' ' A' ' 41' ' ' ASN . 9.8 p -89.58 128.77 41.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.623 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -62.59 -9.68 9.66 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.009 -1.057 . . . . 0.0 110.384 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -47.17 -24.76 0.75 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.904 -1.123 . . . . 0.0 109.016 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.582 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 2.2 mtmp? 74.6 45.6 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 0.0 109.584 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -132.88 -30.62 0.48 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.1 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.529 ' OD1' ' CG1' ' A' ' 36' ' ' VAL . 2.6 p-10 -125.31 29.78 5.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.01 -1.288 . . . . 0.0 110.058 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.578 HD12 ' CD1' ' A' ' 35' ' ' TRP . 6.9 tp -56.85 -65.66 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 109.198 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.29 -9.87 3.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.798 -0.564 . . . . 0.0 110.252 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 3.7 m-20 -78.93 -30.29 44.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.973 -1.079 . . . . 0.0 109.41 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 34' ' ' GLY . 30.8 m -107.61 -14.18 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.341 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -149.3 65.24 7.83 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 109.376 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 3.1 Cg_exo -60.97 161.94 20.65 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.2 1.933 . . . . 0.0 110.317 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.52 38.34 42.82 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 15.8 mmtt -135.58 113.29 10.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -1.161 . . . . 0.0 109.55 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.579 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -89.68 155.43 19.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.531 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 5.4 mm -103.11 111.66 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.839 . . . . 0.0 109.405 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -154.1 160.09 29.21 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.08 19.91 27.25 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.528 ' HB2' ' CG ' ' A' ' 73' ' ' GLU . 4.5 m-20 -88.13 148.11 24.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -1.199 . . . . 0.0 109.467 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.0 mm -68.68 137.49 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.835 . . . . 0.0 109.758 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.641 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 78.2 t80 -110.65 89.72 3.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 108.957 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -62.36 -12.39 20.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.952 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.588 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 47.0 t-20 54.81 61.56 2.92 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.587 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -55.14 -73.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.41 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -43.9 -49.03 8.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.472 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . 89.14 66.59 1.26 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 6.4 mtpt -120.08 -4.51 10.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.505 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.641 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 12.7 mt -94.18 147.29 33.13 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 0.0 109.279 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.567 ' CG ' ' CE1' ' A' ' 97' ' ' TYR . 2.4 Cg_endo -62.03 119.14 6.12 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.139 1.893 . . . . 0.0 110.174 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.34 135.45 2.1 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -94.5 169.78 9.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.222 -1.163 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t -54.13 125.08 17.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.2 -4.63 33.55 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -97.67 153.4 18.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.654 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.89 159.36 25.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 109.43 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.574 ' CZ3' HD23 ' A' ' 63' ' ' LEU . 11.5 m95 -128.74 154.11 46.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.583 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 7.3 mmt180 -117.72 148.65 41.81 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 54' ' ' ASP . 5.9 pt-20 -125.49 155.02 41.19 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.789 -1.194 . . . . 0.0 110.11 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -144.16 155.59 43.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 109.416 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 3.4 m-20 -80.24 143.44 33.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.601 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.48 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 37.3 mm -127.85 119.0 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 73.83 108.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.674 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.513 ' CE1' ' HA ' ' A' ' 83' ' ' ARG . 23.3 t80 -170.71 118.81 0.52 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.336 -0.852 . . . . 0.0 109.46 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.42 -80.1 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.393 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.8 m -137.19 145.1 43.29 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.726 -0.609 . . . . 0.0 109.385 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.2 -174.25 15.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CG ' ' O ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -61.71 140.69 58.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.158 -1.201 . . . . 0.0 109.426 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.513 ' HA ' ' CE1' ' A' ' 78' ' ' TYR . 45.5 mtp180 -44.04 167.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 109.346 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.42 -176.98 3.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.961 . . . . 0.0 109.684 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -113.5 15.67 18.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 109.311 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.432 ' OD2' HG21 ' A' ' 100' ' ' THR . 0.7 OUTLIER -97.96 130.45 44.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.225 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.525 ' CZ ' ' OH ' ' A' ' 103' ' ' TYR . 2.3 mtt180 -152.54 179.57 8.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.967 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.461 ' O ' HG21 ' A' ' 88' ' ' ILE . 1.8 tt -138.77 141.39 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -0.835 . . . . 0.0 108.884 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.3 mm? -111.61 125.09 53.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.365 -0.834 . . . . 0.0 109.667 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.633 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -111.3 142.61 43.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.921 -1.112 . . . . 0.0 108.839 179.003 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.487 ' CB ' ' HB2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -110.88 171.77 7.27 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.186 -0.946 . . . . 0.0 110.184 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.0 p -64.59 -25.76 68.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.435 -0.791 . . . . 0.0 109.518 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.476 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 14.1 p-10 -90.01 19.8 4.68 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.573 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.0 27.77 8.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.68 -0.638 . . . . 0.0 110.133 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.532 ' CD1' ' HG2' ' A' ' 64' ' ' PRO . 7.2 mt -79.62 116.78 20.01 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.402 HG13 ' OXT' ' A' ' 110' ' ' ARG . 2.5 mt -114.6 108.05 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.088 -1.007 . . . . 0.0 110.56 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.567 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 24.9 m-85 -108.25 116.83 32.69 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -88.6 137.97 31.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.867 -1.146 . . . . 0.0 109.997 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -122.0 127.3 50.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.432 HG21 ' OD2' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -111.89 29.37 7.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.11 -0.994 . . . . 0.0 109.59 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -150.06 22.44 0.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.726 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.523 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.5 OUTLIER 77.42 69.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.525 ' OH ' ' CZ ' ' A' ' 87' ' ' ARG . 14.8 m-85 49.45 21.81 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.798 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.453 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . 4.8 mt-30 -88.0 -17.29 31.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 108.97 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.476 ' O ' ' HB ' ' A' ' 99' ' ' THR . 23.0 m -147.27 155.79 42.36 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . 90.2 m-85 -139.76 116.44 10.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.973 -1.08 . . . . 0.0 110.11 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 1.7 m -107.65 127.27 53.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 113.95 17.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 109.646 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.519 HG22 ' CD ' ' A' ' 98' ' ' LYS . 3.5 pt -109.3 -24.25 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.646 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.425 ' OXT' ' O ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -73.79 92.16 2.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.963 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.35 173.84 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.59 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.429 HG23 ' HA ' ' A' ' 10' ' ' VAL . 2.7 mp -120.45 96.26 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.437 -0.789 . . . . 0.0 109.339 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -142.67 47.33 1.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.456 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -136.75 -170.19 2.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.348 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.524 ' CZ ' HG23 ' A' ' 76' ' ' ILE . 52.3 m-85 -77.38 -59.57 2.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.402 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -31.19 67.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.894 . . . . 0.0 109.783 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 4' ' ' ILE . . . -68.56 -51.96 28.31 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.457 HG23 ' OH ' ' A' ' 24' ' ' TYR . 73.7 t -66.09 -45.91 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -1.118 . . . . 0.0 109.313 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -55.95 -38.86 70.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.49 -55.6 26.0 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.679 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 35.1 t80 -58.06 -22.35 49.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.327 -0.858 . . . . 0.0 109.046 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER -71.61 -62.87 1.25 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.43 -0.794 . . . . 0.0 108.989 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -71.28 -5.6 33.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.042 -1.036 . . . . 0.0 109.317 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 25.2 m -89.82 -69.48 0.72 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.952 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.679 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 77.5 m-85 -89.47 -7.79 54.3 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.626 -0.671 . . . . 0.0 109.463 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 23.1 m170 61.01 57.89 2.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.707 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 10.1 ptpt 160.64 129.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.466 HD12 ' HB3' ' A' ' 74' ' ' ALA . 30.4 mt -44.46 147.33 1.04 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 108.997 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.582 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.3 Cg_exo -52.41 160.1 3.86 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.043 1.829 . . . . 0.0 110.336 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -7.74 32.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.139 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -91.75 7.33 42.25 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.582 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.3 m-85 -98.43 98.44 9.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -0.93 . . . . 0.0 109.677 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.473 ' O ' HD11 ' A' ' 51' ' ' ILE . 1.9 pp -106.07 121.34 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 108.953 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 25' ' ' ILE . 16.8 p -46.35 173.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.667 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.87 -44.41 69.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.131 -0.98 . . . . 0.0 108.996 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 m -53.5 -38.7 63.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' O ' ' CD1' ' A' ' 33' ' ' LEU . 2.3 mm-40 -59.51 -39.35 83.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.525 ' CB ' HD12 ' A' ' 42' ' ' LEU . . . -67.55 -37.54 82.85 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.139 -0.976 . . . . 0.0 108.624 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -61.98 -33.02 73.54 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.31 74.74 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.437 -0.789 . . . . 0.0 109.358 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.537 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 3.0 mp -81.17 -15.52 55.51 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.4 0.619 . . . . 0.0 110.181 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 110.44 44.53 0.98 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.641 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 5.6 t90 -109.19 121.29 44.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -1.104 . . . . 0.0 109.184 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 39' ' ' LYS . 4.2 t -89.62 116.31 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.312 -0.867 . . . . 0.0 108.86 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -59.3 -14.02 10.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 0.0 109.75 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.64 -29.48 22.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.099 -1.0 . . . . 0.0 109.677 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -92.16 -16.69 25.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 109.501 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.56 30.0 25.99 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.468 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -85.98 40.99 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -1.132 . . . . 0.0 109.724 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.641 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 5.9 tp -58.56 -53.39 58.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.542 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.22 -19.17 1.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.937 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.11 -32.87 15.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.0 110.292 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -103.17 -57.65 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.929 -1.107 . . . . 0.0 109.683 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.514 ' CB ' ' HE2' ' A' ' 49' ' ' LYS . . . -114.12 79.69 5.11 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.423 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -62.18 156.92 47.49 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.252 1.968 . . . . 0.0 110.197 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.7 69.33 0.63 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HE2' ' CB ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -150.62 116.0 5.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.48 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 5.7 m -89.54 132.22 35.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.532 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 15.8 mm -87.17 104.83 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.364 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.56 168.42 34.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.16 -16.27 38.86 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.73 164.2 23.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -1.159 . . . . 0.0 109.3 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 56' ' ' PHE . 29.9 mm -67.81 166.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.922 . . . . 0.0 109.515 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.633 ' CE2' ' CD1' ' A' ' 63' ' ' LEU . 23.0 t80 -107.34 136.88 46.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.31 -0.869 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 2.5 m -43.81 -85.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.606 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 57' ' ' SER . 6.8 t-20 80.77 19.75 0.48 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.281 0.562 . . . . 0.0 109.488 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -38.61 78.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.153 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -71.34 -43.48 66.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.312 -0.868 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.54 47.43 2.54 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.581 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -96.32 -11.38 25.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -1.208 . . . . 0.0 109.449 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.633 ' CD1' ' CE2' ' A' ' 56' ' ' PHE . 20.9 mt -101.05 152.13 37.8 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.386 -0.821 . . . . 0.0 108.945 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.58 ' HD2' ' CZ2' ' A' ' 71' ' ' TRP . 5.7 Cg_exo -56.52 86.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.058 1.839 . . . . 0.0 110.072 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 66' ' ' LYS . . . -81.44 155.56 36.04 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 65' ' ' GLY . 15.7 mttt -149.11 161.51 41.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -1.073 . . . . 0.0 109.221 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -47.13 102.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 0.0 109.282 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.16 58.55 2.93 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -106.44 126.82 52.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -1.152 . . . . 0.0 109.715 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 m -112.36 99.97 8.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.031 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.583 ' CZ3' HD23 ' A' ' 63' ' ' LEU . 44.2 m95 -83.56 149.95 26.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.157 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -125.17 144.81 50.26 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.512 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 17.2 pt-20 -115.36 159.54 20.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.854 -1.154 . . . . 0.0 110.479 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.466 ' HB3' HD12 ' A' ' 20' ' ' LEU . . . -146.3 149.58 34.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.468 -0.77 . . . . 0.0 109.297 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -71.97 138.68 48.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.524 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 19.8 mm -129.93 138.13 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.686 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 73.21 38.0 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.787 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -69.74 139.81 53.38 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.137 -0.977 . . . . 0.0 109.468 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.32 -79.84 0.38 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.504 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.5 163.18 12.48 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.788 -0.57 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.0 -159.26 52.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 83' ' ' ARG . 10.4 m-85 -51.11 147.64 5.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -1.124 . . . . 0.0 109.529 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 82' ' ' PHE . 5.5 mtp180 -53.04 -173.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.308 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -118.33 179.77 4.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.57 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -100.67 12.81 36.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.327 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.461 ' OD1' ' HA ' ' A' ' 100' ' ' THR . 50.3 m-20 -104.9 128.86 53.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.354 -0.841 . . . . 0.0 109.55 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.525 ' O ' ' CG2' ' A' ' 99' ' ' THR . 68.5 mtt180 -153.91 163.69 39.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.139 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.524 ' CD1' HG23 ' A' ' 96' ' ' ILE . 4.3 tt -121.89 155.39 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.154 -0.966 . . . . 0.0 109.518 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.578 HD13 ' CD1' ' A' ' 56' ' ' PHE . 3.4 mm? -122.36 114.81 21.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.656 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.65 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 3.1 p90 -106.86 139.6 41.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.858 -1.151 . . . . 0.0 109.172 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.563 ' OG ' ' CZ3' ' A' ' 71' ' ' TRP . 1.3 m -110.06 173.7 6.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 p -64.77 -25.25 67.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.617 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.487 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 9.8 p-10 -89.73 18.44 5.55 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.415 -0.803 . . . . 0.0 108.971 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.585 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.45 27.41 8.02 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.743 -0.598 . . . . 0.0 110.233 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.538 ' CD1' ' HG2' ' A' ' 64' ' ' PRO . 6.2 mt -79.57 116.44 19.78 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.524 HG23 ' CD1' ' A' ' 88' ' ' ILE . 5.9 mt -114.9 105.86 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.43 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.518 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 23.0 m-85 -106.05 120.61 42.23 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.449 ' HB3' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -89.4 150.58 22.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 110.191 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -136.42 131.79 34.6 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.461 ' HA ' ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -114.32 6.25 16.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 109.874 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.516 ' HB2' ' CB ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -125.43 24.68 7.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.143 -0.973 . . . . 0.0 109.397 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.6 t-80 76.53 76.01 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.92 . . . . 0.0 109.493 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.488 ' O ' ' CZ ' ' A' ' 106' ' ' PHE . 14.7 m-85 48.93 21.6 0.48 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.516 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -94.02 -34.87 12.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.011 -1.056 . . . . 0.0 109.118 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.475 ' O ' ' HB ' ' A' ' 99' ' ' THR . 95.2 m -121.14 140.81 51.49 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.581 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 94.9 m-85 -134.36 115.55 14.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.043 -1.036 . . . . 0.0 110.131 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 11.2 m -110.15 137.09 48.38 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.358 -0.839 . . . . 0.0 108.947 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -79.68 114.42 18.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 10.5 pt -132.05 68.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.878 . . . . 0.0 109.281 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 3.5 mtp180 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.536 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -138.28 65.5 1.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 109.529 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 2' ' ' GLN . 24.0 m 41.59 -166.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.491 -0.756 . . . . 0.0 109.851 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -116.27 111.04 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.377 -0.827 . . . . 0.0 109.571 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -149.95 54.76 0.93 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.507 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 2.2 p -139.16 -168.82 2.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 98' ' ' LYS . 32.9 m-85 -79.82 -57.7 3.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.619 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.53 -32.46 69.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 0.0 109.792 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.9 -50.04 50.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 6' ' ' THR . 35.1 t -66.98 -43.58 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -1.124 . . . . 0.0 109.385 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.453 ' HA ' HD11 ' A' ' 14' ' ' LEU . . . -57.51 -37.2 72.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.12 -56.32 13.61 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.538 -0.726 . . . . 0.0 109.242 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.638 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 15.8 t80 -60.76 -18.45 54.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 109.064 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.2 mt -74.5 -65.61 0.84 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.499 -0.751 . . . . 0.0 108.975 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -70.26 -6.7 36.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.988 -1.07 . . . . 0.0 109.254 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.434 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 19.8 m -89.42 -68.48 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 96.5 m-85 -92.0 6.42 46.44 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.627 -0.671 . . . . 0.0 109.642 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 19.0 m170 44.97 47.65 9.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.407 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 175.83 129.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 74' ' ' ALA . 27.0 mt -46.03 149.53 1.21 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.196 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.576 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 6.8 Cg_exo -53.93 162.56 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.114 1.876 . . . . 0.0 110.639 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -70.79 -5.71 32.26 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.38 -0.825 . . . . 0.0 109.034 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 53.6 p30 -91.75 0.24 57.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.869 . . . . 0.0 109.596 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.576 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 3.2 m-85 -89.87 107.92 19.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.056 -1.027 . . . . 0.0 109.579 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.532 ' O ' ' CG1' ' A' ' 25' ' ' ILE . 1.7 pp -111.95 115.34 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 109.08 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 25' ' ' ILE . 81.7 p -44.59 168.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.307 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' HG2' ' CG2' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.68 -41.18 88.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.929 -1.107 . . . . 0.0 109.175 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.05 -47.54 82.82 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.467 ' HB2' HD11 ' A' ' 25' ' ' ILE . 47.2 mm-40 -50.63 -35.19 29.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.639 ' CB ' ' CE3' ' A' ' 35' ' ' TRP . . . -70.03 -40.91 74.91 Favored 'General case' 0 C--O 1.202 -1.438 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -60.03 -18.88 49.52 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.345 -1.472 . . . . 0.0 108.01 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.01 -48.0 64.08 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.541 -0.724 . . . . 0.0 111.675 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.592 HD21 ' O ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -81.81 -0.07 41.64 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.928 -1.107 . . . . 0.0 111.713 -178.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.561 ' N ' HD21 ' A' ' 33' ' ' LEU . . . 108.94 25.93 5.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.893 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.639 ' CE3' ' CB ' ' A' ' 30' ' ' ALA . 10.5 t90 -89.12 123.46 33.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.895 -1.356 . . . . 0.0 109.191 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 t -91.93 114.51 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 108.917 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.585 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -60.07 -25.76 65.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.232 -0.917 . . . . 0.0 109.789 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -81.92 -55.33 4.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -69.08 -8.3 43.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.194 -0.941 . . . . 0.0 109.522 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 42.33 86.4 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -137.36 44.74 2.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -1.183 . . . . 0.0 109.623 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 3.7 tp -64.42 -41.01 96.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.344 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -63.26 -9.22 10.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.921 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -102.67 -36.72 8.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.039 -1.038 . . . . 0.0 110.211 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.536 HG23 ' CA ' ' A' ' 35' ' ' TRP . 28.7 m -108.13 -44.93 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.101 -1.0 . . . . 0.0 110.056 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.492 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -128.7 59.95 46.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.835 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 1.7 Cg_endo -62.58 171.08 6.04 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.175 1.917 . . . . 0.0 110.253 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.17 52.21 5.07 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -139.33 135.98 34.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -1.169 . . . . 0.0 109.557 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.495 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 13.3 m -101.64 121.79 42.68 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.235 -0.916 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.539 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 11.3 mm -79.58 105.07 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.161 -0.962 . . . . 0.0 108.902 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -140.9 172.03 23.85 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.456 -1.354 . . . . 0.0 109.932 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.78 11.65 61.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.448 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -84.49 146.97 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -1.195 . . . . 0.0 109.392 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.422 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 19.5 mm -70.2 141.4 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.581 ' CE2' ' HA ' ' A' ' 58' ' ' ASN . 70.6 t80 -119.21 90.92 3.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.447 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -70.31 -4.81 23.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 109.788 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.581 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 4.5 t-20 75.05 91.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.22 -69.63 0.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -92.96 -63.87 1.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.396 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.8 73.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.56 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -117.12 -3.84 11.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -1.16 . . . . 0.0 109.591 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.58 HD13 ' CE2' ' A' ' 56' ' ' PHE . 23.4 mt -93.32 147.95 34.69 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 109.257 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.494 ' HG2' ' CD1' ' A' ' 95' ' ' LEU . 3.1 Cg_exo -60.89 162.76 17.91 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.108 1.872 . . . . 0.0 110.223 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.89 -106.59 1.09 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.32 166.05 28.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -1.145 . . . . 0.0 109.459 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.99 92.78 0.25 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.527 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.86 33.9 1.78 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.81 160.26 19.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 109.429 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.82 103.95 16.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.552 ' CZ3' HD23 ' A' ' 63' ' ' LEU . 8.8 m95 -107.52 161.49 14.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 109.471 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.647 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -117.73 131.25 56.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 0.0 108.819 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.535 ' CB ' HD12 ' A' ' 89' ' ' LEU . 3.6 pt-20 -107.44 147.49 30.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.316 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.474 ' HB1' HG21 ' A' ' 88' ' ' ILE . . . -135.17 147.27 49.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.468 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -70.78 137.01 49.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.354 -0.841 . . . . 0.0 109.818 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.505 ' CD1' HG22 ' A' ' 10' ' ' VAL . 21.5 mm -132.47 134.58 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.847 . . . . 0.0 109.428 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.1 m-20 69.9 125.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.259 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 6.4 t80 -170.4 136.47 1.33 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.201 -0.937 . . . . 0.0 109.615 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.26 -79.56 0.35 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.382 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -153.79 154.89 34.83 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.717 -0.614 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.9 -171.63 20.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.57 169.07 0.72 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -1.159 . . . . 0.0 109.388 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -56.73 177.14 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.158 -0.964 . . . . 0.0 109.315 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 0.2 OUTLIER -118.99 -174.05 2.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.875 . . . . 0.0 109.535 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 p -115.22 29.63 7.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.46 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 52.9 m-20 -114.14 128.84 56.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.573 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.539 ' O ' ' CG2' ' A' ' 99' ' ' THR . 2.2 mtt180 -156.73 137.27 13.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.388 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.596 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 5.1 tt -93.12 126.11 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.117 -0.989 . . . . 0.0 109.258 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.535 HD12 ' CB ' ' A' ' 73' ' ' GLU . 4.0 mm? -95.67 100.36 12.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.472 -0.767 . . . . 0.0 109.994 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.647 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 28.8 p90 -97.54 140.35 32.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.983 -1.073 . . . . 0.0 108.525 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.472 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.3 OUTLIER -107.84 172.37 6.87 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.985 -1.072 . . . . 0.0 110.761 -178.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -22.19 66.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.5 -0.75 . . . . 0.0 109.826 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 41.8 p-10 -89.58 17.88 5.97 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.382 -0.824 . . . . 0.0 108.829 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.567 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.84 23.96 8.29 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.634 -0.666 . . . . 0.0 110.104 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.494 ' CD1' ' HG2' ' A' ' 64' ' ' PRO . 7.2 mt -79.64 101.18 8.2 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.596 ' CG2' ' CD1' ' A' ' 88' ' ' ILE . 5.5 mt -96.5 118.26 42.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.22 -0.925 . . . . 0.0 110.631 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.47 ' O ' HG13 ' A' ' 88' ' ' ILE . 11.9 m-85 -120.11 160.97 21.79 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.57 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -131.79 122.02 25.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.756 -1.215 . . . . 0.0 110.056 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -108.69 131.14 55.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 109.01 179.349 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 p -115.12 18.15 16.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.7 OUTLIER -139.18 23.55 2.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER 78.33 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 50.35 20.89 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.808 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.77 -15.23 26.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.114 -0.992 . . . . 0.0 109.076 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.52 ' CG2' ' OD2' ' A' ' 101' ' ' ASP . 12.5 t -148.78 145.35 27.54 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.56 ' CE1' ' HB2' ' A' ' 62' ' ' LYS . 53.7 m-85 -135.99 111.45 9.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.919 -1.113 . . . . 0.0 110.153 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.522 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.8 m -98.34 131.31 44.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.426 -0.796 . . . . 0.0 108.906 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 76.5 tttt -80.03 122.35 26.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.548 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 pt -119.68 15.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.484 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.489 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.532 ' O ' ' CG2' ' A' ' 3' ' ' VAL . 4.6 mt-30 -104.02 145.38 30.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 2' ' ' GLN . 5.3 m 43.12 -168.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.498 -0.751 . . . . 0.0 109.858 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.426 ' CG2' ' C ' ' A' ' 9' ' ' GLY . 13.3 mt -131.86 106.32 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.373 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -144.22 49.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.489 ' O ' ' CG2' ' A' ' 10' ' ' VAL . 1.2 p -138.68 -173.82 3.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.368 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.607 ' CE2' ' CG2' ' A' ' 100' ' ' THR . 38.2 m-85 -76.57 -57.08 4.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.576 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -32.09 69.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 109.875 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.426 ' C ' ' CG2' ' A' ' 4' ' ' ILE . . . -67.59 -52.76 28.15 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.524 HG22 ' CD1' ' A' ' 76' ' ' ILE . 21.8 t -65.27 -40.71 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -1.14 . . . . 0.0 109.192 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.587 ' HB3' HD13 ' A' ' 109' ' ' ILE . . . -59.23 -37.11 76.71 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 1.242 ' OD1' ' NH2' ' A' ' 110' ' ' ARG . 0.7 OUTLIER -65.52 -55.81 15.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.523 -0.736 . . . . 0.0 109.161 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.641 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 38.0 t80 -60.77 -19.24 58.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.185 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 0.6 OUTLIER -74.94 -60.53 2.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.405 -0.81 . . . . 0.0 109.311 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -71.03 -10.9 60.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.905 -1.122 . . . . 0.0 109.254 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.529 HG23 ' CD1' ' A' ' 17' ' ' TYR . 38.7 m -89.42 -66.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.876 . . . . 0.0 110.411 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 71.0 m-85 -89.38 -6.74 56.35 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.61 -0.681 . . . . 0.0 109.742 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.496 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 18.5 m170 55.94 58.6 4.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.414 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 161.65 131.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 74' ' ' ALA . 33.3 mt -44.47 150.17 0.69 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 109.252 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.584 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 7.4 Cg_exo -53.62 163.27 2.87 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.151 1.901 . . . . 0.0 110.428 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -71.22 -4.88 28.03 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.345 -0.847 . . . . 0.0 109.028 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -95.76 11.76 32.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.606 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.584 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 3.1 m-85 -101.77 109.75 21.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.152 -0.967 . . . . 0.0 109.484 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.4 pp -115.73 118.08 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.327 -0.858 . . . . 0.0 108.989 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.485 ' O ' ' O ' ' A' ' 25' ' ' ILE . 14.2 p -45.82 171.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.301 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.58 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -67.9 -42.94 80.39 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.942 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.6 m -55.43 -41.36 72.68 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.482 ' O ' HD13 ' A' ' 33' ' ' LEU . 11.8 mm-40 -57.11 -40.88 77.93 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.577 ' HB1' ' CE3' ' A' ' 35' ' ' TRP . . . -64.18 -36.84 85.36 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' OE1' ' CE3' ' A' ' 35' ' ' TRP . 6.7 mm100 -60.38 -39.21 86.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.31 -35.52 73.94 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.455 -0.778 . . . . 0.0 109.832 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 29' ' ' GLU . 2.7 mp -81.23 -14.02 57.93 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.628 -0.67 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 45' ' ' VAL . . . 110.77 40.39 1.32 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.582 ' CD1' HD11 ' A' ' 42' ' ' LEU . 10.9 t90 -109.92 118.9 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -1.19 . . . . 0.0 108.993 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -91.35 111.33 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.334 -0.854 . . . . 0.0 109.106 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.578 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -57.71 -16.5 11.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.215 -0.928 . . . . 0.0 109.598 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.81 -55.5 5.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 109.538 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 40' ' ' GLY . 22.5 mttm -81.6 -3.05 52.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.667 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 42.86 85.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.466 ' HB2' ' HB2' ' A' ' 44' ' ' ASP . 1.8 p-10 -134.49 47.17 2.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -1.206 . . . . 0.0 109.623 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.582 HD11 ' CD1' ' A' ' 35' ' ' TRP . 5.8 tp -62.81 -44.95 94.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.185 -0.947 . . . . 0.0 109.666 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.29 -8.1 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 110.128 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 32.7 m-20 -101.6 -22.72 14.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.019 -1.051 . . . . 0.0 110.258 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 35' ' ' TRP . 17.9 m -121.18 -48.54 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.909 -1.12 . . . . 0.0 110.124 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -127.55 60.57 44.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.119 -0.988 . . . . 0.0 110.115 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 1.7 Cg_endo -62.66 -179.55 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.172 1.914 . . . . 0.0 110.177 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.44 59.66 3.03 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HG2' HG12 ' A' ' 25' ' ' ILE . 3.8 mttp -151.51 171.48 17.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -1.157 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.528 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 19.4 m -137.34 118.9 14.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.564 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.549 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 8.7 mm -76.99 103.64 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.048 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -147.38 171.2 28.06 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.86 7.87 54.87 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.434 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 9.7 m-20 -79.99 145.12 32.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -1.209 . . . . 0.0 109.313 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mm -69.97 138.05 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.537 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.58 ' CE2' HD13 ' A' ' 63' ' ' LEU . 60.0 t80 -111.52 91.12 3.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.827 . . . . 0.0 109.359 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.02 -5.12 24.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.66 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.57 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 30.0 t-20 64.91 59.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -62.4 -28.87 70.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.341 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' OE1' ' CB ' ' A' ' 103' ' ' TYR . 2.0 mp0 -78.5 -74.62 0.26 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.375 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.71 48.31 0.3 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 1.9 mttt -118.52 -7.25 10.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 0.0 109.721 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.58 HD13 ' CE2' ' A' ' 56' ' ' PHE . 16.9 mt -94.88 146.39 31.29 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 0.0 109.122 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.459 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 3.8 Cg_exo -60.35 86.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.059 1.839 . . . . 0.0 110.209 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.458 ' HA2' ' HD3' ' A' ' 69' ' ' ARG . . . -102.2 -171.05 27.2 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.44 -173.43 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -1.144 . . . . 0.0 109.573 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.4 m -69.64 88.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.5 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.44 46.63 1.65 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.515 ' NH1' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -121.24 132.86 55.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -1.091 . . . . 0.0 109.433 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.46 165.36 12.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.576 ' CZ3' HD23 ' A' ' 63' ' ' LEU . 23.1 m95 -136.98 165.89 24.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.583 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 35.0 mtt180 -132.87 143.78 49.75 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.671 ' OE2' ' OH ' ' A' ' 103' ' ' TYR . 10.4 pt-20 -121.48 155.39 35.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.972 -1.08 . . . . 0.0 110.459 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HB3' HD12 ' A' ' 20' ' ' LEU . . . -146.77 148.96 32.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 109.144 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -68.72 133.04 47.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.565 HG23 ' CZ ' ' A' ' 7' ' ' PHE . 26.3 mm -119.46 116.09 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.965 . . . . 0.0 109.644 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 72.49 124.29 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.868 . . . . 0.0 109.631 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -170.59 148.06 2.99 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.286 -0.884 . . . . 0.0 109.468 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.98 -79.84 0.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.453 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -145.3 171.86 13.97 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.754 -0.591 . . . . 0.0 109.452 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.61 -166.55 43.55 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -62.89 179.36 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -1.125 . . . . 0.0 109.428 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -78.56 164.55 24.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -104.72 -168.32 1.46 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.299 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.523 ' HB3' ' N ' ' A' ' 102' ' ' HIS . 13.3 m -105.1 16.44 25.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.0 109.649 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.661 ' OD2' HG23 ' A' ' 100' ' ' THR . 0.9 OUTLIER -96.66 126.78 42.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.638 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.618 ' O ' ' CG2' ' A' ' 99' ' ' THR . 1.9 mtt180 -160.09 150.69 18.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 109.499 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.609 HD13 HD12 ' A' ' 109' ' ' ILE . 3.3 tt -108.29 156.64 8.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 109.23 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.453 HD12 ' CB ' ' A' ' 73' ' ' GLU . 3.4 mm? -125.95 107.17 10.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.428 -0.795 . . . . 0.0 109.376 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.583 ' CE2' ' HB3' ' A' ' 72' ' ' ARG . 1.6 p90 -102.44 139.02 38.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.795 -1.191 . . . . 0.0 109.025 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.442 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -108.12 174.64 5.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.262 -0.899 . . . . 0.0 110.396 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.4 p -65.29 -24.68 67.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.515 ' OD2' ' NH1' ' A' ' 69' ' ' ARG . 45.5 p30 -89.76 18.06 5.96 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.581 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.02 29.66 7.9 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.725 -0.609 . . . . 0.0 110.048 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.491 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 9.0 mt -82.21 113.06 19.78 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.523 HG23 ' CD1' ' A' ' 88' ' ' ILE . 2.0 mt -109.24 114.89 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 110.366 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.858 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 26.8 m-85 -121.27 118.63 30.03 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.579 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -88.51 117.3 27.35 Favored 'General case' 0 N--CA 1.492 1.632 1 N-CA-C 125.7 5.444 . . . . 0.0 125.7 -179.282 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.618 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -108.69 131.14 55.21 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 124.652 3.387 . . . . 0.0 109.01 -170.31 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.661 HG23 ' OD2' ' A' ' 86' ' ' ASP . 1.9 p -115.12 18.15 16.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.7 OUTLIER -139.18 23.55 2.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER 78.33 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.671 ' OH ' ' OE2' ' A' ' 73' ' ' GLU . 15.5 m-85 50.35 20.89 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.808 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.77 -15.23 26.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.114 -0.992 . . . . 0.0 109.076 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.52 ' CG2' ' OD2' ' A' ' 101' ' ' ASP . 12.5 t -148.78 145.35 27.54 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.858 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . 53.7 m-85 -135.99 111.45 9.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.919 -1.113 . . . . 0.0 110.153 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.522 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.8 m -98.34 131.31 44.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.426 -0.796 . . . . 0.0 108.906 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -80.03 122.35 26.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.548 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.609 HD12 HD13 ' A' ' 88' ' ' ILE . 11.3 pt -119.68 15.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.484 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 1.242 ' NH2' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.489 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.473 HD12 ' CD1' ' A' ' 13' ' ' TYR . 11.1 mt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -144.48 62.41 1.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.952 . . . . 0.0 109.705 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.556 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -140.0 -174.56 3.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.923 . . . . 0.0 109.323 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.826 ' CE1' HG21 ' A' ' 76' ' ' ILE . 21.3 m-85 -77.31 -60.84 2.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.256 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -33.46 70.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.371 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.28 -48.99 60.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.611 HG12 HD12 ' A' ' 14' ' ' LEU . 41.6 t -68.31 -36.37 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -1.144 . . . . 0.0 109.207 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.1 -38.86 87.78 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.78 -54.79 19.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.546 -0.721 . . . . 0.0 109.118 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE1' ' CD2' ' A' ' 17' ' ' TYR . 47.9 t80 -55.39 -26.67 42.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.844 . . . . 0.0 109.218 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.611 HD12 HG12 ' A' ' 10' ' ' VAL . 1.2 mt -72.84 -60.5 2.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.428 -0.795 . . . . 0.0 109.376 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.426 ' NE2' ' OXT' ' A' ' 110' ' ' ARG . 2.9 mt-30 -70.49 -5.21 27.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.025 -1.047 . . . . 0.0 109.565 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 m -93.15 -68.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.17 -0.956 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD2' ' CE1' ' A' ' 13' ' ' TYR . 58.8 m-85 -89.63 3.96 50.95 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.644 -0.66 . . . . 0.0 109.553 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER 43.89 51.46 6.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER 177.39 130.38 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.536 -0.728 . . . . 0.0 109.117 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.713 HD13 ' HD2' ' A' ' 24' ' ' TYR . 17.6 mt -47.61 159.37 0.44 Allowed Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.093 -1.004 . . . . 0.0 109.131 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.58 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 4.1 Cg_exo -54.7 158.43 10.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.17 1.913 . . . . 0.0 110.454 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.21 -6.3 33.55 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.373 -0.829 . . . . 0.0 109.03 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.3 28.61 8.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.89 . . . . 0.0 109.463 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.713 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.6 m-30 -113.59 79.03 1.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.505 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -94.26 127.96 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.906 . . . . 0.0 108.983 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 25' ' ' ILE . 44.0 p -46.66 176.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 109.992 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.24 -48.64 56.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.102 -0.999 . . . . 0.0 109.161 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -51.57 -36.42 45.3 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.658 ' O ' HD12 ' A' ' 33' ' ' LEU . 10.1 mm-40 -60.62 -43.27 97.66 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -65.21 -33.52 76.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.197 -0.94 . . . . 0.0 108.529 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' CG ' ' CE3' ' A' ' 35' ' ' TRP . 1.0 OUTLIER -66.17 -31.68 72.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.048 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.31 87.42 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.448 -0.782 . . . . 0.0 109.519 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -80.82 -7.12 59.34 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.672 -0.642 . . . . 0.0 109.878 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 45' ' ' VAL . . . 104.18 68.49 0.76 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.713 ' HA ' HG21 ' A' ' 45' ' ' VAL . 2.6 t90 -126.52 133.4 51.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -1.172 . . . . 0.0 109.664 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.507 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 39.3 t -89.6 132.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.604 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.448 0 O-C-N 120.876 -1.14 . . . . 0.0 110.23 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.083 0.468 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.96 HD21 HD11 ' A' ' 51' ' ' ILE . 6.6 tp -57.96 -65.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.121 -0.987 . . . . 0.0 109.049 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.66 -11.13 2.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.836 -0.54 . . . . 0.0 110.228 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -78.98 -39.06 35.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.97 -1.081 . . . . 0.0 109.723 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 35' ' ' TRP . 33.3 m -96.64 -15.26 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.466 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.65 63.92 6.18 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 4.0 Cg_exo -59.59 164.87 10.55 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.191 1.927 . . . . 0.0 110.39 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.11 54.75 24.72 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HG2' HG12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -152.26 162.98 40.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.589 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.599 ' HB3' ' CD1' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -139.04 159.75 41.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.462 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.96 HD11 HD21 ' A' ' 42' ' ' LEU . 3.7 mm -105.01 111.89 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.512 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -157.58 165.0 33.33 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.64 22.56 28.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 39.8 m-20 -97.28 145.44 26.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -1.141 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.51 HD12 HG21 ' A' ' 70' ' ' THR . 16.3 mm -65.54 143.74 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.896 ' CE2' HD12 ' A' ' 63' ' ' LEU . 86.0 t80 . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.302 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.603 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 13.1 mttt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.243 0.544 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.896 HD12 ' CE2' ' A' ' 56' ' ' PHE . 48.5 mt -114.36 147.22 37.49 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.918 . . . . 0.0 109.161 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.877 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.4 Cg_endo -62.38 87.99 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.166 1.911 . . . . 0.0 110.182 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.51 HG21 HD12 ' A' ' 55' ' ' ILE . 7.6 m . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.262 0.553 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.839 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 6.7 m95 -107.64 175.4 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.434 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.652 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 1.4 mmt180 -128.47 137.84 52.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.349 -0.844 . . . . 0.0 108.785 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.811 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -116.96 157.89 24.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.022 -1.049 . . . . 0.0 110.102 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.51 ' HB3' ' CG2' ' A' ' 88' ' ' ILE . . . -148.64 151.03 34.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -0.813 . . . . 0.0 109.129 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -73.03 131.15 41.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.697 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.826 HG21 ' CE1' ' A' ' 7' ' ' PHE . 20.5 mm -115.74 126.15 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.3 -0.875 . . . . 0.0 108.885 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER 68.6 117.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.033 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.427 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 2.5 t80 -170.44 125.21 0.73 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.136 -0.977 . . . . 0.0 109.586 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.01 -80.25 0.46 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.0 p -143.93 156.22 44.35 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.759 -0.588 . . . . 0.0 109.458 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.39 -167.9 17.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 83' ' ' ARG . 1.5 m-85 -65.34 149.67 49.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -1.187 . . . . 0.0 109.264 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.603 ' CZ ' ' CB ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -46.99 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.076 -1.015 . . . . 0.0 109.133 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.77 179.89 3.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.606 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -108.21 11.59 27.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 63.4 m-20 -96.22 129.37 43.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.625 ' O ' HG22 ' A' ' 99' ' ' THR . 0.3 OUTLIER -155.68 156.09 34.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.213 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.059 HD11 ' CG2' ' A' ' 96' ' ' ILE . 18.9 tt -112.26 160.49 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.997 -1.064 . . . . 0.0 109.287 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.871 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.4 mm? -130.48 103.52 6.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.652 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 34.0 p90 -99.62 140.42 33.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.813 -1.18 . . . . 0.0 108.93 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -106.47 176.03 5.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.164 -0.96 . . . . 0.0 110.377 -178.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 p -65.47 -25.17 67.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.447 -0.783 . . . . 0.0 109.576 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.475 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 26.7 p-10 -89.65 17.57 6.34 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.58 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.79 26.04 7.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.659 -0.65 . . . . 0.0 110.291 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.877 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.0 mt -80.34 113.42 18.51 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.059 ' CG2' HD11 ' A' ' 88' ' ' ILE . 2.8 mt -106.82 119.88 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -1.0 . . . . 0.0 110.617 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.608 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 16.3 m-85 -122.89 117.45 25.62 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.519 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.44 147.06 24.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.981 -1.075 . . . . 0.0 110.21 -178.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -132.8 125.71 30.7 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.65 29.11 7.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.728 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -150.0 20.16 0.88 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.643 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER 79.06 68.83 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.389 -0.819 . . . . 0.0 110.073 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 8.1 m-85 54.44 17.5 1.61 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 110.153 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.475 ' CB ' ' OD2' ' A' ' 101' ' ' ASP . 3.9 mm-40 -92.54 -15.85 26.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 109.093 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.501 ' N ' ' OD2' ' A' ' 101' ' ' ASP . 40.8 m -144.54 147.13 32.83 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.603 ' CE1' ' HB2' ' A' ' 62' ' ' LYS . 75.5 m-85 -140.49 130.0 24.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.839 -1.163 . . . . 0.0 110.58 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.496 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 89.9 m -120.05 133.67 55.47 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.23 115.41 18.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -109.84 -83.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 109.536 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.608 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -140.65 53.87 1.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.481 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -137.19 -170.58 2.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.842 ' CE1' HG21 ' A' ' 76' ' ' ILE . 46.2 m-85 -75.18 -58.66 3.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.269 -0.895 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.442 ' OD1' ' NH2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -71.09 -31.5 67.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.808 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.75 -52.27 30.38 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 14' ' ' LEU . 99.9 t -66.74 -42.79 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -1.131 . . . . 0.0 109.386 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 -38.18 73.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.44 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.9 m-20 -65.46 -55.67 16.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.563 -0.711 . . . . 0.0 109.224 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.688 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 53.7 t80 -58.55 -21.32 52.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 109.195 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.668 HD12 HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -74.99 -64.28 1.08 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.394 -0.816 . . . . 0.0 109.212 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -70.43 -5.62 29.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.021 . . . . 0.0 109.45 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 67.9 m -93.85 -67.08 0.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 109.662 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.688 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 78.2 m-85 -89.95 3.66 52.44 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.567 -0.708 . . . . 0.0 109.533 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER 43.75 51.75 6.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.721 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 7.8 ptmt 175.89 129.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.461 -0.774 . . . . 0.0 109.168 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.531 HD13 ' HD2' ' A' ' 24' ' ' TYR . 14.7 mt -44.04 161.06 0.22 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.139 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.577 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.5 Cg_exo -53.51 159.91 5.81 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.124 1.883 . . . . 0.0 110.403 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.75 -3.31 24.48 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.348 -0.845 . . . . 0.0 109.147 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -117.47 34.67 5.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.95 . . . . 0.0 109.61 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.615 ' CE1' ' CB ' ' A' ' 50' ' ' SER . 1.5 m-30 -115.34 90.83 3.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.544 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.2 pt -97.27 124.09 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.925 . . . . 0.0 109.14 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 25' ' ' ILE . 12.2 p -45.44 172.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 109.637 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.86 -42.36 73.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 109.087 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 t -53.98 -37.24 63.76 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.89 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -59.78 -44.28 93.99 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.632 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -61.49 -39.79 92.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.251 -0.906 . . . . 0.0 108.59 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.557 ' CG ' ' CE3' ' A' ' 35' ' ' TRP . 34.0 mt-30 -61.36 -34.86 76.0 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.27 -33.77 74.08 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.442 -0.786 . . . . 0.0 109.38 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.12 -13.74 58.39 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.653 -0.654 . . . . 0.0 109.997 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.471 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 111.74 46.06 0.8 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.632 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 2.9 t90 -106.8 133.13 51.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -1.191 . . . . 0.0 109.725 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.642 HG12 ' OD1' ' A' ' 41' ' ' ASN . 9.1 p -89.57 134.55 28.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.616 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.473 0 O-C-N 120.898 -1.126 . . . . 0.0 110.618 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.642 ' OD1' HG12 ' A' ' 36' ' ' VAL . 3.2 p-10 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.136 0.493 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.009 HD21 HD11 ' A' ' 51' ' ' ILE . 8.1 tp -60.34 -64.65 0.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.962 -1.087 . . . . 0.0 109.191 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.12 -10.05 5.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.735 -0.603 . . . . 0.0 110.158 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 41' ' ' ASN . 27.6 t70 -79.1 -28.66 43.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.018 -1.051 . . . . 0.0 109.6 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 34' ' ' GLY . 4.4 m -110.04 -13.87 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.67 68.11 12.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.65 155.74 51.87 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.206 1.938 . . . . 0.0 110.251 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.03 54.67 24.86 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' HG2' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -153.88 120.1 5.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -1.131 . . . . 0.0 109.469 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.615 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -91.53 166.11 13.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.593 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 1.009 HD11 HD21 ' A' ' 42' ' ' LEU . 2.3 mm -112.13 107.78 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 0.0 109.667 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -161.94 156.35 27.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.92 32.74 3.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.475 ' OD1' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -109.65 155.05 21.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -1.202 . . . . 0.0 109.403 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.0 mm -70.65 151.06 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.565 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.844 ' CE2' HD12 ' A' ' 63' ' ' LEU . 70.7 t80 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 3.4 mptm? . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.355 0.598 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.844 HD12 ' CE2' ' A' ' 56' ' ' PHE . 11.2 mt -99.0 146.22 31.31 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.338 -0.851 . . . . 0.0 109.215 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.506 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 4.0 Cg_exo -60.93 104.19 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.156 1.904 . . . . 0.0 110.323 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 71' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.291 0.567 . . . . 0.0 109.563 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.772 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 18.9 m95 -149.22 171.03 17.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.61 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.629 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 93.4 mtt180 -131.99 151.92 51.45 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.667 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -126.72 152.47 46.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.992 -1.067 . . . . 0.0 110.469 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.489 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -148.06 151.5 35.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.754 . . . . 0.0 108.992 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -73.43 137.93 44.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.993 -1.067 . . . . 0.0 109.789 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.842 HG21 ' CE1' ' A' ' 7' ' ' PHE . 21.8 mm -116.99 112.15 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 108.89 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.2 t-20 74.02 123.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.15 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 78' ' ' TYR . 6.7 t80 -170.41 119.19 0.56 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.262 -0.899 . . . . 0.0 109.439 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.3 -43.9 2.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.124 -0.985 . . . . 0.0 109.561 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 173.63 169.1 0.18 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.613 -0.679 . . . . 0.0 109.444 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.96 -161.7 21.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -70.43 143.76 51.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -1.108 . . . . 0.0 109.685 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.662 ' HE ' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -40.73 142.13 0.49 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER -87.79 -176.45 5.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.181 -0.949 . . . . 0.0 109.752 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.92 3.89 19.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.801 . . . . 0.0 109.558 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.509 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 8.1 m-20 -89.68 128.93 36.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.107 -0.995 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.532 ' O ' ' CG2' ' A' ' 99' ' ' THR . 83.7 mtt180 -159.05 161.77 36.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.758 HD11 HG22 ' A' ' 96' ' ' ILE . 1.3 tt -122.93 153.06 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.13 -0.981 . . . . 0.0 109.672 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.732 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.8 mm? -118.88 120.65 37.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.565 -0.709 . . . . 0.0 109.217 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' A' ' 72' ' ' ARG . 1.7 p90 -113.91 138.36 50.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.851 -1.156 . . . . 0.0 109.011 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.469 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -107.67 172.87 6.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 110.295 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.5 p -66.41 -22.57 66.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.319 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 30.8 p-10 -89.59 16.4 7.84 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.571 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.65 30.39 6.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.755 -0.59 . . . . 0.0 110.316 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.744 HD22 ' HE1' ' A' ' 97' ' ' TYR . 7.4 mt -83.59 117.72 23.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 110' ' ' ARG . 2.5 mt -114.84 109.43 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.096 -1.003 . . . . 0.0 110.615 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.744 ' HE1' HD22 ' A' ' 95' ' ' LEU . 21.5 m-85 -112.93 120.75 42.49 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.58 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -88.81 152.19 21.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.903 -1.123 . . . . 0.0 110.359 -178.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -136.38 123.83 22.1 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.69 29.22 7.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.82 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -150.11 20.71 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.042 -1.036 . . . . 0.0 109.889 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 48.7 t-80 79.52 70.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.46 -0.775 . . . . 0.0 109.877 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.492 ' HE2' HD11 ' A' ' 89' ' ' LEU . 40.6 m-85 49.43 20.91 0.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 110.155 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.459 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . 2.7 mt-30 -91.88 -14.47 29.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 0.0 109.022 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.522 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 97.6 m -144.55 157.14 44.36 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.492 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 92.3 m-85 -146.84 121.64 9.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.894 -1.129 . . . . 0.0 110.242 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -115.13 130.4 56.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 109.018 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.67 113.67 16.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.049 -1.032 . . . . 0.0 109.411 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.697 HD11 HD11 ' A' ' 88' ' ' ILE . 2.4 pt -111.28 -25.65 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.642 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.9 ' HB2' HD12 ' A' ' 96' ' ' ILE . 1.3 mtt-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.56 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 4' ' ' ILE . 3.6 mt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -128.09 40.93 3.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.68 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -133.39 -175.17 3.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.639 ' CG ' HG21 ' A' ' 76' ' ' ILE . 31.6 m-85 -78.94 -47.91 15.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.34 -40.38 70.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.904 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.33 -51.79 35.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 6' ' ' THR . 41.2 t -63.29 -43.99 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.16 -1.2 . . . . 0.0 109.15 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' CB ' ' NH2' ' A' ' 110' ' ' ARG . . . -56.61 -39.35 73.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -55.64 27.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.594 -0.692 . . . . 0.0 109.154 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.679 ' CE1' ' CD2' ' A' ' 17' ' ' TYR . 12.6 t80 -57.6 -23.74 52.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.296 -0.877 . . . . 0.0 109.242 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 2.2 mt -71.45 -63.51 1.1 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.391 -0.818 . . . . 0.0 109.11 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -71.05 -4.99 27.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 109.414 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 48.4 m -91.2 -70.13 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.829 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.679 ' CD2' ' CE1' ' A' ' 13' ' ' TYR . 96.8 m-85 -89.91 -4.2 57.65 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.652 -0.655 . . . . 0.0 109.583 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER 57.04 51.74 10.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.671 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 172.34 129.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.565 -0.709 . . . . 0.0 109.101 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 20' ' ' LEU . 21.1 mt -45.47 148.52 1.19 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.207 -0.933 . . . . 0.0 108.995 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.1 Cg_exo -53.12 160.36 4.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.112 1.875 . . . . 0.0 110.474 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.61 -8.27 33.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.353 -0.842 . . . . 0.0 109.14 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 39.5 p30 -95.2 21.97 7.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.509 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.2 m-85 -114.77 84.14 2.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.761 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 26' ' ' THR . 1.8 pp -96.62 126.18 49.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.709 ' O ' HD12 ' A' ' 25' ' ' ILE . 16.9 p -46.9 174.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.626 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.51 -43.75 69.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.076 -1.015 . . . . 0.0 109.042 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.17 -38.99 69.03 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.787 ' O ' HD12 ' A' ' 33' ' ' LEU . 10.5 mm-40 -58.51 -39.25 79.57 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 25' ' ' ILE . . . -68.21 -36.61 79.81 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.536 ' HG3' ' CE3' ' A' ' 35' ' ' TRP . 25.5 mt-30 -60.74 -34.73 74.87 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.96 -34.86 70.39 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.28 -18.69 45.0 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.52 0.676 . . . . 0.0 110.002 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 116.04 38.56 0.95 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.626 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 10.9 t90 -100.85 121.86 42.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -1.156 . . . . 0.0 109.133 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.692 ' O ' HG13 ' A' ' 36' ' ' VAL . 10.6 p -89.94 113.11 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.285 -0.884 . . . . 0.0 108.962 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.581 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.724 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.671 ' OD1' HG12 ' A' ' 36' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.518 ' HA ' HD12 ' A' ' 42' ' ' LEU . 12.2 tp -54.35 -63.37 1.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.318 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -42.0 -25.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.436 -0.79 . . . . 0.0 110.147 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -79.89 -44.42 20.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.013 -1.054 . . . . 0.0 110.639 -179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 46' ' ' ALA . 33.6 m -94.72 -52.15 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.879 -1.138 . . . . 0.0 110.556 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.602 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -119.92 74.59 19.88 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.886 -1.134 . . . . 0.0 109.918 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -63.06 166.09 15.23 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.165 1.91 . . . . 0.0 110.263 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.479 ' O ' ' HD2' ' A' ' 49' ' ' LYS . . . 43.38 59.24 3.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -139.03 162.56 34.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 0.0 109.438 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 4.3 m -129.33 133.66 47.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.865 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.562 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 6.5 mm -96.41 107.56 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.058 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.6 171.2 33.61 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.46 71.25 1.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 10.2 m-20 -159.66 165.42 32.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -1.105 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.486 ' CD1' HG21 ' A' ' 70' ' ' THR . 23.7 mm -69.27 149.73 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.312 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.955 ' CE2' HD12 ' A' ' 63' ' ' LEU . 45.9 t80 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.61 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 2.0 mmmt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.389 0.614 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.955 HD12 ' CE2' ' A' ' 56' ' ' PHE . 61.0 mt -122.25 148.66 52.76 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.416 -0.803 . . . . 0.0 108.933 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.723 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.7 Cg_endo -60.61 96.45 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.111 1.874 . . . . 0.0 110.037 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.84 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.486 HG21 ' CD1' ' A' ' 55' ' ' ILE . 19.9 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.691 ' CE3' HD13 ' A' ' 63' ' ' LEU . 32.9 m95 -89.05 146.57 24.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.975 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.604 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 4.1 mtm180 -120.58 140.08 52.03 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.748 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -107.62 161.78 14.56 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.004 -1.06 . . . . 0.0 110.551 -178.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.621 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -145.93 148.16 32.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.515 -0.74 . . . . 0.0 109.183 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.3 m-20 -72.55 141.39 48.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.42 -0.8 . . . . 0.0 109.543 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.639 HG21 ' CG ' ' A' ' 7' ' ' PHE . 20.3 mm -135.78 137.46 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 71.62 38.72 0.95 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.479 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -69.62 136.93 51.81 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.327 -0.858 . . . . 0.0 109.576 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -129.64 -80.26 0.56 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.0 109.384 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.3 m -168.15 -178.06 3.53 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.697 -0.627 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 62.9 -155.56 41.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 81' ' ' GLY . 3.3 m-85 -49.45 175.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -1.171 . . . . 0.0 109.57 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -60.62 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.392 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.86 -172.78 2.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.21 1.83 13.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.501 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 5.2 m-20 -109.06 131.37 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.981 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.1 OUTLIER -148.88 139.71 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.234 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.886 HD11 ' CG2' ' A' ' 96' ' ' ILE . 12.5 tt -99.57 142.82 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.047 -1.033 . . . . 0.0 109.587 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.748 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -115.2 114.48 25.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.368 -0.833 . . . . 0.0 109.469 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.613 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 5.0 p90 -108.72 138.5 44.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.823 -1.173 . . . . 0.0 108.739 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.571 ' HB3' ' CE2' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -111.49 177.27 4.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.904 -1.122 . . . . 0.0 110.761 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 p -65.84 -21.18 66.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.564 -0.71 . . . . 0.0 110.387 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 10.3 p-10 -89.01 13.43 12.92 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.181 -0.949 . . . . 0.0 108.95 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.559 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.6 OUTLIER 68.17 26.59 7.04 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.665 -0.647 . . . . 0.0 111.003 178.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.723 HD13 ' HG2' ' A' ' 64' ' ' PRO . 8.4 mt -87.67 130.37 34.82 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.886 ' CG2' HD11 ' A' ' 88' ' ' ILE . 9.5 mt -120.72 108.88 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 110.391 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 108' ' ' LYS . 15.1 m-85 -107.43 112.34 25.09 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.886 ' HE2' HG21 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -88.96 133.5 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.033 -1.042 . . . . 0.0 109.772 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -116.07 122.68 45.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 108.971 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.5 p -104.96 26.83 8.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.357 -0.84 . . . . 0.0 109.822 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.771 ' CG ' HG22 ' A' ' 105' ' ' THR . 22.2 p30 -149.72 25.98 0.84 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.088 -1.007 . . . . 0.0 109.624 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 12.2 t-80 76.14 74.16 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.462 ' OH ' ' NE ' ' A' ' 87' ' ' ARG . 3.7 m-85 42.15 29.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.743 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.436 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 3.3 mt-30 -99.64 -19.32 16.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.771 HG22 ' CG ' ' A' ' 101' ' ' ASP . 13.1 t -147.73 106.88 3.86 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.61 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 71.8 m-85 -93.04 125.39 37.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.127 -0.983 . . . . 0.0 110.387 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 2.6 m -112.93 125.93 54.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.401 -0.812 . . . . 0.0 108.949 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.49 ' HB2' ' CE1' ' A' ' 97' ' ' TYR . 8.9 ttmt -78.96 113.53 17.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.015 -1.053 . . . . 0.0 109.649 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.886 HG21 ' HE2' ' A' ' 98' ' ' LYS . 3.5 pt -116.05 -4.36 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.584 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.873 ' HG3' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.441 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -139.59 57.82 1.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.686 ' O ' HD12 ' A' ' 76' ' ' ILE . 79.2 p -142.58 -177.56 5.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.34 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' CE2' HG22 ' A' ' 100' ' ' THR . 34.2 m-85 -75.64 -57.22 4.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.93 -37.35 72.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.924 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.0 -50.76 56.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.664 HG12 HD12 ' A' ' 14' ' ' LEU . 84.9 t -64.21 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.51 75.15 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -55.54 15.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.513 -0.742 . . . . 0.0 109.039 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.677 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 42.7 t80 -60.2 -19.59 54.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 109.226 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.664 HD12 HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -76.62 -63.26 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.379 -0.826 . . . . 0.0 109.492 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 24.8 pt20 -70.53 -8.63 52.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.049 -1.032 . . . . 0.0 109.515 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.9 m -93.43 -62.43 1.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 109.782 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.677 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 30.3 m-85 -89.47 2.03 55.09 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.671 -0.643 . . . . 0.0 109.57 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER 42.99 46.97 4.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.297 -0.877 . . . . 0.0 109.669 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 5.1 pttt 177.73 129.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.485 -0.76 . . . . 0.0 109.147 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.946 HD11 ' OH ' ' A' ' 90' ' ' TYR . 18.4 mt -44.6 160.66 0.23 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.165 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.7 Cg_exo -53.52 158.86 7.15 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.038 1.825 . . . . 0.0 110.374 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -72.37 -3.86 26.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.165 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.66 7.84 28.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.614 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.715 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.6 m-30 -92.05 77.18 5.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -89.58 129.17 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.031 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.479 ' C ' HG23 ' A' ' 51' ' ' ILE . 28.6 p -44.29 169.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.0 109.447 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.842 ' HG2' HG21 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -67.62 -47.09 70.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.093 -1.005 . . . . 0.0 109.109 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -53.81 -37.13 63.22 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.67 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.2 mt-10 -59.03 -40.9 86.42 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.497 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -66.99 -35.34 79.73 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.611 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 2.7 mm-40 -62.42 -34.07 76.03 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.37 -36.92 83.76 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.67 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.7 mp -81.01 -5.57 57.75 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.73 -0.606 . . . . 0.0 110.255 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.885 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 105.94 62.39 0.62 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.612 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 10.7 t90 -131.54 118.92 20.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -1.156 . . . . 0.0 109.046 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.2 t -90.86 110.16 21.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.184 -0.948 . . . . 0.0 108.872 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.273 -0.892 . . . . 0.0 109.63 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.521 ' O ' HG22 ' A' ' 45' ' ' VAL . 9.8 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.166 0.508 . . . . 0.0 109.844 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 51' ' ' ILE . 11.0 tp -52.53 -66.86 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.118 -0.989 . . . . 0.0 109.214 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.37 -14.87 3.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.482 -0.761 . . . . 0.0 109.932 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -79.46 -33.98 41.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.989 . . . . 0.0 110.017 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.885 HG11 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -100.12 -53.7 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.158 -0.964 . . . . 0.0 109.648 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -113.81 80.13 4.96 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.485 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 1.8 Cg_endo -62.88 164.79 17.97 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.227 1.951 . . . . 0.0 110.466 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 42.41 50.65 5.57 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 5.0 mmtp -145.78 103.71 3.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -1.15 . . . . 0.0 109.509 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.542 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 2.0 m -89.89 159.22 17.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.842 HG21 ' HG2' ' A' ' 27' ' ' LYS . 2.3 mm -99.63 134.7 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.51 149.39 11.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.11 27.69 4.98 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 3.4 m-20 -96.33 145.33 25.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -1.185 . . . . 0.0 109.471 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.507 HD13 ' HA ' ' A' ' 55' ' ' ILE . 15.8 mm -65.68 145.03 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.567 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.885 ' CE2' HD12 ' A' ' 63' ' ' LEU . 71.6 t80 . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 0.0 109.186 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.6 ' HB3' ' CD1' ' A' ' 106' ' ' PHE . 6.1 mmtt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.885 HD12 ' CE2' ' A' ' 56' ' ' PHE . 57.5 mt -91.1 146.8 34.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.962 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.1 Cg_endo -62.17 155.67 54.97 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.096 1.864 . . . . 0.0 110.22 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.803 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 5.4 m95 -129.2 173.31 10.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.621 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -122.24 143.37 49.64 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.754 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -126.56 151.04 48.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.86 -1.15 . . . . 0.0 110.408 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.487 ' HB2' ' OH ' ' A' ' 90' ' ' TYR . . . -143.16 148.84 37.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.801 . . . . 0.0 109.196 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.476 ' OD2' ' HB ' ' A' ' 51' ' ' ILE . 0.9 OUTLIER -76.2 132.59 40.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.686 HD12 ' O ' ' A' ' 6' ' ' THR . 19.4 mm -110.83 134.54 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 7.2 m-20 64.13 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.912 . . . . 0.0 109.457 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 46.2 t80 -170.59 129.82 0.84 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.275 -0.891 . . . . 0.0 109.493 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.0 -80.04 0.62 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.349 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.88 165.53 35.92 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.715 -0.616 . . . . 0.0 109.421 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.38 -151.56 19.94 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.76 -172.29 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -1.098 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' NH1' ' HA ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -72.56 -152.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.06 -177.68 5.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.376 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -116.48 15.86 15.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.584 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 14.6 m-20 -111.59 130.63 55.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -154.18 152.31 30.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 109.424 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.048 HD11 ' CG2' ' A' ' 96' ' ' ILE . 4.0 tt -113.31 138.32 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.272 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.754 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.3 mm? -109.8 116.14 31.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.35 -0.843 . . . . 0.0 109.869 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.946 ' OH ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -104.78 143.1 33.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.829 -1.169 . . . . 0.0 108.922 178.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.46 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -106.58 172.58 6.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.177 -0.952 . . . . 0.0 110.316 -179.158 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 94.7 p -64.67 -24.92 67.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.844 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.479 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 36.8 p-10 -89.73 18.93 5.05 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.423 -0.798 . . . . 0.0 108.926 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.585 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.62 28.12 7.51 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.689 -0.632 . . . . 0.0 110.286 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.962 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.0 mt -79.87 106.71 12.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.048 ' CG2' HD11 ' A' ' 88' ' ' ILE . 1.6 mt -104.41 111.66 34.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.101 -1.0 . . . . 0.0 110.823 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.514 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 20.4 m-85 -111.61 154.9 24.18 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -122.69 141.54 51.66 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.771 -1.205 . . . . 0.0 109.489 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -129.68 120.1 24.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.207 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.505 HG22 ' CE2' ' A' ' 7' ' ' PHE . 44.2 p -104.72 28.54 6.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.44 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -148.12 22.71 1.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 109.481 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 30.1 t-80 77.15 79.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.357 -0.839 . . . . 0.0 109.631 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 11.6 m-85 44.53 53.51 7.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.627 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -120.43 -80.81 0.63 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.0 109.215 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.0 p -89.93 105.36 17.76 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.6 ' CD1' ' HB3' ' A' ' 62' ' ' LYS . 79.6 m-85 -96.28 125.63 40.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.882 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.482 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 56.3 m -111.83 136.4 51.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.432 -0.792 . . . . 0.0 108.956 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -80.06 125.77 30.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.529 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.5 pt -129.96 12.19 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.495 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' A' ' 13' ' ' TYR . 3.5 mp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -138.19 41.71 2.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.247 -0.908 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 10' ' ' VAL . 11.7 p -128.46 -168.09 1.86 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.77 ' CD1' HG21 ' A' ' 76' ' ' ILE . 58.2 m-85 -77.44 -51.99 9.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.53 -40.71 69.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.838 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.466 ' C ' HG23 ' A' ' 4' ' ' ILE . . . -67.34 -51.27 38.75 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 6' ' ' THR . 58.8 t -64.13 -43.23 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -1.151 . . . . 0.0 109.32 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.18 76.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.434 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -62.07 -55.32 30.2 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.532 -0.73 . . . . 0.0 109.3 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.494 ' HB2' HG21 ' A' ' 4' ' ' ILE . 26.2 t80 -57.69 -24.62 57.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.401 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.5 mt -71.55 -62.55 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.038 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -70.93 -5.5 31.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.119 -0.988 . . . . 0.0 109.428 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 54.1 m -91.49 -69.9 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.943 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 96.6 m-85 -89.7 -5.98 56.53 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.631 -0.668 . . . . 0.0 109.63 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER 58.15 58.06 3.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -0.85 . . . . 0.0 109.769 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER 163.99 129.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 53' ' ' GLY . 19.9 mt -45.69 147.14 1.63 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.123 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.566 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.3 Cg_exo -53.06 163.24 2.26 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.2 1.934 . . . . 0.0 110.733 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.07 -7.34 34.92 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 109.144 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -92.29 7.2 43.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.473 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 50' ' ' SER . 3.5 m-85 -103.34 83.56 2.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.199 -0.938 . . . . 0.0 109.75 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pt -95.62 126.73 48.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 25' ' ' ILE . 28.0 p -47.95 176.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.087 -1.008 . . . . 0.0 109.607 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.43 -46.36 64.05 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.381 -0.927 . . . . 0.0 109.162 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.17 -36.63 61.11 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.797 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.3 mm-40 -60.42 -41.13 93.33 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HB1' HD11 ' A' ' 42' ' ' LEU . . . -67.75 -33.14 74.27 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -62.12 -37.59 85.7 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.66 -35.75 68.75 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.461 -0.774 . . . . 0.0 109.586 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -81.16 -19.37 43.57 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.652 -0.655 . . . . 0.0 110.357 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.636 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 118.2 45.42 0.49 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.669 ' CH2' ' HB2' ' A' ' 37' ' ' ALA . 15.6 t90 -110.55 120.74 43.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -1.131 . . . . 0.0 109.272 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.41 110.73 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.347 -0.846 . . . . 0.0 109.098 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.669 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.609 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 1.2 p-10 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.496 ' HA ' HD12 ' A' ' 42' ' ' LEU . 9.1 tp -60.54 -50.86 71.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 0.0 109.258 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -62.8 -10.75 14.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 0.0 109.674 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 41' ' ' ASN . 9.8 t0 -92.95 -33.99 13.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 110.161 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 34' ' ' GLY . 34.0 m -110.72 -50.44 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.998 -1.064 . . . . 0.0 110.125 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.612 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -124.42 70.74 55.35 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.969 -1.082 . . . . 0.0 109.829 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.7 Cg_endo -63.29 -179.76 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.168 1.912 . . . . 0.0 110.242 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 40.75 55.99 3.17 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 17.3 mmtt -141.17 160.09 40.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -1.112 . . . . 0.0 109.637 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.585 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 67.0 m -127.64 138.55 52.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.468 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 27' ' ' LYS . 10.4 mm -102.17 105.3 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 108.967 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -160.3 179.47 35.8 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.466 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 91.81 -4.55 78.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.53 ' OD1' ' CG ' ' A' ' 73' ' ' GLU . 7.5 p30 -93.57 163.17 13.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -1.123 . . . . 0.0 109.348 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.539 HG23 HG22 ' A' ' 70' ' ' THR . 22.4 mt -59.58 159.42 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.516 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.923 ' CE2' HD12 ' A' ' 63' ' ' LEU . 6.4 t80 . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.859 . . . . 0.0 109.332 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 5.8 mmtm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.321 0.582 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.923 HD12 ' CE2' ' A' ' 56' ' ' PHE . 42.8 mt -94.68 143.88 26.96 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.0 109.04 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.78 ' HG2' HD13 ' A' ' 95' ' ' LEU . 1.8 Cg_endo -62.89 84.09 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.001 1.8 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 71' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.686 ' CE3' HD13 ' A' ' 63' ' ' LEU . 5.7 m95 -131.82 169.3 16.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.646 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 21.2 mmt180 -120.74 136.64 54.82 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.354 -0.841 . . . . 0.0 108.78 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.784 ' HA ' HD13 ' A' ' 89' ' ' LEU . 17.1 pt-20 -118.94 162.13 19.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.985 . . . . 0.0 110.386 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -152.85 147.84 26.48 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.409 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -71.51 140.8 50.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.618 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.77 HG21 ' CD1' ' A' ' 7' ' ' PHE . 25.4 mm -134.16 130.82 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.1 m-20 73.27 37.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.464 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 23.3 t80 -69.47 136.82 52.01 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.282 -0.886 . . . . 0.0 109.609 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.34 -79.66 0.38 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.246 -0.909 . . . . 0.0 109.377 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.76 175.71 4.45 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.67 -0.643 . . . . 0.0 109.405 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 72.64 73.74 0.83 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 81' ' ' GLY . 3.6 m-85 56.35 164.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -1.134 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -49.11 171.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.43 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -108.08 -173.83 2.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 109.246 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.32 -8.54 20.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 109.744 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.5 m-20 -91.33 128.66 37.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.599 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.646 ' O ' HG22 ' A' ' 99' ' ' THR . 5.4 mtt180 -158.15 150.66 22.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 109.242 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.774 ' C ' HD22 ' A' ' 89' ' ' LEU . 4.6 tt -108.68 149.81 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.949 -1.094 . . . . 0.0 109.937 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.784 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -122.33 106.99 11.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.437 -0.789 . . . . 0.0 109.462 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.646 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 22.3 p90 -101.91 140.79 35.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.89 -1.131 . . . . 0.0 109.082 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.526 ' HB2' ' CH2' ' A' ' 71' ' ' TRP . 5.3 t -105.98 174.19 5.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.267 -0.896 . . . . 0.0 110.292 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 p -66.07 -21.79 66.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.579 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.484 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 25.0 p-10 -89.56 16.02 8.45 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.441 -0.787 . . . . 0.0 108.898 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.578 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.1 m95 67.26 29.76 7.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.689 -0.632 . . . . 0.0 110.774 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.78 HD13 ' HG2' ' A' ' 64' ' ' PRO . 10.0 mt -87.3 118.01 26.45 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.671 HG22 HD11 ' A' ' 88' ' ' ILE . 3.3 mt -109.33 113.52 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.505 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 16.7 m-85 -113.01 113.12 25.02 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.27 131.64 35.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.045 -1.034 . . . . 0.0 109.977 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 87' ' ' ARG . 1.1 t -115.56 123.81 49.43 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.501 -0.749 . . . . 0.0 108.995 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.4 p -108.95 30.48 6.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.793 . . . . 0.0 109.395 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 17.6 p-10 -150.0 19.16 0.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.389 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 2.2 t-80 79.46 68.51 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.43 -0.794 . . . . 0.0 109.509 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.528 ' OH ' ' CZ ' ' A' ' 87' ' ' ARG . 10.0 m-85 49.41 22.62 0.73 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.652 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.408 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -94.67 -18.14 21.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 99' ' ' THR . 23.1 m -150.18 108.51 3.78 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 86.2 m-85 -95.25 128.73 42.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.165 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 8.2 m -114.17 128.16 56.24 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.385 -0.822 . . . . 0.0 108.836 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -79.11 121.05 24.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.377 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.562 HD11 HD11 ' A' ' 88' ' ' ILE . 2.1 pt -117.45 -39.06 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.64 ' HB2' HD12 ' A' ' 96' ' ' ILE . 3.8 mtt-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.503 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 4' ' ' ILE . 15.0 mm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -129.9 52.87 1.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.8 p -145.6 178.07 8.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.647 ' CD2' HG21 ' A' ' 76' ' ' ILE . 24.3 m-85 -74.56 -53.0 10.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.04 -35.39 71.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 0.0 109.966 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.25 -51.58 31.99 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 6' ' ' THR . 21.7 t -67.46 -38.29 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -1.168 . . . . 0.0 109.414 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.1 88.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.3 OUTLIER -64.42 -55.15 22.89 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.578 -0.701 . . . . 0.0 109.134 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 27.3 t80 -60.48 -21.36 62.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.173 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.1 mt -73.02 -63.46 1.17 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.776 . . . . 0.0 109.242 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -70.94 -8.69 54.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.039 . . . . 0.0 109.403 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 52.9 m -88.98 -67.71 0.82 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 110.032 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 89.5 m-85 -89.44 -2.74 58.49 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.569 -0.707 . . . . 0.0 109.538 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER 53.47 53.72 11.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.375 -0.828 . . . . 0.0 109.762 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 166.72 129.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.462 HD11 ' OH ' ' A' ' 90' ' ' TYR . 65.1 mt -44.05 147.48 0.92 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.219 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.567 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 7.8 Cg_exo -53.02 162.89 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.247 1.965 . . . . 0.0 110.516 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -69.33 -6.68 31.2 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.326 -0.859 . . . . 0.0 109.01 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -93.73 7.22 45.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 109.483 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 2.0 m-85 -97.18 99.79 11.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.104 -0.997 . . . . 0.0 109.555 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pt -107.82 118.61 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 108.986 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.488 ' C ' HG23 ' A' ' 51' ' ' ILE . 21.5 p -45.52 170.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 109.37 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -65.56 -45.29 83.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.095 -1.003 . . . . 0.0 109.088 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -54.36 -39.5 67.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.081 -1.012 . . . . 0.0 108.299 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.716 ' O ' HD12 ' A' ' 33' ' ' LEU . 21.1 mt-10 -59.38 -39.97 85.03 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.678 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.18 -34.52 77.71 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.206 -0.934 . . . . 0.0 108.643 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -63.98 -35.29 80.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.38 -34.77 72.83 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.37 -0.831 . . . . 0.0 109.265 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.716 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.3 -15.83 54.29 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.424 0.631 . . . . 0.0 110.276 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 110.8 36.6 1.84 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.678 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 4.9 t90 -101.69 123.31 45.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.181 -1.188 . . . . 0.0 109.135 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.41 119.18 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 108.776 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.595 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.426 0 O-C-N 121.194 -0.941 . . . . 0.0 109.795 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 35' ' ' TRP . 47.3 p-10 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.16 0.505 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.533 ' CD1' ' HB1' ' A' ' 30' ' ' ALA . 8.5 tp -66.32 -52.02 51.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.307 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -55.21 -16.62 3.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.751 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -87.21 -52.96 5.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 110.289 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 46' ' ' ALA . 21.7 m -94.68 -47.7 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.044 -1.035 . . . . 0.0 110.316 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.679 ' HB1' ' HG3' ' A' ' 49' ' ' LYS . . . -115.78 78.6 7.18 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 109.776 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -63.19 154.32 68.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.188 1.925 . . . . 0.0 110.191 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 43.1 63.68 1.96 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.679 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 6.8 mmtm -134.63 117.19 15.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -1.166 . . . . 0.0 109.405 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.1 m -90.01 128.05 36.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.869 . . . . 0.0 109.622 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.581 HG21 ' HG2' ' A' ' 27' ' ' LYS . 6.5 mm -91.21 105.9 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.144 -0.973 . . . . 0.0 108.999 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.27 169.46 32.11 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.32 36.53 4.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -128.02 170.71 12.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.178 . . . . 0.0 109.31 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.668 HD12 HG21 ' A' ' 70' ' ' THR . 32.4 mm -70.23 150.34 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.845 ' CE2' HD12 ' A' ' 63' ' ' LEU . 13.5 t80 . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.141 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.266 0.555 . . . . 0.0 109.523 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.845 HD12 ' CE2' ' A' ' 56' ' ' PHE . 64.3 mt -115.02 153.67 47.12 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.102 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.75 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.7 Cg_endo -61.57 86.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.2 1.933 . . . . 0.0 110.155 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.668 HG21 HD12 ' A' ' 55' ' ' ILE . 39.0 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.692 ' CE3' HD13 ' A' ' 63' ' ' LEU . 10.3 m95 -112.23 157.62 20.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.689 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.647 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 12.0 mmt180 -115.38 140.85 48.76 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 108.667 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.799 ' HA ' HD13 ' A' ' 89' ' ' LEU . 2.3 pp20? -115.67 156.16 26.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 110.167 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.701 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -142.81 150.37 39.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 0.0 109.421 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.521 ' HA ' ' CD ' ' A' ' 87' ' ' ARG . 3.6 m-20 -71.97 142.34 49.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.5 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.647 HG21 ' CD2' ' A' ' 7' ' ' PHE . 21.6 mm -136.74 145.23 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 110.004 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.01 15.4 8.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.822 . . . . 0.0 109.823 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.528 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 14.6 t80 -69.61 114.71 8.07 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.095 -1.003 . . . . 0.0 109.628 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.3 m -119.67 -79.65 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.271 -0.893 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 p -148.62 166.49 28.14 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.72 -0.612 . . . . 0.0 109.392 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.12 -179.34 52.86 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -46.48 165.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -1.146 . . . . 0.0 109.489 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.546 ' CZ ' ' CB ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -54.09 176.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -0.981 . . . . 0.0 109.405 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 5.1 p30 -115.53 -168.58 1.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.3 p -116.0 13.64 15.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.319 -0.863 . . . . 0.0 109.424 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.551 ' OD2' HG22 ' A' ' 100' ' ' THR . 1.1 m-20 -102.59 126.87 49.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.627 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.547 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -145.6 143.33 29.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.47 -0.769 . . . . 0.0 109.168 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.938 HD11 ' CG2' ' A' ' 96' ' ' ILE . 3.9 tt -109.51 134.85 50.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.862 -1.149 . . . . 0.0 109.089 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.4 mm? -106.75 111.34 23.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 109.992 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.701 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 2.8 p90 -101.69 141.91 33.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.053 -1.029 . . . . 0.0 108.402 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -106.43 172.43 6.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.049 -1.032 . . . . 0.0 110.633 -178.676 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.4 p -66.57 -21.95 66.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.472 -0.768 . . . . 0.0 109.522 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.481 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 36.6 p-10 -89.48 16.3 7.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.567 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 68.12 28.57 6.55 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.658 -0.651 . . . . 0.0 110.471 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.75 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.9 mt -85.65 112.32 20.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.938 ' CG2' HD11 ' A' ' 88' ' ' ILE . 2.0 mt -100.79 125.41 54.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.031 -1.043 . . . . 0.0 110.469 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.536 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 8.1 m-85 -122.89 159.18 28.75 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -131.29 142.18 50.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.757 -1.214 . . . . 0.0 110.024 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -130.13 127.59 40.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.103 -0.998 . . . . 0.0 108.948 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.551 HG22 ' OD2' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -106.18 12.34 30.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.536 ' CG ' ' HG1' ' A' ' 105' ' ' THR . 0.0 OUTLIER -132.16 24.6 4.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.166 -0.959 . . . . 0.0 109.494 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.7 t-80 76.43 75.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 109.824 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.573 ' HA ' ' CE1' ' A' ' 106' ' ' PHE . 14.5 m-85 52.21 60.96 3.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 109.624 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -135.08 -71.33 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.29 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.536 ' HG1' ' CG ' ' A' ' 101' ' ' ASP . 1.2 p -89.45 92.59 9.18 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 83.8 m-85 -89.45 110.08 20.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.238 -0.914 . . . . 0.0 110.03 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 57.3 m -102.82 139.84 37.87 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 2.3 tttt -85.05 125.12 32.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.569 -0.707 . . . . 0.0 109.491 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.64 -10.07 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.418 179.84 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 13' ' ' TYR . 5.3 mt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.406 ' ND2' ' O ' ' A' ' 5' ' ' ASN . 5.1 p-10 -136.89 59.28 1.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.123 -0.986 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.619 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -148.05 -167.44 2.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 109.472 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.755 ' CD1' HG21 ' A' ' 76' ' ' ILE . 38.2 m-85 -77.41 -59.95 2.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.356 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.78 -31.68 68.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.813 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.425 ' C ' HG23 ' A' ' 4' ' ' ILE . . . -67.92 -54.4 18.21 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.593 HG23 ' H ' ' A' ' 6' ' ' THR . 59.0 t -63.11 -41.72 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.361 -1.082 . . . . 0.0 109.002 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.96 -35.67 73.54 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.402 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.3 OUTLIER -64.91 -56.36 13.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.501 -0.749 . . . . 0.0 109.204 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.634 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 30.7 t80 -60.82 -20.14 61.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.186 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.4 mt -73.6 -62.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.833 . . . . 0.0 109.299 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -71.5 -8.95 57.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.928 -1.107 . . . . 0.0 109.405 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 87.7 m -89.49 -66.07 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.153 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 82.4 m-85 -88.99 -6.53 57.16 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.512 -0.743 . . . . 0.0 109.417 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.51 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER 57.28 55.56 5.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.764 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 2.5 pttt 160.93 129.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.746 HD11 ' OH ' ' A' ' 90' ' ' TYR . 36.0 mt -44.53 147.45 1.04 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.023 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.537 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.5 Cg_exo -54.11 162.91 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.021 1.814 . . . . 0.0 110.586 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.91 -7.16 32.29 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.396 -0.815 . . . . 0.0 109.04 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -92.61 6.55 46.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.648 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 50' ' ' SER . 1.7 m-85 -100.61 81.93 2.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.758 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.4 pt -92.7 127.36 44.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 25' ' ' ILE . 43.4 p -48.1 176.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 109.351 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.726 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -70.81 -46.84 62.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 0.0 109.238 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -53.3 -35.8 60.53 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.095 -1.003 . . . . 0.0 108.46 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.7 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -59.39 -41.22 88.88 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -68.17 -36.26 79.34 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.6 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 6.5 mt-30 -61.14 -32.64 72.35 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.62 -34.16 72.41 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.344 -0.848 . . . . 0.0 109.587 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.6 mp -81.29 -16.27 52.99 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.426 0.631 . . . . 0.0 110.051 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.28 40.38 0.88 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.609 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 11.1 t90 -105.06 117.26 33.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -1.137 . . . . 0.0 109.329 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -89.94 110.8 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.852 . . . . 0.0 108.705 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.578 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.792 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.707 HD21 HD11 ' A' ' 51' ' ' ILE . 12.1 tp -58.94 -63.68 1.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 109.647 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.72 -14.45 0.92 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.717 -0.614 . . . . 0.0 110.566 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.1 -36.2 41.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.846 -1.159 . . . . 0.0 110.114 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.8 m -110.4 -0.33 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.929 -1.107 . . . . 0.0 110.008 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -150.99 61.08 4.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 4.8 Cg_exo -59.63 152.28 63.67 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.065 1.843 . . . . 0.0 110.213 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.18 55.4 21.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.574 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 14.8 mttm -135.56 176.36 8.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -1.184 . . . . 0.0 109.72 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.579 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 70.3 m -146.07 136.44 23.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.33 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.726 HD12 ' HA ' ' A' ' 27' ' ' LYS . 11.5 mm -99.37 106.97 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 109.037 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.71 168.18 35.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.33 -7.5 51.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.47 160.57 26.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.117 -1.225 . . . . 0.0 109.37 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.497 ' HA ' HD13 ' A' ' 55' ' ' ILE . 12.7 mm -70.07 144.81 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 109.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.824 ' CE2' HD12 ' A' ' 63' ' ' LEU . 13.5 t80 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 3.8 mptp? . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.36 0.6 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.824 HD12 ' CE2' ' A' ' 56' ' ' PHE . 58.7 mt -100.56 149.97 36.57 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 108.931 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.852 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.1 Cg_exo -59.04 85.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.052 1.835 . . . . 0.0 110.359 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' A' ' 71' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.684 ' CE3' HD13 ' A' ' 63' ' ' LEU . 9.5 m95 -147.71 169.47 19.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -125.03 136.67 53.91 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.764 ' HA ' HD13 ' A' ' 89' ' ' LEU . 20.1 pt-20 -114.67 152.28 32.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.033 . . . . 0.0 110.296 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.633 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -141.11 152.45 44.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 109.298 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.469 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 1.1 m-20 -73.44 139.08 45.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 109.324 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.755 HG21 ' CD1' ' A' ' 7' ' ' PHE . 22.2 mm -132.26 137.73 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.944 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 1.4 m-20 72.53 9.71 5.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 0.0 110.186 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -69.83 143.45 52.88 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.083 -1.01 . . . . 0.0 109.606 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.8 p -139.58 -58.85 0.57 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.58 163.29 12.29 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.76 -0.588 . . . . 0.0 109.518 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 82' ' ' PHE . . . 82.97 -178.9 53.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 81' ' ' GLY . 3.1 m-85 -45.59 159.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -1.19 . . . . 0.0 109.391 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -70.33 160.74 31.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.928 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.79 -167.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.332 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.65 28.11 8.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 109.714 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 2.2 m-20 -109.68 127.5 54.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.118 -0.989 . . . . 0.0 109.659 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.565 ' O ' HG23 ' A' ' 99' ' ' THR . 5.9 mtt180 -157.38 145.14 18.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 109.592 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.972 HD11 ' CG2' ' A' ' 96' ' ' ILE . 4.4 tt -102.69 132.39 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 109.084 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -103.61 103.16 13.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 109.577 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.746 ' OH ' HD11 ' A' ' 20' ' ' LEU . 7.2 p90 -98.22 141.31 31.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 108.86 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.494 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -105.15 168.93 8.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.151 -0.968 . . . . 0.0 110.392 -178.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.6 p -65.13 -20.41 66.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.494 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 24.8 p-10 -89.69 17.6 6.36 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.459 -0.776 . . . . 0.0 108.911 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.566 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.04 27.71 6.93 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.762 -0.586 . . . . 0.0 110.438 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.852 HD13 ' HG2' ' A' ' 64' ' ' PRO . 8.8 mt -86.52 102.58 14.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.972 ' CG2' HD11 ' A' ' 88' ' ' ILE . 3.0 mt -94.25 121.81 45.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.18 -0.95 . . . . 0.0 110.71 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.636 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 7.8 m-85 -121.09 164.02 17.47 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.565 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -135.8 144.65 45.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.83 -1.169 . . . . 0.0 109.81 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -132.01 129.66 40.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -0.891 . . . . 0.0 109.126 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 p -119.66 27.51 8.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.615 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 10.5 p30 -146.25 22.59 1.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.935 . . . . 0.0 109.466 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.554 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.9 t-80 80.22 70.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.519 -0.738 . . . . 0.0 109.315 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' ' 102' ' ' HIS . 18.8 m-85 42.85 26.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.666 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 102' ' ' HIS . 3.7 mm-40 -93.62 -17.5 23.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 108.958 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.0 m -149.61 138.24 20.88 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.593 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 96.5 m-85 -124.01 136.02 54.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.979 . . . . 0.0 110.035 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.441 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.4 m -126.01 137.07 53.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.801 . . . . 0.0 109.024 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -79.72 134.79 36.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.107 -0.995 . . . . 0.0 109.688 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.447 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 2.0 pt -142.4 57.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 0.0 109.403 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.464 ' OXT' HD12 ' A' ' 96' ' ' ILE . 1.6 mtm-85 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.468 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' A' ' 13' ' ' TYR . 1.1 mp . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -140.59 58.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 0.0 109.362 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.821 ' H ' HG23 ' A' ' 10' ' ' VAL . 4.5 p -142.33 -167.27 2.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.597 ' CD1' HG21 ' A' ' 76' ' ' ILE . 31.4 m-85 -76.99 -61.44 1.98 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.146 -0.971 . . . . 0.0 109.186 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.43 -33.47 69.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 109.83 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.7 -55.02 15.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.821 HG23 ' H ' ' A' ' 6' ' ' THR . 95.7 t -63.04 -40.11 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -1.119 . . . . 0.0 108.926 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.488 ' HB1' ' HG3' ' A' ' 110' ' ' ARG . . . -59.48 -35.85 74.9 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.08 -56.74 10.0 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 35.0 t80 -54.58 -25.96 29.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.222 -0.924 . . . . 0.0 108.73 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 3.3 mt -69.52 -60.31 2.41 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -70.81 -5.33 29.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.025 . . . . 0.0 109.492 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 m -90.73 -70.91 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.859 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 68.7 m-85 -89.79 -4.78 57.47 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.67 -0.644 . . . . 0.0 109.642 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER 57.6 57.19 4.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.9 . . . . 0.0 109.356 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 7.2 ptmt 166.24 130.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 20' ' ' LEU . 20.0 mt -43.16 147.26 0.72 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.266 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 8.2 Cg_exo -53.27 164.13 2.05 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.199 1.933 . . . . 0.0 110.463 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.48 -4.94 29.37 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.362 -0.836 . . . . 0.0 108.975 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.498 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -95.05 11.09 33.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.64 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.561 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 5.7 m-85 -105.48 92.94 4.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 109.845 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 30' ' ' ALA . 1.3 pp -104.01 127.78 57.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.513 ' O ' HD12 ' A' ' 25' ' ' ILE . 68.7 p -48.94 178.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.51 -48.4 55.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.026 -1.046 . . . . 0.0 109.566 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -53.46 -37.03 62.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.125 -0.984 . . . . 0.0 108.512 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.794 ' O ' HD12 ' A' ' 33' ' ' LEU . 18.7 mt-10 -59.88 -39.97 87.09 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB2' HD11 ' A' ' 25' ' ' ILE . . . -69.69 -32.56 71.24 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.478 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 2.6 mt-30 -65.86 -30.69 71.34 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.44 76.44 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.457 -0.777 . . . . 0.0 109.362 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -80.96 -11.27 59.6 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.479 0.657 . . . . 0.0 109.978 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.7 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 106.02 53.75 0.74 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.636 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 1.6 t90 -108.97 135.96 49.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -1.131 . . . . 0.0 109.555 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.475 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 6.1 t -89.75 128.26 41.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.636 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.455 0 O-C-N 120.988 -1.07 . . . . 0.0 110.275 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.082 0.468 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 51' ' ' ILE . 6.0 tp -66.96 -63.53 1.04 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 108.935 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.94 -10.45 2.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.823 -0.548 . . . . 0.0 110.143 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -35.19 44.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 109.741 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.7 HG11 ' O ' ' A' ' 34' ' ' GLY . 33.3 m -98.49 -48.12 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.158 -0.964 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB1' ' HD3' ' A' ' 49' ' ' LYS . . . -117.45 77.03 10.07 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.295 -0.878 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.472 ' O ' ' HD2' ' A' ' 49' ' ' LYS . 3.0 Cg_endo -60.41 155.25 47.93 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.235 1.956 . . . . 0.0 110.326 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.53 63.83 4.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.689 ' HD3' ' HB1' ' A' ' 46' ' ' ALA . 3.2 mptt -140.44 155.01 46.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -1.111 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 48.9 m -133.91 123.51 24.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.401 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.553 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 6.6 mm -81.15 105.46 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.019 -1.051 . . . . 0.0 109.017 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -150.65 172.8 30.34 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.522 -1.323 . . . . 0.0 109.851 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.95 10.72 62.44 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 4.4 m-20 -83.34 143.46 30.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -1.121 . . . . 0.0 109.403 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.439 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 13.6 mm -69.57 136.22 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 109.457 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.667 ' CE1' ' CD1' ' A' ' 103' ' ' TYR . 73.9 t80 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.393 -0.817 . . . . 0.0 109.29 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.884 HD22 ' CZ3' ' A' ' 71' ' ' TRP . 4.2 mt -95.13 146.64 31.68 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.205 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.426 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 2.4 Cg_endo -62.26 84.55 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.026 1.818 . . . . 0.0 109.837 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.605 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.406 HG21 HD12 ' A' ' 55' ' ' ILE . 19.8 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.258 0.551 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.884 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 11.9 m95 -102.65 172.85 6.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.634 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 3.6 mtt180 -127.79 132.92 49.44 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' CD ' ' HB2' ' A' ' 54' ' ' ASP . 2.1 pt-20 -116.59 146.82 42.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.906 -1.121 . . . . 0.0 110.627 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.545 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -137.04 148.04 46.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 2.0 m-20 -72.49 122.63 21.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.794 HD12 ' O ' ' A' ' 6' ' ' THR . 30.5 mm -110.69 137.73 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 70.74 122.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 109.25 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.446 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 2.2 t80 -170.13 110.24 0.4 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.02 -78.73 0.58 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.88 155.29 32.65 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.701 -0.624 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.05 -160.09 14.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -66.63 155.77 36.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -1.154 . . . . 0.0 109.507 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 82' ' ' PHE . 12.1 mtm180 -51.75 -178.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.35 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.514 ' O ' ' NH2' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -120.53 -167.98 1.56 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.46 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.5 p -127.55 18.67 6.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 109.565 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.473 ' OD2' ' HA ' ' A' ' 100' ' ' THR . 4.3 m-20 -105.12 129.72 53.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 109.387 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 5.5 mmt180 -146.99 140.81 25.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.56 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.071 HD11 ' CG2' ' A' ' 96' ' ' ILE . 3.3 tt -93.34 129.18 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 108.82 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.49 HD22 ' N ' ' A' ' 89' ' ' LEU . 4.6 mm? -101.11 93.69 5.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 110.194 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 38.2 p90 -91.5 139.85 30.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.889 -1.132 . . . . 0.0 108.652 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -105.47 170.36 7.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.097 -1.002 . . . . 0.0 110.722 -178.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.9 -22.38 66.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 109.6 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 14.5 p-10 -89.79 18.8 5.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.602 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 69.22 26.54 5.4 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.817 -0.552 . . . . 0.0 110.244 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.856 HD22 ' HE1' ' A' ' 97' ' ' TYR . 6.7 mt -82.32 92.6 6.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.071 ' CG2' HD11 ' A' ' 88' ' ' ILE . 12.8 mt -90.64 112.41 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 110.372 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.856 ' HE1' HD22 ' A' ' 95' ' ' LEU . 20.1 m-85 -114.03 167.14 10.92 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.541 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -137.28 130.14 30.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.951 -1.093 . . . . 0.0 109.655 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -119.76 119.07 32.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 109.26 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.473 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 21.1 p -104.16 22.17 15.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.523 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.6 OUTLIER -138.46 22.64 2.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.494 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.534 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 7.1 t-80 77.8 73.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 109.455 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.667 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 34.5 m-85 43.02 43.96 3.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.802 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.43 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 2.2 mm-40 -117.14 -17.01 10.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.249 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' THR . 51.9 m -150.38 94.97 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.332 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.552 ' CE1' ' HA ' ' A' ' 103' ' ' TYR . 14.1 m-85 -90.63 116.76 28.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.747 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 90.4 m -107.86 139.49 42.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.276 -0.89 . . . . 0.0 108.8 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -79.3 127.99 32.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 109.605 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.429 ' CG2' ' HE2' ' A' ' 98' ' ' LYS . 1.5 pt -112.75 -42.04 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.572 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.618 ' CG ' HD12 ' A' ' 96' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.491 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -141.99 61.77 1.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.623 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -147.75 -175.19 4.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.538 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.639 ' CD1' HG21 ' A' ' 76' ' ' ILE . 25.2 m-85 -73.79 -56.73 4.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.509 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -31.4 67.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.972 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.18 -55.39 9.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.623 HG23 ' H ' ' A' ' 6' ' ' THR . 38.8 t -65.83 -40.64 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -1.133 . . . . 0.0 109.296 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.0 85.94 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.34 -55.01 36.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.544 -0.723 . . . . 0.0 109.101 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.681 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 35.5 t80 -59.09 -21.96 60.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.267 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.553 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.7 mt -73.1 -61.16 1.91 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 0.0 109.337 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.57 -9.18 57.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.005 -1.06 . . . . 0.0 109.591 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.2 m -89.62 -65.28 1.03 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.681 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 71.9 m-85 -89.18 -11.36 44.0 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.582 -0.698 . . . . 0.0 109.24 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.47 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 19.1 m170 61.01 53.72 3.6 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.369 -0.832 . . . . 0.0 109.491 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 7.1 pttm 166.97 129.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD11 ' OH ' ' A' ' 90' ' ' TYR . 37.7 mt -44.94 151.74 0.61 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.155 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.57 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.2 Cg_exo -54.6 163.42 3.83 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.147 1.898 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -7.24 33.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.332 -0.855 . . . . 0.0 109.001 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.27 31.82 2.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.526 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.57 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.3 m-85 -121.9 82.45 1.95 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 0.0 109.776 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.5 pt -92.26 128.71 43.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.301 -0.875 . . . . 0.0 108.684 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 25' ' ' ILE . 18.5 p -47.23 174.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.139 -0.975 . . . . 0.0 109.26 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.614 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.73 -43.68 68.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.193 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -55.34 -38.81 69.23 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.153 -0.967 . . . . 0.0 108.464 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 33' ' ' LEU . 5.5 mm-40 -57.84 -40.61 80.46 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.554 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.02 -37.34 83.96 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 4.6 mt-30 -60.98 -32.66 72.21 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.19 -36.88 81.08 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.359 -0.838 . . . . 0.0 109.717 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -81.03 -8.73 59.84 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.65 -0.656 . . . . 0.0 110.318 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.849 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 106.54 51.55 0.8 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.668 ' CH2' ' HB2' ' A' ' 37' ' ' ALA . 9.3 t90 -118.37 124.46 47.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -1.115 . . . . 0.0 109.052 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 t -90.64 113.02 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.153 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.668 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.45 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 45' ' ' VAL . 6.9 p-10 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.551 HD11 ' HB1' ' A' ' 30' ' ' ALA . 10.5 tp -63.1 -57.56 10.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.397 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -49.48 -20.61 0.75 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -37.44 23.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 0.0 110.355 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.849 HG11 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -106.98 -54.34 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.005 -1.059 . . . . 0.0 110.101 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 1.043 ' HB1' ' HG3' ' A' ' 49' ' ' LYS . . . -113.38 80.06 4.33 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.114 -0.991 . . . . 0.0 109.699 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 2.1 Cg_endo -62.16 156.57 49.48 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.238 1.959 . . . . 0.0 110.333 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.53 56.39 4.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 1.043 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 5.3 mmtp -127.79 119.86 26.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -1.13 . . . . 0.0 109.446 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -89.74 137.55 32.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.327 -0.858 . . . . 0.0 109.48 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.551 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 5.3 mm -104.27 113.9 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 108.922 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.55 173.03 40.45 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.92 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.11 6.26 55.85 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.438 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 1.7 m-20 -87.09 148.33 25.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -1.204 . . . . 0.0 109.39 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.5 mm -67.77 139.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.61 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.873 ' CE2' HD12 ' A' ' 63' ' ' LEU . 62.8 t80 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.333 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.599 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 35.6 mttm . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.243 0.544 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.873 HD12 ' CE2' ' A' ' 56' ' ' PHE . 63.6 mt -93.64 148.36 35.28 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.209 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.701 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.5 Cg_exo -60.1 84.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.109 1.873 . . . . 0.0 110.186 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.876 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.629 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 19.9 m95 -132.41 172.17 12.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.73 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.634 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 65.1 mtt180 -136.94 148.65 47.09 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.761 ' HA ' HD13 ' A' ' 89' ' ' LEU . 9.1 pt-20 -124.1 158.67 31.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.048 -1.032 . . . . 0.0 110.467 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -148.76 152.3 36.33 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.4 m-20 -78.67 131.83 36.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.107 -0.996 . . . . 0.0 109.516 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.639 HG21 ' CD1' ' A' ' 7' ' ' PHE . 30.3 mm -116.7 124.42 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.545 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 76' ' ' ILE . 20.7 m-20 69.5 118.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.483 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -170.57 138.94 1.53 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.291 -0.88 . . . . 0.0 109.549 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.67 -79.74 0.49 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.084 -1.01 . . . . 0.0 109.478 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.52 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 1.6 p -140.98 171.1 14.53 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.79 -176.34 54.59 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -48.98 167.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -1.169 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -68.55 -179.87 1.49 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.932 . . . . 0.0 109.609 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -110.0 -172.77 2.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.91 . . . . 0.0 109.405 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -108.17 10.94 27.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 109.581 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 82.0 m-20 -100.37 128.03 46.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.661 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 99' ' ' THR . 0.1 OUTLIER -152.39 158.24 42.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.787 . . . . 0.0 109.164 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.779 HD11 HG22 ' A' ' 96' ' ' ILE . 1.6 tt -118.42 146.33 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.014 -1.054 . . . . 0.0 109.345 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.761 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.2 mm? -117.93 113.14 21.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.463 -0.773 . . . . 0.0 109.68 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 2.5 p90 -105.99 140.39 39.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.842 -1.161 . . . . 0.0 108.934 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.479 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -107.49 174.93 5.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.915 . . . . 0.0 110.444 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -23.34 66.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 109.815 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 42.6 p30 -89.62 16.58 7.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.424 -0.797 . . . . 0.0 108.969 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.568 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.94 27.66 7.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.769 -0.582 . . . . 0.0 110.522 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.701 HD13 ' HG2' ' A' ' 64' ' ' PRO . 14.5 mt -83.66 114.96 21.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.779 HG22 HD11 ' A' ' 88' ' ' ILE . 4.8 mt -111.2 107.65 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 110.574 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.532 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 26.5 m-85 -106.97 117.84 35.12 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -89.19 145.27 25.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 109.924 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -130.49 122.63 28.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 0.0 109.09 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.613 HG23 ' HE2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -110.95 30.66 6.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.633 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.5 OUTLIER -150.21 21.88 0.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER 78.73 73.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.405 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 26.8 m-85 43.78 26.22 0.12 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.392 -0.818 . . . . 0.0 109.682 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -97.05 -18.17 19.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.001 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.47 ' HB ' ' OD2' ' A' ' 101' ' ' ASP . 24.1 m -143.27 142.89 31.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.599 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 86.7 m-85 -133.65 123.77 25.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.086 -1.009 . . . . 0.0 110.267 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -114.18 132.44 56.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.497 -0.752 . . . . 0.0 109.0 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -79.5 109.36 13.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 109.54 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 1.1 pt -125.38 65.78 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.483 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 72.6 mtm180 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.624 HG21 ' HG3' ' A' ' 21' ' ' PRO . 3.1 mp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -143.0 53.87 1.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.649 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -144.63 -176.23 4.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.547 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.645 ' CE1' HG21 ' A' ' 76' ' ' ILE . 31.4 m-85 -75.86 -57.9 3.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 0.0 109.556 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -31.65 67.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.937 . . . . 0.0 109.901 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.95 -52.87 21.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.649 HG23 ' H ' ' A' ' 6' ' ' THR . 46.6 t -67.1 -46.95 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -1.117 . . . . 0.0 109.332 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.61 -38.06 68.95 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -55.1 28.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.482 -0.761 . . . . 0.0 109.093 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 18.0 t80 -62.53 -17.67 60.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.318 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.549 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.4 mt -75.75 -63.37 1.32 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.444 -0.785 . . . . 0.0 109.252 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.476 ' O ' ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -70.78 -11.56 61.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.98 -1.075 . . . . 0.0 109.412 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.3 m -89.74 -64.45 1.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.962 . . . . 0.0 110.069 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.689 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 67.7 m-85 -89.48 -0.16 57.3 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.458 -0.776 . . . . 0.0 109.568 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER 47.91 47.16 18.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.295 -0.878 . . . . 0.0 109.685 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 14.4 ptmt 173.85 128.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 20' ' ' LEU . 23.0 mt -45.94 147.89 1.58 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.154 -0.966 . . . . 0.0 109.022 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.624 ' HG3' HG21 ' A' ' 4' ' ' ILE . 7.5 Cg_exo -53.56 160.42 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.016 1.811 . . . . 0.0 110.469 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.07 -10.32 29.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.258 -0.901 . . . . 0.0 108.981 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 50.9 p30 -92.18 20.68 5.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.588 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.566 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.9 m-85 -115.96 87.79 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 109.725 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.2 pt -99.23 123.15 51.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.299 -0.876 . . . . 0.0 108.735 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.482 ' HB ' ' OD2' ' A' ' 54' ' ' ASP . 19.8 p -45.99 172.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 109.501 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.643 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -67.26 -45.5 76.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.0 -1.062 . . . . 0.0 109.029 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -39.5 67.31 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.834 ' O ' HD12 ' A' ' 33' ' ' LEU . 18.8 mt-10 -59.37 -38.54 80.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.636 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.37 -38.68 85.15 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.097 -1.002 . . . . 0.0 108.544 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 27.4 mt-30 -60.37 -35.39 75.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.1 -34.83 70.6 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.305 -0.872 . . . . 0.0 109.335 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.43 -18.09 46.56 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.694 -0.629 . . . . 0.0 110.271 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 1.021 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 115.64 36.36 1.18 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.636 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 9.5 t90 -100.3 122.35 42.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -1.174 . . . . 0.0 109.122 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.77 110.46 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.161 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 35' ' ' TRP . 56.8 p30 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.565 HD11 ' HB1' ' A' ' 30' ' ' ALA . 6.2 tp -62.45 -46.26 89.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.469 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -61.96 -11.32 12.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.867 . . . . 0.0 109.877 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.45 -51.37 4.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.13 -0.981 . . . . 0.0 109.983 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.021 HG11 ' O ' ' A' ' 34' ' ' GLY . 28.9 m -91.7 -47.3 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.851 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.606 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -118.96 76.59 14.74 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 109.433 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.7 Cg_endo -63.46 155.15 64.17 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.234 1.956 . . . . 0.0 110.562 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 42.74 70.24 0.53 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.577 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 3.7 mmpt? -142.01 160.36 40.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.258 -1.142 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 3.0 m -124.16 130.37 52.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.889 . . . . 0.0 109.398 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 27' ' ' LYS . 17.5 mm -93.12 104.61 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.158 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -158.38 168.2 34.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.82 -15.85 51.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.482 ' OD2' ' HB ' ' A' ' 26' ' ' THR . 3.4 m-20 -79.95 148.41 31.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -1.199 . . . . 0.0 109.331 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 56' ' ' PHE . 14.0 mt -51.54 166.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.366 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.813 ' CE2' HD12 ' A' ' 63' ' ' LEU . 9.0 t80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.456 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.566 ' CB ' ' CE2' ' A' ' 106' ' ' PHE . 12.8 mmtt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.389 0.614 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.813 HD12 ' CE2' ' A' ' 56' ' ' PHE . 44.2 mt -105.38 157.23 34.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.968 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.642 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.8 Cg_endo -61.84 84.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.005 1.803 . . . . 0.0 109.63 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.632 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.622 ' CE3' HD13 ' A' ' 63' ' ' LEU . 15.0 m95 -141.13 157.56 45.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.638 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 28.8 mtp180 -119.07 129.29 55.01 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.742 ' HA ' HD13 ' A' ' 89' ' ' LEU . 12.4 pt-20 -106.3 151.08 25.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.053 -1.029 . . . . 0.0 110.22 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.668 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -138.66 150.97 46.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.46 -0.775 . . . . 0.0 109.111 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.4 OUTLIER -74.41 136.92 42.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.052 -1.03 . . . . 0.0 109.573 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.645 HG21 ' CE1' ' A' ' 7' ' ' PHE . 22.1 mm -120.31 123.32 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.231 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 72.04 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.269 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 78' ' ' TYR . 8.6 t80 -170.39 141.5 1.99 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.144 -0.973 . . . . 0.0 109.537 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.01 -78.81 0.19 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -144.58 161.2 39.71 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.642 -0.661 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.38 -175.32 34.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -55.02 179.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -1.177 . . . . 0.0 109.405 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -175.8 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.44 179.88 3.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.4 m -110.96 8.47 22.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.753 ' OD1' HG22 ' A' ' 100' ' ' THR . 25.5 m-20 -108.94 128.53 55.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.106 -0.996 . . . . 0.0 109.384 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 3.6 mmt180 -143.03 169.94 16.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 109.289 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.0 HD11 ' CG2' ' A' ' 96' ' ' ILE . 3.9 tt -134.15 129.64 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.026 -1.046 . . . . 0.0 108.598 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.793 HD22 ' N ' ' A' ' 89' ' ' LEU . 3.1 mm? -104.87 104.23 13.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.668 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 10.2 p90 -96.31 139.07 32.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.939 -1.101 . . . . 0.0 108.459 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.483 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -100.72 170.88 8.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 -178.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 p -65.22 -21.85 66.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.41 -0.806 . . . . 0.0 109.311 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 27.4 p-10 -89.87 18.08 6.05 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.581 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.1 m95 68.21 29.89 5.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.281 0.562 . . . . 0.0 110.165 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.642 HD13 ' HG2' ' A' ' 64' ' ' PRO . 6.9 mt -85.17 97.53 9.95 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.0 ' CG2' HD11 ' A' ' 88' ' ' ILE . 3.5 mt -90.24 118.66 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.118 -0.989 . . . . 0.0 110.468 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 108' ' ' LYS . 9.0 m-85 -117.32 158.4 24.44 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 7.3 ptpt -126.29 153.38 44.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.943 -1.098 . . . . 0.0 109.428 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.5 OUTLIER -140.66 118.28 11.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.445 -0.785 . . . . 0.0 109.115 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.753 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -101.81 25.56 8.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.594 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.926 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.0 OUTLIER -142.66 18.74 2.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 109.417 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 4.3 t-80 78.2 85.82 0.07 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.379 -0.826 . . . . 0.0 109.981 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' HIS . 33.9 m-85 41.61 27.13 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.385 -0.822 . . . . 0.0 110.067 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.525 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 7.1 tp60 -89.13 -71.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.927 . . . . 0.0 108.982 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.926 HG22 ' OD1' ' A' ' 101' ' ' ASP . 14.2 t -97.61 164.1 12.56 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CE2' ' CB ' ' A' ' 62' ' ' LYS . 92.3 m-85 -145.45 121.15 10.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.914 -1.116 . . . . 0.0 109.947 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 2.0 m -118.28 133.47 55.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 0.0 109.322 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 3.6 ttpm? -79.63 131.92 36.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.435 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 110' ' ' ARG . 1.3 pt -119.8 -45.59 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.888 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.501 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.277 0.56 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -146.1 62.63 1.24 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.404 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.687 ' O ' HD12 ' A' ' 76' ' ' ILE . 1.7 p -145.08 -175.55 4.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.803 ' CE1' HG21 ' A' ' 76' ' ' ILE . 41.7 m-85 -79.57 -54.4 5.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.718 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -33.6 69.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 0.0 110.01 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.27 -53.03 23.78 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.541 HG23 ' H ' ' A' ' 6' ' ' THR . 41.5 t -66.76 -38.85 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.336 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.657 ' HB3' HH21 ' A' ' 110' ' ' ARG . . . -59.53 -39.82 85.17 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.438 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.6 OUTLIER -64.55 -55.45 20.42 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.471 -0.768 . . . . 0.0 109.163 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.556 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 19.6 t80 -59.53 -20.36 54.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.275 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -75.58 -64.38 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.199 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -70.75 -5.55 30.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.976 -1.077 . . . . 0.0 109.34 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 56.2 m -94.29 -66.45 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 109.562 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.556 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 83.3 m-85 -89.86 3.46 52.9 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.705 -0.622 . . . . 0.0 109.439 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER 44.76 48.76 8.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.573 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 17.5 pttt 175.17 129.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.479 -0.763 . . . . 0.0 109.159 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.852 HD11 ' OH ' ' A' ' 90' ' ' TYR . 30.1 mt -47.14 149.01 1.82 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.207 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.9 Cg_exo -53.54 161.82 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.045 1.83 . . . . 0.0 110.422 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -68.73 -7.43 33.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.084 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -92.43 11.15 27.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 109.529 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.568 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 3.2 m-85 -105.11 90.26 3.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.753 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.1 pp -99.29 123.6 52.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 25' ' ' ILE . 44.5 p -47.9 176.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.21 -47.98 59.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.107 -0.996 . . . . 0.0 109.104 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 m -53.51 -38.85 64.11 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' O ' HD12 ' A' ' 33' ' ' LEU . 26.8 mm-40 -57.85 -41.07 81.62 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.593 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -66.69 -33.91 76.69 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.444 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 1.7 mt-30 -62.53 -34.65 77.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.01 72.75 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.466 -0.771 . . . . 0.0 109.592 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.5 mp -80.78 -15.89 55.23 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.451 0.643 . . . . 0.0 110.134 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 113.89 40.31 1.0 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.675 ' HB2' HG21 ' A' ' 45' ' ' VAL . 11.1 t90 -106.88 118.92 37.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -1.176 . . . . 0.0 109.244 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 t -89.87 111.92 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.844 . . . . 0.0 108.966 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.955 . . . . 0.0 109.729 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.451 ' C ' ' ND2' ' A' ' 41' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.149 0.5 . . . . 0.0 109.774 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 42' ' ' LEU . 10.2 tp -59.09 -55.25 37.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.33 -19.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.108 -0.995 . . . . 0.0 110.091 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -96.56 -29.48 13.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.094 . . . . 0.0 110.762 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 35' ' ' TRP . 32.3 m -103.44 -52.57 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.819 -1.175 . . . . 0.0 110.3 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.613 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -127.05 66.19 66.64 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.945 -1.097 . . . . 0.0 109.46 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.475 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 2.1 Cg_endo -62.02 168.27 9.29 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.218 1.946 . . . . 0.0 110.353 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 50.67 45.82 47.67 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -130.52 163.14 27.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -1.198 . . . . 0.0 109.507 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 42.8 m -129.41 126.1 38.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.421 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.532 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 7.2 mm -90.18 106.56 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.142 -0.974 . . . . 0.0 108.907 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.81 169.73 34.64 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.06 -9.31 50.55 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.507 ' OD1' ' CG ' ' A' ' 73' ' ' GLU . 2.6 p30 -86.25 145.23 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -1.139 . . . . 0.0 109.507 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 56' ' ' PHE . 37.4 mm -49.78 161.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.146 -0.971 . . . . 0.0 109.419 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.01 ' CE2' HD12 ' A' ' 63' ' ' LEU . 14.5 t80 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.388 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 2.7 mttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.29 0.567 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.01 HD12 ' CE2' ' A' ' 56' ' ' PHE . 31.7 mt -101.01 142.75 25.24 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.21 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.98 ' HG2' HD13 ' A' ' 95' ' ' LEU . 1.9 Cg_endo -62.92 107.77 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.045 1.83 . . . . 0.0 110.096 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.946 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.478 HG22 HG23 ' A' ' 55' ' ' ILE . 1.5 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.765 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 6.5 m95 -108.89 173.31 6.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.614 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 53.3 mtt180 -130.88 150.57 51.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.711 ' HA ' HD13 ' A' ' 89' ' ' LEU . 20.8 pt-20 -128.55 155.48 44.84 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.008 -1.058 . . . . 0.0 110.418 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB2' ' OH ' ' A' ' 90' ' ' TYR . . . -146.98 148.1 31.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.735 . . . . 0.0 109.102 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.451 ' OD2' ' HB ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -68.81 149.26 49.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 109.595 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.803 HG21 ' CE1' ' A' ' 7' ' ' PHE . 29.1 mm -141.25 145.02 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.274 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 25.2 m120 61.19 39.83 15.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 109.476 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -69.68 128.42 36.37 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.336 -0.853 . . . . 0.0 109.597 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.24 -79.92 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.204 -0.935 . . . . 0.0 109.422 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -172.53 -177.75 1.81 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.642 -0.661 . . . . 0.0 109.486 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.515 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . 67.44 78.21 0.28 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER 56.46 164.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -1.169 . . . . 0.0 109.313 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 171.97 0.05 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.21 -0.931 . . . . 0.0 109.334 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.74 -171.75 1.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.601 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.34 -4.92 13.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.902 . . . . 0.0 109.415 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.48 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 65.0 m-20 -93.87 129.42 40.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.459 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.614 ' O ' HG23 ' A' ' 99' ' ' THR . 11.4 mtt180 -152.79 150.88 29.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.206 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.824 HD11 HD11 ' A' ' 109' ' ' ILE . 4.3 tt -106.98 149.36 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.185 -0.947 . . . . 0.0 109.441 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -117.95 124.69 48.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.374 -0.829 . . . . 0.0 109.515 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.852 ' OH ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -113.26 140.96 47.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.841 -1.162 . . . . 0.0 108.839 179.063 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.591 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 11.4 t -108.27 173.78 6.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.3 p -66.36 -22.77 66.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.473 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 28.4 p-10 -89.67 15.65 9.21 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.582 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.36 31.59 6.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.708 -0.62 . . . . 0.0 110.461 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.98 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.8 mt -87.34 125.05 34.0 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.606 HG22 HD11 ' A' ' 88' ' ' ILE . 1.8 mt -117.62 113.75 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.098 -1.001 . . . . 0.0 110.677 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.551 ' HB2' HD21 ' A' ' 63' ' ' LEU . 21.6 m-85 -113.52 117.45 31.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.21 136.15 33.18 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.961 -1.087 . . . . 0.0 109.8 -179.119 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -122.89 128.66 50.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 108.996 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.459 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.3 31.2 6.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.606 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.563 ' OD2' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -149.88 20.67 0.89 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -0.937 . . . . 0.0 109.36 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 19.6 t-80 76.6 68.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.804 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 5.7 m-85 56.28 55.1 6.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.954 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER -120.87 -81.56 0.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 108.641 179.396 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.563 HG23 ' OD2' ' A' ' 101' ' ' ASP . 17.2 p -90.56 105.25 17.69 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.544 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 83.2 m-85 -90.0 126.52 35.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 110.142 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -111.33 126.98 55.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 108.949 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 24.3 tttt -79.34 117.49 20.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.019 -1.051 . . . . 0.0 109.441 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.824 HD11 HD11 ' A' ' 88' ' ' ILE . 1.4 pt -110.21 -24.76 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.876 . . . . 0.0 109.627 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.657 HH21 ' HB3' ' A' ' 11' ' ' ALA . 2.8 mtt-85 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -138.94 58.46 1.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.676 ' H ' HG23 ' A' ' 10' ' ' VAL . 1.2 p -146.42 -178.26 6.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.62 ' CG ' HG21 ' A' ' 76' ' ' ILE . 11.3 m-85 -73.68 -57.15 4.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.404 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.35 -36.42 71.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 109.824 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.52 -49.98 57.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.676 HG23 ' H ' ' A' ' 6' ' ' THR . 90.0 t -66.03 -44.83 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -1.161 . . . . 0.0 109.278 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.78 67.25 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.83 -56.03 14.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.501 -0.75 . . . . 0.0 109.045 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.641 ' CE1' ' CG ' ' A' ' 17' ' ' TYR . 67.4 t80 -58.97 -17.7 27.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.145 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.504 HD12 HG12 ' A' ' 10' ' ' VAL . 1.6 mt -78.59 -59.84 2.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.241 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.8 -9.67 57.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 109.489 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.496 HG22 ' CD1' ' A' ' 17' ' ' TYR . 99.6 m -95.49 -61.57 1.44 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 109.947 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CG ' ' CE1' ' A' ' 13' ' ' TYR . 6.2 m-85 -89.31 0.67 56.62 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.697 -0.627 . . . . 0.0 109.581 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.514 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 18.1 m170 42.76 48.59 4.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 2.9 pttm 176.84 130.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.508 -0.745 . . . . 0.0 109.128 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.79 HD13 ' HD2' ' A' ' 24' ' ' TYR . 14.2 mt -43.76 160.96 0.21 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 109.182 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 3.1 Cg_exo -55.41 159.31 10.85 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.105 1.87 . . . . 0.0 110.456 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.7 p30 -72.1 -4.71 30.54 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 108.988 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -111.73 31.87 5.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.484 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.79 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.6 m-30 -114.09 78.78 1.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.932 . . . . 0.0 109.449 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 2.2 pt -90.94 128.02 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.357 -0.839 . . . . 0.0 108.977 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 25' ' ' ILE . 46.2 p -46.49 174.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.857 . . . . 0.0 109.516 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.625 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.82 -46.46 65.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.046 -1.034 . . . . 0.0 109.307 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -51.75 -36.07 45.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 108.388 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.686 ' O ' HD12 ' A' ' 33' ' ' LEU . 16.0 mm-40 -60.43 -43.63 96.58 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.464 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -64.12 -34.6 78.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 16.5 mt-30 -62.46 -37.57 86.44 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.44 79.59 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.461 -0.775 . . . . 0.0 109.658 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.01 -12.62 59.33 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.626 -0.672 . . . . 0.0 110.002 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.88 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 109.98 68.92 0.6 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.716 ' CH2' ' HB2' ' A' ' 37' ' ' ALA . 13.0 t90 -137.01 120.81 17.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -1.136 . . . . 0.0 109.191 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.662 ' O ' HG13 ' A' ' 36' ' ' VAL . 9.8 p -89.85 116.56 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.261 -0.899 . . . . 0.0 108.702 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.716 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.526 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.485 ' O ' HG22 ' A' ' 45' ' ' VAL . 3.8 p-10 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.278 0.561 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 51' ' ' ILE . 13.0 tp -53.05 -65.94 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -46.3 -23.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.433 -0.792 . . . . 0.0 110.056 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -80.19 -40.34 27.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.088 -1.007 . . . . 0.0 110.447 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.88 HG11 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -93.17 -55.18 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.035 -1.041 . . . . 0.0 110.227 -179.409 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -120.76 72.73 22.47 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.959 -1.088 . . . . 0.0 110.01 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.5 Cg_endo -63.67 -178.66 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.239 1.959 . . . . 0.0 110.343 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 43.29 46.25 6.65 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.485 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -149.48 167.13 27.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -1.158 . . . . 0.0 109.43 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.609 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -141.89 162.8 34.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.356 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.558 HG21 ' HG2' ' A' ' 27' ' ' LYS . 4.8 mm -110.57 117.93 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -0.876 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -161.33 158.17 29.86 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.474 ' HA2' ' OH ' ' A' ' 90' ' ' TYR . . . 95.08 9.5 58.18 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.496 ' OD2' ' CG ' ' A' ' 27' ' ' LYS . 2.4 m-20 -85.92 142.46 28.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -1.152 . . . . 0.0 109.376 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 55' ' ' ILE . 20.8 mm -52.63 149.59 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.946 ' CE2' HD12 ' A' ' 63' ' ' LEU . 49.0 t80 . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.952 . . . . 0.0 109.594 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.595 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 32.6 mttm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.283 0.563 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.946 HD12 ' CE2' ' A' ' 56' ' ' PHE . 22.8 mt -124.47 151.0 66.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.404 -0.81 . . . . 0.0 108.866 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.631 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.3 Cg_exo -59.51 85.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.143 1.895 . . . . 0.0 110.281 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.583 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 36.9 m95 -127.49 140.13 52.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.631 ' CB ' ' CE1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -111.0 125.31 53.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.295 -0.878 . . . . 0.0 109.134 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.891 ' HA ' HD13 ' A' ' 89' ' ' LEU . 2.4 pt-20 -96.88 146.26 25.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.175 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.582 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -133.2 147.99 52.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.4 m-20 -70.29 142.93 52.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.59 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.821 HG22 ' OD1' ' A' ' 77' ' ' ASN . 19.5 mm -135.47 141.95 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.861 . . . . 0.0 109.558 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.821 ' OD1' HG22 ' A' ' 76' ' ' ILE . 9.6 m120 61.6 34.58 17.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.7 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 56.5 t80 -69.47 143.82 53.41 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.151 -0.968 . . . . 0.0 109.512 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.69 -80.15 0.49 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -170.41 179.67 3.31 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.629 -0.67 . . . . 0.0 109.448 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.446 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . 67.05 -149.12 51.0 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 83' ' ' ARG . 2.4 m-85 -53.5 164.42 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -1.104 . . . . 0.0 109.552 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 82' ' ' PHE . 1.4 mmm-85 -55.98 -164.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.474 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.12 -172.81 2.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.579 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.82 -1.23 11.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 109.589 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 71.0 m-20 -104.96 129.04 53.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 109.519 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.705 ' O ' HG22 ' A' ' 99' ' ' THR . 0.2 OUTLIER -147.23 141.54 26.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.342 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.921 HD11 ' CG2' ' A' ' 96' ' ' ILE . 6.8 tt -102.27 125.27 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 109.313 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.891 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.9 mm? -94.53 99.97 12.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.951 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.631 ' CE1' ' CB ' ' A' ' 72' ' ' ARG . 22.5 p90 -99.36 140.09 34.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.923 -1.111 . . . . 0.0 108.687 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.471 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 8.0 t -108.01 169.53 8.56 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.146 -0.971 . . . . 0.0 110.607 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -65.28 -19.37 65.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.421 -0.8 . . . . 0.0 109.638 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 29.8 p-10 -89.62 16.87 7.1 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.592 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 68.27 30.03 5.75 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.684 -0.635 . . . . 0.0 110.341 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.631 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.8 mt -87.16 101.0 13.07 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.921 ' CG2' HD11 ' A' ' 88' ' ' ILE . 4.1 mt -97.27 115.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.344 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.626 ' HE1' HD22 ' A' ' 95' ' ' LEU . 10.2 m-85 -118.93 161.81 19.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 3.7 ptmt -132.06 143.76 50.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.868 -1.145 . . . . 0.0 110.032 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -130.53 120.55 24.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 108.935 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.47 HG23 ' HE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -103.59 26.69 8.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 0.0 109.857 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -147.78 21.86 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.08 -1.012 . . . . 0.0 109.84 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 10.6 t-80 77.17 71.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.411 ' OH ' ' OE1' ' A' ' 73' ' ' GLU . 15.0 m-85 50.43 20.35 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 110.035 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.52 ' CB ' ' OD1' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -86.96 -20.59 27.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 108.862 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 35.3 p -144.7 157.35 44.23 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.595 ' CE2' ' HB3' ' A' ' 62' ' ' LYS . 73.4 m-85 -141.29 119.53 12.15 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.001 -1.062 . . . . 0.0 110.034 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 3.1 m -112.88 136.5 52.45 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.426 -0.796 . . . . 0.0 108.939 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -83.58 129.1 34.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 0.5 OUTLIER -130.24 19.84 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.428 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.371 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.418 ' O ' HG22 ' A' ' 4' ' ' ILE . 5.5 mt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.276 0.56 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -141.9 57.71 1.49 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.357 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.6 ' H ' HG23 ' A' ' 10' ' ' VAL . 3.9 p -144.8 -168.93 3.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.221 -0.925 . . . . 0.0 109.67 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.885 ' CD1' HG21 ' A' ' 76' ' ' ILE . 46.6 m-85 -76.79 -57.61 3.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.872 . . . . 0.0 109.582 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -34.82 71.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.137 -0.977 . . . . 0.0 109.99 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.88 -52.79 26.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.6 HG23 ' H ' ' A' ' 6' ' ' THR . 67.4 t -64.14 -45.6 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -1.149 . . . . 0.0 109.114 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -56.73 -36.55 69.86 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.5 -56.22 17.83 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.492 -0.755 . . . . 0.0 109.023 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.675 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 32.3 t80 -59.19 -21.13 58.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 108.848 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' A' ' 11' ' ' ALA . 3.6 mt -71.01 -61.32 1.8 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -70.98 -8.93 56.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 109.348 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 86.5 m -85.02 -67.84 0.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.865 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.675 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 98.6 m-85 -95.68 4.17 53.26 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.676 -0.64 . . . . 0.0 109.743 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER 50.92 50.62 18.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.498 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER 171.53 130.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 20' ' ' LEU . 21.4 mt -44.14 150.39 0.62 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 108.96 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 8.8 Cg_exo -53.51 162.93 2.94 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.055 1.837 . . . . 0.0 110.535 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.17 -6.87 37.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.355 -0.84 . . . . 0.0 109.016 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 27.7 p30 -90.92 -1.07 57.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.506 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.7 m-85 -92.14 91.58 7.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 109.891 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 26' ' ' THR . 1.6 pp -96.77 118.61 43.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.31 -0.869 . . . . 0.0 108.771 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.549 ' O ' HD12 ' A' ' 25' ' ' ILE . 13.2 p -43.07 166.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.579 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.615 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -64.15 -43.61 94.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.148 -0.97 . . . . 0.0 108.903 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.52 -38.89 64.19 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.742 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.6 mt-10 -58.21 -40.84 82.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.716 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -64.34 -38.81 92.36 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.436 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 3.5 mm100 -60.05 -36.35 77.12 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.69 -39.16 87.47 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.354 -0.841 . . . . 0.0 109.602 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.8 mp -81.12 -8.03 59.68 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.704 -0.623 . . . . 0.0 110.205 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.06 67.39 0.76 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.716 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 9.4 t90 -136.82 118.94 15.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.157 . . . . 0.0 109.031 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.81 113.55 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.804 . . . . 0.0 109.072 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.587 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.213 -0.929 . . . . 0.0 109.65 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.571 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.201 0.524 . . . . 0.0 109.82 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.641 HD12 ' CD1' ' A' ' 35' ' ' TRP . 4.5 tp -61.95 -45.21 94.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.07 -1.019 . . . . 0.0 109.48 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.49 -10.38 11.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.911 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -105.3 -24.99 12.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 110.27 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.61 HG23 ' N ' ' A' ' 46' ' ' ALA . 34.8 m -115.03 -49.57 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.963 -1.086 . . . . 0.0 110.051 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.61 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -129.74 62.22 62.32 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 2.2 Cg_endo -61.71 177.9 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.133 1.889 . . . . 0.0 110.176 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 49' ' ' LYS . . . 43.96 60.93 3.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.489 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 4.6 mttt -159.52 123.63 3.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -1.151 . . . . 0.0 109.577 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 1.8 m -90.03 134.81 34.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.616 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.592 HD11 HD21 ' A' ' 42' ' ' LEU . 8.4 mm -96.08 108.76 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.181 -0.95 . . . . 0.0 108.775 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.09 167.15 32.75 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.45 -6.96 50.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.33 154.35 29.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -1.165 . . . . 0.0 109.245 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HA ' HD13 ' A' ' 55' ' ' ILE . 19.5 mm -68.46 142.37 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.847 ' CE2' HD12 ' A' ' 63' ' ' LEU . 10.6 t80 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.263 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.229 0.537 . . . . 0.0 109.715 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.847 HD12 ' CE2' ' A' ' 56' ' ' PHE . 58.8 mt -89.5 148.43 40.3 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 108.987 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.87 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.3 Cg_exo -59.69 94.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.08 1.854 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.618 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 10.5 m95 -112.76 166.59 11.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 0.0 109.562 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.629 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -120.49 132.23 55.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 108.745 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.688 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -111.95 153.65 26.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.07 -1.019 . . . . 0.0 110.405 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.702 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -141.18 152.56 44.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.502 -0.749 . . . . 0.0 109.19 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 5.7 m-20 -74.54 141.51 44.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 109.245 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.885 HG21 ' CD1' ' A' ' 7' ' ' PHE . 22.2 mm -135.41 145.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.145 -0.972 . . . . 0.0 109.771 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 65.32 33.84 8.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.472 -0.768 . . . . 0.0 109.81 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.492 ' HA ' ' OD1' ' A' ' 84' ' ' ASN . 17.1 t80 -69.49 137.84 52.9 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.68 -79.88 0.45 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.288 -0.882 . . . . 0.0 109.392 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.83 179.25 6.03 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.739 -0.6 . . . . 0.0 109.475 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.19 -162.95 42.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.53 150.68 6.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.204 -1.174 . . . . 0.0 109.394 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.92 173.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.686 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -107.36 -167.97 1.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.401 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -114.62 11.27 16.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.451 ' C ' ' HG2' ' A' ' 87' ' ' ARG . 42.8 m-20 -96.75 125.67 41.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.056 -1.028 . . . . 0.0 109.52 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -144.65 158.71 43.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 0.0 109.594 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.702 HG22 ' HB3' ' A' ' 74' ' ' ALA . 7.2 tt -122.9 131.58 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.714 HD22 ' N ' ' A' ' 89' ' ' LEU . 3.5 mm? -105.63 96.95 6.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.626 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 36.3 p90 -92.84 139.74 30.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.898 -1.126 . . . . 0.0 108.559 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -105.64 170.53 7.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.138 -0.976 . . . . 0.0 110.565 -178.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -21.37 66.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -0.794 . . . . 0.0 109.388 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 54.8 p30 -89.57 17.53 6.3 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.6 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.8 29.5 5.12 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.723 -0.611 . . . . 0.0 110.375 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.87 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.5 mt -86.4 96.54 10.05 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.995 HD12 ' HB2' ' A' ' 110' ' ' ARG . 8.7 mt -94.64 111.21 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 110.342 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.512 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 9.7 m-85 -110.52 162.48 14.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -129.8 152.37 49.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.98 -1.075 . . . . 0.0 109.329 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.2 118.18 11.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.892 . . . . 0.0 109.031 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 27.01 8.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 109.767 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -145.57 20.21 1.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.478 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 5.8 t-80 78.8 74.3 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -0.815 . . . . 0.0 109.786 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.492 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 29.3 m-85 44.64 24.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 102' ' ' HIS . 5.0 mm-40 -94.67 -16.41 23.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.998 . . . . 0.0 108.887 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.5 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 1.4 m -150.28 136.7 18.89 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 98' ' ' LYS . 71.2 m-85 -124.25 131.37 53.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.01 -1.056 . . . . 0.0 110.33 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -126.11 131.87 52.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 4.5 tttt -79.34 128.25 33.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.037 -1.039 . . . . 0.0 109.549 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pt -112.12 -45.14 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.995 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.462 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -146.63 60.6 1.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.62 ' O ' HD12 ' A' ' 76' ' ' ILE . 14.0 p -144.6 -167.58 2.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.932 . . . . 0.0 109.523 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.993 ' CD1' HG21 ' A' ' 76' ' ' ILE . 37.3 m-85 -79.17 -59.99 2.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.444 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.56 -31.0 67.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.58 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.89 -52.33 29.4 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 6' ' ' THR . 58.0 t -64.6 -44.66 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -1.152 . . . . 0.0 109.138 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -56.06 -38.87 71.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -56.51 16.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.499 -0.751 . . . . 0.0 109.138 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.64 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 22.5 t80 -58.66 -20.21 46.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.045 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.5 mt -73.33 -63.17 1.24 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.458 -0.776 . . . . 0.0 109.001 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.412 ' HG3' HD11 ' A' ' 96' ' ' ILE . 7.2 mt-30 -71.93 -5.96 38.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.091 . . . . 0.0 109.391 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.0 m -91.15 -66.8 0.9 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.166 -0.959 . . . . 0.0 110.044 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 85.0 m-85 -89.22 -10.93 45.15 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.62 -0.675 . . . . 0.0 109.362 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.496 ' HA ' ' CH2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 62.57 54.61 2.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.392 -0.817 . . . . 0.0 109.478 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER 162.56 130.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 74' ' ' ALA . 31.5 mt -43.67 148.51 0.71 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.91 . . . . 0.0 109.116 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 12.0 Cg_exo -51.49 163.49 1.11 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.072 1.848 . . . . 0.0 110.552 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.7 -7.03 35.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.357 -0.84 . . . . 0.0 109.057 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.455 ' CG ' ' HB2' ' A' ' 21' ' ' PRO . 5.6 p30 -92.15 2.54 56.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.85 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 50' ' ' SER . 6.8 m-85 -99.24 93.21 5.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.095 -1.003 . . . . 0.0 109.818 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pp -98.77 118.98 46.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.27 -0.894 . . . . 0.0 108.925 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 25' ' ' ILE . 30.0 p -44.58 169.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -65.53 -44.56 86.51 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.136 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -54.58 -39.61 67.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.847 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.3 mt-10 -58.63 -39.92 81.87 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.619 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -65.44 -39.43 92.05 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.144 -0.972 . . . . 0.0 108.443 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 9.2 mt-30 -59.77 -35.22 74.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.18 73.39 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 109.367 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.847 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.37 -15.77 54.27 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.703 -0.623 . . . . 0.0 110.205 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 1.035 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 112.49 44.59 0.83 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.619 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 8.6 t90 -109.37 124.48 51.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -1.177 . . . . 0.0 109.239 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 t -91.08 113.32 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.835 . . . . 0.0 109.083 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.491 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.485 ' HA ' HD12 ' A' ' 42' ' ' LEU . 10.9 tp -56.77 -60.94 2.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 109.581 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -43.56 -24.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.926 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -82.13 -49.44 10.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 110.64 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.035 HG11 ' O ' ' A' ' 34' ' ' GLY . 31.8 m -95.14 -50.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.906 -1.121 . . . . 0.0 110.488 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.803 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -117.13 76.8 8.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.003 -1.061 . . . . 0.0 109.805 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.8 Cg_endo -62.85 154.23 67.66 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.235 1.956 . . . . 0.0 110.364 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 45.32 73.9 0.25 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.803 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 2.5 mttp -154.42 123.07 6.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.583 ' HB2' ' CD1' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -89.77 131.97 35.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.878 . . . . 0.0 109.472 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.542 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 11.5 mm -91.16 109.85 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.186 -0.946 . . . . 0.0 109.2 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -161.92 175.63 38.42 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.498 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 88.32 33.73 10.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' OD1' ' OE2' ' A' ' 73' ' ' GLU . 2.2 p30 -131.05 143.37 50.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -1.225 . . . . 0.0 109.497 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 54' ' ' ASP . 1.1 mp -44.08 147.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.832 . . . . 0.0 109.003 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.815 ' CE2' HD12 ' A' ' 63' ' ' LEU . 8.1 t80 . . . . . 0 C--N 1.302 -1.469 0 O-C-N 121.311 -0.868 . . . . 0.0 109.211 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 7.5 mtpp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.815 HD12 ' CE2' ' A' ' 56' ' ' PHE . 28.5 mt -115.07 152.2 46.4 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.175 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.602 ' CG ' ' CZ ' ' A' ' 97' ' ' TYR . 2.9 Cg_endo -61.44 156.65 45.33 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.131 1.887 . . . . 0.0 110.233 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.548 ' CE3' HD13 ' A' ' 63' ' ' LEU . 16.4 m95 -137.13 171.51 14.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.509 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 90' ' ' TYR . 8.7 mmt180 -133.06 143.2 49.2 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.391 -0.818 . . . . 0.0 108.819 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.553 ' HA ' HD13 ' A' ' 89' ' ' LEU . 17.3 pt-20 -121.0 149.4 42.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.14 -0.975 . . . . 0.0 110.123 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 20' ' ' LEU . . . -139.53 146.28 39.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.363 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HA ' ' HG3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -65.24 141.17 58.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.519 -0.738 . . . . 0.0 109.629 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.993 HG21 ' CD1' ' A' ' 7' ' ' PHE . 23.1 mm -129.47 122.71 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.948 . . . . 0.0 109.833 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.759 ' OD1' HG22 ' A' ' 76' ' ' ILE . 5.2 m120 77.48 43.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 109.868 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.482 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 36.6 t80 -70.08 149.25 47.83 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.191 -0.943 . . . . 0.0 109.317 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.79 -78.19 0.16 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.171 -0.956 . . . . 0.0 109.488 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.8 m -165.96 168.66 15.51 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.729 -0.607 . . . . 0.0 109.615 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 78.21 -179.25 51.94 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.6 OUTLIER -43.61 165.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -1.087 . . . . 0.0 109.431 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -50.66 175.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.562 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.37 -169.17 1.43 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.892 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.46 9.18 18.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.91 . . . . 0.0 109.508 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.683 ' OD1' HG22 ' A' ' 100' ' ' THR . 61.6 m-20 -107.21 129.24 54.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.523 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -150.02 174.6 12.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.894 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.85 HD11 ' CG2' ' A' ' 96' ' ' ILE . 5.6 tt -137.64 128.68 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 109.119 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.74 HD22 ' N ' ' A' ' 89' ' ' LEU . 3.3 mm? -103.29 102.99 12.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.398 -0.814 . . . . 0.0 110.32 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 72' ' ' ARG . 32.1 p90 -99.38 139.94 34.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.999 -1.063 . . . . 0.0 108.559 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.482 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -103.62 173.2 6.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.059 -1.026 . . . . 0.0 110.826 -178.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 p -66.01 -19.9 66.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.509 -0.745 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 47.5 p-10 -89.58 17.05 6.79 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.598 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 66.89 29.22 8.39 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.726 -0.609 . . . . 0.0 109.989 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.623 HD22 ' HE1' ' A' ' 97' ' ' TYR . 6.9 mt -85.33 99.14 10.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.85 ' CG2' HD11 ' A' ' 88' ' ' ILE . 2.6 mt -93.83 116.92 36.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 110.408 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.623 ' HE1' HD22 ' A' ' 95' ' ' LEU . 7.2 m-85 -116.8 155.58 28.71 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -121.49 154.12 37.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.754 -1.217 . . . . 0.0 109.713 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -140.69 125.01 17.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.496 -0.752 . . . . 0.0 108.993 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.683 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.65 29.38 7.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.784 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.583 ' OD2' HG23 ' A' ' 105' ' ' THR . 0.9 OUTLIER -150.24 21.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.114 -0.991 . . . . 0.0 109.687 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 2.2 t-80 76.61 72.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 109.261 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.463 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 9.2 m-85 50.33 20.8 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.739 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.498 ' HB2' ' CB ' ' A' ' 101' ' ' ASP . 1.2 mt-30 -86.87 -19.98 28.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.913 . . . . 0.0 109.143 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.583 HG23 ' OD2' ' A' ' 101' ' ' ASP . 34.3 p -146.51 157.5 43.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.527 ' CE2' ' HB3' ' A' ' 62' ' ' LYS . 82.6 m-85 -141.98 125.11 16.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 110.042 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -117.0 133.96 55.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.359 -0.838 . . . . 0.0 109.018 179.416 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -79.73 128.3 33.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.596 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 6.8 pt -127.85 17.04 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.524 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -141.25 53.35 1.55 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.608 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.74 -172.76 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.417 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.832 ' CD1' HG21 ' A' ' 76' ' ' ILE . 47.2 m-85 -80.24 -61.96 1.82 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.482 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -30.99 67.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.35 -50.27 45.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.563 HG23 ' H ' ' A' ' 6' ' ' THR . 96.7 t -65.89 -45.8 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -1.115 . . . . 0.0 109.294 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -56.93 -35.93 69.62 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.51 -55.68 19.07 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 22.6 t80 -58.61 -23.13 58.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 0.0 109.183 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 11' ' ' ALA . 5.4 mt -71.9 -63.83 1.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.353 -0.842 . . . . 0.0 108.949 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.424 ' HG3' ' HD2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -71.01 -5.04 28.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.102 -0.999 . . . . 0.0 109.364 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 31.2 m -91.93 -69.96 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -0.952 . . . . 0.0 109.844 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 81.9 m-85 -89.76 -4.82 57.48 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.684 -0.635 . . . . 0.0 109.596 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER 57.51 57.81 4.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.461 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 162.51 129.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.477 HD11 ' OH ' ' A' ' 90' ' ' TYR . 19.0 mt -44.05 148.24 0.82 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.287 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.5 Cg_exo -55.35 164.49 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.172 1.915 . . . . 0.0 110.444 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.81 -5.81 33.05 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.306 -0.871 . . . . 0.0 108.868 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' ' 21' ' ' PRO . 23.2 p30 -92.14 9.79 32.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.525 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.55 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 4.6 m-85 -108.14 99.79 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.006 . . . . 0.0 109.753 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 2.1 pt -106.46 124.45 61.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 108.725 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 25' ' ' ILE . 20.5 p -47.0 176.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.817 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.611 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.19 -44.76 68.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.1 -1.0 . . . . 0.0 109.092 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 m -54.49 -39.9 68.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.844 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.7 mm-40 -58.67 -39.73 81.52 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.61 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.2 -34.56 77.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 108.663 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.526 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 18.6 mt-30 -65.95 -30.75 71.37 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.29 -37.87 84.73 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.692 0.758 . . . . 0.0 109.579 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -80.93 -8.25 59.7 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.649 -0.657 . . . . 0.0 110.124 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' O ' HG21 ' A' ' 45' ' ' VAL . . . 103.01 61.77 0.71 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.63 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 1.7 t90 -118.55 135.45 54.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.195 -1.179 . . . . 0.0 109.599 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.51 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 3.5 t -89.73 131.66 36.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.63 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.494 0 O-C-N 120.965 -1.085 . . . . 0.0 110.311 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.141 0.496 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.564 HD13 ' CD1' ' A' ' 35' ' ' TRP . 11.7 tp -52.94 -66.58 0.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 109.111 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.79 -14.64 1.48 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.787 -0.571 . . . . 0.0 110.359 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.8 -36.56 42.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.89 -1.131 . . . . 0.0 109.516 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 35' ' ' TRP . 22.0 m -105.49 -1.6 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 109.503 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.457 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.4 62.69 5.58 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 109.31 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 5.6 Cg_exo -58.42 152.92 50.95 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.203 1.935 . . . . 0.0 110.286 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 49.8 66.55 2.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HD2' HG12 ' A' ' 25' ' ' ILE . 30.7 mmtp -151.88 154.64 36.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.671 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.532 ' HB2' ' CD1' ' A' ' 24' ' ' TYR . 1.8 m -135.34 124.91 25.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.56 HD11 HD21 ' A' ' 42' ' ' LEU . 11.9 mm -74.64 104.97 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -151.35 173.21 30.8 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.406 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 84.17 15.27 69.83 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.48 154.31 17.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -1.151 . . . . 0.0 109.409 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 55' ' ' ILE . 16.4 mm -70.08 149.67 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.904 ' CE2' HD12 ' A' ' 63' ' ' LEU . 60.6 t80 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.043 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.56 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.227 0.537 . . . . 0.0 109.756 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.904 HD12 ' CE2' ' A' ' 56' ' ' PHE . 41.1 mt -89.85 145.11 32.65 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.151 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.976 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.8 Cg_endo -60.31 156.23 41.84 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.025 1.816 . . . . 0.0 110.359 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.261 0.553 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.795 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 3.9 m95 -122.93 173.57 7.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.554 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.616 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 1.1 mmt180 -121.58 148.83 44.0 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.75 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -128.8 153.8 47.06 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.877 -1.139 . . . . 0.0 110.249 -179.304 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -143.05 148.77 37.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.423 -0.798 . . . . 0.0 109.241 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -77.45 124.07 27.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.727 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.832 HG21 ' CD1' ' A' ' 7' ' ' PHE . 22.3 mm -110.85 138.86 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.113 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.65 ' OD1' HG22 ' A' ' 76' ' ' ILE . 14.9 m120 61.58 112.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.069 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 78' ' ' TYR . 6.8 t80 -170.45 133.95 1.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.062 -1.024 . . . . 0.0 109.674 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -140.9 -79.43 0.27 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.226 -0.921 . . . . 0.0 109.364 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 m -146.14 160.03 42.49 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.716 -0.615 . . . . 0.0 109.436 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.9 -169.15 18.79 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -64.07 144.45 57.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -1.177 . . . . 0.0 109.485 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 82' ' ' PHE . 5.2 mtm180 -43.97 163.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 109.219 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.84 -171.11 1.82 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.944 . . . . 0.0 109.651 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.43 23.28 9.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.5 m-20 -109.24 132.03 54.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.373 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 99' ' ' THR . 36.8 mtt180 -157.81 157.73 33.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.55 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.973 HD11 HD11 ' A' ' 109' ' ' ILE . 1.5 tt -112.93 139.64 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.245 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.4 mm? -108.45 126.59 53.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.795 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -116.69 140.05 49.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.857 -1.152 . . . . 0.0 108.666 178.497 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.451 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -108.12 176.01 5.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.193 -0.942 . . . . 0.0 110.379 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 p -64.23 -25.2 67.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.408 -0.808 . . . . 0.0 110.441 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.483 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -89.3 16.84 6.76 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.108 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.566 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.4 m95 67.5 29.31 7.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.713 -0.617 . . . . 0.0 110.737 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.976 HD13 ' HG2' ' A' ' 64' ' ' PRO . 8.8 mt -83.79 121.87 27.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.544 ' CG1' ' HB2' ' A' ' 110' ' ' ARG . 1.8 mt -115.42 112.82 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 110.75 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.613 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 26.1 m-85 -112.07 118.66 36.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.484 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -88.88 136.13 33.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.818 -1.176 . . . . 0.0 109.866 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -125.54 131.46 52.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.392 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.2 p -114.75 31.75 6.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.159 -0.963 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -150.26 20.4 0.85 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 109.565 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.537 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.5 t-80 79.08 73.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.496 -0.753 . . . . 0.0 109.971 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 5.0 m-85 51.57 37.73 20.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.04 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.434 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 19.7 tp60 -104.29 -72.29 0.71 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.135 -0.978 . . . . 0.0 109.052 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 99' ' ' THR . 0.8 OUTLIER -93.16 124.41 37.12 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.56 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 96.7 m-85 -112.17 121.66 45.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.067 -1.021 . . . . 0.0 110.065 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.484 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 3.8 m -108.64 130.81 55.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.386 -0.821 . . . . 0.0 109.087 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -79.41 113.8 17.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.047 -1.033 . . . . 0.0 109.668 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.973 HD11 HD11 ' A' ' 88' ' ' ILE . 29.5 pt -113.21 -14.98 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 109.328 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.544 ' HB2' ' CG1' ' A' ' 96' ' ' ILE . 1.1 mtt-85 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.237 0.541 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -134.57 49.44 2.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -135.31 -169.93 2.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 0.0 109.443 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.967 ' CE1' HG21 ' A' ' 76' ' ' ILE . 42.6 m-85 -80.14 -59.64 2.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.213 -0.929 . . . . 0.0 109.463 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -28.72 65.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.969 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.37 -51.27 33.03 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 6' ' ' THR . 38.7 t -67.04 -49.36 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -1.153 . . . . 0.0 109.167 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -53.88 -37.04 63.3 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.27 -55.63 23.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 23.2 t80 -59.94 -18.3 44.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.429 -0.794 . . . . 0.0 109.03 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.492 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.7 OUTLIER -76.1 -63.82 1.23 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.328 -0.857 . . . . 0.0 109.296 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -70.51 -8.49 51.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.906 -1.121 . . . . 0.0 109.353 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -91.9 -65.7 0.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.782 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 96.3 m-85 -89.51 3.3 52.88 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.713 -0.617 . . . . 0.0 109.5 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.548 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 45.01 45.48 8.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.6 OUTLIER 174.43 129.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.729 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 20' ' ' LEU . 18.4 mt -45.46 150.73 0.84 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 108.754 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 10.9 Cg_exo -52.98 160.06 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.084 1.856 . . . . 0.0 110.453 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -69.59 -5.89 27.52 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.309 -0.87 . . . . 0.0 109.202 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -93.44 2.87 56.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.336 -0.853 . . . . 0.0 109.628 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.547 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.2 m-85 -93.76 92.72 7.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.002 . . . . 0.0 109.943 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -100.99 125.3 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.264 -0.897 . . . . 0.0 108.937 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.473 ' H ' HG23 ' A' ' 26' ' ' THR . 12.1 p -45.96 172.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.16 -43.09 71.57 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.964 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -39.1 64.14 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.768 ' O ' HD12 ' A' ' 33' ' ' LEU . 5.5 mt-10 -59.67 -41.31 90.32 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.636 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -65.08 -35.98 82.88 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 0.0 108.63 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.408 ' HG3' ' CE3' ' A' ' 35' ' ' TRP . 13.0 mt-30 -63.03 -36.25 82.95 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.22 79.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.447 -0.783 . . . . 0.0 109.533 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.8 mp -81.17 -11.25 59.48 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.365 0.602 . . . . 0.0 110.261 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.764 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 107.68 56.77 0.59 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.636 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 9.8 t90 -127.89 115.48 18.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -1.141 . . . . 0.0 109.025 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 t -90.14 112.04 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 108.994 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.588 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.195 -0.94 . . . . 0.0 109.422 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.599 ' OD1' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.556 HD21 HD11 ' A' ' 51' ' ' ILE . 9.8 tp -59.54 -52.98 63.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.449 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -56.67 -14.96 3.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 109.871 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.83 -53.83 4.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.024 . . . . 0.0 110.331 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.764 HG11 ' O ' ' A' ' 34' ' ' GLY . 20.4 m -89.88 -48.1 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 110.16 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.61 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -116.85 77.35 8.5 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.993 . . . . 0.0 109.542 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 2.7 Cg_endo -60.92 159.47 29.25 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.21 1.94 . . . . 0.0 110.4 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.85 57.28 4.09 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HD3' HG12 ' A' ' 25' ' ' ILE . 2.9 mmtt -137.65 110.16 7.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -1.141 . . . . 0.0 109.588 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 9.2 m -89.7 133.93 34.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.4 -0.813 . . . . 0.0 109.229 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.556 HD11 HD21 ' A' ' 42' ' ' LEU . 10.2 mm -91.06 111.48 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.102 -0.999 . . . . 0.0 109.176 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -155.91 169.21 33.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.77 12.71 55.25 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 5.6 m-20 -104.95 143.86 32.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -1.21 . . . . 0.0 109.38 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 54' ' ' ASP . 7.3 mt -44.44 152.22 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 109.571 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.018 ' CE2' HD12 ' A' ' 63' ' ' LEU . 9.9 t80 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.139 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.602 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 8.0 mptt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.335 0.588 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.018 HD12 ' CE2' ' A' ' 56' ' ' PHE . 56.2 mt -91.59 140.71 25.32 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.24 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.953 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.2 Cg_exo -61.53 84.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.078 1.852 . . . . 0.0 110.067 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.784 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.3 0.571 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.859 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 8.2 m95 -139.79 151.26 45.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 109.299 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.636 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 10.0 mpt_? -110.75 139.16 46.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.202 -0.936 . . . . 0.0 108.671 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.607 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -117.77 158.22 25.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.008 . . . . 0.0 110.269 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -147.91 152.95 38.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -75.39 142.6 43.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 109.323 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.967 HG21 ' CE1' ' A' ' 7' ' ' PHE . 16.8 mm -131.14 121.73 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.09 -1.006 . . . . 0.0 109.732 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.509 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER 71.63 116.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 109.698 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -170.64 127.77 0.78 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.351 -0.843 . . . . 0.0 109.493 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -121.47 -27.91 4.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.745 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 79' ' ' THR . 0.6 OUTLIER 168.91 -174.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.391 -0.818 . . . . 0.0 109.703 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 82' ' ' PHE . . . 67.07 174.7 6.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.456 ' O ' ' O ' ' A' ' 83' ' ' ARG . 7.5 m-85 -43.81 152.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -1.15 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.501 ' CZ ' ' CB ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -46.65 171.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.9 OUTLIER -106.38 -174.74 2.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 m -106.37 3.99 28.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 0.0 109.48 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.2 m-20 -95.9 129.5 43.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 109.53 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 27.2 mtt180 -154.64 178.53 10.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.181 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 96' ' ' ILE . 3.7 tt -135.23 150.95 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.711 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.1 mm? -121.69 109.45 14.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.376 -0.827 . . . . 0.0 109.707 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.636 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 7.9 p90 -104.55 138.89 40.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 109.302 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.583 ' OG ' ' CH2' ' A' ' 71' ' ' TRP . 1.4 m -107.23 174.3 5.95 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.288 -0.882 . . . . 0.0 110.396 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -65.3 -23.9 67.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 109.593 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.473 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 17.8 p-10 -89.7 18.15 5.82 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 108.858 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.572 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.4 m95 66.39 29.49 9.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.677 -0.639 . . . . 0.0 110.173 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.953 HD13 ' HG2' ' A' ' 64' ' ' PRO . 5.7 mt -81.03 112.5 18.48 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.793 HG22 HD11 ' A' ' 88' ' ' ILE . 2.0 mt -109.52 110.83 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.782 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.49 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 31.5 m-85 -113.91 113.49 24.92 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CG ' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -89.36 133.76 34.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 110.215 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -117.13 128.96 55.65 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.33 28.23 8.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.18 -0.95 . . . . 0.0 109.645 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.791 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.7 OUTLIER -150.18 22.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.463 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 8.7 t-80 77.54 71.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.381 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.432 ' OH ' ' HD2' ' A' ' 87' ' ' ARG . 5.1 m-85 50.76 20.91 0.82 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.826 . . . . 0.0 109.752 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.467 ' HB2' ' CB ' ' A' ' 101' ' ' ASP . 1.2 mm-40 -90.33 -17.4 27.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -0.96 . . . . 0.0 108.87 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.791 HG22 ' OD1' ' A' ' 101' ' ' ASP . 14.9 t -143.81 161.5 38.46 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.602 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 99.4 m-85 -148.76 119.72 7.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.817 -1.177 . . . . 0.0 110.223 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.528 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 3.8 m -108.96 124.82 51.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.515 -0.741 . . . . 0.0 109.1 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -79.42 101.13 7.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.447 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.449 HG21 ' HE2' ' A' ' 98' ' ' LYS . 38.1 pt -104.63 18.18 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.789 ' HD2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -143.76 69.74 1.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.516 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.848 ' H ' HG23 ' A' ' 10' ' ' VAL . 1.5 p -149.03 -173.15 4.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.436 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.711 ' CE1' HG21 ' A' ' 76' ' ' ILE . 24.1 m-85 -77.65 -60.29 2.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.893 . . . . 0.0 109.429 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -33.97 70.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.69 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.24 -50.3 46.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.848 HG23 ' H ' ' A' ' 6' ' ' THR . 76.0 t -66.78 -46.98 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -1.147 . . . . 0.0 109.337 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.4 66.97 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.447 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.4 OUTLIER -63.85 -55.77 20.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.518 -0.739 . . . . 0.0 109.246 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.664 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 42.0 t80 -58.18 -21.08 45.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.374 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.539 HD12 HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -75.38 -63.87 1.19 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.401 -0.812 . . . . 0.0 109.317 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' OE1' ' CG ' ' A' ' 110' ' ' ARG . 46.8 mt-30 -70.58 -5.72 31.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.034 -1.041 . . . . 0.0 109.389 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 82.6 m -94.5 -67.37 0.86 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.678 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.664 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 66.6 m-85 -89.78 3.2 53.59 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 109.567 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER 44.14 51.09 7.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER 175.35 129.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.786 HD13 ' HD2' ' A' ' 24' ' ' TYR . 15.7 mt -43.84 160.02 0.23 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.99 . . . . 0.0 109.417 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 3.3 Cg_exo -55.22 159.23 10.46 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.236 1.957 . . . . 0.0 110.553 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.56 -5.05 30.44 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.374 -0.829 . . . . 0.0 108.947 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 50' ' ' SER . 5.6 p-10 -111.42 32.74 5.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.498 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.786 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.2 m-30 -115.18 81.06 1.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.062 -1.024 . . . . 0.0 109.363 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pt -88.14 123.35 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.253 -0.905 . . . . 0.0 108.978 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 25' ' ' ILE . 82.8 p -46.92 175.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.335 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.62 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.24 -45.32 66.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.997 -1.064 . . . . 0.0 109.052 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -52.08 -33.42 39.24 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 108.361 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.7 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.5 mm-40 -61.3 -46.53 89.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.653 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -62.19 -35.92 80.33 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.522 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 33.3 mt-30 -64.45 -33.73 76.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.62 -37.89 85.6 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.19 -8.96 59.85 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.741 -0.599 . . . . 0.0 109.972 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' O ' HG21 ' A' ' 45' ' ' VAL . . . 101.67 71.23 0.91 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.653 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 0.8 OUTLIER -128.2 137.69 52.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -1.188 . . . . 0.0 109.441 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.554 HG12 ' OD1' ' A' ' 41' ' ' ASN . 9.8 p -89.58 128.77 41.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.009 -1.057 . . . . 0.0 110.384 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.554 ' OD1' HG12 ' A' ' 36' ' ' VAL . 2.6 p-10 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.111 0.481 . . . . 0.0 110.058 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.838 HD21 HD11 ' A' ' 51' ' ' ILE . 6.9 tp -56.85 -65.66 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 109.198 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.29 -9.87 3.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.798 -0.564 . . . . 0.0 110.252 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 3.7 m-20 -78.93 -30.29 44.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.973 -1.079 . . . . 0.0 109.41 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 35' ' ' TRP . 30.8 m -107.61 -14.18 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.341 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -149.3 65.24 7.83 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 109.376 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 3.1 Cg_exo -60.97 161.94 20.65 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.2 1.933 . . . . 0.0 110.317 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.52 38.34 42.82 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 15.8 mmtt -135.58 113.29 10.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -1.161 . . . . 0.0 109.55 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -89.68 155.43 19.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.838 HD11 HD21 ' A' ' 42' ' ' LEU . 5.4 mm -103.11 111.66 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.839 . . . . 0.0 109.405 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -154.1 160.09 29.21 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.08 19.91 27.25 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.527 ' HB2' ' CG ' ' A' ' 73' ' ' GLU . 4.5 m-20 -88.13 148.11 24.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -1.199 . . . . 0.0 109.467 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.0 mm -68.68 137.49 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.835 . . . . 0.0 109.758 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.929 ' CE2' HD12 ' A' ' 63' ' ' LEU . 78.2 t80 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 108.957 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 6.4 mtpt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.306 0.574 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.929 HD12 ' CE2' ' A' ' 56' ' ' PHE . 12.7 mt -94.18 147.29 33.13 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 0.0 109.279 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.006 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.4 Cg_endo -62.03 119.14 6.12 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.139 1.893 . . . . 0.0 110.174 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.365 0.603 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.746 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 11.5 m95 -128.74 154.11 46.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 7.3 mmt180 -117.72 148.65 41.81 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.668 ' HA ' HD13 ' A' ' 89' ' ' LEU . 5.9 pt-20 -125.49 155.02 41.19 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.789 -1.194 . . . . 0.0 110.11 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB2' ' OH ' ' A' ' 90' ' ' TYR . . . -144.16 155.59 43.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 109.416 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.475 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 3.4 m-20 -80.24 143.44 33.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.601 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.711 HG21 ' CE1' ' A' ' 7' ' ' PHE . 37.3 mm -127.85 119.0 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 73.83 108.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.674 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.52 ' CE1' ' HA ' ' A' ' 83' ' ' ARG . 23.3 t80 -170.71 118.81 0.52 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.336 -0.852 . . . . 0.0 109.46 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.42 -80.1 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.393 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.8 m -137.19 145.1 43.29 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.726 -0.609 . . . . 0.0 109.385 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.2 -174.25 15.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -61.71 140.69 58.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.158 -1.201 . . . . 0.0 109.426 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.52 ' HA ' ' CE1' ' A' ' 78' ' ' TYR . 45.5 mtp180 -44.04 167.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 109.346 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.42 -176.98 3.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.961 . . . . 0.0 109.684 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -113.5 15.67 18.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 109.311 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.589 ' OD2' HG22 ' A' ' 100' ' ' THR . 0.7 OUTLIER -97.96 130.45 44.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.225 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.525 ' CZ ' ' OH ' ' A' ' 103' ' ' TYR . 2.3 mtt180 -152.54 179.57 8.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.967 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.743 HD11 HD11 ' A' ' 109' ' ' ILE . 1.8 tt -138.77 141.39 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -0.835 . . . . 0.0 108.884 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.747 HD22 ' N ' ' A' ' 89' ' ' LEU . 3.3 mm? -111.61 125.09 53.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.365 -0.834 . . . . 0.0 109.667 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.775 ' OH ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -111.3 142.61 43.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.921 -1.112 . . . . 0.0 108.839 179.003 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.504 ' CB ' ' HB2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -110.88 171.77 7.27 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.186 -0.946 . . . . 0.0 110.184 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.0 p -64.59 -25.76 68.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.435 -0.791 . . . . 0.0 109.518 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.483 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 14.1 p-10 -90.01 19.8 4.68 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.583 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.0 27.77 8.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.68 -0.638 . . . . 0.0 110.133 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.006 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.2 mt -79.62 116.78 20.01 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.535 HG22 HD11 ' A' ' 88' ' ' ILE . 2.5 mt -114.6 108.05 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.088 -1.007 . . . . 0.0 110.56 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.567 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 24.9 m-85 -108.25 116.83 32.69 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.552 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -88.6 137.97 31.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.867 -1.146 . . . . 0.0 109.997 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -122.0 127.3 50.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.589 HG22 ' OD2' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -111.89 29.37 7.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.11 -0.994 . . . . 0.0 109.59 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -150.06 22.44 0.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.726 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.523 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.5 OUTLIER 77.42 69.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.525 ' OH ' ' CZ ' ' A' ' 87' ' ' ARG . 14.8 m-85 49.45 21.81 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.798 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.462 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . 4.8 mt-30 -88.0 -17.29 31.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 108.97 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.485 ' O ' ' HB ' ' A' ' 99' ' ' THR . 23.0 m -147.27 155.79 42.36 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . 90.2 m-85 -139.76 116.44 10.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.973 -1.08 . . . . 0.0 110.11 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 1.7 m -107.65 127.27 53.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 113.95 17.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 109.646 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.743 HD11 HD11 ' A' ' 88' ' ' ILE . 3.5 pt -109.3 -24.25 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.646 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.425 ' OXT' ' O ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.503 HG23 ' C ' ' A' ' 9' ' ' GLY . 2.7 mp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -142.67 47.33 1.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.496 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -136.75 -170.19 2.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.348 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.75 ' CD1' HG21 ' A' ' 76' ' ' ILE . 52.3 m-85 -77.38 -59.57 2.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.402 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -31.19 67.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.894 . . . . 0.0 109.783 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.503 ' C ' HG23 ' A' ' 4' ' ' ILE . . . -68.56 -51.96 28.31 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.496 HG23 ' H ' ' A' ' 6' ' ' THR . 73.7 t -66.09 -45.91 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -1.118 . . . . 0.0 109.313 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -55.95 -38.86 70.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.49 -55.6 26.0 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.679 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 35.1 t80 -58.06 -22.35 49.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.327 -0.858 . . . . 0.0 109.046 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER -71.61 -62.87 1.25 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.43 -0.794 . . . . 0.0 108.989 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -71.28 -5.6 33.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.042 -1.036 . . . . 0.0 109.317 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 25.2 m -89.82 -69.48 0.72 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.952 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.679 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 77.5 m-85 -89.47 -7.79 54.3 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.626 -0.671 . . . . 0.0 109.463 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.5 OUTLIER 61.01 57.89 2.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.707 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 10.1 ptpt 160.64 129.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 20' ' ' LEU . 30.4 mt -44.46 147.33 1.04 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 108.997 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.567 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.3 Cg_exo -52.41 160.1 3.86 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.043 1.829 . . . . 0.0 110.336 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -7.74 32.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.139 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -91.75 7.33 42.25 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.3 m-85 -98.43 98.44 9.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -0.93 . . . . 0.0 109.677 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 26' ' ' THR . 1.9 pp -106.07 121.34 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 108.953 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.848 ' O ' HD12 ' A' ' 25' ' ' ILE . 16.8 p -46.35 173.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.667 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.87 -44.41 69.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.131 -0.98 . . . . 0.0 108.996 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 m -53.5 -38.7 63.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 33' ' ' LEU . 2.3 mm-40 -59.51 -39.35 83.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.736 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.55 -37.54 82.85 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.139 -0.976 . . . . 0.0 108.624 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -61.98 -33.02 73.54 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.31 74.74 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.437 -0.789 . . . . 0.0 109.358 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.0 mp -81.17 -15.52 55.51 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.4 0.619 . . . . 0.0 110.181 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.528 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 110.44 44.53 0.98 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.736 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 5.6 t90 -109.19 121.29 44.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -1.104 . . . . 0.0 109.184 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 t -89.62 116.31 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.312 -0.867 . . . . 0.0 108.86 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 0.0 109.75 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.543 ' O ' HG22 ' A' ' 45' ' ' VAL . 21.2 p-10 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.216 0.531 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.641 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 5.9 tp -58.56 -53.39 58.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.542 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.22 -19.17 1.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.937 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.11 -32.87 15.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.0 110.292 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -103.17 -57.65 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.929 -1.107 . . . . 0.0 109.683 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.841 ' HB1' ' HE2' ' A' ' 49' ' ' LYS . . . -114.12 79.69 5.11 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.423 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -62.18 156.92 47.49 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.252 1.968 . . . . 0.0 110.197 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.7 69.33 0.63 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.841 ' HE2' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -150.62 116.0 5.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.48 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 5.7 m -89.54 132.22 35.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.537 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 15.8 mm -87.17 104.83 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.364 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -157.56 168.42 34.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.16 -16.27 38.86 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.73 164.2 23.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -1.159 . . . . 0.0 109.3 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 56' ' ' PHE . 29.9 mm -67.81 166.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.922 . . . . 0.0 109.515 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.031 ' CE2' HD12 ' A' ' 63' ' ' LEU . 23.0 t80 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.31 -0.869 . . . . 0.0 109.457 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.596 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.331 0.586 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.031 HD12 ' CE2' ' A' ' 56' ' ' PHE . 20.9 mt -101.05 152.13 37.8 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.386 -0.821 . . . . 0.0 108.945 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.004 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.7 Cg_exo -56.52 86.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.058 1.839 . . . . 0.0 110.072 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.889 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.71 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 44.2 m95 -83.56 149.95 26.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.157 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -125.17 144.81 50.26 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HA ' HD13 ' A' ' 89' ' ' LEU . 17.2 pt-20 -115.36 159.54 20.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.854 -1.154 . . . . 0.0 110.479 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.654 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -146.3 149.58 34.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.468 -0.77 . . . . 0.0 109.297 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.97 138.68 48.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.75 HG21 ' CD1' ' A' ' 7' ' ' PHE . 19.8 mm -129.93 138.13 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.686 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 73.21 38.0 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.787 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -69.74 139.81 53.38 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.137 -0.977 . . . . 0.0 109.468 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.32 -79.84 0.38 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.504 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.5 163.18 12.48 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.788 -0.57 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.0 -159.26 52.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 83' ' ' ARG . 10.4 m-85 -51.11 147.64 5.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -1.124 . . . . 0.0 109.529 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 82' ' ' PHE . 5.5 mtp180 -53.04 -173.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.308 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -118.33 179.77 4.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.57 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -100.67 12.81 36.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.327 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.67 ' OD1' HG22 ' A' ' 100' ' ' THR . 50.3 m-20 -104.9 128.86 53.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.354 -0.841 . . . . 0.0 109.55 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 99' ' ' THR . 68.5 mtt180 -153.91 163.69 39.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.139 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.751 ' C ' HD22 ' A' ' 89' ' ' LEU . 4.3 tt -121.89 155.39 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.154 -0.966 . . . . 0.0 109.518 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.751 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.4 mm? -122.36 114.81 21.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.656 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.654 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 3.1 p90 -106.86 139.6 41.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.858 -1.151 . . . . 0.0 109.172 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.563 ' OG ' ' CZ3' ' A' ' 71' ' ' TRP . 1.3 m -110.06 173.7 6.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 p -64.77 -25.25 67.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.617 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.495 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 9.8 p-10 -89.73 18.44 5.55 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.415 -0.803 . . . . 0.0 108.971 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.596 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.45 27.41 8.02 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.743 -0.598 . . . . 0.0 110.233 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 1.004 HD13 ' HG2' ' A' ' 64' ' ' PRO . 6.2 mt -79.57 116.44 19.78 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.661 HG22 HD11 ' A' ' 88' ' ' ILE . 5.9 mt -114.9 105.86 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.43 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.638 ' HE1' HD22 ' A' ' 95' ' ' LEU . 23.0 m-85 -106.05 120.61 42.23 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -89.4 150.58 22.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 110.191 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -136.42 131.79 34.6 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.67 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -114.32 6.25 16.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 109.874 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.514 ' HB2' ' CB ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -125.43 24.68 7.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.143 -0.973 . . . . 0.0 109.397 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.6 t-80 76.53 76.01 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.92 . . . . 0.0 109.493 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.488 ' O ' ' CZ ' ' A' ' 106' ' ' PHE . 14.7 m-85 48.93 21.6 0.48 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.514 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -94.02 -34.87 12.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.011 -1.056 . . . . 0.0 109.118 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.483 ' O ' ' HB ' ' A' ' 99' ' ' THR . 95.2 m -121.14 140.81 51.49 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.596 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 94.9 m-85 -134.36 115.55 14.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.043 -1.036 . . . . 0.0 110.131 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 11.2 m -110.15 137.09 48.38 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.358 -0.839 . . . . 0.0 108.947 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -79.68 114.42 18.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 10.5 pt -132.05 68.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.878 . . . . 0.0 109.281 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 3.5 mtp180 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.263 0.554 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -149.95 54.76 0.93 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 10' ' ' VAL . 2.2 p -139.16 -168.82 2.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.775 ' CD1' HG21 ' A' ' 76' ' ' ILE . 32.9 m-85 -79.82 -57.7 3.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.619 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.53 -32.46 69.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 0.0 109.792 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.9 -50.04 50.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 6' ' ' THR . 35.1 t -66.98 -43.58 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -1.124 . . . . 0.0 109.385 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.51 -37.2 72.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.12 -56.32 13.61 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.538 -0.726 . . . . 0.0 109.242 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.638 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 15.8 t80 -60.76 -18.45 54.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 109.064 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.2 mt -74.5 -65.61 0.84 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.499 -0.751 . . . . 0.0 108.975 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -70.26 -6.7 36.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.988 -1.07 . . . . 0.0 109.254 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.534 HG22 ' CD1' ' A' ' 17' ' ' TYR . 19.8 m -89.42 -68.48 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 96.5 m-85 -92.0 6.42 46.44 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.627 -0.671 . . . . 0.0 109.642 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER 44.97 47.65 9.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.407 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 175.83 129.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.692 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 20' ' ' LEU . 27.0 mt -46.03 149.53 1.21 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.196 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.564 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 6.8 Cg_exo -53.93 162.56 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.114 1.876 . . . . 0.0 110.639 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -70.79 -5.71 32.26 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.38 -0.825 . . . . 0.0 109.034 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 53.6 p30 -91.75 0.24 57.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.869 . . . . 0.0 109.596 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.644 ' OH ' HG21 ' A' ' 10' ' ' VAL . 3.2 m-85 -89.87 107.92 19.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.056 -1.027 . . . . 0.0 109.579 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.957 HD12 ' O ' ' A' ' 26' ' ' THR . 1.7 pp -111.95 115.34 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 109.08 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.957 ' O ' HD12 ' A' ' 25' ' ' ILE . 81.7 p -44.59 168.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.307 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.607 ' N ' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.68 -41.18 88.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.929 -1.107 . . . . 0.0 109.175 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.05 -47.54 82.82 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 47.2 mm-40 -50.63 -35.19 29.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.933 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -70.03 -40.91 74.91 Favored 'General case' 0 C--O 1.202 -1.438 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -60.03 -18.88 49.52 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.345 -1.472 . . . . 0.0 108.01 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -69.01 -48.0 64.08 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.541 -0.724 . . . . 0.0 111.675 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.811 HD13 ' H ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.81 -0.07 41.64 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.928 -1.107 . . . . 0.0 111.713 -178.461 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.448 ' N ' HD22 ' A' ' 33' ' ' LEU . . . 108.94 25.93 5.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.893 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.933 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 10.5 t90 -89.12 123.46 33.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.895 -1.356 . . . . 0.0 109.191 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 t -91.93 114.51 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 108.917 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.593 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.232 -0.917 . . . . 0.0 109.789 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.325 0.584 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 3.7 tp -64.42 -41.01 96.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.344 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . . . -63.26 -9.22 10.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.921 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -102.67 -36.72 8.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.039 -1.038 . . . . 0.0 110.211 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.581 HG23 ' N ' ' A' ' 46' ' ' ALA . 28.7 m -108.13 -44.93 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.101 -1.0 . . . . 0.0 110.056 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -128.7 59.95 46.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.835 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 1.7 Cg_endo -62.58 171.08 6.04 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.175 1.917 . . . . 0.0 110.253 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.17 52.21 5.07 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.572 ' HG3' HG23 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -139.33 135.98 34.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -1.169 . . . . 0.0 109.557 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.514 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 13.3 m -101.64 121.79 42.68 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.235 -0.916 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.607 HG23 ' N ' ' A' ' 27' ' ' LYS . 11.3 mm -79.58 105.07 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.161 -0.962 . . . . 0.0 108.902 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.576 ' O ' HG22 ' A' ' 26' ' ' THR . . . -140.9 172.03 23.85 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.456 -1.354 . . . . 0.0 109.932 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.78 11.65 61.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -84.49 146.97 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -1.195 . . . . 0.0 109.392 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.512 HD13 HH11 ' A' ' 72' ' ' ARG . 19.5 mm -70.2 141.4 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.836 ' CE2' HD12 ' A' ' 63' ' ' LEU . 70.6 t80 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.447 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.245 0.545 . . . . 0.0 109.591 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.887 HD22 ' CZ3' ' A' ' 71' ' ' TRP . 23.4 mt -93.32 147.95 34.69 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 109.257 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.999 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.1 Cg_exo -60.89 162.76 17.91 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.108 1.872 . . . . 0.0 110.223 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.93 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.887 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 8.8 m95 -107.52 161.49 14.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 109.471 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.647 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -117.73 131.25 56.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 0.0 108.819 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.808 ' HA ' HD13 ' A' ' 89' ' ' LEU . 3.6 pt-20 -107.44 147.49 30.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.316 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.66 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -135.17 147.27 49.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -70.78 137.01 49.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.354 -0.841 . . . . 0.0 109.818 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.775 HG21 ' CD1' ' A' ' 7' ' ' PHE . 21.5 mm -132.47 134.58 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.847 . . . . 0.0 109.428 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.562 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 1.1 m-20 69.9 125.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.259 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 78' ' ' TYR . 6.4 t80 -170.4 136.47 1.33 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.201 -0.937 . . . . 0.0 109.615 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.26 -79.56 0.35 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.382 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -153.79 154.89 34.83 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.717 -0.614 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.9 -171.63 20.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.57 169.07 0.72 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -1.159 . . . . 0.0 109.388 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -56.73 177.14 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.158 -0.964 . . . . 0.0 109.315 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 1.3 p30 -118.99 -174.05 2.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.875 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 p -115.22 29.63 7.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 52.9 m-20 -114.14 128.84 56.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.573 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.62 ' O ' HG22 ' A' ' 99' ' ' THR . 2.2 mtt180 -156.73 137.27 13.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.388 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 1.033 HD11 ' CG2' ' A' ' 96' ' ' ILE . 5.1 tt -93.12 126.11 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.117 -0.989 . . . . 0.0 109.258 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.808 HD13 ' HA ' ' A' ' 73' ' ' GLU . 4.0 mm? -95.67 100.36 12.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.472 -0.767 . . . . 0.0 109.994 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.654 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 28.8 p90 -97.54 140.35 32.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.983 -1.073 . . . . 0.0 108.525 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -107.84 172.37 6.87 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.985 -1.072 . . . . 0.0 110.761 -178.774 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -22.19 66.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.5 -0.75 . . . . 0.0 109.826 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 41.8 p-10 -89.58 17.88 5.97 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.382 -0.824 . . . . 0.0 108.829 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.578 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.84 23.96 8.29 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.634 -0.666 . . . . 0.0 110.104 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.999 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.2 mt -79.64 101.18 8.2 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 1.033 ' CG2' HD11 ' A' ' 88' ' ' ILE . 5.5 mt -96.5 118.26 42.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.22 -0.925 . . . . 0.0 110.631 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.498 ' O ' HG13 ' A' ' 88' ' ' ILE . 11.9 m-85 -120.11 160.97 21.79 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -131.79 122.02 25.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.756 -1.215 . . . . 0.0 110.056 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -108.69 131.14 55.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 109.01 179.349 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 p -115.12 18.15 16.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.641 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.7 OUTLIER -139.18 23.55 2.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER 78.33 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 50.35 20.89 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.808 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.77 -15.23 26.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.114 -0.992 . . . . 0.0 109.076 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.641 HG22 ' OD1' ' A' ' 101' ' ' ASP . 12.5 t -148.78 145.35 27.54 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 62' ' ' LYS . 53.7 m-85 -135.99 111.45 9.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.919 -1.113 . . . . 0.0 110.153 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.531 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.8 m -98.34 131.31 44.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.426 -0.796 . . . . 0.0 108.906 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 76.5 tttt -80.03 122.35 26.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.548 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 109' ' ' ILE . 11.3 pt -119.68 15.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.484 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.574 ' CD ' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.489 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.646 HD13 ' HB2' ' A' ' 13' ' ' TYR . 13.3 mt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -144.22 49.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 10' ' ' VAL . 1.2 p -138.68 -173.82 3.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.368 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.97 ' CD1' HG21 ' A' ' 76' ' ' ILE . 38.2 m-85 -76.57 -57.08 4.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.576 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -32.09 69.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 109.875 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.426 ' C ' ' CG2' ' A' ' 4' ' ' ILE . . . -67.59 -52.76 28.15 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 6' ' ' THR . 21.8 t -65.27 -40.71 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -1.14 . . . . 0.0 109.192 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.23 -37.11 76.71 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 1.242 ' OD1' ' NH2' ' A' ' 110' ' ' ARG . 0.7 OUTLIER -65.52 -55.81 15.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.523 -0.736 . . . . 0.0 109.161 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.646 ' HB2' HD13 ' A' ' 4' ' ' ILE . 38.0 t80 -60.77 -19.24 58.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.185 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 0.6 OUTLIER -74.94 -60.53 2.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.405 -0.81 . . . . 0.0 109.311 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -71.03 -10.9 60.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.905 -1.122 . . . . 0.0 109.254 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.7 m -89.42 -66.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.876 . . . . 0.0 110.411 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 71.0 m-85 -89.38 -6.74 56.35 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.61 -0.681 . . . . 0.0 109.742 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.496 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER 55.94 58.6 4.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.414 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 161.65 131.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.488 HD11 ' OH ' ' A' ' 90' ' ' TYR . 33.3 mt -44.47 150.17 0.69 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 109.252 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.57 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 7.4 Cg_exo -53.62 163.27 2.87 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.151 1.901 . . . . 0.0 110.428 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -71.22 -4.88 28.03 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.345 -0.847 . . . . 0.0 109.028 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -95.76 11.76 32.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.606 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.57 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 3.1 m-85 -101.77 109.75 21.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.152 -0.967 . . . . 0.0 109.484 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 26' ' ' THR . 1.4 pp -115.73 118.08 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.327 -0.858 . . . . 0.0 108.989 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' HD12 ' A' ' 25' ' ' ILE . 14.2 p -45.82 171.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.301 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -67.9 -42.94 80.39 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.942 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.6 m -55.43 -41.36 72.68 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.728 ' O ' HD12 ' A' ' 33' ' ' LEU . 11.8 mm-40 -57.11 -40.88 77.93 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.705 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -64.18 -36.84 85.36 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' OE1' ' CE3' ' A' ' 35' ' ' TRP . 6.7 mm100 -60.38 -39.21 86.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.31 -35.52 73.94 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.455 -0.778 . . . . 0.0 109.832 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.7 mp -81.23 -14.02 57.93 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.628 -0.67 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.888 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 110.77 40.39 1.32 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.705 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 10.9 t90 -109.92 118.9 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -1.19 . . . . 0.0 108.993 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -91.35 111.33 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.334 -0.854 . . . . 0.0 109.106 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.649 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.215 -0.928 . . . . 0.0 109.598 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.508 ' O ' HG22 ' A' ' 45' ' ' VAL . 1.8 p-10 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.228 0.537 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.576 HD11 ' CB ' ' A' ' 30' ' ' ALA . 5.8 tp -62.81 -44.95 94.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.185 -0.947 . . . . 0.0 109.666 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.29 -8.1 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 110.128 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 32.7 m-20 -101.6 -22.72 14.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.019 -1.051 . . . . 0.0 110.258 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.888 HG11 ' O ' ' A' ' 34' ' ' GLY . 17.9 m -121.18 -48.54 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.909 -1.12 . . . . 0.0 110.124 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.524 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -127.55 60.57 44.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.119 -0.988 . . . . 0.0 110.115 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.7 Cg_endo -62.66 -179.55 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.172 1.914 . . . . 0.0 110.177 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.44 59.66 3.03 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HE3' HG21 ' A' ' 25' ' ' ILE . 3.8 mttp -151.51 171.48 17.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -1.157 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.545 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 19.4 m -137.34 118.9 14.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.564 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.563 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 8.7 mm -76.99 103.64 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.048 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -147.38 171.2 28.06 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.86 7.87 54.87 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 9.7 m-20 -79.99 145.12 32.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -1.209 . . . . 0.0 109.313 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mm -69.97 138.05 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.537 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.788 ' CE2' HD12 ' A' ' 63' ' ' LEU . 60.0 t80 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.827 . . . . 0.0 109.359 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 1.9 mttt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.282 0.563 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.795 HD22 ' CZ3' ' A' ' 71' ' ' TRP . 16.9 mt -94.88 146.39 31.29 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 0.0 109.122 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.704 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.8 Cg_exo -60.35 86.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.059 1.839 . . . . 0.0 110.209 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.966 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.272 0.558 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.795 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 23.1 m95 -136.98 165.89 24.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 35.0 mtt180 -132.87 143.78 49.75 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.706 ' HA ' HD13 ' A' ' 89' ' ' LEU . 10.4 pt-20 -121.48 155.39 35.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.972 -1.08 . . . . 0.0 110.459 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -146.77 148.96 32.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 109.144 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -68.72 133.04 47.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.97 HG21 ' CD1' ' A' ' 7' ' ' PHE . 26.3 mm -119.46 116.09 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.965 . . . . 0.0 109.644 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 72.49 124.29 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.868 . . . . 0.0 109.631 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -170.59 148.06 2.99 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.286 -0.884 . . . . 0.0 109.468 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.98 -79.84 0.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.453 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -145.3 171.86 13.97 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.754 -0.591 . . . . 0.0 109.452 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.61 -166.55 43.55 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -62.89 179.36 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -1.125 . . . . 0.0 109.428 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -78.56 164.55 24.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -104.72 -168.32 1.46 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.299 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.526 ' HB3' ' N ' ' A' ' 102' ' ' HIS . 13.3 m -105.1 16.44 25.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.0 109.649 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 0.9 OUTLIER -96.66 126.78 42.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.638 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.619 ' O ' HG22 ' A' ' 99' ' ' THR . 1.9 mtt180 -160.09 150.69 18.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 109.499 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.827 HD11 HG22 ' A' ' 96' ' ' ILE . 3.3 tt -108.29 156.64 8.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 109.23 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.727 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.4 mm? -125.95 107.17 10.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.428 -0.795 . . . . 0.0 109.376 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 72' ' ' ARG . 1.6 p90 -102.44 139.02 38.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.795 -1.191 . . . . 0.0 109.025 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.455 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -108.12 174.64 5.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.262 -0.899 . . . . 0.0 110.396 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.4 p -65.29 -24.68 67.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 45.5 p30 -89.76 18.06 5.96 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.592 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.02 29.66 7.9 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.725 -0.609 . . . . 0.0 110.048 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.0 mt -82.21 113.06 19.78 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.827 HG22 HD11 ' A' ' 88' ' ' ILE . 2.0 mt -109.24 114.89 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 110.366 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.895 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 26.8 m-85 -121.27 118.63 30.03 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -88.51 117.3 27.35 Favored 'General case' 0 N--CA 1.492 1.632 1 N-CA-C 125.7 5.444 . . . . 0.0 125.7 -179.282 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -108.69 131.14 55.21 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 124.652 3.387 . . . . 0.0 109.01 -170.31 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 1.9 p -115.12 18.15 16.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.641 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.7 OUTLIER -139.18 23.55 2.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER 78.33 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.671 ' OH ' ' OE2' ' A' ' 73' ' ' GLU . 15.5 m-85 50.35 20.89 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.808 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.77 -15.23 26.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.114 -0.992 . . . . 0.0 109.076 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.641 HG22 ' OD1' ' A' ' 101' ' ' ASP . 12.5 t -148.78 145.35 27.54 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.895 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . 53.7 m-85 -135.99 111.45 9.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.919 -1.113 . . . . 0.0 110.153 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.563 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 1.8 m -98.34 131.31 44.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.426 -0.796 . . . . 0.0 108.906 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -80.03 122.35 26.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.548 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.768 HD11 HD11 ' A' ' 88' ' ' ILE . 11.3 pt -119.68 15.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.484 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 1.242 ' NH2' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.489 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.88 103.6 3.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.402 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.76 -173.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 0.0 109.649 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.473 HD12 ' CD1' ' A' ' 13' ' ' TYR . 11.1 mt -112.0 117.51 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.873 . . . . 0.0 109.369 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -144.48 62.41 1.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.952 . . . . 0.0 109.705 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.556 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -140.0 -174.56 3.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.923 . . . . 0.0 109.323 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.826 ' CE1' HG21 ' A' ' 76' ' ' ILE . 21.3 m-85 -77.31 -60.84 2.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.256 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -33.46 70.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.371 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.28 -48.99 60.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.611 HG12 HD12 ' A' ' 14' ' ' LEU . 41.6 t -68.31 -36.37 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -1.144 . . . . 0.0 109.207 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.1 -38.86 87.78 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.78 -54.79 19.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.546 -0.721 . . . . 0.0 109.118 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE1' ' CD2' ' A' ' 17' ' ' TYR . 47.9 t80 -55.39 -26.67 42.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.844 . . . . 0.0 109.218 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.611 HD12 HG12 ' A' ' 10' ' ' VAL . 1.2 mt -72.84 -60.5 2.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.428 -0.795 . . . . 0.0 109.376 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.426 ' NE2' ' OXT' ' A' ' 110' ' ' ARG . 2.9 mt-30 -70.49 -5.21 27.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.025 -1.047 . . . . 0.0 109.565 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 m -93.15 -68.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.17 -0.956 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD2' ' CE1' ' A' ' 13' ' ' TYR . 58.8 m-85 -89.63 3.96 50.95 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.644 -0.66 . . . . 0.0 109.553 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER 43.89 51.46 6.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER 177.39 130.38 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.536 -0.728 . . . . 0.0 109.117 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.713 HD13 ' HD2' ' A' ' 24' ' ' TYR . 17.6 mt -47.61 159.37 0.44 Allowed Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.093 -1.004 . . . . 0.0 109.131 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.58 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 4.1 Cg_exo -54.7 158.43 10.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.17 1.913 . . . . 0.0 110.454 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.21 -6.3 33.55 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.373 -0.829 . . . . 0.0 109.03 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.3 28.61 8.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.89 . . . . 0.0 109.463 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.713 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.6 m-30 -113.59 79.03 1.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.505 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -94.26 127.96 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.906 . . . . 0.0 108.983 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 25' ' ' ILE . 44.0 p -46.66 176.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 109.992 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.24 -48.64 56.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.102 -0.999 . . . . 0.0 109.161 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -51.57 -36.42 45.3 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.658 ' O ' HD12 ' A' ' 33' ' ' LEU . 10.1 mm-40 -60.62 -43.27 97.66 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -65.21 -33.52 76.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.197 -0.94 . . . . 0.0 108.529 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' CG ' ' CE3' ' A' ' 35' ' ' TRP . 1.0 OUTLIER -66.17 -31.68 72.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.31 87.42 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.448 -0.782 . . . . 0.0 109.519 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -80.82 -7.12 59.34 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.672 -0.642 . . . . 0.0 109.878 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 45' ' ' VAL . . . 104.18 68.49 0.76 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.713 ' HA ' HG21 ' A' ' 45' ' ' VAL . 2.6 t90 -126.52 133.4 51.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -1.172 . . . . 0.0 109.664 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.658 HG12 ' H ' ' A' ' 38' ' ' SER . 39.3 t -89.6 132.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.604 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -63.88 -6.86 6.62 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.876 -1.14 . . . . 0.0 110.23 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.658 ' H ' HG12 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -44.55 -24.06 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 109.102 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.591 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER 68.96 28.27 5.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.563 -0.711 . . . . 0.0 109.8 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.633 ' CA ' ' CE1' ' A' ' 82' ' ' PHE . . . -127.06 10.51 6.98 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -159.26 27.1 0.2 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.11 -1.229 . . . . 0.0 109.861 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.96 HD21 HD11 ' A' ' 51' ' ' ILE . 6.6 tp -57.96 -65.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.121 -0.987 . . . . 0.0 109.049 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.66 -11.13 2.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.836 -0.54 . . . . 0.0 110.228 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -78.98 -39.06 35.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.97 -1.081 . . . . 0.0 109.723 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 35' ' ' TRP . 33.3 m -96.64 -15.26 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.466 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.65 63.92 6.18 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 4.0 Cg_exo -59.59 164.87 10.55 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.191 1.927 . . . . 0.0 110.39 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.11 54.75 24.72 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HG2' HG12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -152.26 162.98 40.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.589 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.599 ' HB3' ' CD1' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -139.04 159.75 41.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.462 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.96 HD11 HD21 ' A' ' 42' ' ' LEU . 3.7 mm -105.01 111.89 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.512 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -157.58 165.0 33.33 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.64 22.56 28.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 39.8 m-20 -97.28 145.44 26.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -1.141 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.51 HD12 HG21 ' A' ' 70' ' ' THR . 16.3 mm -65.54 143.74 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.896 ' CE2' HD12 ' A' ' 63' ' ' LEU . 86.0 t80 -117.89 86.35 2.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.302 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.2 p -70.39 -4.07 20.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 109.861 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.579 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 1.0 OUTLIER 76.89 62.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -48.09 -25.94 1.64 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.39 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.18 -58.6 2.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.409 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . 113.68 85.77 1.42 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.603 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 13.1 mttt -149.95 15.8 0.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -1.133 . . . . 0.0 109.588 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.896 HD12 ' CE2' ' A' ' 56' ' ' PHE . 48.5 mt -114.36 147.22 37.49 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.918 . . . . 0.0 109.161 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.877 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.4 Cg_endo -62.38 87.99 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.166 1.911 . . . . 0.0 110.182 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.32 -176.91 32.92 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -147.23 179.07 7.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -1.188 . . . . 0.0 109.51 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.7 t -60.51 142.21 55.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.424 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.47 -30.83 7.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.522 ' HG2' ' N ' ' A' ' 70' ' ' THR . 5.9 ttt180 -86.7 155.47 20.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 109.321 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.522 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 7.6 m -129.34 145.9 51.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 0.0 109.557 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.839 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 6.7 m95 -107.64 175.4 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.434 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.652 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 1.4 mmt180 -128.47 137.84 52.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.349 -0.844 . . . . 0.0 108.785 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.811 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -116.96 157.89 24.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.022 -1.049 . . . . 0.0 110.102 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.51 ' HB3' ' CG2' ' A' ' 88' ' ' ILE . . . -148.64 151.03 34.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -0.813 . . . . 0.0 109.129 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -73.03 131.15 41.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.697 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.826 HG21 ' CE1' ' A' ' 7' ' ' PHE . 20.5 mm -115.74 126.15 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.3 -0.875 . . . . 0.0 108.885 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER 68.6 117.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.033 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.427 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 2.5 t80 -170.44 125.21 0.73 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.136 -0.977 . . . . 0.0 109.586 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.01 -80.25 0.46 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.0 p -143.93 156.22 44.35 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.759 -0.588 . . . . 0.0 109.458 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.39 -167.9 17.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.633 ' CE1' ' CA ' ' A' ' 40' ' ' GLY . 1.5 m-85 -65.34 149.67 49.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -1.187 . . . . 0.0 109.264 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.603 ' CZ ' ' CB ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -46.99 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.076 -1.015 . . . . 0.0 109.133 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.77 179.89 3.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.606 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -108.21 11.59 27.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 63.4 m-20 -96.22 129.37 43.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.625 ' O ' HG22 ' A' ' 99' ' ' THR . 0.3 OUTLIER -155.68 156.09 34.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.213 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.059 HD11 ' CG2' ' A' ' 96' ' ' ILE . 18.9 tt -112.26 160.49 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.997 -1.064 . . . . 0.0 109.287 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.871 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.4 mm? -130.48 103.52 6.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.652 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 34.0 p90 -99.62 140.42 33.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.813 -1.18 . . . . 0.0 108.93 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -106.47 176.03 5.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.164 -0.96 . . . . 0.0 110.377 -178.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 p -65.47 -25.17 67.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.447 -0.783 . . . . 0.0 109.576 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.475 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 26.7 p-10 -89.65 17.57 6.34 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.58 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.79 26.04 7.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.659 -0.65 . . . . 0.0 110.291 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.877 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.0 mt -80.34 113.42 18.51 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.059 ' CG2' HD11 ' A' ' 88' ' ' ILE . 2.8 mt -106.82 119.88 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -1.0 . . . . 0.0 110.617 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.608 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 16.3 m-85 -122.89 117.45 25.62 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.519 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.44 147.06 24.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.981 -1.075 . . . . 0.0 110.21 -178.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -132.8 125.71 30.7 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.65 29.11 7.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.728 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -150.0 20.16 0.88 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.643 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER 79.06 68.83 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.389 -0.819 . . . . 0.0 110.073 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 8.1 m-85 54.44 17.5 1.61 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 110.153 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.475 ' CB ' ' OD2' ' A' ' 101' ' ' ASP . 3.9 mm-40 -92.54 -15.85 26.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 109.093 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.501 ' N ' ' OD2' ' A' ' 101' ' ' ASP . 40.8 m -144.54 147.13 32.83 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.603 ' CE1' ' HB2' ' A' ' 62' ' ' LYS . 75.5 m-85 -140.49 130.0 24.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.839 -1.163 . . . . 0.0 110.58 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.496 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 89.9 m -120.05 133.67 55.47 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.23 115.41 18.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -109.84 -83.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 109.536 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.608 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.283 0.563 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.94 99.76 9.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.423 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.8 m -71.6 -173.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -122.45 96.02 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 109.472 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -140.65 53.87 1.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.481 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -137.19 -170.58 2.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.842 ' CE1' HG21 ' A' ' 76' ' ' ILE . 46.2 m-85 -75.18 -58.66 3.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.269 -0.895 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.442 ' OD1' ' NH2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -71.09 -31.5 67.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.808 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.75 -52.27 30.38 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 14' ' ' LEU . 99.9 t -66.74 -42.79 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -1.131 . . . . 0.0 109.386 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 -38.18 73.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.44 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.9 m-20 -65.46 -55.67 16.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.563 -0.711 . . . . 0.0 109.224 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.688 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 53.7 t80 -58.55 -21.32 52.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 109.195 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.668 HD12 HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -74.99 -64.28 1.08 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.394 -0.816 . . . . 0.0 109.212 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -70.43 -5.62 29.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.021 . . . . 0.0 109.45 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 67.9 m -93.85 -67.08 0.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 109.662 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.688 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 78.2 m-85 -89.95 3.66 52.44 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.567 -0.708 . . . . 0.0 109.533 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER 43.75 51.75 6.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.721 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 7.8 ptmt 175.89 129.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.461 -0.774 . . . . 0.0 109.168 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.531 HD13 ' HD2' ' A' ' 24' ' ' TYR . 14.7 mt -44.04 161.06 0.22 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.139 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.577 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.5 Cg_exo -53.51 159.91 5.81 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.124 1.883 . . . . 0.0 110.403 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.75 -3.31 24.48 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.348 -0.845 . . . . 0.0 109.147 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -117.47 34.67 5.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.95 . . . . 0.0 109.61 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.615 ' CE1' ' CB ' ' A' ' 50' ' ' SER . 1.5 m-30 -115.34 90.83 3.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.544 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.2 pt -97.27 124.09 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.925 . . . . 0.0 109.14 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 25' ' ' ILE . 12.2 p -45.44 172.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 109.637 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.86 -42.36 73.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 109.087 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 t -53.98 -37.24 63.76 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.89 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -59.78 -44.28 93.99 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.632 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -61.49 -39.79 92.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.251 -0.906 . . . . 0.0 108.59 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.557 ' CG ' ' CE3' ' A' ' 35' ' ' TRP . 34.0 mt-30 -61.36 -34.86 76.0 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.27 -33.77 74.08 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.442 -0.786 . . . . 0.0 109.38 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.12 -13.74 58.39 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.653 -0.654 . . . . 0.0 109.997 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.471 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 111.74 46.06 0.8 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.632 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 2.9 t90 -106.8 133.13 51.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -1.191 . . . . 0.0 109.725 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.642 HG12 ' OD1' ' A' ' 41' ' ' ASN . 9.1 p -89.57 134.55 28.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.616 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -63.42 -5.26 3.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.898 -1.126 . . . . 0.0 110.618 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 17.7 p -45.97 -25.21 0.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.858 -1.152 . . . . 0.0 108.411 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.598 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 3.4 mttt 72.55 39.06 0.74 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.726 -0.609 . . . . 0.0 109.751 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.576 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -131.44 -28.61 0.63 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.373 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.642 ' OD1' HG12 ' A' ' 36' ' ' VAL . 3.2 p-10 -121.4 33.73 5.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.876 -1.367 . . . . 0.0 110.248 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.009 HD21 HD11 ' A' ' 51' ' ' ILE . 8.1 tp -60.34 -64.65 0.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.962 -1.087 . . . . 0.0 109.191 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.12 -10.05 5.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.735 -0.603 . . . . 0.0 110.158 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 41' ' ' ASN . 27.6 t70 -79.1 -28.66 43.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.018 -1.051 . . . . 0.0 109.6 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 34' ' ' GLY . 4.4 m -110.04 -13.87 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.67 68.11 12.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.65 155.74 51.87 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.206 1.938 . . . . 0.0 110.251 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.03 54.67 24.86 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' HG2' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -153.88 120.1 5.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -1.131 . . . . 0.0 109.469 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.615 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -91.53 166.11 13.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.593 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 1.009 HD11 HD21 ' A' ' 42' ' ' LEU . 2.3 mm -112.13 107.78 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 0.0 109.667 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -161.94 156.35 27.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.92 32.74 3.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.475 ' OD1' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -109.65 155.05 21.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -1.202 . . . . 0.0 109.403 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.0 mm -70.65 151.06 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.565 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.844 ' CE2' HD12 ' A' ' 63' ' ' LEU . 70.7 t80 -129.41 88.82 2.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 4.3 t -64.37 -10.17 22.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.091 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.587 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 49.4 t-20 65.04 52.24 1.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.537 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -54.55 -53.71 50.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.506 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -54.06 -41.95 68.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.99 58.07 2.41 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 3.4 mptm? -121.27 -7.95 9.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.342 -1.093 . . . . 0.0 109.565 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.844 HD12 ' CE2' ' A' ' 56' ' ' PHE . 11.2 mt -99.0 146.22 31.31 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.338 -0.851 . . . . 0.0 109.215 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.506 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 4.0 Cg_exo -60.93 104.19 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.156 1.904 . . . . 0.0 110.323 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA2' ' HD3' ' A' ' 69' ' ' ARG . . . -149.8 126.85 2.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 68' ' ' GLY . 6.8 mttt -90.44 170.35 10.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -1.176 . . . . 0.0 109.532 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.6 p -50.56 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 109.691 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 116.32 22.73 4.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.456 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -112.84 121.46 44.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -1.114 . . . . 0.0 109.404 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -96.81 -178.65 4.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.88 . . . . 0.0 109.563 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.772 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 18.9 m95 -149.22 171.03 17.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.61 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.629 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 93.4 mtt180 -131.99 151.92 51.45 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.667 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -126.72 152.47 46.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.992 -1.067 . . . . 0.0 110.469 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.489 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -148.06 151.5 35.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.754 . . . . 0.0 108.992 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -73.43 137.93 44.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.993 -1.067 . . . . 0.0 109.789 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.842 HG21 ' CE1' ' A' ' 7' ' ' PHE . 21.8 mm -116.99 112.15 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 108.89 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.2 t-20 74.02 123.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.15 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 78' ' ' TYR . 6.7 t80 -170.41 119.19 0.56 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.262 -0.899 . . . . 0.0 109.439 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.3 -43.9 2.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.124 -0.985 . . . . 0.0 109.561 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 173.63 169.1 0.18 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.613 -0.679 . . . . 0.0 109.444 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.96 -161.7 21.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -70.43 143.76 51.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -1.108 . . . . 0.0 109.685 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.662 ' HE ' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -40.73 142.13 0.49 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER -87.79 -176.45 5.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.181 -0.949 . . . . 0.0 109.752 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.92 3.89 19.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.801 . . . . 0.0 109.558 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.509 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 8.1 m-20 -89.68 128.93 36.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.107 -0.995 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.532 ' O ' ' CG2' ' A' ' 99' ' ' THR . 83.7 mtt180 -159.05 161.77 36.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.758 HD11 HG22 ' A' ' 96' ' ' ILE . 1.3 tt -122.93 153.06 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.13 -0.981 . . . . 0.0 109.672 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.732 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.8 mm? -118.88 120.65 37.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.565 -0.709 . . . . 0.0 109.217 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' A' ' 72' ' ' ARG . 1.7 p90 -113.91 138.36 50.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.851 -1.156 . . . . 0.0 109.011 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.469 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -107.67 172.87 6.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 110.295 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.5 p -66.41 -22.57 66.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.319 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 30.8 p-10 -89.59 16.4 7.84 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.571 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.65 30.39 6.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.755 -0.59 . . . . 0.0 110.316 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.744 HD22 ' HE1' ' A' ' 97' ' ' TYR . 7.4 mt -83.59 117.72 23.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 110' ' ' ARG . 2.5 mt -114.84 109.43 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.096 -1.003 . . . . 0.0 110.615 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.744 ' HE1' HD22 ' A' ' 95' ' ' LEU . 21.5 m-85 -112.93 120.75 42.49 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.58 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -88.81 152.19 21.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.903 -1.123 . . . . 0.0 110.359 -178.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -136.38 123.83 22.1 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.69 29.22 7.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.82 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -150.11 20.71 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.042 -1.036 . . . . 0.0 109.889 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 48.7 t-80 79.52 70.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.46 -0.775 . . . . 0.0 109.877 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.492 ' HE2' HD11 ' A' ' 89' ' ' LEU . 40.6 m-85 49.43 20.91 0.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 110.155 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.459 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . 2.7 mt-30 -91.88 -14.47 29.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 0.0 109.022 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.522 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 97.6 m -144.55 157.14 44.36 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.492 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 92.3 m-85 -146.84 121.64 9.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.894 -1.129 . . . . 0.0 110.242 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -115.13 130.4 56.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 109.018 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.67 113.67 16.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.049 -1.032 . . . . 0.0 109.411 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.697 HD11 HD11 ' A' ' 88' ' ' ILE . 2.4 pt -111.28 -25.65 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.642 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.9 ' HB2' HD12 ' A' ' 96' ' ' ILE . 1.3 mtt-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.56 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -113.26 143.14 44.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.434 ' H ' HG23 ' A' ' 3' ' ' VAL . 1.8 t -76.56 168.52 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 4' ' ' ILE . 3.6 mt -138.5 67.84 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.464 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -128.09 40.93 3.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.68 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -133.39 -175.17 3.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.639 ' CG ' HG21 ' A' ' 76' ' ' ILE . 31.6 m-85 -78.94 -47.91 15.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.34 -40.38 70.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.904 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.33 -51.79 35.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 6' ' ' THR . 41.2 t -63.29 -43.99 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.16 -1.2 . . . . 0.0 109.15 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' CB ' ' NH2' ' A' ' 110' ' ' ARG . . . -56.61 -39.35 73.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -55.64 27.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.594 -0.692 . . . . 0.0 109.154 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.679 ' CE1' ' CD2' ' A' ' 17' ' ' TYR . 12.6 t80 -57.6 -23.74 52.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.296 -0.877 . . . . 0.0 109.242 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 2.2 mt -71.45 -63.51 1.1 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.391 -0.818 . . . . 0.0 109.11 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -71.05 -4.99 27.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 109.414 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 48.4 m -91.2 -70.13 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.829 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.679 ' CD2' ' CE1' ' A' ' 13' ' ' TYR . 96.8 m-85 -89.91 -4.2 57.65 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.652 -0.655 . . . . 0.0 109.583 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER 57.04 51.74 10.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.671 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 172.34 129.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.565 -0.709 . . . . 0.0 109.101 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 20' ' ' LEU . 21.1 mt -45.47 148.52 1.19 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.207 -0.933 . . . . 0.0 108.995 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.1 Cg_exo -53.12 160.36 4.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.112 1.875 . . . . 0.0 110.474 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.61 -8.27 33.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.353 -0.842 . . . . 0.0 109.14 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 39.5 p30 -95.2 21.97 7.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.509 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.2 m-85 -114.77 84.14 2.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.761 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 26' ' ' THR . 1.8 pp -96.62 126.18 49.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.709 ' O ' HD12 ' A' ' 25' ' ' ILE . 16.9 p -46.9 174.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.626 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.51 -43.75 69.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.076 -1.015 . . . . 0.0 109.042 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.17 -38.99 69.03 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.787 ' O ' HD12 ' A' ' 33' ' ' LEU . 10.5 mm-40 -58.51 -39.25 79.57 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 25' ' ' ILE . . . -68.21 -36.61 79.81 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.536 ' HG3' ' CE3' ' A' ' 35' ' ' TRP . 25.5 mt-30 -60.74 -34.73 74.87 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.96 -34.86 70.39 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.28 -18.69 45.0 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.52 0.676 . . . . 0.0 110.002 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 116.04 38.56 0.95 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.626 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 10.9 t90 -100.85 121.86 42.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -1.156 . . . . 0.0 109.133 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.692 ' O ' HG13 ' A' ' 36' ' ' VAL . 10.6 p -89.94 113.11 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.285 -0.884 . . . . 0.0 108.962 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.581 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -63.99 -10.77 23.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.724 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.58 ' H ' HG22 ' A' ' 36' ' ' VAL . 15.7 m -76.28 -74.2 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.158 -0.964 . . . . 0.0 109.535 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.4 mttp -62.42 -29.55 70.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.451 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.12 64.94 2.61 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.671 ' OD1' HG12 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -111.77 43.47 1.54 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -1.151 . . . . 0.0 109.51 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.518 ' HA ' HD12 ' A' ' 42' ' ' LEU . 12.2 tp -54.35 -63.37 1.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.318 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -42.0 -25.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.436 -0.79 . . . . 0.0 110.147 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -79.89 -44.42 20.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.013 -1.054 . . . . 0.0 110.639 -179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 46' ' ' ALA . 33.6 m -94.72 -52.15 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.879 -1.138 . . . . 0.0 110.556 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.602 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -119.92 74.59 19.88 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.886 -1.134 . . . . 0.0 109.918 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -63.06 166.09 15.23 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.165 1.91 . . . . 0.0 110.263 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.479 ' O ' ' HD2' ' A' ' 49' ' ' LYS . . . 43.38 59.24 3.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -139.03 162.56 34.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 0.0 109.438 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 4.3 m -129.33 133.66 47.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.865 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.562 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 6.5 mm -96.41 107.56 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.058 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.6 171.2 33.61 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.46 71.25 1.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 10.2 m-20 -159.66 165.42 32.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -1.105 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.486 ' CD1' HG21 ' A' ' 70' ' ' THR . 23.7 mm -69.27 149.73 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.312 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.955 ' CE2' HD12 ' A' ' 63' ' ' LEU . 45.9 t80 -112.79 144.48 42.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.496 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.524 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 15.7 m -44.67 -86.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.43 -0.794 . . . . 0.0 109.939 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' ' 57' ' ' SER . 7.6 t-20 68.26 5.78 4.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.912 -0.493 . . . . 0.0 109.687 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -55.03 9.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.333 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -52.01 -43.48 63.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.404 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.07 66.04 0.39 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.61 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 2.0 mmmt -118.45 -11.56 9.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -1.163 . . . . 0.0 109.485 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.955 HD12 ' CE2' ' A' ' 56' ' ' PHE . 61.0 mt -122.25 148.66 52.76 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.416 -0.803 . . . . 0.0 108.933 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.723 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.7 Cg_endo -60.61 96.45 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.111 1.874 . . . . 0.0 110.037 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.96 162.28 38.82 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.495 ' HB2' ' NE ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -139.68 178.65 7.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -1.139 . . . . 0.0 109.494 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.2 m -70.26 94.27 0.91 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.72 59.61 2.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' CZ ' ' O ' ' A' ' 64' ' ' PRO . 21.0 ttp180 -131.84 143.36 50.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -1.157 . . . . 0.0 109.525 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.486 HG21 ' CD1' ' A' ' 55' ' ' ILE . 19.9 m -120.91 128.3 52.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.224 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.691 ' CE3' HD13 ' A' ' 63' ' ' LEU . 32.9 m95 -89.05 146.57 24.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.975 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.604 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 4.1 mtm180 -120.58 140.08 52.03 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.748 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -107.62 161.78 14.56 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.004 -1.06 . . . . 0.0 110.551 -178.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.621 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -145.93 148.16 32.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.515 -0.74 . . . . 0.0 109.183 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.3 m-20 -72.55 141.39 48.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.42 -0.8 . . . . 0.0 109.543 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.639 HG21 ' CG ' ' A' ' 7' ' ' PHE . 20.3 mm -135.78 137.46 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 71.62 38.72 0.95 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.479 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -69.62 136.93 51.81 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.327 -0.858 . . . . 0.0 109.576 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -129.64 -80.26 0.56 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.0 109.384 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.3 m -168.15 -178.06 3.53 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.697 -0.627 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 62.9 -155.56 41.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' CE2' ' O ' ' A' ' 38' ' ' SER . 3.3 m-85 -49.45 175.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -1.171 . . . . 0.0 109.57 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -60.62 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.392 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -122.86 -172.78 2.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.21 1.83 13.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.501 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 5.2 m-20 -109.06 131.37 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.981 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.1 OUTLIER -148.88 139.71 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.234 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.886 HD11 ' CG2' ' A' ' 96' ' ' ILE . 12.5 tt -99.57 142.82 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.047 -1.033 . . . . 0.0 109.587 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.748 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -115.2 114.48 25.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.368 -0.833 . . . . 0.0 109.469 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.613 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 5.0 p90 -108.72 138.5 44.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.823 -1.173 . . . . 0.0 108.739 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.571 ' HB3' ' CE2' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -111.49 177.27 4.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.904 -1.122 . . . . 0.0 110.761 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 p -65.84 -21.18 66.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.564 -0.71 . . . . 0.0 110.387 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 10.3 p-10 -89.01 13.43 12.92 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.181 -0.949 . . . . 0.0 108.95 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.559 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.6 OUTLIER 68.17 26.59 7.04 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.665 -0.647 . . . . 0.0 111.003 178.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.723 HD13 ' HG2' ' A' ' 64' ' ' PRO . 8.4 mt -87.67 130.37 34.82 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.886 ' CG2' HD11 ' A' ' 88' ' ' ILE . 9.5 mt -120.72 108.88 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 110.391 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 108' ' ' LYS . 15.1 m-85 -107.43 112.34 25.09 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.886 ' HE2' HG21 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -88.96 133.5 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.033 -1.042 . . . . 0.0 109.772 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -116.07 122.68 45.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 108.971 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.5 p -104.96 26.83 8.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.357 -0.84 . . . . 0.0 109.822 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.771 ' CG ' HG22 ' A' ' 105' ' ' THR . 22.2 p30 -149.72 25.98 0.84 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.088 -1.007 . . . . 0.0 109.624 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 12.2 t-80 76.14 74.16 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.462 ' OH ' ' NE ' ' A' ' 87' ' ' ARG . 3.7 m-85 42.15 29.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.743 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.436 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 3.3 mt-30 -99.64 -19.32 16.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.771 HG22 ' CG ' ' A' ' 101' ' ' ASP . 13.1 t -147.73 106.88 3.86 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.61 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 71.8 m-85 -93.04 125.39 37.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.127 -0.983 . . . . 0.0 110.387 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 2.6 m -112.93 125.93 54.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.401 -0.812 . . . . 0.0 108.949 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.49 ' HB2' ' CE1' ' A' ' 97' ' ' TYR . 8.9 ttmt -78.96 113.53 17.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.015 -1.053 . . . . 0.0 109.649 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.886 HG21 ' HE2' ' A' ' 98' ' ' LYS . 3.5 pt -116.05 -4.36 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.584 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.873 ' HG3' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.441 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.287 0.565 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 66.95 97.15 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 m -151.76 171.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.502 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.88 100.32 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -139.59 57.82 1.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.686 ' O ' HD12 ' A' ' 76' ' ' ILE . 79.2 p -142.58 -177.56 5.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.34 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' CE2' HG22 ' A' ' 100' ' ' THR . 34.2 m-85 -75.64 -57.22 4.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.93 -37.35 72.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.924 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.0 -50.76 56.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.664 HG12 HD12 ' A' ' 14' ' ' LEU . 84.9 t -64.21 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.51 75.15 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -55.54 15.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.513 -0.742 . . . . 0.0 109.039 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.677 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 42.7 t80 -60.2 -19.59 54.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 109.226 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.664 HD12 HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -76.62 -63.26 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.379 -0.826 . . . . 0.0 109.492 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 24.8 pt20 -70.53 -8.63 52.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.049 -1.032 . . . . 0.0 109.515 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.9 m -93.43 -62.43 1.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 109.782 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.677 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 30.3 m-85 -89.47 2.03 55.09 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.671 -0.643 . . . . 0.0 109.57 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER 42.99 46.97 4.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.297 -0.877 . . . . 0.0 109.669 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 5.1 pttt 177.73 129.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.485 -0.76 . . . . 0.0 109.147 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.946 HD11 ' OH ' ' A' ' 90' ' ' TYR . 18.4 mt -44.6 160.66 0.23 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.165 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.7 Cg_exo -53.52 158.86 7.15 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.038 1.825 . . . . 0.0 110.374 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -72.37 -3.86 26.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.165 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.66 7.84 28.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.614 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.715 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.6 m-30 -92.05 77.18 5.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -89.58 129.17 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.031 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.479 ' C ' HG23 ' A' ' 51' ' ' ILE . 28.6 p -44.29 169.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.0 109.447 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.842 ' HG2' HG21 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -67.62 -47.09 70.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.093 -1.005 . . . . 0.0 109.109 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -53.81 -37.13 63.22 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.67 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.2 mt-10 -59.03 -40.9 86.42 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.497 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -66.99 -35.34 79.73 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.611 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 2.7 mm-40 -62.42 -34.07 76.03 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.37 -36.92 83.76 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.67 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.7 mp -81.01 -5.57 57.75 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.73 -0.606 . . . . 0.0 110.255 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.885 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 105.94 62.39 0.62 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.612 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 10.7 t90 -131.54 118.92 20.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -1.156 . . . . 0.0 109.046 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 38' ' ' SER . 39.2 t -90.86 110.16 21.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.184 -0.948 . . . . 0.0 108.872 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -48.56 -22.97 0.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.273 -0.892 . . . . 0.0 109.63 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.542 ' H ' HG12 ' A' ' 36' ' ' VAL . 3.3 m -105.73 55.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.919 . . . . 0.0 109.626 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -149.44 -50.94 0.15 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.489 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.413 ' HA3' ' CD1' ' A' ' 82' ' ' PHE . . . 95.71 10.26 56.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.521 ' O ' HG22 ' A' ' 45' ' ' VAL . 9.8 p-10 -95.26 31.11 2.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -1.147 . . . . 0.0 109.844 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 51' ' ' ILE . 11.0 tp -52.53 -66.86 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.118 -0.989 . . . . 0.0 109.214 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.37 -14.87 3.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.482 -0.761 . . . . 0.0 109.932 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -79.46 -33.98 41.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.989 . . . . 0.0 110.017 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.885 HG11 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -100.12 -53.7 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.158 -0.964 . . . . 0.0 109.648 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -113.81 80.13 4.96 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.485 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 1.8 Cg_endo -62.88 164.79 17.97 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.227 1.951 . . . . 0.0 110.466 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 42.41 50.65 5.57 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 5.0 mmtp -145.78 103.71 3.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -1.15 . . . . 0.0 109.509 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.542 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 2.0 m -89.89 159.22 17.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.842 HG21 ' HG2' ' A' ' 27' ' ' LYS . 2.3 mm -99.63 134.7 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.51 149.39 11.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.11 27.69 4.98 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 3.4 m-20 -96.33 145.33 25.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -1.185 . . . . 0.0 109.471 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.507 HD13 ' HA ' ' A' ' 55' ' ' ILE . 15.8 mm -65.68 145.03 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.567 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.885 ' CE2' HD12 ' A' ' 63' ' ' LEU . 71.6 t80 -121.4 90.02 3.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 0.0 109.186 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 11.7 p -70.15 -4.98 23.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.859 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.584 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 3.9 t-20 73.97 57.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.631 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -49.5 -40.46 37.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -84.65 -67.89 0.76 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.291 -0.881 . . . . 0.0 109.413 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.32 63.54 0.35 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.6 ' HB3' ' CD1' ' A' ' 106' ' ' PHE . 6.1 mmtt -127.57 -3.17 6.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.137 -1.213 . . . . 0.0 109.598 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.885 HD12 ' CE2' ' A' ' 56' ' ' PHE . 57.5 mt -91.1 146.8 34.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.962 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.1 Cg_endo -62.17 155.67 54.97 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.096 1.864 . . . . 0.0 110.22 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.4 -174.03 21.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.63 166.31 11.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -1.11 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.9 m -64.87 107.07 1.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.452 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.52 0.94 9.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.533 ' HG2' ' N ' ' A' ' 70' ' ' THR . 62.3 ttt180 -86.68 155.38 20.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -1.194 . . . . 0.0 109.494 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.533 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -109.62 153.49 24.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.91 . . . . 0.0 109.451 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.803 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 5.4 m95 -129.2 173.31 10.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.621 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -122.24 143.37 49.64 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.754 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -126.56 151.04 48.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.86 -1.15 . . . . 0.0 110.408 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.487 ' HB2' ' OH ' ' A' ' 90' ' ' TYR . . . -143.16 148.84 37.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.801 . . . . 0.0 109.196 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.476 ' OD2' ' HB ' ' A' ' 51' ' ' ILE . 0.9 OUTLIER -76.2 132.59 40.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.686 HD12 ' O ' ' A' ' 6' ' ' THR . 19.4 mm -110.83 134.54 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 7.2 m-20 64.13 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.912 . . . . 0.0 109.457 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 46.2 t80 -170.59 129.82 0.84 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.275 -0.891 . . . . 0.0 109.493 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.0 -80.04 0.62 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.349 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.88 165.53 35.92 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.715 -0.616 . . . . 0.0 109.421 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.38 -151.56 19.94 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.413 ' CD1' ' HA3' ' A' ' 40' ' ' GLY . 2.9 m-85 -68.76 -172.29 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -1.098 . . . . 0.0 109.478 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' NH1' ' HA ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -72.56 -152.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.06 -177.68 5.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.376 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -116.48 15.86 15.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.584 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 14.6 m-20 -111.59 130.63 55.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -154.18 152.31 30.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 109.424 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.048 HD11 ' CG2' ' A' ' 96' ' ' ILE . 4.0 tt -113.31 138.32 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.272 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.754 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.3 mm? -109.8 116.14 31.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.35 -0.843 . . . . 0.0 109.869 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.946 ' OH ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -104.78 143.1 33.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.829 -1.169 . . . . 0.0 108.922 178.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.523 ' OG ' ' CZ ' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -106.58 172.58 6.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.177 -0.952 . . . . 0.0 110.316 -179.158 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 94.7 p -64.67 -24.92 67.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.844 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.479 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 36.8 p-10 -89.73 18.93 5.05 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.423 -0.798 . . . . 0.0 108.926 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.585 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.62 28.12 7.51 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.689 -0.632 . . . . 0.0 110.286 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.962 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.0 mt -79.87 106.71 12.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.048 ' CG2' HD11 ' A' ' 88' ' ' ILE . 1.6 mt -104.41 111.66 34.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.101 -1.0 . . . . 0.0 110.823 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.514 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 20.4 m-85 -111.61 154.9 24.18 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -122.69 141.54 51.66 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.771 -1.205 . . . . 0.0 109.489 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -129.68 120.1 24.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.207 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.505 HG22 ' CE2' ' A' ' 7' ' ' PHE . 44.2 p -104.72 28.54 6.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.44 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -148.12 22.71 1.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 109.481 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 30.1 t-80 77.15 79.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.357 -0.839 . . . . 0.0 109.631 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 11.6 m-85 44.53 53.51 7.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.627 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -120.43 -80.81 0.63 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.0 109.215 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.0 p -89.93 105.36 17.76 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.6 ' CD1' ' HB3' ' A' ' 62' ' ' LYS . 79.6 m-85 -96.28 125.63 40.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.882 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.482 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 56.3 m -111.83 136.4 51.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.432 -0.792 . . . . 0.0 108.956 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -80.06 125.77 30.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.529 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.5 pt -129.96 12.19 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.495 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 56.78 -174.29 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.456 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.74 139.94 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 109.478 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' A' ' 13' ' ' TYR . 3.5 mp -119.4 82.45 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -138.19 41.71 2.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.247 -0.908 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 10' ' ' VAL . 11.7 p -128.46 -168.09 1.86 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.77 ' CD1' HG21 ' A' ' 76' ' ' ILE . 58.2 m-85 -77.44 -51.99 9.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.53 -40.71 69.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.838 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.466 ' C ' HG23 ' A' ' 4' ' ' ILE . . . -67.34 -51.27 38.75 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 6' ' ' THR . 58.8 t -64.13 -43.23 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -1.151 . . . . 0.0 109.32 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.18 76.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.434 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -62.07 -55.32 30.2 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.532 -0.73 . . . . 0.0 109.3 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.494 ' HB2' HG21 ' A' ' 4' ' ' ILE . 26.2 t80 -57.69 -24.62 57.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.401 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.5 mt -71.55 -62.55 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.038 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -70.93 -5.5 31.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.119 -0.988 . . . . 0.0 109.428 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 54.1 m -91.49 -69.9 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.943 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 96.6 m-85 -89.7 -5.98 56.53 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.631 -0.668 . . . . 0.0 109.63 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER 58.15 58.06 3.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -0.85 . . . . 0.0 109.769 179.667 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER 163.99 129.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 53' ' ' GLY . 19.9 mt -45.69 147.14 1.63 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.123 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.566 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.3 Cg_exo -53.06 163.24 2.26 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.2 1.934 . . . . 0.0 110.733 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.07 -7.34 34.92 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 109.144 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -92.29 7.2 43.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.473 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 50' ' ' SER . 3.5 m-85 -103.34 83.56 2.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.199 -0.938 . . . . 0.0 109.75 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pt -95.62 126.73 48.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 25' ' ' ILE . 28.0 p -47.95 176.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.087 -1.008 . . . . 0.0 109.607 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.43 -46.36 64.05 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.381 -0.927 . . . . 0.0 109.162 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.17 -36.63 61.11 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.797 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.3 mm-40 -60.42 -41.13 93.33 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HB1' HD11 ' A' ' 42' ' ' LEU . . . -67.75 -33.14 74.27 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -62.12 -37.59 85.7 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.66 -35.75 68.75 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.461 -0.774 . . . . 0.0 109.586 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -81.16 -19.37 43.57 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.652 -0.655 . . . . 0.0 110.357 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.636 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 118.2 45.42 0.49 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.669 ' CH2' ' HB2' ' A' ' 37' ' ' ALA . 15.6 t90 -110.55 120.74 43.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -1.131 . . . . 0.0 109.272 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.437 HG12 ' H ' ' A' ' 38' ' ' SER . 38.7 t -90.41 110.73 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.347 -0.846 . . . . 0.0 109.098 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.669 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . -64.15 -17.51 63.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.609 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.437 ' H ' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -77.9 -48.78 15.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.463 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.541 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.6 mmmt -84.03 -8.09 59.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.418 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 47.93 83.6 0.02 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 1.2 p-10 -136.34 45.84 2.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -1.118 . . . . 0.0 109.507 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.496 ' HA ' HD12 ' A' ' 42' ' ' LEU . 9.1 tp -60.54 -50.86 71.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 0.0 109.258 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -62.8 -10.75 14.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 0.0 109.674 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 41' ' ' ASN . 9.8 t0 -92.95 -33.99 13.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 110.161 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 34' ' ' GLY . 34.0 m -110.72 -50.44 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.998 -1.064 . . . . 0.0 110.125 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.612 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -124.42 70.74 55.35 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.969 -1.082 . . . . 0.0 109.829 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.7 Cg_endo -63.29 -179.76 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.168 1.912 . . . . 0.0 110.242 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 40.75 55.99 3.17 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 17.3 mmtt -141.17 160.09 40.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -1.112 . . . . 0.0 109.637 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.585 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 67.0 m -127.64 138.55 52.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.468 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 27' ' ' LYS . 10.4 mm -102.17 105.3 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 108.967 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -160.3 179.47 35.8 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.466 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 91.81 -4.55 78.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.53 ' OD1' ' CG ' ' A' ' 73' ' ' GLU . 7.5 p30 -93.57 163.17 13.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -1.123 . . . . 0.0 109.348 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.539 HG23 HG22 ' A' ' 70' ' ' THR . 22.4 mt -59.58 159.42 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.516 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.923 ' CE2' HD12 ' A' ' 63' ' ' LEU . 6.4 t80 -101.54 145.85 28.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.859 . . . . 0.0 109.332 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 49.1 m -42.54 -87.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.406 -0.809 . . . . 0.0 109.807 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 57' ' ' SER . 2.2 t-20 79.89 13.95 0.96 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.59 -52.38 47.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.36 -0.837 . . . . 0.0 109.423 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.02 -49.9 11.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.67 61.37 0.56 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 5.8 mmtm -94.93 -12.38 26.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -1.196 . . . . 0.0 109.45 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.923 HD12 ' CE2' ' A' ' 56' ' ' PHE . 42.8 mt -94.68 143.88 26.96 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.0 109.04 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.78 ' HG2' HD13 ' A' ' 95' ' ' LEU . 1.8 Cg_endo -62.89 84.09 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.001 1.8 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.84 154.44 22.19 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -98.2 168.0 10.51 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.139 -1.212 . . . . 0.0 109.486 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 m -60.23 130.96 49.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.519 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.26 -30.29 9.36 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.72 131.6 35.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -1.178 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -98.64 179.95 4.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.516 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.686 ' CE3' HD13 ' A' ' 63' ' ' LEU . 5.7 m95 -131.82 169.3 16.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.646 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 21.2 mmt180 -120.74 136.64 54.82 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.354 -0.841 . . . . 0.0 108.78 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.784 ' HA ' HD13 ' A' ' 89' ' ' LEU . 17.1 pt-20 -118.94 162.13 19.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.985 . . . . 0.0 110.386 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -152.85 147.84 26.48 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -71.51 140.8 50.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.618 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.77 HG21 ' CD1' ' A' ' 7' ' ' PHE . 25.4 mm -134.16 130.82 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.1 m-20 73.27 37.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.464 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 23.3 t80 -69.47 136.82 52.01 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.282 -0.886 . . . . 0.0 109.609 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.34 -79.66 0.38 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.246 -0.909 . . . . 0.0 109.377 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.76 175.71 4.45 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.67 -0.643 . . . . 0.0 109.405 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 72.64 73.74 0.83 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 39' ' ' LYS . 3.6 m-85 56.35 164.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -1.134 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -49.11 171.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.43 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -108.08 -173.83 2.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 109.246 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.32 -8.54 20.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 109.744 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.5 m-20 -91.33 128.66 37.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.599 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.646 ' O ' HG22 ' A' ' 99' ' ' THR . 5.4 mtt180 -158.15 150.66 22.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 109.242 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.774 ' C ' HD22 ' A' ' 89' ' ' LEU . 4.6 tt -108.68 149.81 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.949 -1.094 . . . . 0.0 109.937 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.784 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -122.33 106.99 11.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.437 -0.789 . . . . 0.0 109.462 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.646 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 22.3 p90 -101.91 140.79 35.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.89 -1.131 . . . . 0.0 109.082 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.526 ' HB2' ' CH2' ' A' ' 71' ' ' TRP . 5.3 t -105.98 174.19 5.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.267 -0.896 . . . . 0.0 110.292 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 p -66.07 -21.79 66.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.579 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.484 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 25.0 p-10 -89.56 16.02 8.45 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.441 -0.787 . . . . 0.0 108.898 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.578 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.1 m95 67.26 29.76 7.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.689 -0.632 . . . . 0.0 110.774 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.78 HD13 ' HG2' ' A' ' 64' ' ' PRO . 10.0 mt -87.3 118.01 26.45 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.671 HG22 HD11 ' A' ' 88' ' ' ILE . 3.3 mt -109.33 113.52 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.505 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 16.7 m-85 -113.01 113.12 25.02 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.27 131.64 35.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.045 -1.034 . . . . 0.0 109.977 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 87' ' ' ARG . 1.1 t -115.56 123.81 49.43 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.501 -0.749 . . . . 0.0 108.995 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.4 p -108.95 30.48 6.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.793 . . . . 0.0 109.395 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 17.6 p-10 -150.0 19.16 0.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.389 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 2.2 t-80 79.46 68.51 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.43 -0.794 . . . . 0.0 109.509 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.528 ' OH ' ' CZ ' ' A' ' 87' ' ' ARG . 10.0 m-85 49.41 22.62 0.73 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.652 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.408 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -94.67 -18.14 21.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 99' ' ' THR . 23.1 m -150.18 108.51 3.78 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 86.2 m-85 -95.25 128.73 42.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.165 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 8.2 m -114.17 128.16 56.24 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.385 -0.822 . . . . 0.0 108.836 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -79.11 121.05 24.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.377 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.562 HD11 HD11 ' A' ' 88' ' ' ILE . 2.1 pt -117.45 -39.06 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.64 ' HB2' HD12 ' A' ' 96' ' ' ILE . 3.8 mtt-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.503 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.67 101.95 9.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.0 m -112.39 -174.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.849 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 4' ' ' ILE . 15.0 mm -90.36 82.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.388 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -129.9 52.87 1.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.8 p -145.6 178.07 8.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.647 ' CD2' HG21 ' A' ' 76' ' ' ILE . 24.3 m-85 -74.56 -53.0 10.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.04 -35.39 71.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 0.0 109.966 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.25 -51.58 31.99 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 6' ' ' THR . 21.7 t -67.46 -38.29 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -1.168 . . . . 0.0 109.414 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.1 88.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.3 OUTLIER -64.42 -55.15 22.89 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.578 -0.701 . . . . 0.0 109.134 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 27.3 t80 -60.48 -21.36 62.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.173 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.1 mt -73.02 -63.46 1.17 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.776 . . . . 0.0 109.242 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -70.94 -8.69 54.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.039 . . . . 0.0 109.403 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 52.9 m -88.98 -67.71 0.82 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 110.032 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 89.5 m-85 -89.44 -2.74 58.49 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.569 -0.707 . . . . 0.0 109.538 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER 53.47 53.72 11.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.375 -0.828 . . . . 0.0 109.762 179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 166.72 129.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.462 HD11 ' OH ' ' A' ' 90' ' ' TYR . 65.1 mt -44.05 147.48 0.92 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.219 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.567 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 7.8 Cg_exo -53.02 162.89 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.247 1.965 . . . . 0.0 110.516 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -69.33 -6.68 31.2 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.326 -0.859 . . . . 0.0 109.01 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -93.73 7.22 45.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 109.483 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 2.0 m-85 -97.18 99.79 11.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.104 -0.997 . . . . 0.0 109.555 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pt -107.82 118.61 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 108.986 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.488 ' C ' HG23 ' A' ' 51' ' ' ILE . 21.5 p -45.52 170.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 109.37 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -65.56 -45.29 83.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.095 -1.003 . . . . 0.0 109.088 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -54.36 -39.5 67.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.081 -1.012 . . . . 0.0 108.299 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.716 ' O ' HD12 ' A' ' 33' ' ' LEU . 21.1 mt-10 -59.38 -39.97 85.03 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.678 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.18 -34.52 77.71 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.206 -0.934 . . . . 0.0 108.643 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -63.98 -35.29 80.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.38 -34.77 72.83 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.37 -0.831 . . . . 0.0 109.265 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.716 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.3 -15.83 54.29 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.424 0.631 . . . . 0.0 110.276 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 110.8 36.6 1.84 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.678 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 4.9 t90 -101.69 123.31 45.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.181 -1.188 . . . . 0.0 109.135 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 39' ' ' LYS . 21.2 t -89.41 119.18 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 108.776 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.595 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -66.85 -35.23 79.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.194 -0.941 . . . . 0.0 109.795 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -43.17 63.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 0.0 109.564 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 6.5 mttt -83.18 -8.23 59.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 109.61 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 39' ' ' LYS . . . 46.14 96.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 35' ' ' TRP . 47.3 p-10 -146.14 43.22 1.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -1.182 . . . . 0.0 109.686 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.533 ' CD1' ' HB1' ' A' ' 30' ' ' ALA . 8.5 tp -66.32 -52.02 51.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.307 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -55.21 -16.62 3.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.751 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -87.21 -52.96 5.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 110.289 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 46' ' ' ALA . 21.7 m -94.68 -47.7 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.044 -1.035 . . . . 0.0 110.316 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.679 ' HB1' ' HG3' ' A' ' 49' ' ' LYS . . . -115.78 78.6 7.18 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 109.776 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -63.19 154.32 68.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.188 1.925 . . . . 0.0 110.191 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 43.1 63.68 1.96 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.679 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 6.8 mmtm -134.63 117.19 15.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -1.166 . . . . 0.0 109.405 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.1 m -90.01 128.05 36.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.869 . . . . 0.0 109.622 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.581 HG21 ' HG2' ' A' ' 27' ' ' LYS . 6.5 mm -91.21 105.9 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.144 -0.973 . . . . 0.0 108.999 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.27 169.46 32.11 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.32 36.53 4.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -128.02 170.71 12.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.178 . . . . 0.0 109.31 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.668 HD12 HG21 ' A' ' 70' ' ' THR . 32.4 mm -70.23 150.34 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.845 ' CE2' HD12 ' A' ' 63' ' ' LEU . 13.5 t80 -102.84 149.48 24.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.141 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 8.8 m -50.17 -90.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.519 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.557 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 23.4 t-20 67.6 20.3 9.68 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.602 -0.686 . . . . 0.0 109.465 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -57.46 -47.93 80.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 109.362 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.84 -34.54 30.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.826 . . . . 0.0 109.395 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.16 66.23 0.6 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -97.09 -4.93 38.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -1.195 . . . . 0.0 109.523 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.845 HD12 ' CE2' ' A' ' 56' ' ' PHE . 64.3 mt -115.02 153.67 47.12 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.102 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.75 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.7 Cg_endo -61.57 86.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.2 1.933 . . . . 0.0 110.155 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.64 173.16 31.71 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -128.73 -172.9 2.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -1.113 . . . . 0.0 109.401 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.04 128.21 35.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.528 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.51 -6.86 57.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.517 ' HG2' ' N ' ' A' ' 70' ' ' THR . 7.6 ttt180 -98.68 151.36 20.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -1.18 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.668 HG21 HD12 ' A' ' 55' ' ' ILE . 39.0 m -125.71 146.88 49.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.692 ' CE3' HD13 ' A' ' 63' ' ' LEU . 10.3 m95 -112.23 157.62 20.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.689 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.647 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 12.0 mmt180 -115.38 140.85 48.76 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 108.667 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.799 ' HA ' HD13 ' A' ' 89' ' ' LEU . 2.3 pp20? -115.67 156.16 26.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 110.167 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.701 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -142.81 150.37 39.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 0.0 109.421 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.521 ' HA ' ' CD ' ' A' ' 87' ' ' ARG . 3.6 m-20 -71.97 142.34 49.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.5 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.647 HG21 ' CD2' ' A' ' 7' ' ' PHE . 21.6 mm -136.74 145.23 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 110.004 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.01 15.4 8.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.822 . . . . 0.0 109.823 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.528 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 14.6 t80 -69.61 114.71 8.07 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.095 -1.003 . . . . 0.0 109.628 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.3 m -119.67 -79.65 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.271 -0.893 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 p -148.62 166.49 28.14 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.72 -0.612 . . . . 0.0 109.392 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.12 -179.34 52.86 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' CZ ' ' C ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -46.48 165.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -1.146 . . . . 0.0 109.489 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' CZ ' ' CB ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -54.09 176.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -0.981 . . . . 0.0 109.405 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 5.1 p30 -115.53 -168.58 1.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.3 p -116.0 13.64 15.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.319 -0.863 . . . . 0.0 109.424 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.551 ' OD2' HG22 ' A' ' 100' ' ' THR . 1.1 m-20 -102.59 126.87 49.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.627 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.547 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -145.6 143.33 29.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.47 -0.769 . . . . 0.0 109.168 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.938 HD11 ' CG2' ' A' ' 96' ' ' ILE . 3.9 tt -109.51 134.85 50.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.862 -1.149 . . . . 0.0 109.089 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.4 mm? -106.75 111.34 23.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 109.992 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.701 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 2.8 p90 -101.69 141.91 33.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.053 -1.029 . . . . 0.0 108.402 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -106.43 172.43 6.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.049 -1.032 . . . . 0.0 110.633 -178.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.4 p -66.57 -21.95 66.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.472 -0.768 . . . . 0.0 109.522 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.481 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 36.6 p-10 -89.48 16.3 7.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.567 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 68.12 28.57 6.55 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.658 -0.651 . . . . 0.0 110.471 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.75 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.9 mt -85.65 112.32 20.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.938 ' CG2' HD11 ' A' ' 88' ' ' ILE . 2.0 mt -100.79 125.41 54.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.031 -1.043 . . . . 0.0 110.469 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.536 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 8.1 m-85 -122.89 159.18 28.75 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -131.29 142.18 50.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.757 -1.214 . . . . 0.0 110.024 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -130.13 127.59 40.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.103 -0.998 . . . . 0.0 108.948 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.551 HG22 ' OD2' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -106.18 12.34 30.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.536 ' CG ' ' HG1' ' A' ' 105' ' ' THR . 0.0 OUTLIER -132.16 24.6 4.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.166 -0.959 . . . . 0.0 109.494 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.7 t-80 76.43 75.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 109.824 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.573 ' HA ' ' CE1' ' A' ' 106' ' ' PHE . 14.5 m-85 52.21 60.96 3.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 109.624 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -135.08 -71.33 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.29 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.536 ' HG1' ' CG ' ' A' ' 101' ' ' ASP . 1.2 p -89.45 92.59 9.18 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 83.8 m-85 -89.45 110.08 20.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.238 -0.914 . . . . 0.0 110.03 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 57.3 m -102.82 139.84 37.87 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 2.3 tttt -85.05 125.12 32.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.569 -0.707 . . . . 0.0 109.491 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.64 -10.07 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.418 179.84 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -90.67 119.94 31.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.907 HG23 ' OD1' ' A' ' 5' ' ' ASN . 4.2 m -92.67 164.81 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.474 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 13' ' ' TYR . 5.3 mt -91.17 85.9 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.938 . . . . 0.0 109.421 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.907 ' OD1' HG23 ' A' ' 3' ' ' VAL . 5.1 p-10 -136.89 59.28 1.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.123 -0.986 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.619 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -148.05 -167.44 2.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 109.472 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.755 ' CD1' HG21 ' A' ' 76' ' ' ILE . 38.2 m-85 -77.41 -59.95 2.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.356 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.78 -31.68 68.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.813 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.425 ' C ' HG23 ' A' ' 4' ' ' ILE . . . -67.92 -54.4 18.21 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.593 HG23 ' H ' ' A' ' 6' ' ' THR . 59.0 t -63.11 -41.72 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.361 -1.082 . . . . 0.0 109.002 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.96 -35.67 73.54 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.402 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.3 OUTLIER -64.91 -56.36 13.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.501 -0.749 . . . . 0.0 109.204 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.634 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 30.7 t80 -60.82 -20.14 61.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.186 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.4 mt -73.6 -62.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.833 . . . . 0.0 109.299 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -71.5 -8.95 57.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.928 -1.107 . . . . 0.0 109.405 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 87.7 m -89.49 -66.07 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.153 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 82.4 m-85 -88.99 -6.53 57.16 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.512 -0.743 . . . . 0.0 109.417 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.51 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER 57.28 55.56 5.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.764 179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 2.5 pttt 160.93 129.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.746 HD11 ' OH ' ' A' ' 90' ' ' TYR . 36.0 mt -44.53 147.45 1.04 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.023 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.537 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.5 Cg_exo -54.11 162.91 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.021 1.814 . . . . 0.0 110.586 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.91 -7.16 32.29 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.396 -0.815 . . . . 0.0 109.04 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -92.61 6.55 46.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.648 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 50' ' ' SER . 1.7 m-85 -100.61 81.93 2.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.758 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.4 pt -92.7 127.36 44.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 25' ' ' ILE . 43.4 p -48.1 176.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 109.351 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.726 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -70.81 -46.84 62.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 0.0 109.238 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -53.3 -35.8 60.53 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.095 -1.003 . . . . 0.0 108.46 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.7 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -59.39 -41.22 88.88 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -68.17 -36.26 79.34 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.6 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 6.5 mt-30 -61.14 -32.64 72.35 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.62 -34.16 72.41 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.344 -0.848 . . . . 0.0 109.587 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.6 mp -81.29 -16.27 52.99 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.426 0.631 . . . . 0.0 110.051 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.28 40.38 0.88 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.609 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 11.1 t90 -105.06 117.26 33.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -1.137 . . . . 0.0 109.329 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.446 ' HB ' ' HG3' ' A' ' 39' ' ' LYS . 43.5 t -89.94 110.8 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.852 . . . . 0.0 108.705 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.578 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -48.87 -50.38 35.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.792 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -54.92 -61.31 2.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.926 . . . . 0.0 109.923 -179.724 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' CB ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 mtpp -42.8 -43.58 4.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 109.79 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA3' ' CZ ' ' A' ' 82' ' ' PHE . . . 80.04 38.24 19.64 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.5 ' OD1' ' CB ' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -113.11 44.35 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -1.116 . . . . 0.0 109.325 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.707 HD21 HD11 ' A' ' 51' ' ' ILE . 12.1 tp -58.94 -63.68 1.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 109.647 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.72 -14.45 0.92 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.717 -0.614 . . . . 0.0 110.566 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.1 -36.2 41.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.846 -1.159 . . . . 0.0 110.114 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.8 m -110.4 -0.33 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.929 -1.107 . . . . 0.0 110.008 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -150.99 61.08 4.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 4.8 Cg_exo -59.63 152.28 63.67 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.065 1.843 . . . . 0.0 110.213 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.18 55.4 21.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.574 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 14.8 mttm -135.56 176.36 8.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -1.184 . . . . 0.0 109.72 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.579 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 70.3 m -146.07 136.44 23.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.33 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.726 HD12 ' HA ' ' A' ' 27' ' ' LYS . 11.5 mm -99.37 106.97 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 109.037 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.71 168.18 35.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.33 -7.5 51.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.47 160.57 26.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.117 -1.225 . . . . 0.0 109.37 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.497 ' HA ' HD13 ' A' ' 55' ' ' ILE . 12.7 mm -70.07 144.81 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 109.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.824 ' CE2' HD12 ' A' ' 63' ' ' LEU . 13.5 t80 -89.21 144.13 26.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 17.5 t -43.54 -89.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.878 . . . . 0.0 109.609 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 57' ' ' SER . 2.4 t-20 78.61 16.33 1.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.621 -0.675 . . . . 0.0 109.436 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 -45.08 80.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.349 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -81.51 -67.99 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.422 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.46 54.35 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 3.8 mptp? -90.28 -10.75 43.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -1.124 . . . . 0.0 109.484 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.824 HD12 ' CE2' ' A' ' 56' ' ' PHE . 58.7 mt -100.56 149.97 36.57 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 108.931 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.852 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.1 Cg_exo -59.04 85.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.052 1.835 . . . . 0.0 110.359 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' HA2' ' HD2' ' A' ' 69' ' ' ARG . . . -162.92 142.4 7.86 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.99 -171.6 3.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -1.143 . . . . 0.0 109.5 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -69.42 142.33 53.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.477 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.55 -15.29 60.59 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HD2' ' HA2' ' A' ' 65' ' ' GLY . 7.9 ttt180 -84.91 156.38 21.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -1.131 . . . . 0.0 109.609 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' A' ' 71' ' ' TRP . 0.0 OUTLIER -125.7 178.95 5.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.475 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.684 ' CE3' HD13 ' A' ' 63' ' ' LEU . 9.5 m95 -147.71 169.47 19.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -125.03 136.67 53.91 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.764 ' HA ' HD13 ' A' ' 89' ' ' LEU . 20.1 pt-20 -114.67 152.28 32.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.033 . . . . 0.0 110.296 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.633 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -141.11 152.45 44.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 109.298 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.469 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 1.1 m-20 -73.44 139.08 45.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 109.324 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.755 HG21 ' CD1' ' A' ' 7' ' ' PHE . 22.2 mm -132.26 137.73 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.944 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 1.4 m-20 72.53 9.71 5.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 0.0 110.186 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -69.83 143.45 52.88 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.083 -1.01 . . . . 0.0 109.606 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.8 p -139.58 -58.85 0.57 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.58 163.29 12.29 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.76 -0.588 . . . . 0.0 109.518 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 82' ' ' PHE . . . 82.97 -178.9 53.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.439 ' CZ ' ' O ' ' A' ' 39' ' ' LYS . 3.1 m-85 -45.59 159.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -1.19 . . . . 0.0 109.391 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -70.33 160.74 31.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.928 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.79 -167.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.332 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.65 28.11 8.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 109.714 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 2.2 m-20 -109.68 127.5 54.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.118 -0.989 . . . . 0.0 109.659 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.565 ' O ' HG23 ' A' ' 99' ' ' THR . 5.9 mtt180 -157.38 145.14 18.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 109.592 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.972 HD11 ' CG2' ' A' ' 96' ' ' ILE . 4.4 tt -102.69 132.39 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 109.084 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -103.61 103.16 13.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 109.577 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.746 ' OH ' HD11 ' A' ' 20' ' ' LEU . 7.2 p90 -98.22 141.31 31.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 108.86 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.494 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -105.15 168.93 8.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.151 -0.968 . . . . 0.0 110.392 -178.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.6 p -65.13 -20.41 66.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.494 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 24.8 p-10 -89.69 17.6 6.36 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.459 -0.776 . . . . 0.0 108.911 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.566 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.04 27.71 6.93 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.762 -0.586 . . . . 0.0 110.438 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.852 HD13 ' HG2' ' A' ' 64' ' ' PRO . 8.8 mt -86.52 102.58 14.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.972 ' CG2' HD11 ' A' ' 88' ' ' ILE . 3.0 mt -94.25 121.81 45.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.18 -0.95 . . . . 0.0 110.71 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.636 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 7.8 m-85 -121.09 164.02 17.47 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.565 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -135.8 144.65 45.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.83 -1.169 . . . . 0.0 109.81 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -132.01 129.66 40.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -0.891 . . . . 0.0 109.126 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 p -119.66 27.51 8.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.615 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 10.5 p30 -146.25 22.59 1.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.935 . . . . 0.0 109.466 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.554 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.9 t-80 80.22 70.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.519 -0.738 . . . . 0.0 109.315 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' ' 102' ' ' HIS . 18.8 m-85 42.85 26.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.666 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 102' ' ' HIS . 3.7 mm-40 -93.62 -17.5 23.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 108.958 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.0 m -149.61 138.24 20.88 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.593 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 96.5 m-85 -124.01 136.02 54.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.979 . . . . 0.0 110.035 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.441 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.4 m -126.01 137.07 53.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.801 . . . . 0.0 109.024 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -79.72 134.79 36.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.107 -0.995 . . . . 0.0 109.688 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.447 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 2.0 pt -142.4 57.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 0.0 109.403 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.464 ' OXT' HD12 ' A' ' 96' ' ' ILE . 1.6 mtm-85 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.468 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.14 115.25 27.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.374 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 4' ' ' ILE . 4.7 t -137.85 172.23 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.577 ' H ' HG12 ' A' ' 3' ' ' VAL . 1.1 mp -107.74 86.99 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.454 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -140.59 58.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 0.0 109.362 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.821 ' H ' HG23 ' A' ' 10' ' ' VAL . 4.5 p -142.33 -167.27 2.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.597 ' CD1' HG21 ' A' ' 76' ' ' ILE . 31.4 m-85 -76.99 -61.44 1.98 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.146 -0.971 . . . . 0.0 109.186 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.43 -33.47 69.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 109.83 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.7 -55.02 15.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.821 HG23 ' H ' ' A' ' 6' ' ' THR . 95.7 t -63.04 -40.11 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -1.119 . . . . 0.0 108.926 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.488 ' HB1' ' HG3' ' A' ' 110' ' ' ARG . . . -59.48 -35.85 74.9 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.08 -56.74 10.0 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 35.0 t80 -54.58 -25.96 29.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.222 -0.924 . . . . 0.0 108.73 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 3.3 mt -69.52 -60.31 2.41 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -70.81 -5.33 29.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.025 . . . . 0.0 109.492 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 m -90.73 -70.91 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.859 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 68.7 m-85 -89.79 -4.78 57.47 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.67 -0.644 . . . . 0.0 109.642 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER 57.6 57.19 4.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.9 . . . . 0.0 109.356 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 7.2 ptmt 166.24 130.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 20' ' ' LEU . 20.0 mt -43.16 147.26 0.72 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.266 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 8.2 Cg_exo -53.27 164.13 2.05 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.199 1.933 . . . . 0.0 110.463 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.48 -4.94 29.37 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.362 -0.836 . . . . 0.0 108.975 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.498 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -95.05 11.09 33.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.64 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.561 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 5.7 m-85 -105.48 92.94 4.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 109.845 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 30' ' ' ALA . 1.3 pp -104.01 127.78 57.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.513 ' O ' HD12 ' A' ' 25' ' ' ILE . 68.7 p -48.94 178.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.51 -48.4 55.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.026 -1.046 . . . . 0.0 109.566 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -53.46 -37.03 62.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.125 -0.984 . . . . 0.0 108.512 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.794 ' O ' HD12 ' A' ' 33' ' ' LEU . 18.7 mt-10 -59.88 -39.97 87.09 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB2' HD11 ' A' ' 25' ' ' ILE . . . -69.69 -32.56 71.24 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.478 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 2.6 mt-30 -65.86 -30.69 71.34 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.44 76.44 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.457 -0.777 . . . . 0.0 109.362 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -80.96 -11.27 59.6 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.479 0.657 . . . . 0.0 109.978 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.7 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 106.02 53.75 0.74 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.636 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 1.6 t90 -108.97 135.96 49.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -1.131 . . . . 0.0 109.555 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.475 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 6.1 t -89.75 128.26 41.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.636 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -60.82 -11.1 6.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.988 -1.07 . . . . 0.0 110.275 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -45.75 -25.28 0.47 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.921 -1.112 . . . . 0.0 109.146 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.581 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 8.2 mttt 72.83 29.96 1.81 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.374 -0.829 . . . . 0.0 109.591 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.601 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -127.89 9.31 6.76 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.031 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -158.62 35.11 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.973 -1.31 . . . . 0.0 109.988 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 51' ' ' ILE . 6.0 tp -66.96 -63.53 1.04 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 108.935 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.94 -10.45 2.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.823 -0.548 . . . . 0.0 110.143 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -35.19 44.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 109.741 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.7 HG11 ' O ' ' A' ' 34' ' ' GLY . 33.3 m -98.49 -48.12 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.158 -0.964 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB1' ' HD3' ' A' ' 49' ' ' LYS . . . -117.45 77.03 10.07 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.295 -0.878 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.472 ' O ' ' HD2' ' A' ' 49' ' ' LYS . 3.0 Cg_endo -60.41 155.25 47.93 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.235 1.956 . . . . 0.0 110.326 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.53 63.83 4.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.689 ' HD3' ' HB1' ' A' ' 46' ' ' ALA . 3.2 mptt -140.44 155.01 46.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -1.111 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 48.9 m -133.91 123.51 24.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.401 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.553 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 6.6 mm -81.15 105.46 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.019 -1.051 . . . . 0.0 109.017 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -150.65 172.8 30.34 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.522 -1.323 . . . . 0.0 109.851 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.95 10.72 62.44 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 4.4 m-20 -83.34 143.46 30.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -1.121 . . . . 0.0 109.403 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.439 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 13.6 mm -69.57 136.22 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 109.457 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.667 ' CE1' ' CD1' ' A' ' 103' ' ' TYR . 73.9 t80 -111.39 91.16 3.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.393 -0.817 . . . . 0.0 109.29 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 0.2 OUTLIER -70.09 -4.84 23.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.826 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.594 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 5.6 t-20 77.06 70.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 109.626 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -41.5 65.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -0.916 . . . . 0.0 109.331 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -89.54 -65.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.38 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . 114.2 49.93 0.52 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.7 -2.07 16.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -1.131 . . . . 0.0 109.545 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.884 HD22 ' CZ3' ' A' ' 71' ' ' TRP . 4.2 mt -95.13 146.64 31.68 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.205 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 2.4 Cg_endo -62.26 84.55 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.026 1.818 . . . . 0.0 109.837 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.3 -164.98 32.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.35 -165.84 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -1.124 . . . . 0.0 109.352 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.9 m -70.18 101.89 1.97 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 0.0 109.468 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.03 55.95 8.66 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.801 HH22 HD12 ' A' ' 95' ' ' LEU . 13.0 ttt180 -108.13 152.5 24.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -1.185 . . . . 0.0 109.349 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.406 HG21 HD12 ' A' ' 55' ' ' ILE . 19.8 m -122.0 133.52 54.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.884 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 11.9 m95 -102.65 172.85 6.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.634 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 3.6 mtt180 -127.79 132.92 49.44 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' CD ' ' HB2' ' A' ' 54' ' ' ASP . 2.1 pt-20 -116.59 146.82 42.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.906 -1.121 . . . . 0.0 110.627 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.545 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -137.04 148.04 46.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 2.0 m-20 -72.49 122.63 21.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.794 HD12 ' O ' ' A' ' 6' ' ' THR . 30.5 mm -110.69 137.73 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 70.74 122.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 109.25 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.446 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 2.2 t80 -170.13 110.24 0.4 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.02 -78.73 0.58 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.88 155.29 32.65 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.701 -0.624 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.05 -160.09 14.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.601 ' CE1' ' HA3' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -66.63 155.77 36.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -1.154 . . . . 0.0 109.507 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NE ' ' HD3' ' A' ' 39' ' ' LYS . 12.1 mtm180 -51.75 -178.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.35 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.514 ' O ' ' NH2' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -120.53 -167.98 1.56 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.46 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.5 p -127.55 18.67 6.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 109.565 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.473 ' OD2' ' HA ' ' A' ' 100' ' ' THR . 4.3 m-20 -105.12 129.72 53.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 109.387 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 5.5 mmt180 -146.99 140.81 25.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.56 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.071 HD11 ' CG2' ' A' ' 96' ' ' ILE . 3.3 tt -93.34 129.18 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 108.82 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.49 HD22 ' N ' ' A' ' 89' ' ' LEU . 4.6 mm? -101.11 93.69 5.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 110.194 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 38.2 p90 -91.5 139.85 30.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.889 -1.132 . . . . 0.0 108.652 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -105.47 170.36 7.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.097 -1.002 . . . . 0.0 110.722 -178.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.9 -22.38 66.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 109.6 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 14.5 p-10 -89.79 18.8 5.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.602 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 69.22 26.54 5.4 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.817 -0.552 . . . . 0.0 110.244 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.856 HD22 ' HE1' ' A' ' 97' ' ' TYR . 6.7 mt -82.32 92.6 6.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.071 ' CG2' HD11 ' A' ' 88' ' ' ILE . 12.8 mt -90.64 112.41 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 110.372 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.856 ' HE1' HD22 ' A' ' 95' ' ' LEU . 20.1 m-85 -114.03 167.14 10.92 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.541 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -137.28 130.14 30.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.951 -1.093 . . . . 0.0 109.655 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -119.76 119.07 32.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 109.26 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.473 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 21.1 p -104.16 22.17 15.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.523 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.6 OUTLIER -138.46 22.64 2.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.494 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.534 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 7.1 t-80 77.8 73.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 109.455 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.667 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 34.5 m-85 43.02 43.96 3.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.802 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.43 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 2.2 mm-40 -117.14 -17.01 10.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.249 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' THR . 51.9 m -150.38 94.97 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.332 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.552 ' CE1' ' HA ' ' A' ' 103' ' ' TYR . 14.1 m-85 -90.63 116.76 28.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.747 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 90.4 m -107.86 139.49 42.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.276 -0.89 . . . . 0.0 108.8 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -79.3 127.99 32.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 109.605 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.429 ' CG2' ' HE2' ' A' ' 98' ' ' LYS . 1.5 pt -112.75 -42.04 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.572 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.618 ' CG ' HD12 ' A' ' 96' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.491 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.24 0.543 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.97 142.19 31.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.543 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 m -146.9 -173.66 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.455 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mt -113.18 93.75 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.501 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -141.99 61.77 1.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.623 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -147.75 -175.19 4.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.538 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.639 ' CD1' HG21 ' A' ' 76' ' ' ILE . 25.2 m-85 -73.79 -56.73 4.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.509 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -31.4 67.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.972 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.18 -55.39 9.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.623 HG23 ' H ' ' A' ' 6' ' ' THR . 38.8 t -65.83 -40.64 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -1.133 . . . . 0.0 109.296 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.0 85.94 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.34 -55.01 36.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.544 -0.723 . . . . 0.0 109.101 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.681 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 35.5 t80 -59.09 -21.96 60.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.267 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.553 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.7 mt -73.1 -61.16 1.91 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 0.0 109.337 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.57 -9.18 57.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.005 -1.06 . . . . 0.0 109.591 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.2 m -89.62 -65.28 1.03 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.681 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 71.9 m-85 -89.18 -11.36 44.0 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.582 -0.698 . . . . 0.0 109.24 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.47 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 19.1 m170 61.01 53.72 3.6 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.369 -0.832 . . . . 0.0 109.491 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 7.1 pttm 166.97 129.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD11 ' OH ' ' A' ' 90' ' ' TYR . 37.7 mt -44.94 151.74 0.61 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.155 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.57 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.2 Cg_exo -54.6 163.42 3.83 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.147 1.898 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -7.24 33.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.332 -0.855 . . . . 0.0 109.001 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.27 31.82 2.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.526 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.57 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.3 m-85 -121.9 82.45 1.95 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 0.0 109.776 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.5 pt -92.26 128.71 43.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.301 -0.875 . . . . 0.0 108.684 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 25' ' ' ILE . 18.5 p -47.23 174.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.139 -0.975 . . . . 0.0 109.26 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.614 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.73 -43.68 68.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.193 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -55.34 -38.81 69.23 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.153 -0.967 . . . . 0.0 108.464 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 33' ' ' LEU . 5.5 mm-40 -57.84 -40.61 80.46 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.554 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.02 -37.34 83.96 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 4.6 mt-30 -60.98 -32.66 72.21 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.19 -36.88 81.08 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.359 -0.838 . . . . 0.0 109.717 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -81.03 -8.73 59.84 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.65 -0.656 . . . . 0.0 110.318 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.849 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 106.54 51.55 0.8 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.668 ' CH2' ' HB2' ' A' ' 37' ' ' ALA . 9.3 t90 -118.37 124.46 47.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -1.115 . . . . 0.0 109.052 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 39' ' ' LYS . 4.8 t -90.64 113.02 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.153 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.668 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . -67.27 -16.43 64.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.45 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -89.47 -13.38 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.437 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -113.7 -9.84 13.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 109.492 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.57 65.54 3.1 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 45' ' ' VAL . 6.9 p-10 -120.82 43.11 2.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -1.187 . . . . 0.0 109.496 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.551 HD11 ' HB1' ' A' ' 30' ' ' ALA . 10.5 tp -63.1 -57.56 10.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.397 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -49.48 -20.61 0.75 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -37.44 23.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 0.0 110.355 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.849 HG11 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -106.98 -54.34 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.005 -1.059 . . . . 0.0 110.101 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 1.043 ' HB1' ' HG3' ' A' ' 49' ' ' LYS . . . -113.38 80.06 4.33 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.114 -0.991 . . . . 0.0 109.699 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 2.1 Cg_endo -62.16 156.57 49.48 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.238 1.959 . . . . 0.0 110.333 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.53 56.39 4.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 1.043 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 5.3 mmtp -127.79 119.86 26.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -1.13 . . . . 0.0 109.446 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -89.74 137.55 32.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.327 -0.858 . . . . 0.0 109.48 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.551 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 5.3 mm -104.27 113.9 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 108.922 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.55 173.03 40.45 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.92 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.11 6.26 55.85 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.438 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 1.7 m-20 -87.09 148.33 25.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -1.204 . . . . 0.0 109.39 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.5 mm -67.77 139.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.61 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.873 ' CE2' HD12 ' A' ' 63' ' ' LEU . 62.8 t80 -101.7 92.32 4.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.333 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 6.0 p -70.24 -4.67 22.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 109.748 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 1.2 t-20 71.48 89.41 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 109.527 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -49.57 -36.63 24.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 109.413 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -124.65 -70.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.344 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.43 72.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.599 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 35.6 mttm -116.08 -7.7 11.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -1.152 . . . . 0.0 109.591 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.873 HD12 ' CE2' ' A' ' 56' ' ' PHE . 63.6 mt -93.64 148.36 35.28 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.209 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.701 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.5 Cg_exo -60.1 84.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.109 1.873 . . . . 0.0 110.186 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -96.22 167.5 25.07 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -148.28 -170.8 3.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -1.131 . . . . 0.0 109.364 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 t -67.29 96.01 0.46 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.453 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.79 57.84 2.0 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.517 ' NH1' ' OD2' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -125.94 136.92 53.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -1.138 . . . . 0.0 109.582 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.16 160.32 19.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.629 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 19.9 m95 -132.41 172.17 12.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.73 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.634 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 65.1 mtt180 -136.94 148.65 47.09 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.761 ' HA ' HD13 ' A' ' 89' ' ' LEU . 9.1 pt-20 -124.1 158.67 31.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.048 -1.032 . . . . 0.0 110.467 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -148.76 152.3 36.33 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.4 m-20 -78.67 131.83 36.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.107 -0.996 . . . . 0.0 109.516 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.639 HG21 ' CD1' ' A' ' 7' ' ' PHE . 30.3 mm -116.7 124.42 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.545 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 76' ' ' ILE . 20.7 m-20 69.5 118.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.483 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -170.57 138.94 1.53 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.291 -0.88 . . . . 0.0 109.549 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.67 -79.74 0.49 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.084 -1.01 . . . . 0.0 109.478 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.52 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 1.6 p -140.98 171.1 14.53 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.79 -176.34 54.59 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -48.98 167.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -1.169 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -68.55 -179.87 1.49 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.932 . . . . 0.0 109.609 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -110.0 -172.77 2.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.91 . . . . 0.0 109.405 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -108.17 10.94 27.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 109.581 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 82.0 m-20 -100.37 128.03 46.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.661 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 99' ' ' THR . 0.1 OUTLIER -152.39 158.24 42.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.787 . . . . 0.0 109.164 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.779 HD11 HG22 ' A' ' 96' ' ' ILE . 1.6 tt -118.42 146.33 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.014 -1.054 . . . . 0.0 109.345 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.761 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.2 mm? -117.93 113.14 21.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.463 -0.773 . . . . 0.0 109.68 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 2.5 p90 -105.99 140.39 39.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.842 -1.161 . . . . 0.0 108.934 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.479 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -107.49 174.93 5.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.915 . . . . 0.0 110.444 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -23.34 66.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 109.815 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.517 ' OD2' ' NH1' ' A' ' 69' ' ' ARG . 42.6 p30 -89.62 16.58 7.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.424 -0.797 . . . . 0.0 108.969 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.568 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.94 27.66 7.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.769 -0.582 . . . . 0.0 110.522 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.701 HD13 ' HG2' ' A' ' 64' ' ' PRO . 14.5 mt -83.66 114.96 21.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.779 HG22 HD11 ' A' ' 88' ' ' ILE . 4.8 mt -111.2 107.65 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 110.574 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.532 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 26.5 m-85 -106.97 117.84 35.12 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -89.19 145.27 25.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 109.924 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -130.49 122.63 28.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 0.0 109.09 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.613 HG23 ' HE2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -110.95 30.66 6.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.633 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.5 OUTLIER -150.21 21.88 0.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER 78.73 73.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.405 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 26.8 m-85 43.78 26.22 0.12 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.392 -0.818 . . . . 0.0 109.682 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -97.05 -18.17 19.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.001 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.47 ' HB ' ' OD2' ' A' ' 101' ' ' ASP . 24.1 m -143.27 142.89 31.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.599 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 86.7 m-85 -133.65 123.77 25.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.086 -1.009 . . . . 0.0 110.267 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -114.18 132.44 56.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.497 -0.752 . . . . 0.0 109.0 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -79.5 109.36 13.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 109.54 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 1.1 pt -125.38 65.78 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.483 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 72.6 mtm180 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.314 0.578 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -179.25 140.26 0.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.53 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 2' ' ' GLN . 2.5 m -156.1 153.99 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.473 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.624 HG21 ' HG3' ' A' ' 21' ' ' PRO . 3.1 mp -132.48 87.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.524 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -143.0 53.87 1.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.649 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -144.63 -176.23 4.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.547 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.645 ' CE1' HG21 ' A' ' 76' ' ' ILE . 31.4 m-85 -75.86 -57.9 3.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 0.0 109.556 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -31.65 67.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.937 . . . . 0.0 109.901 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.95 -52.87 21.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.649 HG23 ' H ' ' A' ' 6' ' ' THR . 46.6 t -67.1 -46.95 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -1.117 . . . . 0.0 109.332 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.61 -38.06 68.95 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -55.1 28.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.482 -0.761 . . . . 0.0 109.093 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 18.0 t80 -62.53 -17.67 60.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.318 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.549 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.4 mt -75.75 -63.37 1.32 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.444 -0.785 . . . . 0.0 109.252 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.476 ' O ' ' CE1' ' A' ' 18' ' ' HIS . 0.0 OUTLIER -70.78 -11.56 61.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.98 -1.075 . . . . 0.0 109.412 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.3 m -89.74 -64.45 1.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.962 . . . . 0.0 110.069 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.689 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 67.7 m-85 -89.48 -0.16 57.3 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.458 -0.776 . . . . 0.0 109.568 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER 47.91 47.16 18.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.295 -0.878 . . . . 0.0 109.685 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 14.4 ptmt 173.85 128.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 20' ' ' LEU . 23.0 mt -45.94 147.89 1.58 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.154 -0.966 . . . . 0.0 109.022 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.624 ' HG3' HG21 ' A' ' 4' ' ' ILE . 7.5 Cg_exo -53.56 160.42 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.016 1.811 . . . . 0.0 110.469 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.07 -10.32 29.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.258 -0.901 . . . . 0.0 108.981 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 50.9 p30 -92.18 20.68 5.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.588 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.566 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.9 m-85 -115.96 87.79 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 109.725 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.2 pt -99.23 123.15 51.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.299 -0.876 . . . . 0.0 108.735 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.482 ' HB ' ' OD2' ' A' ' 54' ' ' ASP . 19.8 p -45.99 172.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 109.501 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.643 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -67.26 -45.5 76.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.0 -1.062 . . . . 0.0 109.029 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -39.5 67.31 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.834 ' O ' HD12 ' A' ' 33' ' ' LEU . 18.8 mt-10 -59.37 -38.54 80.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.636 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.37 -38.68 85.15 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.097 -1.002 . . . . 0.0 108.544 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 27.4 mt-30 -60.37 -35.39 75.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.1 -34.83 70.6 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.305 -0.872 . . . . 0.0 109.335 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.43 -18.09 46.56 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.694 -0.629 . . . . 0.0 110.271 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 1.021 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 115.64 36.36 1.18 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.636 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 9.5 t90 -100.3 122.35 42.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -1.174 . . . . 0.0 109.122 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 38' ' ' SER . 41.1 t -89.77 110.46 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.161 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -60.33 -14.24 17.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.579 ' H ' HG12 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -78.32 -63.19 1.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.55 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 29.9 mttp -80.36 0.61 32.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.664 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 44.42 84.08 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 35' ' ' TRP . 56.8 p30 -122.44 44.46 2.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.208 -1.172 . . . . 0.0 109.503 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.565 HD11 ' HB1' ' A' ' 30' ' ' ALA . 6.2 tp -62.45 -46.26 89.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.469 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -61.96 -11.32 12.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.867 . . . . 0.0 109.877 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.45 -51.37 4.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.13 -0.981 . . . . 0.0 109.983 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.021 HG11 ' O ' ' A' ' 34' ' ' GLY . 28.9 m -91.7 -47.3 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.851 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.606 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -118.96 76.59 14.74 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 109.433 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.7 Cg_endo -63.46 155.15 64.17 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.234 1.956 . . . . 0.0 110.562 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 42.74 70.24 0.53 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.577 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 3.7 mmpt? -142.01 160.36 40.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.258 -1.142 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 3.0 m -124.16 130.37 52.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.889 . . . . 0.0 109.398 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 27' ' ' LYS . 17.5 mm -93.12 104.61 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.158 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -158.38 168.2 34.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.82 -15.85 51.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.482 ' OD2' ' HB ' ' A' ' 26' ' ' THR . 3.4 m-20 -79.95 148.41 31.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -1.199 . . . . 0.0 109.331 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 56' ' ' PHE . 14.0 mt -51.54 166.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.366 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.813 ' CE2' HD12 ' A' ' 63' ' ' LEU . 9.0 t80 -106.88 145.83 31.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.537 ' OG ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -45.52 -88.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.671 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 57' ' ' SER . 1.0 OUTLIER 78.36 20.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.622 -0.673 . . . . 0.0 109.374 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -74.25 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.397 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -62.78 -35.92 81.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.384 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.45 77.07 1.23 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.566 ' CB ' ' CE2' ' A' ' 106' ' ' PHE . 12.8 mmtt -102.17 -9.01 20.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -1.144 . . . . 0.0 109.51 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.813 HD12 ' CE2' ' A' ' 56' ' ' PHE . 44.2 mt -105.38 157.23 34.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.968 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.642 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.8 Cg_endo -61.84 84.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.005 1.803 . . . . 0.0 109.63 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.435 ' C ' ' HG2' ' A' ' 66' ' ' LYS . . . -93.7 164.39 26.52 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.435 ' HG2' ' C ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -138.44 -148.75 0.27 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -1.151 . . . . 0.0 109.444 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 t -61.02 102.61 0.21 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.452 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.65 72.18 0.43 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.817 HH22 HD12 ' A' ' 95' ' ' LEU . 3.5 ttt180 -114.96 149.48 37.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -1.13 . . . . 0.0 109.568 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.54 171.85 7.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.622 ' CE3' HD13 ' A' ' 63' ' ' LEU . 15.0 m95 -141.13 157.56 45.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.638 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 28.8 mtp180 -119.07 129.29 55.01 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.742 ' HA ' HD13 ' A' ' 89' ' ' LEU . 12.4 pt-20 -106.3 151.08 25.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.053 -1.029 . . . . 0.0 110.22 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.668 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -138.66 150.97 46.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.46 -0.775 . . . . 0.0 109.111 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.4 OUTLIER -74.41 136.92 42.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.052 -1.03 . . . . 0.0 109.573 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.645 HG21 ' CE1' ' A' ' 7' ' ' PHE . 22.1 mm -120.31 123.32 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.231 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 72.04 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.269 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 78' ' ' TYR . 8.6 t80 -170.39 141.5 1.99 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.144 -0.973 . . . . 0.0 109.537 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.01 -78.81 0.19 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -144.58 161.2 39.71 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.642 -0.661 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.38 -175.32 34.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CE1' ' O ' ' A' ' 39' ' ' LYS . 1.1 m-85 -55.02 179.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -1.177 . . . . 0.0 109.405 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -175.8 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.44 179.88 3.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.4 m -110.96 8.47 22.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.753 ' OD1' HG22 ' A' ' 100' ' ' THR . 25.5 m-20 -108.94 128.53 55.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.106 -0.996 . . . . 0.0 109.384 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 3.6 mmt180 -143.03 169.94 16.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 109.289 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.0 HD11 ' CG2' ' A' ' 96' ' ' ILE . 3.9 tt -134.15 129.64 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.026 -1.046 . . . . 0.0 108.598 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.793 HD22 ' N ' ' A' ' 89' ' ' LEU . 3.1 mm? -104.87 104.23 13.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.668 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 10.2 p90 -96.31 139.07 32.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.939 -1.101 . . . . 0.0 108.459 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.483 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -100.72 170.88 8.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 -178.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 p -65.22 -21.85 66.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.41 -0.806 . . . . 0.0 109.311 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 27.4 p-10 -89.87 18.08 6.05 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.581 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.1 m95 68.21 29.89 5.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.281 0.562 . . . . 0.0 110.165 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.817 HD12 HH22 ' A' ' 69' ' ' ARG . 6.9 mt -85.17 97.53 9.95 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.0 ' CG2' HD11 ' A' ' 88' ' ' ILE . 3.5 mt -90.24 118.66 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.118 -0.989 . . . . 0.0 110.468 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 108' ' ' LYS . 9.0 m-85 -117.32 158.4 24.44 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 7.3 ptpt -126.29 153.38 44.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.943 -1.098 . . . . 0.0 109.428 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.5 OUTLIER -140.66 118.28 11.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.445 -0.785 . . . . 0.0 109.115 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.753 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -101.81 25.56 8.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.594 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.926 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.0 OUTLIER -142.66 18.74 2.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 109.417 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 4.3 t-80 78.2 85.82 0.07 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.379 -0.826 . . . . 0.0 109.981 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' HIS . 33.9 m-85 41.61 27.13 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.385 -0.822 . . . . 0.0 110.067 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.525 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 7.1 tp60 -89.13 -71.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.927 . . . . 0.0 108.982 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.926 HG22 ' OD1' ' A' ' 101' ' ' ASP . 14.2 t -97.61 164.1 12.56 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CE2' ' CB ' ' A' ' 62' ' ' LYS . 92.3 m-85 -145.45 121.15 10.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.914 -1.116 . . . . 0.0 109.947 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 2.0 m -118.28 133.47 55.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 0.0 109.322 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 3.6 ttpm? -79.63 131.92 36.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.435 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 110' ' ' ARG . 1.3 pt -119.8 -45.59 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.888 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.501 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -111.54 96.78 6.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.401 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -51.66 134.46 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.5 105.53 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -146.1 62.63 1.24 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.404 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.687 ' O ' HD12 ' A' ' 76' ' ' ILE . 1.7 p -145.08 -175.55 4.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.803 ' CE1' HG21 ' A' ' 76' ' ' ILE . 41.7 m-85 -79.57 -54.4 5.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.718 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -33.6 69.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 0.0 110.01 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.27 -53.03 23.78 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.541 HG23 ' H ' ' A' ' 6' ' ' THR . 41.5 t -66.76 -38.85 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.336 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.657 ' HB3' HH21 ' A' ' 110' ' ' ARG . . . -59.53 -39.82 85.17 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.438 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.6 OUTLIER -64.55 -55.45 20.42 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.471 -0.768 . . . . 0.0 109.163 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.556 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 19.6 t80 -59.53 -20.36 54.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.275 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -75.58 -64.38 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.199 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -70.75 -5.55 30.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.976 -1.077 . . . . 0.0 109.34 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 56.2 m -94.29 -66.45 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 109.562 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.556 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 83.3 m-85 -89.86 3.46 52.9 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.705 -0.622 . . . . 0.0 109.439 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER 44.76 48.76 8.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.573 179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 17.5 pttt 175.17 129.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.479 -0.763 . . . . 0.0 109.159 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.852 HD11 ' OH ' ' A' ' 90' ' ' TYR . 30.1 mt -47.14 149.01 1.82 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.207 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.9 Cg_exo -53.54 161.82 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.045 1.83 . . . . 0.0 110.422 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -68.73 -7.43 33.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.084 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -92.43 11.15 27.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 109.529 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.568 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 3.2 m-85 -105.11 90.26 3.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.753 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.1 pp -99.29 123.6 52.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 25' ' ' ILE . 44.5 p -47.9 176.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.21 -47.98 59.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.107 -0.996 . . . . 0.0 109.104 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 m -53.51 -38.85 64.11 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' O ' HD12 ' A' ' 33' ' ' LEU . 26.8 mm-40 -57.85 -41.07 81.62 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.593 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -66.69 -33.91 76.69 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.444 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 1.7 mt-30 -62.53 -34.65 77.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.01 72.75 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.466 -0.771 . . . . 0.0 109.592 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.5 mp -80.78 -15.89 55.23 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.451 0.643 . . . . 0.0 110.134 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 113.89 40.31 1.0 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.675 ' HB2' HG21 ' A' ' 45' ' ' VAL . 11.1 t90 -106.88 118.92 37.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -1.176 . . . . 0.0 109.244 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 38' ' ' SER . 16.0 t -89.87 111.92 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.844 . . . . 0.0 108.966 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -54.64 -18.3 4.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.955 . . . . 0.0 109.729 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -81.46 -35.57 30.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.765 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.3 mmtp -90.28 -10.7 43.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.805 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 42.96 39.6 3.8 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.451 ' C ' ' ND2' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -94.28 44.06 1.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.149 -1.206 . . . . 0.0 109.774 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 42' ' ' LEU . 10.2 tp -59.09 -55.25 37.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.33 -19.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.108 -0.995 . . . . 0.0 110.091 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -96.56 -29.48 13.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.094 . . . . 0.0 110.762 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 35' ' ' TRP . 32.3 m -103.44 -52.57 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.819 -1.175 . . . . 0.0 110.3 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.613 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -127.05 66.19 66.64 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.945 -1.097 . . . . 0.0 109.46 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.475 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 2.1 Cg_endo -62.02 168.27 9.29 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.218 1.946 . . . . 0.0 110.353 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 50.67 45.82 47.67 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -130.52 163.14 27.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -1.198 . . . . 0.0 109.507 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 42.8 m -129.41 126.1 38.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.421 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.532 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 7.2 mm -90.18 106.56 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.142 -0.974 . . . . 0.0 108.907 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.81 169.73 34.64 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.06 -9.31 50.55 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.507 ' OD1' ' CG ' ' A' ' 73' ' ' GLU . 2.6 p30 -86.25 145.23 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -1.139 . . . . 0.0 109.507 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 56' ' ' PHE . 37.4 mm -49.78 161.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.146 -0.971 . . . . 0.0 109.419 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.01 ' CE2' HD12 ' A' ' 63' ' ' LEU . 14.5 t80 -101.33 143.11 31.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.388 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.8 t -56.15 -85.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.426 -0.796 . . . . 0.0 109.664 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.629 ' ND2' ' HA2' ' A' ' 61' ' ' GLY . 1.2 t30 80.63 48.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -68.01 -68.54 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -60.75 -42.96 98.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.629 ' HA2' ' ND2' ' A' ' 58' ' ' ASN . . . 102.01 63.61 0.74 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 2.7 mttt -97.73 -6.28 33.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -1.147 . . . . 0.0 109.636 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.01 HD12 ' CE2' ' A' ' 56' ' ' PHE . 31.7 mt -101.01 142.75 25.24 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.21 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.98 ' HG2' HD13 ' A' ' 95' ' ' LEU . 1.9 Cg_endo -62.92 107.77 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.045 1.83 . . . . 0.0 110.096 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 69' ' ' ARG . . . -152.41 159.23 28.28 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.14 176.35 5.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.246 -1.149 . . . . 0.0 109.491 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 107.31 3.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.486 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.29 12.6 10.66 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 70' ' ' THR . 3.3 ttm180 -114.28 142.51 46.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -1.184 . . . . 0.0 109.608 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.478 HG22 HG23 ' A' ' 55' ' ' ILE . 1.5 m -113.79 151.42 32.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.441 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.765 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 6.5 m95 -108.89 173.31 6.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.614 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 53.3 mtt180 -130.88 150.57 51.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.711 ' HA ' HD13 ' A' ' 89' ' ' LEU . 20.8 pt-20 -128.55 155.48 44.84 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.008 -1.058 . . . . 0.0 110.418 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB2' ' OH ' ' A' ' 90' ' ' TYR . . . -146.98 148.1 31.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.735 . . . . 0.0 109.102 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.451 ' OD2' ' HB ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -68.81 149.26 49.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 109.595 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.803 HG21 ' CE1' ' A' ' 7' ' ' PHE . 29.1 mm -141.25 145.02 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.274 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 25.2 m120 61.19 39.83 15.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 109.476 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -69.68 128.42 36.37 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.336 -0.853 . . . . 0.0 109.597 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.24 -79.92 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.204 -0.935 . . . . 0.0 109.422 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -172.53 -177.75 1.81 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.642 -0.661 . . . . 0.0 109.486 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.515 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . 67.44 78.21 0.28 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 39' ' ' LYS . 0.7 OUTLIER 56.46 164.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -1.169 . . . . 0.0 109.313 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 171.97 0.05 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.21 -0.931 . . . . 0.0 109.334 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.74 -171.75 1.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.601 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.34 -4.92 13.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.902 . . . . 0.0 109.415 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.48 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 65.0 m-20 -93.87 129.42 40.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.459 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.614 ' O ' HG23 ' A' ' 99' ' ' THR . 11.4 mtt180 -152.79 150.88 29.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.206 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.824 HD11 HD11 ' A' ' 109' ' ' ILE . 4.3 tt -106.98 149.36 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.185 -0.947 . . . . 0.0 109.441 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -117.95 124.69 48.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.374 -0.829 . . . . 0.0 109.515 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.852 ' OH ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -113.26 140.96 47.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.841 -1.162 . . . . 0.0 108.839 179.063 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.591 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 11.4 t -108.27 173.78 6.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.3 p -66.36 -22.77 66.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.473 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 28.4 p-10 -89.67 15.65 9.21 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.582 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.36 31.59 6.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.708 -0.62 . . . . 0.0 110.461 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.98 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.8 mt -87.34 125.05 34.0 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.606 HG22 HD11 ' A' ' 88' ' ' ILE . 1.8 mt -117.62 113.75 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.098 -1.001 . . . . 0.0 110.677 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.551 ' HB2' HD21 ' A' ' 63' ' ' LEU . 21.6 m-85 -113.52 117.45 31.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.21 136.15 33.18 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.961 -1.087 . . . . 0.0 109.8 -179.119 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -122.89 128.66 50.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 108.996 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.459 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.3 31.2 6.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.606 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.563 ' OD2' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -149.88 20.67 0.89 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -0.937 . . . . 0.0 109.36 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 19.6 t-80 76.6 68.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.804 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 5.7 m-85 56.28 55.1 6.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.954 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER -120.87 -81.56 0.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 108.641 179.396 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.563 HG23 ' OD2' ' A' ' 101' ' ' ASP . 17.2 p -90.56 105.25 17.69 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.544 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 83.2 m-85 -90.0 126.52 35.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 110.142 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -111.33 126.98 55.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 108.949 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 24.3 tttt -79.34 117.49 20.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.019 -1.051 . . . . 0.0 109.441 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.824 HD11 HD11 ' A' ' 88' ' ' ILE . 1.4 pt -110.21 -24.76 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.876 . . . . 0.0 109.627 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.657 HH21 ' HB3' ' A' ' 11' ' ' ALA . 2.8 mtt-85 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -141.16 102.47 4.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 4' ' ' ILE . 3.5 t 62.95 170.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.506 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.527 ' H ' HG12 ' A' ' 3' ' ' VAL . 3.1 mp -140.87 95.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 109.599 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -138.94 58.46 1.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.676 ' H ' HG23 ' A' ' 10' ' ' VAL . 1.2 p -146.42 -178.26 6.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.62 ' CG ' HG21 ' A' ' 76' ' ' ILE . 11.3 m-85 -73.68 -57.15 4.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.404 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.35 -36.42 71.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 109.824 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.52 -49.98 57.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.676 HG23 ' H ' ' A' ' 6' ' ' THR . 90.0 t -66.03 -44.83 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -1.161 . . . . 0.0 109.278 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.78 67.25 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.83 -56.03 14.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.501 -0.75 . . . . 0.0 109.045 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.641 ' CE1' ' CG ' ' A' ' 17' ' ' TYR . 67.4 t80 -58.97 -17.7 27.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.145 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.504 HD12 HG12 ' A' ' 10' ' ' VAL . 1.6 mt -78.59 -59.84 2.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.241 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.8 -9.67 57.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 109.489 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.496 HG22 ' CD1' ' A' ' 17' ' ' TYR . 99.6 m -95.49 -61.57 1.44 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 109.947 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CG ' ' CE1' ' A' ' 13' ' ' TYR . 6.2 m-85 -89.31 0.67 56.62 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.697 -0.627 . . . . 0.0 109.581 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.514 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 18.1 m170 42.76 48.59 4.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 2.9 pttm 176.84 130.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.508 -0.745 . . . . 0.0 109.128 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.79 HD13 ' HD2' ' A' ' 24' ' ' TYR . 14.2 mt -43.76 160.96 0.21 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 109.182 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 3.1 Cg_exo -55.41 159.31 10.85 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.105 1.87 . . . . 0.0 110.456 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.7 p30 -72.1 -4.71 30.54 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 108.988 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -111.73 31.87 5.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.484 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.79 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.6 m-30 -114.09 78.78 1.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.932 . . . . 0.0 109.449 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 2.2 pt -90.94 128.02 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.357 -0.839 . . . . 0.0 108.977 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 25' ' ' ILE . 46.2 p -46.49 174.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.857 . . . . 0.0 109.516 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.625 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.82 -46.46 65.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.046 -1.034 . . . . 0.0 109.307 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -51.75 -36.07 45.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 108.388 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.686 ' O ' HD12 ' A' ' 33' ' ' LEU . 16.0 mm-40 -60.43 -43.63 96.58 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.464 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -64.12 -34.6 78.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 16.5 mt-30 -62.46 -37.57 86.44 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.44 79.59 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.461 -0.775 . . . . 0.0 109.658 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.01 -12.62 59.33 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.626 -0.672 . . . . 0.0 110.002 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.88 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 109.98 68.92 0.6 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.716 ' CH2' ' HB2' ' A' ' 37' ' ' ALA . 13.0 t90 -137.01 120.81 17.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -1.136 . . . . 0.0 109.191 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.662 ' O ' HG13 ' A' ' 36' ' ' VAL . 9.8 p -89.85 116.56 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.261 -0.899 . . . . 0.0 108.702 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.716 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . -70.22 83.76 0.54 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.526 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.511 ' O ' ' CZ ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER 167.44 -64.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.516 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.525 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -53.11 -23.1 7.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.503 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.482 ' HA3' ' CD1' ' A' ' 82' ' ' PHE . . . 70.66 74.68 0.67 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.485 ' O ' HG22 ' A' ' 45' ' ' VAL . 3.8 p-10 -144.3 28.16 1.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -1.173 . . . . 0.0 109.634 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 51' ' ' ILE . 13.0 tp -53.05 -65.94 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -46.3 -23.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.433 -0.792 . . . . 0.0 110.056 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -80.19 -40.34 27.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.088 -1.007 . . . . 0.0 110.447 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.88 HG11 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -93.17 -55.18 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.035 -1.041 . . . . 0.0 110.227 -179.409 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -120.76 72.73 22.47 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.959 -1.088 . . . . 0.0 110.01 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.5 Cg_endo -63.67 -178.66 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.239 1.959 . . . . 0.0 110.343 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 43.29 46.25 6.65 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.485 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -149.48 167.13 27.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -1.158 . . . . 0.0 109.43 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.609 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -141.89 162.8 34.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.356 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.558 HG21 ' HG2' ' A' ' 27' ' ' LYS . 4.8 mm -110.57 117.93 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -0.876 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -161.33 158.17 29.86 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.474 ' HA2' ' OH ' ' A' ' 90' ' ' TYR . . . 95.08 9.5 58.18 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.496 ' OD2' ' CG ' ' A' ' 27' ' ' LYS . 2.4 m-20 -85.92 142.46 28.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -1.152 . . . . 0.0 109.376 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 55' ' ' ILE . 20.8 mm -52.63 149.59 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.946 ' CE2' HD12 ' A' ' 63' ' ' LEU . 49.0 t80 -110.96 144.59 39.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.952 . . . . 0.0 109.594 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 3.7 m -43.99 -92.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.578 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 57' ' ' SER . 28.8 t30 74.63 5.27 4.47 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.4 -0.813 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -69.98 -26.06 63.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 109.294 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -80.92 0.2 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.39 40.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.595 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 32.6 mttm -88.07 -8.68 55.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -1.191 . . . . 0.0 109.526 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.946 HD12 ' CE2' ' A' ' 56' ' ' PHE . 22.8 mt -124.47 151.0 66.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.404 -0.81 . . . . 0.0 108.866 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.631 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.3 Cg_exo -59.51 85.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.143 1.895 . . . . 0.0 110.281 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.492 ' HA2' ' HD3' ' A' ' 69' ' ' ARG . . . -160.02 139.0 5.86 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -104.2 -166.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.517 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.7 m -68.48 95.0 0.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.594 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.91 -6.65 4.1 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.492 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -93.82 136.95 33.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -1.165 . . . . 0.0 109.446 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.12 150.25 26.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.425 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.583 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 36.9 m95 -127.49 140.13 52.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.631 ' CB ' ' CE1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -111.0 125.31 53.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.295 -0.878 . . . . 0.0 109.134 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.891 ' HA ' HD13 ' A' ' 89' ' ' LEU . 2.4 pt-20 -96.88 146.26 25.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.175 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.582 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -133.2 147.99 52.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.4 m-20 -70.29 142.93 52.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.59 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.821 HG22 ' OD1' ' A' ' 77' ' ' ASN . 19.5 mm -135.47 141.95 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.861 . . . . 0.0 109.558 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.821 ' OD1' HG22 ' A' ' 76' ' ' ILE . 9.6 m120 61.6 34.58 17.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.7 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 56.5 t80 -69.47 143.82 53.41 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.151 -0.968 . . . . 0.0 109.512 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.69 -80.15 0.49 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -170.41 179.67 3.31 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.629 -0.67 . . . . 0.0 109.448 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.446 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . 67.05 -149.12 51.0 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.511 ' CZ ' ' O ' ' A' ' 38' ' ' SER . 2.4 m-85 -53.5 164.42 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -1.104 . . . . 0.0 109.552 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 82' ' ' PHE . 1.4 mmm-85 -55.98 -164.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.474 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.12 -172.81 2.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.579 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.82 -1.23 11.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 109.589 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 71.0 m-20 -104.96 129.04 53.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 109.519 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.705 ' O ' HG22 ' A' ' 99' ' ' THR . 0.2 OUTLIER -147.23 141.54 26.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.342 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.921 HD11 ' CG2' ' A' ' 96' ' ' ILE . 6.8 tt -102.27 125.27 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 109.313 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.891 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.9 mm? -94.53 99.97 12.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.951 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.631 ' CE1' ' CB ' ' A' ' 72' ' ' ARG . 22.5 p90 -99.36 140.09 34.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.923 -1.111 . . . . 0.0 108.687 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.471 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 8.0 t -108.01 169.53 8.56 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.146 -0.971 . . . . 0.0 110.607 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -65.28 -19.37 65.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.421 -0.8 . . . . 0.0 109.638 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 29.8 p-10 -89.62 16.87 7.1 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.592 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 68.27 30.03 5.75 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.684 -0.635 . . . . 0.0 110.341 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.631 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.8 mt -87.16 101.0 13.07 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.921 ' CG2' HD11 ' A' ' 88' ' ' ILE . 4.1 mt -97.27 115.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.344 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.626 ' HE1' HD22 ' A' ' 95' ' ' LEU . 10.2 m-85 -118.93 161.81 19.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 3.7 ptmt -132.06 143.76 50.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.868 -1.145 . . . . 0.0 110.032 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -130.53 120.55 24.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 108.935 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.47 HG23 ' HE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -103.59 26.69 8.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 0.0 109.857 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -147.78 21.86 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.08 -1.012 . . . . 0.0 109.84 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 10.6 t-80 77.17 71.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.411 ' OH ' ' OE1' ' A' ' 73' ' ' GLU . 15.0 m-85 50.43 20.35 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 110.035 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.52 ' CB ' ' OD1' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -86.96 -20.59 27.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 108.862 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 35.3 p -144.7 157.35 44.23 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.595 ' CE2' ' HB3' ' A' ' 62' ' ' LYS . 73.4 m-85 -141.29 119.53 12.15 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.001 -1.062 . . . . 0.0 110.034 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 3.1 m -112.88 136.5 52.45 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.426 -0.796 . . . . 0.0 108.939 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -83.58 129.1 34.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 0.5 OUTLIER -130.24 19.84 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.428 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.371 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.251 0.548 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.416 ' O ' ' O ' ' A' ' 3' ' ' VAL . 3.9 mm-40 -125.79 95.79 4.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.555 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 4' ' ' ILE . 1.9 t 51.85 178.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.598 ' H ' HG12 ' A' ' 3' ' ' VAL . 5.5 mt -124.46 78.76 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.226 -0.921 . . . . 0.0 109.613 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -141.9 57.71 1.49 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.357 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.6 ' H ' HG23 ' A' ' 10' ' ' VAL . 3.9 p -144.8 -168.93 3.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.221 -0.925 . . . . 0.0 109.67 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.885 ' CD1' HG21 ' A' ' 76' ' ' ILE . 46.6 m-85 -76.79 -57.61 3.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.872 . . . . 0.0 109.582 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -34.82 71.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.137 -0.977 . . . . 0.0 109.99 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.88 -52.79 26.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.6 HG23 ' H ' ' A' ' 6' ' ' THR . 67.4 t -64.14 -45.6 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -1.149 . . . . 0.0 109.114 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -56.73 -36.55 69.86 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.5 -56.22 17.83 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.492 -0.755 . . . . 0.0 109.023 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.675 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 32.3 t80 -59.19 -21.13 58.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 108.848 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' A' ' 11' ' ' ALA . 3.6 mt -71.01 -61.32 1.8 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -70.98 -8.93 56.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 109.348 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 86.5 m -85.02 -67.84 0.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.865 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.675 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 98.6 m-85 -95.68 4.17 53.26 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.676 -0.64 . . . . 0.0 109.743 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER 50.92 50.62 18.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.498 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER 171.53 130.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 20' ' ' LEU . 21.4 mt -44.14 150.39 0.62 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 108.96 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 8.8 Cg_exo -53.51 162.93 2.94 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.055 1.837 . . . . 0.0 110.535 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.17 -6.87 37.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.355 -0.84 . . . . 0.0 109.016 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 27.7 p30 -90.92 -1.07 57.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.506 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.7 m-85 -92.14 91.58 7.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 109.891 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 26' ' ' THR . 1.6 pp -96.77 118.61 43.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.31 -0.869 . . . . 0.0 108.771 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.549 ' O ' HD12 ' A' ' 25' ' ' ILE . 13.2 p -43.07 166.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.579 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.615 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -64.15 -43.61 94.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.148 -0.97 . . . . 0.0 108.903 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.52 -38.89 64.19 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.742 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.6 mt-10 -58.21 -40.84 82.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.716 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -64.34 -38.81 92.36 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.436 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 3.5 mm100 -60.05 -36.35 77.12 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.69 -39.16 87.47 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.354 -0.841 . . . . 0.0 109.602 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.8 mp -81.12 -8.03 59.68 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.704 -0.623 . . . . 0.0 110.205 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.06 67.39 0.76 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.716 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 9.4 t90 -136.82 118.94 15.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.157 . . . . 0.0 109.031 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 38' ' ' SER . 16.1 t -89.81 113.55 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.804 . . . . 0.0 109.072 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.587 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -59.17 -16.25 19.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.213 -0.929 . . . . 0.0 109.65 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.531 ' H ' HG12 ' A' ' 36' ' ' VAL . 1.3 t -80.1 -31.82 39.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.965 . . . . 0.0 109.444 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.1 OUTLIER -97.01 -9.7 27.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 43.71 45.3 7.15 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.571 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -97.78 45.29 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.102 -1.234 . . . . 0.0 109.82 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.641 HD12 ' CD1' ' A' ' 35' ' ' TRP . 4.5 tp -61.95 -45.21 94.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.07 -1.019 . . . . 0.0 109.48 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.49 -10.38 11.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.911 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -105.3 -24.99 12.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 110.27 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.61 HG23 ' N ' ' A' ' 46' ' ' ALA . 34.8 m -115.03 -49.57 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.963 -1.086 . . . . 0.0 110.051 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.61 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -129.74 62.22 62.32 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 2.2 Cg_endo -61.71 177.9 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.133 1.889 . . . . 0.0 110.176 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 49' ' ' LYS . . . 43.96 60.93 3.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.489 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 4.6 mttt -159.52 123.63 3.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -1.151 . . . . 0.0 109.577 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 1.8 m -90.03 134.81 34.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.616 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.592 HD11 HD21 ' A' ' 42' ' ' LEU . 8.4 mm -96.08 108.76 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.181 -0.95 . . . . 0.0 108.775 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.09 167.15 32.75 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.45 -6.96 50.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.33 154.35 29.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -1.165 . . . . 0.0 109.245 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HA ' HD13 ' A' ' 55' ' ' ILE . 19.5 mm -68.46 142.37 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.847 ' CE2' HD12 ' A' ' 63' ' ' LEU . 10.6 t80 -84.06 108.13 16.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.263 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' PHE . 3.1 t -42.43 -39.61 2.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.0 110.121 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 11.9 t-20 51.36 29.67 5.35 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.507 -0.746 . . . . 0.0 109.515 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -45.14 -52.45 9.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.518 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -63.02 -58.24 7.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' OD1' ' A' ' 58' ' ' ASN . . . 98.88 47.46 1.91 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -96.74 -2.43 44.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.173 -1.192 . . . . 0.0 109.715 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.847 HD12 ' CE2' ' A' ' 56' ' ' PHE . 58.8 mt -89.5 148.43 40.3 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 108.987 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.87 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.3 Cg_exo -59.69 94.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.08 1.854 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' CA ' ' HD3' ' A' ' 69' ' ' ARG . . . -164.83 170.25 39.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -72.34 -172.56 0.94 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -1.167 . . . . 0.0 109.52 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.0 m -61.25 88.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 0.0 109.385 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.82 60.81 1.56 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.495 ' HD3' ' CA ' ' A' ' 65' ' ' GLY . 4.7 ttp180 -80.42 163.64 23.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -1.162 . . . . 0.0 109.594 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.68 108.46 19.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.326 -0.859 . . . . 0.0 109.31 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.618 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 10.5 m95 -112.76 166.59 11.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 0.0 109.562 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.629 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -120.49 132.23 55.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 108.745 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.688 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -111.95 153.65 26.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.07 -1.019 . . . . 0.0 110.405 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.702 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -141.18 152.56 44.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.502 -0.749 . . . . 0.0 109.19 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 5.7 m-20 -74.54 141.51 44.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 109.245 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.885 HG21 ' CD1' ' A' ' 7' ' ' PHE . 22.2 mm -135.41 145.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.145 -0.972 . . . . 0.0 109.771 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 65.32 33.84 8.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.472 -0.768 . . . . 0.0 109.81 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.492 ' HA ' ' OD1' ' A' ' 84' ' ' ASN . 17.1 t80 -69.49 137.84 52.9 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.68 -79.88 0.45 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.288 -0.882 . . . . 0.0 109.392 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.83 179.25 6.03 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.739 -0.6 . . . . 0.0 109.475 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.19 -162.95 42.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.53 150.68 6.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.204 -1.174 . . . . 0.0 109.394 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.92 173.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.686 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -107.36 -167.97 1.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.401 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -114.62 11.27 16.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.451 ' C ' ' HG2' ' A' ' 87' ' ' ARG . 42.8 m-20 -96.75 125.67 41.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.056 -1.028 . . . . 0.0 109.52 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -144.65 158.71 43.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 0.0 109.594 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.702 HG22 ' HB3' ' A' ' 74' ' ' ALA . 7.2 tt -122.9 131.58 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.714 HD22 ' N ' ' A' ' 89' ' ' LEU . 3.5 mm? -105.63 96.95 6.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.626 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 36.3 p90 -92.84 139.74 30.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.898 -1.126 . . . . 0.0 108.559 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.478 ' OG ' ' CZ ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -105.64 170.53 7.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.138 -0.976 . . . . 0.0 110.565 -178.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -21.37 66.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -0.794 . . . . 0.0 109.388 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 54.8 p30 -89.57 17.53 6.3 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.6 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.8 29.5 5.12 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.723 -0.611 . . . . 0.0 110.375 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.87 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.5 mt -86.4 96.54 10.05 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.995 HD12 ' HB2' ' A' ' 110' ' ' ARG . 8.7 mt -94.64 111.21 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 110.342 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.512 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 9.7 m-85 -110.52 162.48 14.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -129.8 152.37 49.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.98 -1.075 . . . . 0.0 109.329 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.2 118.18 11.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.892 . . . . 0.0 109.031 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 27.01 8.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 109.767 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -145.57 20.21 1.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.478 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 5.8 t-80 78.8 74.3 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -0.815 . . . . 0.0 109.786 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.492 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 29.3 m-85 44.64 24.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 102' ' ' HIS . 5.0 mm-40 -94.67 -16.41 23.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.998 . . . . 0.0 108.887 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.5 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 1.4 m -150.28 136.7 18.89 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 98' ' ' LYS . 71.2 m-85 -124.25 131.37 53.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.01 -1.056 . . . . 0.0 110.33 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -126.11 131.87 52.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 4.5 tttt -79.34 128.25 33.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.037 -1.039 . . . . 0.0 109.549 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pt -112.12 -45.14 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.995 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.462 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.375 0.607 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -160.45 177.52 10.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 109.372 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.58 HG23 ' OD1' ' A' ' 5' ' ' ASN . 29.2 m -105.73 146.43 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mp -97.65 92.76 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.58 ' OD1' HG23 ' A' ' 3' ' ' VAL . 16.8 p-10 -146.63 60.6 1.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.62 ' O ' HD12 ' A' ' 76' ' ' ILE . 14.0 p -144.6 -167.58 2.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.932 . . . . 0.0 109.523 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.993 ' CD1' HG21 ' A' ' 76' ' ' ILE . 37.3 m-85 -79.17 -59.99 2.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.444 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.56 -31.0 67.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.58 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.89 -52.33 29.4 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 6' ' ' THR . 58.0 t -64.6 -44.66 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -1.152 . . . . 0.0 109.138 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -56.06 -38.87 71.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -56.51 16.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.499 -0.751 . . . . 0.0 109.138 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.64 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 22.5 t80 -58.66 -20.21 46.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.045 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.5 mt -73.33 -63.17 1.24 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.458 -0.776 . . . . 0.0 109.001 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.412 ' HG3' HD11 ' A' ' 96' ' ' ILE . 7.2 mt-30 -71.93 -5.96 38.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.091 . . . . 0.0 109.391 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.0 m -91.15 -66.8 0.9 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.166 -0.959 . . . . 0.0 110.044 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 85.0 m-85 -89.22 -10.93 45.15 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.62 -0.675 . . . . 0.0 109.362 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.496 ' HA ' ' CH2' ' A' ' 94' ' ' TRP . 0.4 OUTLIER 62.57 54.61 2.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.392 -0.817 . . . . 0.0 109.478 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER 162.56 130.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 74' ' ' ALA . 31.5 mt -43.67 148.51 0.71 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.91 . . . . 0.0 109.116 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 12.0 Cg_exo -51.49 163.49 1.11 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.072 1.848 . . . . 0.0 110.552 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.7 -7.03 35.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.357 -0.84 . . . . 0.0 109.057 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.455 ' CG ' ' HB2' ' A' ' 21' ' ' PRO . 5.6 p30 -92.15 2.54 56.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.85 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 50' ' ' SER . 6.8 m-85 -99.24 93.21 5.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.095 -1.003 . . . . 0.0 109.818 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pp -98.77 118.98 46.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.27 -0.894 . . . . 0.0 108.925 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 25' ' ' ILE . 30.0 p -44.58 169.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -65.53 -44.56 86.51 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.136 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -54.58 -39.61 67.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.847 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.3 mt-10 -58.63 -39.92 81.87 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.619 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -65.44 -39.43 92.05 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.144 -0.972 . . . . 0.0 108.443 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 9.2 mt-30 -59.77 -35.22 74.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.18 73.39 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 109.367 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.847 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.37 -15.77 54.27 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.703 -0.623 . . . . 0.0 110.205 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 1.035 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 112.49 44.59 0.83 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.619 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 8.6 t90 -109.37 124.48 51.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -1.177 . . . . 0.0 109.239 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 38' ' ' SER . 5.4 t -91.08 113.32 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.835 . . . . 0.0 109.083 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . -64.6 -10.74 28.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.491 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 36' ' ' VAL . 1.7 m -90.22 -29.22 18.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.453 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.517 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mttt -103.17 -4.88 23.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.651 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 42.93 62.08 2.42 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -111.75 42.76 1.66 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.143 -1.21 . . . . 0.0 109.415 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.485 ' HA ' HD12 ' A' ' 42' ' ' LEU . 10.9 tp -56.77 -60.94 2.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 109.581 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -43.56 -24.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.926 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -82.13 -49.44 10.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 110.64 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.035 HG11 ' O ' ' A' ' 34' ' ' GLY . 31.8 m -95.14 -50.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.906 -1.121 . . . . 0.0 110.488 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.803 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -117.13 76.8 8.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.003 -1.061 . . . . 0.0 109.805 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.8 Cg_endo -62.85 154.23 67.66 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.235 1.956 . . . . 0.0 110.364 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 45.32 73.9 0.25 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.803 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 2.5 mttp -154.42 123.07 6.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.583 ' HB2' ' CD1' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -89.77 131.97 35.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.878 . . . . 0.0 109.472 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.542 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 11.5 mm -91.16 109.85 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.186 -0.946 . . . . 0.0 109.2 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -161.92 175.63 38.42 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.498 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 88.32 33.73 10.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' OD1' ' OE2' ' A' ' 73' ' ' GLU . 2.2 p30 -131.05 143.37 50.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -1.225 . . . . 0.0 109.497 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 54' ' ' ASP . 1.1 mp -44.08 147.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.832 . . . . 0.0 109.003 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.815 ' CE2' HD12 ' A' ' 63' ' ' LEU . 8.1 t80 -101.63 146.99 26.96 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.311 -0.868 . . . . 0.0 109.211 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 58.0 m -43.31 -91.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.565 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 57' ' ' SER . 21.4 t30 77.85 19.26 1.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.53 -0.731 . . . . 0.0 109.448 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -59.96 -72.26 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.915 . . . . 0.0 109.391 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -56.41 -30.48 62.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.943 . . . . 0.0 109.292 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.4 63.55 0.9 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 7.5 mtpp -91.76 -3.9 55.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -1.142 . . . . 0.0 109.533 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.815 HD12 ' CE2' ' A' ' 56' ' ' PHE . 28.5 mt -115.07 152.2 46.4 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.175 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.602 ' CG ' ' CZ ' ' A' ' 97' ' ' TYR . 2.9 Cg_endo -61.44 156.65 45.33 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.131 1.887 . . . . 0.0 110.233 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.483 ' HA3' ' HD3' ' A' ' 69' ' ' ARG . . . 135.71 -177.12 19.72 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -109.27 175.99 5.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -1.139 . . . . 0.0 109.384 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -65.18 108.18 1.8 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.79 11.61 9.16 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.483 ' HD3' ' HA3' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -86.08 133.27 33.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -1.14 . . . . 0.0 109.537 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.35 153.93 18.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.548 ' CE3' HD13 ' A' ' 63' ' ' LEU . 16.4 m95 -137.13 171.51 14.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.509 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 90' ' ' TYR . 8.7 mmt180 -133.06 143.2 49.2 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.391 -0.818 . . . . 0.0 108.819 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.553 ' HA ' HD13 ' A' ' 89' ' ' LEU . 17.3 pt-20 -121.0 149.4 42.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.14 -0.975 . . . . 0.0 110.123 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 20' ' ' LEU . . . -139.53 146.28 39.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.363 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HA ' ' HG3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -65.24 141.17 58.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.519 -0.738 . . . . 0.0 109.629 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.993 HG21 ' CD1' ' A' ' 7' ' ' PHE . 23.1 mm -129.47 122.71 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.948 . . . . 0.0 109.833 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.759 ' OD1' HG22 ' A' ' 76' ' ' ILE . 5.2 m120 77.48 43.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 109.868 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.482 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 36.6 t80 -70.08 149.25 47.83 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.191 -0.943 . . . . 0.0 109.317 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.79 -78.19 0.16 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.171 -0.956 . . . . 0.0 109.488 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.8 m -165.96 168.66 15.51 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.729 -0.607 . . . . 0.0 109.615 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 78.21 -179.25 51.94 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER -43.61 165.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -1.087 . . . . 0.0 109.431 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -50.66 175.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.562 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.37 -169.17 1.43 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.892 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.46 9.18 18.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.91 . . . . 0.0 109.508 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.683 ' OD1' HG22 ' A' ' 100' ' ' THR . 61.6 m-20 -107.21 129.24 54.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.523 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -150.02 174.6 12.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.894 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.85 HD11 ' CG2' ' A' ' 96' ' ' ILE . 5.6 tt -137.64 128.68 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 109.119 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.74 HD22 ' N ' ' A' ' 89' ' ' LEU . 3.3 mm? -103.29 102.99 12.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.398 -0.814 . . . . 0.0 110.32 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 72' ' ' ARG . 32.1 p90 -99.38 139.94 34.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.999 -1.063 . . . . 0.0 108.559 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.482 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -103.62 173.2 6.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.059 -1.026 . . . . 0.0 110.826 -178.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 p -66.01 -19.9 66.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.509 -0.745 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 47.5 p-10 -89.58 17.05 6.79 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.598 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 66.89 29.22 8.39 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.726 -0.609 . . . . 0.0 109.989 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.623 HD22 ' HE1' ' A' ' 97' ' ' TYR . 6.9 mt -85.33 99.14 10.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.85 ' CG2' HD11 ' A' ' 88' ' ' ILE . 2.6 mt -93.83 116.92 36.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 110.408 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.623 ' HE1' HD22 ' A' ' 95' ' ' LEU . 7.2 m-85 -116.8 155.58 28.71 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -121.49 154.12 37.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.754 -1.217 . . . . 0.0 109.713 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -140.69 125.01 17.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.496 -0.752 . . . . 0.0 108.993 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.683 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.65 29.38 7.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.784 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.583 ' OD2' HG23 ' A' ' 105' ' ' THR . 0.9 OUTLIER -150.24 21.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.114 -0.991 . . . . 0.0 109.687 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 2.2 t-80 76.61 72.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 109.261 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.463 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 9.2 m-85 50.33 20.8 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.739 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.498 ' HB2' ' CB ' ' A' ' 101' ' ' ASP . 1.2 mt-30 -86.87 -19.98 28.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.913 . . . . 0.0 109.143 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.583 HG23 ' OD2' ' A' ' 101' ' ' ASP . 34.3 p -146.51 157.5 43.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.527 ' CE2' ' HB3' ' A' ' 62' ' ' LYS . 82.6 m-85 -141.98 125.11 16.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 110.042 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -117.0 133.96 55.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.359 -0.838 . . . . 0.0 109.018 179.416 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -79.73 128.3 33.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.596 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 6.8 pt -127.85 17.04 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.524 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.252 0.549 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 2' ' ' GLN . 2.8 pt20 -151.92 67.45 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.548 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 m -122.7 160.49 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.505 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mm -91.31 93.66 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -141.25 53.35 1.55 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.608 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.74 -172.76 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.417 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.832 ' CD1' HG21 ' A' ' 76' ' ' ILE . 47.2 m-85 -80.24 -61.96 1.82 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.482 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -30.99 67.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.35 -50.27 45.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.563 HG23 ' H ' ' A' ' 6' ' ' THR . 96.7 t -65.89 -45.8 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -1.115 . . . . 0.0 109.294 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -56.93 -35.93 69.62 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.51 -55.68 19.07 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 22.6 t80 -58.61 -23.13 58.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 0.0 109.183 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 11' ' ' ALA . 5.4 mt -71.9 -63.83 1.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.353 -0.842 . . . . 0.0 108.949 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.424 ' HG3' ' HD2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -71.01 -5.04 28.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.102 -0.999 . . . . 0.0 109.364 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 31.2 m -91.93 -69.96 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -0.952 . . . . 0.0 109.844 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 81.9 m-85 -89.76 -4.82 57.48 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.684 -0.635 . . . . 0.0 109.596 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER 57.51 57.81 4.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.461 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 162.51 129.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.477 HD11 ' OH ' ' A' ' 90' ' ' TYR . 19.0 mt -44.05 148.24 0.82 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.287 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.5 Cg_exo -55.35 164.49 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.172 1.915 . . . . 0.0 110.444 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.81 -5.81 33.05 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.306 -0.871 . . . . 0.0 108.868 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' ' 21' ' ' PRO . 23.2 p30 -92.14 9.79 32.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.525 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.55 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 4.6 m-85 -108.14 99.79 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.006 . . . . 0.0 109.753 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 2.1 pt -106.46 124.45 61.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 108.725 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 25' ' ' ILE . 20.5 p -47.0 176.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.817 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.611 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.19 -44.76 68.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.1 -1.0 . . . . 0.0 109.092 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 m -54.49 -39.9 68.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.844 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.7 mm-40 -58.67 -39.73 81.52 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.61 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.2 -34.56 77.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 108.663 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.526 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 18.6 mt-30 -65.95 -30.75 71.37 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.29 -37.87 84.73 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.692 0.758 . . . . 0.0 109.579 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -80.93 -8.25 59.7 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.649 -0.657 . . . . 0.0 110.124 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' O ' HG21 ' A' ' 45' ' ' VAL . . . 103.01 61.77 0.71 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.63 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 1.7 t90 -118.55 135.45 54.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.195 -1.179 . . . . 0.0 109.599 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.51 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 3.5 t -89.73 131.66 36.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.63 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -63.09 -8.04 6.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.965 -1.085 . . . . 0.0 110.311 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 3.0 t -55.26 -17.91 5.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.926 -1.109 . . . . 0.0 109.048 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.577 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 11.3 mtmt 64.59 47.5 2.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -0.809 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.602 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -127.19 -12.8 3.05 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.224 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -147.07 27.36 1.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.958 -1.319 . . . . 0.0 109.995 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.564 HD13 ' CD1' ' A' ' 35' ' ' TRP . 11.7 tp -52.94 -66.58 0.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 109.111 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.79 -14.64 1.48 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.787 -0.571 . . . . 0.0 110.359 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.8 -36.56 42.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.89 -1.131 . . . . 0.0 109.516 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 35' ' ' TRP . 22.0 m -105.49 -1.6 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 109.503 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.4 62.69 5.58 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 109.31 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 5.6 Cg_exo -58.42 152.92 50.95 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.203 1.935 . . . . 0.0 110.286 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 49.8 66.55 2.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HD2' HG12 ' A' ' 25' ' ' ILE . 30.7 mmtp -151.88 154.64 36.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.671 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.532 ' HB2' ' CD1' ' A' ' 24' ' ' TYR . 1.8 m -135.34 124.91 25.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.56 HD11 HD21 ' A' ' 42' ' ' LEU . 11.9 mm -74.64 104.97 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -151.35 173.21 30.8 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 84.17 15.27 69.83 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.48 154.31 17.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -1.151 . . . . 0.0 109.409 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 55' ' ' ILE . 16.4 mm -70.08 149.67 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.904 ' CE2' HD12 ' A' ' 63' ' ' LEU . 60.6 t80 -118.66 91.3 3.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.043 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 26.4 m -69.65 -5.32 23.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 1.1 t-20 70.74 89.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -60.71 -20.85 62.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.404 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -125.4 -51.45 1.63 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.504 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . 108.82 65.82 0.57 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.56 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -120.51 -0.48 10.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -1.149 . . . . 0.0 109.756 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.904 HD12 ' CE2' ' A' ' 56' ' ' PHE . 41.1 mt -89.85 145.11 32.65 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.151 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.976 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.8 Cg_endo -60.31 156.23 41.84 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.025 1.816 . . . . 0.0 110.359 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.17 -173.63 22.35 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -114.21 158.72 20.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.13 126.46 18.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.14 8.67 57.65 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -89.18 132.17 34.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -1.156 . . . . 0.0 109.443 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -90.96 147.6 23.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.795 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 3.9 m95 -122.93 173.57 7.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.554 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.616 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 1.1 mmt180 -121.58 148.83 44.0 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.75 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -128.8 153.8 47.06 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.877 -1.139 . . . . 0.0 110.249 -179.304 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -143.05 148.77 37.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.423 -0.798 . . . . 0.0 109.241 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -77.45 124.07 27.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.727 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.832 HG21 ' CD1' ' A' ' 7' ' ' PHE . 22.3 mm -110.85 138.86 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.113 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.65 ' OD1' HG22 ' A' ' 76' ' ' ILE . 14.9 m120 61.58 112.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.069 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 78' ' ' TYR . 6.8 t80 -170.45 133.95 1.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.062 -1.024 . . . . 0.0 109.674 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -140.9 -79.43 0.27 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.226 -0.921 . . . . 0.0 109.364 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 m -146.14 160.03 42.49 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.716 -0.615 . . . . 0.0 109.436 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.9 -169.15 18.79 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.602 ' CD1' ' HA2' ' A' ' 40' ' ' GLY . 0.3 OUTLIER -64.07 144.45 57.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -1.177 . . . . 0.0 109.485 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.536 ' CD ' ' HG2' ' A' ' 39' ' ' LYS . 5.2 mtm180 -43.97 163.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 109.219 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.84 -171.11 1.82 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.944 . . . . 0.0 109.651 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.43 23.28 9.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.5 m-20 -109.24 132.03 54.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.373 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 99' ' ' THR . 36.8 mtt180 -157.81 157.73 33.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.55 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.973 HD11 HD11 ' A' ' 109' ' ' ILE . 1.5 tt -112.93 139.64 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.245 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.4 mm? -108.45 126.59 53.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.795 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -116.69 140.05 49.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.857 -1.152 . . . . 0.0 108.666 178.497 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.451 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -108.12 176.01 5.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.193 -0.942 . . . . 0.0 110.379 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 p -64.23 -25.2 67.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.408 -0.808 . . . . 0.0 110.441 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.483 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -89.3 16.84 6.76 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.108 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.566 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.4 m95 67.5 29.31 7.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.713 -0.617 . . . . 0.0 110.737 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.976 HD13 ' HG2' ' A' ' 64' ' ' PRO . 8.8 mt -83.79 121.87 27.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.544 ' CG1' ' HB2' ' A' ' 110' ' ' ARG . 1.8 mt -115.42 112.82 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 110.75 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.613 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 26.1 m-85 -112.07 118.66 36.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.484 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -88.88 136.13 33.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.818 -1.176 . . . . 0.0 109.866 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -125.54 131.46 52.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.392 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.2 p -114.75 31.75 6.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.159 -0.963 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -150.26 20.4 0.85 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 109.565 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.537 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.5 t-80 79.08 73.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.496 -0.753 . . . . 0.0 109.971 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 5.0 m-85 51.57 37.73 20.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.04 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.434 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 19.7 tp60 -104.29 -72.29 0.71 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.135 -0.978 . . . . 0.0 109.052 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 99' ' ' THR . 0.8 OUTLIER -93.16 124.41 37.12 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.56 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 96.7 m-85 -112.17 121.66 45.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.067 -1.021 . . . . 0.0 110.065 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.484 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 3.8 m -108.64 130.81 55.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.386 -0.821 . . . . 0.0 109.087 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -79.41 113.8 17.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.047 -1.033 . . . . 0.0 109.668 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.973 HD11 HD11 ' A' ' 88' ' ' ILE . 29.5 pt -113.21 -14.98 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 109.328 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.544 ' HB2' ' CG1' ' A' ' 96' ' ' ILE . 1.1 mtt-85 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -129.69 118.94 22.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.98 151.3 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 109.438 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mp -114.35 87.55 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.934 . . . . 0.0 109.557 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -134.57 49.44 2.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -135.31 -169.93 2.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 0.0 109.443 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.967 ' CE1' HG21 ' A' ' 76' ' ' ILE . 42.6 m-85 -80.14 -59.64 2.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.213 -0.929 . . . . 0.0 109.463 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -28.72 65.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.969 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.37 -51.27 33.03 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 6' ' ' THR . 38.7 t -67.04 -49.36 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -1.153 . . . . 0.0 109.167 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -53.88 -37.04 63.3 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.27 -55.63 23.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 23.2 t80 -59.94 -18.3 44.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.429 -0.794 . . . . 0.0 109.03 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.492 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.7 OUTLIER -76.1 -63.82 1.23 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.328 -0.857 . . . . 0.0 109.296 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -70.51 -8.49 51.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.906 -1.121 . . . . 0.0 109.353 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -91.9 -65.7 0.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.782 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 96.3 m-85 -89.51 3.3 52.88 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.713 -0.617 . . . . 0.0 109.5 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.548 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 0.3 OUTLIER 45.01 45.48 8.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.6 OUTLIER 174.43 129.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.729 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 20' ' ' LEU . 18.4 mt -45.46 150.73 0.84 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 108.754 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 10.9 Cg_exo -52.98 160.06 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.084 1.856 . . . . 0.0 110.453 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -69.59 -5.89 27.52 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.309 -0.87 . . . . 0.0 109.202 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -93.44 2.87 56.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.336 -0.853 . . . . 0.0 109.628 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.547 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.2 m-85 -93.76 92.72 7.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.002 . . . . 0.0 109.943 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -100.99 125.3 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.264 -0.897 . . . . 0.0 108.937 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.473 ' H ' HG23 ' A' ' 26' ' ' THR . 12.1 p -45.96 172.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.16 -43.09 71.57 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.964 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -39.1 64.14 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.768 ' O ' HD12 ' A' ' 33' ' ' LEU . 5.5 mt-10 -59.67 -41.31 90.32 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.636 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -65.08 -35.98 82.88 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 0.0 108.63 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.408 ' HG3' ' CE3' ' A' ' 35' ' ' TRP . 13.0 mt-30 -63.03 -36.25 82.95 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.22 79.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.447 -0.783 . . . . 0.0 109.533 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.8 mp -81.17 -11.25 59.48 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.365 0.602 . . . . 0.0 110.261 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.764 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 107.68 56.77 0.59 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.636 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 9.8 t90 -127.89 115.48 18.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -1.141 . . . . 0.0 109.025 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 38' ' ' SER . 14.0 t -90.14 112.04 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 108.994 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.588 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -51.83 -20.89 2.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.195 -0.94 . . . . 0.0 109.422 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.55 ' O ' ' CZ ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -83.94 -49.97 8.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.309 -0.869 . . . . 0.0 109.669 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 40' ' ' GLY . 10.0 mttp -67.3 -13.33 61.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.607 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 39' ' ' LYS . . . 44.26 93.73 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.599 ' OD1' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -159.86 44.33 0.22 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -1.148 . . . . 0.0 109.444 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.556 HD21 HD11 ' A' ' 51' ' ' ILE . 9.8 tp -59.54 -52.98 63.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.449 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -56.67 -14.96 3.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 109.871 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.83 -53.83 4.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.024 . . . . 0.0 110.331 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.764 HG11 ' O ' ' A' ' 34' ' ' GLY . 20.4 m -89.88 -48.1 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 110.16 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.61 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -116.85 77.35 8.5 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.993 . . . . 0.0 109.542 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 2.7 Cg_endo -60.92 159.47 29.25 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.21 1.94 . . . . 0.0 110.4 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.85 57.28 4.09 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HD3' HG12 ' A' ' 25' ' ' ILE . 2.9 mmtt -137.65 110.16 7.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -1.141 . . . . 0.0 109.588 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 9.2 m -89.7 133.93 34.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.4 -0.813 . . . . 0.0 109.229 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.556 HD11 HD21 ' A' ' 42' ' ' LEU . 10.2 mm -91.06 111.48 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.102 -0.999 . . . . 0.0 109.176 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -155.91 169.21 33.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.77 12.71 55.25 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 5.6 m-20 -104.95 143.86 32.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -1.21 . . . . 0.0 109.38 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 54' ' ' ASP . 7.3 mt -44.44 152.22 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 109.571 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.018 ' CE2' HD12 ' A' ' 63' ' ' LEU . 9.9 t80 -92.42 134.12 35.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.139 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 0.4 OUTLIER -44.28 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.482 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 57' ' ' SER . 10.2 t-20 80.63 39.87 0.07 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -48.21 66.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.315 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.82 -51.03 12.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.898 . . . . 0.0 109.383 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.6 60.56 0.66 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.602 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 8.0 mptt -102.15 -7.5 22.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -1.18 . . . . 0.0 109.64 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.018 HD12 ' CE2' ' A' ' 56' ' ' PHE . 56.2 mt -91.59 140.71 25.32 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.24 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.953 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.2 Cg_exo -61.53 84.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.078 1.852 . . . . 0.0 110.067 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.66 164.29 12.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' H ' ' CB ' ' A' ' 69' ' ' ARG . 14.5 mtmt -118.98 169.8 9.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -1.062 . . . . 0.0 109.334 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.6 m -55.73 103.18 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.878 . . . . 0.0 109.453 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.6 52.55 2.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.4 ' CB ' ' H ' ' A' ' 66' ' ' LYS . 31.9 ttt180 -126.54 159.21 34.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -1.139 . . . . 0.0 109.483 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.58 170.0 10.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.157 -0.965 . . . . 0.0 109.615 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.859 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 8.2 m95 -139.79 151.26 45.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 109.299 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.636 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 10.0 mpt_? -110.75 139.16 46.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.202 -0.936 . . . . 0.0 108.671 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.607 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -117.77 158.22 25.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.008 . . . . 0.0 110.269 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -147.91 152.95 38.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -75.39 142.6 43.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 109.323 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.967 HG21 ' CE1' ' A' ' 7' ' ' PHE . 16.8 mm -131.14 121.73 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.09 -1.006 . . . . 0.0 109.732 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.509 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER 71.63 116.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 109.698 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -170.64 127.77 0.78 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.351 -0.843 . . . . 0.0 109.493 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -121.47 -27.91 4.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.745 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 79' ' ' THR . 0.6 OUTLIER 168.91 -174.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.391 -0.818 . . . . 0.0 109.703 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 82' ' ' PHE . . . 67.07 174.7 6.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CZ ' ' O ' ' A' ' 38' ' ' SER . 7.5 m-85 -43.81 152.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -1.15 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.501 ' CZ ' ' CB ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -46.65 171.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.9 OUTLIER -106.38 -174.74 2.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 m -106.37 3.99 28.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 0.0 109.48 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.2 m-20 -95.9 129.5 43.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 109.53 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 27.2 mtt180 -154.64 178.53 10.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.181 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 96' ' ' ILE . 3.7 tt -135.23 150.95 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.711 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.1 mm? -121.69 109.45 14.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.376 -0.827 . . . . 0.0 109.707 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.636 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 7.9 p90 -104.55 138.89 40.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 109.302 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.583 ' OG ' ' CH2' ' A' ' 71' ' ' TRP . 1.4 m -107.23 174.3 5.95 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.288 -0.882 . . . . 0.0 110.396 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -65.3 -23.9 67.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 109.593 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.473 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 17.8 p-10 -89.7 18.15 5.82 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 108.858 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.572 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.4 m95 66.39 29.49 9.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.677 -0.639 . . . . 0.0 110.173 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.953 HD13 ' HG2' ' A' ' 64' ' ' PRO . 5.7 mt -81.03 112.5 18.48 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.793 HG22 HD11 ' A' ' 88' ' ' ILE . 2.0 mt -109.52 110.83 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.782 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.49 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 31.5 m-85 -113.91 113.49 24.92 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CG ' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -89.36 133.76 34.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 110.215 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -117.13 128.96 55.65 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.33 28.23 8.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.18 -0.95 . . . . 0.0 109.645 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.791 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.7 OUTLIER -150.18 22.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.463 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 8.7 t-80 77.54 71.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.381 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.432 ' OH ' ' HD2' ' A' ' 87' ' ' ARG . 5.1 m-85 50.76 20.91 0.82 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.826 . . . . 0.0 109.752 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.467 ' HB2' ' CB ' ' A' ' 101' ' ' ASP . 1.2 mm-40 -90.33 -17.4 27.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -0.96 . . . . 0.0 108.87 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.791 HG22 ' OD1' ' A' ' 101' ' ' ASP . 14.9 t -143.81 161.5 38.46 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.602 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 99.4 m-85 -148.76 119.72 7.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.817 -1.177 . . . . 0.0 110.223 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.528 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 3.8 m -108.96 124.82 51.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.515 -0.741 . . . . 0.0 109.1 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -79.42 101.13 7.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.447 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.449 HG21 ' HE2' ' A' ' 98' ' ' LYS . 38.1 pt -104.63 18.18 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.789 ' HD2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' O ' HG13 ' A' ' 3' ' ' VAL . 80.5 mt-30 -112.8 109.8 19.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.434 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 2' ' ' GLN . 1.4 m -155.22 -174.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mp -106.04 109.49 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -0.885 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -143.76 69.74 1.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.516 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.848 ' H ' HG23 ' A' ' 10' ' ' VAL . 1.5 p -149.03 -173.15 4.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.436 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.711 ' CE1' HG21 ' A' ' 76' ' ' ILE . 24.1 m-85 -77.65 -60.29 2.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.893 . . . . 0.0 109.429 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -33.97 70.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.69 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.24 -50.3 46.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.848 HG23 ' H ' ' A' ' 6' ' ' THR . 76.0 t -66.78 -46.98 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -1.147 . . . . 0.0 109.337 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.4 66.97 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.447 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.4 OUTLIER -63.85 -55.77 20.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.518 -0.739 . . . . 0.0 109.246 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.664 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 42.0 t80 -58.18 -21.08 45.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.374 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.539 HD12 HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -75.38 -63.87 1.19 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.401 -0.812 . . . . 0.0 109.317 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' OE1' ' CG ' ' A' ' 110' ' ' ARG . 46.8 mt-30 -70.58 -5.72 31.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.034 -1.041 . . . . 0.0 109.389 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 82.6 m -94.5 -67.37 0.86 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.678 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.664 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 66.6 m-85 -89.78 3.2 53.59 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 109.567 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER 44.14 51.09 7.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER 175.35 129.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.786 HD13 ' HD2' ' A' ' 24' ' ' TYR . 15.7 mt -43.84 160.02 0.23 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.99 . . . . 0.0 109.417 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 3.3 Cg_exo -55.22 159.23 10.46 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.236 1.957 . . . . 0.0 110.553 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.56 -5.05 30.44 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.374 -0.829 . . . . 0.0 108.947 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 50' ' ' SER . 5.6 p-10 -111.42 32.74 5.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.498 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.786 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.2 m-30 -115.18 81.06 1.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.062 -1.024 . . . . 0.0 109.363 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pt -88.14 123.35 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.253 -0.905 . . . . 0.0 108.978 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 25' ' ' ILE . 82.8 p -46.92 175.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.335 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.62 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.24 -45.32 66.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.997 -1.064 . . . . 0.0 109.052 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -52.08 -33.42 39.24 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 108.361 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.7 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.5 mm-40 -61.3 -46.53 89.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.653 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -62.19 -35.92 80.33 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.522 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 33.3 mt-30 -64.45 -33.73 76.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.62 -37.89 85.6 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.19 -8.96 59.85 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.741 -0.599 . . . . 0.0 109.972 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' O ' HG21 ' A' ' 45' ' ' VAL . . . 101.67 71.23 0.91 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.653 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 0.8 OUTLIER -128.2 137.69 52.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -1.188 . . . . 0.0 109.441 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.554 HG12 ' OD1' ' A' ' 41' ' ' ASN . 9.8 p -89.58 128.77 41.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -62.59 -9.68 9.66 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.009 -1.057 . . . . 0.0 110.384 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -47.17 -24.76 0.75 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.904 -1.123 . . . . 0.0 109.016 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.582 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 2.2 mtmp? 74.6 45.6 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 0.0 109.584 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.521 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -132.88 -30.62 0.48 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.1 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.554 ' OD1' HG12 ' A' ' 36' ' ' VAL . 2.6 p-10 -125.31 29.78 5.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.01 -1.288 . . . . 0.0 110.058 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.838 HD21 HD11 ' A' ' 51' ' ' ILE . 6.9 tp -56.85 -65.66 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 109.198 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.29 -9.87 3.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.798 -0.564 . . . . 0.0 110.252 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 3.7 m-20 -78.93 -30.29 44.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.973 -1.079 . . . . 0.0 109.41 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 35' ' ' TRP . 30.8 m -107.61 -14.18 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.341 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -149.3 65.24 7.83 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 109.376 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 3.1 Cg_exo -60.97 161.94 20.65 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.2 1.933 . . . . 0.0 110.317 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.52 38.34 42.82 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 15.8 mmtt -135.58 113.29 10.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -1.161 . . . . 0.0 109.55 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -89.68 155.43 19.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.838 HD11 HD21 ' A' ' 42' ' ' LEU . 5.4 mm -103.11 111.66 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.839 . . . . 0.0 109.405 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -154.1 160.09 29.21 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.08 19.91 27.25 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.527 ' HB2' ' CG ' ' A' ' 73' ' ' GLU . 4.5 m-20 -88.13 148.11 24.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -1.199 . . . . 0.0 109.467 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.0 mm -68.68 137.49 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.835 . . . . 0.0 109.758 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.929 ' CE2' HD12 ' A' ' 63' ' ' LEU . 78.2 t80 -110.65 89.72 3.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 108.957 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -62.36 -12.39 20.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.952 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.591 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 47.0 t-20 54.81 61.56 2.92 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.587 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -55.14 -73.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.41 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -43.9 -49.03 8.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.472 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . 89.14 66.59 1.26 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 6.4 mtpt -120.08 -4.51 10.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.505 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.929 HD12 ' CE2' ' A' ' 56' ' ' PHE . 12.7 mt -94.18 147.29 33.13 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 0.0 109.279 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.006 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.4 Cg_endo -62.03 119.14 6.12 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.139 1.893 . . . . 0.0 110.174 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.34 135.45 2.1 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -94.5 169.78 9.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.222 -1.163 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t -54.13 125.08 17.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.2 -4.63 33.55 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -97.67 153.4 18.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.654 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.89 159.36 25.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 109.43 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.746 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 11.5 m95 -128.74 154.11 46.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 7.3 mmt180 -117.72 148.65 41.81 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.668 ' HA ' HD13 ' A' ' 89' ' ' LEU . 5.9 pt-20 -125.49 155.02 41.19 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.789 -1.194 . . . . 0.0 110.11 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB2' ' OH ' ' A' ' 90' ' ' TYR . . . -144.16 155.59 43.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 109.416 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.475 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 3.4 m-20 -80.24 143.44 33.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.601 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.711 HG21 ' CE1' ' A' ' 7' ' ' PHE . 37.3 mm -127.85 119.0 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 73.83 108.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.674 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.52 ' CE1' ' HA ' ' A' ' 83' ' ' ARG . 23.3 t80 -170.71 118.81 0.52 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.336 -0.852 . . . . 0.0 109.46 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.42 -80.1 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.393 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.8 m -137.19 145.1 43.29 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.726 -0.609 . . . . 0.0 109.385 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.2 -174.25 15.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CG ' ' O ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -61.71 140.69 58.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.158 -1.201 . . . . 0.0 109.426 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.52 ' HA ' ' CE1' ' A' ' 78' ' ' TYR . 45.5 mtp180 -44.04 167.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 109.346 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.42 -176.98 3.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.961 . . . . 0.0 109.684 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -113.5 15.67 18.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 109.311 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.589 ' OD2' HG22 ' A' ' 100' ' ' THR . 0.7 OUTLIER -97.96 130.45 44.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.225 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.525 ' CZ ' ' OH ' ' A' ' 103' ' ' TYR . 2.3 mtt180 -152.54 179.57 8.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.967 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.743 HD11 HD11 ' A' ' 109' ' ' ILE . 1.8 tt -138.77 141.39 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -0.835 . . . . 0.0 108.884 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.747 HD22 ' N ' ' A' ' 89' ' ' LEU . 3.3 mm? -111.61 125.09 53.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.365 -0.834 . . . . 0.0 109.667 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.775 ' OH ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -111.3 142.61 43.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.921 -1.112 . . . . 0.0 108.839 179.003 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.504 ' CB ' ' HB2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -110.88 171.77 7.27 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.186 -0.946 . . . . 0.0 110.184 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.0 p -64.59 -25.76 68.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.435 -0.791 . . . . 0.0 109.518 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.483 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 14.1 p-10 -90.01 19.8 4.68 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.583 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.0 27.77 8.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.68 -0.638 . . . . 0.0 110.133 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.006 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.2 mt -79.62 116.78 20.01 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.535 HG22 HD11 ' A' ' 88' ' ' ILE . 2.5 mt -114.6 108.05 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.088 -1.007 . . . . 0.0 110.56 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.567 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 24.9 m-85 -108.25 116.83 32.69 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.552 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -88.6 137.97 31.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.867 -1.146 . . . . 0.0 109.997 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -122.0 127.3 50.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.589 HG22 ' OD2' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -111.89 29.37 7.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.11 -0.994 . . . . 0.0 109.59 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -150.06 22.44 0.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.726 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.523 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.5 OUTLIER 77.42 69.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.525 ' OH ' ' CZ ' ' A' ' 87' ' ' ARG . 14.8 m-85 49.45 21.81 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.798 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.462 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . 4.8 mt-30 -88.0 -17.29 31.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 108.97 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.485 ' O ' ' HB ' ' A' ' 99' ' ' THR . 23.0 m -147.27 155.79 42.36 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . 90.2 m-85 -139.76 116.44 10.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.973 -1.08 . . . . 0.0 110.11 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 1.7 m -107.65 127.27 53.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 113.95 17.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 109.646 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.743 HD11 HD11 ' A' ' 88' ' ' ILE . 3.5 pt -109.3 -24.25 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.646 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.425 ' OXT' ' O ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -73.79 92.16 2.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.963 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 4' ' ' ILE . 2.5 t -80.35 173.84 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.582 ' H ' HG12 ' A' ' 3' ' ' VAL . 2.7 mp -120.45 96.26 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.437 -0.789 . . . . 0.0 109.339 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -142.67 47.33 1.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.496 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -136.75 -170.19 2.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.348 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.75 ' CD1' HG21 ' A' ' 76' ' ' ILE . 52.3 m-85 -77.38 -59.57 2.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.402 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -31.19 67.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.894 . . . . 0.0 109.783 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.503 ' C ' HG23 ' A' ' 4' ' ' ILE . . . -68.56 -51.96 28.31 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.496 HG23 ' H ' ' A' ' 6' ' ' THR . 73.7 t -66.09 -45.91 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -1.118 . . . . 0.0 109.313 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -55.95 -38.86 70.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.49 -55.6 26.0 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.679 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 35.1 t80 -58.06 -22.35 49.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.327 -0.858 . . . . 0.0 109.046 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER -71.61 -62.87 1.25 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.43 -0.794 . . . . 0.0 108.989 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -71.28 -5.6 33.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.042 -1.036 . . . . 0.0 109.317 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 25.2 m -89.82 -69.48 0.72 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.952 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.679 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 77.5 m-85 -89.47 -7.79 54.3 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.626 -0.671 . . . . 0.0 109.463 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.5 OUTLIER 61.01 57.89 2.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.707 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 10.1 ptpt 160.64 129.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 20' ' ' LEU . 30.4 mt -44.46 147.33 1.04 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 108.997 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.567 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.3 Cg_exo -52.41 160.1 3.86 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.043 1.829 . . . . 0.0 110.336 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -7.74 32.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.139 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -91.75 7.33 42.25 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.3 m-85 -98.43 98.44 9.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -0.93 . . . . 0.0 109.677 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 26' ' ' THR . 1.9 pp -106.07 121.34 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 108.953 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.848 ' O ' HD12 ' A' ' 25' ' ' ILE . 16.8 p -46.35 173.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.667 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.87 -44.41 69.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.131 -0.98 . . . . 0.0 108.996 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 m -53.5 -38.7 63.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 33' ' ' LEU . 2.3 mm-40 -59.51 -39.35 83.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.736 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.55 -37.54 82.85 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.139 -0.976 . . . . 0.0 108.624 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -61.98 -33.02 73.54 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.31 74.74 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.437 -0.789 . . . . 0.0 109.358 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.0 mp -81.17 -15.52 55.51 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.4 0.619 . . . . 0.0 110.181 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.528 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 110.44 44.53 0.98 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.736 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 5.6 t90 -109.19 121.29 44.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -1.104 . . . . 0.0 109.184 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 38' ' ' SER . 4.2 t -89.62 116.31 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.312 -0.867 . . . . 0.0 108.86 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -59.3 -14.02 10.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 0.0 109.75 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.439 ' H ' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -86.64 -29.48 22.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.099 -1.0 . . . . 0.0 109.677 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -92.16 -16.69 25.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 109.501 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.56 30.0 25.99 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.543 ' O ' HG22 ' A' ' 45' ' ' VAL . 21.2 p-10 -85.98 40.99 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -1.132 . . . . 0.0 109.724 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.641 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 5.9 tp -58.56 -53.39 58.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.542 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.22 -19.17 1.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.937 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.11 -32.87 15.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.0 110.292 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -103.17 -57.65 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.929 -1.107 . . . . 0.0 109.683 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.841 ' HB1' ' HE2' ' A' ' 49' ' ' LYS . . . -114.12 79.69 5.11 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.423 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -62.18 156.92 47.49 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.252 1.968 . . . . 0.0 110.197 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.7 69.33 0.63 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.841 ' HE2' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -150.62 116.0 5.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.48 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 5.7 m -89.54 132.22 35.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.537 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 15.8 mm -87.17 104.83 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.364 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -157.56 168.42 34.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.16 -16.27 38.86 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.73 164.2 23.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -1.159 . . . . 0.0 109.3 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 56' ' ' PHE . 29.9 mm -67.81 166.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.922 . . . . 0.0 109.515 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.031 ' CE2' HD12 ' A' ' 63' ' ' LEU . 23.0 t80 -107.34 136.88 46.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.31 -0.869 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 2.5 m -43.81 -85.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.606 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 57' ' ' SER . 6.8 t-20 80.77 19.75 0.48 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.281 0.562 . . . . 0.0 109.488 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -38.61 78.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.153 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -71.34 -43.48 66.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.312 -0.868 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.54 47.43 2.54 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.596 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -96.32 -11.38 25.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -1.208 . . . . 0.0 109.449 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.031 HD12 ' CE2' ' A' ' 56' ' ' PHE . 20.9 mt -101.05 152.13 37.8 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.386 -0.821 . . . . 0.0 108.945 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.004 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.7 Cg_exo -56.52 86.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.058 1.839 . . . . 0.0 110.072 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 66' ' ' LYS . . . -81.44 155.56 36.04 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 65' ' ' GLY . 15.7 mttt -149.11 161.51 41.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -1.073 . . . . 0.0 109.221 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -47.13 102.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 0.0 109.282 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.16 58.55 2.93 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.467 ' NH2' HD12 ' A' ' 95' ' ' LEU . 12.8 tpp180 -106.44 126.82 52.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -1.152 . . . . 0.0 109.715 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 m -112.36 99.97 8.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.031 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.71 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 44.2 m95 -83.56 149.95 26.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.157 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -125.17 144.81 50.26 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HA ' HD13 ' A' ' 89' ' ' LEU . 17.2 pt-20 -115.36 159.54 20.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.854 -1.154 . . . . 0.0 110.479 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.654 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -146.3 149.58 34.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.468 -0.77 . . . . 0.0 109.297 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.97 138.68 48.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.75 HG21 ' CD1' ' A' ' 7' ' ' PHE . 19.8 mm -129.93 138.13 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.686 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 73.21 38.0 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.787 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -69.74 139.81 53.38 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.137 -0.977 . . . . 0.0 109.468 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.32 -79.84 0.38 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.504 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.5 163.18 12.48 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.788 -0.57 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.0 -159.26 52.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 83' ' ' ARG . 10.4 m-85 -51.11 147.64 5.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -1.124 . . . . 0.0 109.529 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 82' ' ' PHE . 5.5 mtp180 -53.04 -173.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.308 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -118.33 179.77 4.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.57 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -100.67 12.81 36.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.327 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.67 ' OD1' HG22 ' A' ' 100' ' ' THR . 50.3 m-20 -104.9 128.86 53.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.354 -0.841 . . . . 0.0 109.55 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 99' ' ' THR . 68.5 mtt180 -153.91 163.69 39.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.139 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.751 ' C ' HD22 ' A' ' 89' ' ' LEU . 4.3 tt -121.89 155.39 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.154 -0.966 . . . . 0.0 109.518 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.751 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.4 mm? -122.36 114.81 21.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.656 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.654 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 3.1 p90 -106.86 139.6 41.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.858 -1.151 . . . . 0.0 109.172 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.563 ' OG ' ' CZ3' ' A' ' 71' ' ' TRP . 1.3 m -110.06 173.7 6.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 p -64.77 -25.25 67.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.617 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.495 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 9.8 p-10 -89.73 18.44 5.55 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.415 -0.803 . . . . 0.0 108.971 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.596 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.45 27.41 8.02 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.743 -0.598 . . . . 0.0 110.233 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 1.004 HD13 ' HG2' ' A' ' 64' ' ' PRO . 6.2 mt -79.57 116.44 19.78 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.661 HG22 HD11 ' A' ' 88' ' ' ILE . 5.9 mt -114.9 105.86 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.43 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.638 ' HE1' HD22 ' A' ' 95' ' ' LEU . 23.0 m-85 -106.05 120.61 42.23 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -89.4 150.58 22.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 110.191 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -136.42 131.79 34.6 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.67 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -114.32 6.25 16.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 109.874 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.514 ' HB2' ' CB ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -125.43 24.68 7.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.143 -0.973 . . . . 0.0 109.397 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.6 t-80 76.53 76.01 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.92 . . . . 0.0 109.493 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.488 ' O ' ' CZ ' ' A' ' 106' ' ' PHE . 14.7 m-85 48.93 21.6 0.48 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.514 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -94.02 -34.87 12.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.011 -1.056 . . . . 0.0 109.118 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.483 ' O ' ' HB ' ' A' ' 99' ' ' THR . 95.2 m -121.14 140.81 51.49 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.596 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 94.9 m-85 -134.36 115.55 14.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.043 -1.036 . . . . 0.0 110.131 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 11.2 m -110.15 137.09 48.38 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.358 -0.839 . . . . 0.0 108.947 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -79.68 114.42 18.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 10.5 pt -132.05 68.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.878 . . . . 0.0 109.281 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 3.5 mtp180 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.555 ' O ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -138.28 65.5 1.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 109.529 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 2' ' ' GLN . 24.0 m 41.59 -166.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.491 -0.756 . . . . 0.0 109.851 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -116.27 111.04 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.377 -0.827 . . . . 0.0 109.571 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -149.95 54.76 0.93 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 10' ' ' VAL . 2.2 p -139.16 -168.82 2.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.775 ' CD1' HG21 ' A' ' 76' ' ' ILE . 32.9 m-85 -79.82 -57.7 3.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.619 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.53 -32.46 69.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 0.0 109.792 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.9 -50.04 50.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 6' ' ' THR . 35.1 t -66.98 -43.58 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -1.124 . . . . 0.0 109.385 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.51 -37.2 72.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.12 -56.32 13.61 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.538 -0.726 . . . . 0.0 109.242 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.638 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 15.8 t80 -60.76 -18.45 54.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 109.064 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.2 mt -74.5 -65.61 0.84 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.499 -0.751 . . . . 0.0 108.975 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -70.26 -6.7 36.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.988 -1.07 . . . . 0.0 109.254 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.534 HG22 ' CD1' ' A' ' 17' ' ' TYR . 19.8 m -89.42 -68.48 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 96.5 m-85 -92.0 6.42 46.44 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.627 -0.671 . . . . 0.0 109.642 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER 44.97 47.65 9.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.407 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 175.83 129.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 20' ' ' LEU . 27.0 mt -46.03 149.53 1.21 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.196 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.564 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 6.8 Cg_exo -53.93 162.56 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.114 1.876 . . . . 0.0 110.639 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -70.79 -5.71 32.26 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.38 -0.825 . . . . 0.0 109.034 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 53.6 p30 -91.75 0.24 57.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.869 . . . . 0.0 109.596 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.644 ' OH ' HG21 ' A' ' 10' ' ' VAL . 3.2 m-85 -89.87 107.92 19.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.056 -1.027 . . . . 0.0 109.579 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.957 HD12 ' O ' ' A' ' 26' ' ' THR . 1.7 pp -111.95 115.34 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 109.08 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.957 ' O ' HD12 ' A' ' 25' ' ' ILE . 81.7 p -44.59 168.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.307 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.607 ' N ' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.68 -41.18 88.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.929 -1.107 . . . . 0.0 109.175 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.05 -47.54 82.82 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 47.2 mm-40 -50.63 -35.19 29.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.933 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -70.03 -40.91 74.91 Favored 'General case' 0 C--O 1.202 -1.438 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -60.03 -18.88 49.52 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.345 -1.472 . . . . 0.0 108.01 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -69.01 -48.0 64.08 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.541 -0.724 . . . . 0.0 111.675 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.811 HD13 ' H ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.81 -0.07 41.64 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.928 -1.107 . . . . 0.0 111.713 -178.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.448 ' N ' HD22 ' A' ' 33' ' ' LEU . . . 108.94 25.93 5.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.893 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.933 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 10.5 t90 -89.12 123.46 33.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.895 -1.356 . . . . 0.0 109.191 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 t -91.93 114.51 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 108.917 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.593 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -60.07 -25.76 65.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.232 -0.917 . . . . 0.0 109.789 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -81.92 -55.33 4.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -69.08 -8.3 43.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.194 -0.941 . . . . 0.0 109.522 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 42.33 86.4 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -137.36 44.74 2.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -1.183 . . . . 0.0 109.623 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 3.7 tp -64.42 -41.01 96.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.344 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . . . -63.26 -9.22 10.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.921 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -102.67 -36.72 8.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.039 -1.038 . . . . 0.0 110.211 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.581 HG23 ' N ' ' A' ' 46' ' ' ALA . 28.7 m -108.13 -44.93 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.101 -1.0 . . . . 0.0 110.056 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -128.7 59.95 46.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.835 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 1.7 Cg_endo -62.58 171.08 6.04 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.175 1.917 . . . . 0.0 110.253 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.17 52.21 5.07 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.572 ' HG3' HG23 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -139.33 135.98 34.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -1.169 . . . . 0.0 109.557 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.514 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 13.3 m -101.64 121.79 42.68 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.235 -0.916 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.607 HG23 ' N ' ' A' ' 27' ' ' LYS . 11.3 mm -79.58 105.07 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.161 -0.962 . . . . 0.0 108.902 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.576 ' O ' HG22 ' A' ' 26' ' ' THR . . . -140.9 172.03 23.85 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.456 -1.354 . . . . 0.0 109.932 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.78 11.65 61.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -84.49 146.97 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -1.195 . . . . 0.0 109.392 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.512 HD13 HH11 ' A' ' 72' ' ' ARG . 19.5 mm -70.2 141.4 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.836 ' CE2' HD12 ' A' ' 63' ' ' LEU . 70.6 t80 -119.21 90.92 3.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.447 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -70.31 -4.81 23.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 109.788 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.59 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 4.5 t-20 75.05 91.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.22 -69.63 0.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -92.96 -63.87 1.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.396 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.8 73.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -117.12 -3.84 11.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -1.16 . . . . 0.0 109.591 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.887 HD22 ' CZ3' ' A' ' 71' ' ' TRP . 23.4 mt -93.32 147.95 34.69 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 109.257 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.999 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.1 Cg_exo -60.89 162.76 17.91 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.108 1.872 . . . . 0.0 110.223 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.89 -106.59 1.09 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.32 166.05 28.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -1.145 . . . . 0.0 109.459 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.99 92.78 0.25 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.527 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.86 33.9 1.78 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.81 160.26 19.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 109.429 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.82 103.95 16.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.887 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 8.8 m95 -107.52 161.49 14.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 109.471 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.647 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -117.73 131.25 56.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 0.0 108.819 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.808 ' HA ' HD13 ' A' ' 89' ' ' LEU . 3.6 pt-20 -107.44 147.49 30.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.316 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.66 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -135.17 147.27 49.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -70.78 137.01 49.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.354 -0.841 . . . . 0.0 109.818 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.775 HG21 ' CD1' ' A' ' 7' ' ' PHE . 21.5 mm -132.47 134.58 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.847 . . . . 0.0 109.428 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.562 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 1.1 m-20 69.9 125.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.259 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.535 ' CD1' ' C ' ' A' ' 78' ' ' TYR . 6.4 t80 -170.4 136.47 1.33 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.201 -0.937 . . . . 0.0 109.615 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.26 -79.56 0.35 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.382 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -153.79 154.89 34.83 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.717 -0.614 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.9 -171.63 20.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.57 169.07 0.72 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -1.159 . . . . 0.0 109.388 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -56.73 177.14 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.158 -0.964 . . . . 0.0 109.315 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 1.3 p30 -118.99 -174.05 2.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.875 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 p -115.22 29.63 7.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 52.9 m-20 -114.14 128.84 56.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.573 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.62 ' O ' HG22 ' A' ' 99' ' ' THR . 2.2 mtt180 -156.73 137.27 13.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.388 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 1.033 HD11 ' CG2' ' A' ' 96' ' ' ILE . 5.1 tt -93.12 126.11 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.117 -0.989 . . . . 0.0 109.258 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.808 HD13 ' HA ' ' A' ' 73' ' ' GLU . 4.0 mm? -95.67 100.36 12.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.472 -0.767 . . . . 0.0 109.994 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.654 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 28.8 p90 -97.54 140.35 32.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.983 -1.073 . . . . 0.0 108.525 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -107.84 172.37 6.87 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.985 -1.072 . . . . 0.0 110.761 -178.774 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -22.19 66.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.5 -0.75 . . . . 0.0 109.826 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 41.8 p-10 -89.58 17.88 5.97 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.382 -0.824 . . . . 0.0 108.829 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.578 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.84 23.96 8.29 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.634 -0.666 . . . . 0.0 110.104 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.999 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.2 mt -79.64 101.18 8.2 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 1.033 ' CG2' HD11 ' A' ' 88' ' ' ILE . 5.5 mt -96.5 118.26 42.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.22 -0.925 . . . . 0.0 110.631 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.498 ' O ' HG13 ' A' ' 88' ' ' ILE . 11.9 m-85 -120.11 160.97 21.79 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -131.79 122.02 25.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.756 -1.215 . . . . 0.0 110.056 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -108.69 131.14 55.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 109.01 179.349 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 p -115.12 18.15 16.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.641 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.7 OUTLIER -139.18 23.55 2.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER 78.33 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 50.35 20.89 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.808 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.77 -15.23 26.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.114 -0.992 . . . . 0.0 109.076 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.641 HG22 ' OD1' ' A' ' 101' ' ' ASP . 12.5 t -148.78 145.35 27.54 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 62' ' ' LYS . 53.7 m-85 -135.99 111.45 9.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.919 -1.113 . . . . 0.0 110.153 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.531 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.8 m -98.34 131.31 44.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.426 -0.796 . . . . 0.0 108.906 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 76.5 tttt -80.03 122.35 26.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.548 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 109' ' ' ILE . 11.3 pt -119.68 15.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.484 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.574 ' CD ' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.489 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.678 ' O ' HG22 ' A' ' 3' ' ' VAL . 4.6 mt-30 -104.02 145.38 30.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 2' ' ' GLN . 5.3 m 43.12 -168.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.498 -0.751 . . . . 0.0 109.858 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.646 HD13 ' HB2' ' A' ' 13' ' ' TYR . 13.3 mt -131.86 106.32 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.373 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -144.22 49.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 10' ' ' VAL . 1.2 p -138.68 -173.82 3.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.368 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.97 ' CD1' HG21 ' A' ' 76' ' ' ILE . 38.2 m-85 -76.57 -57.08 4.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.576 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -32.09 69.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 109.875 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.426 ' C ' ' CG2' ' A' ' 4' ' ' ILE . . . -67.59 -52.76 28.15 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 6' ' ' THR . 21.8 t -65.27 -40.71 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -1.14 . . . . 0.0 109.192 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.23 -37.11 76.71 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 1.242 ' OD1' ' NH2' ' A' ' 110' ' ' ARG . 0.7 OUTLIER -65.52 -55.81 15.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.523 -0.736 . . . . 0.0 109.161 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.646 ' HB2' HD13 ' A' ' 4' ' ' ILE . 38.0 t80 -60.77 -19.24 58.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.185 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 0.6 OUTLIER -74.94 -60.53 2.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.405 -0.81 . . . . 0.0 109.311 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -71.03 -10.9 60.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.905 -1.122 . . . . 0.0 109.254 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.7 m -89.42 -66.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.876 . . . . 0.0 110.411 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 71.0 m-85 -89.38 -6.74 56.35 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.61 -0.681 . . . . 0.0 109.742 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.496 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.3 OUTLIER 55.94 58.6 4.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.414 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 161.65 131.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.488 HD11 ' OH ' ' A' ' 90' ' ' TYR . 33.3 mt -44.47 150.17 0.69 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 109.252 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.57 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 7.4 Cg_exo -53.62 163.27 2.87 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.151 1.901 . . . . 0.0 110.428 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -71.22 -4.88 28.03 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.345 -0.847 . . . . 0.0 109.028 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -95.76 11.76 32.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.606 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.57 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 3.1 m-85 -101.77 109.75 21.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.152 -0.967 . . . . 0.0 109.484 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 26' ' ' THR . 1.4 pp -115.73 118.08 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.327 -0.858 . . . . 0.0 108.989 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' HD12 ' A' ' 25' ' ' ILE . 14.2 p -45.82 171.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.301 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -67.9 -42.94 80.39 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.942 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.6 m -55.43 -41.36 72.68 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.728 ' O ' HD12 ' A' ' 33' ' ' LEU . 11.8 mm-40 -57.11 -40.88 77.93 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.705 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -64.18 -36.84 85.36 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' OE1' ' CE3' ' A' ' 35' ' ' TRP . 6.7 mm100 -60.38 -39.21 86.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.31 -35.52 73.94 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.455 -0.778 . . . . 0.0 109.832 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.7 mp -81.23 -14.02 57.93 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.628 -0.67 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.888 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 110.77 40.39 1.32 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.705 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 10.9 t90 -109.92 118.9 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -1.19 . . . . 0.0 108.993 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 38' ' ' SER . 26.0 t -91.35 111.33 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.334 -0.854 . . . . 0.0 109.106 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.649 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . -57.71 -16.5 11.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.215 -0.928 . . . . 0.0 109.598 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.561 ' H ' HG12 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -77.81 -55.5 5.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 109.538 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 40' ' ' GLY . 22.5 mttm -81.6 -3.05 52.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.667 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 42.86 85.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.508 ' O ' HG22 ' A' ' 45' ' ' VAL . 1.8 p-10 -134.49 47.17 2.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -1.206 . . . . 0.0 109.623 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.576 HD11 ' CB ' ' A' ' 30' ' ' ALA . 5.8 tp -62.81 -44.95 94.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.185 -0.947 . . . . 0.0 109.666 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.29 -8.1 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 110.128 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 32.7 m-20 -101.6 -22.72 14.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.019 -1.051 . . . . 0.0 110.258 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.888 HG11 ' O ' ' A' ' 34' ' ' GLY . 17.9 m -121.18 -48.54 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.909 -1.12 . . . . 0.0 110.124 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.524 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -127.55 60.57 44.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.119 -0.988 . . . . 0.0 110.115 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.7 Cg_endo -62.66 -179.55 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.172 1.914 . . . . 0.0 110.177 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.44 59.66 3.03 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HE3' HG21 ' A' ' 25' ' ' ILE . 3.8 mttp -151.51 171.48 17.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -1.157 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.545 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 19.4 m -137.34 118.9 14.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.564 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.563 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 8.7 mm -76.99 103.64 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.048 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -147.38 171.2 28.06 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.86 7.87 54.87 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 9.7 m-20 -79.99 145.12 32.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -1.209 . . . . 0.0 109.313 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mm -69.97 138.05 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.537 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.788 ' CE2' HD12 ' A' ' 63' ' ' LEU . 60.0 t80 -111.52 91.12 3.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.827 . . . . 0.0 109.359 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.02 -5.12 24.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.66 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.576 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 30.0 t-20 64.91 59.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -62.4 -28.87 70.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.341 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' OE1' ' CB ' ' A' ' 103' ' ' TYR . 2.0 mp0 -78.5 -74.62 0.26 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.375 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.71 48.31 0.3 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 1.9 mttt -118.52 -7.25 10.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 0.0 109.721 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.795 HD22 ' CZ3' ' A' ' 71' ' ' TRP . 16.9 mt -94.88 146.39 31.29 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 0.0 109.122 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.704 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.8 Cg_exo -60.35 86.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.059 1.839 . . . . 0.0 110.209 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.473 ' HA2' ' HD3' ' A' ' 69' ' ' ARG . . . -102.2 -171.05 27.2 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.44 -173.43 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -1.144 . . . . 0.0 109.573 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.4 m -69.64 88.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.5 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.44 46.63 1.65 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.515 ' NH1' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -121.24 132.86 55.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -1.091 . . . . 0.0 109.433 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.46 165.36 12.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.795 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 23.1 m95 -136.98 165.89 24.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 35.0 mtt180 -132.87 143.78 49.75 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.706 ' HA ' HD13 ' A' ' 89' ' ' LEU . 10.4 pt-20 -121.48 155.39 35.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.972 -1.08 . . . . 0.0 110.459 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -146.77 148.96 32.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 109.144 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -68.72 133.04 47.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.97 HG21 ' CD1' ' A' ' 7' ' ' PHE . 26.3 mm -119.46 116.09 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.965 . . . . 0.0 109.644 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 72.49 124.29 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.868 . . . . 0.0 109.631 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -170.59 148.06 2.99 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.286 -0.884 . . . . 0.0 109.468 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.98 -79.84 0.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.453 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -145.3 171.86 13.97 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.754 -0.591 . . . . 0.0 109.452 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.61 -166.55 43.55 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -62.89 179.36 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -1.125 . . . . 0.0 109.428 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -78.56 164.55 24.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -104.72 -168.32 1.46 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.299 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.526 ' HB3' ' N ' ' A' ' 102' ' ' HIS . 13.3 m -105.1 16.44 25.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.0 109.649 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 0.9 OUTLIER -96.66 126.78 42.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.638 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.619 ' O ' HG22 ' A' ' 99' ' ' THR . 1.9 mtt180 -160.09 150.69 18.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 109.499 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.827 HD11 HG22 ' A' ' 96' ' ' ILE . 3.3 tt -108.29 156.64 8.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 109.23 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.727 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.4 mm? -125.95 107.17 10.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.428 -0.795 . . . . 0.0 109.376 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 72' ' ' ARG . 1.6 p90 -102.44 139.02 38.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.795 -1.191 . . . . 0.0 109.025 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.455 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -108.12 174.64 5.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.262 -0.899 . . . . 0.0 110.396 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.4 p -65.29 -24.68 67.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.515 ' OD2' ' NH1' ' A' ' 69' ' ' ARG . 45.5 p30 -89.76 18.06 5.96 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.592 ' CE3' ' HA ' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.02 29.66 7.9 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.725 -0.609 . . . . 0.0 110.048 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.0 mt -82.21 113.06 19.78 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.827 HG22 HD11 ' A' ' 88' ' ' ILE . 2.0 mt -109.24 114.89 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 110.366 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.895 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 26.8 m-85 -121.27 118.63 30.03 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -88.51 117.3 27.35 Favored 'General case' 0 N--CA 1.492 1.632 1 N-CA-C 125.7 5.444 . . . . 0.0 125.7 -179.282 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -108.69 131.14 55.21 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 124.652 3.387 . . . . 0.0 109.01 -170.31 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 1.9 p -115.12 18.15 16.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.641 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.7 OUTLIER -139.18 23.55 2.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER 78.33 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.671 ' OH ' ' OE2' ' A' ' 73' ' ' GLU . 15.5 m-85 50.35 20.89 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.808 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.77 -15.23 26.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.114 -0.992 . . . . 0.0 109.076 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.641 HG22 ' OD1' ' A' ' 101' ' ' ASP . 12.5 t -148.78 145.35 27.54 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.895 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . 53.7 m-85 -135.99 111.45 9.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.919 -1.113 . . . . 0.0 110.153 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.563 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 1.8 m -98.34 131.31 44.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.426 -0.796 . . . . 0.0 108.906 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -80.03 122.35 26.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.548 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.768 HD11 HD11 ' A' ' 88' ' ' ILE . 11.3 pt -119.68 15.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.484 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 1.242 ' NH2' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.489 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.473 HD12 ' CD1' ' A' ' 13' ' ' TYR . 11.1 mt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -144.48 62.41 1.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.952 . . . . 0.0 109.705 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.556 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -140.0 -174.56 3.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.923 . . . . 0.0 109.323 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.826 ' CE1' HG21 ' A' ' 76' ' ' ILE . 21.3 m-85 -77.31 -60.84 2.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.256 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -33.46 70.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.371 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.28 -48.99 60.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.611 HG12 HD12 ' A' ' 14' ' ' LEU . 41.6 t -68.31 -36.37 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -1.144 . . . . 0.0 109.207 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.1 -38.86 87.78 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.78 -54.79 19.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.546 -0.721 . . . . 0.0 109.118 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE1' ' CD2' ' A' ' 17' ' ' TYR . 47.9 t80 -55.39 -26.67 42.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.844 . . . . 0.0 109.218 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.611 HD12 HG12 ' A' ' 10' ' ' VAL . 1.2 mt -72.84 -60.5 2.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.428 -0.795 . . . . 0.0 109.376 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.426 ' NE2' ' OXT' ' A' ' 110' ' ' ARG . 2.9 mt-30 -70.49 -5.21 27.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.025 -1.047 . . . . 0.0 109.565 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 m -93.15 -68.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.17 -0.956 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD2' ' CE1' ' A' ' 13' ' ' TYR . 58.8 m-85 -89.63 3.96 50.95 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.644 -0.66 . . . . 0.0 109.553 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.7 m170 43.89 51.46 6.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER 177.39 130.38 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.536 -0.728 . . . . 0.0 109.117 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.713 HD13 ' HD2' ' A' ' 24' ' ' TYR . 17.6 mt -47.61 159.37 0.44 Allowed Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.093 -1.004 . . . . 0.0 109.131 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.58 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 4.1 Cg_exo -54.7 158.43 10.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.17 1.913 . . . . 0.0 110.454 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.21 -6.3 33.55 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.373 -0.829 . . . . 0.0 109.03 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.3 28.61 8.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.89 . . . . 0.0 109.463 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.713 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.6 m-30 -113.59 79.03 1.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.505 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -94.26 127.96 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.906 . . . . 0.0 108.983 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 25' ' ' ILE . 44.0 p -46.66 176.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 109.992 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.24 -48.64 56.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.102 -0.999 . . . . 0.0 109.161 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -51.57 -36.42 45.3 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.658 ' O ' HD12 ' A' ' 33' ' ' LEU . 10.1 mm-40 -60.62 -43.27 97.66 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -65.21 -33.52 76.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.197 -0.94 . . . . 0.0 108.529 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' CG ' ' CE3' ' A' ' 35' ' ' TRP . 1.0 OUTLIER -66.17 -31.68 72.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.31 87.42 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.448 -0.782 . . . . 0.0 109.519 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -80.82 -7.12 59.34 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.672 -0.642 . . . . 0.0 109.878 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 45' ' ' VAL . . . 104.18 68.49 0.76 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.713 ' HA ' HG21 ' A' ' 45' ' ' VAL . 2.6 t90 -126.52 133.4 51.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -1.172 . . . . 0.0 109.664 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.507 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 39.3 t -89.6 132.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.604 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.448 0 O-C-N 120.876 -1.14 . . . . 0.0 110.23 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.083 0.468 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.96 HD21 HD11 ' A' ' 51' ' ' ILE . 6.6 tp -57.96 -65.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.121 -0.987 . . . . 0.0 109.049 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.66 -11.13 2.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.836 -0.54 . . . . 0.0 110.228 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -78.98 -39.06 35.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.97 -1.081 . . . . 0.0 109.723 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 35' ' ' TRP . 33.3 m -96.64 -15.26 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.466 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.65 63.92 6.18 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 4.0 Cg_exo -59.59 164.87 10.55 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.191 1.927 . . . . 0.0 110.39 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.11 54.75 24.72 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HG2' HG12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -152.26 162.98 40.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.589 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.599 ' HB3' ' CD1' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -139.04 159.75 41.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.462 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.96 HD11 HD21 ' A' ' 42' ' ' LEU . 3.7 mm -105.01 111.89 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.512 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -157.58 165.0 33.33 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.64 22.56 28.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 39.8 m-20 -97.28 145.44 26.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -1.141 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.51 HD12 HG21 ' A' ' 70' ' ' THR . 16.3 mm -65.54 143.74 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.896 ' CE2' HD12 ' A' ' 63' ' ' LEU . 86.0 t80 . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.302 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.603 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 13.1 mttt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.243 0.544 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.896 HD12 ' CE2' ' A' ' 56' ' ' PHE . 48.5 mt -114.36 147.22 37.49 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.918 . . . . 0.0 109.161 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.877 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.4 Cg_endo -62.38 87.99 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.166 1.911 . . . . 0.0 110.182 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.412 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.51 HG21 HD12 ' A' ' 55' ' ' ILE . 7.6 m . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.262 0.553 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.839 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 6.7 m95 -107.64 175.4 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.434 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.652 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 1.4 mmt180 -128.47 137.84 52.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.349 -0.844 . . . . 0.0 108.785 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.811 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -116.96 157.89 24.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.022 -1.049 . . . . 0.0 110.102 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.51 ' HB3' ' CG2' ' A' ' 88' ' ' ILE . . . -148.64 151.03 34.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -0.813 . . . . 0.0 109.129 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -73.03 131.15 41.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.697 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.826 HG21 ' CE1' ' A' ' 7' ' ' PHE . 20.5 mm -115.74 126.15 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.3 -0.875 . . . . 0.0 108.885 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER 68.6 117.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.033 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.427 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 2.5 t80 -170.44 125.21 0.73 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.136 -0.977 . . . . 0.0 109.586 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.01 -80.25 0.46 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.0 p -143.93 156.22 44.35 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.759 -0.588 . . . . 0.0 109.458 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.39 -167.9 17.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 83' ' ' ARG . 1.5 m-85 -65.34 149.67 49.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -1.187 . . . . 0.0 109.264 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.603 ' CB ' ' CZ ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -46.99 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.076 -1.015 . . . . 0.0 109.133 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.77 179.89 3.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.606 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -108.21 11.59 27.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 63.4 m-20 -96.22 129.37 43.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.625 ' O ' HG22 ' A' ' 99' ' ' THR . 0.3 OUTLIER -155.68 156.09 34.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.213 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.059 HD11 ' CG2' ' A' ' 96' ' ' ILE . 18.9 tt -112.26 160.49 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.997 -1.064 . . . . 0.0 109.287 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.871 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.4 mm? -130.48 103.52 6.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.652 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 34.0 p90 -99.62 140.42 33.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.813 -1.18 . . . . 0.0 108.93 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -106.47 176.03 5.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.164 -0.96 . . . . 0.0 110.377 -178.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 p -65.47 -25.17 67.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.447 -0.783 . . . . 0.0 109.576 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.475 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 26.7 p-10 -89.65 17.57 6.34 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.58 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.79 26.04 7.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.659 -0.65 . . . . 0.0 110.291 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.877 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.0 mt -80.34 113.42 18.51 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.059 ' CG2' HD11 ' A' ' 88' ' ' ILE . 2.8 mt -106.82 119.88 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -1.0 . . . . 0.0 110.617 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.608 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 16.3 m-85 -122.89 117.45 25.62 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.519 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.44 147.06 24.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.981 -1.075 . . . . 0.0 110.21 -178.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -132.8 125.71 30.7 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.65 29.11 7.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.728 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -150.0 20.16 0.88 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.643 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER 79.06 68.83 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.389 -0.819 . . . . 0.0 110.073 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 8.1 m-85 54.44 17.5 1.61 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 110.153 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.475 ' CB ' ' OD2' ' A' ' 101' ' ' ASP . 3.9 mm-40 -92.54 -15.85 26.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 109.093 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.501 ' N ' ' OD2' ' A' ' 101' ' ' ASP . 40.8 m -144.54 147.13 32.83 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.603 ' CE1' ' HB2' ' A' ' 62' ' ' LYS . 75.5 m-85 -140.49 130.0 24.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.839 -1.163 . . . . 0.0 110.58 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.496 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 89.9 m -120.05 133.67 55.47 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.23 115.41 18.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -109.84 -83.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 109.536 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.608 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -140.65 53.87 1.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.481 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -137.19 -170.58 2.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.842 ' CE1' HG21 ' A' ' 76' ' ' ILE . 46.2 m-85 -75.18 -58.66 3.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.269 -0.895 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.442 ' OD1' ' NH2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -71.09 -31.5 67.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.808 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.75 -52.27 30.38 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 14' ' ' LEU . 99.9 t -66.74 -42.79 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -1.131 . . . . 0.0 109.386 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 -38.18 73.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.44 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.9 m-20 -65.46 -55.67 16.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.563 -0.711 . . . . 0.0 109.224 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.688 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 53.7 t80 -58.55 -21.32 52.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 109.195 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.668 HD12 HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -74.99 -64.28 1.08 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.394 -0.816 . . . . 0.0 109.212 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -70.43 -5.62 29.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.021 . . . . 0.0 109.45 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 67.9 m -93.85 -67.08 0.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 109.662 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.688 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 78.2 m-85 -89.95 3.66 52.44 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.567 -0.708 . . . . 0.0 109.533 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 25.8 m170 43.75 51.75 6.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.721 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 7.8 ptmt 175.89 129.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.461 -0.774 . . . . 0.0 109.168 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.531 HD13 ' HD2' ' A' ' 24' ' ' TYR . 14.7 mt -44.04 161.06 0.22 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.139 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.577 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.5 Cg_exo -53.51 159.91 5.81 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.124 1.883 . . . . 0.0 110.403 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.75 -3.31 24.48 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.348 -0.845 . . . . 0.0 109.147 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -117.47 34.67 5.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.95 . . . . 0.0 109.61 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.615 ' CE1' ' CB ' ' A' ' 50' ' ' SER . 1.5 m-30 -115.34 90.83 3.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.544 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.2 pt -97.27 124.09 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.925 . . . . 0.0 109.14 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 25' ' ' ILE . 12.2 p -45.44 172.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 109.637 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.86 -42.36 73.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 109.087 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 t -53.98 -37.24 63.76 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.89 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -59.78 -44.28 93.99 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.632 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -61.49 -39.79 92.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.251 -0.906 . . . . 0.0 108.59 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.557 ' CG ' ' CE3' ' A' ' 35' ' ' TRP . 34.0 mt-30 -61.36 -34.86 76.0 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.27 -33.77 74.08 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.442 -0.786 . . . . 0.0 109.38 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.12 -13.74 58.39 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.653 -0.654 . . . . 0.0 109.997 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.471 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 111.74 46.06 0.8 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.632 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 2.9 t90 -106.8 133.13 51.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -1.191 . . . . 0.0 109.725 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.642 HG12 ' OD1' ' A' ' 41' ' ' ASN . 9.1 p -89.57 134.55 28.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.616 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.473 0 O-C-N 120.898 -1.126 . . . . 0.0 110.618 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.642 ' OD1' HG12 ' A' ' 36' ' ' VAL . 3.2 p-10 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.136 0.493 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.009 HD21 HD11 ' A' ' 51' ' ' ILE . 8.1 tp -60.34 -64.65 0.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.962 -1.087 . . . . 0.0 109.191 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.12 -10.05 5.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.735 -0.603 . . . . 0.0 110.158 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 41' ' ' ASN . 27.6 t70 -79.1 -28.66 43.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.018 -1.051 . . . . 0.0 109.6 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 34' ' ' GLY . 4.4 m -110.04 -13.87 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.67 68.11 12.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.65 155.74 51.87 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.206 1.938 . . . . 0.0 110.251 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.03 54.67 24.86 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' HG2' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -153.88 120.1 5.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -1.131 . . . . 0.0 109.469 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.615 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -91.53 166.11 13.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.593 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 1.009 HD11 HD21 ' A' ' 42' ' ' LEU . 2.3 mm -112.13 107.78 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 0.0 109.667 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -161.94 156.35 27.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.92 32.74 3.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.475 ' OD1' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -109.65 155.05 21.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -1.202 . . . . 0.0 109.403 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.0 mm -70.65 151.06 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.565 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.844 ' CE2' HD12 ' A' ' 63' ' ' LEU . 70.7 t80 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 3.4 mptm? . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.355 0.598 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.844 HD12 ' CE2' ' A' ' 56' ' ' PHE . 11.2 mt -99.0 146.22 31.31 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.338 -0.851 . . . . 0.0 109.215 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.506 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 4.0 Cg_exo -60.93 104.19 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.156 1.904 . . . . 0.0 110.323 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 71' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.291 0.567 . . . . 0.0 109.563 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.772 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 18.9 m95 -149.22 171.03 17.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.61 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.629 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 93.4 mtt180 -131.99 151.92 51.45 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.667 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -126.72 152.47 46.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.992 -1.067 . . . . 0.0 110.469 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.489 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -148.06 151.5 35.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.754 . . . . 0.0 108.992 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -73.43 137.93 44.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.993 -1.067 . . . . 0.0 109.789 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.842 HG21 ' CE1' ' A' ' 7' ' ' PHE . 21.8 mm -116.99 112.15 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 108.89 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.2 t-20 74.02 123.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.15 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 6.7 t80 -170.41 119.19 0.56 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.262 -0.899 . . . . 0.0 109.439 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.3 -43.9 2.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.124 -0.985 . . . . 0.0 109.561 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 173.63 169.1 0.18 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.613 -0.679 . . . . 0.0 109.444 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.96 -161.7 21.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -70.43 143.76 51.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -1.108 . . . . 0.0 109.685 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.662 ' HE ' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -40.73 142.13 0.49 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER -87.79 -176.45 5.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.181 -0.949 . . . . 0.0 109.752 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.92 3.89 19.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.801 . . . . 0.0 109.558 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.509 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 8.1 m-20 -89.68 128.93 36.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.107 -0.995 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.532 ' O ' ' CG2' ' A' ' 99' ' ' THR . 83.7 mtt180 -159.05 161.77 36.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.758 HD11 HG22 ' A' ' 96' ' ' ILE . 1.3 tt -122.93 153.06 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.13 -0.981 . . . . 0.0 109.672 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.732 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.8 mm? -118.88 120.65 37.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.565 -0.709 . . . . 0.0 109.217 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' A' ' 72' ' ' ARG . 1.7 p90 -113.91 138.36 50.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.851 -1.156 . . . . 0.0 109.011 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.469 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -107.67 172.87 6.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 110.295 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.5 p -66.41 -22.57 66.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.319 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 30.8 p-10 -89.59 16.4 7.84 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.571 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.65 30.39 6.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.755 -0.59 . . . . 0.0 110.316 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.744 HD22 ' HE1' ' A' ' 97' ' ' TYR . 7.4 mt -83.59 117.72 23.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 110' ' ' ARG . 2.5 mt -114.84 109.43 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.096 -1.003 . . . . 0.0 110.615 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.744 ' HE1' HD22 ' A' ' 95' ' ' LEU . 21.5 m-85 -112.93 120.75 42.49 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.58 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -88.81 152.19 21.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.903 -1.123 . . . . 0.0 110.359 -178.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -136.38 123.83 22.1 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.69 29.22 7.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.82 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -150.11 20.71 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.042 -1.036 . . . . 0.0 109.889 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 48.7 t-80 79.52 70.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.46 -0.775 . . . . 0.0 109.877 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.492 ' HE2' HD11 ' A' ' 89' ' ' LEU . 40.6 m-85 49.43 20.91 0.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 110.155 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.459 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . 2.7 mt-30 -91.88 -14.47 29.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 0.0 109.022 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.522 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 97.6 m -144.55 157.14 44.36 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.492 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 92.3 m-85 -146.84 121.64 9.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.894 -1.129 . . . . 0.0 110.242 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -115.13 130.4 56.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 109.018 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.67 113.67 16.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.049 -1.032 . . . . 0.0 109.411 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.697 HD11 HD11 ' A' ' 88' ' ' ILE . 2.4 pt -111.28 -25.65 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.642 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.9 ' HB2' HD12 ' A' ' 96' ' ' ILE . 1.3 mtt-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.56 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 4' ' ' ILE . 3.6 mt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -128.09 40.93 3.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.68 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -133.39 -175.17 3.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.639 ' CG ' HG21 ' A' ' 76' ' ' ILE . 31.6 m-85 -78.94 -47.91 15.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.34 -40.38 70.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.904 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.33 -51.79 35.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 6' ' ' THR . 41.2 t -63.29 -43.99 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.16 -1.2 . . . . 0.0 109.15 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.432 ' CB ' ' NH2' ' A' ' 110' ' ' ARG . . . -56.61 -39.35 73.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -55.64 27.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.594 -0.692 . . . . 0.0 109.154 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.679 ' CE1' ' CD2' ' A' ' 17' ' ' TYR . 12.6 t80 -57.6 -23.74 52.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.296 -0.877 . . . . 0.0 109.242 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 2.2 mt -71.45 -63.51 1.1 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.391 -0.818 . . . . 0.0 109.11 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -71.05 -4.99 27.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 109.414 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 48.4 m -91.2 -70.13 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.829 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.679 ' CD2' ' CE1' ' A' ' 13' ' ' TYR . 96.8 m-85 -89.91 -4.2 57.65 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.652 -0.655 . . . . 0.0 109.583 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.3 m170 57.04 51.74 10.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.671 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 172.34 129.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.565 -0.709 . . . . 0.0 109.101 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 20' ' ' LEU . 21.1 mt -45.47 148.52 1.19 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.207 -0.933 . . . . 0.0 108.995 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.1 Cg_exo -53.12 160.36 4.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.112 1.875 . . . . 0.0 110.474 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.61 -8.27 33.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.353 -0.842 . . . . 0.0 109.14 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 39.5 p30 -95.2 21.97 7.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.509 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.2 m-85 -114.77 84.14 2.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.761 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 26' ' ' THR . 1.8 pp -96.62 126.18 49.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.709 ' O ' HD12 ' A' ' 25' ' ' ILE . 16.9 p -46.9 174.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.626 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.51 -43.75 69.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.076 -1.015 . . . . 0.0 109.042 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.17 -38.99 69.03 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.787 ' O ' HD12 ' A' ' 33' ' ' LEU . 10.5 mm-40 -58.51 -39.25 79.57 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 25' ' ' ILE . . . -68.21 -36.61 79.81 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.536 ' HG3' ' CE3' ' A' ' 35' ' ' TRP . 25.5 mt-30 -60.74 -34.73 74.87 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.96 -34.86 70.39 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.28 -18.69 45.0 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.52 0.676 . . . . 0.0 110.002 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 116.04 38.56 0.95 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.626 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 10.9 t90 -100.85 121.86 42.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -1.156 . . . . 0.0 109.133 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 36' ' ' VAL . 10.6 p -89.94 113.11 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.285 -0.884 . . . . 0.0 108.962 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.581 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.724 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.671 ' OD1' HG12 ' A' ' 36' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 42' ' ' LEU . 12.2 tp -54.35 -63.37 1.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.318 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -42.0 -25.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.436 -0.79 . . . . 0.0 110.147 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -79.89 -44.42 20.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.013 -1.054 . . . . 0.0 110.639 -179.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 46' ' ' ALA . 33.6 m -94.72 -52.15 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.879 -1.138 . . . . 0.0 110.556 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.602 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -119.92 74.59 19.88 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.886 -1.134 . . . . 0.0 109.918 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -63.06 166.09 15.23 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.165 1.91 . . . . 0.0 110.263 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.479 ' O ' ' HD2' ' A' ' 49' ' ' LYS . . . 43.38 59.24 3.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -139.03 162.56 34.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 0.0 109.438 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 4.3 m -129.33 133.66 47.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.865 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.562 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 6.5 mm -96.41 107.56 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.058 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.6 171.2 33.61 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.46 71.25 1.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 10.2 m-20 -159.66 165.42 32.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -1.105 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.486 ' CD1' HG21 ' A' ' 70' ' ' THR . 23.7 mm -69.27 149.73 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.312 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.955 ' CE2' HD12 ' A' ' 63' ' ' LEU . 45.9 t80 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.496 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.61 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 2.0 mmmt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.389 0.614 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.955 HD12 ' CE2' ' A' ' 56' ' ' PHE . 61.0 mt -122.25 148.66 52.76 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.416 -0.803 . . . . 0.0 108.933 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.723 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.7 Cg_endo -60.61 96.45 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.111 1.874 . . . . 0.0 110.037 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.84 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.486 HG21 ' CD1' ' A' ' 55' ' ' ILE . 19.9 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.691 ' CE3' HD13 ' A' ' 63' ' ' LEU . 32.9 m95 -89.05 146.57 24.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.975 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.604 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 4.1 mtm180 -120.58 140.08 52.03 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.748 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -107.62 161.78 14.56 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.004 -1.06 . . . . 0.0 110.551 -178.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.621 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -145.93 148.16 32.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.515 -0.74 . . . . 0.0 109.183 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.3 m-20 -72.55 141.39 48.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.42 -0.8 . . . . 0.0 109.543 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.639 HG21 ' CG ' ' A' ' 7' ' ' PHE . 20.3 mm -135.78 137.46 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 71.62 38.72 0.95 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.479 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -69.62 136.93 51.81 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.327 -0.858 . . . . 0.0 109.576 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -129.64 -80.26 0.56 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.0 109.384 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.3 m -168.15 -178.06 3.53 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.697 -0.627 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 62.9 -155.56 41.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.416 ' O ' ' O ' ' A' ' 81' ' ' GLY . 3.3 m-85 -49.45 175.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -1.171 . . . . 0.0 109.57 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -60.62 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.392 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.86 -172.78 2.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.21 1.83 13.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.501 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 5.2 m-20 -109.06 131.37 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.981 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.1 OUTLIER -148.88 139.71 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.234 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.886 HD11 ' CG2' ' A' ' 96' ' ' ILE . 12.5 tt -99.57 142.82 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.047 -1.033 . . . . 0.0 109.587 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.748 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -115.2 114.48 25.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.368 -0.833 . . . . 0.0 109.469 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.613 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 5.0 p90 -108.72 138.5 44.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.823 -1.173 . . . . 0.0 108.739 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.571 ' HB3' ' CE2' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -111.49 177.27 4.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.904 -1.122 . . . . 0.0 110.761 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 p -65.84 -21.18 66.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.564 -0.71 . . . . 0.0 110.387 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 10.3 p-10 -89.01 13.43 12.92 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.181 -0.949 . . . . 0.0 108.95 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.559 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.6 OUTLIER 68.17 26.59 7.04 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.665 -0.647 . . . . 0.0 111.003 178.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.723 HD13 ' HG2' ' A' ' 64' ' ' PRO . 8.4 mt -87.67 130.37 34.82 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.886 ' CG2' HD11 ' A' ' 88' ' ' ILE . 9.5 mt -120.72 108.88 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 110.391 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 108' ' ' LYS . 15.1 m-85 -107.43 112.34 25.09 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.886 ' HE2' HG21 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -88.96 133.5 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.033 -1.042 . . . . 0.0 109.772 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -116.07 122.68 45.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 108.971 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.5 p -104.96 26.83 8.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.357 -0.84 . . . . 0.0 109.822 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.771 ' CG ' HG22 ' A' ' 105' ' ' THR . 22.2 p30 -149.72 25.98 0.84 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.088 -1.007 . . . . 0.0 109.624 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 12.2 t-80 76.14 74.16 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.462 ' OH ' ' NE ' ' A' ' 87' ' ' ARG . 3.7 m-85 42.15 29.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.743 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.436 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER -99.64 -19.32 16.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.771 HG22 ' CG ' ' A' ' 101' ' ' ASP . 13.1 t -147.73 106.88 3.86 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.61 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 71.8 m-85 -93.04 125.39 37.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.127 -0.983 . . . . 0.0 110.387 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 2.6 m -112.93 125.93 54.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.401 -0.812 . . . . 0.0 108.949 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.49 ' HB2' ' CE1' ' A' ' 97' ' ' TYR . 8.9 ttmt -78.96 113.53 17.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.015 -1.053 . . . . 0.0 109.649 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.886 HG21 ' HE2' ' A' ' 98' ' ' LYS . 3.5 pt -116.05 -4.36 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.584 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.873 ' HG3' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.441 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -139.59 57.82 1.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.686 ' O ' HD12 ' A' ' 76' ' ' ILE . 79.2 p -142.58 -177.56 5.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.34 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' CE2' HG22 ' A' ' 100' ' ' THR . 34.2 m-85 -75.64 -57.22 4.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.93 -37.35 72.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.924 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.0 -50.76 56.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.664 HG12 HD12 ' A' ' 14' ' ' LEU . 84.9 t -64.21 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.51 75.15 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -55.54 15.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.513 -0.742 . . . . 0.0 109.039 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.677 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 42.7 t80 -60.2 -19.59 54.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 109.226 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.664 HD12 HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -76.62 -63.26 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.379 -0.826 . . . . 0.0 109.492 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 24.8 pt20 -70.53 -8.63 52.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.049 -1.032 . . . . 0.0 109.515 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.9 m -93.43 -62.43 1.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 109.782 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.677 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 30.3 m-85 -89.47 2.03 55.09 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.671 -0.643 . . . . 0.0 109.57 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 16.7 m170 42.99 46.97 4.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.297 -0.877 . . . . 0.0 109.669 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 5.1 pttt 177.73 129.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.485 -0.76 . . . . 0.0 109.147 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.946 HD11 ' OH ' ' A' ' 90' ' ' TYR . 18.4 mt -44.6 160.66 0.23 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.165 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.7 Cg_exo -53.52 158.86 7.15 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.038 1.825 . . . . 0.0 110.374 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -72.37 -3.86 26.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.165 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.66 7.84 28.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.614 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.715 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.6 m-30 -92.05 77.18 5.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -89.58 129.17 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.031 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.479 ' C ' HG23 ' A' ' 51' ' ' ILE . 28.6 p -44.29 169.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.0 109.447 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.842 ' HG2' HG21 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -67.62 -47.09 70.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.093 -1.005 . . . . 0.0 109.109 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -53.81 -37.13 63.22 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.67 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.2 mt-10 -59.03 -40.9 86.42 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.497 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -66.99 -35.34 79.73 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.611 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 2.7 mm-40 -62.42 -34.07 76.03 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.37 -36.92 83.76 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.67 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.7 mp -81.01 -5.57 57.75 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.73 -0.606 . . . . 0.0 110.255 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.885 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 105.94 62.39 0.62 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.612 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 10.7 t90 -131.54 118.92 20.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -1.156 . . . . 0.0 109.046 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.2 t -90.86 110.16 21.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.184 -0.948 . . . . 0.0 108.872 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.273 -0.892 . . . . 0.0 109.63 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.521 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.166 0.508 . . . . 0.0 109.844 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 51' ' ' ILE . 11.0 tp -52.53 -66.86 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.118 -0.989 . . . . 0.0 109.214 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.37 -14.87 3.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.482 -0.761 . . . . 0.0 109.932 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -79.46 -33.98 41.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.989 . . . . 0.0 110.017 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.885 HG11 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -100.12 -53.7 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.158 -0.964 . . . . 0.0 109.648 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -113.81 80.13 4.96 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.485 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 1.8 Cg_endo -62.88 164.79 17.97 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.227 1.951 . . . . 0.0 110.466 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 42.41 50.65 5.57 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 5.0 mmtp -145.78 103.71 3.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -1.15 . . . . 0.0 109.509 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.542 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 2.0 m -89.89 159.22 17.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.842 HG21 ' HG2' ' A' ' 27' ' ' LYS . 2.3 mm -99.63 134.7 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.51 149.39 11.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.11 27.69 4.98 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 3.4 m-20 -96.33 145.33 25.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -1.185 . . . . 0.0 109.471 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.507 HD13 ' HA ' ' A' ' 55' ' ' ILE . 15.8 mm -65.68 145.03 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.567 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.885 ' CE2' HD12 ' A' ' 63' ' ' LEU . 71.6 t80 . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 0.0 109.186 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.6 ' HB3' ' CD1' ' A' ' 106' ' ' PHE . 6.1 mmtt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.885 HD12 ' CE2' ' A' ' 56' ' ' PHE . 57.5 mt -91.1 146.8 34.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.962 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.1 Cg_endo -62.17 155.67 54.97 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.096 1.864 . . . . 0.0 110.22 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.803 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 5.4 m95 -129.2 173.31 10.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.621 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -122.24 143.37 49.64 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.754 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -126.56 151.04 48.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.86 -1.15 . . . . 0.0 110.408 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.487 ' HB2' ' OH ' ' A' ' 90' ' ' TYR . . . -143.16 148.84 37.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.801 . . . . 0.0 109.196 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.476 ' OD2' ' HB ' ' A' ' 51' ' ' ILE . 0.9 OUTLIER -76.2 132.59 40.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.686 HD12 ' O ' ' A' ' 6' ' ' THR . 19.4 mm -110.83 134.54 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 7.2 m-20 64.13 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.912 . . . . 0.0 109.457 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 46.2 t80 -170.59 129.82 0.84 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.275 -0.891 . . . . 0.0 109.493 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.0 -80.04 0.62 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.349 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.88 165.53 35.92 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.715 -0.616 . . . . 0.0 109.421 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.38 -151.56 19.94 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -68.76 -172.29 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -1.098 . . . . 0.0 109.478 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -72.56 -152.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.06 -177.68 5.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.376 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -116.48 15.86 15.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.584 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 14.6 m-20 -111.59 130.63 55.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -154.18 152.31 30.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 109.424 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.048 HD11 ' CG2' ' A' ' 96' ' ' ILE . 4.0 tt -113.31 138.32 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.272 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.754 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.3 mm? -109.8 116.14 31.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.35 -0.843 . . . . 0.0 109.869 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.946 ' OH ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -104.78 143.1 33.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.829 -1.169 . . . . 0.0 108.922 178.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.46 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -106.58 172.58 6.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.177 -0.952 . . . . 0.0 110.316 -179.158 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 94.7 p -64.67 -24.92 67.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.844 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.479 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 36.8 p-10 -89.73 18.93 5.05 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.423 -0.798 . . . . 0.0 108.926 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.585 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.62 28.12 7.51 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.689 -0.632 . . . . 0.0 110.286 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.962 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.0 mt -79.87 106.71 12.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.048 ' CG2' HD11 ' A' ' 88' ' ' ILE . 1.6 mt -104.41 111.66 34.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.101 -1.0 . . . . 0.0 110.823 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.514 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 20.4 m-85 -111.61 154.9 24.18 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -122.69 141.54 51.66 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.771 -1.205 . . . . 0.0 109.489 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -129.68 120.1 24.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.207 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.505 HG22 ' CE2' ' A' ' 7' ' ' PHE . 44.2 p -104.72 28.54 6.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.44 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -148.12 22.71 1.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 109.481 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 30.1 t-80 77.15 79.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.357 -0.839 . . . . 0.0 109.631 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 11.6 m-85 44.53 53.51 7.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.627 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -120.43 -80.81 0.63 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.0 109.215 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.0 p -89.93 105.36 17.76 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.6 ' CD1' ' HB3' ' A' ' 62' ' ' LYS . 79.6 m-85 -96.28 125.63 40.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.882 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.482 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 56.3 m -111.83 136.4 51.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.432 -0.792 . . . . 0.0 108.956 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -80.06 125.77 30.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.529 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.5 pt -129.96 12.19 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.495 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' A' ' 13' ' ' TYR . 3.5 mp . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -138.19 41.71 2.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.247 -0.908 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 10' ' ' VAL . 11.7 p -128.46 -168.09 1.86 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.77 ' CD1' HG21 ' A' ' 76' ' ' ILE . 58.2 m-85 -77.44 -51.99 9.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.53 -40.71 69.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.838 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.466 ' C ' HG23 ' A' ' 4' ' ' ILE . . . -67.34 -51.27 38.75 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 6' ' ' THR . 58.8 t -64.13 -43.23 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -1.151 . . . . 0.0 109.32 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.18 76.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.434 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -62.07 -55.32 30.2 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.532 -0.73 . . . . 0.0 109.3 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.494 ' HB2' HG21 ' A' ' 4' ' ' ILE . 26.2 t80 -57.69 -24.62 57.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.401 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.5 mt -71.55 -62.55 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.038 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -70.93 -5.5 31.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.119 -0.988 . . . . 0.0 109.428 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 54.1 m -91.49 -69.9 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.943 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.49 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 96.6 m-85 -89.7 -5.98 56.53 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.631 -0.668 . . . . 0.0 109.63 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 23.3 m170 58.15 58.06 3.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -0.85 . . . . 0.0 109.769 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER 163.99 129.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 53' ' ' GLY . 19.9 mt -45.69 147.14 1.63 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.123 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.566 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.3 Cg_exo -53.06 163.24 2.26 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.2 1.934 . . . . 0.0 110.733 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.07 -7.34 34.92 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 109.144 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -92.29 7.2 43.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.473 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 50' ' ' SER . 3.5 m-85 -103.34 83.56 2.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.199 -0.938 . . . . 0.0 109.75 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pt -95.62 126.73 48.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 25' ' ' ILE . 28.0 p -47.95 176.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.087 -1.008 . . . . 0.0 109.607 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.43 -46.36 64.05 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.381 -0.927 . . . . 0.0 109.162 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.17 -36.63 61.11 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.797 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.3 mm-40 -60.42 -41.13 93.33 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HB1' HD11 ' A' ' 42' ' ' LEU . . . -67.75 -33.14 74.27 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -62.12 -37.59 85.7 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.66 -35.75 68.75 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.461 -0.774 . . . . 0.0 109.586 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -81.16 -19.37 43.57 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.652 -0.655 . . . . 0.0 110.357 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.636 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 118.2 45.42 0.49 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.669 ' CH2' ' HB2' ' A' ' 37' ' ' ALA . 15.6 t90 -110.55 120.74 43.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -1.131 . . . . 0.0 109.272 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.41 110.73 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.347 -0.846 . . . . 0.0 109.098 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.669 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.609 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 1.2 p-10 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 42' ' ' LEU . 9.1 tp -60.54 -50.86 71.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 0.0 109.258 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -62.8 -10.75 14.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 0.0 109.674 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 41' ' ' ASN . 9.8 t0 -92.95 -33.99 13.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 110.161 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 34' ' ' GLY . 34.0 m -110.72 -50.44 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.998 -1.064 . . . . 0.0 110.125 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.612 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -124.42 70.74 55.35 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.969 -1.082 . . . . 0.0 109.829 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.7 Cg_endo -63.29 -179.76 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.168 1.912 . . . . 0.0 110.242 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 40.75 55.99 3.17 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 17.3 mmtt -141.17 160.09 40.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -1.112 . . . . 0.0 109.637 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.585 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 67.0 m -127.64 138.55 52.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.468 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 27' ' ' LYS . 10.4 mm -102.17 105.3 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 108.967 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -160.3 179.47 35.8 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.466 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 91.81 -4.55 78.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.53 ' OD1' ' CG ' ' A' ' 73' ' ' GLU . 7.5 p30 -93.57 163.17 13.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -1.123 . . . . 0.0 109.348 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.539 HG23 HG22 ' A' ' 70' ' ' THR . 22.4 mt -59.58 159.42 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.516 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.923 ' CE2' HD12 ' A' ' 63' ' ' LEU . 6.4 t80 . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.859 . . . . 0.0 109.332 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 5.8 mmtm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.321 0.582 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.923 HD12 ' CE2' ' A' ' 56' ' ' PHE . 42.8 mt -94.68 143.88 26.96 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.0 109.04 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.78 ' HG2' HD13 ' A' ' 95' ' ' LEU . 1.8 Cg_endo -62.89 84.09 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.001 1.8 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 71' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.686 ' CE3' HD13 ' A' ' 63' ' ' LEU . 5.7 m95 -131.82 169.3 16.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.646 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 21.2 mmt180 -120.74 136.64 54.82 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.354 -0.841 . . . . 0.0 108.78 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.784 ' HA ' HD13 ' A' ' 89' ' ' LEU . 17.1 pt-20 -118.94 162.13 19.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.985 . . . . 0.0 110.386 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -152.85 147.84 26.48 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.409 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -71.51 140.8 50.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.618 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.77 HG21 ' CD1' ' A' ' 7' ' ' PHE . 25.4 mm -134.16 130.82 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.1 m-20 73.27 37.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.464 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 23.3 t80 -69.47 136.82 52.01 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.282 -0.886 . . . . 0.0 109.609 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.34 -79.66 0.38 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.246 -0.909 . . . . 0.0 109.377 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.76 175.71 4.45 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.67 -0.643 . . . . 0.0 109.405 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 72.64 73.74 0.83 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 81' ' ' GLY . 3.6 m-85 56.35 164.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -1.134 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -49.11 171.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.43 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -108.08 -173.83 2.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 109.246 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.32 -8.54 20.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 109.744 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.5 m-20 -91.33 128.66 37.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.599 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.646 ' O ' HG22 ' A' ' 99' ' ' THR . 5.4 mtt180 -158.15 150.66 22.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 109.242 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.774 ' C ' HD22 ' A' ' 89' ' ' LEU . 4.6 tt -108.68 149.81 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.949 -1.094 . . . . 0.0 109.937 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.784 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -122.33 106.99 11.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.437 -0.789 . . . . 0.0 109.462 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.646 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 22.3 p90 -101.91 140.79 35.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.89 -1.131 . . . . 0.0 109.082 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.526 ' HB2' ' CH2' ' A' ' 71' ' ' TRP . 5.3 t -105.98 174.19 5.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.267 -0.896 . . . . 0.0 110.292 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 p -66.07 -21.79 66.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.579 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.484 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 25.0 p-10 -89.56 16.02 8.45 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.441 -0.787 . . . . 0.0 108.898 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.578 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.1 m95 67.26 29.76 7.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.689 -0.632 . . . . 0.0 110.774 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.78 HD13 ' HG2' ' A' ' 64' ' ' PRO . 10.0 mt -87.3 118.01 26.45 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.671 HG22 HD11 ' A' ' 88' ' ' ILE . 3.3 mt -109.33 113.52 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.505 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 16.7 m-85 -113.01 113.12 25.02 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.27 131.64 35.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.045 -1.034 . . . . 0.0 109.977 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 87' ' ' ARG . 1.1 t -115.56 123.81 49.43 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.501 -0.749 . . . . 0.0 108.995 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.4 p -108.95 30.48 6.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.793 . . . . 0.0 109.395 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 17.6 p-10 -150.0 19.16 0.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.389 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 2.2 t-80 79.46 68.51 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.43 -0.794 . . . . 0.0 109.509 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.528 ' OH ' ' CZ ' ' A' ' 87' ' ' ARG . 10.0 m-85 49.41 22.62 0.73 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.652 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.408 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -94.67 -18.14 21.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 99' ' ' THR . 23.1 m -150.18 108.51 3.78 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 86.2 m-85 -95.25 128.73 42.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.165 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 8.2 m -114.17 128.16 56.24 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.385 -0.822 . . . . 0.0 108.836 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -79.11 121.05 24.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.562 HD11 HD11 ' A' ' 88' ' ' ILE . 2.1 pt -117.45 -39.06 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.64 ' HB2' HD12 ' A' ' 96' ' ' ILE . 3.8 mtt-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.503 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 4' ' ' ILE . 15.0 mm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -129.9 52.87 1.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.8 p -145.6 178.07 8.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.647 ' CD2' HG21 ' A' ' 76' ' ' ILE . 24.3 m-85 -74.56 -53.0 10.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.04 -35.39 71.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 0.0 109.966 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.25 -51.58 31.99 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 6' ' ' THR . 21.7 t -67.46 -38.29 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -1.168 . . . . 0.0 109.414 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.1 88.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.3 OUTLIER -64.42 -55.15 22.89 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.578 -0.701 . . . . 0.0 109.134 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 27.3 t80 -60.48 -21.36 62.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.173 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.1 mt -73.02 -63.46 1.17 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.776 . . . . 0.0 109.242 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -70.94 -8.69 54.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.039 . . . . 0.0 109.403 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 52.9 m -88.98 -67.71 0.82 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 110.032 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 89.5 m-85 -89.44 -2.74 58.49 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.569 -0.707 . . . . 0.0 109.538 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 17.2 m170 53.47 53.72 11.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.375 -0.828 . . . . 0.0 109.762 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 166.72 129.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.462 HD11 ' OH ' ' A' ' 90' ' ' TYR . 65.1 mt -44.05 147.48 0.92 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.219 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.567 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 7.8 Cg_exo -53.02 162.89 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.247 1.965 . . . . 0.0 110.516 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -69.33 -6.68 31.2 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.326 -0.859 . . . . 0.0 109.01 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -93.73 7.22 45.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 109.483 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 2.0 m-85 -97.18 99.79 11.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.104 -0.997 . . . . 0.0 109.555 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pt -107.82 118.61 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 108.986 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.488 ' C ' HG23 ' A' ' 51' ' ' ILE . 21.5 p -45.52 170.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 109.37 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -65.56 -45.29 83.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.095 -1.003 . . . . 0.0 109.088 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -54.36 -39.5 67.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.081 -1.012 . . . . 0.0 108.299 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.716 ' O ' HD12 ' A' ' 33' ' ' LEU . 21.1 mt-10 -59.38 -39.97 85.03 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.678 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.18 -34.52 77.71 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.206 -0.934 . . . . 0.0 108.643 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -63.98 -35.29 80.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.38 -34.77 72.83 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.37 -0.831 . . . . 0.0 109.265 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.716 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.3 -15.83 54.29 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.424 0.631 . . . . 0.0 110.276 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 110.8 36.6 1.84 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.678 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 4.9 t90 -101.69 123.31 45.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.181 -1.188 . . . . 0.0 109.135 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.41 119.18 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 108.776 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.595 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.426 0 O-C-N 121.194 -0.941 . . . . 0.0 109.795 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 35' ' ' TRP . 47.3 p-10 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.16 0.505 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.533 ' CD1' ' HB1' ' A' ' 30' ' ' ALA . 8.5 tp -66.32 -52.02 51.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.307 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -55.21 -16.62 3.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.751 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -87.21 -52.96 5.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 110.289 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 46' ' ' ALA . 21.7 m -94.68 -47.7 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.044 -1.035 . . . . 0.0 110.316 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.679 ' HB1' ' HG3' ' A' ' 49' ' ' LYS . . . -115.78 78.6 7.18 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 109.776 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -63.19 154.32 68.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.188 1.925 . . . . 0.0 110.191 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 43.1 63.68 1.96 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.679 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 6.8 mmtm -134.63 117.19 15.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -1.166 . . . . 0.0 109.405 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.1 m -90.01 128.05 36.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.869 . . . . 0.0 109.622 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.581 HG21 ' HG2' ' A' ' 27' ' ' LYS . 6.5 mm -91.21 105.9 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.144 -0.973 . . . . 0.0 108.999 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.27 169.46 32.11 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.32 36.53 4.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -128.02 170.71 12.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.178 . . . . 0.0 109.31 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.668 HD12 HG21 ' A' ' 70' ' ' THR . 32.4 mm -70.23 150.34 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.845 ' CE2' HD12 ' A' ' 63' ' ' LEU . 13.5 t80 . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.141 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.266 0.555 . . . . 0.0 109.523 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.845 HD12 ' CE2' ' A' ' 56' ' ' PHE . 64.3 mt -115.02 153.67 47.12 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.102 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.75 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.7 Cg_endo -61.57 86.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.2 1.933 . . . . 0.0 110.155 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.668 HG21 HD12 ' A' ' 55' ' ' ILE . 39.0 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.692 ' CE3' HD13 ' A' ' 63' ' ' LEU . 10.3 m95 -112.23 157.62 20.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.689 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.647 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 12.0 mmt180 -115.38 140.85 48.76 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 108.667 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.799 ' HA ' HD13 ' A' ' 89' ' ' LEU . 2.3 pp20? -115.67 156.16 26.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 110.167 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.701 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -142.81 150.37 39.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 0.0 109.421 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.521 ' HA ' ' CD ' ' A' ' 87' ' ' ARG . 3.6 m-20 -71.97 142.34 49.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.5 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.647 HG21 ' CD2' ' A' ' 7' ' ' PHE . 21.6 mm -136.74 145.23 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 110.004 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.01 15.4 8.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.822 . . . . 0.0 109.823 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.528 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 14.6 t80 -69.61 114.71 8.07 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.095 -1.003 . . . . 0.0 109.628 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.3 m -119.67 -79.65 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.271 -0.893 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 p -148.62 166.49 28.14 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.72 -0.612 . . . . 0.0 109.392 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.12 -179.34 52.86 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -46.48 165.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -1.146 . . . . 0.0 109.489 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -54.09 176.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -0.981 . . . . 0.0 109.405 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 5.1 p30 -115.53 -168.58 1.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.3 p -116.0 13.64 15.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.319 -0.863 . . . . 0.0 109.424 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.551 ' OD2' HG22 ' A' ' 100' ' ' THR . 1.1 m-20 -102.59 126.87 49.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.627 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.547 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -145.6 143.33 29.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.47 -0.769 . . . . 0.0 109.168 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.938 HD11 ' CG2' ' A' ' 96' ' ' ILE . 3.9 tt -109.51 134.85 50.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.862 -1.149 . . . . 0.0 109.089 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.4 mm? -106.75 111.34 23.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 109.992 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.701 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 2.8 p90 -101.69 141.91 33.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.053 -1.029 . . . . 0.0 108.402 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -106.43 172.43 6.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.049 -1.032 . . . . 0.0 110.633 -178.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.4 p -66.57 -21.95 66.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.472 -0.768 . . . . 0.0 109.522 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.481 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 36.6 p-10 -89.48 16.3 7.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.567 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 68.12 28.57 6.55 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.658 -0.651 . . . . 0.0 110.471 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.75 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.9 mt -85.65 112.32 20.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.938 ' CG2' HD11 ' A' ' 88' ' ' ILE . 2.0 mt -100.79 125.41 54.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.031 -1.043 . . . . 0.0 110.469 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.536 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 8.1 m-85 -122.89 159.18 28.75 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -131.29 142.18 50.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.757 -1.214 . . . . 0.0 110.024 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -130.13 127.59 40.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.103 -0.998 . . . . 0.0 108.948 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.551 HG22 ' OD2' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -106.18 12.34 30.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.536 ' CG ' ' HG1' ' A' ' 105' ' ' THR . 0.0 OUTLIER -132.16 24.6 4.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.166 -0.959 . . . . 0.0 109.494 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.7 t-80 76.43 75.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 109.824 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.573 ' HA ' ' CE1' ' A' ' 106' ' ' PHE . 14.5 m-85 52.21 60.96 3.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 109.624 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -135.08 -71.33 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.29 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.536 ' HG1' ' CG ' ' A' ' 101' ' ' ASP . 1.2 p -89.45 92.59 9.18 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 83.8 m-85 -89.45 110.08 20.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.238 -0.914 . . . . 0.0 110.03 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 57.3 m -102.82 139.84 37.87 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 2.3 tttt -85.05 125.12 32.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.569 -0.707 . . . . 0.0 109.491 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.64 -10.07 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.418 179.84 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 13' ' ' TYR . 5.3 mt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.406 ' O ' ' ND2' ' A' ' 5' ' ' ASN . 5.1 p-10 -136.89 59.28 1.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.123 -0.986 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.619 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -148.05 -167.44 2.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 109.472 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.755 ' CD1' HG21 ' A' ' 76' ' ' ILE . 38.2 m-85 -77.41 -59.95 2.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.356 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.78 -31.68 68.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.813 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.425 ' C ' HG23 ' A' ' 4' ' ' ILE . . . -67.92 -54.4 18.21 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.593 HG23 ' H ' ' A' ' 6' ' ' THR . 59.0 t -63.11 -41.72 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.361 -1.082 . . . . 0.0 109.002 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.96 -35.67 73.54 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.402 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.3 OUTLIER -64.91 -56.36 13.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.501 -0.749 . . . . 0.0 109.204 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.634 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 30.7 t80 -60.82 -20.14 61.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.186 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.4 mt -73.6 -62.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.833 . . . . 0.0 109.299 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -71.5 -8.95 57.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.928 -1.107 . . . . 0.0 109.405 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 87.7 m -89.49 -66.07 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.153 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 82.4 m-85 -88.99 -6.53 57.16 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.512 -0.743 . . . . 0.0 109.417 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.51 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 15.5 m170 57.28 55.56 5.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.764 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 2.5 pttt 160.93 129.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.746 HD11 ' OH ' ' A' ' 90' ' ' TYR . 36.0 mt -44.53 147.45 1.04 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.023 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.537 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.5 Cg_exo -54.11 162.91 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.021 1.814 . . . . 0.0 110.586 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.91 -7.16 32.29 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.396 -0.815 . . . . 0.0 109.04 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -92.61 6.55 46.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.648 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 50' ' ' SER . 1.7 m-85 -100.61 81.93 2.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.758 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.4 pt -92.7 127.36 44.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 25' ' ' ILE . 43.4 p -48.1 176.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 109.351 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.726 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -70.81 -46.84 62.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 0.0 109.238 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -53.3 -35.8 60.53 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.095 -1.003 . . . . 0.0 108.46 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.7 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -59.39 -41.22 88.88 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -68.17 -36.26 79.34 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.6 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 6.5 mt-30 -61.14 -32.64 72.35 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.62 -34.16 72.41 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.344 -0.848 . . . . 0.0 109.587 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.6 mp -81.29 -16.27 52.99 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.426 0.631 . . . . 0.0 110.051 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.28 40.38 0.88 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.609 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 11.1 t90 -105.06 117.26 33.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -1.137 . . . . 0.0 109.329 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -89.94 110.8 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.852 . . . . 0.0 108.705 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.578 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.792 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.707 HD21 HD11 ' A' ' 51' ' ' ILE . 12.1 tp -58.94 -63.68 1.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 109.647 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.72 -14.45 0.92 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.717 -0.614 . . . . 0.0 110.566 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.1 -36.2 41.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.846 -1.159 . . . . 0.0 110.114 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.8 m -110.4 -0.33 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.929 -1.107 . . . . 0.0 110.008 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -150.99 61.08 4.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 4.8 Cg_exo -59.63 152.28 63.67 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.065 1.843 . . . . 0.0 110.213 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.18 55.4 21.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.574 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 14.8 mttm -135.56 176.36 8.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -1.184 . . . . 0.0 109.72 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.579 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 70.3 m -146.07 136.44 23.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.33 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.726 HD12 ' HA ' ' A' ' 27' ' ' LYS . 11.5 mm -99.37 106.97 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 109.037 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.71 168.18 35.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.33 -7.5 51.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.47 160.57 26.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.117 -1.225 . . . . 0.0 109.37 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.497 ' HA ' HD13 ' A' ' 55' ' ' ILE . 12.7 mm -70.07 144.81 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 109.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.824 ' CE2' HD12 ' A' ' 63' ' ' LEU . 13.5 t80 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 3.8 mptp? . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.36 0.6 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.824 HD12 ' CE2' ' A' ' 56' ' ' PHE . 58.7 mt -100.56 149.97 36.57 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 108.931 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.852 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.1 Cg_exo -59.04 85.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.052 1.835 . . . . 0.0 110.359 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' A' ' 71' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.684 ' CE3' HD13 ' A' ' 63' ' ' LEU . 9.5 m95 -147.71 169.47 19.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -125.03 136.67 53.91 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.764 ' HA ' HD13 ' A' ' 89' ' ' LEU . 20.1 pt-20 -114.67 152.28 32.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.033 . . . . 0.0 110.296 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.633 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -141.11 152.45 44.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 109.298 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.469 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 1.1 m-20 -73.44 139.08 45.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 109.324 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.755 HG21 ' CD1' ' A' ' 7' ' ' PHE . 22.2 mm -132.26 137.73 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.944 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 1.4 m-20 72.53 9.71 5.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 0.0 110.186 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -69.83 143.45 52.88 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.083 -1.01 . . . . 0.0 109.606 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.8 p -139.58 -58.85 0.57 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.58 163.29 12.29 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.76 -0.588 . . . . 0.0 109.518 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 82' ' ' PHE . . . 82.97 -178.9 53.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 81' ' ' GLY . 3.1 m-85 -45.59 159.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -1.19 . . . . 0.0 109.391 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -70.33 160.74 31.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.928 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.79 -167.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.332 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.65 28.11 8.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 109.714 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 2.2 m-20 -109.68 127.5 54.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.118 -0.989 . . . . 0.0 109.659 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.565 ' O ' HG23 ' A' ' 99' ' ' THR . 5.9 mtt180 -157.38 145.14 18.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 109.592 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.972 HD11 ' CG2' ' A' ' 96' ' ' ILE . 4.4 tt -102.69 132.39 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 109.084 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -103.61 103.16 13.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 109.577 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.746 ' OH ' HD11 ' A' ' 20' ' ' LEU . 7.2 p90 -98.22 141.31 31.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 108.86 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.494 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -105.15 168.93 8.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.151 -0.968 . . . . 0.0 110.392 -178.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.6 p -65.13 -20.41 66.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.494 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 24.8 p-10 -89.69 17.6 6.36 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.459 -0.776 . . . . 0.0 108.911 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.566 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.04 27.71 6.93 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.762 -0.586 . . . . 0.0 110.438 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.852 HD13 ' HG2' ' A' ' 64' ' ' PRO . 8.8 mt -86.52 102.58 14.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.972 ' CG2' HD11 ' A' ' 88' ' ' ILE . 3.0 mt -94.25 121.81 45.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.18 -0.95 . . . . 0.0 110.71 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.636 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 7.8 m-85 -121.09 164.02 17.47 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.565 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -135.8 144.65 45.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.83 -1.169 . . . . 0.0 109.81 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -132.01 129.66 40.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -0.891 . . . . 0.0 109.126 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 p -119.66 27.51 8.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.615 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 10.5 p30 -146.25 22.59 1.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.935 . . . . 0.0 109.466 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.554 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.9 t-80 80.22 70.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.519 -0.738 . . . . 0.0 109.315 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' ' 102' ' ' HIS . 18.8 m-85 42.85 26.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.666 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 102' ' ' HIS . 3.7 mm-40 -93.62 -17.5 23.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 108.958 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.0 m -149.61 138.24 20.88 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.593 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 96.5 m-85 -124.01 136.02 54.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.979 . . . . 0.0 110.035 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.441 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.4 m -126.01 137.07 53.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.801 . . . . 0.0 109.024 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -79.72 134.79 36.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.107 -0.995 . . . . 0.0 109.688 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.447 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 2.0 pt -142.4 57.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 0.0 109.403 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.464 ' OXT' HD12 ' A' ' 96' ' ' ILE . 1.6 mtm-85 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.468 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' A' ' 13' ' ' TYR . 1.1 mp . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -140.59 58.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 0.0 109.362 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.821 ' H ' HG23 ' A' ' 10' ' ' VAL . 4.5 p -142.33 -167.27 2.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.597 ' CD1' HG21 ' A' ' 76' ' ' ILE . 31.4 m-85 -76.99 -61.44 1.98 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.146 -0.971 . . . . 0.0 109.186 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.43 -33.47 69.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 109.83 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.7 -55.02 15.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.821 HG23 ' H ' ' A' ' 6' ' ' THR . 95.7 t -63.04 -40.11 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -1.119 . . . . 0.0 108.926 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.488 ' HB1' ' HG3' ' A' ' 110' ' ' ARG . . . -59.48 -35.85 74.9 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.08 -56.74 10.0 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 35.0 t80 -54.58 -25.96 29.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.222 -0.924 . . . . 0.0 108.73 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 3.3 mt -69.52 -60.31 2.41 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -70.81 -5.33 29.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.025 . . . . 0.0 109.492 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 m -90.73 -70.91 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.859 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 68.7 m-85 -89.79 -4.78 57.47 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.67 -0.644 . . . . 0.0 109.642 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 17.8 m170 57.6 57.19 4.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.9 . . . . 0.0 109.356 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 7.2 ptmt 166.24 130.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 20' ' ' LEU . 20.0 mt -43.16 147.26 0.72 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.266 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 8.2 Cg_exo -53.27 164.13 2.05 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.199 1.933 . . . . 0.0 110.463 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.48 -4.94 29.37 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.362 -0.836 . . . . 0.0 108.975 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.498 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -95.05 11.09 33.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.64 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.561 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 5.7 m-85 -105.48 92.94 4.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 109.845 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 30' ' ' ALA . 1.3 pp -104.01 127.78 57.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.513 ' O ' HD12 ' A' ' 25' ' ' ILE . 68.7 p -48.94 178.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.51 -48.4 55.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.026 -1.046 . . . . 0.0 109.566 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -53.46 -37.03 62.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.125 -0.984 . . . . 0.0 108.512 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.794 ' O ' HD12 ' A' ' 33' ' ' LEU . 18.7 mt-10 -59.88 -39.97 87.09 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB2' HD11 ' A' ' 25' ' ' ILE . . . -69.69 -32.56 71.24 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.478 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 2.6 mt-30 -65.86 -30.69 71.34 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.44 76.44 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.457 -0.777 . . . . 0.0 109.362 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -80.96 -11.27 59.6 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.479 0.657 . . . . 0.0 109.978 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.7 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 106.02 53.75 0.74 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.636 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 1.6 t90 -108.97 135.96 49.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -1.131 . . . . 0.0 109.555 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.475 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 6.1 t -89.75 128.26 41.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.636 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.455 0 O-C-N 120.988 -1.07 . . . . 0.0 110.275 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.082 0.468 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 51' ' ' ILE . 6.0 tp -66.96 -63.53 1.04 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 108.935 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.94 -10.45 2.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.823 -0.548 . . . . 0.0 110.143 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -35.19 44.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 109.741 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.7 HG11 ' O ' ' A' ' 34' ' ' GLY . 33.3 m -98.49 -48.12 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.158 -0.964 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB1' ' HD3' ' A' ' 49' ' ' LYS . . . -117.45 77.03 10.07 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.295 -0.878 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.472 ' O ' ' HD2' ' A' ' 49' ' ' LYS . 3.0 Cg_endo -60.41 155.25 47.93 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.235 1.956 . . . . 0.0 110.326 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.53 63.83 4.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.689 ' HD3' ' HB1' ' A' ' 46' ' ' ALA . 3.2 mptt -140.44 155.01 46.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -1.111 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 48.9 m -133.91 123.51 24.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.401 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.553 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 6.6 mm -81.15 105.46 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.019 -1.051 . . . . 0.0 109.017 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -150.65 172.8 30.34 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.522 -1.323 . . . . 0.0 109.851 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.95 10.72 62.44 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 4.4 m-20 -83.34 143.46 30.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -1.121 . . . . 0.0 109.403 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.439 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 13.6 mm -69.57 136.22 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 109.457 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.667 ' CE1' ' CD1' ' A' ' 103' ' ' TYR . 73.9 t80 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.393 -0.817 . . . . 0.0 109.29 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.884 HD22 ' CZ3' ' A' ' 71' ' ' TRP . 4.2 mt -95.13 146.64 31.68 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.205 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.426 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 2.4 Cg_endo -62.26 84.55 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.026 1.818 . . . . 0.0 109.837 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.605 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.406 HG21 HD12 ' A' ' 55' ' ' ILE . 19.8 m . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.258 0.551 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.884 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 11.9 m95 -102.65 172.85 6.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.634 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 3.6 mtt180 -127.79 132.92 49.44 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' CD ' ' HB2' ' A' ' 54' ' ' ASP . 2.1 pt-20 -116.59 146.82 42.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.906 -1.121 . . . . 0.0 110.627 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.545 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -137.04 148.04 46.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 2.0 m-20 -72.49 122.63 21.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.794 HD12 ' O ' ' A' ' 6' ' ' THR . 30.5 mm -110.69 137.73 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 70.74 122.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 109.25 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.446 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 2.2 t80 -170.13 110.24 0.4 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.02 -78.73 0.58 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.88 155.29 32.65 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.701 -0.624 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.05 -160.09 14.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -66.63 155.77 36.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -1.154 . . . . 0.0 109.507 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' A' ' 82' ' ' PHE . 12.1 mtm180 -51.75 -178.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.35 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.514 ' O ' ' NH2' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -120.53 -167.98 1.56 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.46 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.5 p -127.55 18.67 6.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 109.565 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.473 ' OD2' ' HA ' ' A' ' 100' ' ' THR . 4.3 m-20 -105.12 129.72 53.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 109.387 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 5.5 mmt180 -146.99 140.81 25.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.56 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.071 HD11 ' CG2' ' A' ' 96' ' ' ILE . 3.3 tt -93.34 129.18 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 108.82 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.49 ' N ' HD22 ' A' ' 89' ' ' LEU . 4.6 mm? -101.11 93.69 5.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 110.194 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 38.2 p90 -91.5 139.85 30.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.889 -1.132 . . . . 0.0 108.652 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -105.47 170.36 7.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.097 -1.002 . . . . 0.0 110.722 -178.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.9 -22.38 66.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 109.6 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 14.5 p-10 -89.79 18.8 5.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.602 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 69.22 26.54 5.4 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.817 -0.552 . . . . 0.0 110.244 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.856 HD22 ' HE1' ' A' ' 97' ' ' TYR . 6.7 mt -82.32 92.6 6.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.071 ' CG2' HD11 ' A' ' 88' ' ' ILE . 12.8 mt -90.64 112.41 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 110.372 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.856 ' HE1' HD22 ' A' ' 95' ' ' LEU . 20.1 m-85 -114.03 167.14 10.92 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.541 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -137.28 130.14 30.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.951 -1.093 . . . . 0.0 109.655 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -119.76 119.07 32.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 109.26 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.473 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 21.1 p -104.16 22.17 15.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.523 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.6 OUTLIER -138.46 22.64 2.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.494 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.534 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 7.1 t-80 77.8 73.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 109.455 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.667 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 34.5 m-85 43.02 43.96 3.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.802 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.43 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 2.2 mm-40 -117.14 -17.01 10.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.249 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' THR . 51.9 m -150.38 94.97 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.332 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.552 ' CE1' ' HA ' ' A' ' 103' ' ' TYR . 14.1 m-85 -90.63 116.76 28.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.747 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 90.4 m -107.86 139.49 42.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.276 -0.89 . . . . 0.0 108.8 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -79.3 127.99 32.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 109.605 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.429 ' CG2' ' HE2' ' A' ' 98' ' ' LYS . 1.5 pt -112.75 -42.04 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.572 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.618 ' CG ' HD12 ' A' ' 96' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.491 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -141.99 61.77 1.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.623 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -147.75 -175.19 4.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.538 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.639 ' CD1' HG21 ' A' ' 76' ' ' ILE . 25.2 m-85 -73.79 -56.73 4.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.509 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -31.4 67.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.972 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.18 -55.39 9.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.623 HG23 ' H ' ' A' ' 6' ' ' THR . 38.8 t -65.83 -40.64 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -1.133 . . . . 0.0 109.296 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.0 85.94 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.34 -55.01 36.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.544 -0.723 . . . . 0.0 109.101 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.681 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 35.5 t80 -59.09 -21.96 60.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.267 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.553 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.7 mt -73.1 -61.16 1.91 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 0.0 109.337 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.57 -9.18 57.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.005 -1.06 . . . . 0.0 109.591 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.2 m -89.62 -65.28 1.03 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.681 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 71.9 m-85 -89.18 -11.36 44.0 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.582 -0.698 . . . . 0.0 109.24 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.47 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 19.1 m170 61.01 53.72 3.6 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.369 -0.832 . . . . 0.0 109.491 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 7.1 pttm 166.97 129.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.459 HD11 ' OH ' ' A' ' 90' ' ' TYR . 37.7 mt -44.94 151.74 0.61 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.155 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.57 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.2 Cg_exo -54.6 163.42 3.83 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.147 1.898 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -7.24 33.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.332 -0.855 . . . . 0.0 109.001 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.27 31.82 2.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.526 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.57 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.3 m-85 -121.9 82.45 1.95 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 0.0 109.776 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.5 pt -92.26 128.71 43.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.301 -0.875 . . . . 0.0 108.684 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 25' ' ' ILE . 18.5 p -47.23 174.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.139 -0.975 . . . . 0.0 109.26 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.614 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.73 -43.68 68.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.193 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -55.34 -38.81 69.23 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.153 -0.967 . . . . 0.0 108.464 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 33' ' ' LEU . 5.5 mm-40 -57.84 -40.61 80.46 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.554 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.02 -37.34 83.96 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 4.6 mt-30 -60.98 -32.66 72.21 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.19 -36.88 81.08 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.359 -0.838 . . . . 0.0 109.717 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -81.03 -8.73 59.84 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.65 -0.656 . . . . 0.0 110.318 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.849 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 106.54 51.55 0.8 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.668 ' CH2' ' HB2' ' A' ' 37' ' ' ALA . 9.3 t90 -118.37 124.46 47.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -1.115 . . . . 0.0 109.052 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.8 t -90.64 113.02 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.153 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.668 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.45 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 45' ' ' VAL . 6.9 p-10 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.551 HD11 ' HB1' ' A' ' 30' ' ' ALA . 10.5 tp -63.1 -57.56 10.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.397 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -49.48 -20.61 0.75 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -37.44 23.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 0.0 110.355 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.849 HG11 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -106.98 -54.34 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.005 -1.059 . . . . 0.0 110.101 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 1.043 ' HB1' ' HG3' ' A' ' 49' ' ' LYS . . . -113.38 80.06 4.33 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.114 -0.991 . . . . 0.0 109.699 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 2.1 Cg_endo -62.16 156.57 49.48 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.238 1.959 . . . . 0.0 110.333 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.53 56.39 4.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 1.043 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 5.3 mmtp -127.79 119.86 26.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -1.13 . . . . 0.0 109.446 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -89.74 137.55 32.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.327 -0.858 . . . . 0.0 109.48 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.551 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 5.3 mm -104.27 113.9 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 108.922 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.55 173.03 40.45 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.92 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.11 6.26 55.85 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.438 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 1.7 m-20 -87.09 148.33 25.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -1.204 . . . . 0.0 109.39 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.5 mm -67.77 139.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.61 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.873 ' CE2' HD12 ' A' ' 63' ' ' LEU . 62.8 t80 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.333 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.599 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 35.6 mttm . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.243 0.544 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.873 HD12 ' CE2' ' A' ' 56' ' ' PHE . 63.6 mt -93.64 148.36 35.28 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.209 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.701 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.5 Cg_exo -60.1 84.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.109 1.873 . . . . 0.0 110.186 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.876 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.629 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 19.9 m95 -132.41 172.17 12.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.73 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.634 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 65.1 mtt180 -136.94 148.65 47.09 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.761 ' HA ' HD13 ' A' ' 89' ' ' LEU . 9.1 pt-20 -124.1 158.67 31.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.048 -1.032 . . . . 0.0 110.467 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -148.76 152.3 36.33 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.4 m-20 -78.67 131.83 36.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.107 -0.996 . . . . 0.0 109.516 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.639 HG21 ' CD1' ' A' ' 7' ' ' PHE . 30.3 mm -116.7 124.42 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.545 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 76' ' ' ILE . 20.7 m-20 69.5 118.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.483 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -170.57 138.94 1.53 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.291 -0.88 . . . . 0.0 109.549 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.67 -79.74 0.49 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.084 -1.01 . . . . 0.0 109.478 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.52 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 1.6 p -140.98 171.1 14.53 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.79 -176.34 54.59 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -48.98 167.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -1.169 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -68.55 -179.87 1.49 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.932 . . . . 0.0 109.609 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -110.0 -172.77 2.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.91 . . . . 0.0 109.405 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -108.17 10.94 27.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 109.581 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 82.0 m-20 -100.37 128.03 46.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.661 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 99' ' ' THR . 0.1 OUTLIER -152.39 158.24 42.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.787 . . . . 0.0 109.164 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.779 HD11 HG22 ' A' ' 96' ' ' ILE . 1.6 tt -118.42 146.33 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.014 -1.054 . . . . 0.0 109.345 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.761 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.2 mm? -117.93 113.14 21.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.463 -0.773 . . . . 0.0 109.68 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 2.5 p90 -105.99 140.39 39.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.842 -1.161 . . . . 0.0 108.934 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.479 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -107.49 174.93 5.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.915 . . . . 0.0 110.444 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -23.34 66.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 109.815 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 42.6 p30 -89.62 16.58 7.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.424 -0.797 . . . . 0.0 108.969 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.568 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.94 27.66 7.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.769 -0.582 . . . . 0.0 110.522 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.701 HD13 ' HG2' ' A' ' 64' ' ' PRO . 14.5 mt -83.66 114.96 21.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.779 HG22 HD11 ' A' ' 88' ' ' ILE . 4.8 mt -111.2 107.65 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 110.574 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.532 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 26.5 m-85 -106.97 117.84 35.12 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -89.19 145.27 25.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 109.924 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -130.49 122.63 28.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 0.0 109.09 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.613 HG23 ' HE2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -110.95 30.66 6.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.633 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.5 OUTLIER -150.21 21.88 0.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER 78.73 73.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.405 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 26.8 m-85 43.78 26.22 0.12 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.392 -0.818 . . . . 0.0 109.682 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -97.05 -18.17 19.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.001 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.47 ' HB ' ' OD2' ' A' ' 101' ' ' ASP . 24.1 m -143.27 142.89 31.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.599 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 86.7 m-85 -133.65 123.77 25.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.086 -1.009 . . . . 0.0 110.267 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -114.18 132.44 56.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.497 -0.752 . . . . 0.0 109.0 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -79.5 109.36 13.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 109.54 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 1.1 pt -125.38 65.78 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.483 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 72.6 mtm180 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.624 HG21 ' HG3' ' A' ' 21' ' ' PRO . 3.1 mp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -143.0 53.87 1.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.649 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -144.63 -176.23 4.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.547 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.645 ' CE1' HG21 ' A' ' 76' ' ' ILE . 31.4 m-85 -75.86 -57.9 3.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 0.0 109.556 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -31.65 67.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.937 . . . . 0.0 109.901 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.95 -52.87 21.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.649 HG23 ' H ' ' A' ' 6' ' ' THR . 46.6 t -67.1 -46.95 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -1.117 . . . . 0.0 109.332 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.61 -38.06 68.95 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -55.1 28.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.482 -0.761 . . . . 0.0 109.093 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 18.0 t80 -62.53 -17.67 60.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.318 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.549 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.4 mt -75.75 -63.37 1.32 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.444 -0.785 . . . . 0.0 109.252 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -11.56 61.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.98 -1.075 . . . . 0.0 109.412 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.3 m -89.74 -64.45 1.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.962 . . . . 0.0 110.069 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.689 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 67.7 m-85 -89.48 -0.16 57.3 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.458 -0.776 . . . . 0.0 109.568 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 19.2 m170 47.91 47.16 18.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.295 -0.878 . . . . 0.0 109.685 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 14.4 ptmt 173.85 128.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 20' ' ' LEU . 23.0 mt -45.94 147.89 1.58 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.154 -0.966 . . . . 0.0 109.022 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.624 ' HG3' HG21 ' A' ' 4' ' ' ILE . 7.5 Cg_exo -53.56 160.42 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.016 1.811 . . . . 0.0 110.469 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.07 -10.32 29.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.258 -0.901 . . . . 0.0 108.981 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 50.9 p30 -92.18 20.68 5.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.588 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.566 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.9 m-85 -115.96 87.79 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 109.725 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.2 pt -99.23 123.15 51.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.299 -0.876 . . . . 0.0 108.735 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.482 ' HB ' ' OD2' ' A' ' 54' ' ' ASP . 19.8 p -45.99 172.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 109.501 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.643 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -67.26 -45.5 76.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.0 -1.062 . . . . 0.0 109.029 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -39.5 67.31 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.834 ' O ' HD12 ' A' ' 33' ' ' LEU . 18.8 mt-10 -59.37 -38.54 80.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.636 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.37 -38.68 85.15 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.097 -1.002 . . . . 0.0 108.544 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 27.4 mt-30 -60.37 -35.39 75.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.1 -34.83 70.6 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.305 -0.872 . . . . 0.0 109.335 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.43 -18.09 46.56 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.694 -0.629 . . . . 0.0 110.271 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 1.021 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 115.64 36.36 1.18 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.636 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 9.5 t90 -100.3 122.35 42.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -1.174 . . . . 0.0 109.122 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.77 110.46 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.161 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 35' ' ' TRP . 56.8 p30 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.565 HD11 ' HB1' ' A' ' 30' ' ' ALA . 6.2 tp -62.45 -46.26 89.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.469 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -61.96 -11.32 12.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.867 . . . . 0.0 109.877 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.45 -51.37 4.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.13 -0.981 . . . . 0.0 109.983 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.021 HG11 ' O ' ' A' ' 34' ' ' GLY . 28.9 m -91.7 -47.3 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.851 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.606 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -118.96 76.59 14.74 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 109.433 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.7 Cg_endo -63.46 155.15 64.17 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.234 1.956 . . . . 0.0 110.562 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 42.74 70.24 0.53 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.577 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 3.7 mmpt? -142.01 160.36 40.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.258 -1.142 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 3.0 m -124.16 130.37 52.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.889 . . . . 0.0 109.398 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 27' ' ' LYS . 17.5 mm -93.12 104.61 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.158 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -158.38 168.2 34.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.82 -15.85 51.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.482 ' OD2' ' HB ' ' A' ' 26' ' ' THR . 3.4 m-20 -79.95 148.41 31.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -1.199 . . . . 0.0 109.331 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 56' ' ' PHE . 14.0 mt -51.54 166.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.366 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.813 ' CE2' HD12 ' A' ' 63' ' ' LEU . 9.0 t80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.456 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.566 ' CB ' ' CE2' ' A' ' 106' ' ' PHE . 12.8 mmtt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.389 0.614 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.813 HD12 ' CE2' ' A' ' 56' ' ' PHE . 44.2 mt -105.38 157.23 34.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.968 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.642 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.8 Cg_endo -61.84 84.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.005 1.803 . . . . 0.0 109.63 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.632 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.622 ' CE3' HD13 ' A' ' 63' ' ' LEU . 15.0 m95 -141.13 157.56 45.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.638 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 28.8 mtp180 -119.07 129.29 55.01 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.742 ' HA ' HD13 ' A' ' 89' ' ' LEU . 12.4 pt-20 -106.3 151.08 25.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.053 -1.029 . . . . 0.0 110.22 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.668 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -138.66 150.97 46.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.46 -0.775 . . . . 0.0 109.111 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.4 OUTLIER -74.41 136.92 42.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.052 -1.03 . . . . 0.0 109.573 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.645 HG21 ' CE1' ' A' ' 7' ' ' PHE . 22.1 mm -120.31 123.32 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.231 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER 72.04 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.269 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 8.6 t80 -170.39 141.5 1.99 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.144 -0.973 . . . . 0.0 109.537 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.01 -78.81 0.19 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -144.58 161.2 39.71 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.642 -0.661 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.38 -175.32 34.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -55.02 179.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -1.177 . . . . 0.0 109.405 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -175.8 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.44 179.88 3.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.4 m -110.96 8.47 22.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.753 ' OD1' HG22 ' A' ' 100' ' ' THR . 25.5 m-20 -108.94 128.53 55.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.106 -0.996 . . . . 0.0 109.384 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 3.6 mmt180 -143.03 169.94 16.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 109.289 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.0 HD11 ' CG2' ' A' ' 96' ' ' ILE . 3.9 tt -134.15 129.64 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.026 -1.046 . . . . 0.0 108.598 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.793 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.1 mm? -104.87 104.23 13.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.668 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 10.2 p90 -96.31 139.07 32.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.939 -1.101 . . . . 0.0 108.459 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.483 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -100.72 170.88 8.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 -178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 p -65.22 -21.85 66.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.41 -0.806 . . . . 0.0 109.311 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 27.4 p-10 -89.87 18.08 6.05 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.581 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.1 m95 68.21 29.89 5.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.281 0.562 . . . . 0.0 110.165 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.642 HD13 ' HG2' ' A' ' 64' ' ' PRO . 6.9 mt -85.17 97.53 9.95 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.0 ' CG2' HD11 ' A' ' 88' ' ' ILE . 3.5 mt -90.24 118.66 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.118 -0.989 . . . . 0.0 110.468 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 108' ' ' LYS . 9.0 m-85 -117.32 158.4 24.44 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 7.3 ptpt -126.29 153.38 44.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.943 -1.098 . . . . 0.0 109.428 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.5 OUTLIER -140.66 118.28 11.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.445 -0.785 . . . . 0.0 109.115 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.753 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -101.81 25.56 8.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.594 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.926 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.0 OUTLIER -142.66 18.74 2.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 109.417 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 4.3 t-80 78.2 85.82 0.07 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.379 -0.826 . . . . 0.0 109.981 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' HIS . 33.9 m-85 41.61 27.13 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.385 -0.822 . . . . 0.0 110.067 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.525 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 7.1 tp60 -89.13 -71.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.927 . . . . 0.0 108.982 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.926 HG22 ' OD1' ' A' ' 101' ' ' ASP . 14.2 t -97.61 164.1 12.56 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CE2' ' CB ' ' A' ' 62' ' ' LYS . 92.3 m-85 -145.45 121.15 10.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.914 -1.116 . . . . 0.0 109.947 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 2.0 m -118.28 133.47 55.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 0.0 109.322 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 3.6 ttpm? -79.63 131.92 36.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.435 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 110' ' ' ARG . 1.3 pt -119.8 -45.59 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.888 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.501 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.277 0.56 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -146.1 62.63 1.24 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.404 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.687 ' O ' HD12 ' A' ' 76' ' ' ILE . 1.7 p -145.08 -175.55 4.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.803 ' CE1' HG21 ' A' ' 76' ' ' ILE . 41.7 m-85 -79.57 -54.4 5.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.718 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -33.6 69.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 0.0 110.01 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.27 -53.03 23.78 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.541 HG23 ' H ' ' A' ' 6' ' ' THR . 41.5 t -66.76 -38.85 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.336 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.657 ' HB3' HH21 ' A' ' 110' ' ' ARG . . . -59.53 -39.82 85.17 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.438 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.6 OUTLIER -64.55 -55.45 20.42 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.471 -0.768 . . . . 0.0 109.163 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.556 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 19.6 t80 -59.53 -20.36 54.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.275 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -75.58 -64.38 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.199 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -70.75 -5.55 30.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.976 -1.077 . . . . 0.0 109.34 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 56.2 m -94.29 -66.45 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 109.562 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.556 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 83.3 m-85 -89.86 3.46 52.9 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.705 -0.622 . . . . 0.0 109.439 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 19.7 m170 44.76 48.76 8.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 17.5 pttt 175.17 129.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.479 -0.763 . . . . 0.0 109.159 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.852 HD11 ' OH ' ' A' ' 90' ' ' TYR . 30.1 mt -47.14 149.01 1.82 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.207 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.9 Cg_exo -53.54 161.82 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.045 1.83 . . . . 0.0 110.422 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -68.73 -7.43 33.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.084 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -92.43 11.15 27.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 109.529 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.568 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 3.2 m-85 -105.11 90.26 3.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.753 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.1 pp -99.29 123.6 52.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 25' ' ' ILE . 44.5 p -47.9 176.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.21 -47.98 59.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.107 -0.996 . . . . 0.0 109.104 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 m -53.51 -38.85 64.11 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' O ' HD12 ' A' ' 33' ' ' LEU . 26.8 mm-40 -57.85 -41.07 81.62 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.593 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -66.69 -33.91 76.69 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.444 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 1.7 mt-30 -62.53 -34.65 77.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.01 72.75 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.466 -0.771 . . . . 0.0 109.592 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.5 mp -80.78 -15.89 55.23 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.451 0.643 . . . . 0.0 110.134 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 113.89 40.31 1.0 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.675 ' HB2' HG21 ' A' ' 45' ' ' VAL . 11.1 t90 -106.88 118.92 37.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -1.176 . . . . 0.0 109.244 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.0 t -89.87 111.92 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.844 . . . . 0.0 108.966 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.955 . . . . 0.0 109.729 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.451 ' C ' ' ND2' ' A' ' 41' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.149 0.5 . . . . 0.0 109.774 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 42' ' ' LEU . 10.2 tp -59.09 -55.25 37.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.33 -19.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.108 -0.995 . . . . 0.0 110.091 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -96.56 -29.48 13.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.094 . . . . 0.0 110.762 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 35' ' ' TRP . 32.3 m -103.44 -52.57 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.819 -1.175 . . . . 0.0 110.3 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.613 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -127.05 66.19 66.64 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.945 -1.097 . . . . 0.0 109.46 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.475 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 2.1 Cg_endo -62.02 168.27 9.29 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.218 1.946 . . . . 0.0 110.353 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 50.67 45.82 47.67 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -130.52 163.14 27.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -1.198 . . . . 0.0 109.507 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 42.8 m -129.41 126.1 38.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.421 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.532 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 7.2 mm -90.18 106.56 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.142 -0.974 . . . . 0.0 108.907 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.81 169.73 34.64 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.06 -9.31 50.55 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.507 ' OD1' ' CG ' ' A' ' 73' ' ' GLU . 2.6 p30 -86.25 145.23 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -1.139 . . . . 0.0 109.507 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 56' ' ' PHE . 37.4 mm -49.78 161.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.146 -0.971 . . . . 0.0 109.419 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.01 ' CE2' HD12 ' A' ' 63' ' ' LEU . 14.5 t80 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.388 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 2.7 mttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.29 0.567 . . . . 0.0 109.636 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.01 HD12 ' CE2' ' A' ' 56' ' ' PHE . 31.7 mt -101.01 142.75 25.24 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.21 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.98 ' HG2' HD13 ' A' ' 95' ' ' LEU . 1.9 Cg_endo -62.92 107.77 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.045 1.83 . . . . 0.0 110.096 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.478 HG22 HG23 ' A' ' 55' ' ' ILE . 1.5 m . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.765 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 6.5 m95 -108.89 173.31 6.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.614 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 53.3 mtt180 -130.88 150.57 51.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.711 ' HA ' HD13 ' A' ' 89' ' ' LEU . 20.8 pt-20 -128.55 155.48 44.84 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.008 -1.058 . . . . 0.0 110.418 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB2' ' OH ' ' A' ' 90' ' ' TYR . . . -146.98 148.1 31.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.735 . . . . 0.0 109.102 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.451 ' OD2' ' HB ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -68.81 149.26 49.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 109.595 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.803 HG21 ' CE1' ' A' ' 7' ' ' PHE . 29.1 mm -141.25 145.02 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.274 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 73.7 m-20 61.19 39.83 15.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 109.476 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.486 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 60.5 t80 -69.68 128.42 36.37 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.336 -0.853 . . . . 0.0 109.597 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.24 -79.92 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.204 -0.935 . . . . 0.0 109.422 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -172.53 -177.75 1.81 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.642 -0.661 . . . . 0.0 109.486 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.515 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . 67.44 78.21 0.28 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.453 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.7 OUTLIER 56.46 164.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -1.169 . . . . 0.0 109.313 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 171.97 0.05 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.21 -0.931 . . . . 0.0 109.334 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -103.74 -171.75 1.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.601 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.34 -4.92 13.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.902 . . . . 0.0 109.415 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.48 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 65.0 m-20 -93.87 129.42 40.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.459 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.614 ' O ' HG23 ' A' ' 99' ' ' THR . 11.4 mtt180 -152.79 150.88 29.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.206 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.824 HD11 HD11 ' A' ' 109' ' ' ILE . 4.3 tt -106.98 149.36 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.185 -0.947 . . . . 0.0 109.441 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -117.95 124.69 48.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.374 -0.829 . . . . 0.0 109.515 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.852 ' OH ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -113.26 140.96 47.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.841 -1.162 . . . . 0.0 108.839 179.063 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.591 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 11.4 t -108.27 173.78 6.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.3 p -66.36 -22.77 66.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.473 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 28.4 p-10 -89.67 15.65 9.21 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.582 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.36 31.59 6.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.708 -0.62 . . . . 0.0 110.461 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.98 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.8 mt -87.34 125.05 34.0 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.606 HG22 HD11 ' A' ' 88' ' ' ILE . 1.8 mt -117.62 113.75 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.098 -1.001 . . . . 0.0 110.677 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.551 ' HB2' HD21 ' A' ' 63' ' ' LEU . 21.6 m-85 -113.52 117.45 31.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.21 136.15 33.18 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.961 -1.087 . . . . 0.0 109.8 -179.119 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -122.89 128.66 50.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 108.996 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.459 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.3 31.2 6.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.606 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.563 ' OD2' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -149.88 20.67 0.89 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -0.937 . . . . 0.0 109.36 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 19.6 t-80 76.6 68.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.804 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 5.7 m-85 56.28 55.1 6.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.954 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER -120.87 -81.56 0.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 108.641 179.396 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.563 HG23 ' OD2' ' A' ' 101' ' ' ASP . 17.2 p -90.56 105.25 17.69 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.544 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 83.2 m-85 -90.0 126.52 35.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 110.142 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -111.33 126.98 55.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 108.949 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 24.3 tttt -79.34 117.49 20.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.019 -1.051 . . . . 0.0 109.441 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.824 HD11 HD11 ' A' ' 88' ' ' ILE . 1.4 pt -110.21 -24.76 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.876 . . . . 0.0 109.627 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.657 HH21 ' HB3' ' A' ' 11' ' ' ALA . 2.8 mtt-85 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -138.94 58.46 1.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.676 ' H ' HG23 ' A' ' 10' ' ' VAL . 1.2 p -146.42 -178.26 6.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.62 ' CG ' HG21 ' A' ' 76' ' ' ILE . 11.3 m-85 -73.68 -57.15 4.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.404 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.35 -36.42 71.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 109.824 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.52 -49.98 57.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.676 HG23 ' H ' ' A' ' 6' ' ' THR . 90.0 t -66.03 -44.83 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -1.161 . . . . 0.0 109.278 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.78 67.25 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.83 -56.03 14.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.501 -0.75 . . . . 0.0 109.045 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.641 ' CE1' ' CG ' ' A' ' 17' ' ' TYR . 67.4 t80 -58.97 -17.7 27.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.145 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.504 HD12 HG12 ' A' ' 10' ' ' VAL . 1.6 mt -78.59 -59.84 2.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.241 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.8 -9.67 57.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 109.489 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.496 HG22 ' CD1' ' A' ' 17' ' ' TYR . 99.6 m -95.49 -61.57 1.44 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 109.947 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CG ' ' CE1' ' A' ' 13' ' ' TYR . 6.2 m-85 -89.31 0.67 56.62 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.697 -0.627 . . . . 0.0 109.581 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.514 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 18.1 m170 42.76 48.59 4.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 2.9 pttm 176.84 130.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.508 -0.745 . . . . 0.0 109.128 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.79 HD13 ' HD2' ' A' ' 24' ' ' TYR . 14.2 mt -43.76 160.96 0.21 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 109.182 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 3.1 Cg_exo -55.41 159.31 10.85 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.105 1.87 . . . . 0.0 110.456 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.7 p30 -72.1 -4.71 30.54 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 108.988 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -111.73 31.87 5.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.484 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.79 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.6 m-30 -114.09 78.78 1.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.932 . . . . 0.0 109.449 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 2.2 pt -90.94 128.02 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.357 -0.839 . . . . 0.0 108.977 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 25' ' ' ILE . 46.2 p -46.49 174.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.857 . . . . 0.0 109.516 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.625 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.82 -46.46 65.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.046 -1.034 . . . . 0.0 109.307 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -51.75 -36.07 45.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 108.388 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.686 ' O ' HD12 ' A' ' 33' ' ' LEU . 16.0 mm-40 -60.43 -43.63 96.58 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.464 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -64.12 -34.6 78.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 16.5 mt-30 -62.46 -37.57 86.44 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.44 79.59 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.461 -0.775 . . . . 0.0 109.658 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.01 -12.62 59.33 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.626 -0.672 . . . . 0.0 110.002 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.88 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 109.98 68.92 0.6 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.716 ' CH2' ' HB2' ' A' ' 37' ' ' ALA . 13.0 t90 -137.01 120.81 17.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -1.136 . . . . 0.0 109.191 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 36' ' ' VAL . 9.8 p -89.85 116.56 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.261 -0.899 . . . . 0.0 108.702 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.716 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.526 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.485 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.278 0.561 . . . . 0.0 109.634 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 51' ' ' ILE . 13.0 tp -53.05 -65.94 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -46.3 -23.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.433 -0.792 . . . . 0.0 110.056 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -80.19 -40.34 27.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.088 -1.007 . . . . 0.0 110.447 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.88 HG11 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -93.17 -55.18 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.035 -1.041 . . . . 0.0 110.227 -179.409 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -120.76 72.73 22.47 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.959 -1.088 . . . . 0.0 110.01 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.5 Cg_endo -63.67 -178.66 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.239 1.959 . . . . 0.0 110.343 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 43.29 46.25 6.65 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.485 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -149.48 167.13 27.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -1.158 . . . . 0.0 109.43 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.609 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -141.89 162.8 34.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.356 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.558 HG21 ' HG2' ' A' ' 27' ' ' LYS . 4.8 mm -110.57 117.93 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -0.876 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -161.33 158.17 29.86 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.474 ' HA2' ' OH ' ' A' ' 90' ' ' TYR . . . 95.08 9.5 58.18 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.496 ' OD2' ' CG ' ' A' ' 27' ' ' LYS . 2.4 m-20 -85.92 142.46 28.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -1.152 . . . . 0.0 109.376 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 55' ' ' ILE . 20.8 mm -52.63 149.59 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.946 ' CE2' HD12 ' A' ' 63' ' ' LEU . 49.0 t80 . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.952 . . . . 0.0 109.594 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.595 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 32.6 mttm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.283 0.563 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.946 HD12 ' CE2' ' A' ' 56' ' ' PHE . 22.8 mt -124.47 151.0 66.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.404 -0.81 . . . . 0.0 108.866 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.631 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.3 Cg_exo -59.51 85.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.143 1.895 . . . . 0.0 110.281 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.583 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 36.9 m95 -127.49 140.13 52.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.631 ' CB ' ' CE1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -111.0 125.31 53.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.295 -0.878 . . . . 0.0 109.134 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.891 ' HA ' HD13 ' A' ' 89' ' ' LEU . 2.4 pt-20 -96.88 146.26 25.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.175 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.582 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -133.2 147.99 52.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.4 m-20 -70.29 142.93 52.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.59 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.821 HG22 ' OD1' ' A' ' 77' ' ' ASN . 19.5 mm -135.47 141.95 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.861 . . . . 0.0 109.558 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.821 ' OD1' HG22 ' A' ' 76' ' ' ILE . 9.6 m120 61.6 34.58 17.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.7 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 56.5 t80 -69.47 143.82 53.41 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.151 -0.968 . . . . 0.0 109.512 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.69 -80.15 0.49 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -170.41 179.67 3.31 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.629 -0.67 . . . . 0.0 109.448 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.446 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . 67.05 -149.12 51.0 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 83' ' ' ARG . 2.4 m-85 -53.5 164.42 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -1.104 . . . . 0.0 109.552 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 82' ' ' PHE . 1.4 mmm-85 -55.98 -164.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.474 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.12 -172.81 2.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.579 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.82 -1.23 11.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 109.589 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 71.0 m-20 -104.96 129.04 53.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 109.519 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.705 ' O ' HG22 ' A' ' 99' ' ' THR . 0.2 OUTLIER -147.23 141.54 26.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.342 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.921 HD11 ' CG2' ' A' ' 96' ' ' ILE . 6.8 tt -102.27 125.27 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 109.313 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.891 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.9 mm? -94.53 99.97 12.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.951 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.631 ' CE1' ' CB ' ' A' ' 72' ' ' ARG . 22.5 p90 -99.36 140.09 34.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.923 -1.111 . . . . 0.0 108.687 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.471 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 8.0 t -108.01 169.53 8.56 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.146 -0.971 . . . . 0.0 110.607 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -65.28 -19.37 65.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.421 -0.8 . . . . 0.0 109.638 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 29.8 p-10 -89.62 16.87 7.1 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.592 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 68.27 30.03 5.75 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.684 -0.635 . . . . 0.0 110.341 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.631 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.8 mt -87.16 101.0 13.07 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.921 ' CG2' HD11 ' A' ' 88' ' ' ILE . 4.1 mt -97.27 115.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.344 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.626 ' HE1' HD22 ' A' ' 95' ' ' LEU . 10.2 m-85 -118.93 161.81 19.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 3.7 ptmt -132.06 143.76 50.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.868 -1.145 . . . . 0.0 110.032 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -130.53 120.55 24.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 108.935 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.47 HG23 ' HE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -103.59 26.69 8.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 0.0 109.857 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -147.78 21.86 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.08 -1.012 . . . . 0.0 109.84 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 10.6 t-80 77.17 71.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.411 ' OH ' ' OE1' ' A' ' 73' ' ' GLU . 15.0 m-85 50.43 20.35 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 110.035 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.52 ' CB ' ' OD1' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -86.96 -20.59 27.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 108.862 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 35.3 p -144.7 157.35 44.23 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.595 ' CE2' ' HB3' ' A' ' 62' ' ' LYS . 73.4 m-85 -141.29 119.53 12.15 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.001 -1.062 . . . . 0.0 110.034 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 3.1 m -112.88 136.5 52.45 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.426 -0.796 . . . . 0.0 108.939 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -83.58 129.1 34.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 0.5 OUTLIER -130.24 19.84 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.428 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.371 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 4' ' ' ILE . 5.5 mt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.276 0.56 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -141.9 57.71 1.49 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.357 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.6 ' O ' HD12 ' A' ' 76' ' ' ILE . 3.9 p -144.8 -168.93 3.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.221 -0.925 . . . . 0.0 109.67 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.885 ' CD1' HG21 ' A' ' 76' ' ' ILE . 46.6 m-85 -76.79 -57.61 3.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.872 . . . . 0.0 109.582 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -34.82 71.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.137 -0.977 . . . . 0.0 109.99 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.88 -52.79 26.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.6 HG23 ' H ' ' A' ' 6' ' ' THR . 67.4 t -64.14 -45.6 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -1.149 . . . . 0.0 109.114 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -56.73 -36.55 69.86 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.5 -56.22 17.83 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.492 -0.755 . . . . 0.0 109.023 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.675 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 32.3 t80 -59.19 -21.13 58.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 108.848 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' A' ' 11' ' ' ALA . 3.6 mt -71.01 -61.32 1.8 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -70.98 -8.93 56.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 109.348 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 86.5 m -85.02 -67.84 0.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.865 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.675 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 98.6 m-85 -95.68 4.17 53.26 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.676 -0.64 . . . . 0.0 109.743 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 16.6 m170 50.92 50.62 18.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.498 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER 171.53 130.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 20' ' ' LEU . 21.4 mt -44.14 150.39 0.62 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 108.96 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 8.8 Cg_exo -53.51 162.93 2.94 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.055 1.837 . . . . 0.0 110.535 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.17 -6.87 37.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.355 -0.84 . . . . 0.0 109.016 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 27.7 p30 -90.92 -1.07 57.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.506 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.7 m-85 -92.14 91.58 7.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 109.891 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 26' ' ' THR . 1.6 pp -96.77 118.61 43.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.31 -0.869 . . . . 0.0 108.771 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.549 ' O ' HD12 ' A' ' 25' ' ' ILE . 13.2 p -43.07 166.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.579 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.615 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -64.15 -43.61 94.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.148 -0.97 . . . . 0.0 108.903 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.52 -38.89 64.19 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.742 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.6 mt-10 -58.21 -40.84 82.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.716 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -64.34 -38.81 92.36 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.436 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 3.5 mm100 -60.05 -36.35 77.12 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.69 -39.16 87.47 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.354 -0.841 . . . . 0.0 109.602 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.8 mp -81.12 -8.03 59.68 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.704 -0.623 . . . . 0.0 110.205 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.06 67.39 0.76 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.716 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 9.4 t90 -136.82 118.94 15.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.157 . . . . 0.0 109.031 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.1 t -89.81 113.55 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.804 . . . . 0.0 109.072 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.587 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.466 0 O-C-N 121.213 -0.929 . . . . 0.0 109.65 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.571 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.201 0.524 . . . . 0.0 109.82 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.641 HD12 ' CD1' ' A' ' 35' ' ' TRP . 4.5 tp -61.95 -45.21 94.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.07 -1.019 . . . . 0.0 109.48 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.49 -10.38 11.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.911 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -105.3 -24.99 12.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 110.27 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.61 HG23 ' N ' ' A' ' 46' ' ' ALA . 34.8 m -115.03 -49.57 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.963 -1.086 . . . . 0.0 110.051 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.61 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -129.74 62.22 62.32 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 2.2 Cg_endo -61.71 177.9 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.133 1.889 . . . . 0.0 110.176 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 49' ' ' LYS . . . 43.96 60.93 3.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.489 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 4.6 mttt -159.52 123.63 3.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -1.151 . . . . 0.0 109.577 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 1.8 m -90.03 134.81 34.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.616 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.592 HD11 HD21 ' A' ' 42' ' ' LEU . 8.4 mm -96.08 108.76 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.181 -0.95 . . . . 0.0 108.775 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.09 167.15 32.75 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.45 -6.96 50.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.33 154.35 29.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -1.165 . . . . 0.0 109.245 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HA ' HD13 ' A' ' 55' ' ' ILE . 19.5 mm -68.46 142.37 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.847 ' CE2' HD12 ' A' ' 63' ' ' LEU . 10.6 t80 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.263 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.229 0.537 . . . . 0.0 109.715 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.847 HD12 ' CE2' ' A' ' 56' ' ' PHE . 58.8 mt -89.5 148.43 40.3 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 108.987 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.87 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.3 Cg_exo -59.69 94.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.08 1.854 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.618 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 10.5 m95 -112.76 166.59 11.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 0.0 109.562 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.629 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -120.49 132.23 55.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 108.745 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.688 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -111.95 153.65 26.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.07 -1.019 . . . . 0.0 110.405 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.702 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -141.18 152.56 44.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.502 -0.749 . . . . 0.0 109.19 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 5.7 m-20 -74.54 141.51 44.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 109.245 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.885 HG21 ' CD1' ' A' ' 7' ' ' PHE . 22.2 mm -135.41 145.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.145 -0.972 . . . . 0.0 109.771 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 65.32 33.84 8.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.472 -0.768 . . . . 0.0 109.81 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.492 ' HA ' ' OD1' ' A' ' 84' ' ' ASN . 17.1 t80 -69.49 137.84 52.9 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.68 -79.88 0.45 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.288 -0.882 . . . . 0.0 109.392 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.83 179.25 6.03 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.739 -0.6 . . . . 0.0 109.475 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.19 -162.95 42.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.53 150.68 6.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.204 -1.174 . . . . 0.0 109.394 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.92 173.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.686 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -107.36 -167.97 1.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.401 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -114.62 11.27 16.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.451 ' C ' ' HG2' ' A' ' 87' ' ' ARG . 42.8 m-20 -96.75 125.67 41.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.056 -1.028 . . . . 0.0 109.52 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -144.65 158.71 43.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 0.0 109.594 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.702 HG22 ' HB3' ' A' ' 74' ' ' ALA . 7.2 tt -122.9 131.58 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.714 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.5 mm? -105.63 96.95 6.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.626 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 36.3 p90 -92.84 139.74 30.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.898 -1.126 . . . . 0.0 108.559 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.471 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -105.64 170.53 7.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.138 -0.976 . . . . 0.0 110.565 -178.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -21.37 66.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -0.794 . . . . 0.0 109.388 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 54.8 p30 -89.57 17.53 6.3 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.6 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.8 29.5 5.12 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.723 -0.611 . . . . 0.0 110.375 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.87 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.5 mt -86.4 96.54 10.05 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.995 HD12 ' HB2' ' A' ' 110' ' ' ARG . 8.7 mt -94.64 111.21 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 110.342 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.512 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 9.7 m-85 -110.52 162.48 14.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -129.8 152.37 49.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.98 -1.075 . . . . 0.0 109.329 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.2 118.18 11.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.892 . . . . 0.0 109.031 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 27.01 8.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 109.767 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -145.57 20.21 1.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.478 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 5.8 t-80 78.8 74.3 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -0.815 . . . . 0.0 109.786 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.492 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 29.3 m-85 44.64 24.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 102' ' ' HIS . 5.0 mm-40 -94.67 -16.41 23.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.998 . . . . 0.0 108.887 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.5 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 1.4 m -150.28 136.7 18.89 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 98' ' ' LYS . 71.2 m-85 -124.25 131.37 53.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.01 -1.056 . . . . 0.0 110.33 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -126.11 131.87 52.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 4.5 tttt -79.34 128.25 33.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.037 -1.039 . . . . 0.0 109.549 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pt -112.12 -45.14 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.995 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.462 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -146.63 60.6 1.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.62 ' O ' HD12 ' A' ' 76' ' ' ILE . 14.0 p -144.6 -167.58 2.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.932 . . . . 0.0 109.523 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.993 ' CD1' HG21 ' A' ' 76' ' ' ILE . 37.3 m-85 -79.17 -59.99 2.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.444 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.56 -31.0 67.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.58 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.89 -52.33 29.4 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 6' ' ' THR . 58.0 t -64.6 -44.66 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -1.152 . . . . 0.0 109.138 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -56.06 -38.87 71.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -56.51 16.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.499 -0.751 . . . . 0.0 109.138 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.64 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 22.5 t80 -58.66 -20.21 46.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.045 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.5 mt -73.33 -63.17 1.24 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.458 -0.776 . . . . 0.0 109.001 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.412 ' HG3' HD11 ' A' ' 96' ' ' ILE . 7.2 mt-30 -71.93 -5.96 38.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.091 . . . . 0.0 109.391 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.0 m -91.15 -66.8 0.9 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.166 -0.959 . . . . 0.0 110.044 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 85.0 m-85 -89.22 -10.93 45.15 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.62 -0.675 . . . . 0.0 109.362 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.496 ' HA ' ' CH2' ' A' ' 94' ' ' TRP . 22.5 m170 62.57 54.61 2.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.392 -0.817 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER 162.56 130.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 74' ' ' ALA . 31.5 mt -43.67 148.51 0.71 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.91 . . . . 0.0 109.116 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 12.0 Cg_exo -51.49 163.49 1.11 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.072 1.848 . . . . 0.0 110.552 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.7 -7.03 35.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.357 -0.84 . . . . 0.0 109.057 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.455 ' CG ' ' HB2' ' A' ' 21' ' ' PRO . 5.6 p30 -92.15 2.54 56.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.85 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 50' ' ' SER . 6.8 m-85 -99.24 93.21 5.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.095 -1.003 . . . . 0.0 109.818 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pp -98.77 118.98 46.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.27 -0.894 . . . . 0.0 108.925 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 25' ' ' ILE . 30.0 p -44.58 169.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -65.53 -44.56 86.51 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.136 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -54.58 -39.61 67.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.847 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.3 mt-10 -58.63 -39.92 81.87 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.619 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -65.44 -39.43 92.05 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.144 -0.972 . . . . 0.0 108.443 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 9.2 mt-30 -59.77 -35.22 74.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.18 73.39 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 109.367 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.847 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.37 -15.77 54.27 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.703 -0.623 . . . . 0.0 110.205 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 1.035 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 112.49 44.59 0.83 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.619 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 8.6 t90 -109.37 124.48 51.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -1.177 . . . . 0.0 109.239 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 t -91.08 113.32 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.835 . . . . 0.0 109.083 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.491 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 42' ' ' LEU . 10.9 tp -56.77 -60.94 2.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 109.581 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -43.56 -24.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.926 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -82.13 -49.44 10.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 110.64 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.035 HG11 ' O ' ' A' ' 34' ' ' GLY . 31.8 m -95.14 -50.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.906 -1.121 . . . . 0.0 110.488 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.803 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -117.13 76.8 8.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.003 -1.061 . . . . 0.0 109.805 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.8 Cg_endo -62.85 154.23 67.66 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.235 1.956 . . . . 0.0 110.364 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 45.32 73.9 0.25 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.803 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 2.5 mttp -154.42 123.07 6.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.583 ' HB2' ' CD1' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -89.77 131.97 35.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.878 . . . . 0.0 109.472 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.542 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 11.5 mm -91.16 109.85 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.186 -0.946 . . . . 0.0 109.2 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -161.92 175.63 38.42 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.498 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 88.32 33.73 10.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' OD1' ' OE2' ' A' ' 73' ' ' GLU . 2.2 p30 -131.05 143.37 50.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -1.225 . . . . 0.0 109.497 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 54' ' ' ASP . 1.1 mp -44.08 147.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.832 . . . . 0.0 109.003 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.815 ' CE2' HD12 ' A' ' 63' ' ' LEU . 8.1 t80 . . . . . 0 C--N 1.302 -1.469 0 O-C-N 121.311 -0.868 . . . . 0.0 109.211 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 7.5 mtpp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.815 HD12 ' CE2' ' A' ' 56' ' ' PHE . 28.5 mt -115.07 152.2 46.4 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.175 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.602 ' CG ' ' CZ ' ' A' ' 97' ' ' TYR . 2.9 Cg_endo -61.44 156.65 45.33 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.131 1.887 . . . . 0.0 110.233 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.548 ' CE3' HD13 ' A' ' 63' ' ' LEU . 16.4 m95 -137.13 171.51 14.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.509 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 90' ' ' TYR . 8.7 mmt180 -133.06 143.2 49.2 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.391 -0.818 . . . . 0.0 108.819 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.553 ' HA ' HD13 ' A' ' 89' ' ' LEU . 17.3 pt-20 -121.0 149.4 42.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.14 -0.975 . . . . 0.0 110.123 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 20' ' ' LEU . . . -139.53 146.28 39.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.363 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HA ' ' HG3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -65.24 141.17 58.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.519 -0.738 . . . . 0.0 109.629 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.993 HG21 ' CD1' ' A' ' 7' ' ' PHE . 23.1 mm -129.47 122.71 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.948 . . . . 0.0 109.833 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.759 ' OD1' HG22 ' A' ' 76' ' ' ILE . 5.2 m120 77.48 43.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 109.868 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.507 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 36.6 t80 -70.08 149.25 47.83 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.191 -0.943 . . . . 0.0 109.317 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.79 -78.19 0.16 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.171 -0.956 . . . . 0.0 109.488 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.8 m -165.96 168.66 15.51 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.729 -0.607 . . . . 0.0 109.615 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 78.21 -179.25 51.94 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.6 OUTLIER -43.61 165.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -1.087 . . . . 0.0 109.431 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -50.66 175.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.562 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 1.3 p30 -109.37 -169.17 1.43 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.892 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.46 9.18 18.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.91 . . . . 0.0 109.508 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.683 ' OD1' HG22 ' A' ' 100' ' ' THR . 61.6 m-20 -107.21 129.24 54.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.523 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -150.02 174.6 12.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.894 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.85 HD11 ' CG2' ' A' ' 96' ' ' ILE . 5.6 tt -137.64 128.68 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 109.119 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.74 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.3 mm? -103.29 102.99 12.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.398 -0.814 . . . . 0.0 110.32 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 72' ' ' ARG . 32.1 p90 -99.38 139.94 34.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.999 -1.063 . . . . 0.0 108.559 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.482 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -103.62 173.2 6.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.059 -1.026 . . . . 0.0 110.826 -178.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 p -66.01 -19.9 66.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.509 -0.745 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 47.5 p-10 -89.58 17.05 6.79 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.598 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 66.89 29.22 8.39 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.726 -0.609 . . . . 0.0 109.989 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.623 HD22 ' HE1' ' A' ' 97' ' ' TYR . 6.9 mt -85.33 99.14 10.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.85 ' CG2' HD11 ' A' ' 88' ' ' ILE . 2.6 mt -93.83 116.92 36.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 110.408 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.623 ' HE1' HD22 ' A' ' 95' ' ' LEU . 7.2 m-85 -116.8 155.58 28.71 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -121.49 154.12 37.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.754 -1.217 . . . . 0.0 109.713 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -140.69 125.01 17.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.496 -0.752 . . . . 0.0 108.993 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.683 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.65 29.38 7.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.784 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.583 ' OD2' HG23 ' A' ' 105' ' ' THR . 0.9 OUTLIER -150.24 21.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.114 -0.991 . . . . 0.0 109.687 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 2.2 t-80 76.61 72.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 109.261 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.463 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 9.2 m-85 50.33 20.8 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.739 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.498 ' HB2' ' CB ' ' A' ' 101' ' ' ASP . 1.2 mt-30 -86.87 -19.98 28.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.913 . . . . 0.0 109.143 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.583 HG23 ' OD2' ' A' ' 101' ' ' ASP . 34.3 p -146.51 157.5 43.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.527 ' CE2' ' HB3' ' A' ' 62' ' ' LYS . 82.6 m-85 -141.98 125.11 16.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 110.042 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -117.0 133.96 55.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.359 -0.838 . . . . 0.0 109.018 179.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -79.73 128.3 33.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.596 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 6.8 pt -127.85 17.04 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.524 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -141.25 53.35 1.55 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.608 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.74 -172.76 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.417 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.832 ' CD1' HG21 ' A' ' 76' ' ' ILE . 47.2 m-85 -80.24 -61.96 1.82 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.482 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -30.99 67.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.35 -50.27 45.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.563 HG23 ' H ' ' A' ' 6' ' ' THR . 96.7 t -65.89 -45.8 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -1.115 . . . . 0.0 109.294 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -56.93 -35.93 69.62 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.51 -55.68 19.07 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 22.6 t80 -58.61 -23.13 58.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 0.0 109.183 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 11' ' ' ALA . 5.4 mt -71.9 -63.83 1.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.353 -0.842 . . . . 0.0 108.949 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.424 ' HG3' ' HD2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -71.01 -5.04 28.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.102 -0.999 . . . . 0.0 109.364 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 31.2 m -91.93 -69.96 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -0.952 . . . . 0.0 109.844 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 81.9 m-85 -89.76 -4.82 57.48 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.684 -0.635 . . . . 0.0 109.596 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 21.4 m170 57.51 57.81 4.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 162.51 129.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.477 HD11 ' OH ' ' A' ' 90' ' ' TYR . 19.0 mt -44.05 148.24 0.82 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.287 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.5 Cg_exo -55.35 164.49 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.172 1.915 . . . . 0.0 110.444 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.81 -5.81 33.05 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.306 -0.871 . . . . 0.0 108.868 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' ' 21' ' ' PRO . 23.2 p30 -92.14 9.79 32.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.525 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.55 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 4.6 m-85 -108.14 99.79 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.006 . . . . 0.0 109.753 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 2.1 pt -106.46 124.45 61.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 108.725 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 25' ' ' ILE . 20.5 p -47.0 176.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.817 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.611 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.19 -44.76 68.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.1 -1.0 . . . . 0.0 109.092 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 m -54.49 -39.9 68.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.844 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.7 mm-40 -58.67 -39.73 81.52 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.61 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.2 -34.56 77.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 108.663 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.526 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 18.6 mt-30 -65.95 -30.75 71.37 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.29 -37.87 84.73 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.692 0.758 . . . . 0.0 109.579 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -80.93 -8.25 59.7 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.649 -0.657 . . . . 0.0 110.124 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.516 ' O ' HG21 ' A' ' 45' ' ' VAL . . . 103.01 61.77 0.71 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.63 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 1.7 t90 -118.55 135.45 54.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.195 -1.179 . . . . 0.0 109.599 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.51 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 3.5 t -89.73 131.66 36.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.63 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.494 0 O-C-N 120.965 -1.085 . . . . 0.0 110.311 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.464 ' C ' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.141 0.496 . . . . 0.0 109.995 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.564 HD13 ' CD1' ' A' ' 35' ' ' TRP . 11.7 tp -52.94 -66.58 0.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 109.111 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.79 -14.64 1.48 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.787 -0.571 . . . . 0.0 110.359 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.8 -36.56 42.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.89 -1.131 . . . . 0.0 109.516 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 35' ' ' TRP . 22.0 m -105.49 -1.6 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 109.503 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.457 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.4 62.69 5.58 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 109.31 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 5.6 Cg_exo -58.42 152.92 50.95 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.203 1.935 . . . . 0.0 110.286 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 49.8 66.55 2.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HD2' HG12 ' A' ' 25' ' ' ILE . 30.7 mmtp -151.88 154.64 36.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.671 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.532 ' HB2' ' CD1' ' A' ' 24' ' ' TYR . 1.8 m -135.34 124.91 25.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.56 HD11 HD21 ' A' ' 42' ' ' LEU . 11.9 mm -74.64 104.97 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -151.35 173.21 30.8 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.406 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 84.17 15.27 69.83 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.48 154.31 17.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -1.151 . . . . 0.0 109.409 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 55' ' ' ILE . 16.4 mm -70.08 149.67 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.904 ' CE2' HD12 ' A' ' 63' ' ' LEU . 60.6 t80 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.043 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.56 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.227 0.537 . . . . 0.0 109.756 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.904 HD12 ' CE2' ' A' ' 56' ' ' PHE . 41.1 mt -89.85 145.11 32.65 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.151 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.976 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.8 Cg_endo -60.31 156.23 41.84 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.025 1.816 . . . . 0.0 110.359 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.261 0.553 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.795 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 3.9 m95 -122.93 173.57 7.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.554 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.616 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 1.1 mmt180 -121.58 148.83 44.0 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.75 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -128.8 153.8 47.06 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.877 -1.139 . . . . 0.0 110.249 -179.304 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -143.05 148.77 37.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.423 -0.798 . . . . 0.0 109.241 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -77.45 124.07 27.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.727 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.832 HG21 ' CD1' ' A' ' 7' ' ' PHE . 22.3 mm -110.85 138.86 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.113 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.65 ' OD1' HG22 ' A' ' 76' ' ' ILE . 14.9 m120 61.58 112.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.069 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 6.8 t80 -170.45 133.95 1.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.062 -1.024 . . . . 0.0 109.674 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -140.9 -79.43 0.27 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.226 -0.921 . . . . 0.0 109.364 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 m -146.14 160.03 42.49 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.716 -0.615 . . . . 0.0 109.436 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.9 -169.15 18.79 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -64.07 144.45 57.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -1.177 . . . . 0.0 109.485 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 82' ' ' PHE . 5.2 mtm180 -43.97 163.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 109.219 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -106.84 -171.11 1.82 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.944 . . . . 0.0 109.651 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.43 23.28 9.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.5 m-20 -109.24 132.03 54.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.373 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 99' ' ' THR . 36.8 mtt180 -157.81 157.73 33.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.55 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.973 HD11 HD11 ' A' ' 109' ' ' ILE . 1.5 tt -112.93 139.64 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.245 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.4 mm? -108.45 126.59 53.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.795 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -116.69 140.05 49.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.857 -1.152 . . . . 0.0 108.666 178.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.451 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -108.12 176.01 5.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.193 -0.942 . . . . 0.0 110.379 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 p -64.23 -25.2 67.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.408 -0.808 . . . . 0.0 110.441 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.483 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -89.3 16.84 6.76 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.108 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.566 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.4 m95 67.5 29.31 7.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.713 -0.617 . . . . 0.0 110.737 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.976 HD13 ' HG2' ' A' ' 64' ' ' PRO . 8.8 mt -83.79 121.87 27.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.544 ' CG1' ' HB2' ' A' ' 110' ' ' ARG . 1.8 mt -115.42 112.82 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 110.75 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.613 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 26.1 m-85 -112.07 118.66 36.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.484 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -88.88 136.13 33.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.818 -1.176 . . . . 0.0 109.866 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -125.54 131.46 52.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.392 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.2 p -114.75 31.75 6.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.159 -0.963 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -150.26 20.4 0.85 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 109.565 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.537 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.5 t-80 79.08 73.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.496 -0.753 . . . . 0.0 109.971 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 5.0 m-85 51.57 37.73 20.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.04 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.434 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 19.7 tp60 -104.29 -72.29 0.71 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.135 -0.978 . . . . 0.0 109.052 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 99' ' ' THR . 0.8 OUTLIER -93.16 124.41 37.12 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.56 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 96.7 m-85 -112.17 121.66 45.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.067 -1.021 . . . . 0.0 110.065 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.484 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 3.8 m -108.64 130.81 55.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.386 -0.821 . . . . 0.0 109.087 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -79.41 113.8 17.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.047 -1.033 . . . . 0.0 109.668 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.973 HD11 HD11 ' A' ' 88' ' ' ILE . 29.5 pt -113.21 -14.98 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 109.328 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.544 ' HB2' ' CG1' ' A' ' 96' ' ' ILE . 1.1 mtt-85 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.237 0.541 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -134.57 49.44 2.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -135.31 -169.93 2.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 0.0 109.443 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.967 ' CE1' HG21 ' A' ' 76' ' ' ILE . 42.6 m-85 -80.14 -59.64 2.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.213 -0.929 . . . . 0.0 109.463 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -28.72 65.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.969 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.37 -51.27 33.03 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 6' ' ' THR . 38.7 t -67.04 -49.36 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -1.153 . . . . 0.0 109.167 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -53.88 -37.04 63.3 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.27 -55.63 23.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 23.2 t80 -59.94 -18.3 44.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.429 -0.794 . . . . 0.0 109.03 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.492 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.7 OUTLIER -76.1 -63.82 1.23 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.328 -0.857 . . . . 0.0 109.296 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.422 ' NE2' ' HD3' ' A' ' 110' ' ' ARG . 3.1 pt20 -70.51 -8.49 51.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.906 -1.121 . . . . 0.0 109.353 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -91.9 -65.7 0.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.782 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 96.3 m-85 -89.51 3.3 52.88 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.713 -0.617 . . . . 0.0 109.5 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.548 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 16.6 m170 45.01 45.48 8.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.6 OUTLIER 174.43 129.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 20' ' ' LEU . 18.4 mt -45.46 150.73 0.84 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 108.754 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 10.9 Cg_exo -52.98 160.06 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.084 1.856 . . . . 0.0 110.453 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -69.59 -5.89 27.52 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.309 -0.87 . . . . 0.0 109.202 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -93.44 2.87 56.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.336 -0.853 . . . . 0.0 109.628 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.547 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.2 m-85 -93.76 92.72 7.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.002 . . . . 0.0 109.943 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -100.99 125.3 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.264 -0.897 . . . . 0.0 108.937 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.473 ' H ' HG23 ' A' ' 26' ' ' THR . 12.1 p -45.96 172.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.16 -43.09 71.57 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.964 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -39.1 64.14 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.768 ' O ' HD12 ' A' ' 33' ' ' LEU . 5.5 mt-10 -59.67 -41.31 90.32 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.636 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -65.08 -35.98 82.88 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 0.0 108.63 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.408 ' HG3' ' CE3' ' A' ' 35' ' ' TRP . 13.0 mt-30 -63.03 -36.25 82.95 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.22 79.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.447 -0.783 . . . . 0.0 109.533 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.8 mp -81.17 -11.25 59.48 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.365 0.602 . . . . 0.0 110.261 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.764 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 107.68 56.77 0.59 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.636 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 9.8 t90 -127.89 115.48 18.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -1.141 . . . . 0.0 109.025 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.0 t -90.14 112.04 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 108.994 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.588 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.195 -0.94 . . . . 0.0 109.422 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.599 ' OD1' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.556 HD21 HD11 ' A' ' 51' ' ' ILE . 9.8 tp -59.54 -52.98 63.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.449 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -56.67 -14.96 3.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 109.871 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.83 -53.83 4.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.024 . . . . 0.0 110.331 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.764 HG11 ' O ' ' A' ' 34' ' ' GLY . 20.4 m -89.88 -48.1 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 110.16 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.61 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -116.85 77.35 8.5 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.993 . . . . 0.0 109.542 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 2.7 Cg_endo -60.92 159.47 29.25 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.21 1.94 . . . . 0.0 110.4 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.85 57.28 4.09 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HD3' HG12 ' A' ' 25' ' ' ILE . 2.9 mmtt -137.65 110.16 7.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -1.141 . . . . 0.0 109.588 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 9.2 m -89.7 133.93 34.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.4 -0.813 . . . . 0.0 109.229 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.556 HD11 HD21 ' A' ' 42' ' ' LEU . 10.2 mm -91.06 111.48 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.102 -0.999 . . . . 0.0 109.176 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -155.91 169.21 33.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.77 12.71 55.25 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 5.6 m-20 -104.95 143.86 32.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -1.21 . . . . 0.0 109.38 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 54' ' ' ASP . 7.3 mt -44.44 152.22 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 109.571 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.018 ' CE2' HD12 ' A' ' 63' ' ' LEU . 9.9 t80 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.139 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.602 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 8.0 mptt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.335 0.588 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.018 HD12 ' CE2' ' A' ' 56' ' ' PHE . 56.2 mt -91.59 140.71 25.32 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.24 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.953 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.2 Cg_exo -61.53 84.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.078 1.852 . . . . 0.0 110.067 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.784 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.3 0.571 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.859 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 8.2 m95 -139.79 151.26 45.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 109.299 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.636 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 10.0 mpt_? -110.75 139.16 46.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.202 -0.936 . . . . 0.0 108.671 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.607 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -117.77 158.22 25.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.008 . . . . 0.0 110.269 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -147.91 152.95 38.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -75.39 142.6 43.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 109.323 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.967 HG21 ' CE1' ' A' ' 7' ' ' PHE . 16.8 mm -131.14 121.73 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.09 -1.006 . . . . 0.0 109.732 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.509 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER 71.63 116.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 109.698 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -170.64 127.77 0.78 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.351 -0.843 . . . . 0.0 109.493 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -121.47 -27.91 4.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.745 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 79' ' ' THR . 0.6 OUTLIER 168.91 -174.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.391 -0.818 . . . . 0.0 109.703 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 82' ' ' PHE . . . 67.07 174.7 6.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.456 ' O ' ' O ' ' A' ' 83' ' ' ARG . 7.5 m-85 -43.81 152.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -1.15 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -46.65 171.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.9 OUTLIER -106.38 -174.74 2.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 m -106.37 3.99 28.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 0.0 109.48 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.2 m-20 -95.9 129.5 43.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 109.53 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 27.2 mtt180 -154.64 178.53 10.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.181 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 96' ' ' ILE . 3.7 tt -135.23 150.95 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.711 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.1 mm? -121.69 109.45 14.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.376 -0.827 . . . . 0.0 109.707 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.636 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 7.9 p90 -104.55 138.89 40.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 109.302 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.583 ' OG ' ' CH2' ' A' ' 71' ' ' TRP . 1.4 m -107.23 174.3 5.95 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.288 -0.882 . . . . 0.0 110.396 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -65.3 -23.9 67.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 109.593 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.473 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 17.8 p-10 -89.7 18.15 5.82 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 108.858 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.572 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.4 m95 66.39 29.49 9.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.677 -0.639 . . . . 0.0 110.173 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.953 HD13 ' HG2' ' A' ' 64' ' ' PRO . 5.7 mt -81.03 112.5 18.48 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.793 HG22 HD11 ' A' ' 88' ' ' ILE . 2.0 mt -109.52 110.83 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.782 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.49 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 31.5 m-85 -113.91 113.49 24.92 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CG ' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -89.36 133.76 34.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 110.215 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -117.13 128.96 55.65 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.33 28.23 8.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.18 -0.95 . . . . 0.0 109.645 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.791 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.7 OUTLIER -150.18 22.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.463 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 8.7 t-80 77.54 71.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.381 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.432 ' OH ' ' HD2' ' A' ' 87' ' ' ARG . 5.1 m-85 50.76 20.91 0.82 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.826 . . . . 0.0 109.752 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.467 ' HB2' ' CB ' ' A' ' 101' ' ' ASP . 1.2 mm-40 -90.33 -17.4 27.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -0.96 . . . . 0.0 108.87 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.791 HG22 ' OD1' ' A' ' 101' ' ' ASP . 14.9 t -143.81 161.5 38.46 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.602 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 99.4 m-85 -148.76 119.72 7.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.817 -1.177 . . . . 0.0 110.223 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.528 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 3.8 m -108.96 124.82 51.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.515 -0.741 . . . . 0.0 109.1 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -79.42 101.13 7.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.447 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.449 HG21 ' HE2' ' A' ' 98' ' ' LYS . 38.1 pt -104.63 18.18 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.789 ' HD2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -143.76 69.74 1.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.516 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.848 ' H ' HG23 ' A' ' 10' ' ' VAL . 1.5 p -149.03 -173.15 4.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.436 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.711 ' CE1' HG21 ' A' ' 76' ' ' ILE . 24.1 m-85 -77.65 -60.29 2.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.893 . . . . 0.0 109.429 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -33.97 70.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.69 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.24 -50.3 46.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.848 HG23 ' H ' ' A' ' 6' ' ' THR . 76.0 t -66.78 -46.98 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -1.147 . . . . 0.0 109.337 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.4 66.97 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.447 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.4 OUTLIER -63.85 -55.77 20.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.518 -0.739 . . . . 0.0 109.246 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.664 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 42.0 t80 -58.18 -21.08 45.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.374 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.539 HD12 HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -75.38 -63.87 1.19 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.401 -0.812 . . . . 0.0 109.317 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' OE1' ' CG ' ' A' ' 110' ' ' ARG . 46.8 mt-30 -70.58 -5.72 31.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.034 -1.041 . . . . 0.0 109.389 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 82.6 m -94.5 -67.37 0.86 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.678 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.664 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 66.6 m-85 -89.78 3.2 53.59 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 109.567 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.9 m170 44.14 51.09 7.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER 175.35 129.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.786 HD13 ' HD2' ' A' ' 24' ' ' TYR . 15.7 mt -43.84 160.02 0.23 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.99 . . . . 0.0 109.417 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 3.3 Cg_exo -55.22 159.23 10.46 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.236 1.957 . . . . 0.0 110.553 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.56 -5.05 30.44 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.374 -0.829 . . . . 0.0 108.947 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 21' ' ' PRO . 6.1 p30 -111.42 32.74 5.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.498 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.786 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.2 m-30 -115.18 81.06 1.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.062 -1.024 . . . . 0.0 109.363 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pt -88.14 123.35 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.253 -0.905 . . . . 0.0 108.978 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 25' ' ' ILE . 82.8 p -46.92 175.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.335 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.62 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.24 -45.32 66.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.997 -1.064 . . . . 0.0 109.052 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -52.08 -33.42 39.24 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 108.361 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.7 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.5 mm-40 -61.3 -46.53 89.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.653 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -62.19 -35.92 80.33 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.522 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 33.3 mt-30 -64.45 -33.73 76.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.62 -37.89 85.6 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.19 -8.96 59.85 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.741 -0.599 . . . . 0.0 109.972 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' O ' HG21 ' A' ' 45' ' ' VAL . . . 101.67 71.23 0.91 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.653 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 0.8 OUTLIER -128.2 137.69 52.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -1.188 . . . . 0.0 109.441 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.554 HG12 ' OD1' ' A' ' 41' ' ' ASN . 9.8 p -89.58 128.77 41.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.009 -1.057 . . . . 0.0 110.384 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.554 ' OD1' HG12 ' A' ' 36' ' ' VAL . 2.6 p-10 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.111 0.481 . . . . 0.0 110.058 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.838 HD21 HD11 ' A' ' 51' ' ' ILE . 6.9 tp -56.85 -65.66 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 109.198 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.29 -9.87 3.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.798 -0.564 . . . . 0.0 110.252 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 3.7 m-20 -78.93 -30.29 44.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.973 -1.079 . . . . 0.0 109.41 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 35' ' ' TRP . 30.8 m -107.61 -14.18 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.341 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -149.3 65.24 7.83 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 109.376 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 3.1 Cg_exo -60.97 161.94 20.65 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.2 1.933 . . . . 0.0 110.317 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.52 38.34 42.82 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 15.8 mmtt -135.58 113.29 10.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -1.161 . . . . 0.0 109.55 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -89.68 155.43 19.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.838 HD11 HD21 ' A' ' 42' ' ' LEU . 5.4 mm -103.11 111.66 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.839 . . . . 0.0 109.405 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -154.1 160.09 29.21 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.08 19.91 27.25 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.527 ' HB2' ' CG ' ' A' ' 73' ' ' GLU . 4.5 m-20 -88.13 148.11 24.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -1.199 . . . . 0.0 109.467 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.0 mm -68.68 137.49 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.835 . . . . 0.0 109.758 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.929 ' CE2' HD12 ' A' ' 63' ' ' LEU . 78.2 t80 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 108.957 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 6.4 mtpt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.306 0.574 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.929 HD12 ' CE2' ' A' ' 56' ' ' PHE . 12.7 mt -94.18 147.29 33.13 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 0.0 109.279 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.006 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.4 Cg_endo -62.03 119.14 6.12 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.139 1.893 . . . . 0.0 110.174 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.365 0.603 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.746 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 11.5 m95 -128.74 154.11 46.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 7.3 mmt180 -117.72 148.65 41.81 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.668 ' HA ' HD13 ' A' ' 89' ' ' LEU . 5.9 pt-20 -125.49 155.02 41.19 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.789 -1.194 . . . . 0.0 110.11 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB2' ' OH ' ' A' ' 90' ' ' TYR . . . -144.16 155.59 43.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 109.416 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.475 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 3.4 m-20 -80.24 143.44 33.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.601 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.711 HG21 ' CE1' ' A' ' 7' ' ' PHE . 37.3 mm -127.85 119.0 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 73.83 108.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.674 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.52 ' CE1' ' HA ' ' A' ' 83' ' ' ARG . 23.3 t80 -170.71 118.81 0.52 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.336 -0.852 . . . . 0.0 109.46 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.42 -80.1 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.393 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.8 m -137.19 145.1 43.29 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.726 -0.609 . . . . 0.0 109.385 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.2 -174.25 15.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -61.71 140.69 58.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.158 -1.201 . . . . 0.0 109.426 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.52 ' HA ' ' CE1' ' A' ' 78' ' ' TYR . 45.5 mtp180 -44.04 167.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 109.346 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.42 -176.98 3.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.961 . . . . 0.0 109.684 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -113.5 15.67 18.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 109.311 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.589 ' OD2' HG22 ' A' ' 100' ' ' THR . 0.7 OUTLIER -97.96 130.45 44.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.225 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.525 ' CZ ' ' OH ' ' A' ' 103' ' ' TYR . 2.3 mtt180 -152.54 179.57 8.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.967 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.743 HD11 HD11 ' A' ' 109' ' ' ILE . 1.8 tt -138.77 141.39 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -0.835 . . . . 0.0 108.884 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.747 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.3 mm? -111.61 125.09 53.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.365 -0.834 . . . . 0.0 109.667 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.775 ' OH ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -111.3 142.61 43.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.921 -1.112 . . . . 0.0 108.839 179.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.504 ' CB ' ' HB2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -110.88 171.77 7.27 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.186 -0.946 . . . . 0.0 110.184 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.0 p -64.59 -25.76 68.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.435 -0.791 . . . . 0.0 109.518 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.483 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 14.1 p-10 -90.01 19.8 4.68 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.583 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.0 27.77 8.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.68 -0.638 . . . . 0.0 110.133 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.006 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.2 mt -79.62 116.78 20.01 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.535 HG22 HD11 ' A' ' 88' ' ' ILE . 2.5 mt -114.6 108.05 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.088 -1.007 . . . . 0.0 110.56 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.567 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 24.9 m-85 -108.25 116.83 32.69 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.552 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -88.6 137.97 31.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.867 -1.146 . . . . 0.0 109.997 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -122.0 127.3 50.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.589 HG22 ' OD2' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -111.89 29.37 7.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.11 -0.994 . . . . 0.0 109.59 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -150.06 22.44 0.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.726 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.523 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.5 OUTLIER 77.42 69.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.525 ' OH ' ' CZ ' ' A' ' 87' ' ' ARG . 14.8 m-85 49.45 21.81 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.798 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.462 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . 4.8 mt-30 -88.0 -17.29 31.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 108.97 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.485 ' O ' ' HB ' ' A' ' 99' ' ' THR . 23.0 m -147.27 155.79 42.36 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . 90.2 m-85 -139.76 116.44 10.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.973 -1.08 . . . . 0.0 110.11 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 1.7 m -107.65 127.27 53.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 113.95 17.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 109.646 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.743 HD11 HD11 ' A' ' 88' ' ' ILE . 3.5 pt -109.3 -24.25 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.646 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.425 ' OXT' ' O ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.503 HG23 ' C ' ' A' ' 9' ' ' GLY . 2.7 mp . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -142.67 47.33 1.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.496 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -136.75 -170.19 2.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.348 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.75 ' CD1' HG21 ' A' ' 76' ' ' ILE . 52.3 m-85 -77.38 -59.57 2.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.402 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -31.19 67.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.894 . . . . 0.0 109.783 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.503 ' C ' HG23 ' A' ' 4' ' ' ILE . . . -68.56 -51.96 28.31 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.496 HG23 ' H ' ' A' ' 6' ' ' THR . 73.7 t -66.09 -45.91 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -1.118 . . . . 0.0 109.313 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -55.95 -38.86 70.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.49 -55.6 26.0 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.679 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 35.1 t80 -58.06 -22.35 49.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.327 -0.858 . . . . 0.0 109.046 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER -71.61 -62.87 1.25 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.43 -0.794 . . . . 0.0 108.989 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -71.28 -5.6 33.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.042 -1.036 . . . . 0.0 109.317 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 25.2 m -89.82 -69.48 0.72 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.952 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.679 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 77.5 m-85 -89.47 -7.79 54.3 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.626 -0.671 . . . . 0.0 109.463 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 23.1 m170 61.01 57.89 2.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.707 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 10.1 ptpt 160.64 129.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 20' ' ' LEU . 30.4 mt -44.46 147.33 1.04 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 108.997 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.567 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.3 Cg_exo -52.41 160.1 3.86 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.043 1.829 . . . . 0.0 110.336 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -7.74 32.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.139 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -91.75 7.33 42.25 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.3 m-85 -98.43 98.44 9.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -0.93 . . . . 0.0 109.677 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 26' ' ' THR . 1.9 pp -106.07 121.34 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 108.953 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.848 ' O ' HD12 ' A' ' 25' ' ' ILE . 16.8 p -46.35 173.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.667 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.87 -44.41 69.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.131 -0.98 . . . . 0.0 108.996 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 m -53.5 -38.7 63.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 33' ' ' LEU . 2.3 mm-40 -59.51 -39.35 83.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.736 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.55 -37.54 82.85 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.139 -0.976 . . . . 0.0 108.624 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -61.98 -33.02 73.54 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.31 74.74 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.437 -0.789 . . . . 0.0 109.358 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.0 mp -81.17 -15.52 55.51 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.4 0.619 . . . . 0.0 110.181 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.528 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 110.44 44.53 0.98 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.736 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 5.6 t90 -109.19 121.29 44.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -1.104 . . . . 0.0 109.184 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.2 t -89.62 116.31 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.312 -0.867 . . . . 0.0 108.86 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 0.0 109.75 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.543 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.216 0.531 . . . . 0.0 109.724 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.641 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 5.9 tp -58.56 -53.39 58.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.542 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.22 -19.17 1.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.937 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.11 -32.87 15.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.0 110.292 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -103.17 -57.65 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.929 -1.107 . . . . 0.0 109.683 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.841 ' HB1' ' HE2' ' A' ' 49' ' ' LYS . . . -114.12 79.69 5.11 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.423 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -62.18 156.92 47.49 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.252 1.968 . . . . 0.0 110.197 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.7 69.33 0.63 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.841 ' HE2' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -150.62 116.0 5.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.48 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 5.7 m -89.54 132.22 35.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.537 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 15.8 mm -87.17 104.83 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.364 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -157.56 168.42 34.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.16 -16.27 38.86 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.73 164.2 23.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -1.159 . . . . 0.0 109.3 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 56' ' ' PHE . 29.9 mm -67.81 166.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.922 . . . . 0.0 109.515 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.031 ' CE2' HD12 ' A' ' 63' ' ' LEU . 23.0 t80 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.31 -0.869 . . . . 0.0 109.457 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.596 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.331 0.586 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.031 HD12 ' CE2' ' A' ' 56' ' ' PHE . 20.9 mt -101.05 152.13 37.8 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.386 -0.821 . . . . 0.0 108.945 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.004 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.7 Cg_exo -56.52 86.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.058 1.839 . . . . 0.0 110.072 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.889 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.71 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 44.2 m95 -83.56 149.95 26.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.157 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -125.17 144.81 50.26 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HA ' HD13 ' A' ' 89' ' ' LEU . 17.2 pt-20 -115.36 159.54 20.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.854 -1.154 . . . . 0.0 110.479 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.654 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -146.3 149.58 34.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.468 -0.77 . . . . 0.0 109.297 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.97 138.68 48.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.75 HG21 ' CD1' ' A' ' 7' ' ' PHE . 19.8 mm -129.93 138.13 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.686 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 73.21 38.0 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.787 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -69.74 139.81 53.38 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.137 -0.977 . . . . 0.0 109.468 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.32 -79.84 0.38 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.504 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.5 163.18 12.48 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.788 -0.57 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.0 -159.26 52.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 83' ' ' ARG . 10.4 m-85 -51.11 147.64 5.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -1.124 . . . . 0.0 109.529 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 82' ' ' PHE . 5.5 mtp180 -53.04 -173.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.308 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -118.33 179.77 4.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.57 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -100.67 12.81 36.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.327 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.67 ' OD1' HG22 ' A' ' 100' ' ' THR . 50.3 m-20 -104.9 128.86 53.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.354 -0.841 . . . . 0.0 109.55 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 99' ' ' THR . 68.5 mtt180 -153.91 163.69 39.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.139 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.751 ' C ' HD22 ' A' ' 89' ' ' LEU . 4.3 tt -121.89 155.39 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.154 -0.966 . . . . 0.0 109.518 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.751 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.4 mm? -122.36 114.81 21.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.656 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.654 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 3.1 p90 -106.86 139.6 41.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.858 -1.151 . . . . 0.0 109.172 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.563 ' OG ' ' CZ3' ' A' ' 71' ' ' TRP . 1.3 m -110.06 173.7 6.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 p -64.77 -25.25 67.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.617 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.495 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 9.8 p-10 -89.73 18.44 5.55 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.415 -0.803 . . . . 0.0 108.971 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.596 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.45 27.41 8.02 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.743 -0.598 . . . . 0.0 110.233 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 1.004 HD13 ' HG2' ' A' ' 64' ' ' PRO . 6.2 mt -79.57 116.44 19.78 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.661 HG22 HD11 ' A' ' 88' ' ' ILE . 5.9 mt -114.9 105.86 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.43 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.638 ' HE1' HD22 ' A' ' 95' ' ' LEU . 23.0 m-85 -106.05 120.61 42.23 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -89.4 150.58 22.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 110.191 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -136.42 131.79 34.6 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.67 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -114.32 6.25 16.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 109.874 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.514 ' HB2' ' CB ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -125.43 24.68 7.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.143 -0.973 . . . . 0.0 109.397 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.6 t-80 76.53 76.01 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.92 . . . . 0.0 109.493 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.488 ' O ' ' CZ ' ' A' ' 106' ' ' PHE . 14.7 m-85 48.93 21.6 0.48 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.514 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -94.02 -34.87 12.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.011 -1.056 . . . . 0.0 109.118 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.483 ' O ' ' HB ' ' A' ' 99' ' ' THR . 95.2 m -121.14 140.81 51.49 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.596 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 94.9 m-85 -134.36 115.55 14.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.043 -1.036 . . . . 0.0 110.131 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 11.2 m -110.15 137.09 48.38 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.358 -0.839 . . . . 0.0 108.947 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -79.68 114.42 18.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 10.5 pt -132.05 68.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.878 . . . . 0.0 109.281 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 3.5 mtp180 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.263 0.554 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -149.95 54.76 0.93 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 10' ' ' VAL . 2.2 p -139.16 -168.82 2.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.775 ' CD1' HG21 ' A' ' 76' ' ' ILE . 32.9 m-85 -79.82 -57.7 3.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.619 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.53 -32.46 69.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 0.0 109.792 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.9 -50.04 50.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 6' ' ' THR . 35.1 t -66.98 -43.58 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -1.124 . . . . 0.0 109.385 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.51 -37.2 72.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.12 -56.32 13.61 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.538 -0.726 . . . . 0.0 109.242 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.638 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 15.8 t80 -60.76 -18.45 54.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 109.064 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.2 mt -74.5 -65.61 0.84 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.499 -0.751 . . . . 0.0 108.975 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -70.26 -6.7 36.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.988 -1.07 . . . . 0.0 109.254 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.534 HG22 ' CD1' ' A' ' 17' ' ' TYR . 19.8 m -89.42 -68.48 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 96.5 m-85 -92.0 6.42 46.44 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.627 -0.671 . . . . 0.0 109.642 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 19.0 m170 44.97 47.65 9.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.407 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 175.83 129.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 20' ' ' LEU . 27.0 mt -46.03 149.53 1.21 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.196 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.564 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 6.8 Cg_exo -53.93 162.56 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.114 1.876 . . . . 0.0 110.639 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -70.79 -5.71 32.26 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.38 -0.825 . . . . 0.0 109.034 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 53.6 p30 -91.75 0.24 57.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.869 . . . . 0.0 109.596 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.644 ' OH ' HG21 ' A' ' 10' ' ' VAL . 3.2 m-85 -89.87 107.92 19.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.056 -1.027 . . . . 0.0 109.579 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.957 HD12 ' O ' ' A' ' 26' ' ' THR . 1.7 pp -111.95 115.34 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 109.08 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.957 ' O ' HD12 ' A' ' 25' ' ' ILE . 81.7 p -44.59 168.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.307 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.607 ' N ' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.68 -41.18 88.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.929 -1.107 . . . . 0.0 109.175 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.05 -47.54 82.82 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 47.2 mm-40 -50.63 -35.19 29.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.933 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -70.03 -40.91 74.91 Favored 'General case' 0 C--O 1.202 -1.438 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -60.03 -18.88 49.52 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.345 -1.472 . . . . 0.0 108.01 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -69.01 -48.0 64.08 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.541 -0.724 . . . . 0.0 111.675 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.811 HD13 ' H ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.81 -0.07 41.64 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.928 -1.107 . . . . 0.0 111.713 -178.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.448 ' N ' HD22 ' A' ' 33' ' ' LEU . . . 108.94 25.93 5.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.893 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.933 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 10.5 t90 -89.12 123.46 33.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.895 -1.356 . . . . 0.0 109.191 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 t -91.93 114.51 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 108.917 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.593 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.232 -0.917 . . . . 0.0 109.789 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.325 0.584 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 3.7 tp -64.42 -41.01 96.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.344 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . . . -63.26 -9.22 10.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.921 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -102.67 -36.72 8.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.039 -1.038 . . . . 0.0 110.211 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.581 HG23 ' N ' ' A' ' 46' ' ' ALA . 28.7 m -108.13 -44.93 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.101 -1.0 . . . . 0.0 110.056 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.581 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -128.7 59.95 46.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.835 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 1.7 Cg_endo -62.58 171.08 6.04 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.175 1.917 . . . . 0.0 110.253 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.17 52.21 5.07 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.572 ' HG3' HG23 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -139.33 135.98 34.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -1.169 . . . . 0.0 109.557 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.514 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 13.3 m -101.64 121.79 42.68 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.235 -0.916 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.607 HG23 ' N ' ' A' ' 27' ' ' LYS . 11.3 mm -79.58 105.07 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.161 -0.962 . . . . 0.0 108.902 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.576 ' O ' HG22 ' A' ' 26' ' ' THR . . . -140.9 172.03 23.85 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.456 -1.354 . . . . 0.0 109.932 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.78 11.65 61.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -84.49 146.97 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -1.195 . . . . 0.0 109.392 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.512 HD13 HH11 ' A' ' 72' ' ' ARG . 19.5 mm -70.2 141.4 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.836 ' CE2' HD12 ' A' ' 63' ' ' LEU . 70.6 t80 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.447 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.245 0.545 . . . . 0.0 109.591 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.887 HD22 ' CZ3' ' A' ' 71' ' ' TRP . 23.4 mt -93.32 147.95 34.69 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 109.257 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.999 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.1 Cg_exo -60.89 162.76 17.91 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.108 1.872 . . . . 0.0 110.223 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.93 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.887 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 8.8 m95 -107.52 161.49 14.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 109.471 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.647 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -117.73 131.25 56.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 0.0 108.819 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.808 ' HA ' HD13 ' A' ' 89' ' ' LEU . 3.6 pt-20 -107.44 147.49 30.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.316 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.66 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -135.17 147.27 49.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -70.78 137.01 49.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.354 -0.841 . . . . 0.0 109.818 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.775 HG21 ' CD1' ' A' ' 7' ' ' PHE . 21.5 mm -132.47 134.58 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.847 . . . . 0.0 109.428 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.1 m-20 69.9 125.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.259 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 6.4 t80 -170.4 136.47 1.33 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.201 -0.937 . . . . 0.0 109.615 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.26 -79.56 0.35 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.382 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -153.79 154.89 34.83 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.717 -0.614 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.9 -171.63 20.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.57 169.07 0.72 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -1.159 . . . . 0.0 109.388 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -56.73 177.14 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.158 -0.964 . . . . 0.0 109.315 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 0.2 OUTLIER -118.99 -174.05 2.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.875 . . . . 0.0 109.535 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 p -115.22 29.63 7.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 52.9 m-20 -114.14 128.84 56.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.573 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.62 ' O ' HG22 ' A' ' 99' ' ' THR . 2.2 mtt180 -156.73 137.27 13.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.388 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 1.033 HD11 ' CG2' ' A' ' 96' ' ' ILE . 5.1 tt -93.12 126.11 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.117 -0.989 . . . . 0.0 109.258 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.808 HD13 ' HA ' ' A' ' 73' ' ' GLU . 4.0 mm? -95.67 100.36 12.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.472 -0.767 . . . . 0.0 109.994 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.654 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 28.8 p90 -97.54 140.35 32.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.983 -1.073 . . . . 0.0 108.525 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -107.84 172.37 6.87 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.985 -1.072 . . . . 0.0 110.761 -178.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -22.19 66.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.5 -0.75 . . . . 0.0 109.826 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 41.8 p-10 -89.58 17.88 5.97 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.382 -0.824 . . . . 0.0 108.829 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.578 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.84 23.96 8.29 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.634 -0.666 . . . . 0.0 110.104 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.999 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.2 mt -79.64 101.18 8.2 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 1.033 ' CG2' HD11 ' A' ' 88' ' ' ILE . 5.5 mt -96.5 118.26 42.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.22 -0.925 . . . . 0.0 110.631 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.498 ' O ' HG13 ' A' ' 88' ' ' ILE . 11.9 m-85 -120.11 160.97 21.79 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -131.79 122.02 25.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.756 -1.215 . . . . 0.0 110.056 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -108.69 131.14 55.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 109.01 179.349 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 p -115.12 18.15 16.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.641 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.7 OUTLIER -139.18 23.55 2.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER 78.33 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 50.35 20.89 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.808 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.77 -15.23 26.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.114 -0.992 . . . . 0.0 109.076 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.641 HG22 ' OD1' ' A' ' 101' ' ' ASP . 12.5 t -148.78 145.35 27.54 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 62' ' ' LYS . 53.7 m-85 -135.99 111.45 9.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.919 -1.113 . . . . 0.0 110.153 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.531 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.8 m -98.34 131.31 44.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.426 -0.796 . . . . 0.0 108.906 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 76.5 tttt -80.03 122.35 26.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.548 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 109' ' ' ILE . 11.3 pt -119.68 15.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.484 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.574 ' CD ' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.489 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.646 HD13 ' HB2' ' A' ' 13' ' ' TYR . 13.3 mt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -144.22 49.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 10' ' ' VAL . 1.2 p -138.68 -173.82 3.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.368 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.97 ' CD1' HG21 ' A' ' 76' ' ' ILE . 38.2 m-85 -76.57 -57.08 4.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.576 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -32.09 69.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 109.875 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.426 ' C ' ' CG2' ' A' ' 4' ' ' ILE . . . -67.59 -52.76 28.15 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 6' ' ' THR . 21.8 t -65.27 -40.71 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -1.14 . . . . 0.0 109.192 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.23 -37.11 76.71 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 1.242 ' OD1' ' NH2' ' A' ' 110' ' ' ARG . 0.7 OUTLIER -65.52 -55.81 15.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.523 -0.736 . . . . 0.0 109.161 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.646 ' HB2' HD13 ' A' ' 4' ' ' ILE . 38.0 t80 -60.77 -19.24 58.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.185 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 0.6 OUTLIER -74.94 -60.53 2.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.405 -0.81 . . . . 0.0 109.311 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -71.03 -10.9 60.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.905 -1.122 . . . . 0.0 109.254 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.7 m -89.42 -66.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.876 . . . . 0.0 110.411 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 71.0 m-85 -89.38 -6.74 56.35 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.61 -0.681 . . . . 0.0 109.742 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.496 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 18.5 m170 55.94 58.6 4.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.414 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 161.65 131.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.488 HD11 ' OH ' ' A' ' 90' ' ' TYR . 33.3 mt -44.47 150.17 0.69 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 109.252 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.57 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 7.4 Cg_exo -53.62 163.27 2.87 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.151 1.901 . . . . 0.0 110.428 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -71.22 -4.88 28.03 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.345 -0.847 . . . . 0.0 109.028 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -95.76 11.76 32.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.606 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.57 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 3.1 m-85 -101.77 109.75 21.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.152 -0.967 . . . . 0.0 109.484 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 26' ' ' THR . 1.4 pp -115.73 118.08 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.327 -0.858 . . . . 0.0 108.989 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' HD12 ' A' ' 25' ' ' ILE . 14.2 p -45.82 171.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.301 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -67.9 -42.94 80.39 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.942 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.6 m -55.43 -41.36 72.68 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.728 ' O ' HD12 ' A' ' 33' ' ' LEU . 11.8 mm-40 -57.11 -40.88 77.93 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.705 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -64.18 -36.84 85.36 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' OE1' ' CE3' ' A' ' 35' ' ' TRP . 6.7 mm100 -60.38 -39.21 86.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.31 -35.52 73.94 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.455 -0.778 . . . . 0.0 109.832 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.7 mp -81.23 -14.02 57.93 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.628 -0.67 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.888 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 110.77 40.39 1.32 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.705 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 10.9 t90 -109.92 118.9 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -1.19 . . . . 0.0 108.993 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -91.35 111.33 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.334 -0.854 . . . . 0.0 109.106 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.649 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.215 -0.928 . . . . 0.0 109.598 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.508 ' O ' HG22 ' A' ' 45' ' ' VAL . 1.8 p-10 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.228 0.537 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.576 HD11 ' CB ' ' A' ' 30' ' ' ALA . 5.8 tp -62.81 -44.95 94.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.185 -0.947 . . . . 0.0 109.666 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.29 -8.1 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 110.128 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 32.7 m-20 -101.6 -22.72 14.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.019 -1.051 . . . . 0.0 110.258 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.888 HG11 ' O ' ' A' ' 34' ' ' GLY . 17.9 m -121.18 -48.54 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.909 -1.12 . . . . 0.0 110.124 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.524 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -127.55 60.57 44.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.119 -0.988 . . . . 0.0 110.115 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.7 Cg_endo -62.66 -179.55 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.172 1.914 . . . . 0.0 110.177 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.44 59.66 3.03 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HE3' HG21 ' A' ' 25' ' ' ILE . 3.8 mttp -151.51 171.48 17.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -1.157 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.545 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 19.4 m -137.34 118.9 14.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.564 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.563 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 8.7 mm -76.99 103.64 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.048 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -147.38 171.2 28.06 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.86 7.87 54.87 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 9.7 m-20 -79.99 145.12 32.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -1.209 . . . . 0.0 109.313 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mm -69.97 138.05 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.537 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.788 ' CE2' HD12 ' A' ' 63' ' ' LEU . 60.0 t80 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.827 . . . . 0.0 109.359 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 1.9 mttt . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.282 0.563 . . . . 0.0 109.721 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.795 HD22 ' CZ3' ' A' ' 71' ' ' TRP . 16.9 mt -94.88 146.39 31.29 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 0.0 109.122 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.704 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.8 Cg_exo -60.35 86.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.059 1.839 . . . . 0.0 110.209 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.966 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.272 0.558 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.795 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 23.1 m95 -136.98 165.89 24.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 35.0 mtt180 -132.87 143.78 49.75 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.706 ' HA ' HD13 ' A' ' 89' ' ' LEU . 10.4 pt-20 -121.48 155.39 35.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.972 -1.08 . . . . 0.0 110.459 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -146.77 148.96 32.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 109.144 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -68.72 133.04 47.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.97 HG21 ' CD1' ' A' ' 7' ' ' PHE . 26.3 mm -119.46 116.09 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.965 . . . . 0.0 109.644 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 72.49 124.29 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.868 . . . . 0.0 109.631 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -170.59 148.06 2.99 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.286 -0.884 . . . . 0.0 109.468 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.98 -79.84 0.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.453 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -145.3 171.86 13.97 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.754 -0.591 . . . . 0.0 109.452 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.61 -166.55 43.55 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -62.89 179.36 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -1.125 . . . . 0.0 109.428 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -78.56 164.55 24.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -104.72 -168.32 1.46 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.299 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.526 ' HB3' ' N ' ' A' ' 102' ' ' HIS . 13.3 m -105.1 16.44 25.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.0 109.649 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 0.9 OUTLIER -96.66 126.78 42.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.638 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.619 ' O ' HG22 ' A' ' 99' ' ' THR . 1.9 mtt180 -160.09 150.69 18.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 109.499 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.827 HD11 HG22 ' A' ' 96' ' ' ILE . 3.3 tt -108.29 156.64 8.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 109.23 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.727 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.4 mm? -125.95 107.17 10.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.428 -0.795 . . . . 0.0 109.376 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 72' ' ' ARG . 1.6 p90 -102.44 139.02 38.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.795 -1.191 . . . . 0.0 109.025 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.455 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -108.12 174.64 5.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.262 -0.899 . . . . 0.0 110.396 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.4 p -65.29 -24.68 67.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 45.5 p30 -89.76 18.06 5.96 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.592 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.02 29.66 7.9 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.725 -0.609 . . . . 0.0 110.048 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.0 mt -82.21 113.06 19.78 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.827 HG22 HD11 ' A' ' 88' ' ' ILE . 2.0 mt -109.24 114.89 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 110.366 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.895 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 26.8 m-85 -121.27 118.63 30.03 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -88.51 117.3 27.35 Favored 'General case' 0 N--CA 1.492 1.632 1 N-CA-C 125.7 5.444 . . . . 0.0 125.7 -179.282 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -108.69 131.14 55.21 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 124.652 3.387 . . . . 0.0 109.01 -170.31 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 1.9 p -115.12 18.15 16.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.641 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.7 OUTLIER -139.18 23.55 2.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER 78.33 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.671 ' OH ' ' OE2' ' A' ' 73' ' ' GLU . 15.5 m-85 50.35 20.89 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.808 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.77 -15.23 26.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.114 -0.992 . . . . 0.0 109.076 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.641 HG22 ' OD1' ' A' ' 101' ' ' ASP . 12.5 t -148.78 145.35 27.54 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.895 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . 53.7 m-85 -135.99 111.45 9.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.919 -1.113 . . . . 0.0 110.153 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.563 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 1.8 m -98.34 131.31 44.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.426 -0.796 . . . . 0.0 108.906 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -80.03 122.35 26.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.548 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.768 HD11 HD11 ' A' ' 88' ' ' ILE . 11.3 pt -119.68 15.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.484 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 1.242 ' NH2' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.489 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.88 103.6 3.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.402 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.76 -173.24 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.928 . . . . 0.0 109.649 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.473 HD12 ' CD1' ' A' ' 13' ' ' TYR . 11.1 mt -112.0 117.51 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.873 . . . . 0.0 109.369 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -144.48 62.41 1.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.176 -0.952 . . . . 0.0 109.705 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.556 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -140.0 -174.56 3.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.923 . . . . 0.0 109.323 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.826 ' CE1' HG21 ' A' ' 76' ' ' ILE . 21.3 m-85 -77.31 -60.84 2.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.256 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -33.46 70.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.283 -0.885 . . . . 0.0 109.371 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.28 -48.99 60.08 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.611 HG12 HD12 ' A' ' 14' ' ' LEU . 41.6 t -68.31 -36.37 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.255 -1.144 . . . . 0.0 109.207 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.1 -38.86 87.78 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.78 -54.79 19.06 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.546 -0.721 . . . . 0.0 109.118 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE1' ' CD2' ' A' ' 17' ' ' TYR . 47.9 t80 -55.39 -26.67 42.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.35 -0.844 . . . . 0.0 109.218 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.611 HD12 HG12 ' A' ' 10' ' ' VAL . 1.2 mt -72.84 -60.5 2.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.428 -0.795 . . . . 0.0 109.376 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.426 ' NE2' ' OXT' ' A' ' 110' ' ' ARG . 2.9 mt-30 -70.49 -5.21 27.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.025 -1.047 . . . . 0.0 109.565 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.1 m -93.15 -68.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.17 -0.956 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD2' ' CE1' ' A' ' 13' ' ' TYR . 58.8 m-85 -89.63 3.96 50.95 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.644 -0.66 . . . . 0.0 109.553 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.7 m170 43.89 51.46 6.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.355 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.5 OUTLIER 177.39 130.38 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.536 -0.728 . . . . 0.0 109.117 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.713 HD13 ' HD2' ' A' ' 24' ' ' TYR . 17.6 mt -47.61 159.37 0.44 Allowed Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.093 -1.004 . . . . 0.0 109.131 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.58 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 4.1 Cg_exo -54.7 158.43 10.65 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.17 1.913 . . . . 0.0 110.454 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.21 -6.3 33.55 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.373 -0.829 . . . . 0.0 109.03 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.3 28.61 8.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.275 -0.89 . . . . 0.0 109.463 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.713 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.6 m-30 -113.59 79.03 1.19 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.18 -0.95 . . . . 0.0 109.505 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -94.26 127.96 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.251 -0.906 . . . . 0.0 108.983 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' O ' ' A' ' 25' ' ' ILE . 44.0 p -46.66 176.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 109.992 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.24 -48.64 56.07 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.102 -0.999 . . . . 0.0 109.161 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.6 t -51.57 -36.42 45.3 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.658 ' O ' HD12 ' A' ' 33' ' ' LEU . 10.1 mm-40 -60.62 -43.27 97.66 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -65.21 -33.52 76.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.197 -0.94 . . . . 0.0 108.529 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' CG ' ' CE3' ' A' ' 35' ' ' TRP . 1.0 OUTLIER -66.17 -31.68 72.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.72 -38.31 87.42 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.448 -0.782 . . . . 0.0 109.519 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -80.82 -7.12 59.34 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.672 -0.642 . . . . 0.0 109.878 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 45' ' ' VAL . . . 104.18 68.49 0.76 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.713 ' HA ' HG21 ' A' ' 45' ' ' VAL . 2.6 t90 -126.52 133.4 51.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -1.172 . . . . 0.0 109.664 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.658 HG12 ' H ' ' A' ' 38' ' ' SER . 39.3 t -89.6 132.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.604 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -63.88 -6.86 6.62 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.876 -1.14 . . . . 0.0 110.23 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.658 ' H ' HG12 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -44.55 -24.06 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 109.102 179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.591 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 0.2 OUTLIER 68.96 28.27 5.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.563 -0.711 . . . . 0.0 109.8 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.633 ' CA ' ' CE1' ' A' ' 82' ' ' PHE . . . -127.06 10.51 6.98 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -159.26 27.1 0.2 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.11 -1.229 . . . . 0.0 109.861 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.96 HD21 HD11 ' A' ' 51' ' ' ILE . 6.6 tp -57.96 -65.32 0.66 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.121 -0.987 . . . . 0.0 109.049 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.66 -11.13 2.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.836 -0.54 . . . . 0.0 110.228 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -78.98 -39.06 35.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.97 -1.081 . . . . 0.0 109.723 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 35' ' ' TRP . 33.3 m -96.64 -15.26 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 109.466 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.65 63.92 6.18 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.849 . . . . 0.0 109.133 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 4.0 Cg_exo -59.59 164.87 10.55 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.191 1.927 . . . . 0.0 110.39 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.11 54.75 24.72 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HG2' HG12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -152.26 162.98 40.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.589 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.599 ' HB3' ' CD1' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -139.04 159.75 41.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.883 . . . . 0.0 109.462 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.96 HD11 HD21 ' A' ' 42' ' ' LEU . 3.7 mm -105.01 111.89 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 0.0 109.512 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -157.58 165.0 33.33 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.64 22.56 28.38 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.428 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 39.8 m-20 -97.28 145.44 26.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -1.141 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.51 HD12 HG21 ' A' ' 70' ' ' THR . 16.3 mm -65.54 143.74 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.896 ' CE2' HD12 ' A' ' 63' ' ' LEU . 86.0 t80 -117.89 86.35 2.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.931 . . . . 0.0 109.302 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.2 p -70.39 -4.07 20.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.862 . . . . 0.0 109.861 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.579 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 1.0 OUTLIER 76.89 62.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -48.09 -25.94 1.64 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.39 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.18 -58.6 2.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.409 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.411 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . 113.68 85.77 1.42 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.603 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 13.1 mttt -149.95 15.8 0.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -1.133 . . . . 0.0 109.588 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.896 HD12 ' CE2' ' A' ' 56' ' ' PHE . 48.5 mt -114.36 147.22 37.49 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.918 . . . . 0.0 109.161 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.877 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.4 Cg_endo -62.38 87.99 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.166 1.911 . . . . 0.0 110.182 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.32 -176.91 32.92 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -147.23 179.07 7.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -1.188 . . . . 0.0 109.51 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.7 t -60.51 142.21 55.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.424 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.47 -30.83 7.32 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.522 ' HG2' ' N ' ' A' ' 70' ' ' THR . 5.9 ttt180 -86.7 155.47 20.36 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -1.102 . . . . 0.0 109.321 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.522 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 7.6 m -129.34 145.9 51.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.164 -0.96 . . . . 0.0 109.557 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.839 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 6.7 m95 -107.64 175.4 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.434 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.652 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 1.4 mmt180 -128.47 137.84 52.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.349 -0.844 . . . . 0.0 108.785 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.811 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -116.96 157.89 24.99 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.022 -1.049 . . . . 0.0 110.102 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.51 ' HB3' ' CG2' ' A' ' 88' ' ' ILE . . . -148.64 151.03 34.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -0.813 . . . . 0.0 109.129 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.477 ' CB ' ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -73.03 131.15 41.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.119 -0.988 . . . . 0.0 109.697 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.826 HG21 ' CE1' ' A' ' 7' ' ' PHE . 20.5 mm -115.74 126.15 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.3 -0.875 . . . . 0.0 108.885 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.6 OUTLIER 68.6 117.89 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.033 -179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.427 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 2.5 t80 -170.44 125.21 0.73 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.136 -0.977 . . . . 0.0 109.586 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.01 -80.25 0.46 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.0 p -143.93 156.22 44.35 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.759 -0.588 . . . . 0.0 109.458 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.39 -167.9 17.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.633 ' CE1' ' CA ' ' A' ' 40' ' ' GLY . 1.5 m-85 -65.34 149.67 49.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.183 -1.187 . . . . 0.0 109.264 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.603 ' CB ' ' CZ ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -46.99 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.076 -1.015 . . . . 0.0 109.133 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.77 179.89 3.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.185 -0.947 . . . . 0.0 109.606 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -108.21 11.59 27.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 63.4 m-20 -96.22 129.37 43.54 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.625 ' O ' HG22 ' A' ' 99' ' ' THR . 0.3 OUTLIER -155.68 156.09 34.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.291 -0.881 . . . . 0.0 109.213 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.059 HD11 ' CG2' ' A' ' 96' ' ' ILE . 18.9 tt -112.26 160.49 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.997 -1.064 . . . . 0.0 109.287 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.871 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.4 mm? -130.48 103.52 6.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 0.0 109.878 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.652 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 34.0 p90 -99.62 140.42 33.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.813 -1.18 . . . . 0.0 108.93 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -106.47 176.03 5.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.164 -0.96 . . . . 0.0 110.377 -178.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.3 p -65.47 -25.17 67.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.447 -0.783 . . . . 0.0 109.576 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.475 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 26.7 p-10 -89.65 17.57 6.34 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.58 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.79 26.04 7.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.659 -0.65 . . . . 0.0 110.291 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.877 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.0 mt -80.34 113.42 18.51 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.059 ' CG2' HD11 ' A' ' 88' ' ' ILE . 2.8 mt -106.82 119.88 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.101 -1.0 . . . . 0.0 110.617 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.608 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 16.3 m-85 -122.89 117.45 25.62 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.519 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.44 147.06 24.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.981 -1.075 . . . . 0.0 110.21 -178.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.9 OUTLIER -132.8 125.71 30.7 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.65 29.11 7.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.728 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -150.0 20.16 0.88 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.643 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER 79.06 68.83 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.389 -0.819 . . . . 0.0 110.073 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 8.1 m-85 54.44 17.5 1.61 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 110.153 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.475 ' CB ' ' OD2' ' A' ' 101' ' ' ASP . 3.9 mm-40 -92.54 -15.85 26.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 109.093 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.501 ' N ' ' OD2' ' A' ' 101' ' ' ASP . 40.8 m -144.54 147.13 32.83 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.603 ' CE1' ' HB2' ' A' ' 62' ' ' LYS . 75.5 m-85 -140.49 130.0 24.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.839 -1.163 . . . . 0.0 110.58 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.496 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 89.9 m -120.05 133.67 55.47 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.23 115.41 18.87 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 0.0 109.399 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -109.84 -83.63 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 109.536 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.608 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.491 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.283 0.563 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.94 99.76 9.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.423 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.8 m -71.6 -173.1 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 109.533 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 mp -122.45 96.02 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.888 . . . . 0.0 109.472 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.8 p-10 -140.65 53.87 1.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.473 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.481 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.7 OUTLIER -137.19 -170.58 2.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 0.0 109.511 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.842 ' CE1' HG21 ' A' ' 76' ' ' ILE . 46.2 m-85 -75.18 -58.66 3.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.269 -0.895 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.442 ' OD1' ' NH2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -71.09 -31.5 67.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.808 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.75 -52.27 30.38 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.668 HG12 HD12 ' A' ' 14' ' ' LEU . 99.9 t -66.74 -42.79 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -1.131 . . . . 0.0 109.386 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 -38.18 73.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.44 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.9 m-20 -65.46 -55.67 16.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.563 -0.711 . . . . 0.0 109.224 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.688 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 53.7 t80 -58.55 -21.32 52.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 0.0 109.195 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.668 HD12 HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -74.99 -64.28 1.08 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.394 -0.816 . . . . 0.0 109.212 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -70.43 -5.62 29.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.067 -1.021 . . . . 0.0 109.45 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 67.9 m -93.85 -67.08 0.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 0.0 109.662 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.688 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 78.2 m-85 -89.95 3.66 52.44 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.567 -0.708 . . . . 0.0 109.533 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.462 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 25.8 m170 43.75 51.75 6.55 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.306 -0.871 . . . . 0.0 109.721 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 7.8 ptmt 175.89 129.82 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.461 -0.774 . . . . 0.0 109.168 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.531 HD13 ' HD2' ' A' ' 24' ' ' TYR . 14.7 mt -44.04 161.06 0.22 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.139 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.577 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.5 Cg_exo -53.51 159.91 5.81 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.124 1.883 . . . . 0.0 110.403 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.75 -3.31 24.48 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.348 -0.845 . . . . 0.0 109.147 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -117.47 34.67 5.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.95 . . . . 0.0 109.61 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.615 ' CE1' ' CB ' ' A' ' 50' ' ' SER . 1.5 m-30 -115.34 90.83 3.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 109.544 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.2 pt -97.27 124.09 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.925 . . . . 0.0 109.14 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 25' ' ' ILE . 12.2 p -45.44 172.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 109.637 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.86 -42.36 73.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.038 -1.039 . . . . 0.0 109.087 179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 t -53.98 -37.24 63.76 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.89 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -59.78 -44.28 93.99 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.632 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -61.49 -39.79 92.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.251 -0.906 . . . . 0.0 108.59 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.557 ' CG ' ' CE3' ' A' ' 35' ' ' TRP . 34.0 mt-30 -61.36 -34.86 76.0 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.27 -33.77 74.08 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.442 -0.786 . . . . 0.0 109.38 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.12 -13.74 58.39 Favored 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.653 -0.654 . . . . 0.0 109.997 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.471 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 111.74 46.06 0.8 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.632 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 2.9 t90 -106.8 133.13 51.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -1.191 . . . . 0.0 109.725 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.642 HG12 ' OD1' ' A' ' 41' ' ' ASN . 9.1 p -89.57 134.55 28.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.616 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -63.42 -5.26 3.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.898 -1.126 . . . . 0.0 110.618 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 17.7 p -45.97 -25.21 0.51 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.858 -1.152 . . . . 0.0 108.411 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.598 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 3.4 mttt 72.55 39.06 0.74 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.726 -0.609 . . . . 0.0 109.751 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.576 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -131.44 -28.61 0.63 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.373 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.642 ' OD1' HG12 ' A' ' 36' ' ' VAL . 3.2 p-10 -121.4 33.73 5.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.876 -1.367 . . . . 0.0 110.248 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.009 HD21 HD11 ' A' ' 51' ' ' ILE . 8.1 tp -60.34 -64.65 0.88 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.962 -1.087 . . . . 0.0 109.191 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.12 -10.05 5.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.735 -0.603 . . . . 0.0 110.158 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 41' ' ' ASN . 27.6 t70 -79.1 -28.66 43.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.018 -1.051 . . . . 0.0 109.6 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 34' ' ' GLY . 4.4 m -110.04 -13.87 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -145.67 68.11 12.98 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.482 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.65 155.74 51.87 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.206 1.938 . . . . 0.0 110.251 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.03 54.67 24.86 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' HG2' HG12 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -153.88 120.1 5.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -1.131 . . . . 0.0 109.469 179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.615 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.5 OUTLIER -91.53 166.11 13.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.593 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 1.009 HD11 HD21 ' A' ' 42' ' ' LEU . 2.3 mm -112.13 107.78 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.915 . . . . 0.0 109.667 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -161.94 156.35 27.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.92 32.74 3.98 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.475 ' OD1' ' HB ' ' A' ' 26' ' ' THR . 0.2 OUTLIER -109.65 155.05 21.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.157 -1.202 . . . . 0.0 109.403 179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.0 mm -70.65 151.06 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.565 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.844 ' CE2' HD12 ' A' ' 63' ' ' LEU . 70.7 t80 -129.41 88.82 2.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 108.929 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 4.3 t -64.37 -10.17 22.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.091 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.587 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 49.4 t-20 65.04 52.24 1.56 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.153 -0.967 . . . . 0.0 109.537 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -54.55 -53.71 50.92 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.506 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -54.06 -41.95 68.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.291 -0.881 . . . . 0.0 109.459 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.99 58.07 2.41 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 3.4 mptm? -121.27 -7.95 9.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.342 -1.093 . . . . 0.0 109.565 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.844 HD12 ' CE2' ' A' ' 56' ' ' PHE . 11.2 mt -99.0 146.22 31.31 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.338 -0.851 . . . . 0.0 109.215 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.506 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 4.0 Cg_exo -60.93 104.19 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.156 1.904 . . . . 0.0 110.323 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA2' ' HD3' ' A' ' 69' ' ' ARG . . . -149.8 126.85 2.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 68' ' ' GLY . 6.8 mttt -90.44 170.35 10.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.2 -1.176 . . . . 0.0 109.532 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.6 p -50.56 97.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 109.691 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 116.32 22.73 4.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.456 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -112.84 121.46 44.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.306 -1.114 . . . . 0.0 109.404 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -96.81 -178.65 4.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.291 -0.88 . . . . 0.0 109.563 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.772 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 18.9 m95 -149.22 171.03 17.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.61 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.629 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 93.4 mtt180 -131.99 151.92 51.45 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.667 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -126.72 152.47 46.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.992 -1.067 . . . . 0.0 110.469 -179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.489 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -148.06 151.5 35.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.493 -0.754 . . . . 0.0 108.992 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.0 OUTLIER -73.43 137.93 44.89 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.993 -1.067 . . . . 0.0 109.789 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.842 HG21 ' CE1' ' A' ' 7' ' ' PHE . 21.8 mm -116.99 112.15 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 108.89 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.2 t-20 74.02 123.12 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.292 -0.88 . . . . 0.0 109.15 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 6.7 t80 -170.41 119.19 0.56 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.262 -0.899 . . . . 0.0 109.439 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.3 -43.9 2.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.124 -0.985 . . . . 0.0 109.561 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 173.63 169.1 0.18 Allowed 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.613 -0.679 . . . . 0.0 109.444 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.96 -161.7 21.84 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -70.43 143.76 51.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -1.108 . . . . 0.0 109.685 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.662 ' HE ' HD22 ' A' ' 42' ' ' LEU . 0.0 OUTLIER -40.73 142.13 0.49 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.402 -0.811 . . . . 0.0 109.474 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 0.3 OUTLIER -87.79 -176.45 5.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.181 -0.949 . . . . 0.0 109.752 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.92 3.89 19.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.801 . . . . 0.0 109.558 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.509 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 8.1 m-20 -89.68 128.93 36.16 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.107 -0.995 . . . . 0.0 109.287 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.532 ' O ' ' CG2' ' A' ' 99' ' ' THR . 83.7 mtt180 -159.05 161.77 36.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.345 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.758 HD11 HG22 ' A' ' 96' ' ' ILE . 1.3 tt -122.93 153.06 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.13 -0.981 . . . . 0.0 109.672 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.732 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.8 mm? -118.88 120.65 37.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.565 -0.709 . . . . 0.0 109.217 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' A' ' 72' ' ' ARG . 1.7 p90 -113.91 138.36 50.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.851 -1.156 . . . . 0.0 109.011 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.469 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -107.67 172.87 6.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.221 -0.925 . . . . 0.0 110.295 -178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.5 p -66.41 -22.57 66.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.319 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 30.8 p-10 -89.59 16.4 7.84 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.571 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.65 30.39 6.56 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.755 -0.59 . . . . 0.0 110.316 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.744 HD22 ' HE1' ' A' ' 97' ' ' TYR . 7.4 mt -83.59 117.72 23.34 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.9 HD12 ' HB2' ' A' ' 110' ' ' ARG . 2.5 mt -114.84 109.43 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.096 -1.003 . . . . 0.0 110.615 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.744 ' HE1' HD22 ' A' ' 95' ' ' LEU . 21.5 m-85 -112.93 120.75 42.49 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.58 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -88.81 152.19 21.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.903 -1.123 . . . . 0.0 110.359 -178.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -136.38 123.83 22.1 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.69 29.22 7.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.82 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.0 OUTLIER -150.11 20.71 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.042 -1.036 . . . . 0.0 109.889 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 48.7 t-80 79.52 70.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.46 -0.775 . . . . 0.0 109.877 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.492 ' HE2' HD11 ' A' ' 89' ' ' LEU . 40.6 m-85 49.43 20.91 0.51 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 110.155 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.459 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . 2.7 mt-30 -91.88 -14.47 29.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 0.0 109.022 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.522 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 97.6 m -144.55 157.14 44.36 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.492 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 92.3 m-85 -146.84 121.64 9.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.894 -1.129 . . . . 0.0 110.242 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -115.13 130.4 56.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 109.018 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.67 113.67 16.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.049 -1.032 . . . . 0.0 109.411 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.697 HD11 HD11 ' A' ' 88' ' ' ILE . 2.4 pt -111.28 -25.65 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.642 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.9 ' HB2' HD12 ' A' ' 96' ' ' ILE . 1.3 mtt-85 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.56 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -113.26 143.14 44.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.889 . . . . 0.0 109.472 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.434 ' H ' HG23 ' A' ' 3' ' ' VAL . 1.8 t -76.56 168.52 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 4' ' ' ILE . 3.6 mt -138.5 67.84 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.464 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -128.09 40.93 3.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.532 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.68 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -133.39 -175.17 3.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.19 -0.944 . . . . 0.0 109.457 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.639 ' CG ' HG21 ' A' ' 76' ' ' ILE . 31.6 m-85 -78.94 -47.91 15.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.0 109.45 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.34 -40.38 70.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.271 -0.893 . . . . 0.0 109.904 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.33 -51.79 35.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 6' ' ' THR . 41.2 t -63.29 -43.99 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.16 -1.2 . . . . 0.0 109.15 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.432 ' CB ' ' NH2' ' A' ' 110' ' ' ARG . . . -56.61 -39.35 73.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -55.64 27.56 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.594 -0.692 . . . . 0.0 109.154 179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.679 ' CE1' ' CD2' ' A' ' 17' ' ' TYR . 12.6 t80 -57.6 -23.74 52.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.296 -0.877 . . . . 0.0 109.242 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 2.2 mt -71.45 -63.51 1.1 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.391 -0.818 . . . . 0.0 109.11 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -71.05 -4.99 27.96 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.004 . . . . 0.0 109.414 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 48.4 m -91.2 -70.13 0.7 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.829 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.679 ' CD2' ' CE1' ' A' ' 13' ' ' TYR . 96.8 m-85 -89.91 -4.2 57.65 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.652 -0.655 . . . . 0.0 109.583 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.3 m170 57.04 51.74 10.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.671 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 172.34 129.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.565 -0.709 . . . . 0.0 109.101 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 20' ' ' LEU . 21.1 mt -45.47 148.52 1.19 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.207 -0.933 . . . . 0.0 108.995 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.1 Cg_exo -53.12 160.36 4.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.112 1.875 . . . . 0.0 110.474 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.61 -8.27 33.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.353 -0.842 . . . . 0.0 109.14 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 39.5 p30 -95.2 21.97 7.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.509 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.565 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.2 m-85 -114.77 84.14 2.02 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.0 109.761 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.709 HD12 ' O ' ' A' ' 26' ' ' THR . 1.8 pp -96.62 126.18 49.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.709 ' O ' HD12 ' A' ' 25' ' ' ILE . 16.9 p -46.9 174.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.56 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.626 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.51 -43.75 69.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.076 -1.015 . . . . 0.0 109.042 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.17 -38.99 69.03 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.787 ' O ' HD12 ' A' ' 33' ' ' LEU . 10.5 mm-40 -58.51 -39.25 79.57 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 25' ' ' ILE . . . -68.21 -36.61 79.81 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.536 ' HG3' ' CE3' ' A' ' 35' ' ' TRP . 25.5 mt-30 -60.74 -34.73 74.87 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.96 -34.86 70.39 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.28 -18.69 45.0 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.52 0.676 . . . . 0.0 110.002 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.439 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 116.04 38.56 0.95 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.626 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 10.9 t90 -100.85 121.86 42.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.234 -1.156 . . . . 0.0 109.133 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 36' ' ' VAL . 10.6 p -89.94 113.11 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.285 -0.884 . . . . 0.0 108.962 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.581 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -63.99 -10.77 23.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.22 -0.925 . . . . 0.0 109.724 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.58 ' H ' HG22 ' A' ' 36' ' ' VAL . 15.7 m -76.28 -74.2 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.158 -0.964 . . . . 0.0 109.535 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.4 mttp -62.42 -29.55 70.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.451 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.12 64.94 2.61 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.671 ' OD1' HG12 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -111.77 43.47 1.54 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.243 -1.151 . . . . 0.0 109.51 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 42' ' ' LEU . 12.2 tp -54.35 -63.37 1.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 109.318 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -42.0 -25.07 0.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.436 -0.79 . . . . 0.0 110.147 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -79.89 -44.42 20.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.013 -1.054 . . . . 0.0 110.639 -179.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.602 HG23 ' N ' ' A' ' 46' ' ' ALA . 33.6 m -94.72 -52.15 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.879 -1.138 . . . . 0.0 110.556 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.602 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -119.92 74.59 19.88 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.886 -1.134 . . . . 0.0 109.918 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -63.06 166.09 15.23 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.165 1.91 . . . . 0.0 110.263 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.479 ' O ' ' HD2' ' A' ' 49' ' ' LYS . . . 43.38 59.24 3.63 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -139.03 162.56 34.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 0.0 109.438 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 4.3 m -129.33 133.66 47.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.317 -0.865 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.562 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 6.5 mm -96.41 107.56 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 109.058 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.6 171.2 33.61 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.46 71.25 1.23 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 10.2 m-20 -159.66 165.42 32.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -1.105 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.486 ' CD1' HG21 ' A' ' 70' ' ' THR . 23.7 mm -69.27 149.73 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.312 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.955 ' CE2' HD12 ' A' ' 63' ' ' LEU . 45.9 t80 -112.79 144.48 42.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.496 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.524 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 15.7 m -44.67 -86.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.43 -0.794 . . . . 0.0 109.939 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' ' 57' ' ' SER . 7.6 t-20 68.26 5.78 4.9 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.912 -0.493 . . . . 0.0 109.687 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -55.03 9.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.156 -0.965 . . . . 0.0 109.333 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -52.01 -43.48 63.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.404 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.07 66.04 0.39 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.61 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 2.0 mmmt -118.45 -11.56 9.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -1.163 . . . . 0.0 109.485 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.955 HD12 ' CE2' ' A' ' 56' ' ' PHE . 61.0 mt -122.25 148.66 52.76 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.416 -0.803 . . . . 0.0 108.933 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.723 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.7 Cg_endo -60.61 96.45 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.111 1.874 . . . . 0.0 110.037 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.96 162.28 38.82 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.495 ' HB2' ' NE ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -139.68 178.65 7.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -1.139 . . . . 0.0 109.494 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.2 m -70.26 94.27 0.91 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.636 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.72 59.61 2.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' CZ ' ' O ' ' A' ' 64' ' ' PRO . 21.0 ttp180 -131.84 143.36 50.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -1.157 . . . . 0.0 109.525 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.486 HG21 ' CD1' ' A' ' 55' ' ' ILE . 19.9 m -120.91 128.3 52.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.224 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.691 ' CE3' HD13 ' A' ' 63' ' ' LEU . 32.9 m95 -89.05 146.57 24.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 109.975 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.604 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 4.1 mtm180 -120.58 140.08 52.03 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.748 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -107.62 161.78 14.56 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.004 -1.06 . . . . 0.0 110.551 -178.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.621 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -145.93 148.16 32.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.515 -0.74 . . . . 0.0 109.183 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.3 m-20 -72.55 141.39 48.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.42 -0.8 . . . . 0.0 109.543 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.639 HG21 ' CG ' ' A' ' 7' ' ' PHE . 20.3 mm -135.78 137.46 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.127 -0.983 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 71.62 38.72 0.95 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.479 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -69.62 136.93 51.81 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.327 -0.858 . . . . 0.0 109.576 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -129.64 -80.26 0.56 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.0 109.384 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.3 m -168.15 -178.06 3.53 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.697 -0.627 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 62.9 -155.56 41.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' CE2' ' O ' ' A' ' 38' ' ' SER . 3.3 m-85 -49.45 175.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.21 -1.171 . . . . 0.0 109.57 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -60.62 -160.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.392 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -122.86 -172.78 2.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.457 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.21 1.83 13.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.501 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 5.2 m-20 -109.06 131.37 55.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.981 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.1 OUTLIER -148.88 139.71 22.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.234 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.886 HD11 ' CG2' ' A' ' 96' ' ' ILE . 12.5 tt -99.57 142.82 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.047 -1.033 . . . . 0.0 109.587 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.748 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -115.2 114.48 25.3 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.368 -0.833 . . . . 0.0 109.469 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.613 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 5.0 p90 -108.72 138.5 44.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.823 -1.173 . . . . 0.0 108.739 179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.571 ' HB3' ' CE2' ' A' ' 71' ' ' TRP . 0.1 OUTLIER -111.49 177.27 4.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.904 -1.122 . . . . 0.0 110.761 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 p -65.84 -21.18 66.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.564 -0.71 . . . . 0.0 110.387 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 10.3 p-10 -89.01 13.43 12.92 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.181 -0.949 . . . . 0.0 108.95 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.559 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.6 OUTLIER 68.17 26.59 7.04 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.665 -0.647 . . . . 0.0 111.003 178.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.723 HD13 ' HG2' ' A' ' 64' ' ' PRO . 8.4 mt -87.67 130.37 34.82 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.886 ' CG2' HD11 ' A' ' 88' ' ' ILE . 9.5 mt -120.72 108.88 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.239 -0.913 . . . . 0.0 110.391 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 108' ' ' LYS . 15.1 m-85 -107.43 112.34 25.09 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.886 ' HE2' HG21 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -88.96 133.5 34.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.033 -1.042 . . . . 0.0 109.772 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -116.07 122.68 45.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.382 -0.824 . . . . 0.0 108.971 179.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.5 p -104.96 26.83 8.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.357 -0.84 . . . . 0.0 109.822 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.771 ' CG ' HG22 ' A' ' 105' ' ' THR . 22.2 p30 -149.72 25.98 0.84 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.088 -1.007 . . . . 0.0 109.624 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.517 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 12.2 t-80 76.14 74.16 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.462 ' OH ' ' NE ' ' A' ' 87' ' ' ARG . 3.7 m-85 42.15 29.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 109.743 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.436 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER -99.64 -19.32 16.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.771 HG22 ' CG ' ' A' ' 101' ' ' ASP . 13.1 t -147.73 106.88 3.86 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.61 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 71.8 m-85 -93.04 125.39 37.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.127 -0.983 . . . . 0.0 110.387 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 2.6 m -112.93 125.93 54.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.401 -0.812 . . . . 0.0 108.949 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.49 ' HB2' ' CE1' ' A' ' 97' ' ' TYR . 8.9 ttmt -78.96 113.53 17.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.015 -1.053 . . . . 0.0 109.649 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.886 HG21 ' HE2' ' A' ' 98' ' ' LYS . 3.5 pt -116.05 -4.36 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.287 -0.883 . . . . 0.0 109.584 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.873 ' HG3' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.441 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.287 0.565 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 66.95 97.15 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.43 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 m -151.76 171.32 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.234 -0.916 . . . . 0.0 109.502 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 mt -101.88 100.32 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -0.888 . . . . 0.0 109.41 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -139.59 57.82 1.63 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.489 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.686 ' O ' HD12 ' A' ' 76' ' ' ILE . 79.2 p -142.58 -177.56 5.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.34 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' CE2' HG22 ' A' ' 100' ' ' THR . 34.2 m-85 -75.64 -57.22 4.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.93 -37.35 72.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 109.924 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.0 -50.76 56.34 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.664 HG12 HD12 ' A' ' 14' ' ' LEU . 84.9 t -64.21 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.307 -1.114 . . . . 0.0 109.042 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.05 -36.51 75.15 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.41 -55.54 15.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.513 -0.742 . . . . 0.0 109.039 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.677 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 42.7 t80 -60.2 -19.59 54.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.373 -0.829 . . . . 0.0 109.226 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.664 HD12 HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -76.62 -63.26 1.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.379 -0.826 . . . . 0.0 109.492 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 24.8 pt20 -70.53 -8.63 52.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.049 -1.032 . . . . 0.0 109.515 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.9 m -93.43 -62.43 1.37 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 109.782 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.677 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 30.3 m-85 -89.47 2.03 55.09 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.671 -0.643 . . . . 0.0 109.57 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.438 ' O ' ' HB3' ' A' ' 19' ' ' LYS . 16.7 m170 42.99 46.97 4.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.297 -0.877 . . . . 0.0 109.669 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 5.1 pttt 177.73 129.86 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.485 -0.76 . . . . 0.0 109.147 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.946 HD11 ' OH ' ' A' ' 90' ' ' TYR . 18.4 mt -44.6 160.66 0.23 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.165 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.602 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.7 Cg_exo -53.52 158.86 7.15 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.038 1.825 . . . . 0.0 110.374 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -72.37 -3.86 26.54 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.282 -0.886 . . . . 0.0 109.165 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.66 7.84 28.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -0.916 . . . . 0.0 109.614 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.715 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.6 m-30 -92.05 77.18 5.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 109.641 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -89.58 129.17 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.276 -0.89 . . . . 0.0 109.031 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.479 ' C ' HG23 ' A' ' 51' ' ' ILE . 28.6 p -44.29 169.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.882 . . . . 0.0 109.447 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.842 ' HG2' HG21 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -67.62 -47.09 70.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.093 -1.005 . . . . 0.0 109.109 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.3 m -53.81 -37.13 63.22 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.67 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.2 mt-10 -59.03 -40.9 86.42 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.497 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -66.99 -35.34 79.73 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.611 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 2.7 mm-40 -62.42 -34.07 76.03 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.37 -36.92 83.76 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.399 -0.813 . . . . 0.0 109.663 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.67 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.7 mp -81.01 -5.57 57.75 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.73 -0.606 . . . . 0.0 110.255 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.885 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 105.94 62.39 0.62 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.612 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 10.7 t90 -131.54 118.92 20.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -1.156 . . . . 0.0 109.046 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 38' ' ' SER . 39.2 t -90.86 110.16 21.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.184 -0.948 . . . . 0.0 108.872 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.557 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -48.56 -22.97 0.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.273 -0.892 . . . . 0.0 109.63 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.542 ' H ' HG12 ' A' ' 36' ' ' VAL . 3.3 m -105.73 55.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.919 . . . . 0.0 109.626 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -149.44 -50.94 0.15 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.914 . . . . 0.0 109.489 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.413 ' HA3' ' CD1' ' A' ' 82' ' ' PHE . . . 95.71 10.26 56.77 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.521 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -95.26 31.11 2.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.249 -1.147 . . . . 0.0 109.844 -179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 51' ' ' ILE . 11.0 tp -52.53 -66.86 0.31 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.118 -0.989 . . . . 0.0 109.214 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.37 -14.87 3.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.482 -0.761 . . . . 0.0 109.932 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -79.46 -33.98 41.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.989 . . . . 0.0 110.017 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.885 HG11 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -100.12 -53.7 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.158 -0.964 . . . . 0.0 109.648 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -113.81 80.13 4.96 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.485 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 1.8 Cg_endo -62.88 164.79 17.97 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.227 1.951 . . . . 0.0 110.466 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 42.41 50.65 5.57 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 5.0 mmtp -145.78 103.71 3.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -1.15 . . . . 0.0 109.509 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.542 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 2.0 m -89.89 159.22 17.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.842 HG21 ' HG2' ' A' ' 27' ' ' LYS . 2.3 mm -99.63 134.7 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.271 -0.893 . . . . 0.0 109.257 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.51 149.39 11.02 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.11 27.69 4.98 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 3.4 m-20 -96.33 145.33 25.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.185 -1.185 . . . . 0.0 109.471 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.507 HD13 ' HA ' ' A' ' 55' ' ' ILE . 15.8 mm -65.68 145.03 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.567 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.885 ' CE2' HD12 ' A' ' 63' ' ' LEU . 71.6 t80 -121.4 90.02 3.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 0.0 109.186 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.485 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 11.7 p -70.15 -4.98 23.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.859 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.584 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 3.9 t-20 73.97 57.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.631 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -49.5 -40.46 37.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.901 . . . . 0.0 109.363 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -84.65 -67.89 0.76 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.291 -0.881 . . . . 0.0 109.413 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 116.32 63.54 0.35 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.6 ' HB3' ' CD1' ' A' ' 106' ' ' PHE . 6.1 mmtt -127.57 -3.17 6.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.137 -1.213 . . . . 0.0 109.598 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.885 HD12 ' CE2' ' A' ' 56' ' ' PHE . 57.5 mt -91.1 146.8 34.31 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.962 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.1 Cg_endo -62.17 155.67 54.97 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.096 1.864 . . . . 0.0 110.22 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.4 -174.03 21.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.63 166.31 11.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.313 -1.11 . . . . 0.0 109.463 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.9 m -64.87 107.07 1.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.452 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 123.52 0.94 9.28 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.533 ' HG2' ' N ' ' A' ' 70' ' ' THR . 62.3 ttt180 -86.68 155.38 20.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.171 -1.194 . . . . 0.0 109.494 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.533 ' N ' ' HG2' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -109.62 153.49 24.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.91 . . . . 0.0 109.451 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.803 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 5.4 m95 -129.2 173.31 10.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.529 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.621 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -122.24 143.37 49.64 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.754 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -126.56 151.04 48.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.86 -1.15 . . . . 0.0 110.408 -179.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.487 ' HB2' ' OH ' ' A' ' 90' ' ' TYR . . . -143.16 148.84 37.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.419 -0.801 . . . . 0.0 109.196 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.476 ' OD2' ' HB ' ' A' ' 51' ' ' ILE . 0.9 OUTLIER -76.2 132.59 40.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.384 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.686 HD12 ' O ' ' A' ' 6' ' ' THR . 19.4 mm -110.83 134.54 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 7.2 m-20 64.13 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.912 . . . . 0.0 109.457 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 46.2 t80 -170.59 129.82 0.84 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.275 -0.891 . . . . 0.0 109.493 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.0 -80.04 0.62 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.349 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.88 165.53 35.92 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.715 -0.616 . . . . 0.0 109.421 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 96.38 -151.56 19.94 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.413 ' CD1' ' HA3' ' A' ' 40' ' ' GLY . 2.9 m-85 -68.76 -172.29 0.36 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -1.098 . . . . 0.0 109.478 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HA ' ' NH1' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -72.56 -152.58 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.06 -177.68 5.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.154 -0.966 . . . . 0.0 109.376 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -116.48 15.86 15.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.231 -0.918 . . . . 0.0 109.584 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 14.6 m-20 -111.59 130.63 55.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -154.18 152.31 30.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.365 -0.834 . . . . 0.0 109.424 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.048 HD11 ' CG2' ' A' ' 96' ' ' ILE . 4.0 tt -113.31 138.32 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.272 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.754 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.3 mm? -109.8 116.14 31.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.35 -0.843 . . . . 0.0 109.869 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.946 ' OH ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -104.78 143.1 33.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.829 -1.169 . . . . 0.0 108.922 178.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.523 ' OG ' ' CZ ' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -106.58 172.58 6.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.177 -0.952 . . . . 0.0 110.316 -179.158 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 94.7 p -64.67 -24.92 67.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 0.0 109.844 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.479 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 36.8 p-10 -89.73 18.93 5.05 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.423 -0.798 . . . . 0.0 108.926 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.585 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.62 28.12 7.51 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.689 -0.632 . . . . 0.0 110.286 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.962 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.0 mt -79.87 106.71 12.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.048 ' CG2' HD11 ' A' ' 88' ' ' ILE . 1.6 mt -104.41 111.66 34.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.101 -1.0 . . . . 0.0 110.823 -178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.514 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 20.4 m-85 -111.61 154.9 24.18 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -122.69 141.54 51.66 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.771 -1.205 . . . . 0.0 109.489 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -129.68 120.1 24.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.207 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.505 HG22 ' CE2' ' A' ' 7' ' ' PHE . 44.2 p -104.72 28.54 6.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.44 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -148.12 22.71 1.08 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 109.481 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 30.1 t-80 77.15 79.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.357 -0.839 . . . . 0.0 109.631 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.583 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 11.6 m-85 44.53 53.51 7.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.627 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -120.43 -80.81 0.63 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.124 -0.985 . . . . 0.0 109.215 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.0 p -89.93 105.36 17.76 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.6 ' CD1' ' HB3' ' A' ' 62' ' ' LYS . 79.6 m-85 -96.28 125.63 40.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.882 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.482 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 56.3 m -111.83 136.4 51.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.432 -0.792 . . . . 0.0 108.956 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -80.06 125.77 30.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.529 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.5 pt -129.96 12.19 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.495 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 56.78 -174.29 0.07 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.456 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.2 m -94.74 139.94 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 109.478 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' A' ' 13' ' ' TYR . 3.5 mp -119.4 82.45 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -138.19 41.71 2.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.247 -0.908 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.572 ' O ' HG23 ' A' ' 10' ' ' VAL . 11.7 p -128.46 -168.09 1.86 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.77 ' CD1' HG21 ' A' ' 76' ' ' ILE . 58.2 m-85 -77.44 -51.99 9.85 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 109.515 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.53 -40.71 69.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 109.838 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.466 ' C ' HG23 ' A' ' 4' ' ' ILE . . . -67.34 -51.27 38.75 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 6' ' ' THR . 58.8 t -64.13 -43.23 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -1.151 . . . . 0.0 109.32 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.18 76.03 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.434 ' O ' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -62.07 -55.32 30.2 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.532 -0.73 . . . . 0.0 109.3 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.494 ' HB2' HG21 ' A' ' 4' ' ' ILE . 26.2 t80 -57.69 -24.62 57.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.401 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.5 mt -71.55 -62.55 1.37 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.324 -0.86 . . . . 0.0 109.038 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -70.93 -5.5 31.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.119 -0.988 . . . . 0.0 109.428 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 54.1 m -91.49 -69.9 0.71 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.0 109.943 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.49 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 96.6 m-85 -89.7 -5.98 56.53 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.631 -0.668 . . . . 0.0 109.63 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 23.3 m170 58.15 58.06 3.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.34 -0.85 . . . . 0.0 109.769 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER 163.99 129.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 53' ' ' GLY . 19.9 mt -45.69 147.14 1.63 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.123 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.566 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.3 Cg_exo -53.06 163.24 2.26 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.2 1.934 . . . . 0.0 110.733 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.07 -7.34 34.92 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.338 -0.851 . . . . 0.0 109.144 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -92.29 7.2 43.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.473 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.585 ' CE1' ' HB3' ' A' ' 50' ' ' SER . 3.5 m-85 -103.34 83.56 2.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.199 -0.938 . . . . 0.0 109.75 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pt -95.62 126.73 48.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.471 ' O ' ' O ' ' A' ' 25' ' ' ILE . 28.0 p -47.95 176.28 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.087 -1.008 . . . . 0.0 109.607 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.43 -46.36 64.05 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 119.381 -0.927 . . . . 0.0 109.162 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -53.17 -36.63 61.11 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.797 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.3 mm-40 -60.42 -41.13 93.33 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HB1' HD11 ' A' ' 42' ' ' LEU . . . -67.75 -33.14 74.27 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -62.12 -37.59 85.7 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.66 -35.75 68.75 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.461 -0.774 . . . . 0.0 109.586 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.797 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -81.16 -19.37 43.57 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.652 -0.655 . . . . 0.0 110.357 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.636 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 118.2 45.42 0.49 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.669 ' CH2' ' HB2' ' A' ' 37' ' ' ALA . 15.6 t90 -110.55 120.74 43.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.277 -1.131 . . . . 0.0 109.272 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.437 HG12 ' H ' ' A' ' 38' ' ' SER . 38.7 t -90.41 110.73 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.347 -0.846 . . . . 0.0 109.098 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.669 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . -64.15 -17.51 63.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.609 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.437 ' H ' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -77.9 -48.78 15.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.463 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.541 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.6 mmmt -84.03 -8.09 59.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.305 -0.872 . . . . 0.0 109.418 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 47.93 83.6 0.02 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 1.2 p-10 -136.34 45.84 2.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -1.118 . . . . 0.0 109.507 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 42' ' ' LEU . 9.1 tp -60.54 -50.86 71.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.238 -0.914 . . . . 0.0 109.258 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -62.8 -10.75 14.13 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.369 -0.832 . . . . 0.0 109.674 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 41' ' ' ASN . 9.8 t0 -92.95 -33.99 13.95 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 110.161 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.636 HG11 ' O ' ' A' ' 34' ' ' GLY . 34.0 m -110.72 -50.44 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.998 -1.064 . . . . 0.0 110.125 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.612 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -124.42 70.74 55.35 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.969 -1.082 . . . . 0.0 109.829 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.461 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.7 Cg_endo -63.29 -179.76 0.69 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.168 1.912 . . . . 0.0 110.242 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 40.75 55.99 3.17 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 48' ' ' GLY . 17.3 mmtt -141.17 160.09 40.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -1.112 . . . . 0.0 109.637 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.585 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 67.0 m -127.64 138.55 52.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.879 . . . . 0.0 109.468 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.605 HD12 ' HA ' ' A' ' 27' ' ' LYS . 10.4 mm -102.17 105.3 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 108.967 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.416 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -160.3 179.47 35.8 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.466 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 91.81 -4.55 78.89 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.53 ' OD1' ' CG ' ' A' ' 73' ' ' GLU . 7.5 p30 -93.57 163.17 13.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -1.123 . . . . 0.0 109.348 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.539 HG23 HG22 ' A' ' 70' ' ' THR . 22.4 mt -59.58 159.42 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.516 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.923 ' CE2' HD12 ' A' ' 63' ' ' LEU . 6.4 t80 -101.54 145.85 28.46 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.859 . . . . 0.0 109.332 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 49.1 m -42.54 -87.18 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.406 -0.809 . . . . 0.0 109.807 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 57' ' ' SER . 2.2 t-20 79.89 13.95 0.96 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.59 -52.38 47.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.36 -0.837 . . . . 0.0 109.423 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.02 -49.9 11.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.22 -0.925 . . . . 0.0 109.399 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.67 61.37 0.56 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 5.8 mmtm -94.93 -12.38 26.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -1.196 . . . . 0.0 109.45 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.923 HD12 ' CE2' ' A' ' 56' ' ' PHE . 42.8 mt -94.68 143.88 26.96 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.0 109.04 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.78 ' HG2' HD13 ' A' ' 95' ' ' LEU . 1.8 Cg_endo -62.89 84.09 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.001 1.8 . . . . 0.0 110.075 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -136.84 154.44 22.19 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.5 mmtp -98.2 168.0 10.51 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.139 -1.212 . . . . 0.0 109.486 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.4 m -60.23 130.96 49.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 109.519 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.26 -30.29 9.36 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -79.72 131.6 35.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -1.178 . . . . 0.0 109.546 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.57 HG22 ' H ' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -98.64 179.95 4.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.516 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.686 ' CE3' HD13 ' A' ' 63' ' ' LEU . 5.7 m95 -131.82 169.3 16.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.477 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.646 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 21.2 mmt180 -120.74 136.64 54.82 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.354 -0.841 . . . . 0.0 108.78 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.784 ' HA ' HD13 ' A' ' 89' ' ' LEU . 17.1 pt-20 -118.94 162.13 19.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.123 -0.985 . . . . 0.0 110.386 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -152.85 147.84 26.48 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' O ' ' OH ' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -71.51 140.8 50.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.618 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.77 HG21 ' CD1' ' A' ' 7' ' ' PHE . 25.4 mm -134.16 130.82 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.248 -0.907 . . . . 0.0 109.527 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.1 m-20 73.27 37.98 0.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.464 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 23.3 t80 -69.47 136.82 52.01 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.282 -0.886 . . . . 0.0 109.609 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.34 -79.66 0.38 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.246 -0.909 . . . . 0.0 109.377 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.76 175.71 4.45 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.67 -0.643 . . . . 0.0 109.405 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 72.64 73.74 0.83 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.541 ' CE1' ' O ' ' A' ' 39' ' ' LYS . 3.6 m-85 56.35 164.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -1.134 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -49.11 171.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.43 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 84' ' ' ASN . 0.1 OUTLIER -108.08 -173.83 2.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 109.246 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.32 -8.54 20.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.212 -0.93 . . . . 0.0 109.744 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.488 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.5 m-20 -91.33 128.66 37.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.599 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.646 ' O ' HG22 ' A' ' 99' ' ' THR . 5.4 mtt180 -158.15 150.66 22.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.327 -0.858 . . . . 0.0 109.242 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.774 ' C ' HD22 ' A' ' 89' ' ' LEU . 4.6 tt -108.68 149.81 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.949 -1.094 . . . . 0.0 109.937 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.784 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -122.33 106.99 11.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.437 -0.789 . . . . 0.0 109.462 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.646 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 22.3 p90 -101.91 140.79 35.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.89 -1.131 . . . . 0.0 109.082 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.526 ' HB2' ' CH2' ' A' ' 71' ' ' TRP . 5.3 t -105.98 174.19 5.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.267 -0.896 . . . . 0.0 110.292 -179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 24.9 p -66.07 -21.79 66.39 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.354 -0.841 . . . . 0.0 109.579 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.484 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 25.0 p-10 -89.56 16.02 8.45 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.441 -0.787 . . . . 0.0 108.898 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.578 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.1 m95 67.26 29.76 7.47 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.689 -0.632 . . . . 0.0 110.774 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.78 HD13 ' HG2' ' A' ' 64' ' ' PRO . 10.0 mt -87.3 118.01 26.45 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.671 HG22 HD11 ' A' ' 88' ' ' ILE . 3.3 mt -109.33 113.52 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 110.608 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.505 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 16.7 m-85 -113.01 113.12 25.02 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.27 131.64 35.28 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.045 -1.034 . . . . 0.0 109.977 -179.188 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.646 HG22 ' O ' ' A' ' 87' ' ' ARG . 1.1 t -115.56 123.81 49.43 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.501 -0.749 . . . . 0.0 108.995 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 4.4 p -108.95 30.48 6.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.432 -0.793 . . . . 0.0 109.395 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 17.6 p-10 -150.0 19.16 0.88 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.389 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 2.2 t-80 79.46 68.51 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.43 -0.794 . . . . 0.0 109.509 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.528 ' OH ' ' CZ ' ' A' ' 87' ' ' ARG . 10.0 m-85 49.41 22.62 0.73 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.652 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.408 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -94.67 -18.14 21.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 99' ' ' THR . 23.1 m -150.18 108.51 3.78 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 86.2 m-85 -95.25 128.73 42.32 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.133 -0.979 . . . . 0.0 110.165 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 8.2 m -114.17 128.16 56.24 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.385 -0.822 . . . . 0.0 108.836 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 0.0 OUTLIER -79.11 121.05 24.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.834 -179.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.562 HD11 HD11 ' A' ' 88' ' ' ILE . 2.1 pt -117.45 -39.06 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.64 ' HB2' HD12 ' A' ' 96' ' ' ILE . 3.8 mtt-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.503 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.67 101.95 9.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.0 m -112.39 -174.7 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.341 -0.849 . . . . 0.0 109.444 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 4' ' ' ILE . 15.0 mm -90.36 82.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.308 -0.87 . . . . 0.0 109.388 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -129.9 52.87 1.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 10' ' ' VAL . 8.8 p -145.6 178.07 8.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.265 -0.897 . . . . 0.0 109.464 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.647 ' CD2' HG21 ' A' ' 76' ' ' ILE . 24.3 m-85 -74.56 -53.0 10.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.192 -0.942 . . . . 0.0 109.696 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.04 -35.39 71.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 0.0 109.966 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.25 -51.58 31.99 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 6' ' ' THR . 21.7 t -67.46 -38.29 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -1.168 . . . . 0.0 109.414 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.1 88.5 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.3 OUTLIER -64.42 -55.15 22.89 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.578 -0.701 . . . . 0.0 109.134 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 27.3 t80 -60.48 -21.36 62.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.173 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.1 mt -73.02 -63.46 1.17 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.458 -0.776 . . . . 0.0 109.242 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -70.94 -8.69 54.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.037 -1.039 . . . . 0.0 109.403 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 52.9 m -88.98 -67.71 0.82 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 110.032 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.583 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 89.5 m-85 -89.44 -2.74 58.49 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.569 -0.707 . . . . 0.0 109.538 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 17.2 m170 53.47 53.72 11.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.375 -0.828 . . . . 0.0 109.762 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 166.72 129.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.462 HD11 ' OH ' ' A' ' 90' ' ' TYR . 65.1 mt -44.05 147.48 0.92 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.219 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.567 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 7.8 Cg_exo -53.02 162.89 2.4 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.247 1.965 . . . . 0.0 110.516 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -69.33 -6.68 31.2 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.326 -0.859 . . . . 0.0 109.01 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -93.73 7.22 45.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 109.483 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 2.0 m-85 -97.18 99.79 11.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.104 -0.997 . . . . 0.0 109.555 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pt -107.82 118.61 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 108.986 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.488 ' C ' HG23 ' A' ' 51' ' ' ILE . 21.5 p -45.52 170.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 109.37 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -65.56 -45.29 83.89 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.095 -1.003 . . . . 0.0 109.088 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -54.36 -39.5 67.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.081 -1.012 . . . . 0.0 108.299 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.716 ' O ' HD12 ' A' ' 33' ' ' LEU . 21.1 mt-10 -59.38 -39.97 85.03 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.678 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.18 -34.52 77.71 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.206 -0.934 . . . . 0.0 108.643 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -63.98 -35.29 80.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.38 -34.77 72.83 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.37 -0.831 . . . . 0.0 109.265 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.716 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.3 -15.83 54.29 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.424 0.631 . . . . 0.0 110.276 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 110.8 36.6 1.84 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.678 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 4.9 t90 -101.69 123.31 45.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.181 -1.188 . . . . 0.0 109.135 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 39' ' ' LYS . 21.2 t -89.41 119.18 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.336 -0.852 . . . . 0.0 108.776 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.595 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -66.85 -35.23 79.57 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.194 -0.941 . . . . 0.0 109.795 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -43.17 63.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.941 . . . . 0.0 109.564 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.488 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 6.5 mttt -83.18 -8.23 59.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 0.0 109.61 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 39' ' ' LYS . . . 46.14 96.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.452 ' OD1' ' HA ' ' A' ' 35' ' ' TRP . 47.3 p-10 -146.14 43.22 1.22 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -1.182 . . . . 0.0 109.686 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.533 ' CD1' ' HB1' ' A' ' 30' ' ' ALA . 8.5 tp -66.32 -52.02 51.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.0 109.307 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -55.21 -16.62 3.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -0.923 . . . . 0.0 109.751 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -87.21 -52.96 5.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 110.289 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.611 HG23 ' N ' ' A' ' 46' ' ' ALA . 21.7 m -94.68 -47.7 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.044 -1.035 . . . . 0.0 110.316 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.679 ' HB1' ' HG3' ' A' ' 49' ' ' LYS . . . -115.78 78.6 7.18 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.078 -1.014 . . . . 0.0 109.776 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -63.19 154.32 68.42 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.188 1.925 . . . . 0.0 110.191 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 43.1 63.68 1.96 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.679 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 6.8 mmtm -134.63 117.19 15.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -1.166 . . . . 0.0 109.405 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 27.1 m -90.01 128.05 36.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.309 -0.869 . . . . 0.0 109.622 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.581 HG21 ' HG2' ' A' ' 27' ' ' LYS . 6.5 mm -91.21 105.9 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.144 -0.973 . . . . 0.0 108.999 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -153.27 169.46 32.11 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.32 36.53 4.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -128.02 170.71 12.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -1.178 . . . . 0.0 109.31 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.668 HD12 HG21 ' A' ' 70' ' ' THR . 32.4 mm -70.23 150.34 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.502 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.845 ' CE2' HD12 ' A' ' 63' ' ' LEU . 13.5 t80 -102.84 149.48 24.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.294 -0.879 . . . . 0.0 109.141 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.486 ' O ' ' HB3' ' A' ' 58' ' ' ASN . 8.8 m -50.17 -90.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.519 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.557 ' HB2' ' CD2' ' A' ' 56' ' ' PHE . 23.4 t-20 67.6 20.3 9.68 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.602 -0.686 . . . . 0.0 109.465 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -57.46 -47.93 80.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 109.362 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.84 -34.54 30.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.379 -0.826 . . . . 0.0 109.395 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.16 66.23 0.6 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -97.09 -4.93 38.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -1.195 . . . . 0.0 109.523 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.845 HD12 ' CE2' ' A' ' 56' ' ' PHE . 64.3 mt -115.02 153.67 47.12 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.102 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.75 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.7 Cg_endo -61.57 86.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.2 1.933 . . . . 0.0 110.155 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.64 173.16 31.71 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -128.73 -172.9 2.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -1.113 . . . . 0.0 109.401 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.04 128.21 35.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.528 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.51 -6.86 57.72 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.517 ' HG2' ' N ' ' A' ' 70' ' ' THR . 7.6 ttt180 -98.68 151.36 20.81 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -1.18 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.668 HG21 HD12 ' A' ' 55' ' ' ILE . 39.0 m -125.71 146.88 49.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 109.486 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.692 ' CE3' HD13 ' A' ' 63' ' ' LEU . 10.3 m95 -112.23 157.62 20.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.689 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.647 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 12.0 mmt180 -115.38 140.85 48.76 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.263 -0.898 . . . . 0.0 108.667 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.799 ' HA ' HD13 ' A' ' 89' ' ' LEU . 2.3 pp20? -115.67 156.16 26.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 110.167 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.701 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -142.81 150.37 39.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 0.0 109.421 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.521 ' HA ' ' CD ' ' A' ' 87' ' ' ARG . 3.6 m-20 -71.97 142.34 49.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.5 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.647 HG21 ' CD2' ' A' ' 7' ' ' PHE . 21.6 mm -136.74 145.23 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 110.004 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.01 15.4 8.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.822 . . . . 0.0 109.823 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.528 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 14.6 t80 -69.61 114.71 8.07 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.095 -1.003 . . . . 0.0 109.628 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 23.3 m -119.67 -79.65 0.6 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.271 -0.893 . . . . 0.0 109.439 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 p -148.62 166.49 28.14 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.72 -0.612 . . . . 0.0 109.392 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.12 -179.34 52.86 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' CZ ' ' C ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -46.48 165.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -1.146 . . . . 0.0 109.489 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.546 ' CB ' ' CZ ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -54.09 176.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.131 -0.981 . . . . 0.0 109.405 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 5.1 p30 -115.53 -168.58 1.43 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.3 p -116.0 13.64 15.94 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.319 -0.863 . . . . 0.0 109.424 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.551 ' OD2' HG22 ' A' ' 100' ' ' THR . 1.1 m-20 -102.59 126.87 49.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.951 . . . . 0.0 109.627 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.547 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -145.6 143.33 29.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.47 -0.769 . . . . 0.0 109.168 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.938 HD11 ' CG2' ' A' ' 96' ' ' ILE . 3.9 tt -109.51 134.85 50.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.862 -1.149 . . . . 0.0 109.089 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.4 mm? -106.75 111.34 23.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 109.992 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.701 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 2.8 p90 -101.69 141.91 33.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.053 -1.029 . . . . 0.0 108.402 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -106.43 172.43 6.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.049 -1.032 . . . . 0.0 110.633 -178.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.4 p -66.57 -21.95 66.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.472 -0.768 . . . . 0.0 109.522 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.481 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 36.6 p-10 -89.48 16.3 7.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.567 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 68.12 28.57 6.55 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.658 -0.651 . . . . 0.0 110.471 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.75 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.9 mt -85.65 112.32 20.89 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.938 ' CG2' HD11 ' A' ' 88' ' ' ILE . 2.0 mt -100.79 125.41 54.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.031 -1.043 . . . . 0.0 110.469 -179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.536 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 8.1 m-85 -122.89 159.18 28.75 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -131.29 142.18 50.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.757 -1.214 . . . . 0.0 110.024 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -130.13 127.59 40.1 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.103 -0.998 . . . . 0.0 108.948 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.551 HG22 ' OD2' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -106.18 12.34 30.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.0 109.805 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.536 ' CG ' ' HG1' ' A' ' 105' ' ' THR . 0.0 OUTLIER -132.16 24.6 4.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.166 -0.959 . . . . 0.0 109.494 179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.522 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.7 t-80 76.43 75.31 0.08 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.285 -0.884 . . . . 0.0 109.824 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.573 ' HA ' ' CE1' ' A' ' 106' ' ' PHE . 14.5 m-85 52.21 60.96 3.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.17 -0.956 . . . . 0.0 109.624 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -135.08 -71.33 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.29 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.536 ' HG1' ' CG ' ' A' ' 101' ' ' ASP . 1.2 p -89.45 92.59 9.18 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 83.8 m-85 -89.45 110.08 20.94 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.238 -0.914 . . . . 0.0 110.03 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 57.3 m -102.82 139.84 37.87 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 2.3 tttt -85.05 125.12 32.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.569 -0.707 . . . . 0.0 109.491 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.64 -10.07 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.887 . . . . 0.0 109.457 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.076 -0.964 . . . . 0.0 109.418 179.84 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -90.67 119.94 31.32 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.472 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.907 HG23 ' OD1' ' A' ' 5' ' ' ASN . 4.2 m -92.67 164.81 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.474 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 13' ' ' TYR . 5.3 mt -91.17 85.9 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.938 . . . . 0.0 109.421 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.907 ' OD1' HG23 ' A' ' 3' ' ' VAL . 5.1 p-10 -136.89 59.28 1.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.123 -0.986 . . . . 0.0 109.529 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.619 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -148.05 -167.44 2.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.177 -0.952 . . . . 0.0 109.472 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.755 ' CD1' HG21 ' A' ' 76' ' ' ILE . 38.2 m-85 -77.41 -59.95 2.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.278 -0.889 . . . . 0.0 109.356 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.78 -31.68 68.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.813 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.425 ' C ' HG23 ' A' ' 4' ' ' ILE . . . -67.92 -54.4 18.21 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.593 HG23 ' H ' ' A' ' 6' ' ' THR . 59.0 t -63.11 -41.72 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.361 -1.082 . . . . 0.0 109.002 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.96 -35.67 73.54 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.402 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.3 OUTLIER -64.91 -56.36 13.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.501 -0.749 . . . . 0.0 109.204 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.634 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 30.7 t80 -60.82 -20.14 61.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 109.186 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.4 mt -73.6 -62.68 1.4 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.368 -0.833 . . . . 0.0 109.299 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -71.5 -8.95 57.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.928 -1.107 . . . . 0.0 109.405 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 87.7 m -89.49 -66.07 0.96 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.153 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 82.4 m-85 -88.99 -6.53 57.16 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 121.512 -0.743 . . . . 0.0 109.417 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.51 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 15.5 m170 57.28 55.56 5.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 109.764 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 2.5 pttt 160.93 129.58 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.746 HD11 ' OH ' ' A' ' 90' ' ' TYR . 36.0 mt -44.53 147.45 1.04 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.209 -0.932 . . . . 0.0 109.023 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.537 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.5 Cg_exo -54.11 162.91 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.021 1.814 . . . . 0.0 110.586 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.91 -7.16 32.29 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.396 -0.815 . . . . 0.0 109.04 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -92.61 6.55 46.9 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.648 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 50' ' ' SER . 1.7 m-85 -100.61 81.93 2.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.758 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.4 pt -92.7 127.36 44.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 25' ' ' ILE . 43.4 p -48.1 176.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 109.351 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.726 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -70.81 -46.84 62.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 0.0 109.238 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -53.3 -35.8 60.53 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.095 -1.003 . . . . 0.0 108.46 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.7 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.8 OUTLIER -59.39 -41.22 88.88 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -68.17 -36.26 79.34 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.6 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 6.5 mt-30 -61.14 -32.64 72.35 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.62 -34.16 72.41 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.344 -0.848 . . . . 0.0 109.587 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.6 mp -81.29 -16.27 52.99 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.426 0.631 . . . . 0.0 110.051 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.28 40.38 0.88 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.609 ' CH2' ' HB3' ' A' ' 27' ' ' LYS . 11.1 t90 -105.06 117.26 33.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -1.137 . . . . 0.0 109.329 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.446 ' HB ' ' HG3' ' A' ' 39' ' ' LYS . 43.5 t -89.94 110.8 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.336 -0.852 . . . . 0.0 108.705 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.578 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -48.87 -50.38 35.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.792 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -54.92 -61.31 2.39 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.926 . . . . 0.0 109.923 -179.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.5 ' CB ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 mtpp -42.8 -43.58 4.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.231 -0.918 . . . . 0.0 109.79 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.428 ' HA3' ' CZ ' ' A' ' 82' ' ' PHE . . . 80.04 38.24 19.64 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.5 ' OD1' ' CB ' ' A' ' 39' ' ' LYS . 0.7 OUTLIER -113.11 44.35 1.55 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -1.116 . . . . 0.0 109.325 179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.707 HD21 HD11 ' A' ' 51' ' ' ILE . 12.1 tp -58.94 -63.68 1.21 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -0.856 . . . . 0.0 109.647 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.72 -14.45 0.92 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.717 -0.614 . . . . 0.0 110.566 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.1 -36.2 41.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.846 -1.159 . . . . 0.0 110.114 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.8 m -110.4 -0.33 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.929 -1.107 . . . . 0.0 110.008 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.574 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -150.99 61.08 4.31 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.445 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 4.8 Cg_exo -59.63 152.28 63.67 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.065 1.843 . . . . 0.0 110.213 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 52.18 55.4 21.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.574 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 14.8 mttm -135.56 176.36 8.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -1.184 . . . . 0.0 109.72 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.579 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 70.3 m -146.07 136.44 23.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 0.0 109.33 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.726 HD12 ' HA ' ' A' ' 27' ' ' LYS . 11.5 mm -99.37 106.97 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -0.926 . . . . 0.0 109.037 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.71 168.18 35.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.33 -7.5 51.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.47 160.57 26.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.117 -1.225 . . . . 0.0 109.37 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.497 ' HA ' HD13 ' A' ' 55' ' ' ILE . 12.7 mm -70.07 144.81 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.231 -0.918 . . . . 0.0 109.389 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.824 ' CE2' HD12 ' A' ' 63' ' ' LEU . 13.5 t80 -89.21 144.13 26.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 17.5 t -43.54 -89.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.878 . . . . 0.0 109.609 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 57' ' ' SER . 2.4 t-20 78.61 16.33 1.14 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.621 -0.675 . . . . 0.0 109.436 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.31 -45.08 80.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.349 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -81.51 -67.99 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.314 -0.866 . . . . 0.0 109.422 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.46 54.35 0.08 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.593 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 3.8 mptp? -90.28 -10.75 43.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -1.124 . . . . 0.0 109.484 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.824 HD12 ' CE2' ' A' ' 56' ' ' PHE . 58.7 mt -100.56 149.97 36.57 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 108.931 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.852 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.1 Cg_exo -59.04 85.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.052 1.835 . . . . 0.0 110.359 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' HA2' ' HD2' ' A' ' 69' ' ' ARG . . . -162.92 142.4 7.86 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.99 -171.6 3.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -1.143 . . . . 0.0 109.5 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.5 t -69.42 142.33 53.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.477 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.55 -15.29 60.59 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HD2' ' HA2' ' A' ' 65' ' ' GLY . 7.9 ttt180 -84.91 156.38 21.26 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -1.131 . . . . 0.0 109.609 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.517 ' O ' ' CD1' ' A' ' 71' ' ' TRP . 0.0 OUTLIER -125.7 178.95 5.39 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.181 -0.949 . . . . 0.0 109.475 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.684 ' CE3' HD13 ' A' ' 63' ' ' LEU . 9.5 m95 -147.71 169.47 19.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -125.03 136.67 53.91 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.764 ' HA ' HD13 ' A' ' 89' ' ' LEU . 20.1 pt-20 -114.67 152.28 32.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.033 . . . . 0.0 110.296 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.633 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -141.11 152.45 44.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.419 -0.801 . . . . 0.0 109.298 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.469 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 1.1 m-20 -73.44 139.08 45.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.181 -0.95 . . . . 0.0 109.324 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.755 HG21 ' CD1' ' A' ' 7' ' ' PHE . 22.2 mm -132.26 137.73 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.185 -0.947 . . . . 0.0 109.944 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 1.4 m-20 72.53 9.71 5.71 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 0.0 110.186 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -69.83 143.45 52.88 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.083 -1.01 . . . . 0.0 109.606 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 33.8 p -139.58 -58.85 0.57 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.226 -0.922 . . . . 0.0 109.521 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.58 163.29 12.29 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.76 -0.588 . . . . 0.0 109.518 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 82' ' ' PHE . . . 82.97 -178.9 53.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.439 ' CZ ' ' O ' ' A' ' 39' ' ' LYS . 3.1 m-85 -45.59 159.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -1.19 . . . . 0.0 109.391 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 78.1 mtm180 -70.33 160.74 31.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.928 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.79 -167.38 1.31 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.0 109.332 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.65 28.11 8.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.135 -0.978 . . . . 0.0 109.714 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 2.2 m-20 -109.68 127.5 54.62 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.118 -0.989 . . . . 0.0 109.659 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.565 ' O ' HG23 ' A' ' 99' ' ' THR . 5.9 mtt180 -157.38 145.14 18.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 109.592 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.972 HD11 ' CG2' ' A' ' 96' ' ' ILE . 4.4 tt -102.69 132.39 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 109.084 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -103.61 103.16 13.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -0.846 . . . . 0.0 109.577 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.746 ' OH ' HD11 ' A' ' 20' ' ' LEU . 7.2 p90 -98.22 141.31 31.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 108.86 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.494 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -105.15 168.93 8.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.151 -0.968 . . . . 0.0 110.392 -178.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.6 p -65.13 -20.41 66.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.494 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 24.8 p-10 -89.69 17.6 6.36 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.459 -0.776 . . . . 0.0 108.911 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.566 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.04 27.71 6.93 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.762 -0.586 . . . . 0.0 110.438 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.852 HD13 ' HG2' ' A' ' 64' ' ' PRO . 8.8 mt -86.52 102.58 14.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.972 ' CG2' HD11 ' A' ' 88' ' ' ILE . 3.0 mt -94.25 121.81 45.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.18 -0.95 . . . . 0.0 110.71 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.636 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 7.8 m-85 -121.09 164.02 17.47 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.565 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -135.8 144.65 45.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.83 -1.169 . . . . 0.0 109.81 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -132.01 129.66 40.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -0.891 . . . . 0.0 109.126 179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.0 p -119.66 27.51 8.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.615 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.554 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 10.5 p30 -146.25 22.59 1.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.203 -0.935 . . . . 0.0 109.466 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.554 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.9 t-80 80.22 70.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.519 -0.738 . . . . 0.0 109.315 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.429 ' C ' ' O ' ' A' ' 102' ' ' HIS . 18.8 m-85 42.85 26.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.666 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 102' ' ' HIS . 3.7 mm-40 -93.62 -17.5 23.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.294 -0.879 . . . . 0.0 108.958 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.0 m -149.61 138.24 20.88 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.593 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 96.5 m-85 -124.01 136.02 54.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.979 . . . . 0.0 110.035 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.441 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.4 m -126.01 137.07 53.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.419 -0.801 . . . . 0.0 109.024 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -79.72 134.79 36.41 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.107 -0.995 . . . . 0.0 109.688 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.447 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 2.0 pt -142.4 57.76 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 0.0 109.403 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.464 ' OXT' HD12 ' A' ' 96' ' ' ILE . 1.6 mtm-85 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.468 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.14 115.25 27.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.374 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 4' ' ' ILE . 4.7 t -137.85 172.23 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.577 ' H ' HG12 ' A' ' 3' ' ' VAL . 1.1 mp -107.74 86.99 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.185 -0.947 . . . . 0.0 109.454 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -140.59 58.59 1.56 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 0.0 109.362 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.821 ' H ' HG23 ' A' ' 10' ' ' VAL . 4.5 p -142.33 -167.27 2.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.597 ' CD1' HG21 ' A' ' 76' ' ' ILE . 31.4 m-85 -76.99 -61.44 1.98 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.146 -0.971 . . . . 0.0 109.186 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.43 -33.47 69.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.338 -0.851 . . . . 0.0 109.83 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.7 -55.02 15.89 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.821 HG23 ' H ' ' A' ' 6' ' ' THR . 95.7 t -63.04 -40.11 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -1.119 . . . . 0.0 108.926 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.488 ' HB1' ' HG3' ' A' ' 110' ' ' ARG . . . -59.48 -35.85 74.9 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.08 -56.74 10.0 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 35.0 t80 -54.58 -25.96 29.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.222 -0.924 . . . . 0.0 108.73 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 3.3 mt -69.52 -60.31 2.41 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -70.81 -5.33 29.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.061 -1.025 . . . . 0.0 109.492 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.0 m -90.73 -70.91 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.859 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.66 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 68.7 m-85 -89.79 -4.78 57.47 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.67 -0.644 . . . . 0.0 109.642 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 17.8 m170 57.6 57.19 4.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -0.9 . . . . 0.0 109.356 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 7.2 ptmt 166.24 130.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 20' ' ' LEU . 20.0 mt -43.16 147.26 0.72 Allowed Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.266 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 8.2 Cg_exo -53.27 164.13 2.05 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.199 1.933 . . . . 0.0 110.463 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.48 -4.94 29.37 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.362 -0.836 . . . . 0.0 108.975 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.498 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 1.0 OUTLIER -95.05 11.09 33.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.64 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.561 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 5.7 m-85 -105.48 92.94 4.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.086 -1.009 . . . . 0.0 109.845 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 30' ' ' ALA . 1.3 pp -104.01 127.78 57.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.513 ' O ' HD12 ' A' ' 25' ' ' ILE . 68.7 p -48.94 178.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.546 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.6 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.51 -48.4 55.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.026 -1.046 . . . . 0.0 109.566 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 t -53.46 -37.03 62.26 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.125 -0.984 . . . . 0.0 108.512 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.794 ' O ' HD12 ' A' ' 33' ' ' LEU . 18.7 mt-10 -59.88 -39.97 87.09 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HB2' HD11 ' A' ' 25' ' ' ILE . . . -69.69 -32.56 71.24 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.478 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 2.6 mt-30 -65.86 -30.69 71.34 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.44 76.44 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.457 -0.777 . . . . 0.0 109.362 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -80.96 -11.27 59.6 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.479 0.657 . . . . 0.0 109.978 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.7 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 106.02 53.75 0.74 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.636 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 1.6 t90 -108.97 135.96 49.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -1.131 . . . . 0.0 109.555 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.475 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 6.1 t -89.75 128.26 41.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.636 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -60.82 -11.1 6.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.988 -1.07 . . . . 0.0 110.275 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -45.75 -25.28 0.47 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.921 -1.112 . . . . 0.0 109.146 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.581 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 8.2 mttt 72.83 29.96 1.81 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.374 -0.829 . . . . 0.0 109.591 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.601 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -127.89 9.31 6.76 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.031 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -158.62 35.11 0.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.973 -1.31 . . . . 0.0 109.988 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 51' ' ' ILE . 6.0 tp -66.96 -63.53 1.04 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 108.935 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.94 -10.45 2.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.823 -0.548 . . . . 0.0 110.143 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.77 -35.19 44.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.912 -1.118 . . . . 0.0 109.741 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.7 HG11 ' O ' ' A' ' 34' ' ' GLY . 33.3 m -98.49 -48.12 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.158 -0.964 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HB1' ' HD3' ' A' ' 49' ' ' LYS . . . -117.45 77.03 10.07 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.295 -0.878 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.472 ' O ' ' HD2' ' A' ' 49' ' ' LYS . 3.0 Cg_endo -60.41 155.25 47.93 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.235 1.956 . . . . 0.0 110.326 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.53 63.83 4.75 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.689 ' HD3' ' HB1' ' A' ' 46' ' ' ALA . 3.2 mptt -140.44 155.01 46.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.311 -1.111 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.558 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 48.9 m -133.91 123.51 24.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.401 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.553 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 6.6 mm -81.15 105.46 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.019 -1.051 . . . . 0.0 109.017 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -150.65 172.8 30.34 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.522 -1.323 . . . . 0.0 109.851 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.95 10.72 62.44 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' HB2' ' CD ' ' A' ' 73' ' ' GLU . 4.4 m-20 -83.34 143.46 30.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -1.121 . . . . 0.0 109.403 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.439 ' O ' ' OE1' ' A' ' 73' ' ' GLU . 13.6 mm -69.57 136.22 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 0.0 109.457 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.667 ' CE1' ' CD1' ' A' ' 103' ' ' TYR . 73.9 t80 -111.39 91.16 3.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.393 -0.817 . . . . 0.0 109.29 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 0.2 OUTLIER -70.09 -4.84 23.06 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.826 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.594 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 5.6 t-20 77.06 70.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.0 109.626 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -41.5 65.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.234 -0.916 . . . . 0.0 109.331 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -89.54 -65.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.38 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . 114.2 49.93 0.52 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.7 -2.07 16.43 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -1.131 . . . . 0.0 109.545 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.884 HD22 ' CZ3' ' A' ' 71' ' ' TRP . 4.2 mt -95.13 146.64 31.68 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.243 -0.911 . . . . 0.0 109.205 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' HG3' ' OH ' ' A' ' 97' ' ' TYR . 2.4 Cg_endo -62.26 84.55 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.026 1.818 . . . . 0.0 109.837 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.3 -164.98 32.22 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.35 -165.84 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -1.124 . . . . 0.0 109.352 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.9 m -70.18 101.89 1.97 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.226 -0.921 . . . . 0.0 109.468 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.03 55.95 8.66 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.801 HH22 HD12 ' A' ' 95' ' ' LEU . 13.0 ttt180 -108.13 152.5 24.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -1.185 . . . . 0.0 109.349 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.406 HG21 HD12 ' A' ' 55' ' ' ILE . 19.8 m -122.0 133.52 54.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.156 -0.965 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.884 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 11.9 m95 -102.65 172.85 6.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.634 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 3.6 mtt180 -127.79 132.92 49.44 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' CD ' ' HB2' ' A' ' 54' ' ' ASP . 2.1 pt-20 -116.59 146.82 42.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.906 -1.121 . . . . 0.0 110.627 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.545 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -137.04 148.04 46.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 2.0 m-20 -72.49 122.63 21.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.281 -0.887 . . . . 0.0 109.731 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.794 HD12 ' O ' ' A' ' 6' ' ' THR . 30.5 mm -110.69 137.73 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.265 -0.897 . . . . 0.0 109.347 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 70.74 122.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 109.25 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.446 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 2.2 t80 -170.13 110.24 0.4 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.02 -78.73 0.58 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 0.0 109.35 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.88 155.29 32.65 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.701 -0.624 . . . . 0.0 109.407 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.05 -160.09 14.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.601 ' CE1' ' HA3' ' A' ' 40' ' ' GLY . 0.5 OUTLIER -66.63 155.77 36.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -1.154 . . . . 0.0 109.507 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NE ' ' HD3' ' A' ' 39' ' ' LYS . 12.1 mtm180 -51.75 -178.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.35 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.514 ' O ' ' NH2' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -120.53 -167.98 1.56 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.951 . . . . 0.0 109.46 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.5 p -127.55 18.67 6.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.2 -0.937 . . . . 0.0 109.565 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.473 ' OD2' ' HA ' ' A' ' 100' ' ' THR . 4.3 m-20 -105.12 129.72 53.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 109.387 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.535 ' O ' ' CG2' ' A' ' 99' ' ' THR . 5.5 mmt180 -146.99 140.81 25.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.56 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.071 HD11 ' CG2' ' A' ' 96' ' ' ILE . 3.3 tt -93.34 129.18 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 108.82 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.49 ' N ' HD22 ' A' ' 89' ' ' LEU . 4.6 mm? -101.11 93.69 5.6 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 0.0 110.194 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 38.2 p90 -91.5 139.85 30.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.889 -1.132 . . . . 0.0 108.652 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -105.47 170.36 7.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.097 -1.002 . . . . 0.0 110.722 -178.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.9 -22.38 66.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 109.6 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 14.5 p-10 -89.79 18.8 5.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.602 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 69.22 26.54 5.4 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.817 -0.552 . . . . 0.0 110.244 179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.856 HD22 ' HE1' ' A' ' 97' ' ' TYR . 6.7 mt -82.32 92.6 6.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.071 ' CG2' HD11 ' A' ' 88' ' ' ILE . 12.8 mt -90.64 112.41 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 110.372 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.856 ' HE1' HD22 ' A' ' 95' ' ' LEU . 20.1 m-85 -114.03 167.14 10.92 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.541 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -137.28 130.14 30.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.951 -1.093 . . . . 0.0 109.655 -179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -119.76 119.07 32.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.143 -0.973 . . . . 0.0 109.26 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.473 ' HA ' ' OD2' ' A' ' 86' ' ' ASP . 21.1 p -104.16 22.17 15.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.259 -0.901 . . . . 0.0 109.523 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.6 OUTLIER -138.46 22.64 2.73 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.494 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.534 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 7.1 t-80 77.8 73.92 0.06 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 109.455 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.667 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 34.5 m-85 43.02 43.96 3.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.802 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.43 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 2.2 mm-40 -117.14 -17.01 10.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 109.249 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' THR . 51.9 m -150.38 94.97 2.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.502 -0.749 . . . . 0.0 109.332 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.552 ' CE1' ' HA ' ' A' ' 103' ' ' TYR . 14.1 m-85 -90.63 116.76 28.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.747 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 90.4 m -107.86 139.49 42.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.276 -0.89 . . . . 0.0 108.8 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -79.3 127.99 32.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 109.605 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.429 ' CG2' ' HE2' ' A' ' 98' ' ' LYS . 1.5 pt -112.75 -42.04 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.572 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.618 ' CG ' HD12 ' A' ' 96' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.491 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.24 0.543 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.97 142.19 31.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.543 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 m -146.9 -173.66 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.455 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.6 mt -113.18 93.75 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.501 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -141.99 61.77 1.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.445 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.623 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -147.75 -175.19 4.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.538 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.639 ' CD1' HG21 ' A' ' 76' ' ' ILE . 25.2 m-85 -73.79 -56.73 4.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.23 -0.919 . . . . 0.0 109.509 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.34 -31.4 67.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 109.972 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.18 -55.39 9.16 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.623 HG23 ' H ' ' A' ' 6' ' ' THR . 38.8 t -65.83 -40.64 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -1.133 . . . . 0.0 109.296 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.35 -42.0 85.94 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.34 -55.01 36.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.544 -0.723 . . . . 0.0 109.101 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.681 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 35.5 t80 -59.09 -21.96 60.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.369 -0.832 . . . . 0.0 109.267 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.553 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.7 mt -73.1 -61.16 1.91 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 0.0 109.337 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.57 -9.18 57.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.005 -1.06 . . . . 0.0 109.591 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.2 m -89.62 -65.28 1.03 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.199 -0.938 . . . . 0.0 110.299 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.681 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 71.9 m-85 -89.18 -11.36 44.0 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.582 -0.698 . . . . 0.0 109.24 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.47 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 19.1 m170 61.01 53.72 3.6 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.369 -0.832 . . . . 0.0 109.491 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 7.1 pttm 166.97 129.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.459 HD11 ' OH ' ' A' ' 90' ' ' TYR . 37.7 mt -44.94 151.74 0.61 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.124 -0.985 . . . . 0.0 109.155 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.57 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.2 Cg_exo -54.6 163.42 3.83 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.147 1.898 . . . . 0.0 110.598 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -7.24 33.84 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.332 -0.855 . . . . 0.0 109.001 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.27 31.82 2.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.334 -0.854 . . . . 0.0 109.526 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.57 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.3 m-85 -121.9 82.45 1.95 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 0.0 109.776 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.5 pt -92.26 128.71 43.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.301 -0.875 . . . . 0.0 108.684 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.47 ' O ' ' O ' ' A' ' 25' ' ' ILE . 18.5 p -47.23 174.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.139 -0.975 . . . . 0.0 109.26 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.614 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.73 -43.68 68.4 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.193 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.1 m -55.34 -38.81 69.23 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.153 -0.967 . . . . 0.0 108.464 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 33' ' ' LEU . 5.5 mm-40 -57.84 -40.61 80.46 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.554 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.02 -37.34 83.96 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 4.6 mt-30 -60.98 -32.66 72.21 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.19 -36.88 81.08 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.359 -0.838 . . . . 0.0 109.717 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -81.03 -8.73 59.84 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.65 -0.656 . . . . 0.0 110.318 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.849 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 106.54 51.55 0.8 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.668 ' CH2' ' HB2' ' A' ' 37' ' ' ALA . 9.3 t90 -118.37 124.46 47.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -1.115 . . . . 0.0 109.052 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 39' ' ' LYS . 4.8 t -90.64 113.02 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.153 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.668 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . -67.27 -16.43 64.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.0 109.45 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.9 m -89.47 -13.38 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 0.0 109.437 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -113.7 -9.84 13.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 109.492 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.57 65.54 3.1 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 45' ' ' VAL . 6.9 p-10 -120.82 43.11 2.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -1.187 . . . . 0.0 109.496 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.551 HD11 ' HB1' ' A' ' 30' ' ' ALA . 10.5 tp -63.1 -57.56 10.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.397 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -49.48 -20.61 0.75 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.47 -37.44 23.14 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.07 -1.019 . . . . 0.0 110.355 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.849 HG11 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -106.98 -54.34 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.005 -1.059 . . . . 0.0 110.101 -179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 1.043 ' HB1' ' HG3' ' A' ' 49' ' ' LYS . . . -113.38 80.06 4.33 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.114 -0.991 . . . . 0.0 109.699 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 2.1 Cg_endo -62.16 156.57 49.48 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.238 1.959 . . . . 0.0 110.333 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.53 56.39 4.2 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 1.043 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 5.3 mmtp -127.79 119.86 26.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -1.13 . . . . 0.0 109.446 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 0.9 OUTLIER -89.74 137.55 32.24 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.327 -0.858 . . . . 0.0 109.48 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.551 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 5.3 mm -104.27 113.9 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 108.922 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.55 173.03 40.45 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.549 -1.31 . . . . 0.0 109.92 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.11 6.26 55.85 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.438 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 1.7 m-20 -87.09 148.33 25.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -1.204 . . . . 0.0 109.39 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.5 mm -67.77 139.79 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.61 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.873 ' CE2' HD12 ' A' ' 63' ' ' LEU . 62.8 t80 -101.7 92.32 4.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.333 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 6.0 p -70.24 -4.67 22.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 0.0 109.748 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 1.2 t-20 71.48 89.41 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.151 -0.968 . . . . 0.0 109.527 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -49.57 -36.63 24.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 109.413 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -124.65 -70.18 0.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.281 -0.887 . . . . 0.0 109.344 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 147.43 72.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.599 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 35.6 mttm -116.08 -7.7 11.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -1.152 . . . . 0.0 109.591 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.873 HD12 ' CE2' ' A' ' 56' ' ' PHE . 63.6 mt -93.64 148.36 35.28 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.209 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.701 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.5 Cg_exo -60.1 84.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.109 1.873 . . . . 0.0 110.186 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 66' ' ' LYS . . . -96.22 167.5 25.07 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -148.28 -170.8 3.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.277 -1.131 . . . . 0.0 109.364 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 t -67.29 96.01 0.46 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.453 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.79 57.84 2.0 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.517 ' NH1' ' OD2' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -125.94 136.92 53.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -1.138 . . . . 0.0 109.582 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.16 160.32 19.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -0.892 . . . . 0.0 109.388 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.629 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 19.9 m95 -132.41 172.17 12.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.162 -0.961 . . . . 0.0 109.73 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.634 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 65.1 mtt180 -136.94 148.65 47.09 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.761 ' HA ' HD13 ' A' ' 89' ' ' LEU . 9.1 pt-20 -124.1 158.67 31.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.048 -1.032 . . . . 0.0 110.467 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -148.76 152.3 36.33 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.4 m-20 -78.67 131.83 36.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.107 -0.996 . . . . 0.0 109.516 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.639 HG21 ' CD1' ' A' ' 7' ' ' PHE . 30.3 mm -116.7 124.42 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.545 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.583 ' ND2' HG22 ' A' ' 76' ' ' ILE . 20.7 m-20 69.5 118.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.483 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -170.57 138.94 1.53 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.291 -0.88 . . . . 0.0 109.549 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.67 -79.74 0.49 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.084 -1.01 . . . . 0.0 109.478 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.52 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 1.6 p -140.98 171.1 14.53 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.61 -0.681 . . . . 0.0 109.574 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.79 -176.34 54.59 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -48.98 167.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -1.169 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -68.55 -179.87 1.49 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.932 . . . . 0.0 109.609 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER -110.0 -172.77 2.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.245 -0.91 . . . . 0.0 109.405 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.5 m -108.17 10.94 27.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 109.581 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 82.0 m-20 -100.37 128.03 46.54 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.156 -0.965 . . . . 0.0 109.661 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 99' ' ' THR . 0.1 OUTLIER -152.39 158.24 42.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.787 . . . . 0.0 109.164 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.779 HD11 HG22 ' A' ' 96' ' ' ILE . 1.6 tt -118.42 146.33 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.014 -1.054 . . . . 0.0 109.345 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.761 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.2 mm? -117.93 113.14 21.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.463 -0.773 . . . . 0.0 109.68 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 2.5 p90 -105.99 140.39 39.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.842 -1.161 . . . . 0.0 108.934 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.479 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -107.49 174.93 5.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.237 -0.915 . . . . 0.0 110.444 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -23.34 66.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 109.815 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.517 ' OD2' ' NH1' ' A' ' 69' ' ' ARG . 42.6 p30 -89.62 16.58 7.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.424 -0.797 . . . . 0.0 108.969 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.568 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.94 27.66 7.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.769 -0.582 . . . . 0.0 110.522 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.701 HD13 ' HG2' ' A' ' 64' ' ' PRO . 14.5 mt -83.66 114.96 21.93 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.779 HG22 HD11 ' A' ' 88' ' ' ILE . 4.8 mt -111.2 107.65 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.108 -0.995 . . . . 0.0 110.574 -178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.532 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 26.5 m-85 -106.97 117.84 35.12 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -89.19 145.27 25.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 109.924 -179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -130.49 122.63 28.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.413 -0.804 . . . . 0.0 109.09 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.613 HG23 ' HE2' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -110.95 30.66 6.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 109.633 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.5 OUTLIER -150.21 21.88 0.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.542 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.3 OUTLIER 78.73 73.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.405 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.452 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 26.8 m-85 43.78 26.22 0.12 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.392 -0.818 . . . . 0.0 109.682 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -97.05 -18.17 19.54 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.21 -0.931 . . . . 0.0 109.001 179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.47 ' HB ' ' OD2' ' A' ' 101' ' ' ASP . 24.1 m -143.27 142.89 31.5 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.599 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 86.7 m-85 -133.65 123.77 25.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.086 -1.009 . . . . 0.0 110.267 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -114.18 132.44 56.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.497 -0.752 . . . . 0.0 109.0 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.1 ttpt -79.5 109.36 13.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 109.54 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.442 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 1.1 pt -125.38 65.78 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.247 -0.908 . . . . 0.0 109.483 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 72.6 mtm180 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.408 ' O ' ' HB3' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.314 0.578 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -179.25 140.26 0.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.954 . . . . 0.0 109.53 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 2' ' ' GLN . 2.5 m -156.1 153.99 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.473 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.624 HG21 ' HG3' ' A' ' 21' ' ' PRO . 3.1 mp -132.48 87.38 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 109.524 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -143.0 53.87 1.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.649 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -144.63 -176.23 4.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.547 179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.645 ' CE1' HG21 ' A' ' 76' ' ' ILE . 31.4 m-85 -75.86 -57.9 3.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 0.0 109.556 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -31.65 67.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.937 . . . . 0.0 109.901 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.95 -52.87 21.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.649 HG23 ' H ' ' A' ' 6' ' ' THR . 46.6 t -67.1 -46.95 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -1.117 . . . . 0.0 109.332 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.61 -38.06 68.95 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -55.1 28.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.482 -0.761 . . . . 0.0 109.093 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 18.0 t80 -62.53 -17.67 60.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.325 -0.859 . . . . 0.0 109.318 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.549 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 1.4 mt -75.75 -63.37 1.32 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.444 -0.785 . . . . 0.0 109.252 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -11.56 61.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.98 -1.075 . . . . 0.0 109.412 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.3 m -89.74 -64.45 1.14 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.962 . . . . 0.0 110.069 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.689 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 67.7 m-85 -89.48 -0.16 57.3 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.458 -0.776 . . . . 0.0 109.568 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 19.2 m170 47.91 47.16 18.73 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.295 -0.878 . . . . 0.0 109.685 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 14.4 ptmt 173.85 128.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' A' ' 20' ' ' LEU . 23.0 mt -45.94 147.89 1.58 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.154 -0.966 . . . . 0.0 109.022 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.624 ' HG3' HG21 ' A' ' 4' ' ' ILE . 7.5 Cg_exo -53.56 160.42 5.29 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.016 1.811 . . . . 0.0 110.469 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.07 -10.32 29.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.258 -0.901 . . . . 0.0 108.981 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 50.9 p30 -92.18 20.68 5.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.333 -0.854 . . . . 0.0 109.588 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.566 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.9 m-85 -115.96 87.79 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -0.964 . . . . 0.0 109.725 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.2 pt -99.23 123.15 51.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.299 -0.876 . . . . 0.0 108.735 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.482 ' HB ' ' OD2' ' A' ' 54' ' ' ASP . 19.8 p -45.99 172.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 109.501 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.643 ' HA ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -67.26 -45.5 76.49 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.0 -1.062 . . . . 0.0 109.029 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -39.5 67.31 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.834 ' O ' HD12 ' A' ' 33' ' ' LEU . 18.8 mt-10 -59.37 -38.54 80.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.636 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.37 -38.68 85.15 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.097 -1.002 . . . . 0.0 108.544 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 27.4 mt-30 -60.37 -35.39 75.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.1 -34.83 70.6 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.305 -0.872 . . . . 0.0 109.335 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.43 -18.09 46.56 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.694 -0.629 . . . . 0.0 110.271 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 1.021 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 115.64 36.36 1.18 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.636 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 9.5 t90 -100.3 122.35 42.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -1.174 . . . . 0.0 109.122 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 38' ' ' SER . 41.1 t -89.77 110.46 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.23 -0.919 . . . . 0.0 109.161 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -60.33 -14.24 17.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.579 ' H ' HG12 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -78.32 -63.19 1.46 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.55 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.496 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 29.9 mttp -80.36 0.61 32.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.664 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 44.42 84.08 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 35' ' ' TRP . 56.8 p30 -122.44 44.46 2.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.208 -1.172 . . . . 0.0 109.503 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.565 HD11 ' HB1' ' A' ' 30' ' ' ALA . 6.2 tp -62.45 -46.26 89.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.212 -0.93 . . . . 0.0 109.469 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -61.96 -11.32 12.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.312 -0.867 . . . . 0.0 109.877 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.45 -51.37 4.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.13 -0.981 . . . . 0.0 109.983 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.021 HG11 ' O ' ' A' ' 34' ' ' GLY . 28.9 m -91.7 -47.3 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.851 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.606 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -118.96 76.59 14.74 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 109.433 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 1.7 Cg_endo -63.46 155.15 64.17 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.234 1.956 . . . . 0.0 110.562 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 42.74 70.24 0.53 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.577 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 3.7 mmpt? -142.01 160.36 40.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.258 -1.142 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 3.0 m -124.16 130.37 52.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.889 . . . . 0.0 109.398 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.643 HD12 ' HA ' ' A' ' 27' ' ' LYS . 17.5 mm -93.12 104.61 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.158 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -158.38 168.2 34.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.82 -15.85 51.73 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.482 ' OD2' ' HB ' ' A' ' 26' ' ' THR . 3.4 m-20 -79.95 148.41 31.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.162 -1.199 . . . . 0.0 109.331 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 56' ' ' PHE . 14.0 mt -51.54 166.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.366 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.813 ' CE2' HD12 ' A' ' 63' ' ' LEU . 9.0 t80 -106.88 145.83 31.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.537 ' OG ' ' CE1' ' A' ' 56' ' ' PHE . 0.1 OUTLIER -45.52 -88.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.866 . . . . 0.0 109.671 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 57' ' ' SER . 9.9 t-20 78.36 20.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.622 -0.673 . . . . 0.0 109.374 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -74.25 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.397 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -62.78 -35.92 81.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.384 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.45 77.07 1.23 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.566 ' CB ' ' CE2' ' A' ' 106' ' ' PHE . 12.8 mmtt -102.17 -9.01 20.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -1.144 . . . . 0.0 109.51 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.813 HD12 ' CE2' ' A' ' 56' ' ' PHE . 44.2 mt -105.38 157.23 34.89 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 0.0 108.968 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.642 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.8 Cg_endo -61.84 84.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.005 1.803 . . . . 0.0 109.63 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.435 ' C ' ' HG2' ' A' ' 66' ' ' LYS . . . -93.7 164.39 26.52 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.435 ' HG2' ' C ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -138.44 -148.75 0.27 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -1.151 . . . . 0.0 109.444 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 t -61.02 102.61 0.21 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.452 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 46.65 72.18 0.43 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.817 HH22 HD12 ' A' ' 95' ' ' LEU . 3.5 ttt180 -114.96 149.48 37.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -1.13 . . . . 0.0 109.568 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.54 171.85 7.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 0.0 109.503 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.622 ' CE3' HD13 ' A' ' 63' ' ' LEU . 15.0 m95 -141.13 157.56 45.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.428 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.638 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 28.8 mtp180 -119.07 129.29 55.01 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.742 ' HA ' HD13 ' A' ' 89' ' ' LEU . 12.4 pt-20 -106.3 151.08 25.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.053 -1.029 . . . . 0.0 110.22 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.668 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -138.66 150.97 46.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.46 -0.775 . . . . 0.0 109.111 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.4 OUTLIER -74.41 136.92 42.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.052 -1.03 . . . . 0.0 109.573 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.645 HG21 ' CE1' ' A' ' 7' ' ' PHE . 22.1 mm -120.31 123.32 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.231 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER 72.04 129.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 109.269 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.492 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 8.6 t80 -170.39 141.5 1.99 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.144 -0.973 . . . . 0.0 109.537 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.01 -78.81 0.19 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -144.58 161.2 39.71 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.642 -0.661 . . . . 0.0 109.5 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.38 -175.32 34.49 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.496 ' CE1' ' O ' ' A' ' 39' ' ' LYS . 1.1 m-85 -55.02 179.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -1.177 . . . . 0.0 109.405 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -175.8 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.218 -0.926 . . . . 0.0 109.558 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.44 179.88 3.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.4 m -110.96 8.47 22.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 109.536 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.753 ' OD1' HG22 ' A' ' 100' ' ' THR . 25.5 m-20 -108.94 128.53 55.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.106 -0.996 . . . . 0.0 109.384 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 86' ' ' ASP . 3.6 mmt180 -143.03 169.94 16.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.318 -0.864 . . . . 0.0 109.289 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.0 HD11 ' CG2' ' A' ' 96' ' ' ILE . 3.9 tt -134.15 129.64 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.026 -1.046 . . . . 0.0 108.598 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.793 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.1 mm? -104.87 104.23 13.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.668 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 10.2 p90 -96.31 139.07 32.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.939 -1.101 . . . . 0.0 108.459 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.483 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.4 OUTLIER -100.72 170.88 8.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 -178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 p -65.22 -21.85 66.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.41 -0.806 . . . . 0.0 109.311 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 27.4 p-10 -89.87 18.08 6.05 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.581 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.1 m95 68.21 29.89 5.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.281 0.562 . . . . 0.0 110.165 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.817 HD12 HH22 ' A' ' 69' ' ' ARG . 6.9 mt -85.17 97.53 9.95 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.0 ' CG2' HD11 ' A' ' 88' ' ' ILE . 3.5 mt -90.24 118.66 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.118 -0.989 . . . . 0.0 110.468 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 108' ' ' LYS . 9.0 m-85 -117.32 158.4 24.44 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 7.3 ptpt -126.29 153.38 44.89 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.943 -1.098 . . . . 0.0 109.428 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.5 OUTLIER -140.66 118.28 11.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.445 -0.785 . . . . 0.0 109.115 179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.753 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -101.81 25.56 8.46 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.931 . . . . 0.0 109.594 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.926 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.0 OUTLIER -142.66 18.74 2.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.285 -0.884 . . . . 0.0 109.417 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 4.3 t-80 78.2 85.82 0.07 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.379 -0.826 . . . . 0.0 109.981 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' HIS . 33.9 m-85 41.61 27.13 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.385 -0.822 . . . . 0.0 110.067 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.525 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 7.1 tp60 -89.13 -71.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.927 . . . . 0.0 108.982 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.926 HG22 ' OD1' ' A' ' 101' ' ' ASP . 14.2 t -97.61 164.1 12.56 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.566 ' CE2' ' CB ' ' A' ' 62' ' ' LYS . 92.3 m-85 -145.45 121.15 10.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.914 -1.116 . . . . 0.0 109.947 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 2.0 m -118.28 133.47 55.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.829 . . . . 0.0 109.322 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 3.6 ttpm? -79.63 131.92 36.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 109.435 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 110' ' ' ARG . 1.3 pt -119.8 -45.59 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.888 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.501 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -111.54 96.78 6.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.401 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -51.66 134.46 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -114.5 105.53 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -146.1 62.63 1.24 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 109.404 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.687 ' O ' HD12 ' A' ' 76' ' ' ILE . 1.7 p -145.08 -175.55 4.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.803 ' CE1' HG21 ' A' ' 76' ' ' ILE . 41.7 m-85 -79.57 -54.4 5.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 0.0 109.718 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.3 -33.6 69.85 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.213 -0.929 . . . . 0.0 110.01 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.27 -53.03 23.78 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.541 HG23 ' H ' ' A' ' 6' ' ' THR . 41.5 t -66.76 -38.85 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.336 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.657 ' HB3' HH21 ' A' ' 110' ' ' ARG . . . -59.53 -39.82 85.17 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.438 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.6 OUTLIER -64.55 -55.45 20.42 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.471 -0.768 . . . . 0.0 109.163 179.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.556 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 19.6 t80 -59.53 -20.36 54.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.275 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER -75.58 -64.38 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.199 179.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -70.75 -5.55 30.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.976 -1.077 . . . . 0.0 109.34 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 56.2 m -94.29 -66.45 0.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.242 -0.911 . . . . 0.0 109.562 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.556 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 83.3 m-85 -89.86 3.46 52.9 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.705 -0.622 . . . . 0.0 109.439 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 19.7 m170 44.76 48.76 8.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 17.5 pttt 175.17 129.29 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.479 -0.763 . . . . 0.0 109.159 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.852 HD11 ' OH ' ' A' ' 90' ' ' TYR . 30.1 mt -47.14 149.01 1.82 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.207 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.568 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 7.9 Cg_exo -53.54 161.82 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.045 1.83 . . . . 0.0 110.422 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -68.73 -7.43 33.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.084 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -92.43 11.15 27.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.389 -0.819 . . . . 0.0 109.529 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.568 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 3.2 m-85 -105.11 90.26 3.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.753 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 26' ' ' THR . 1.1 pp -99.29 123.6 52.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 25' ' ' ILE . 44.5 p -47.9 176.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.225 -0.922 . . . . 0.0 109.5 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.21 -47.98 59.06 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.107 -0.996 . . . . 0.0 109.104 -179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.4 m -53.51 -38.85 64.11 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' O ' HD12 ' A' ' 33' ' ' LEU . 26.8 mm-40 -57.85 -41.07 81.62 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.593 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -66.69 -33.91 76.69 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.444 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 1.7 mt-30 -62.53 -34.65 77.34 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.01 72.75 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.466 -0.771 . . . . 0.0 109.592 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.5 mp -80.78 -15.89 55.23 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.451 0.643 . . . . 0.0 110.134 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 113.89 40.31 1.0 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.675 ' HB2' HG21 ' A' ' 45' ' ' VAL . 11.1 t90 -106.88 118.92 37.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.201 -1.176 . . . . 0.0 109.244 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 38' ' ' SER . 16.0 t -89.87 111.92 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.349 -0.844 . . . . 0.0 108.966 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -54.64 -18.3 4.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.955 . . . . 0.0 109.729 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -81.46 -35.57 30.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.198 -0.939 . . . . 0.0 109.765 -179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.3 mmtp -90.28 -10.7 43.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.805 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 42.96 39.6 3.8 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.451 ' C ' ' ND2' ' A' ' 41' ' ' ASN . 0.1 OUTLIER -94.28 44.06 1.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.149 -1.206 . . . . 0.0 109.774 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 42' ' ' LEU . 10.2 tp -59.09 -55.25 37.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.33 -19.94 0.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.108 -0.995 . . . . 0.0 110.091 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -96.56 -29.48 13.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.95 -1.094 . . . . 0.0 110.762 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 35' ' ' TRP . 32.3 m -103.44 -52.57 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.819 -1.175 . . . . 0.0 110.3 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.613 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -127.05 66.19 66.64 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.945 -1.097 . . . . 0.0 109.46 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.475 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 2.1 Cg_endo -62.02 168.27 9.29 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.218 1.946 . . . . 0.0 110.353 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 50.67 45.82 47.67 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.413 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -130.52 163.14 27.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -1.198 . . . . 0.0 109.507 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.541 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 42.8 m -129.41 126.1 38.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.322 -0.861 . . . . 0.0 109.421 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.532 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 7.2 mm -90.18 106.56 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.142 -0.974 . . . . 0.0 108.907 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.81 169.73 34.64 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.896 -1.281 . . . . 0.0 109.896 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.06 -9.31 50.55 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.507 ' OD1' ' CG ' ' A' ' 73' ' ' GLU . 2.6 p30 -86.25 145.23 27.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -1.139 . . . . 0.0 109.507 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 56' ' ' PHE . 37.4 mm -49.78 161.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.146 -0.971 . . . . 0.0 109.419 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.01 ' CE2' HD12 ' A' ' 63' ' ' LEU . 14.5 t80 -101.33 143.11 31.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.295 -0.878 . . . . 0.0 109.388 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.536 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 1.8 t -56.15 -85.72 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.426 -0.796 . . . . 0.0 109.664 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 57' ' ' SER . 10.2 t-20 80.63 48.69 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -68.01 -68.54 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -60.75 -42.96 98.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.478 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.47 ' HA2' ' OD1' ' A' ' 58' ' ' ASN . . . 102.01 63.61 0.74 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.544 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 2.7 mttt -97.73 -6.28 33.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -1.147 . . . . 0.0 109.636 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.01 HD12 ' CE2' ' A' ' 56' ' ' PHE . 31.7 mt -101.01 142.75 25.24 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.21 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.98 ' HG2' HD13 ' A' ' 95' ' ' LEU . 1.9 Cg_endo -62.92 107.77 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.045 1.83 . . . . 0.0 110.096 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.41 ' HA2' ' HD2' ' A' ' 69' ' ' ARG . . . -152.41 159.23 28.28 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.14 176.35 5.09 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.246 -1.149 . . . . 0.0 109.491 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.09 107.31 3.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -0.883 . . . . 0.0 109.486 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.29 12.6 10.66 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 70' ' ' THR . 3.3 ttm180 -114.28 142.51 46.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -1.184 . . . . 0.0 109.608 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.478 HG22 HG23 ' A' ' 55' ' ' ILE . 1.5 m -113.79 151.42 32.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.441 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.765 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 6.5 m95 -108.89 173.31 6.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.168 -0.958 . . . . 0.0 109.669 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.614 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 53.3 mtt180 -130.88 150.57 51.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.711 ' HA ' HD13 ' A' ' 89' ' ' LEU . 20.8 pt-20 -128.55 155.48 44.84 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.008 -1.058 . . . . 0.0 110.418 -179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB2' ' OH ' ' A' ' 90' ' ' TYR . . . -146.98 148.1 31.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.525 -0.735 . . . . 0.0 109.102 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.451 ' OD2' ' HB ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -68.81 149.26 49.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.323 -0.86 . . . . 0.0 109.595 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.803 HG21 ' CE1' ' A' ' 7' ' ' PHE . 29.1 mm -141.25 145.02 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 0.0 109.274 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 73.7 m-20 61.19 39.83 15.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.885 . . . . 0.0 109.476 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.486 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 60.5 t80 -69.68 128.42 36.37 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.336 -0.853 . . . . 0.0 109.597 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.24 -79.92 0.56 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.204 -0.935 . . . . 0.0 109.422 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -172.53 -177.75 1.81 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.642 -0.661 . . . . 0.0 109.486 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.515 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . 67.44 78.21 0.28 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.575 ' CE1' ' O ' ' A' ' 39' ' ' LYS . 0.7 OUTLIER 56.46 164.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -1.169 . . . . 0.0 109.313 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 171.97 0.05 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.21 -0.931 . . . . 0.0 109.334 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.486 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 0.6 OUTLIER -103.74 -171.75 1.99 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.601 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.34 -4.92 13.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.902 . . . . 0.0 109.415 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.48 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 65.0 m-20 -93.87 129.42 40.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 0.0 109.459 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.614 ' O ' HG23 ' A' ' 99' ' ' THR . 11.4 mtt180 -152.79 150.88 29.83 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.885 . . . . 0.0 109.206 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.824 HD11 HD11 ' A' ' 109' ' ' ILE . 4.3 tt -106.98 149.36 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.185 -0.947 . . . . 0.0 109.441 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.5 mm? -117.95 124.69 48.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.374 -0.829 . . . . 0.0 109.515 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.852 ' OH ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -113.26 140.96 47.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.841 -1.162 . . . . 0.0 108.839 179.063 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.591 ' HB2' ' CZ2' ' A' ' 71' ' ' TRP . 11.4 t -108.27 173.78 6.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.893 . . . . 0.0 110.155 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.3 p -66.36 -22.77 66.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.379 -0.826 . . . . 0.0 109.475 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.473 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 28.4 p-10 -89.67 15.65 9.21 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.582 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.36 31.59 6.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.708 -0.62 . . . . 0.0 110.461 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.98 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.8 mt -87.34 125.05 34.0 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.606 HG22 HD11 ' A' ' 88' ' ' ILE . 1.8 mt -117.62 113.75 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.098 -1.001 . . . . 0.0 110.677 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.551 ' HB2' HD21 ' A' ' 63' ' ' LEU . 21.6 m-85 -113.52 117.45 31.7 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -89.21 136.15 33.18 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.961 -1.087 . . . . 0.0 109.8 -179.119 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -122.89 128.66 50.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.0 108.996 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.459 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.3 31.2 6.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.131 -0.981 . . . . 0.0 109.606 -179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.563 ' OD2' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -149.88 20.67 0.89 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.2 -0.937 . . . . 0.0 109.36 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 19.6 t-80 76.6 68.9 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 0.0 109.804 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 5.7 m-85 56.28 55.1 6.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.954 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 101' ' ' ASP . 0.8 OUTLIER -120.87 -81.56 0.64 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 108.641 179.396 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.563 HG23 ' OD2' ' A' ' 101' ' ' ASP . 17.2 p -90.56 105.25 17.69 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.544 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 83.2 m-85 -90.0 126.52 35.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.225 -0.922 . . . . 0.0 110.142 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -111.33 126.98 55.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.346 -0.846 . . . . 0.0 108.949 179.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 24.3 tttt -79.34 117.49 20.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.019 -1.051 . . . . 0.0 109.441 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.824 HD11 HD11 ' A' ' 88' ' ' ILE . 1.4 pt -110.21 -24.76 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.876 . . . . 0.0 109.627 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.657 HH21 ' HB3' ' A' ' 11' ' ' ALA . 2.8 mtt-85 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.535 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -141.16 102.47 4.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.223 -0.923 . . . . 0.0 109.497 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.527 HG12 ' H ' ' A' ' 4' ' ' ILE . 3.5 t 62.95 170.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.506 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.527 ' H ' HG12 ' A' ' 3' ' ' VAL . 3.1 mp -140.87 95.12 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.306 -0.871 . . . . 0.0 109.599 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -138.94 58.46 1.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.676 ' H ' HG23 ' A' ' 10' ' ' VAL . 1.2 p -146.42 -178.26 6.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.62 ' CG ' HG21 ' A' ' 76' ' ' ILE . 11.3 m-85 -73.68 -57.15 4.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.227 -0.921 . . . . 0.0 109.404 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.35 -36.42 71.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.912 . . . . 0.0 109.824 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.52 -49.98 57.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.676 HG23 ' H ' ' A' ' 6' ' ' THR . 90.0 t -66.03 -44.83 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.227 -1.161 . . . . 0.0 109.278 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.09 -37.78 67.25 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.83 -56.03 14.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.501 -0.75 . . . . 0.0 109.045 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.641 ' CE1' ' CG ' ' A' ' 17' ' ' TYR . 67.4 t80 -58.97 -17.7 27.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.885 . . . . 0.0 109.145 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.504 HD12 HG12 ' A' ' 10' ' ' VAL . 1.6 mt -78.59 -59.84 2.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.357 -0.839 . . . . 0.0 109.241 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.8 -9.67 57.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.009 -1.057 . . . . 0.0 109.489 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.496 HG22 ' CD1' ' A' ' 17' ' ' TYR . 99.6 m -95.49 -61.57 1.44 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.287 -0.883 . . . . 0.0 109.947 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CG ' ' CE1' ' A' ' 13' ' ' TYR . 6.2 m-85 -89.31 0.67 56.62 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 121.697 -0.627 . . . . 0.0 109.581 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.514 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 18.1 m170 42.76 48.59 4.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.256 -0.902 . . . . 0.0 109.688 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 2.9 pttm 176.84 130.06 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.508 -0.745 . . . . 0.0 109.128 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.79 HD13 ' HD2' ' A' ' 24' ' ' TYR . 14.2 mt -43.76 160.96 0.21 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 109.182 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 3.1 Cg_exo -55.41 159.31 10.85 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.105 1.87 . . . . 0.0 110.456 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.7 p30 -72.1 -4.71 30.54 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 108.988 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -111.73 31.87 5.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.484 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.79 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.6 m-30 -114.09 78.78 1.18 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.21 -0.932 . . . . 0.0 109.449 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 2.2 pt -90.94 128.02 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.357 -0.839 . . . . 0.0 108.977 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 25' ' ' ILE . 46.2 p -46.49 174.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.857 . . . . 0.0 109.516 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.625 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.82 -46.46 65.6 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.046 -1.034 . . . . 0.0 109.307 -179.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -51.75 -36.07 45.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 108.388 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.686 ' O ' HD12 ' A' ' 33' ' ' LEU . 16.0 mm-40 -60.43 -43.63 96.58 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.464 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -64.12 -34.6 78.41 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 16.5 mt-30 -62.46 -37.57 86.44 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.11 -38.44 79.59 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.461 -0.775 . . . . 0.0 109.658 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.01 -12.62 59.33 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.626 -0.672 . . . . 0.0 110.002 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.88 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 109.98 68.92 0.6 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.716 ' CH2' ' HB2' ' A' ' 37' ' ' ALA . 13.0 t90 -137.01 120.81 17.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -1.136 . . . . 0.0 109.191 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.662 HG13 ' O ' ' A' ' 36' ' ' VAL . 9.8 p -89.85 116.56 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.261 -0.899 . . . . 0.0 108.702 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.716 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . -70.22 83.76 0.54 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.23 -0.919 . . . . 0.0 109.526 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.511 ' O ' ' CZ ' ' A' ' 82' ' ' PHE . 0.6 OUTLIER 167.44 -64.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -0.965 . . . . 0.0 109.516 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.525 ' HB2' ' CG1' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -53.11 -23.1 7.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -0.907 . . . . 0.0 109.503 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.482 ' HA3' ' CD1' ' A' ' 82' ' ' PHE . . . 70.66 74.68 0.67 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.485 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -144.3 28.16 1.37 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.205 -1.173 . . . . 0.0 109.634 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 51' ' ' ILE . 13.0 tp -53.05 -65.94 0.47 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.351 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -46.3 -23.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.433 -0.792 . . . . 0.0 110.056 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -80.19 -40.34 27.4 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.088 -1.007 . . . . 0.0 110.447 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.88 HG11 ' O ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -93.17 -55.18 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.035 -1.041 . . . . 0.0 110.227 -179.409 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -120.76 72.73 22.47 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.959 -1.088 . . . . 0.0 110.01 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.473 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.5 Cg_endo -63.67 -178.66 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.239 1.959 . . . . 0.0 110.343 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 43.29 46.25 6.65 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.485 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 0.4 OUTLIER -149.48 167.13 27.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -1.158 . . . . 0.0 109.43 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.609 ' CB ' ' CE1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -141.89 162.8 34.56 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.356 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.558 HG21 ' HG2' ' A' ' 27' ' ' LYS . 4.8 mm -110.57 117.93 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -0.876 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -161.33 158.17 29.86 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.474 ' HA2' ' OH ' ' A' ' 90' ' ' TYR . . . 95.08 9.5 58.18 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.496 ' OD2' ' CG ' ' A' ' 27' ' ' LYS . 2.4 m-20 -85.92 142.46 28.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -1.152 . . . . 0.0 109.376 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 55' ' ' ILE . 20.8 mm -52.63 149.59 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.946 ' CE2' HD12 ' A' ' 63' ' ' LEU . 49.0 t80 -110.96 144.59 39.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.178 -0.952 . . . . 0.0 109.594 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 3.7 m -43.99 -92.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.831 . . . . 0.0 109.578 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 57' ' ' SER . 8.5 t-20 74.63 5.27 4.47 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.4 -0.813 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -69.98 -26.06 63.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 0.0 109.294 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -80.92 0.2 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.454 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 156.39 40.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.595 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 32.6 mttm -88.07 -8.68 55.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -1.191 . . . . 0.0 109.526 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.946 HD12 ' CE2' ' A' ' 56' ' ' PHE . 22.8 mt -124.47 151.0 66.23 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.404 -0.81 . . . . 0.0 108.866 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.631 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.3 Cg_exo -59.51 85.3 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.143 1.895 . . . . 0.0 110.281 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.492 ' HA2' ' HD3' ' A' ' 69' ' ' ARG . . . -160.02 139.0 5.86 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -104.2 -166.66 1.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -1.15 . . . . 0.0 109.517 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.7 m -68.48 95.0 0.6 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 109.594 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.91 -6.65 4.1 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.492 ' HD3' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -93.82 136.95 33.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -1.165 . . . . 0.0 109.446 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.12 150.25 26.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.26 -0.9 . . . . 0.0 109.425 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.583 ' CE2' ' HB3' ' A' ' 63' ' ' LEU . 36.9 m95 -127.49 140.13 52.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.631 ' CB ' ' CE1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -111.0 125.31 53.6 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.295 -0.878 . . . . 0.0 109.134 179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.891 ' HA ' HD13 ' A' ' 89' ' ' LEU . 2.4 pt-20 -96.88 146.26 25.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 0.0 110.175 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.582 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -133.2 147.99 52.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 1.4 m-20 -70.29 142.93 52.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.59 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.821 HG22 ' OD1' ' A' ' 77' ' ' ASN . 19.5 mm -135.47 141.95 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.861 . . . . 0.0 109.558 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.821 ' OD1' HG22 ' A' ' 76' ' ' ILE . 9.6 m120 61.6 34.58 17.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.252 -0.905 . . . . 0.0 109.7 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.457 ' OH ' ' HB3' ' A' ' 42' ' ' LEU . 56.5 t80 -69.47 143.82 53.41 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.151 -0.968 . . . . 0.0 109.512 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.69 -80.15 0.49 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.446 ' OG ' ' N ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -170.41 179.67 3.31 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.629 -0.67 . . . . 0.0 109.448 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.446 ' N ' ' OG ' ' A' ' 80' ' ' SER . . . 67.05 -149.12 51.0 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.511 ' CZ ' ' O ' ' A' ' 38' ' ' SER . 2.4 m-85 -53.5 164.42 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -1.104 . . . . 0.0 109.552 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 82' ' ' PHE . 1.4 mmm-85 -55.98 -164.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.474 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.12 -172.81 2.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.579 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.82 -1.23 11.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.875 . . . . 0.0 109.589 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 71.0 m-20 -104.96 129.04 53.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 109.519 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.705 ' O ' HG22 ' A' ' 99' ' ' THR . 0.2 OUTLIER -147.23 141.54 26.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.381 -0.824 . . . . 0.0 109.342 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.921 HD11 ' CG2' ' A' ' 96' ' ' ILE . 6.8 tt -102.27 125.27 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 109.313 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.891 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.9 mm? -94.53 99.97 12.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.951 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.631 ' CE1' ' CB ' ' A' ' 72' ' ' ARG . 22.5 p90 -99.36 140.09 34.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.923 -1.111 . . . . 0.0 108.687 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.471 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 8.0 t -108.01 169.53 8.56 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.146 -0.971 . . . . 0.0 110.607 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -65.28 -19.37 65.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.421 -0.8 . . . . 0.0 109.638 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 29.8 p-10 -89.62 16.87 7.1 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.592 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 68.27 30.03 5.75 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.684 -0.635 . . . . 0.0 110.341 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.631 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.8 mt -87.16 101.0 13.07 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.921 ' CG2' HD11 ' A' ' 88' ' ' ILE . 4.1 mt -97.27 115.79 37.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.344 -178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.626 ' HE1' HD22 ' A' ' 95' ' ' LEU . 10.2 m-85 -118.93 161.81 19.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HB3' ' CD1' ' A' ' 7' ' ' PHE . 3.7 ptmt -132.06 143.76 50.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.868 -1.145 . . . . 0.0 110.032 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -130.53 120.55 24.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 108.935 179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.47 HG23 ' HE2' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -103.59 26.69 8.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 0.0 109.857 -179.595 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -147.78 21.86 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.08 -1.012 . . . . 0.0 109.84 179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.525 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 10.6 t-80 77.17 71.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.411 ' OH ' ' OE1' ' A' ' 73' ' ' GLU . 15.0 m-85 50.43 20.35 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.305 -0.872 . . . . 0.0 110.035 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.52 ' CB ' ' OD1' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -86.96 -20.59 27.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.071 -1.018 . . . . 0.0 108.862 179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 35.3 p -144.7 157.35 44.23 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.595 ' CE2' ' HB3' ' A' ' 62' ' ' LYS . 73.4 m-85 -141.29 119.53 12.15 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.001 -1.062 . . . . 0.0 110.034 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 3.1 m -112.88 136.5 52.45 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.426 -0.796 . . . . 0.0 108.939 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -83.58 129.1 34.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.52 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 0.5 OUTLIER -130.24 19.84 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.428 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.371 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.251 0.548 . . . . 0.0 109.548 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.416 ' O ' ' O ' ' A' ' 3' ' ' VAL . 3.9 mm-40 -125.79 95.79 4.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.902 . . . . 0.0 109.555 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.598 HG12 ' H ' ' A' ' 4' ' ' ILE . 1.9 t 51.85 178.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.598 ' H ' HG12 ' A' ' 3' ' ' VAL . 5.5 mt -124.46 78.76 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.226 -0.921 . . . . 0.0 109.613 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -141.9 57.71 1.49 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.323 -0.861 . . . . 0.0 109.357 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.6 ' O ' HD12 ' A' ' 76' ' ' ILE . 3.9 p -144.8 -168.93 3.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.221 -0.925 . . . . 0.0 109.67 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.885 ' CD1' HG21 ' A' ' 76' ' ' ILE . 46.6 m-85 -76.79 -57.61 3.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.872 . . . . 0.0 109.582 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.95 -34.82 71.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.137 -0.977 . . . . 0.0 109.99 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.88 -52.79 26.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.6 HG23 ' H ' ' A' ' 6' ' ' THR . 67.4 t -64.14 -45.6 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -1.149 . . . . 0.0 109.114 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -56.73 -36.55 69.86 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.5 -56.22 17.83 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.492 -0.755 . . . . 0.0 109.023 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.675 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 32.3 t80 -59.19 -21.13 58.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 108.848 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' A' ' 11' ' ' ALA . 3.6 mt -71.01 -61.32 1.8 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -70.98 -8.93 56.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 109.348 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.415 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 86.5 m -85.02 -67.84 0.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.865 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.675 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 98.6 m-85 -95.68 4.17 53.26 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.676 -0.64 . . . . 0.0 109.743 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 16.6 m170 50.92 50.62 18.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.899 . . . . 0.0 109.498 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.2 OUTLIER 171.53 130.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.729 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 20' ' ' LEU . 21.4 mt -44.14 150.39 0.62 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 108.96 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.56 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 8.8 Cg_exo -53.51 162.93 2.94 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.055 1.837 . . . . 0.0 110.535 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.17 -6.87 37.35 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.355 -0.84 . . . . 0.0 109.016 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 27.7 p30 -90.92 -1.07 57.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.281 -0.887 . . . . 0.0 109.506 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.56 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.7 m-85 -92.14 91.58 7.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 109.891 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.549 HD12 ' O ' ' A' ' 26' ' ' THR . 1.6 pp -96.77 118.61 43.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.31 -0.869 . . . . 0.0 108.771 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.549 ' O ' HD12 ' A' ' 25' ' ' ILE . 13.2 p -43.07 166.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.353 -0.842 . . . . 0.0 109.579 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.615 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -64.15 -43.61 94.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.148 -0.97 . . . . 0.0 108.903 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.52 -38.89 64.19 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.742 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.6 mt-10 -58.21 -40.84 82.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.716 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -64.34 -38.81 92.36 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.436 ' HG2' ' CE3' ' A' ' 35' ' ' TRP . 3.5 mm100 -60.05 -36.35 77.12 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.69 -39.16 87.47 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.354 -0.841 . . . . 0.0 109.602 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.8 mp -81.12 -8.03 59.68 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.704 -0.623 . . . . 0.0 110.205 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.06 67.39 0.76 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.716 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 9.4 t90 -136.82 118.94 15.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.157 . . . . 0.0 109.031 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 38' ' ' SER . 16.1 t -89.81 113.55 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.414 -0.804 . . . . 0.0 109.072 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.587 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -59.17 -16.25 19.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.213 -0.929 . . . . 0.0 109.65 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.531 ' H ' HG12 ' A' ' 36' ' ' VAL . 1.3 t -80.1 -31.82 39.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.965 . . . . 0.0 109.444 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.1 OUTLIER -97.01 -9.7 27.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 43.71 45.3 7.15 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.571 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -97.78 45.29 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.102 -1.234 . . . . 0.0 109.82 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.641 HD12 ' CD1' ' A' ' 35' ' ' TRP . 4.5 tp -61.95 -45.21 94.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.07 -1.019 . . . . 0.0 109.48 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.49 -10.38 11.59 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.911 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -105.3 -24.99 12.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.103 -0.998 . . . . 0.0 110.27 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.61 HG23 ' N ' ' A' ' 46' ' ' ALA . 34.8 m -115.03 -49.57 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.963 -1.086 . . . . 0.0 110.051 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.61 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -129.74 62.22 62.32 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 2.2 Cg_endo -61.71 177.9 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.133 1.889 . . . . 0.0 110.176 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 49' ' ' LYS . . . 43.96 60.93 3.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.489 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 4.6 mttt -159.52 123.63 3.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.243 -1.151 . . . . 0.0 109.577 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 1.8 m -90.03 134.81 34.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.365 -0.834 . . . . 0.0 109.616 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.592 HD11 HD21 ' A' ' 42' ' ' LEU . 8.4 mm -96.08 108.76 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.181 -0.95 . . . . 0.0 108.775 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -155.09 167.15 32.75 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.45 -6.96 50.2 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.33 154.35 29.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -1.165 . . . . 0.0 109.245 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.431 ' HA ' HD13 ' A' ' 55' ' ' ILE . 19.5 mm -68.46 142.37 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.847 ' CE2' HD12 ' A' ' 63' ' ' LEU . 10.6 t80 -84.06 108.13 16.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.263 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' PHE . 3.1 t -42.43 -39.61 2.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.321 -0.862 . . . . 0.0 110.121 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 11.9 t-20 51.36 29.67 5.35 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.507 -0.746 . . . . 0.0 109.515 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -45.14 -52.45 9.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.208 -0.932 . . . . 0.0 109.518 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -63.02 -58.24 7.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 0.0 109.418 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' OD1' ' A' ' 58' ' ' ASN . . . 98.88 47.46 1.91 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.469 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -96.74 -2.43 44.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.173 -1.192 . . . . 0.0 109.715 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.847 HD12 ' CE2' ' A' ' 56' ' ' PHE . 58.8 mt -89.5 148.43 40.3 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 108.987 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.87 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.3 Cg_exo -59.69 94.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.08 1.854 . . . . 0.0 110.234 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' CA ' ' HD3' ' A' ' 69' ' ' ARG . . . -164.83 170.25 39.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -72.34 -172.56 0.94 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -1.167 . . . . 0.0 109.52 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.0 m -61.25 88.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 0.0 109.385 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.82 60.81 1.56 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.495 ' HD3' ' CA ' ' A' ' 65' ' ' GLY . 4.7 ttp180 -80.42 163.64 23.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -1.162 . . . . 0.0 109.594 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.68 108.46 19.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.326 -0.859 . . . . 0.0 109.31 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.618 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 10.5 m95 -112.76 166.59 11.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 0.0 109.562 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.629 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -120.49 132.23 55.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 108.745 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.688 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -111.95 153.65 26.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.07 -1.019 . . . . 0.0 110.405 -179.216 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.702 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -141.18 152.56 44.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.502 -0.749 . . . . 0.0 109.19 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 5.7 m-20 -74.54 141.51 44.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 0.0 109.245 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.885 HG21 ' CD1' ' A' ' 7' ' ' PHE . 22.2 mm -135.41 145.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.145 -0.972 . . . . 0.0 109.771 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 65.32 33.84 8.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.472 -0.768 . . . . 0.0 109.81 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.492 ' HA ' ' OD1' ' A' ' 84' ' ' ASN . 17.1 t80 -69.49 137.84 52.9 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.68 -79.88 0.45 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.288 -0.882 . . . . 0.0 109.392 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.83 179.25 6.03 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.739 -0.6 . . . . 0.0 109.475 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.19 -162.95 42.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -53.53 150.68 6.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.204 -1.174 . . . . 0.0 109.394 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.92 173.07 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.686 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 78' ' ' TYR . 0.3 OUTLIER -107.36 -167.97 1.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.334 -0.854 . . . . 0.0 109.401 -179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.1 p -114.62 11.27 16.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.55 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.451 ' C ' ' HG2' ' A' ' 87' ' ' ARG . 42.8 m-20 -96.75 125.67 41.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.056 -1.028 . . . . 0.0 109.52 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -144.65 158.71 43.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.402 -0.811 . . . . 0.0 109.594 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.702 HG22 ' HB3' ' A' ' 74' ' ' ALA . 7.2 tt -122.9 131.58 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.714 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.5 mm? -105.63 96.95 6.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.626 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.629 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 36.3 p90 -92.84 139.74 30.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.898 -1.126 . . . . 0.0 108.559 178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.478 ' OG ' ' CZ ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -105.64 170.53 7.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.138 -0.976 . . . . 0.0 110.565 -178.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.74 -21.37 66.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -0.794 . . . . 0.0 109.388 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' TRP . 54.8 p30 -89.57 17.53 6.3 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.6 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 68.8 29.5 5.12 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.723 -0.611 . . . . 0.0 110.375 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.87 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.5 mt -86.4 96.54 10.05 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.995 HD12 ' HB2' ' A' ' 110' ' ' ARG . 8.7 mt -94.64 111.21 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 110.342 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.512 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 9.7 m-85 -110.52 162.48 14.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -129.8 152.37 49.37 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.98 -1.075 . . . . 0.0 109.329 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.2 118.18 11.19 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.892 . . . . 0.0 109.031 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.36 27.01 8.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.972 . . . . 0.0 109.767 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.1 OUTLIER -145.57 20.21 1.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.478 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.535 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 5.8 t-80 78.8 74.3 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.396 -0.815 . . . . 0.0 109.786 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.492 ' CD1' ' CE1' ' A' ' 56' ' ' PHE . 29.3 m-85 44.64 24.97 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.4 ' N ' ' O ' ' A' ' 102' ' ' HIS . 5.0 mm-40 -94.67 -16.41 23.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.998 . . . . 0.0 108.887 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.5 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 1.4 m -150.28 136.7 18.89 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 98' ' ' LYS . 71.2 m-85 -124.25 131.37 53.52 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.01 -1.056 . . . . 0.0 110.33 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 m -126.11 131.87 52.0 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 4.5 tttt -79.34 128.25 33.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.037 -1.039 . . . . 0.0 109.549 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.3 pt -112.12 -45.14 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 0.0 109.59 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.995 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.462 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.375 0.607 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -160.45 177.52 10.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 109.372 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.58 HG23 ' OD1' ' A' ' 5' ' ' ASN . 29.2 m -105.73 146.43 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.236 -0.915 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 mp -97.65 92.76 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.58 ' OD1' HG23 ' A' ' 3' ' ' VAL . 16.8 p-10 -146.63 60.6 1.21 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.62 ' O ' HD12 ' A' ' 76' ' ' ILE . 14.0 p -144.6 -167.58 2.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.932 . . . . 0.0 109.523 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.993 ' CD1' HG21 ' A' ' 76' ' ' ILE . 37.3 m-85 -79.17 -59.99 2.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.444 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.56 -31.0 67.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.58 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.89 -52.33 29.4 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 6' ' ' THR . 58.0 t -64.6 -44.66 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -1.152 . . . . 0.0 109.138 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -56.06 -38.87 71.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.91 -56.51 16.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.499 -0.751 . . . . 0.0 109.138 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.64 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 22.5 t80 -58.66 -20.21 46.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.045 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.5 mt -73.33 -63.17 1.24 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.458 -0.776 . . . . 0.0 109.001 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.412 ' HG3' HD11 ' A' ' 96' ' ' ILE . 7.2 mt-30 -71.93 -5.96 38.5 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.955 -1.091 . . . . 0.0 109.391 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.0 m -91.15 -66.8 0.9 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.166 -0.959 . . . . 0.0 110.044 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 85.0 m-85 -89.22 -10.93 45.15 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.62 -0.675 . . . . 0.0 109.362 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.496 ' HA ' ' CH2' ' A' ' 94' ' ' TRP . 22.5 m170 62.57 54.61 2.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.392 -0.817 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.1 OUTLIER 162.56 130.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.608 HD11 ' HB2' ' A' ' 74' ' ' ALA . 31.5 mt -43.67 148.51 0.71 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.91 . . . . 0.0 109.116 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 12.0 Cg_exo -51.49 163.49 1.11 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.072 1.848 . . . . 0.0 110.552 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.7 -7.03 35.74 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.357 -0.84 . . . . 0.0 109.057 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.455 ' CG ' ' HB2' ' A' ' 21' ' ' PRO . 5.6 p30 -92.15 2.54 56.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.341 -0.85 . . . . 0.0 109.487 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 50' ' ' SER . 6.8 m-85 -99.24 93.21 5.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.095 -1.003 . . . . 0.0 109.818 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pp -98.77 118.98 46.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.27 -0.894 . . . . 0.0 108.925 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 25' ' ' ILE . 30.0 p -44.58 169.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.19 -0.944 . . . . 0.0 109.303 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -65.53 -44.56 86.51 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.136 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -54.58 -39.61 67.99 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.847 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.3 mt-10 -58.63 -39.92 81.87 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.619 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -65.44 -39.43 92.05 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.144 -0.972 . . . . 0.0 108.443 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 35' ' ' TRP . 9.2 mt-30 -59.77 -35.22 74.2 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.5 -36.18 73.39 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.378 -0.826 . . . . 0.0 109.367 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.847 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.5 mp -81.37 -15.77 54.27 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.703 -0.623 . . . . 0.0 110.205 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 1.035 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 112.49 44.59 0.83 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.619 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 8.6 t90 -109.37 124.48 51.05 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.199 -1.177 . . . . 0.0 109.239 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 38' ' ' SER . 5.4 t -91.08 113.32 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.365 -0.835 . . . . 0.0 109.083 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . -64.6 -10.74 28.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.952 . . . . 0.0 109.491 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 36' ' ' VAL . 1.7 m -90.22 -29.22 18.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.453 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.517 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mttt -103.17 -4.88 23.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.651 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 42.93 62.08 2.42 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -111.75 42.76 1.66 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.143 -1.21 . . . . 0.0 109.415 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 42' ' ' LEU . 10.9 tp -56.77 -60.94 2.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.907 . . . . 0.0 109.581 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -43.56 -24.75 0.12 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.926 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -82.13 -49.44 10.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 110.64 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.035 HG11 ' O ' ' A' ' 34' ' ' GLY . 31.8 m -95.14 -50.83 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.906 -1.121 . . . . 0.0 110.488 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.803 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -117.13 76.8 8.85 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.003 -1.061 . . . . 0.0 109.805 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.8 Cg_endo -62.85 154.23 67.66 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.235 1.956 . . . . 0.0 110.364 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 45.32 73.9 0.25 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.803 ' HD2' ' HB1' ' A' ' 46' ' ' ALA . 2.5 mttp -154.42 123.07 6.18 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.194 -1.18 . . . . 0.0 109.599 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.583 ' HB2' ' CD1' ' A' ' 24' ' ' TYR . 0.8 OUTLIER -89.77 131.97 35.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.878 . . . . 0.0 109.472 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.542 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 11.5 mm -91.16 109.85 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.186 -0.946 . . . . 0.0 109.2 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 74' ' ' ALA . . . -161.92 175.63 38.42 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.498 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 88.32 33.73 10.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' OD1' ' OE2' ' A' ' 73' ' ' GLU . 2.2 p30 -131.05 143.37 50.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -1.225 . . . . 0.0 109.497 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 54' ' ' ASP . 1.1 mp -44.08 147.93 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.832 . . . . 0.0 109.003 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.815 ' CE2' HD12 ' A' ' 63' ' ' LEU . 8.1 t80 -101.63 146.99 26.96 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.311 -0.868 . . . . 0.0 109.211 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 58.0 m -43.31 -91.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.565 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' ' 57' ' ' SER . 6.8 t-20 77.85 19.26 1.14 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.53 -0.731 . . . . 0.0 109.448 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -59.96 -72.26 0.11 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.915 . . . . 0.0 109.391 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -56.41 -30.48 62.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.943 . . . . 0.0 109.292 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.4 63.55 0.9 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 7.5 mtpp -91.76 -3.9 55.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -1.142 . . . . 0.0 109.533 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.815 HD12 ' CE2' ' A' ' 56' ' ' PHE . 28.5 mt -115.07 152.2 46.4 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.282 -0.886 . . . . 0.0 109.175 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.602 ' CG ' ' CZ ' ' A' ' 97' ' ' TYR . 2.9 Cg_endo -61.44 156.65 45.33 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.131 1.887 . . . . 0.0 110.233 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.483 ' HA3' ' HD3' ' A' ' 69' ' ' ARG . . . 135.71 -177.12 19.72 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -109.27 175.99 5.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.264 -1.139 . . . . 0.0 109.384 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.0 m -65.18 108.18 1.8 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 116.79 11.61 9.16 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.483 ' HD3' ' HA3' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -86.08 133.27 33.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -1.14 . . . . 0.0 109.537 179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.35 153.93 18.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.548 ' CE3' HD13 ' A' ' 63' ' ' LEU . 16.4 m95 -137.13 171.51 14.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.509 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 90' ' ' TYR . 8.7 mmt180 -133.06 143.2 49.2 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.391 -0.818 . . . . 0.0 108.819 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.553 ' HA ' HD13 ' A' ' 89' ' ' LEU . 17.3 pt-20 -121.0 149.4 42.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.14 -0.975 . . . . 0.0 110.123 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 20' ' ' LEU . . . -139.53 146.28 39.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.363 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HA ' ' HG3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -65.24 141.17 58.73 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.519 -0.738 . . . . 0.0 109.629 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.993 HG21 ' CD1' ' A' ' 7' ' ' PHE . 23.1 mm -129.47 122.71 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.184 -0.948 . . . . 0.0 109.833 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.759 ' OD1' HG22 ' A' ' 76' ' ' ILE . 5.2 m120 77.48 43.12 0.11 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 109.868 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.507 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 36.6 t80 -70.08 149.25 47.83 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.191 -0.943 . . . . 0.0 109.317 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.79 -78.19 0.16 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.171 -0.956 . . . . 0.0 109.488 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.8 m -165.96 168.66 15.51 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.729 -0.607 . . . . 0.0 109.615 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . 78.21 -179.25 51.94 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' A' ' 39' ' ' LYS . 0.6 OUTLIER -43.61 165.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -1.087 . . . . 0.0 109.431 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -50.66 175.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.562 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 78' ' ' TYR . 1.3 p30 -109.37 -169.17 1.43 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.892 . . . . 0.0 109.471 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.46 9.18 18.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.91 . . . . 0.0 109.508 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.683 ' OD1' HG22 ' A' ' 100' ' ' THR . 61.6 m-20 -107.21 129.24 54.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.523 ' HG3' ' HA ' ' A' ' 75' ' ' ASP . 0.4 OUTLIER -150.02 174.6 12.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.894 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.85 HD11 ' CG2' ' A' ' 96' ' ' ILE . 5.6 tt -137.64 128.68 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.843 . . . . 0.0 109.119 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.74 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.3 mm? -103.29 102.99 12.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.398 -0.814 . . . . 0.0 110.32 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 72' ' ' ARG . 32.1 p90 -99.38 139.94 34.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.999 -1.063 . . . . 0.0 108.559 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.482 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -103.62 173.2 6.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.059 -1.026 . . . . 0.0 110.826 -178.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 p -66.01 -19.9 66.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.509 -0.745 . . . . 0.0 109.483 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 47.5 p-10 -89.58 17.05 6.79 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.598 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 66.89 29.22 8.39 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.726 -0.609 . . . . 0.0 109.989 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.623 HD22 ' HE1' ' A' ' 97' ' ' TYR . 6.9 mt -85.33 99.14 10.96 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.85 ' CG2' HD11 ' A' ' 88' ' ' ILE . 2.6 mt -93.83 116.92 36.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.252 -0.905 . . . . 0.0 110.408 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.623 ' HE1' HD22 ' A' ' 95' ' ' LEU . 7.2 m-85 -116.8 155.58 28.71 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 0.2 OUTLIER -121.49 154.12 37.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.754 -1.217 . . . . 0.0 109.713 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -140.69 125.01 17.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.496 -0.752 . . . . 0.0 108.993 179.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.683 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -110.65 29.38 7.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.909 . . . . 0.0 109.784 -179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.583 ' OD2' HG23 ' A' ' 105' ' ' THR . 0.9 OUTLIER -150.24 21.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.114 -0.991 . . . . 0.0 109.687 179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.52 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 2.2 t-80 76.61 72.34 0.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.203 -0.936 . . . . 0.0 109.261 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.463 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 9.2 m-85 50.33 20.8 0.71 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.384 -0.822 . . . . 0.0 109.739 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.498 ' HB2' ' CB ' ' A' ' 101' ' ' ASP . 1.2 mt-30 -86.87 -19.98 28.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.24 -0.913 . . . . 0.0 109.143 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.583 HG23 ' OD2' ' A' ' 101' ' ' ASP . 34.3 p -146.51 157.5 43.75 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.527 ' CE2' ' HB3' ' A' ' 62' ' ' LYS . 82.6 m-85 -141.98 125.11 16.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 110.042 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -117.0 133.96 55.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.359 -0.838 . . . . 0.0 109.018 179.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -79.73 128.3 33.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.596 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.492 ' O ' ' CB ' ' A' ' 110' ' ' ARG . 6.8 pt -127.85 17.04 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.524 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.252 0.549 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 2' ' ' GLN . 2.8 pt20 -151.92 67.45 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.29 -0.881 . . . . 0.0 109.548 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 m -122.7 160.49 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.505 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.7 mm -91.31 93.66 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.411 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -141.25 53.35 1.55 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.608 ' O ' HD12 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -136.74 -172.76 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.279 -0.888 . . . . 0.0 109.417 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.832 ' CD1' HG21 ' A' ' 76' ' ' ILE . 47.2 m-85 -80.24 -61.96 1.82 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 109.482 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.53 -30.99 67.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 0.0 109.756 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.35 -50.27 45.76 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.563 HG23 ' H ' ' A' ' 6' ' ' THR . 96.7 t -65.89 -45.8 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.304 -1.115 . . . . 0.0 109.294 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -56.93 -35.93 69.62 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.51 -55.68 19.07 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 22.6 t80 -58.61 -23.13 58.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.26 -0.9 . . . . 0.0 109.183 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 11' ' ' ALA . 5.4 mt -71.9 -63.83 1.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.353 -0.842 . . . . 0.0 108.949 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.424 ' HG3' ' HD2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -71.01 -5.04 28.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.102 -0.999 . . . . 0.0 109.364 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 31.2 m -91.93 -69.96 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.177 -0.952 . . . . 0.0 109.844 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.627 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 81.9 m-85 -89.76 -4.82 57.48 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.684 -0.635 . . . . 0.0 109.596 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 21.4 m170 57.51 57.81 4.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.869 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 162.51 129.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.477 HD11 ' OH ' ' A' ' 90' ' ' TYR . 19.0 mt -44.05 148.24 0.82 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 109.287 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 6.5 Cg_exo -55.35 164.49 3.89 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.172 1.915 . . . . 0.0 110.444 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.81 -5.81 33.05 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.306 -0.871 . . . . 0.0 108.868 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.527 ' ND2' ' HB2' ' A' ' 21' ' ' PRO . 23.2 p30 -92.14 9.79 32.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.298 -0.876 . . . . 0.0 109.525 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.55 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 4.6 m-85 -108.14 99.79 9.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.006 . . . . 0.0 109.753 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 2.1 pt -106.46 124.45 61.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 108.725 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 25' ' ' ILE . 20.5 p -47.0 176.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.206 -0.934 . . . . 0.0 109.817 -179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.611 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.19 -44.76 68.05 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.1 -1.0 . . . . 0.0 109.092 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 m -54.49 -39.9 68.0 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.844 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.7 mm-40 -58.67 -39.73 81.52 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.61 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.2 -34.56 77.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -0.897 . . . . 0.0 108.663 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.526 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 18.6 mt-30 -65.95 -30.75 71.37 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.29 -37.87 84.73 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.692 0.758 . . . . 0.0 109.579 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.1 mp -80.93 -8.25 59.7 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.649 -0.657 . . . . 0.0 110.124 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.516 ' O ' HG21 ' A' ' 45' ' ' VAL . . . 103.01 61.77 0.71 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.63 ' CZ2' ' HA ' ' A' ' 37' ' ' ALA . 1.7 t90 -118.55 135.45 54.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.195 -1.179 . . . . 0.0 109.599 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.51 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 3.5 t -89.73 131.66 36.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.63 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -63.09 -8.04 6.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.965 -1.085 . . . . 0.0 110.311 -178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 39' ' ' LYS . 3.0 t -55.26 -17.91 5.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.926 -1.109 . . . . 0.0 109.048 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.577 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 11.3 mtmt 64.59 47.5 2.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -0.809 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.602 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -127.19 -12.8 3.05 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.224 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' C ' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -147.07 27.36 1.05 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.958 -1.319 . . . . 0.0 109.995 -179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.564 HD13 ' CD1' ' A' ' 35' ' ' TRP . 11.7 tp -52.94 -66.58 0.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 0.0 109.111 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.79 -14.64 1.48 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.787 -0.571 . . . . 0.0 110.359 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -78.8 -36.56 42.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.89 -1.131 . . . . 0.0 109.516 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 35' ' ' TRP . 22.0 m -105.49 -1.6 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.188 -0.945 . . . . 0.0 109.503 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' N ' ' HD3' ' A' ' 47' ' ' PRO . . . -150.4 62.69 5.58 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 109.31 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 5.6 Cg_exo -58.42 152.92 50.95 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.203 1.935 . . . . 0.0 110.286 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 49' ' ' LYS . . . 49.8 66.55 2.24 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HD2' HG12 ' A' ' 25' ' ' ILE . 30.7 mmtp -151.88 154.64 36.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.671 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.532 ' HB2' ' CD1' ' A' ' 24' ' ' TYR . 1.8 m -135.34 124.91 25.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.461 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.56 HD11 HD21 ' A' ' 42' ' ' LEU . 11.9 mm -74.64 104.97 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.207 -0.933 . . . . 0.0 109.321 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -151.35 173.21 30.8 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' N ' HD12 ' A' ' 20' ' ' LEU . . . 84.17 15.27 69.83 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.48 154.31 17.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -1.151 . . . . 0.0 109.409 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 55' ' ' ILE . 16.4 mm -70.08 149.67 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.197 -0.939 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.904 ' CE2' HD12 ' A' ' 63' ' ' LEU . 60.6 t80 -118.66 91.3 3.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 109.043 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 26.4 m -69.65 -5.32 23.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.934 . . . . 0.0 109.934 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 56' ' ' PHE . 1.1 t-20 70.74 89.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -60.71 -20.85 62.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.404 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -125.4 -51.45 1.63 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.302 -0.874 . . . . 0.0 109.504 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . 108.82 65.82 0.57 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.401 -1.479 . . . . 0.0 109.401 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.56 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -120.51 -0.48 10.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -1.149 . . . . 0.0 109.756 -179.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.904 HD12 ' CE2' ' A' ' 56' ' ' PHE . 41.1 mt -89.85 145.11 32.65 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.115 -0.991 . . . . 0.0 109.151 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.976 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.8 Cg_endo -60.31 156.23 41.84 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.025 1.816 . . . . 0.0 110.359 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.17 -173.63 22.35 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.0 mttt -114.21 158.72 20.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.13 126.46 18.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.429 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.14 8.67 57.65 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -89.18 132.17 34.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -1.156 . . . . 0.0 109.443 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.0 m -90.96 147.6 23.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.795 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 3.9 m95 -122.93 173.57 7.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.275 -0.891 . . . . 0.0 109.554 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.616 ' HB2' ' CD2' ' A' ' 90' ' ' TYR . 1.1 mmt180 -121.58 148.83 44.0 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.75 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -128.8 153.8 47.06 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.877 -1.139 . . . . 0.0 110.249 -179.304 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -143.05 148.77 37.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.423 -0.798 . . . . 0.0 109.241 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -77.45 124.07 27.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 109.727 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.832 HG21 ' CD1' ' A' ' 7' ' ' PHE . 22.3 mm -110.85 138.86 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.871 . . . . 0.0 109.113 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.65 ' OD1' HG22 ' A' ' 76' ' ' ILE . 14.9 m120 61.58 112.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.069 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 6.8 t80 -170.45 133.95 1.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.062 -1.024 . . . . 0.0 109.674 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -140.9 -79.43 0.27 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.226 -0.921 . . . . 0.0 109.364 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 m -146.14 160.03 42.49 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.716 -0.615 . . . . 0.0 109.436 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.9 -169.15 18.79 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.602 ' CD1' ' HA2' ' A' ' 40' ' ' GLY . 0.3 OUTLIER -64.07 144.45 57.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -1.177 . . . . 0.0 109.485 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.536 ' CD ' ' HG2' ' A' ' 39' ' ' LYS . 5.2 mtm180 -43.97 163.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.202 -0.936 . . . . 0.0 109.219 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -106.84 -171.11 1.82 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.189 -0.944 . . . . 0.0 109.651 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.43 23.28 9.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.493 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.5 m-20 -109.24 132.03 54.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.373 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.592 ' O ' HG23 ' A' ' 99' ' ' THR . 36.8 mtt180 -157.81 157.73 33.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.55 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.973 HD11 HD11 ' A' ' 109' ' ' ILE . 1.5 tt -112.93 139.64 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.245 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 73' ' ' GLU . 3.4 mm? -108.45 126.59 53.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.326 -0.859 . . . . 0.0 109.795 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -116.69 140.05 49.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.857 -1.152 . . . . 0.0 108.666 178.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.451 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 0.8 OUTLIER -108.12 176.01 5.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.193 -0.942 . . . . 0.0 110.379 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.3 p -64.23 -25.2 67.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.408 -0.808 . . . . 0.0 110.441 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.483 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -89.3 16.84 6.76 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.108 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.566 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.4 m95 67.5 29.31 7.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.713 -0.617 . . . . 0.0 110.737 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.976 HD13 ' HG2' ' A' ' 64' ' ' PRO . 8.8 mt -83.79 121.87 27.9 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.544 ' CG1' ' HB2' ' A' ' 110' ' ' ARG . 1.8 mt -115.42 112.82 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.132 -0.98 . . . . 0.0 110.75 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.613 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 26.1 m-85 -112.07 118.66 36.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.484 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -88.88 136.13 33.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.818 -1.176 . . . . 0.0 109.866 -179.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -125.54 131.46 52.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.392 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.2 p -114.75 31.75 6.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.159 -0.963 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -150.26 20.4 0.85 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.205 -0.934 . . . . 0.0 109.565 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.537 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 3.5 t-80 79.08 73.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.496 -0.753 . . . . 0.0 109.971 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 106' ' ' PHE . 5.0 m-85 51.57 37.73 20.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 110.04 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.434 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 19.7 tp60 -104.29 -72.29 0.71 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.135 -0.978 . . . . 0.0 109.052 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 99' ' ' THR . 0.8 OUTLIER -93.16 124.41 37.12 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.56 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 96.7 m-85 -112.17 121.66 45.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.067 -1.021 . . . . 0.0 110.065 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.484 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 3.8 m -108.64 130.81 55.32 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.386 -0.821 . . . . 0.0 109.087 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -79.41 113.8 17.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.047 -1.033 . . . . 0.0 109.668 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.973 HD11 HD11 ' A' ' 88' ' ' ILE . 29.5 pt -113.21 -14.98 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.34 -0.85 . . . . 0.0 109.328 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.544 ' HB2' ' CG1' ' A' ' 96' ' ' ILE . 1.1 mtt-85 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -129.69 118.94 22.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.472 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.98 151.3 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 109.438 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 mp -114.35 87.55 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.934 . . . . 0.0 109.557 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -134.57 49.44 2.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -135.31 -169.93 2.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 0.0 109.443 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.967 ' CE1' HG21 ' A' ' 76' ' ' ILE . 42.6 m-85 -80.14 -59.64 2.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.213 -0.929 . . . . 0.0 109.463 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.51 -28.72 65.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.149 -0.969 . . . . 0.0 109.507 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.37 -51.27 33.03 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 6' ' ' THR . 38.7 t -67.04 -49.36 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -1.153 . . . . 0.0 109.167 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' HA ' HD12 ' A' ' 14' ' ' LEU . . . -53.88 -37.04 63.3 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.27 -55.63 23.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.686 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 23.2 t80 -59.94 -18.3 44.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.429 -0.794 . . . . 0.0 109.03 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.492 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.7 OUTLIER -76.1 -63.82 1.23 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.328 -0.857 . . . . 0.0 109.296 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.422 ' NE2' ' HD3' ' A' ' 110' ' ' ARG . 3.1 pt20 -70.51 -8.49 51.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.906 -1.121 . . . . 0.0 109.353 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.7 m -91.9 -65.7 0.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.782 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.686 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 96.3 m-85 -89.51 3.3 52.88 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.713 -0.617 . . . . 0.0 109.5 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.548 ' HA ' ' CZ2' ' A' ' 94' ' ' TRP . 16.6 m170 45.01 45.48 8.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.304 -0.872 . . . . 0.0 109.523 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.6 OUTLIER 174.43 129.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.454 ' HA ' HD23 ' A' ' 20' ' ' LEU . 18.4 mt -45.46 150.73 0.84 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 108.754 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 10.9 Cg_exo -52.98 160.06 4.61 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.084 1.856 . . . . 0.0 110.453 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -69.59 -5.89 27.52 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.309 -0.87 . . . . 0.0 109.202 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.45 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -93.44 2.87 56.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.336 -0.853 . . . . 0.0 109.628 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.547 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.2 m-85 -93.76 92.72 7.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.002 . . . . 0.0 109.943 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 1.8 pt -100.99 125.3 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.264 -0.897 . . . . 0.0 108.937 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.473 ' H ' HG23 ' A' ' 26' ' ' THR . 12.1 p -45.96 172.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.16 -43.09 71.57 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.179 -1.009 . . . . 0.0 108.964 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -39.1 64.14 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.768 ' O ' HD12 ' A' ' 33' ' ' LEU . 5.5 mt-10 -59.67 -41.31 90.32 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.636 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -65.08 -35.98 82.88 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 0.0 108.63 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.408 ' HG3' ' CE3' ' A' ' 35' ' ' TRP . 13.0 mt-30 -63.03 -36.25 82.95 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.21 -37.22 79.62 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.447 -0.783 . . . . 0.0 109.533 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.768 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.8 mp -81.17 -11.25 59.48 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.365 0.602 . . . . 0.0 110.261 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.764 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 107.68 56.77 0.59 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.636 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 9.8 t90 -127.89 115.48 18.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.26 -1.141 . . . . 0.0 109.025 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 38' ' ' SER . 14.0 t -90.14 112.04 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 108.994 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.588 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -51.83 -20.89 2.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.195 -0.94 . . . . 0.0 109.422 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.55 ' O ' ' CZ ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -83.94 -49.97 8.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.309 -0.869 . . . . 0.0 109.669 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 40' ' ' GLY . 10.0 mttp -67.3 -13.33 61.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 109.607 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 39' ' ' LYS . . . 44.26 93.73 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.599 ' OD1' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -159.86 44.33 0.22 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.248 -1.148 . . . . 0.0 109.444 179.709 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.556 HD21 HD11 ' A' ' 51' ' ' ILE . 9.8 tp -59.54 -52.98 63.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.449 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' A' ' 47' ' ' PRO . . . -56.67 -14.96 3.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.0 109.871 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.83 -53.83 4.43 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.061 -1.024 . . . . 0.0 110.331 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.764 HG11 ' O ' ' A' ' 34' ' ' GLY . 20.4 m -89.88 -48.1 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.125 -0.984 . . . . 0.0 110.16 -179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.61 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -116.85 77.35 8.5 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.993 . . . . 0.0 109.542 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 2.7 Cg_endo -60.92 159.47 29.25 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.21 1.94 . . . . 0.0 110.4 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.85 57.28 4.09 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HD3' HG12 ' A' ' 25' ' ' ILE . 2.9 mmtt -137.65 110.16 7.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -1.141 . . . . 0.0 109.588 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 9.2 m -89.7 133.93 34.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.4 -0.813 . . . . 0.0 109.229 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.556 HD11 HD21 ' A' ' 42' ' ' LEU . 10.2 mm -91.06 111.48 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.102 -0.999 . . . . 0.0 109.176 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -155.91 169.21 33.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.77 12.71 55.25 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.841 -1.303 . . . . 0.0 109.841 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.454 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 5.6 m-20 -104.95 143.86 32.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -1.21 . . . . 0.0 109.38 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.412 ' C ' ' O ' ' A' ' 54' ' ' ASP . 7.3 mt -44.44 152.22 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 0.0 109.571 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.018 ' CE2' HD12 ' A' ' 63' ' ' LEU . 9.9 t80 -92.42 134.12 35.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.139 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 0.4 OUTLIER -44.28 -84.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.276 -0.89 . . . . 0.0 109.482 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 57' ' ' SER . 10.2 t-20 80.63 39.87 0.07 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -48.21 66.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.315 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -76.82 -51.03 12.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -0.898 . . . . 0.0 109.383 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.6 60.56 0.66 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.602 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 8.0 mptt -102.15 -7.5 22.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -1.18 . . . . 0.0 109.64 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.018 HD12 ' CE2' ' A' ' 56' ' ' PHE . 56.2 mt -91.59 140.71 25.32 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.24 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.953 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.2 Cg_exo -61.53 84.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.078 1.852 . . . . 0.0 110.067 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.66 164.29 12.98 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' H ' ' CB ' ' A' ' 69' ' ' ARG . 14.5 mtmt -118.98 169.8 9.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -1.062 . . . . 0.0 109.334 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.6 m -55.73 103.18 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.878 . . . . 0.0 109.453 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 87.6 52.55 2.97 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.4 ' CB ' ' H ' ' A' ' 66' ' ' LYS . 31.9 ttt180 -126.54 159.21 34.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -1.139 . . . . 0.0 109.483 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.58 170.0 10.88 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.157 -0.965 . . . . 0.0 109.615 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.859 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 8.2 m95 -139.79 151.26 45.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.392 -0.818 . . . . 0.0 109.299 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.636 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 10.0 mpt_? -110.75 139.16 46.29 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.202 -0.936 . . . . 0.0 108.671 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.607 ' HA ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -117.77 158.22 25.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.088 -1.008 . . . . 0.0 110.269 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -147.91 152.95 38.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.457 -0.777 . . . . 0.0 109.193 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.3 OUTLIER -75.39 142.6 43.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 109.323 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.967 HG21 ' CE1' ' A' ' 7' ' ' PHE . 16.8 mm -131.14 121.73 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.09 -1.006 . . . . 0.0 109.732 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.509 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER 71.63 116.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 0.0 109.698 179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -170.64 127.77 0.78 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.351 -0.843 . . . . 0.0 109.493 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.453 ' O ' ' CB ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -121.47 -27.91 4.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.939 . . . . 0.0 109.745 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 79' ' ' THR . 0.6 OUTLIER 168.91 -174.35 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.391 -0.818 . . . . 0.0 109.703 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 82' ' ' PHE . . . 67.07 174.7 6.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CZ ' ' O ' ' A' ' 38' ' ' SER . 7.5 m-85 -43.81 152.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -1.15 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.501 ' CB ' ' CZ ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -46.65 171.9 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.279 -0.888 . . . . 0.0 109.407 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 0.9 OUTLIER -106.38 -174.74 2.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 -179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 m -106.37 3.99 28.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 0.0 109.48 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 1.2 m-20 -95.9 129.5 43.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 109.53 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 86' ' ' ASP . 27.2 mtt180 -154.64 178.53 10.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 109.181 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 96' ' ' ILE . 3.7 tt -135.23 150.95 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.095 -1.003 . . . . 0.0 109.261 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.711 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.1 mm? -121.69 109.45 14.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.376 -0.827 . . . . 0.0 109.707 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.636 ' CE2' ' CB ' ' A' ' 72' ' ' ARG . 7.9 p90 -104.55 138.89 40.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 109.302 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.583 ' OG ' ' CH2' ' A' ' 71' ' ' TRP . 1.4 m -107.23 174.3 5.95 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.288 -0.882 . . . . 0.0 110.396 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -65.3 -23.9 67.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 109.593 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.473 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 17.8 p-10 -89.7 18.15 5.82 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.412 -0.805 . . . . 0.0 108.858 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.572 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.4 m95 66.39 29.49 9.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.677 -0.639 . . . . 0.0 110.173 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.953 HD13 ' HG2' ' A' ' 64' ' ' PRO . 5.7 mt -81.03 112.5 18.48 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 178.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.793 HG22 HD11 ' A' ' 88' ' ' ILE . 2.0 mt -109.52 110.83 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 110.782 -178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.49 ' OH ' ' HG3' ' A' ' 64' ' ' PRO . 31.5 m-85 -113.91 113.49 24.92 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.528 ' CG ' ' HB ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -89.36 133.76 34.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.083 -1.011 . . . . 0.0 110.215 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -117.13 128.96 55.65 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.33 28.23 8.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.18 -0.95 . . . . 0.0 109.645 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.791 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.7 OUTLIER -150.18 22.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.251 -0.905 . . . . 0.0 109.463 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.519 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 8.7 t-80 77.54 71.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 109.381 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.432 ' OH ' ' HD2' ' A' ' 87' ' ' ARG . 5.1 m-85 50.76 20.91 0.82 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.378 -0.826 . . . . 0.0 109.752 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.467 ' HB2' ' CB ' ' A' ' 101' ' ' ASP . 1.2 mm-40 -90.33 -17.4 27.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.164 -0.96 . . . . 0.0 108.87 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.791 HG22 ' OD1' ' A' ' 101' ' ' ASP . 14.9 t -143.81 161.5 38.46 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.602 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 99.4 m-85 -148.76 119.72 7.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.817 -1.177 . . . . 0.0 110.223 -179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.528 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 3.8 m -108.96 124.82 51.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.515 -0.741 . . . . 0.0 109.1 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -79.42 101.13 7.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.447 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.449 HG21 ' HE2' ' A' ' 98' ' ' LYS . 38.1 pt -104.63 18.18 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.558 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.789 ' HD2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.456 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' O ' HG13 ' A' ' 3' ' ' VAL . 80.5 mt-30 -112.8 109.8 19.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.434 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 2' ' ' GLN . 1.4 m -155.22 -174.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 mp -106.04 109.49 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -0.885 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -143.76 69.74 1.29 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.516 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.848 ' H ' HG23 ' A' ' 10' ' ' VAL . 1.5 p -149.03 -173.15 4.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.436 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.711 ' CE1' HG21 ' A' ' 76' ' ' ILE . 24.1 m-85 -77.65 -60.29 2.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.272 -0.893 . . . . 0.0 109.429 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -33.97 70.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.69 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.24 -50.3 46.23 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.848 HG23 ' H ' ' A' ' 6' ' ' THR . 76.0 t -66.78 -46.98 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -1.147 . . . . 0.0 109.337 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.69 -38.4 66.97 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.447 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.4 OUTLIER -63.85 -55.77 20.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.518 -0.739 . . . . 0.0 109.246 179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.664 ' CE1' ' CD1' ' A' ' 17' ' ' TYR . 42.0 t80 -58.18 -21.08 45.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.374 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.539 HD12 HG12 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -75.38 -63.87 1.19 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.401 -0.812 . . . . 0.0 109.317 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' OE1' ' CG ' ' A' ' 110' ' ' ARG . 46.8 mt-30 -70.58 -5.72 31.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.034 -1.041 . . . . 0.0 109.389 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 12' ' ' ASP . 82.6 m -94.5 -67.37 0.86 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.678 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.664 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 66.6 m-85 -89.78 3.2 53.59 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.558 -0.714 . . . . 0.0 109.567 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.9 m170 44.14 51.09 7.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.353 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.7 OUTLIER 175.35 129.83 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.786 HD13 ' HD2' ' A' ' 24' ' ' TYR . 15.7 mt -43.84 160.02 0.23 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.117 -0.99 . . . . 0.0 109.417 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 3.3 Cg_exo -55.22 159.23 10.46 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.236 1.957 . . . . 0.0 110.553 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.56 -5.05 30.44 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.374 -0.829 . . . . 0.0 108.947 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 21' ' ' PRO . 6.1 p30 -111.42 32.74 5.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.498 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.786 ' HD2' HD13 ' A' ' 20' ' ' LEU . 1.2 m-30 -115.18 81.06 1.51 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.062 -1.024 . . . . 0.0 109.363 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 29' ' ' GLU . 1.1 pt -88.14 123.35 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.253 -0.905 . . . . 0.0 108.978 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 25' ' ' ILE . 82.8 p -46.92 175.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 0.0 109.335 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.62 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -70.24 -45.32 66.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.997 -1.064 . . . . 0.0 109.052 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -52.08 -33.42 39.24 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.121 -0.987 . . . . 0.0 108.361 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.7 ' O ' HD12 ' A' ' 33' ' ' LEU . 1.5 mm-40 -61.3 -46.53 89.9 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.653 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -62.19 -35.92 80.33 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.522 ' HG3' ' CZ3' ' A' ' 35' ' ' TRP . 33.3 mt-30 -64.45 -33.73 76.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.62 -37.89 85.6 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.358 -0.839 . . . . 0.0 109.334 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.9 mp -81.19 -8.96 59.85 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.741 -0.599 . . . . 0.0 109.972 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' O ' HG21 ' A' ' 45' ' ' VAL . . . 101.67 71.23 0.91 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.653 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 0.8 OUTLIER -128.2 137.69 52.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.18 -1.188 . . . . 0.0 109.441 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.554 HG12 ' OD1' ' A' ' 41' ' ' ASN . 9.8 p -89.58 128.77 41.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -62.59 -9.68 9.66 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.009 -1.057 . . . . 0.0 110.384 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -47.17 -24.76 0.75 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.904 -1.123 . . . . 0.0 109.016 179.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.582 ' O ' ' CG ' ' A' ' 82' ' ' PHE . 2.2 mtmp? 74.6 45.6 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.333 -0.855 . . . . 0.0 109.584 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.521 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -132.88 -30.62 0.48 Allowed Glycine 0 N--CA 1.491 2.33 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.1 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.554 ' OD1' HG12 ' A' ' 36' ' ' VAL . 2.6 p-10 -125.31 29.78 5.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.01 -1.288 . . . . 0.0 110.058 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.838 HD21 HD11 ' A' ' 51' ' ' ILE . 6.9 tp -56.85 -65.66 0.58 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.154 -0.966 . . . . 0.0 109.198 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.29 -9.87 3.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.798 -0.564 . . . . 0.0 110.252 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 3.7 m-20 -78.93 -30.29 44.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.973 -1.079 . . . . 0.0 109.41 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 35' ' ' TRP . 30.8 m -107.61 -14.18 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.341 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 49' ' ' LYS . . . -149.3 65.24 7.83 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.249 -0.907 . . . . 0.0 109.376 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 3.1 Cg_exo -60.97 161.94 20.65 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.2 1.933 . . . . 0.0 110.317 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 51.52 38.34 42.82 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 15.8 mmtt -135.58 113.29 10.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.226 -1.161 . . . . 0.0 109.55 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.599 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -89.68 155.43 19.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.838 HD11 HD21 ' A' ' 42' ' ' LEU . 5.4 mm -103.11 111.66 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.839 . . . . 0.0 109.405 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -154.1 160.09 29.21 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.08 19.91 27.25 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.527 ' HB2' ' CG ' ' A' ' 73' ' ' GLU . 4.5 m-20 -88.13 148.11 24.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -1.199 . . . . 0.0 109.467 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.0 mm -68.68 137.49 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.365 -0.835 . . . . 0.0 109.758 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.929 ' CE2' HD12 ' A' ' 63' ' ' LEU . 78.2 t80 -110.65 89.72 3.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.333 -0.854 . . . . 0.0 108.957 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -62.36 -12.39 20.99 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 0.0 109.952 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.591 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 47.0 t-20 54.81 61.56 2.92 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.587 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -55.14 -73.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.41 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -43.9 -49.03 8.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.309 -0.87 . . . . 0.0 109.472 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' CG ' ' A' ' 58' ' ' ASN . . . 89.14 66.59 1.26 Allowed Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 6.4 mtpt -120.08 -4.51 10.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.505 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.929 HD12 ' CE2' ' A' ' 56' ' ' PHE . 12.7 mt -94.18 147.29 33.13 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.194 -0.941 . . . . 0.0 109.279 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.006 ' HG2' HD13 ' A' ' 95' ' ' LEU . 2.4 Cg_endo -62.03 119.14 6.12 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.139 1.893 . . . . 0.0 110.174 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.34 135.45 2.1 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mtmt -94.5 169.78 9.95 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.222 -1.163 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t -54.13 125.08 17.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.2 -4.63 33.55 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -97.67 153.4 18.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -1.171 . . . . 0.0 109.654 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.89 159.36 25.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.895 . . . . 0.0 109.43 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.746 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 11.5 m95 -128.74 154.11 46.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -0.974 . . . . 0.0 109.54 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 7.3 mmt180 -117.72 148.65 41.81 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.668 ' HA ' HD13 ' A' ' 89' ' ' LEU . 5.9 pt-20 -125.49 155.02 41.19 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.789 -1.194 . . . . 0.0 110.11 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB2' ' OH ' ' A' ' 90' ' ' TYR . . . -144.16 155.59 43.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 0.0 109.416 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.475 ' HA ' ' HD3' ' A' ' 87' ' ' ARG . 3.4 m-20 -80.24 143.44 33.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.209 -0.932 . . . . 0.0 109.601 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.711 HG21 ' CE1' ' A' ' 7' ' ' PHE . 37.3 mm -127.85 119.0 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.215 -0.928 . . . . 0.0 109.561 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 0.7 OUTLIER 73.83 108.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.325 -0.859 . . . . 0.0 109.674 179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.52 ' CE1' ' HA ' ' A' ' 83' ' ' ARG . 23.3 t80 -170.71 118.81 0.52 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.336 -0.852 . . . . 0.0 109.46 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.42 -80.1 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.393 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.8 m -137.19 145.1 43.29 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.726 -0.609 . . . . 0.0 109.385 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 115.2 -174.25 15.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CG ' ' O ' ' A' ' 39' ' ' LYS . 0.3 OUTLIER -61.71 140.69 58.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.158 -1.201 . . . . 0.0 109.426 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.52 ' HA ' ' CE1' ' A' ' 78' ' ' TYR . 45.5 mtp180 -44.04 167.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 109.346 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.42 -176.98 3.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.163 -0.961 . . . . 0.0 109.684 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.8 p -113.5 15.67 18.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.337 -0.852 . . . . 0.0 109.311 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.589 ' OD2' HG22 ' A' ' 100' ' ' THR . 0.7 OUTLIER -97.96 130.45 44.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.225 179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.525 ' CZ ' ' OH ' ' A' ' 103' ' ' TYR . 2.3 mtt180 -152.54 179.57 8.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.152 -0.967 . . . . 0.0 109.481 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.743 HD11 HD11 ' A' ' 109' ' ' ILE . 1.8 tt -138.77 141.39 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.365 -0.835 . . . . 0.0 108.884 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.747 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.3 mm? -111.61 125.09 53.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.365 -0.834 . . . . 0.0 109.667 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.775 ' OH ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -111.3 142.61 43.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.921 -1.112 . . . . 0.0 108.839 179.003 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.504 ' CB ' ' HB2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -110.88 171.77 7.27 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.186 -0.946 . . . . 0.0 110.184 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.0 p -64.59 -25.76 68.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.435 -0.791 . . . . 0.0 109.518 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.483 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 14.1 p-10 -90.01 19.8 4.68 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.583 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.0 27.77 8.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.68 -0.638 . . . . 0.0 110.133 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.006 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.2 mt -79.62 116.78 20.01 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.535 HG22 HD11 ' A' ' 88' ' ' ILE . 2.5 mt -114.6 108.05 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.088 -1.007 . . . . 0.0 110.56 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.567 ' CE1' ' CG ' ' A' ' 64' ' ' PRO . 24.9 m-85 -108.25 116.83 32.69 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.552 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -88.6 137.97 31.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.867 -1.146 . . . . 0.0 109.997 -179.062 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.485 ' HB ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -122.0 127.3 50.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.589 HG22 ' OD2' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -111.89 29.37 7.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.11 -0.994 . . . . 0.0 109.59 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 102' ' ' HIS . 0.4 OUTLIER -150.06 22.44 0.86 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.0 109.726 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.523 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 0.5 OUTLIER 77.42 69.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.215 -0.928 . . . . 0.0 109.442 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.525 ' OH ' ' CZ ' ' A' ' 87' ' ' ARG . 14.8 m-85 49.45 21.81 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.798 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.462 ' HB2' ' OD1' ' A' ' 101' ' ' ASP . 4.8 mt-30 -88.0 -17.29 31.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 108.97 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.485 ' O ' ' HB ' ' A' ' 99' ' ' THR . 23.0 m -147.27 155.79 42.36 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . 90.2 m-85 -139.76 116.44 10.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.973 -1.08 . . . . 0.0 110.11 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 1.7 m -107.65 127.27 53.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 113.95 17.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.037 -1.04 . . . . 0.0 109.646 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.743 HD11 HD11 ' A' ' 88' ' ' ILE . 3.5 pt -109.3 -24.25 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.296 -0.877 . . . . 0.0 109.646 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.425 ' OXT' ' O ' ' A' ' 94' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -73.79 92.16 2.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.963 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 4' ' ' ILE . 2.5 t -80.35 173.84 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.59 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.582 ' H ' HG12 ' A' ' 3' ' ' VAL . 2.7 mp -120.45 96.26 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.437 -0.789 . . . . 0.0 109.339 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -142.67 47.33 1.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.616 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.496 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -136.75 -170.19 2.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.348 179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.75 ' CD1' HG21 ' A' ' 76' ' ' ILE . 52.3 m-85 -77.38 -59.57 2.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.402 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.01 -31.19 67.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.894 . . . . 0.0 109.783 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.503 ' C ' HG23 ' A' ' 4' ' ' ILE . . . -68.56 -51.96 28.31 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.496 HG23 ' H ' ' A' ' 6' ' ' THR . 73.7 t -66.09 -45.91 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.3 -1.118 . . . . 0.0 109.313 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 14' ' ' LEU . . . -55.95 -38.86 70.91 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.49 -55.6 26.0 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.679 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 35.1 t80 -58.06 -22.35 49.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.327 -0.858 . . . . 0.0 109.046 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER -71.61 -62.87 1.25 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.43 -0.794 . . . . 0.0 108.989 179.71 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -71.28 -5.6 33.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.042 -1.036 . . . . 0.0 109.317 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' A' ' 13' ' ' TYR . 25.2 m -89.82 -69.48 0.72 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.952 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.679 ' CD2' ' CE2' ' A' ' 13' ' ' TYR . 77.5 m-85 -89.47 -7.79 54.3 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.626 -0.671 . . . . 0.0 109.463 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 23.1 m170 61.01 57.89 2.42 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -0.843 . . . . 0.0 109.707 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 10.1 ptpt 160.64 129.64 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.467 ' HA ' HD23 ' A' ' 20' ' ' LEU . 30.4 mt -44.46 147.33 1.04 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 108.997 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.567 ' HD2' ' CD2' ' A' ' 24' ' ' TYR . 9.3 Cg_exo -52.41 160.1 3.86 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.043 1.829 . . . . 0.0 110.336 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -7.74 32.54 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.139 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.468 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -91.75 7.33 42.25 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.0 109.596 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.567 ' CD2' ' HD2' ' A' ' 21' ' ' PRO . 2.3 m-85 -98.43 98.44 9.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -0.93 . . . . 0.0 109.677 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 26' ' ' THR . 1.9 pp -106.07 121.34 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.297 -0.877 . . . . 0.0 108.953 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.848 ' O ' HD12 ' A' ' 25' ' ' ILE . 16.8 p -46.35 173.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.667 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -69.87 -44.41 69.86 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.131 -0.98 . . . . 0.0 108.996 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 m -53.5 -38.7 63.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 33' ' ' LEU . 2.3 mm-40 -59.51 -39.35 83.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.736 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -67.55 -37.54 82.85 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.139 -0.976 . . . . 0.0 108.624 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -61.98 -33.02 73.54 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.27 -37.31 74.74 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.437 -0.789 . . . . 0.0 109.358 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 29' ' ' GLU . 3.0 mp -81.17 -15.52 55.51 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.4 0.619 . . . . 0.0 110.181 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.528 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 110.44 44.53 0.98 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.736 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 5.6 t90 -109.19 121.29 44.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -1.104 . . . . 0.0 109.184 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 38' ' ' SER . 4.2 t -89.62 116.31 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.312 -0.867 . . . . 0.0 108.86 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -59.3 -14.02 10.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 0.0 109.75 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.439 ' H ' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -86.64 -29.48 22.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.099 -1.0 . . . . 0.0 109.677 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -92.16 -16.69 25.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.961 . . . . 0.0 109.501 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 51.56 30.0 25.99 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.543 ' O ' HG22 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -85.98 40.99 0.89 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.276 -1.132 . . . . 0.0 109.724 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.641 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 5.9 tp -58.56 -53.39 58.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.542 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -52.22 -19.17 1.86 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.937 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.11 -32.87 15.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.0 110.292 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -103.17 -57.65 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.929 -1.107 . . . . 0.0 109.683 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.841 ' HB1' ' HE2' ' A' ' 49' ' ' LYS . . . -114.12 79.69 5.11 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.228 -0.92 . . . . 0.0 109.423 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 45' ' ' VAL . 1.9 Cg_endo -62.18 156.92 47.49 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.252 1.968 . . . . 0.0 110.197 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.7 69.33 0.63 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.841 ' HE2' ' HB1' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -150.62 116.0 5.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -1.15 . . . . 0.0 109.48 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 24' ' ' TYR . 5.7 m -89.54 132.22 35.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.849 . . . . 0.0 109.437 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.537 ' CG2' ' HG2' ' A' ' 27' ' ' LYS . 15.8 mm -87.17 104.83 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.285 -0.884 . . . . 0.0 109.364 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -157.56 168.42 34.27 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.16 -16.27 38.86 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.73 164.2 23.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.23 -1.159 . . . . 0.0 109.3 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.61 HG22 ' N ' ' A' ' 56' ' ' PHE . 29.9 mm -67.81 166.08 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.922 . . . . 0.0 109.515 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.031 ' CE2' HD12 ' A' ' 63' ' ' LEU . 23.0 t80 -107.34 136.88 46.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.31 -0.869 . . . . 0.0 109.457 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 2.5 m -43.81 -85.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.606 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 57' ' ' SER . 6.8 t-20 80.77 19.75 0.48 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.281 0.562 . . . . 0.0 109.488 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -38.61 78.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.2 -0.937 . . . . 0.0 109.153 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -71.34 -43.48 66.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.312 -0.868 . . . . 0.0 109.318 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.54 47.43 2.54 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.596 ' HB3' ' CD2' ' A' ' 106' ' ' PHE . 0.3 OUTLIER -96.32 -11.38 25.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.146 -1.208 . . . . 0.0 109.449 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.031 HD12 ' CE2' ' A' ' 56' ' ' PHE . 20.9 mt -101.05 152.13 37.8 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.386 -0.821 . . . . 0.0 108.945 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.004 ' HG2' HD13 ' A' ' 95' ' ' LEU . 5.7 Cg_exo -56.52 86.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.058 1.839 . . . . 0.0 110.072 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 66' ' ' LYS . . . -81.44 155.56 36.04 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.674 -1.371 . . . . 0.0 109.674 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 65' ' ' GLY . 15.7 mttt -149.11 161.51 41.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.375 -1.073 . . . . 0.0 109.221 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -47.13 102.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 0.0 109.282 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 79.16 58.55 2.93 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.467 ' NH2' HD12 ' A' ' 95' ' ' LEU . 12.8 tpp180 -106.44 126.82 52.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -1.152 . . . . 0.0 109.715 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.1 m -112.36 99.97 8.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.334 -0.854 . . . . 0.0 109.031 179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.71 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 44.2 m95 -83.56 149.95 26.26 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.157 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.65 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -125.17 144.81 50.26 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.717 ' HA ' HD13 ' A' ' 89' ' ' LEU . 17.2 pt-20 -115.36 159.54 20.95 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.854 -1.154 . . . . 0.0 110.479 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.654 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -146.3 149.58 34.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.468 -0.77 . . . . 0.0 109.297 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.97 138.68 48.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.75 HG21 ' CD1' ' A' ' 7' ' ' PHE . 19.8 mm -129.93 138.13 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.686 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER 73.21 38.0 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.353 -0.842 . . . . 0.0 109.787 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -69.74 139.81 53.38 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.137 -0.977 . . . . 0.0 109.468 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.32 -79.84 0.38 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.238 -0.914 . . . . 0.0 109.504 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.5 163.18 12.48 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.788 -0.57 . . . . 0.0 109.493 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.0 -159.26 52.67 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 83' ' ' ARG . 10.4 m-85 -51.11 147.64 5.16 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -1.124 . . . . 0.0 109.529 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 82' ' ' PHE . 5.5 mtp180 -53.04 -173.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.308 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -118.33 179.77 4.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.57 179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.7 t -100.67 12.81 36.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.324 -0.86 . . . . 0.0 109.327 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.67 ' OD1' HG22 ' A' ' 100' ' ' THR . 50.3 m-20 -104.9 128.86 53.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.354 -0.841 . . . . 0.0 109.55 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.569 ' O ' HG23 ' A' ' 99' ' ' THR . 68.5 mtt180 -153.91 163.69 39.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 0.0 109.139 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.751 ' C ' HD22 ' A' ' 89' ' ' LEU . 4.3 tt -121.89 155.39 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.154 -0.966 . . . . 0.0 109.518 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.751 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.4 mm? -122.36 114.81 21.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.656 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.654 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 3.1 p90 -106.86 139.6 41.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.858 -1.151 . . . . 0.0 109.172 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.563 ' OG ' ' CZ3' ' A' ' 71' ' ' TRP . 1.3 m -110.06 173.7 6.2 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.245 -0.909 . . . . 0.0 110.18 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.3 p -64.77 -25.25 67.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 109.617 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.495 ' OD2' ' HG ' ' A' ' 95' ' ' LEU . 9.8 p-10 -89.73 18.44 5.55 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.415 -0.803 . . . . 0.0 108.971 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.596 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 1.0 OUTLIER 67.45 27.41 8.02 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.743 -0.598 . . . . 0.0 110.233 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 1.004 HD13 ' HG2' ' A' ' 64' ' ' PRO . 6.2 mt -79.57 116.44 19.78 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.661 HG22 HD11 ' A' ' 88' ' ' ILE . 5.9 mt -114.9 105.86 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.43 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.638 ' HE1' HD22 ' A' ' 95' ' ' LEU . 23.0 m-85 -106.05 120.61 42.23 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -89.4 150.58 22.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.945 -1.097 . . . . 0.0 110.191 -178.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -136.42 131.79 34.6 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.67 HG22 ' OD1' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -114.32 6.25 16.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 109.874 -179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.514 ' HB2' ' CB ' ' A' ' 104' ' ' GLN . 0.0 OUTLIER -125.43 24.68 7.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.143 -0.973 . . . . 0.0 109.397 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.6 t-80 76.53 76.01 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.92 . . . . 0.0 109.493 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.488 ' O ' ' CZ ' ' A' ' 106' ' ' PHE . 14.7 m-85 48.93 21.6 0.48 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.875 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.514 ' CB ' ' HB2' ' A' ' 101' ' ' ASP . 0.2 OUTLIER -94.02 -34.87 12.86 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.011 -1.056 . . . . 0.0 109.118 179.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.483 ' O ' ' HB ' ' A' ' 99' ' ' THR . 95.2 m -121.14 140.81 51.49 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.596 ' CD2' ' HB3' ' A' ' 62' ' ' LYS . 94.9 m-85 -134.36 115.55 14.18 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.043 -1.036 . . . . 0.0 110.131 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 97' ' ' TYR . 11.2 m -110.15 137.09 48.38 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.358 -0.839 . . . . 0.0 108.947 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -79.68 114.42 18.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.173 -0.954 . . . . 0.0 109.699 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 110' ' ' ARG . 10.5 pt -132.05 68.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.878 . . . . 0.0 109.281 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 3.5 mtp180 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.382 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.555 ' O ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -138.28 65.5 1.47 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.229 -0.92 . . . . 0.0 109.529 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 2' ' ' GLN . 24.0 m 41.59 -166.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.491 -0.756 . . . . 0.0 109.851 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -116.27 111.04 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.377 -0.827 . . . . 0.0 109.571 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -149.95 54.76 0.93 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.509 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 10' ' ' VAL . 2.2 p -139.16 -168.82 2.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.775 ' CD1' HG21 ' A' ' 76' ' ' ILE . 32.9 m-85 -79.82 -57.7 3.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.619 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.53 -32.46 69.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 0.0 109.792 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.9 -50.04 50.15 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 6' ' ' THR . 35.1 t -66.98 -43.58 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -1.124 . . . . 0.0 109.385 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.51 -37.2 72.62 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.12 -56.32 13.61 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.538 -0.726 . . . . 0.0 109.242 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.638 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 15.8 t80 -60.76 -18.45 54.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.272 -0.892 . . . . 0.0 109.064 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 18' ' ' HIS . 1.2 mt -74.5 -65.61 0.84 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.499 -0.751 . . . . 0.0 108.975 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -70.26 -6.7 36.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.988 -1.07 . . . . 0.0 109.254 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.534 HG22 ' CD1' ' A' ' 17' ' ' TYR . 19.8 m -89.42 -68.48 0.77 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.29 -0.881 . . . . 0.0 109.607 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 96.5 m-85 -92.0 6.42 46.44 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 121.627 -0.671 . . . . 0.0 109.642 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.467 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 19.0 m170 44.97 47.65 9.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.248 -0.908 . . . . 0.0 109.407 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 175.83 129.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 20' ' ' LEU . 27.0 mt -46.03 149.53 1.21 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.196 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.564 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 6.8 Cg_exo -53.93 162.56 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.114 1.876 . . . . 0.0 110.639 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -70.79 -5.71 32.26 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.38 -0.825 . . . . 0.0 109.034 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 21' ' ' PRO . 53.6 p30 -91.75 0.24 57.5 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.869 . . . . 0.0 109.596 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.644 ' OH ' HG21 ' A' ' 10' ' ' VAL . 3.2 m-85 -89.87 107.92 19.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.056 -1.027 . . . . 0.0 109.579 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.957 HD12 ' O ' ' A' ' 26' ' ' THR . 1.7 pp -111.95 115.34 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.911 . . . . 0.0 109.08 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.957 ' O ' HD12 ' A' ' 25' ' ' ILE . 81.7 p -44.59 168.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -0.945 . . . . 0.0 109.307 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.607 ' N ' HG23 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.68 -41.18 88.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.929 -1.107 . . . . 0.0 109.175 179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.05 -47.54 82.82 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 47.2 mm-40 -50.63 -35.19 29.32 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.933 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -70.03 -40.91 74.91 Favored 'General case' 0 C--O 1.202 -1.438 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -60.03 -18.88 49.52 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.345 -1.472 . . . . 0.0 108.01 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 29' ' ' GLU . . . -69.01 -48.0 64.08 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.541 -0.724 . . . . 0.0 111.675 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.811 HD13 ' H ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -81.81 -0.07 41.64 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.928 -1.107 . . . . 0.0 111.713 -178.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.448 ' N ' HD22 ' A' ' 33' ' ' LEU . . . 108.94 25.93 5.45 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.893 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.933 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 10.5 t90 -89.12 123.46 33.41 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.895 -1.356 . . . . 0.0 109.191 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.8 t -91.93 114.51 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.403 -0.811 . . . . 0.0 108.917 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.593 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . . . -60.07 -25.76 65.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.232 -0.917 . . . . 0.0 109.789 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.4 m -81.92 -55.33 4.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -69.08 -8.3 43.95 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.194 -0.941 . . . . 0.0 109.522 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 42.33 86.4 0.01 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -137.36 44.74 2.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -1.183 . . . . 0.0 109.623 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.635 ' CD1' ' CD1' ' A' ' 35' ' ' TRP . 3.7 tp -64.42 -41.01 96.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.344 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 47' ' ' PRO . . . -63.26 -9.22 10.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.321 -0.862 . . . . 0.0 109.921 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -102.67 -36.72 8.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.039 -1.038 . . . . 0.0 110.211 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.581 HG23 ' N ' ' A' ' 46' ' ' ALA . 28.7 m -108.13 -44.93 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.101 -1.0 . . . . 0.0 110.056 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.581 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -128.7 59.95 46.12 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 109.835 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.51 ' HD3' ' N ' ' A' ' 46' ' ' ALA . 1.7 Cg_endo -62.58 171.08 6.04 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.175 1.917 . . . . 0.0 110.253 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.17 52.21 5.07 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.572 ' HG3' HG23 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -139.33 135.98 34.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -1.169 . . . . 0.0 109.557 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.514 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 13.3 m -101.64 121.79 42.68 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.235 -0.916 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.607 HG23 ' N ' ' A' ' 27' ' ' LYS . 11.3 mm -79.58 105.07 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.161 -0.962 . . . . 0.0 108.902 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.576 ' O ' HG22 ' A' ' 26' ' ' THR . . . -140.9 172.03 23.85 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 119.456 -1.354 . . . . 0.0 109.932 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.78 11.65 61.63 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -84.49 146.97 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -1.195 . . . . 0.0 109.392 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.512 HD13 HH11 ' A' ' 72' ' ' ARG . 19.5 mm -70.2 141.4 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.836 ' CE2' HD12 ' A' ' 63' ' ' LEU . 70.6 t80 -119.21 90.92 3.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.313 -0.867 . . . . 0.0 109.447 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -70.31 -4.81 23.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 109.788 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.59 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 4.5 t-20 75.05 91.67 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.22 -69.63 0.13 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.239 -0.913 . . . . 0.0 109.443 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -92.96 -63.87 1.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 0.0 109.396 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 138.8 73.59 0.05 OUTLIER Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -117.12 -3.84 11.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -1.16 . . . . 0.0 109.591 -179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.887 HD22 ' CZ3' ' A' ' 71' ' ' TRP . 23.4 mt -93.32 147.95 34.69 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 109.257 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.999 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.1 Cg_exo -60.89 162.76 17.91 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.108 1.872 . . . . 0.0 110.223 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 121.89 -106.59 1.09 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.32 166.05 28.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.254 -1.145 . . . . 0.0 109.459 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.99 92.78 0.25 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.527 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.86 33.9 1.78 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.81 160.26 19.52 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -1.136 . . . . 0.0 109.429 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.82 103.95 16.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.887 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 8.8 m95 -107.52 161.49 14.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 0.0 109.471 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.647 ' CB ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -117.73 131.25 56.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 0.0 108.819 179.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.808 ' HA ' HD13 ' A' ' 89' ' ' LEU . 3.6 pt-20 -107.44 147.49 30.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.316 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.66 ' HB3' HG22 ' A' ' 88' ' ' ILE . . . -135.17 147.27 49.36 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.442 -0.786 . . . . 0.0 109.185 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.4 OUTLIER -70.78 137.01 49.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.354 -0.841 . . . . 0.0 109.818 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.775 HG21 ' CD1' ' A' ' 7' ' ' PHE . 21.5 mm -132.47 134.58 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.344 -0.847 . . . . 0.0 109.428 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 76' ' ' ILE . 1.1 m-20 69.9 125.33 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.266 -0.896 . . . . 0.0 109.259 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.535 ' C ' ' CD1' ' A' ' 78' ' ' TYR . 6.4 t80 -170.4 136.47 1.33 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.201 -0.937 . . . . 0.0 109.615 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.26 -79.56 0.35 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.382 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -153.79 154.89 34.83 Favored 'General case' 0 C--N 1.294 -1.828 0 O-C-N 121.717 -0.614 . . . . 0.0 109.449 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.9 -171.63 20.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.491 -1.443 . . . . 0.0 109.491 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -57.57 169.07 0.72 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -1.159 . . . . 0.0 109.388 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -56.73 177.14 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.158 -0.964 . . . . 0.0 109.315 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.407 ' OD1' ' O ' ' A' ' 77' ' ' ASN . 0.2 OUTLIER -118.99 -174.05 2.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.875 . . . . 0.0 109.535 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 p -115.22 29.63 7.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.624 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 87' ' ' ARG . 52.9 m-20 -114.14 128.84 56.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.244 -0.91 . . . . 0.0 109.573 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.62 ' O ' HG22 ' A' ' 99' ' ' THR . 2.2 mtt180 -156.73 137.27 13.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.388 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 1.033 HD11 ' CG2' ' A' ' 96' ' ' ILE . 5.1 tt -93.12 126.11 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.117 -0.989 . . . . 0.0 109.258 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.808 HD13 ' HA ' ' A' ' 73' ' ' GLU . 4.0 mm? -95.67 100.36 12.09 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.472 -0.767 . . . . 0.0 109.994 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.654 ' HE1' ' HB2' ' A' ' 74' ' ' ALA . 28.8 p90 -97.54 140.35 32.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.983 -1.073 . . . . 0.0 108.525 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -107.84 172.37 6.87 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.985 -1.072 . . . . 0.0 110.761 -178.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -22.19 66.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.5 -0.75 . . . . 0.0 109.826 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 41.8 p-10 -89.58 17.88 5.97 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.382 -0.824 . . . . 0.0 108.829 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.578 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.8 OUTLIER 67.84 23.96 8.29 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.634 -0.666 . . . . 0.0 110.104 179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.999 HD13 ' HG2' ' A' ' 64' ' ' PRO . 7.2 mt -79.64 101.18 8.2 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 1.033 ' CG2' HD11 ' A' ' 88' ' ' ILE . 5.5 mt -96.5 118.26 42.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.22 -0.925 . . . . 0.0 110.631 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.498 ' O ' HG13 ' A' ' 88' ' ' ILE . 11.9 m-85 -120.11 160.97 21.79 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.585 ' HB2' ' CE1' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -131.79 122.02 25.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.756 -1.215 . . . . 0.0 110.056 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -108.69 131.14 55.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.316 -0.865 . . . . 0.0 109.01 179.349 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 p -115.12 18.15 16.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.641 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.7 OUTLIER -139.18 23.55 2.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER 78.33 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 50.35 20.89 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.808 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.77 -15.23 26.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.114 -0.992 . . . . 0.0 109.076 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.641 HG22 ' OD1' ' A' ' 101' ' ' ASP . 12.5 t -148.78 145.35 27.54 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 62' ' ' LYS . 53.7 m-85 -135.99 111.45 9.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.919 -1.113 . . . . 0.0 110.153 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.531 ' HB ' ' CG ' ' A' ' 98' ' ' LYS . 1.8 m -98.34 131.31 44.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.426 -0.796 . . . . 0.0 108.906 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.402 ' HB2' ' CZ ' ' A' ' 97' ' ' TYR . 76.5 tttt -80.03 122.35 26.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.548 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 109' ' ' ILE . 11.3 pt -119.68 15.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.484 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.574 ' CD ' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.489 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.678 ' O ' HG22 ' A' ' 3' ' ' VAL . 4.6 mt-30 -104.02 145.38 30.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.455 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 2' ' ' GLN . 5.3 m 43.12 -168.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.498 -0.751 . . . . 0.0 109.858 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.646 HD13 ' HB2' ' A' ' 13' ' ' TYR . 13.3 mt -131.86 106.32 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.373 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -144.22 49.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -0.909 . . . . 0.0 109.553 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.751 ' O ' HG23 ' A' ' 10' ' ' VAL . 1.2 p -138.68 -173.82 3.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.92 . . . . 0.0 109.368 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.97 ' CD1' HG21 ' A' ' 76' ' ' ILE . 38.2 m-85 -76.57 -57.08 4.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.292 -0.88 . . . . 0.0 109.576 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -32.09 69.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.179 -0.951 . . . . 0.0 109.875 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.426 ' C ' ' CG2' ' A' ' 4' ' ' ILE . . . -67.59 -52.76 28.15 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 6' ' ' THR . 21.8 t -65.27 -40.71 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -1.14 . . . . 0.0 109.192 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.23 -37.11 76.71 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 1.242 ' OD1' ' NH2' ' A' ' 110' ' ' ARG . 0.7 OUTLIER -65.52 -55.81 15.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.523 -0.736 . . . . 0.0 109.161 179.399 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.646 ' HB2' HD13 ' A' ' 4' ' ' ILE . 38.0 t80 -60.77 -19.24 58.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.185 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.522 ' O ' ' CH2' ' A' ' 94' ' ' TRP . 0.6 OUTLIER -74.94 -60.53 2.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.405 -0.81 . . . . 0.0 109.311 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -71.03 -10.9 60.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.905 -1.122 . . . . 0.0 109.254 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.7 m -89.42 -66.83 0.88 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.298 -0.876 . . . . 0.0 110.411 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 71.0 m-85 -89.38 -6.74 56.35 Favored 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.61 -0.681 . . . . 0.0 109.742 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.496 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 18.5 m170 55.94 58.6 4.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.414 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' CB ' ' O ' ' A' ' 18' ' ' HIS . 0.0 OUTLIER 161.65 131.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.488 HD11 ' OH ' ' A' ' 90' ' ' TYR . 33.3 mt -44.47 150.17 0.69 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.107 -0.996 . . . . 0.0 109.252 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.57 ' HD2' ' CD1' ' A' ' 24' ' ' TYR . 7.4 Cg_exo -53.62 163.27 2.87 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.151 1.901 . . . . 0.0 110.428 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -71.22 -4.88 28.03 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.345 -0.847 . . . . 0.0 109.028 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -95.76 11.76 32.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.871 . . . . 0.0 109.606 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.57 ' CD1' ' HD2' ' A' ' 21' ' ' PRO . 3.1 m-85 -101.77 109.75 21.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.152 -0.967 . . . . 0.0 109.484 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.488 HD12 ' O ' ' A' ' 26' ' ' THR . 1.4 pp -115.73 118.08 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.327 -0.858 . . . . 0.0 108.989 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.488 ' O ' HD12 ' A' ' 25' ' ' ILE . 14.2 p -45.82 171.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.301 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.603 ' HB3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -67.9 -42.94 80.39 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.942 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.6 m -55.43 -41.36 72.68 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.728 ' O ' HD12 ' A' ' 33' ' ' LEU . 11.8 mm-40 -57.11 -40.88 77.93 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.705 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . . . -64.18 -36.84 85.36 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' OE1' ' CE3' ' A' ' 35' ' ' TRP . 6.7 mm100 -60.38 -39.21 86.43 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.31 -35.52 73.94 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.455 -0.778 . . . . 0.0 109.832 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 29' ' ' GLU . 2.7 mp -81.23 -14.02 57.93 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.628 -0.67 . . . . 0.0 110.398 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.888 ' O ' HG11 ' A' ' 45' ' ' VAL . . . 110.77 40.39 1.32 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.705 ' CE3' ' HB3' ' A' ' 30' ' ' ALA . 10.9 t90 -109.92 118.9 37.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.177 -1.19 . . . . 0.0 108.993 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 38' ' ' SER . 26.0 t -91.35 111.33 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.334 -0.854 . . . . 0.0 109.106 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.649 ' HB2' ' CH2' ' A' ' 35' ' ' TRP . . . -57.71 -16.5 11.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.215 -0.928 . . . . 0.0 109.598 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.561 ' H ' HG12 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -77.81 -55.5 5.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 109.538 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 40' ' ' GLY . 22.5 mttm -81.6 -3.05 52.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.667 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 39' ' ' LYS . . . 42.86 85.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.508 ' O ' HG22 ' A' ' 45' ' ' VAL . 1.8 p-10 -134.49 47.17 2.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -1.206 . . . . 0.0 109.623 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.576 HD11 ' CB ' ' A' ' 30' ' ' ALA . 5.8 tp -62.81 -44.95 94.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.185 -0.947 . . . . 0.0 109.666 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.29 -8.1 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 110.128 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 41' ' ' ASN . 32.7 m-20 -101.6 -22.72 14.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.019 -1.051 . . . . 0.0 110.258 -179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.888 HG11 ' O ' ' A' ' 34' ' ' GLY . 17.9 m -121.18 -48.54 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.909 -1.12 . . . . 0.0 110.124 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.524 ' N ' HG23 ' A' ' 45' ' ' VAL . . . -127.55 60.57 44.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.119 -0.988 . . . . 0.0 110.115 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 45' ' ' VAL . 1.7 Cg_endo -62.66 -179.55 0.52 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.172 1.914 . . . . 0.0 110.177 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . 42.44 59.66 3.03 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' HE3' HG21 ' A' ' 25' ' ' ILE . 3.8 mttp -151.51 171.48 17.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -1.157 . . . . 0.0 109.378 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.545 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 19.4 m -137.34 118.9 14.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.564 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.563 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 8.7 mm -76.99 103.64 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.048 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . -147.38 171.2 28.06 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.86 7.87 54.87 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.431 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 9.7 m-20 -79.99 145.12 32.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.145 -1.209 . . . . 0.0 109.313 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.8 mm -69.97 138.05 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.537 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.788 ' CE2' HD12 ' A' ' 63' ' ' LEU . 60.0 t80 -111.52 91.12 3.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.827 . . . . 0.0 109.359 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.02 -5.12 24.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.66 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.576 ' HA ' ' CE2' ' A' ' 56' ' ' PHE . 30.0 t-20 64.91 59.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.945 . . . . 0.0 109.619 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -62.4 -28.87 70.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.91 . . . . 0.0 109.341 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' OE1' ' CB ' ' A' ' 103' ' ' TYR . 2.0 mp0 -78.5 -74.62 0.26 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 0.0 109.375 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.71 48.31 0.3 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . 1.9 mttt -118.52 -7.25 10.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -1.151 . . . . 0.0 109.721 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.795 HD22 ' CZ3' ' A' ' 71' ' ' TRP . 16.9 mt -94.88 146.39 31.29 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.249 -0.907 . . . . 0.0 109.122 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.704 ' HG2' HD13 ' A' ' 95' ' ' LEU . 3.8 Cg_exo -60.35 86.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.059 1.839 . . . . 0.0 110.209 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.473 ' HA2' ' HD3' ' A' ' 69' ' ' ARG . . . -102.2 -171.05 27.2 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.44 -173.43 2.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -1.144 . . . . 0.0 109.573 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.4 m -69.64 88.99 0.53 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.5 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.44 46.63 1.65 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.515 ' NH1' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -121.24 132.86 55.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.345 -1.091 . . . . 0.0 109.433 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.46 165.36 12.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.795 ' CZ3' HD22 ' A' ' 63' ' ' LEU . 23.1 m95 -136.98 165.89 24.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.524 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.608 ' HB3' ' CE2' ' A' ' 90' ' ' TYR . 35.0 mtt180 -132.87 143.78 49.75 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.706 ' HA ' HD13 ' A' ' 89' ' ' LEU . 10.4 pt-20 -121.48 155.39 35.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.972 -1.08 . . . . 0.0 110.459 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB2' ' HE1' ' A' ' 90' ' ' TYR . . . -146.77 148.96 32.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.411 -0.806 . . . . 0.0 109.144 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' HA ' ' HG2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -68.72 133.04 47.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.091 -1.006 . . . . 0.0 109.419 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.97 HG21 ' CD1' ' A' ' 7' ' ' PHE . 26.3 mm -119.46 116.09 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.155 -0.965 . . . . 0.0 109.644 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER 72.49 124.29 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.31 -0.868 . . . . 0.0 109.631 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -170.59 148.06 2.99 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.286 -0.884 . . . . 0.0 109.468 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.98 -79.84 0.49 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.27 -0.894 . . . . 0.0 109.453 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -145.3 171.86 13.97 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.754 -0.591 . . . . 0.0 109.452 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.61 -166.55 43.55 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -62.89 179.36 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.288 -1.125 . . . . 0.0 109.428 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -78.56 164.55 24.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.619 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -104.72 -168.32 1.46 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 0.0 109.299 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.526 ' HB3' ' N ' ' A' ' 102' ' ' HIS . 13.3 m -105.1 16.44 25.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.0 109.649 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 100' ' ' THR . 0.9 OUTLIER -96.66 126.78 42.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.204 -0.935 . . . . 0.0 109.638 179.973 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.619 ' O ' HG22 ' A' ' 99' ' ' THR . 1.9 mtt180 -160.09 150.69 18.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.35 -0.844 . . . . 0.0 109.499 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.827 HD11 HG22 ' A' ' 96' ' ' ILE . 3.3 tt -108.29 156.64 8.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.173 -0.954 . . . . 0.0 109.23 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.727 HD22 ' C ' ' A' ' 88' ' ' ILE . 3.4 mm? -125.95 107.17 10.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.428 -0.795 . . . . 0.0 109.376 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 72' ' ' ARG . 1.6 p90 -102.44 139.02 38.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.795 -1.191 . . . . 0.0 109.025 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.455 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 0.5 OUTLIER -108.12 174.64 5.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.262 -0.899 . . . . 0.0 110.396 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 80.4 p -65.29 -24.68 67.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.515 ' OD2' ' NH1' ' A' ' 69' ' ' ARG . 45.5 p30 -89.76 18.06 5.96 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.592 ' HA ' ' CE3' ' A' ' 94' ' ' TRP . 0.9 OUTLIER 67.02 29.66 7.9 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.725 -0.609 . . . . 0.0 110.048 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 64' ' ' PRO . 9.0 mt -82.21 113.06 19.78 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.827 HG22 HD11 ' A' ' 88' ' ' ILE . 2.0 mt -109.24 114.89 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.873 . . . . 0.0 110.366 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.895 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 26.8 m-85 -121.27 118.63 30.03 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.563 ' HG3' ' HB ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -88.51 117.3 27.35 Favored 'General case' 0 N--CA 1.492 1.632 1 N-CA-C 125.7 5.444 . . . . 0.0 125.7 -179.282 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 87' ' ' ARG . 0.1 OUTLIER -108.69 131.14 55.21 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 124.652 3.387 . . . . 0.0 109.01 -170.31 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 1.9 p -115.12 18.15 16.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.641 ' OD1' HG22 ' A' ' 105' ' ' THR . 0.7 OUTLIER -139.18 23.55 2.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.925 . . . . 0.0 109.678 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.528 ' CB ' ' O ' ' A' ' 101' ' ' ASP . 1.0 OUTLIER 78.33 70.73 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 0.0 109.57 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.671 ' OH ' ' OE2' ' A' ' 73' ' ' GLU . 15.5 m-85 50.35 20.89 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.808 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -92.77 -15.23 26.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.114 -0.992 . . . . 0.0 109.076 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.641 HG22 ' OD1' ' A' ' 101' ' ' ASP . 12.5 t -148.78 145.35 27.54 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.895 ' HB3' ' HB3' ' A' ' 97' ' ' TYR . 53.7 m-85 -135.99 111.45 9.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.919 -1.113 . . . . 0.0 110.153 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.563 ' HB ' ' HG3' ' A' ' 98' ' ' LYS . 1.8 m -98.34 131.31 44.75 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.426 -0.796 . . . . 0.0 108.906 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -80.03 122.35 26.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.548 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.768 HD11 HD11 ' A' ' 88' ' ' ILE . 11.3 pt -119.68 15.85 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.484 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 1.242 ' NH2' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.489 179.975 . . . . . . . . 2 2 . 1 stop_ save_